CatalogNumber,Item Name,CAS Number,Plate Location,Rack Number,M.w.,Solvent ,Formula,SMILES,Solubility,Form,Pathway,Target,Information,URLA1042,Angiotensin II,4474-91-3,A01,L1021-01,1046.2,DMSO,C50H71N13O12,CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N.CC(=O)O,insoluble in DMSO; insoluble in EtOH; ≥100.2 mg/mL in H2O ,,Cardiovascular,Angiotensin Receptor,,https://www.apexbt.com/search.php?catalog=A1042A1198,Levetiracetam,102767-28-2,A02,L1021-01,170.21,DMSO,C8H14N2O2,CCC(C(=O)N)N1CCCC1=O,≥25.4 mg/mL in H2O; ≥27.4 mg/mL in EtOH; ≥8.51 mg/mL in DMSO ,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic drug,https://www.apexbt.com/search.php?catalog=A1198A1206,Daptomycin,103060-53-3,A03,L1021-01,1620.67,DMSO,C72H101N17O26,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,≥81.03 mg/mL in H2O; ≥81.05 mg/mL in DMSO; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Calcium-dependent antibiotic,https://www.apexbt.com/search.php?catalog=A1206A1229,Lansoprazole,103577-45-3,A04,L1021-01,369.36,DMSO,C16H14F3N3O2S,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,insoluble in H2O; ≥10.32 mg/mL in EtOH with ultrasonic; ≥18.47 mg/mL in DMSO ,Free Base,Membrane Transporter/Ion Channel,Proton Pump,"H+,K+-ATPase inhibitor",https://www.apexbt.com/search.php?catalog=A1229A1267,Adapalene,106685-40-9,A05,L1021-01,412.52,DMSO,C28H28O3,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL in DMSO ,Free Base,Others,Others,RAR_ and RAR_ agonist,https://www.apexbt.com/search.php?catalog=A1267A1295,Granisetron HCl,107007-99-8,A06,L1021-01,348.87,DMSO,C18H24N4O·HCl,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl,insoluble in DMSO; ≥17.44 mg/mL in H2O; ≥17.44 mg/mL in DMSO with gentle warming,Hydrochloride,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,https://www.apexbt.com/search.php?catalog=A1295A1296,Exemestane,107868-30-4,A07,L1021-01,296.4,DMSO,C20H24O2,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,insoluble in H2O; ≥14.82 mg/mL in DMSO; ≥15.23 mg/mL in EtOH ,Free Base,Endocrinology and Hormones,Aromatase,"Steroidal aromatase inhibitor,selective and irreversible",https://www.apexbt.com/search.php?catalog=A1296A1307,Letrozole,112809-51-5,A08,L1021-01,285.3,DMSO,C17H11N5,N#CC1=CC=C(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)C=C1,insoluble in EtOH;insoluble in H2O;≥14.265 mg/mL in DMSO ,Free Base,Endocrinology and Hormones,Aromatase,Non-steroidal aromatase inhibitor,https://www.apexbt.com/search.php?catalog=A1307A1313,Gatifloxacin,112811-59-3,A09,L1021-01,375.39,DMSO,C19H22FN3O4,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,insoluble in EtOH; insoluble in H2O; ≥3.75 mg/mL in DMSO with gentle warming,Free Base,DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolone antibiotic,inhibits bacterial TOPO II",https://www.apexbt.com/search.php?catalog=A1313A1334,Mosapride Citrate,112885-42-4,A10,L1021-01,614.02,DMSO,C21H25ClFN3O3·C6H8O7,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥30.7 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Citrate,Neuroscience,5-HT Receptor,5-HT receptor agonist,https://www.apexbt.com/search.php?catalog=A1334A1366,Rocuronium Bromide,119302-91-9,A11,L1021-01,609.68,DMSO,C32H53N2O4·Br,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],≥30.48 mg/mL in DMSO; ≥40.6 mg/mL in H2O; ≥58.4 mg/mL in EtOH ,Bromide,Neuroscience,AChR,TGF-_R I kinase inhibitor,https://www.apexbt.com/search.php?catalog=A1366A1373,Biapenem,120410-24-4,B01,L1021-01,350.39,H2O,C15H18N4O4S,CC1C2C(C(=O)N2C(=C1SC3CN4C=NC=[N+]4C3)C(=O)[O-])C(C)O,≥18.65 mg/mL in H2O with gentle warming; insoluble in DMSO; insoluble in EtOH,,Microbiology & Virology,Antibiotic,Highly broad spectrum antibiotic agent,https://www.apexbt.com/search.php?catalog=A1373A1379,Nelarabine,121032-29-9,B02,L1021-01,297.27,DMSO,C11H15N5O5,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,insoluble in EtOH; ≥14.85 mg/mL in DMSO; ≥2.77 mg/mL in H2O with gentle warming and ultrasonic,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Prodrug of ara-G for T-LBL/T-ALL,https://www.apexbt.com/search.php?catalog=A1379A1402,Gemcitabine HCl,122111-03-9,B03,L1021-01,299.66,DMSO,C9H11F2N3O4·HCI,C1=CN(C(=O)N=C1N)[[C@H]2C([[C@@H]([[C@H](O2)CO)O)(F)F,≥10.1 mg/mL in H2O with ultrasonic; ≥2.64 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.49 mg/mL in H2O ,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,"Inhibits DNA synthesis,deoxycytidine analog",https://www.apexbt.com/search.php?catalog=A1402A1404,Rigosertib sodium salt,1225497-78-8,B04,L1021-01,473.47,DMSO,C21H24NNaO8S,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)[O-].[Na+],≥23.65 mg/mL in DMSO; insoluble in EtOH; ≥52.3 mg/mL in H2O ,Sodium Salt,Cell Cycle/Checkpoint,PLK,Plk1 inhibitor,https://www.apexbt.com/search.php?catalog=A1404A1412,Clofarabine,123318-82-1,B05,L1021-01,303.68,DMSO,C10H11ClFN5O3,C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl,insoluble in H2O; insoluble in EtOH; ≥15.18 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase",https://www.apexbt.com/search.php?catalog=A1412A1425,Losartan Potassium (DuP 753),124750-99-8,B06,L1021-01,461,DMSO,C22H22ClKN6O,ClC1=C(CO)N(C(CCCC)=N1)CC(C=C2)=CC=C2C3=CC=CC=C3C4=N[N-]N=N4.[K+],≥21.35 mg/mL in DMSO; ≥42.9 mg/mL in H2O; ≥47.7 mg/mL in EtOH ,Potassium,Endocrinology and Hormones,RAAS,Angiotensin AT1 receptor antagonist,https://www.apexbt.com/search.php?catalog=A1425A1428,"Fulvestrant (ICI 182,780)",129453-61-8,B07,L1021-01,606.77,DMSO,C32H47F5O3S,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,≥30.35 mg/mL in DMSO; insoluble in H2O; ≥58.9 mg/mL in EtOH ,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,"Estrogen receptor antagonist,high affinity",https://www.apexbt.com/search.php?catalog=A1428A1435,CP-945598 HCl,686347-12-6,B08,L1021-01,546.88,DMSO,C25H25Cl2N7O·HCl,CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N.Cl,≥27.35 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,,GPCR/G protein,Cannabinoid Receptor,"CB1 antagonist,selective and high affinity",https://www.apexbt.com/search.php?catalog=A1435A1447,Cilnidipine,132203-70-4,B09,L1021-01,492.52,DMSO,C27H28N2O7,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,≥24.63 mg/mL in DMSO; insoluble in H2O; ≥6.1 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Blocker of Dual L- and N-type calcium channel,https://www.apexbt.com/search.php?catalog=A1447A1450,Lidocaine,137-58-6,B10,L1021-01,234.34,DMSO,C14H22N2O,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,insoluble in H2O; ≥11.72 mg/mL in DMSO; ≥227.27 mg/mL in EtOH ,Free Base,Neuroscience,Histamine Receptor,Anasthetic and class Ib antiarrhythmic agent,https://www.apexbt.com/search.php?catalog=A1450A1602,"Dexrazoxane HCl (ICRF-187, ADR-529)",149003-01-0,B11,L1021-01,304.73,DMSO,C11H16N4O4·HCl,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl,insoluble in EtOH; ≥15.24 mg/mL in DMSO; ≥16 mg/mL in H2O ,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,"Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent",https://www.apexbt.com/search.php?catalog=A1602A1607,Prasugrel,150322-43-3,C01,L1021-01,373.44,DMSO,C20H20FNO3S,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,insoluble in H2O; insoluble in EtOH; ≥6.22 mg/mL in DMSO ,Free Base,Neuroscience,P2 Receptor,ADP receptor inhibitor,https://www.apexbt.com/search.php?catalog=A1607A1630,"Epothilone B (EPO906, Patupilone)",152044-54-7,C02,L1021-01,507.68,DMSO,C27H41NO6S,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,≥25.4 mg/mL in DMSO; insoluble in H2O; ≥12.44 mg/mL in EtOH ,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule stabilizing macrolide,https://www.apexbt.com/search.php?catalog=A1630A1652,Dimesna,16208-51-8,C03,L1021-01,326.34,DMSO,C4H8Na2O6S4,C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-].[Na+].[Na+],insoluble in EtOH; ≥16.35 mg/mL in DMSO; ≥58.6 mg/mL in H2O ,,Others,Others,Uroprotective agent,https://www.apexbt.com/search.php?catalog=A1652A1659,Dutasteride,164656-23-9,C04,L1021-01,528.53,DMSO,C27H30F6N2O2,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,≥26.43 mg/mL in DMSO; insoluble in EtOH; ≥13.75 mg/mL in H2O with ultrasonic,Free Base,Endocrinology and Hormones,5-alpha Reductase,5-alpha-reductase inhibitor,https://www.apexbt.com/search.php?catalog=A1659A1664,Celecoxib,169590-42-5,C05,L1021-01,381.37,DMSO,C17H14F3N3O2S,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,insoluble in H2O; ≥16.8 mg/mL in EtOH; ≥19.07 mg/mL in DMSO ,Free Base,Neuroscience,COX,Selective cyclooxygenase-2 (COX-2) inhibitor,https://www.apexbt.com/search.php?catalog=A1664A1670,Enzastaurin (LY317615),170364-57-5,C06,L1021-01,515.61,DMSO,C32H29N5O2,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL in DMSO ,Free Base,TGF-_ / Smad Signaling,PKC,"PKC beta inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A1670A1684,Aprepitant,170729-80-3,C07,L1021-01,534.43,DMSO,C23H21F7N4O3,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,≥26.72 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Neuroscience,Substance P/NK1 Receptor,Substance P (SP) inhibitor,https://www.apexbt.com/search.php?catalog=A1684A1718,Posaconazole,171228-49-2,C08,L1021-01,700.78,DMSO,C37H42F2N8O4,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,≥35.04 mg/mL in DMSO; insoluble in H2O; ≥2.55 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,C14_ demethylase,Sterol C14_ demethylase inhibitor,https://www.apexbt.com/search.php?catalog=A1718A1720,"Duvelisib (IPI-145, INK1197)",1201438-56-3,C09,L1021-01,416.86,DMSO,C22H17ClN6O,O=C1N(C([[C@H](C)NC2=C3N=CNC3=NC=N2)=CC4=C1C(Cl)=CC=C4)C5=CC=CC=C5,≥20.84 mg/mL in DMSO; insoluble in H2O; ≥24.9 mg/mL in EtOH ,Free Base,PI3K/Akt/mTOR Signaling,PI3K,PI3K-_/PI3K-_ inhibitor,https://www.apexbt.com/search.php?catalog=A1720A1723,"Roscovitine (Seliciclib,CYC202)",186692-46-6,C10,L1021-01,354.45,DMSO,C19H26N6O,CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C,insoluble in H2O; ≥17.72 mg/mL in DMSO; ≥53.5 mg/mL in EtOH ,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A1723A1736,PA-824,187235-37-6,C11,L1021-01,359.26,DMSO,C14H12F3N3O5,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL in DMSO ,,Others,Others,,https://www.apexbt.com/search.php?catalog=A1736A1745,Galanthamine HBr,1953-04-4,D01,L1021-01,368.27,DMSO,C17H21NO3·HBr,COC1=CC=C2C3=C1O[[C@H]4([H])[[C@H]3(C=C[[C@H](O)C4)CCN(C)C2.Br,insoluble in ETOH; ≥36.9 mg/mL in H2O with gentle warming and ultrasonic; ≥4.60 mg/mL in DMSO ,Hydrobromide,Neuroscience,AChR,Acetylcholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=A1745A1748,Ramelteon,196597-26-9,D02,L1021-01,259.34,DMSO,C16H21NO2,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,insoluble in H2O; ≥12.95 mg/mL in DMSO; ≥54.9 mg/mL in EtOH ,Free Base,GPCR/G protein,MT Receptor,"Agonist of melatonin receptor(M1-M2),highly selective",https://www.apexbt.com/search.php?catalog=A1748A1755,Tenofovir Disoproxil Fumarate,202138-50-9,D03,L1021-01,635.51,DMSO,C19H30N5O10P·C4H4O4,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O,≥31.78 mg/mL in DMSO; ≥2.615 mg/mL in H2O with gentle warming and ultrasonic; ≥8.48 mg/mL in EtOH with ultrasonic,Fumarate,Microbiology & Virology,Reverse Transcriptase,Antiretroviral agent( HIV-1 RT inhibitor),https://www.apexbt.com/search.php?catalog=A1755A1765,Vincristine sulfate,2068-78-2,D04,L1021-01,923.04,DMSO,C46H58N4O14S,O[[C@H]1(CC)CN(CC2)C[[C@H@](C1)([H])C[[C@H](C(OC)=O)(C3=C(OC)C=C(N(C=O)[[C@H]4([H])[[C@H@]56C7[[C@H](C=CCN7CC6)(CC)C(OC(C)=O)[[C@H@]4(C(OC)=O)O)C5=C3)C8=C2C9=CC=CC=C9N8.OS(O)(=O)=O,≥46.15 mg/mL in DMSO; ≥57 mg/mL in EtOH; ≥58.5 mg/mL in H2O ,Sulfate,Cell Cycle/Checkpoint,Microtubule/Tubulin,"Microtubule disrupter,antitumor agent",https://www.apexbt.com/search.php?catalog=A1765A1767,Entecavir Hydrate,209216-23-9,D05,L1021-01,295.29,DMSO,C12H15N5O3·H2O,C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N.O,insoluble in EtOH; insoluble in H2O; ≥9.7 mg/mL in DMSO ,Hydrate,Microbiology & Virology,Reverse Transcriptase,Antiviral drug used in hepatitis B infection,https://www.apexbt.com/search.php?catalog=A1767A1778,Vatalanib (PTK787) 2HCl,212141-51-0,D06,L1021-01,419.73,DMSO,C20H15ClN4·2HCl,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl,≥21 mg/mL in DMSO; ≥24.5 mg/mL in H2O; ≥3.41 mg/mL in EtOH with ultrasonic,Dihydrochloride,Tyrosine Kinase,VEGFR,Tyrosine kinase receptor inhibitor,https://www.apexbt.com/search.php?catalog=A1778A1794,LY2835219,1231930-82-7,D07,L1021-01,602.7,DMSO,C27H32F2N8·CH4O3S,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F.CS(=O)(=O)O,≥30.15 mg/mL in DMSO; ≥55.2 mg/mL in H2O; ≥6.61 mg/mL in EtOH with ultrasonic,Mesylate,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A1794A1796,Mianserin HCl,21535-47-7,D08,L1021-01,300.83,DMSO,C18H20N2·HCl,CN1CC2C3=C(C=CC=C3)CC4=C(C=CC=C4)N2CC1.Cl,≥15.04 mg/mL in DMSO; ≥2.71 mg/mL in H2O with gentle warming and ultrasonic; ≥8.23 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,5-HT2 receptor antagonist,https://www.apexbt.com/search.php?catalog=A1796A1805,Imatinib Mesylate (STI571),220127-57-1,D09,L1021-01,589.71,DMSO,C29H31N7O·CH4SO3,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,≥29.5 mg/mL in DMSO; ≥2.84 mg/mL in EtOH with gentle warming and ultrasonic; ≥49.9 mg/mL in H2O ,Mesylate,TGF-_ / Smad Signaling,Bcr-Abl,Abl/c-kit/PDGFR inhibitor,https://www.apexbt.com/search.php?catalog=A1805A1832,Doxorubicin (Adriamycin) HCl,25316-40-9,D10,L1021-01,579.98,DMSO,C27H29NO11·HCl,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,≥29 mg/mL in DMSO; ≥57.2 mg/mL in H2O; insoluble in EtOH,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,"Antitumour antibiotic,inhibits TOPO II.",https://www.apexbt.com/search.php?catalog=A1832A1835,Pelitinib (EKB-569),257933-82-7,D11,L1021-01,467.92,DMSO,C24H23ClFN5O2,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,insoluble in EtOH; insoluble in H2O; ≥11.7 mg/mL in DMSO ,Free Base,JAK/STAT Signaling,EGFR,"EGFR inhibitor,potent and irreversible",https://www.apexbt.com/search.php?catalog=A1835A1855,Bumetanide,28395-03-1,E01,L1021-01,364.42,DMSO,C17H20N2O5S,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,insoluble in H2O; ≥18.22 mg/mL in DMSO; ≥4.04 mg/mL in EtOH ,Free Base,Membrane Transporter/Ion Channel,NKCC,NKCC cotransporter inhibitor,https://www.apexbt.com/search.php?catalog=A1855A1882,Cediranib (AZD217),288383-20-0,E02,L1021-01,450.51,DMSO,C25H27FN4O3,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,≥22.52 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,VEGFR,"VEGFR inhibitor receptor,highly potent",https://www.apexbt.com/search.php?catalog=A1882A1903,E 64d,88321-09-9,E03,L1021-01,342.43,DMSO,C17H30N2O5,CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C,insoluble in H2O; ≥17.12 mg/mL in DMSO; ≥18.5 mg/mL in EtOH ,Free Base,Proteases,Cathepsin,Cysteine protease inhibitor,https://www.apexbt.com/search.php?catalog=A1903A1906,"Decitabine (NSC127716, 5AZA-CdR)",2353-33-5,E04,L1021-01,228.08,DMSO,C8H12N4O4,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,insoluble in EtOH; ≥11.4 mg/mL in DMSO; ≥23.3 mg/mL in H2O with gentle warming,Free Base,Chromatin/Epigenetics,DNA Methyltransferase,Deoxycytidine analog and cellular diifferentiation inducer,https://www.apexbt.com/search.php?catalog=A1906A1907,5-Azacytidine,320-67-2,E05,L1021-01,244.2,DMSO,C8H12N4O5,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,insoluble in EtOH; ≥12.21 mg/mL in DMSO; ≥13.55 mg/mL in H2O with ultrasonic,Free Base,Chromatin/Epigenetics,DNA Methyltransferase,DNA methyltransferase inhibitor.,https://www.apexbt.com/search.php?catalog=A1907A1929,Macitentan,441798-33-0,E06,L1021-01,588.27,DMSO,C19H20Br2N6O4S,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,≥24.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,GPCR/G protein,Endothelin Receptor,Endothelin (ET)(A) and ET(B) receptor antagonist,https://www.apexbt.com/search.php?catalog=A1929A1932,(-)-Huperzine A,102518-79-6,E07,L1021-01,242.3,DMSO,C15H18N2O,C/C=C1[[C@H@]2(N)C3=C(NC(C=C3)=O)C[[C@H]/1([H])C=C(C)C2,insoluble in H2O; ≥12.12 mg/mL in DMSO; ≥23.13 mg/mL in EtOH ,,Neuroscience,Alzheimer,NMDA receptor antagonist/AChE inhibitor,https://www.apexbt.com/search.php?catalog=A1932A1933,Carfilzomib (PR-171),868540-17-4,E08,L1021-01,719.91,DMSO,C40H57N5O7,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,≥35.99 mg/mL in DMSO; insoluble in H2O; ≥2.64 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Ubiquitination/Proteasome,Proteasome,"Proteasome inhibitor,epoxomicin analog",https://www.apexbt.com/search.php?catalog=A1933A1958,Etomidate,33125-97-2,E09,L1021-01,244.29,DMSO,C14H16N2O2,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,insoluble in H2O; ≥12.212 mg/mL in DMSO; ≥16.87 mg/mL in EtOH ,Free Base,Neuroscience,GABA Receptor,General anesthetic with GABA modulatory and GABA-mimetic actions,https://www.apexbt.com/search.php?catalog=A1958A1971,Etoposide,33419-42-0,E10,L1021-01,588.56,DMSO,C29H32O13,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,≥29.45 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,Topoisomerase,Topo II inhibitor,https://www.apexbt.com/search.php?catalog=A1971A1984,Bendamustine HCl,3543-75-7,E11,L1021-01,394.72,DMSO,C16H21Cl2N3O2·HCl,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,insoluble in H2O; ≥10.4 mg/mL in EtOH; ≥19.74 mg/mL in DMSO ,Hydrochloride,Apoptosis,Apoptosis Inducers,Cytostatic agent for non-Hodgkin lymphomas,https://www.apexbt.com/search.php?catalog=A1984A2025,Plerixafor (AMD3100),110078-46-1,F01,L1021-01,502.78,EtOH,C28H54N8,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,≥25.14 mg/mL in EtOH; insoluble in DMSO; ≥2.9 mg/mL in H2O with gentle warming,Free Base,GPCR/G protein,CXCR,CXCR4 chemokine receptor antagonist,https://www.apexbt.com/search.php?catalog=A2025A2036,Doripenem Hydrate,364622-82-2,F02,L1021-01,438.52,DMSO,C15H24N4O6S2·H2O,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O.O,insoluble in EtOH; ≥10.96 mg/mL in DMSO; ≥9.4 mg/mL in H2O ,Free Base,Microbiology & Virology,Antibiotic,"Injectable antibiotic,ultra-broad spectrum",https://www.apexbt.com/search.php?catalog=A2036A2097,Ifosfamide,3778-73-2,F03,L1021-01,261.09,DMSO,C7H15Cl2N2O2P,C1CN(P(=O)(OC1)NCCCl)CCCl,≥13.05 mg/mL in DMSO; ≥22 mg/mL in H2O; ≥61.5 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Cytostatic agent,https://www.apexbt.com/search.php?catalog=A2097A2133,Saracatinib (AZD0530),379231-04-6,F04,L1021-01,542.03,DMSO,C27H32ClN5O5,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,≥27.1 mg/mL in DMSO; insoluble in EtOH; ≥2.36 mg/mL in H2O with ultrasonic,Free Base,TGF-_ / Smad Signaling,Bcr-Abl,"Src/Abl inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A2133A2149,Bosutinib (SKI-606),380843-75-4,F05,L1021-01,530.45,DMSO,C26H29Cl2N5O3,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,≥26.5 mg/mL in DMSO; insoluble in H2O; ≥2.16 mg/mL in EtOH with ultrasonic,Free Base,TGF-_ / Smad Signaling,Bcr-Abl,Potent Abl/Src kinases,https://www.apexbt.com/search.php?catalog=A2149A2168,"Dovitinib (TKI-258, CHIR-258)",405169-16-6,F06,L1021-01,392.43,DMSO,C21H21FN6O,CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL in DMSO ,,Tyrosine Kinase,FGFR,Multitargeted RTK inhibitor,https://www.apexbt.com/search.php?catalog=A2168A2171,Carboplatin,41575-94-4,F07,L1021-01,371.26,DMSO,C6H12N2O4Pt,>>O=C1C2(CCC2)C(O[Pt]O1)=O.N.N,insoluble in ETOH; ≥42.2 mg/mL in DMSO with gentle warming and ultrasonic; ≥9.28 mg/mL in H2O with gentle warming,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent that forms platinum-DNA adducts.,https://www.apexbt.com/search.php?catalog=A2171A2174,Lenvatinib (E7080),417716-92-8,F08,L1021-01,426.85,DMSO,C21H19ClN4O4,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,≥21.35 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Tyrosine Kinase,VEGFR,VEGFR inhibitor,https://www.apexbt.com/search.php?catalog=A2174A2187,Cladribine,4291-63-8,F09,L1021-01,285.69,DMSO,C10H12ClN5O3,C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,≥41.67 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Apoptosis inducer in CLL cells,https://www.apexbt.com/search.php?catalog=A2187A2197,Dacarbazine,4342-03-4,F10,L1021-01,182.18,DMSO,C6H10N6O,CN(C)NN=C1C(=NC=N1)C(=O)N,insoluble in EtOH; ≥0.54 mg/mL in H2O; ≥2.28 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic( malignant melanoma and sarcomas),https://www.apexbt.com/search.php?catalog=A2197A2198,Genistein,446-72-0,F11,L1021-01,270.24,DMSO,C15H10O5,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,≥13.5 mg/mL in DMSO; insoluble in H2O; ≥2.59 mg/mL in EtOH with gentle warming,Free Base,DNA Damage/DNA Repair,Topoisomerase,ER agonist,https://www.apexbt.com/search.php?catalog=A2198A2251,Tivozanib (AV-951),475108-18-0,G01,L1021-01,454.86,DMSO,C22H19ClN4O5,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,≥22.75 mg/mL in DMSO; insoluble in H2O; ≥2.68 mg/mL in EtOH with gentle warming,Free Base,Tyrosine Kinase,VEGFR,"VEGFR inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A2251A2306,Ellagic acid,476-66-4,G02,L1021-01,302.19,DMSO,C14H6O8,OC1=C(O)C2=C3C(C(OC4=C3C(C(O2)=O)=CC(O)=C4O)=O)=C1,insoluble in H2O; insoluble in EtOH; ≥3.78 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,Topoisomerase,Casein kinase 2 (CK2) inhibitor,https://www.apexbt.com/search.php?catalog=A2306A2308,TAK-438,1260141-27-2,G03,L1021-01,461.46,DMSO,C17H16FN3O2S·C4H4O4,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=CC(=O)O)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO ,,Membrane Transporter/Ion Channel,ATPase,Blocker of potassium-competitive acid,https://www.apexbt.com/search.php?catalog=A2308A2324,Dexamethasone (DHAP),50-02-2,G04,L1021-01,392.46,DMSO,C22H29FO5,O=C1C=C[[C@H@]2(C)C(CC[[C@H@]3([H])[[C@H]2(F)[[C@@H](O)C[[C@H@]4(C)[[C@H@]3([H])C[[C@@H](C)[[C@H@]4(C(CO)=O)O)=C1,insoluble in H2O; ≥19.623 mg/mL in DMSO; ≥5.18 mg/mL in EtOH ,Free Base,Ubiquitination/Proteasome,Autophagy,Glucocorticoidan;anti-inflammatory,https://www.apexbt.com/search.php?catalog=A2324A2343,Cyclophosphamide,50-18-0,G05,L1021-01,261.09,DMSO,C7H15Cl2N2O2P,C1CNP(=O)(OC1)N(CCCl)CCCl,≥11.85 mg/mL in H2O with gentle warming and ultrasonic; ≥13.05 mg/mL in DMSO; ≥50.8 mg/mL in EtOH ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Nitrogen mustard alkylating agent and prodrug.,https://www.apexbt.com/search.php?catalog=A2343A2355,Mercaptopurine (6-MP),50-44-2,G06,L1021-01,152.18,DMSO,C5H4N4S,C1=NC2=C(N1)C(=S)N=CN2,insoluble in EtOH; insoluble in H2O; ≥7.61 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Purine synthesis inhibitor,https://www.apexbt.com/search.php?catalog=A2355A2402,Floxuridine,50-91-9,G07,L1021-01,246.19,DMSO,C9H11FN2O5,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,≥12.31 mg/mL in DMSO; ≥19.53 mg/mL in EtOH; ≥85.5 mg/mL in H2O ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic antimetabolite,https://www.apexbt.com/search.php?catalog=A2402A2415,Acitretin,55079-83-9,G08,L1021-01,326.43,DMSO,C21H26O3,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,insoluble in EtOH; insoluble in H2O; ≥16.32 mg/mL in DMSO ,Free Base,Others,RAR/RXR,Metabolite of etretinate,https://www.apexbt.com/search.php?catalog=A2415A2431,Acarbose,56180-94-0,G09,L1021-01,645.6,DMSO,C25H43NO18,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,≥22.35 mg/mL in DMSO; insoluble in EtOH; ≥51 mg/mL in H2O ,Free Base,Others,Others,Alpha-glucosidase inhibitor,https://www.apexbt.com/search.php?catalog=A2431A2436,Fluoxetine HCl,56296-78-7,G10,L1021-01,345.79,DMSO,C17H18F3NO·HCl,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl,insoluble in H2O; ≥17.3 mg/mL in DMSO; ≥32.2 mg/mL in EtOH ,Hydrochloride,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective",https://www.apexbt.com/search.php?catalog=A2436A2451,Epirubicin HCl,56390-09-1,G11,L1021-01,579.98,DMSO,C27H29NO11·HCl,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,≥29.00 mg/mL in DMSO; ≥10.12 mg/mL in EtOH with gentle warming and ultrasonic; ≥40.33 mg/mL in H2O with gentle warming,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,Antibiotic antitumor agent,https://www.apexbt.com/search.php?catalog=A2451A2456,Pamidronate Disodium,57248-88-1,H01,L1021-01,279.03,H2O,C3H9NNa2O7P2,O=P([O-])(O)C(CCN)(P([O-])(O)=O)O.[Na+].[Na+],insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL in H2O ,Disodium,Others,Others,Bisphosphonate antiresorptive agent & bone resorption inhibitor,https://www.apexbt.com/search.php?catalog=A2456A2476,Idarubicin HCl,57852-57-0,H02,L1021-01,533.95,DMSO,C26H28ClNO9,O=C(C1=C2C(O)=C3C([[C@@H](O[[C@H]4([H])O[[C@@H](C)[[C@@H](O)[[C@@H](N)C4)C[[C@H](O)(C(C)=O)C3)=C1O)C5=CC=CC=C5C2=O.Cl,≥26.7 mg/mL in DMSO; insoluble in EtOH; ≥2.39 mg/mL in H2O with ultrasonic,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,"Anthracycline and daunorubicin analog,topoisomerase inhibitor",https://www.apexbt.com/search.php?catalog=A2476A2486,Malotilate,59937-28-9,H03,L1021-01,288.38,DMSO,C12H16O4S2,CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C,insoluble in H2O; ≥14.419 mg/mL in DMSO; ≥25.83 mg/mL in EtOH ,Free Base,Metabolism,5-Lipoxygenase,Stimulates hepatocyte regeneration,https://www.apexbt.com/search.php?catalog=A2486A2489,Leucovorin Calcium,6035-45-6,H04,L1021-01,601.58,H2O,C20H31CaN7O12,O=C1C(N2C([H])=O)=C(NCC2CNC3=CC=C(C(N[[C@@H](CCC([O-])=O)C([O-])=O)=O)C=C3)NC(N)=N1.O.O.O.O.[Ca+2].O,insoluble in DMSO; insoluble in EtOH; ≥15.04 mg/mL in H2O with gentle warming,Calcium,Metabolism,Folate Analogue,Derivative of folic acid,https://www.apexbt.com/search.php?catalog=A2489A2510,Ampicillin,69-52-3,H05,L1021-01,371.4,DMSO,C16H18N3NaO4S,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+],≥18.57 mg/mL in H2O; ≥73.6 mg/mL in DMSO; ≥75.2 mg/mL in EtOH ,Sodium,Microbiology & Virology,Antibiotic,_-lactam antibiotic,https://www.apexbt.com/search.php?catalog=A2510A2511,"Carbenicillin, Disodium Salt",4800-94-6,H06,L1021-01,422.4,DMSO,C17H16N2O6SNa2,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],insoluble in EtOH; ≥8.64 mg/mL in DMSO with gentle warming and ultrasonic; ≥80.8 mg/mL in H2O ,,Microbiology & Virology,Antibiotic,"Inhibits the cell-wall synthesis,antibiotic",https://www.apexbt.com/search.php?catalog=A2511A2512,Chloramphenicol,56-75-7,H07,L1021-01,323.13,DMSO,C11H12Cl2N2O5,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],≥16.16 mg/mL in DMSO; ≥16.25 mg/mL in H2O with gentle warming and ultrasonic; ≥33 mg/mL in EtOH ,Free Base,Microbiology & Virology,Antibiotic,Inhibits translation(blocking peptidyl transferase),https://www.apexbt.com/search.php?catalog=A2512A2513,"Geneticin, G-418 Sulfate",108321-42-2,H08,L1021-01,692.71,H2O,C20H40N4O10·2H2SO4,CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O.OS(=O)(=O)O.OS(=O)(=O)O,insoluble in EtOH; insoluble in DMSO; ≥64.6 mg/mL in H2O ,,Microbiology & Virology,Antibiotic,Aminoglycosidic antibiotic,https://www.apexbt.com/search.php?catalog=A2513A2514,Gentamycin Sulfate,1405-41-0,H09,L1021-01,1506.80,H2O,C60H127N15O26S,C[[C@H]1(O)CO[[C@H](O[[C@H]2[[C@H](N)C[[C@H](N)[[C@@H](O[[C@H]3O[[C@H@]([H])([[C@@H](C)NC)CC[[C@H]3N)[[C@@H]2O)[[C@H](O)[[C@H]1NC.C[[C@H]4(O)CO[[C@H](O[[C@H]5[[C@H](N)C[[C@H](N)[[C@@H](O[[C@H]6O[[C@H](CN)CC[[C@H]6N)[[C@@H]5O)[[C@H](O)[[C@H]4NC.C[[C@H]7(O)CO[[C@H](O[[C@H]8[[C@H](N)C[[C@H](,≥51.1 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Free Base,Microbiology & Virology,Antibiotic,Aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=A2514A2515,Hygromycin B,31282-04-9,H10,L1021-01,527.5,DMSO,C20H37N3O13,CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N,≥26.38 mg/mL in H2O; ≥5.35 mg/mL in EtOH; ≥9.14 mg/mL in DMSO ,Free Base,Microbiology & Virology,Antibiotic,Suitable for mammalian cell selection,https://www.apexbt.com/search.php?catalog=A2515A2516,Kanamycin Sulfate,25389-94-0,H11,L1021-01,582.58,H2O,C18H36N4O11·H2SO4,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O,≥29.13 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO,Sulfate,Microbiology & Virology,Antibiotic,Water-soluble antibiotic,https://www.apexbt.com/search.php?catalog=A2516A2517,Tetracycline Hydrochloride,64-75-5,A01,L1021-02,480.90,DMSO,C22H25ClN2O8,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,insoluble in EtOH; ≥12.02 mg/mL in DMSO with gentle warming; ≥57.7 mg/mL in H2O ,Hydrochloride,Microbiology & Virology,Antibiotic,Bacteriostatic antibiotics,https://www.apexbt.com/search.php?catalog=A2517A2547,Vortioxetine (Lu AA21004) HBr,960203-27-4,A02,L1021-02,379.36,DMSO,C18H22N2S·HBr,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br,insoluble in H2O; ≥50 mg/mL in DMSO; ≥5.44 mg/mL in EtOH with ultrasonic,HBr,Neuroscience,5-HT Receptor,"5-HT receptor modulator, antidepressant and anxiolytic",https://www.apexbt.com/search.php?catalog=A2547A2548,Carmofur,61422-45-5,A03,L1021-02,257.26,DMSO,C11H16FN3O3,CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,insoluble in H2O; ≥10.5 mg/mL in EtOH with ultrasonic; ≥12.2 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"Cytostatic derivative of fluorouracilm,antineoplatic agent",https://www.apexbt.com/search.php?catalog=A2548A2552,Quercetin dihydrate,6151-25-3,A04,L1021-02,338.27,DMSO,C15H10O7·2H2O,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O.O.O,≥33.8 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,PI3K/Akt/mTOR Signaling,PI3K,,https://www.apexbt.com/search.php?catalog=A2552A2553,Fluvoxamine maleate,61718-82-9,A05,L1021-02,434.41,DMSO,C14H18F3N2O2·C4H4O4,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O,≥21.72 mg/mL in DMSO; ≥2.78 mg/mL in H2O with gentle warming and ultrasonic; ≥56.7 mg/mL in EtOH ,Maleate,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective,antidepressant",https://www.apexbt.com/search.php?catalog=A2553A2559,Altretamine,645-05-6,A06,L1021-02,210.28,DMSO,C9H18N6,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,insoluble in H2O; ≥36.3 mg/mL in DMSO with ultrasonic; ≥8.85 mg/mL in EtOH ,,DNA Damage/DNA Repair,DNA Alkylating,Antineoplastic agent,https://www.apexbt.com/search.php?catalog=A2559A2574,Aprotinin,9087-70-1,A07,L1021-02,6511.44,H2O,C284H432N84O79S7,CC(O)=O.CC.CC.CCccC.[R].[P].[2H].[L].[E].[P].[P].[Y].[3H].[G].[KH].[R].[R].[Y].F.[Y].[*].[L].F.[V].[Y].[G].[G].[R].[KH].[R].N.N.F.[KH].S.[*].[2H].[R].[G].[G].[*].[KH].[*].[3H].C.[*].F.[P].[*].I.I.N.[Q].[3H].[M],≥195 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Free Base,Proteases,Serine Protease,Inhibitor of bovine pancreatic trypsin,https://www.apexbt.com/search.php?catalog=A2574A2575,Bestatin,58970-76-6,A08,L1021-02,308.37,DMSO,C16H24N2O4,CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O,insoluble in H2O; insoluble in EtOH; ≥12.34 mg/mL in DMSO ,,Proteases,Aminopeptidase,Aminopeptidase inhibitor,https://www.apexbt.com/search.php?catalog=A2575A2577,Batimastat (BB-94),130370-60-4,A09,L1021-02,477.64,DMSO,C23H31N3O4S2,CNC([[C@@H](NC([[C@@H]([[C@H](CSC1=CC=CS1)C(NO)=O)CC(C)C)=O)CC2=CC=CC=C2)=O,≥23.88 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,MMP,MMP inhibitor,https://www.apexbt.com/search.php?catalog=A2577A2586,Nafamostat Mesylate(FUT-175),82956-11-4,A10,L1021-02,539.59,DMSO,C19H17N5O2·2CH4O3S,CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,≥27 mg/mL in DMSO; ≥54 mg/mL in H2O; insoluble in EtOH,Mesylate,Proteases,Serine Protease,Serine protease inhibitor,https://www.apexbt.com/search.php?catalog=A2586A2587,PMSF,329-98-6,A11,L1021-02,174.2,DMSO,C7H7FO2S,C1=CC=C(C=C1)CS(=O)(=O)F,insoluble in H2O; ≥17.4 mg/mL in DMSO; ≥28.3 mg/mL in EtOH ,Free Base,Proteases,Serine Protease,"Serine proteinases inhibitor, irreversible",https://www.apexbt.com/search.php?catalog=A2587A2600,(-)-Epigallocatechin gallate (EGCG),989-51-5,B01,L1021-02,458.37,DMSO,C22H18O11,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,≥22.9 mg/mL in DMSO; ≥10.9 mg/mL in H2O with ultrasonic; ≥6.76 mg/mL in EtOH with ultrasonic,#N/A,TGF-_ / Smad Signaling,PKC,"Antioxidant, antiangiogenic and antitumor agent",https://www.apexbt.com/search.php?catalog=A2600A2610,Fenbendazole,43210-67-9,B02,L1021-02,299.35,DMSO,C15H13N3O2S,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,insoluble in EtOH; insoluble in H2O; ≥7.48 mg/mL in DMSO ,Free Base,Others,Others,For pinworm treatment in animals,https://www.apexbt.com/search.php?catalog=A2610A2614,Bortezomib (PS-341),179324-69-7,B03,L1021-02,384.24,DMSO,C19H25BN4O4,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL in DMSO ,,Ubiquitination/Proteasome,Proteasome,,https://www.apexbt.com/search.php?catalog=A2614A2664,VX-661,1152311-62-0,B04,L1021-02,520.5,DMSO,C26H27F3N2O6,CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,≥21.8 mg/mL in DMSO; insoluble in EtOH; ≥24.3 mg/mL in H2O ,,Membrane Transporter/Ion Channel,CFTR,,https://www.apexbt.com/search.php?catalog=A2664A2782,Amonafide,69408-81-7,B05,L1021-02,283.33,DMSO,C16H17N3O2,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,insoluble in EtOH; insoluble in H2O; ≥14.17 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,Topoisomerase,"DNA intercalator,Topo II inhibitor",https://www.apexbt.com/search.php?catalog=A2782A2813,Ivermectin,70288-86-7,B06,L1021-02,875.09,DMSO,C48H74O14,C/C([[C@@H](O[[C@H]1C[[C@H](OC)[[C@@H](O[[C@H]2C[[C@H](OC)[[C@@H](O)[[C@H](C)O2)[[C@H](C)O1)[[C@@H](C)/C=C/C=C(CO3)/[[C@H@]([[C@H@]3([H])[[C@H](O)C(C)=C4)(O)[[C@@H]4C5=O)=C\C[[C@@H]6C[[C@H](O5)C[[C@H@]7(O[[C@H@]([[C@@H](C)CC)([H])[[C@@H](C)CC7)O6,≥43.75 mg/mL in DMSO; insoluble in H2O; ≥19.8 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,P2X purinergic receptor,NAChR/purinergic P2X4 receptor modulator,https://www.apexbt.com/search.php?catalog=A2813A2842,Melatonin,73-31-4,B07,L1021-02,232.28,DMSO,C13H16N2O2,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,≥23.2 mg/mL in DMSO; insoluble in H2O; ≥79.9 mg/mL in EtOH,Free Base,Others,Others,Melatonin receptors agonist,https://www.apexbt.com/search.php?catalog=A2842A2845,Omeprazole,73590-58-6,B08,L1021-02,345.42,DMSO,C17H19N3O3S,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,insoluble in H2O; insoluble in EtOH; ≥17.27 mg/mL in DMSO,Free Base,Ubiquitination/Proteasome,Autophagy,"H+,K+-ATPase inhibitor",https://www.apexbt.com/search.php?catalog=A2845A2852,Leflunomide,75706-12-6,B09,L1021-02,270.21,DMSO,C12H9F3N2O2,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,≥83.33 mg/mL in DMSO; insoluble in H2O; ≥18.57 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,"AHR agonist,immunosuppressive agent",https://www.apexbt.com/search.php?catalog=A2852A2877,Camptothecin,7689-03-4,B10,L1021-02,348.35,DMSO,C20H16N2O4,O=C(N(CC1=CC(C=CC=C2)=C2N=C13)C3=C4)C(CO5)=C4[[C@H@](O)(CC)C5=O,insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL in DMSO,,DNA Damage/DNA Repair,Topoisomerase,,https://www.apexbt.com/search.php?catalog=A2877A2884,Doxazosin Mesylate,77883-43-3,B11,L1021-02,547.58,DMSO,C23H25N5O5·CH4O3S,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O,insoluble in EtOH; insoluble in H2O; ≥13.69 mg/mL in DMSO with gentle warming,Mesylate,GPCR/G protein,Adrenergic Receptor,_1-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=A2884A2890,Nepafenac,78281-72-8,C01,L1021-02,254.28,DMSO,C15H14N2O2,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N,insoluble in EtOH; insoluble in H2O; ≥9.95 mg/mL in DMSO,Free Base,Neuroscience,COX,COX-1 and COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=A2890A2917,Flumazenil,78755-81-4,C02,L1021-02,303.29,DMSO,C15H14FN3O3,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,insoluble in H2O; insoluble in EtOH; ≥15.16 mg/mL in DMSO,Free Base,Neuroscience,GABA Receptor,Benzodiazepine antagonist,https://www.apexbt.com/search.php?catalog=A2917A2942,Masitinib (AB1010),790299-79-5,C03,L1021-02,498.64,DMSO,C28H30N6OS,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,≥24.95 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,c-Kit,"Tyrosine kinase inhibitor, potent and selective",https://www.apexbt.com/search.php?catalog=A2942A2949,Linifanib (ABT-869),796967-16-3,C04,L1021-02,375.41,DMSO,C21H18FN5O,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL in DMSO,,Tyrosine Kinase,VEGFR,VEGFR/PDGFR inhibitor,https://www.apexbt.com/search.php?catalog=A2949A2960,Loratadine,79794-75-5,C05,L1021-02,382.88,DMSO,C22H23ClN2O2,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,insoluble in H2O; ≥19.14 mg/mL in DMSO; ≥21.85 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,Peripheral HH1R antagonist,https://www.apexbt.com/search.php?catalog=A2960A2974,Foretinib (GSK1363089),849217-64-7,C06,L1021-02,632.65,DMSO,C34H34F2N4O6,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,≥31.65 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,VEGFR,VEGF and HGF receptor inhibitor,https://www.apexbt.com/search.php?catalog=A2974A2977,"Cabozantinib (XL184, BMS-907351)",849217-68-1,C07,L1021-02,501.51,DMSO,C28H24FN3O5,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,≥25.08 mg/mL in DMSO; insoluble in H2O; ≥20.65 mg/mL in EtOH,Free Base,Tyrosine Kinase,c-MET,VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor,https://www.apexbt.com/search.php?catalog=A2977A3001,PCI-32765 (Ibrutinib),936563-96-1,C08,L1021-02,440.5,DMSO,C25H24N6O2,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,≥22.02 mg/mL in DMSO; insoluble in H2O; ≥10.4 mg/mL in EtOH with ultrasonic,Free Base,Angiogenesis,BTK,Bruton's tyrosine kinase (BTK) inhibitor,https://www.apexbt.com/search.php?catalog=A3001A3002,ABT-888 (Veliparib),912444-00-9,C09,L1021-02,244.3,DMSO,C13H16N4O,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,insoluble in H2O; ≥10.6 mg/mL in EtOH with ultrasonic; ≥6.11 mg/mL in DMSO,Free Base,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,https://www.apexbt.com/search.php?catalog=A3002A3003,MDV3100 (Enzalutamide),915087-33-1,C10,L1021-02,464.4,DMSO,C21H16F4N4O2S,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,≥23.22 mg/mL in DMSO; insoluble in H2O; ≥9.44 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,https://www.apexbt.com/search.php?catalog=A3003A3004,"Vemurafenib (PLX4032, RG7204)",918504-65-1,C11,L1021-02,489.93,DMSO,C23H18ClF2N3O3S,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,≥24.5 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,MAPK Signaling,MEK1/2,BRAF kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3004A3005,"CAL-101 (Idelalisib, GS-1101)",870281-82-6,D01,L1021-02,415.43,DMSO,C22H18FN7O,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,insoluble in H2O; ≥2.1 mg/mL in EtOH with gentle warming and ultrasonic; ≥80.2 mg/mL in DMSO,Free Base,PI3K/Akt/mTOR Signaling,PI3K,PI3K inhibitor,https://www.apexbt.com/search.php?catalog=A3005A3007,ABT-263 (Navitoclax),923564-51-6,D02,L1021-02,974.61,DMSO,C47H55ClF3N5O6S3,CC(CC1)(C)CC(CN2CCN(C3=CC=C(C(NS(C4=CC=C(N[[C@@H](CSC5=CC=CC=C5)CCN6CCOCC6)C(S(C(F)(F)F)(=O)=O)=C4)(=O)=O)=O)C=C3)CC2)=C1C7=CC=C(Cl)C=C7,≥48.73 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Apoptosis,Bcl-2 Family,"Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w",https://www.apexbt.com/search.php?catalog=A3007A3009,Sorafenib,284461-73-0,D03,L1021-02,464.82,DMSO,C21H16ClF3N4O3,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,≥23.25 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,MAPK Signaling,Raf,Raf kinases and tyrosine kinases inhibitor,https://www.apexbt.com/search.php?catalog=A3009A3012,Ruxolitinib (INCB018424),941678-49-5,D04,L1021-02,306.37,DMSO,C17H18N6,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,insoluble in H2O; ≥15.32 mg/mL in DMSO; ≥17.53 mg/mL in EtOH,Free Base,Chromatin/Epigenetics,JAK,JAK inhibitor,https://www.apexbt.com/search.php?catalog=A3012A3017,Dasatinib (BMS-354825),302962-49-8,D05,L1021-02,488.01,DMSO,C22H26ClN7O2S,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,≥24.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,TGF-_ / Smad Signaling,Bcr-Abl,Src and BCR-Abl inhibitor,https://www.apexbt.com/search.php?catalog=A3017A3018,Trametinib (GSK1120212),871700-17-3,D06,L1021-02,615.39,DMSO,C26H23FIN5O4,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5,insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL in DMSO,Free Base,MAPK Signaling,MEK1/2,"MEK1 and MEK2 inhibitor, potent and selective",https://www.apexbt.com/search.php?catalog=A3018A3020,(R)-Crizotinib,877399-52-5,D07,L1021-02,450.34,DMSO,C21H22Cl2FN5O,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL in DMSO,Free Base,Tyrosine Kinase,c-MET,"C-MET/ALK inhibitor,potent and ATP-competitve",https://www.apexbt.com/search.php?catalog=A3020A3021,GDC-0449 (Vismodegib),879085-55-9,D08,L1021-02,421.3,DMSO,C19H14Cl2N2O3S,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,≥21.08 mg/mL in DMSO; insoluble in H2O; ≥4.96 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Stem Cell,Hedgehog,"Hedgehog antagonist,potent and selective",https://www.apexbt.com/search.php?catalog=A3021A3022,Pazopanib (GW-786034),444731-52-6,D09,L1021-02,437.52,DMSO,C21H23N7O2S,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,insoluble in EtOH; insoluble in H2O; ≥10.95 mg/mL in DMSO,Hydrochloride,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3022A3139,Abacavir,136470-78-5,D10,L1021-02,286.33,DMSO,C14H18N6O,C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N,≥39.3 mg/mL in EtOH with gentle warming; ≥57 mg/mL in DMSO; ≥7.16 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Inhibitor of HIV reverse transcriptase,https://www.apexbt.com/search.php?catalog=A3139A3142,Acamprosate calcium,77337-73-6,D11,L1021-02,400.48,H2O,C10H20CaN2O8S2,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],≥40 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist and modulator of glutamatergic systems,https://www.apexbt.com/search.php?catalog=A3142A3145,Afatinib dimaleate,850140-73-7,E01,L1021-02,718.08,DMSO,C32H33ClFN5O11,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,≥35.9 mg/mL in DMSO; ≥147.2 mg/mL in H2O; ≥6.39 mg/mL in EtOH with gentle warming and ultrasonic,Salt,Tyrosine Kinase,HER2,EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3145A3151,Alarelin Acetate,79561-22-1,E02,L1021-02,1287.42,DMSO,C60H86N16O16,CC/N=C(O)/[[C@H]1([H])CCCN1C([[C@H](/N=C(O)/[[C@H](/N=C(O)/[[C@H@](/N=C(O)/[[C@H](/N=C(O)/[[C@H](/N=C(O)/[[C@H](/N=C(O)/[[C@H](/N=C(O)/C2([H])CCC(O)=N2)([H])CC3=CN=CN3)([H])CC4=CNC5=CC=CC=C45)([H])CO)([H])CC6=CC=C(O)C=C6)([H])C)([H])CC(C)C)([H])CCCNC(N)=N)=O.CC(O)=O.CC(O,≥128.7 mg/mL in DMSO; ≥128.6 mg/mL in EtOH; ≥128.8 mg/mL in H2O,,Endocrinology and Hormones,GnRH,,https://www.apexbt.com/search.php?catalog=A3151A3153,Aliskiren,173334-57-1,E03,L1021-02,551.77,DMSO,C30H53N3O6,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,insoluble in H2O; ≥13.93 mg/mL in EtOH; ≥23.35 mg/mL in DMSO,,Others,Renin,Direct renin inhibitor,https://www.apexbt.com/search.php?catalog=A3153A3156,Alogliptin Benzoate,850649-62-6,E04,L1021-02,461.51,DMSO,C25H27N5O4,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O,≥46.2 mg/mL in DMSO; ≥3.02 mg/mL in EtOH with gentle warming and ultrasonic; ≥46.2 mg/mL in H2O with gentle warming,,Proteases,DPP-4,"DPP-4 inhibitor,selective and potent,antidiabetic drug",https://www.apexbt.com/search.php?catalog=A3156A3159,Alosetron Hydrochloride,122852-69-1,E05,L1021-02,330.81,DMSO,C17H19ClN4O,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,insoluble in EtOH; ≥16.54 mg/mL in DMSO; ≥46.4 mg/mL in H2O with gentle warming,,Neuroscience,5-HT Receptor,"5-HT3 receptor antagonist,potent and highly selective",https://www.apexbt.com/search.php?catalog=A3159A3162,Alvimopan,156053-89-3,E06,L1021-02,424.53,DMSO,C25H32N2O4,C[[C@H@]1([H])CN(C[[C@H](/C(O)=N/CC(O)=O)([H])CC2=CC=CC=C2)CC[[C@H]1(C3=CC(O)=CC=C3)C,insoluble in H2O; insoluble in EtOH; ≥25.7 mg/mL in DMSO,,Endocrinology and Hormones,Opioid Receptor,Mu-opioid receptors antagonist,https://www.apexbt.com/search.php?catalog=A3162A3176,Ampalex,154235-83-3,E07,L1021-02,241.29,DMSO,C14H15N3O,C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2,≥13.45 mg/mL in DMSO; ≥24.1 mg/mL in H2O with gentle warming; ≥92 mg/mL in EtOH,#N/A,Membrane Transporter/Ion Channel,AMPAR,Ampakine and nootropic,https://www.apexbt.com/search.php?catalog=A3176A3177,AN-2690,174671-46-6,E08,L1021-02,151.93,DMSO,C7H6BFO2,B1(C2=C(CO1)C=C(C=C2)F)O,≥3.72 mg/mL in H2O with gentle warming; ≥7.05 mg/mL in DMSO; ≥88.6 mg/mL in EtOH,,Microbiology & Virology,Antibiotic,Antifungal agent,https://www.apexbt.com/search.php?catalog=A3177A3178,AN-2728,906673-24-3,E09,L1021-02,251.05,DMSO,C14H10BNO3,N#CC1=CC=C(OC2=CC=C3C(COB3O)=C2)C=C1,insoluble in H2O; ≥12.55 mg/mL in DMSO; ≥94.4 mg/mL in EtOH,,Metabolism,PDE,"PDE4 inhibitor,anti-inflammatory compound",https://www.apexbt.com/search.php?catalog=A3178A3179,Anamorelin,249921-19-5,E10,L1021-02,546.7,DMSO,C31H42N6O3,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N,insoluble in H2O; ≥20.52 mg/mL in EtOH; ≥91.4 mg/mL in DMSO,#N/A,GPCR/G protein,GHSR,"Ghrelin receptor agonist, synthetic, orally active",https://www.apexbt.com/search.php?catalog=A3179A3191,Ascomycin(FK 520),104987-12-4,E11,L1021-02,792.01,DMSO,C43H69NO12,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)C)C,≥38.9 mg/mL in DMSO; insoluble in H2O; ≥98.6 mg/mL in EtOH,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=A3191A3195,Asunaprevir (BMS-650032),630420-16-5,F01,L1021-02,748.29,DMSO,C35H46ClN5O9S,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,≥37.41 mg/mL in DMSO; insoluble in H2O; ≥48.6 mg/mL in EtOH,,Proteases,HCV Protease,NS3 protease inhibitor,https://www.apexbt.com/search.php?catalog=A3195A3209,AXL1717,477-47-4,F02,L1021-02,414.41,DMSO,C22H22O8,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,≥20.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Tyrosine Kinase,IGF1R,,https://www.apexbt.com/search.php?catalog=A3209A3221,Bardoxolone methyl,218600-53-4,F03,L1021-02,505.69,DMSO,C32H43NO4,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,≥25.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,JAK,"IKK inhibitor, potent antioxidant inflammation modulator",https://www.apexbt.com/search.php?catalog=A3221A3222,Baricitinib phosphate,1187595-84-1,F04,L1021-02,469.41,DMSO,C16H20N7O6PS,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O,insoluble in EtOH; insoluble in H2O; ≥172.6 mg/mL in DMSO,,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor,https://www.apexbt.com/search.php?catalog=A3222A3233,Bazedoxifene acetate,198481-33-3,F05,L1021-02,530.65,DMSO,C32H38N2O5,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O,insoluble in H2O; ≥182 mg/mL in DMSO; ≥8.483 mg/mL in EtOH with gentle warming and ultrasonic,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor modulator,https://www.apexbt.com/search.php?catalog=A3233A3242,Bitopertin,845614-11-1,F06,L1021-02,543.46,DMSO,C21H20F7N3O4S,CC(C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F,insoluble in H2O; ≥17.94 mg/mL in EtOH; ≥88.9 mg/mL in DMSO with ultrasonic,#N/A,Membrane Transporter/Ion Channel,GlyT1,Glycine reuptake inhibitor(GlyT1),https://www.apexbt.com/search.php?catalog=A3242A3244,Bivalirudin Trifluoroacetate,128270-60-0,F07,L1021-02,2180.29,DMSO,C98H138N24O33,CC[[C@H]([[C@H@](/N=C(O)/[[C@H](/N=C(O)/[[C@H](/N=C(O)/[[C@H](/N=C(O)/[[C@H](/N=C(O)/C/N=C(O)/[[C@H](/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/[[C@H]1([H])CCCN1C([[C@H](/N=C(O)/[[C@H]2([H])CCCN2C([[C@H@](N)([H])CC3=CC=CC=C3)=O)([H])CCCNC(N)=N)=O)([H])CC(O)=N)([H])CC(O)=O)([H,≥54.5 mg/mL in DMSO with gentle warming; ≥10.18 mg/mL in EtOH with gentle warming and ultrasonic; ≥43.5 mg/mL in H2O with gentle warming,,Proteases,Thrombin,Reversible thrombin inhibitor,https://www.apexbt.com/search.php?catalog=A3244A3261,Boceprevir,394730-60-0,F08,L1021-02,519.68,DMSO,C27H45N5O5,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,≥25.98 mg/mL in DMSO; insoluble in H2O; ≥89.8 mg/mL in EtOH,Free Base,Proteases,HCV Protease,"HCV protease inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3261A3271,Calcipotriol,112965-21-6,F09,L1021-02,412.60,DMSO,C27H40O3,O[[C@@H]1C/C(C([[C@@H](O)C1)=C)=C/C=C2[[C@H@](CC[[C@H]3([H])[[C@H](C)/C=C/[[C@@H](O)C4CC4)([H])[[C@H]3(C)CCC/2,≥16.7 mg/mL in DMSO ,,Vitamin D Related,VD/VDR,"Vitamin D3 analog,regulates cell differentiation and proliferation",https://www.apexbt.com/search.php?catalog=A3271A3278,Capsaicin,404-86-4,F10,L1021-02,293.40,DMSO,C17H27NO3,OC1=CC=C(CNC(CCCCCCCC)=O)C=C1OC,insoluble in H2O; ≥15.27 mg/mL in DMSO; ≥52.3 mg/mL in EtOH with gentle warming,Free Base,Apoptosis,Apoptosis Inducers,TRPV1 receptor agonist,https://www.apexbt.com/search.php?catalog=A3278A3282,Cariprazine,839712-12-8,F11,L1021-02,427.41,DMSO,C21H32Cl2N4O,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,≥21.05 mg/mL in EtOH with gentle warming; ≥3.22 mg/mL in H2O with gentle warming and ultrasonic; ≥7.12 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,"D2/D3 partial agonist,antipsychotic drug",https://www.apexbt.com/search.php?catalog=A3282A3298,Cetirizine,83881-51-0,G01,L1021-02,388.89,DMSO,C21H25ClN2O3,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,insoluble in EtOH; ≥122 mg/mL in H2O; ≥19.44 mg/mL in DMSO,Free Base,Neuroscience,Histamine Receptor,Antihistamine,https://www.apexbt.com/search.php?catalog=A3298A3308,Choline Fenofibrate,856676-23-8,G02,L1021-02,421.91,DMSO,C22H28ClNO5,CC(C([O-])=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C.C[N+](C)(CCO)C,≥106.6 mg/mL in H2O; ≥55.8 mg/mL in EtOH with gentle warming; ≥8.44 mg/mL in DMSO with gentle warming,,Immunology/Inflammation,I_B/IKK,Choline salt of fenofibric acid,https://www.apexbt.com/search.php?catalog=A3308A3313,Cinacalcet,226256-56-0,G03,L1021-02,357.41,DMSO,C22H22F3N,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,≥20.9 mg/mL in DMSO; insoluble in H2O; ≥68.5 mg/mL in EtOH,Free Base,GPCR/G protein,Calcimimetic Agent,"Calcimimetic agent,orally active",https://www.apexbt.com/search.php?catalog=A3313A3315,Clemizole,442-52-4,G04,L1021-02,325.84,DMSO,C19H20ClN3,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl,insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥95.8 mg/mL in EtOH,#N/A,Neuroscience,Histamine Receptor,H1 histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3315A3316,Clemizole hydrochloride,1163-36-6,G05,L1021-02,362.3,DMSO,C19H21Cl2N3,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl.Cl,≥15.13 mg/mL in EtOH with gentle warming and ultrasonic; ≥18.12 mg/mL in DMSO; ≥5.12 mg/mL in H2O with gentle warming and ultrasonic,,Neuroscience,HCV; HCV Protease; Histamine Receptor,H1 histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3316A3317,Clozapine N-oxide (CNO),34233-69-7,G06,L1021-02,342.82,DMSO,C18H19ClN4O,C[N+]1(CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl)[O-],insoluble in EtOH; ≥17.15 mg/mL in DMSO; ≥49 mg/mL in H2O with gentle warming,#N/A,Neuroscience,5-HT Receptor,"Metabolite of clozapine, used in chemogenetics.",https://www.apexbt.com/search.php?catalog=A3317A3320,CO-1686 (AVL-301),1374640-70-6,G07,L1021-02,555.55,DMSO,C27H28F3N7O3,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,≥27.8 mg/mL in DMSO; insoluble in H2O; ≥4.68 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,JAK/STAT Signaling,EGFR,EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3320A3321,Cobimetinib,934660-93-2,G08,L1021-02,531.31,DMSO,C21H21F3IN3O2,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,≥26.55 mg/mL in DMSO; insoluble in H2O; ≥33.53 mg/mL in EtOH with gentle warming,Free Base,MAPK Signaling,MEK1/2,Selective MEK inhibitor,https://www.apexbt.com/search.php?catalog=A3321A3324,Colchicine,64-86-8,G09,L1021-02,399.44,DMSO,C22H25NO6,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,≥19.97 mg/mL in DMSO; ≥45.5 mg/mL in H2O with gentle warming; ≥50.8 mg/mL in EtOH with gentle warming,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Tubulin Inhibitor,https://www.apexbt.com/search.php?catalog=A3324A3327,Costunolide,553-21-9,G10,L1021-02,232.32,DMSO,C15H20O2,CC1=CCCC(=CC2C(CC1)C(=C)C(=O)O2)C,≥35.71 mg/mL in DMSO; insoluble in H2O; ≥45.2 mg/mL in EtOH with gentle warming and ultrasonic,,DNA Damage/DNA Repair,Telomerase,,https://www.apexbt.com/search.php?catalog=A3327A3335,Curcumin,458-37-7,G11,L1021-02,368.38,DMSO,C21H20O6,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,≥36.8 mg/mL in DMSO; insoluble in H2O; ≥3.5 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Immunology/Inflammation,KEAP1-Nrf2,Tyrosinase inhibitor,https://www.apexbt.com/search.php?catalog=A3335A3345,Dabigatran etexilate mesylate,872728-81-9,H01,L1021-02,723.84,DMSO,C35H45N7O8S,CCCCCCOC(NC(C1=CC=C(NCC2=NC3=C(C=CC(C(N(C4=CC=CC=N4)CCC(OCC)=O)=O)=C3)N2C)C=C1)=N)=O.CS(=O)(O)=O,≥36.19 mg/mL in DMSO; insoluble in H2O; ≥45.8 mg/mL in EtOH with gentle warming,mesylate,Proteases,Thrombin,"Direct thrombin inhibitor,anticoagulant,prodrug of dabigatran",https://www.apexbt.com/search.php?catalog=A3345A3347,Dabrafenib Mesylate (GSK-2118436),1195768-06-9,H02,L1021-02,615.67,DMSO,C24H24F3N5O5S3,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O,≥30.75 mg/mL in DMSO; insoluble in H2O; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic,,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants,https://www.apexbt.com/search.php?catalog=A3347A3348,Daminozide,1596-84-5,H03,L1021-02,160.17,DMSO,C6H12N2O3,CN(C)NC(=O)CCC(=O)O,≥16.3 mg/mL in EtOH with gentle warming and ultrasonic; ≥21.4 mg/mL in H2O with gentle warming; ≥7.3 mg/mL in DMSO,,DNA Damage/DNA Repair,HDAC,,https://www.apexbt.com/search.php?catalog=A3348A3351,Dasatinib hydrochloride,854001-07-3,H04,L1021-02,524.47,DMSO,C22H27Cl2N7O2S,CC1=C(/N=C(O)/C(S2)=CN=C2NC3=CC(N4CCN(CCO)CC4)=NC(C)=N3)C(Cl)=CC=C1.Cl,insoluble in EtOH; insoluble in H2O; ≥8.41 mg/mL in DMSO with ultrasonic,#N/A,Tyrosine Kinase,Src,"Multi-BCR/Abl and Src kinase inhibitor, oral active",https://www.apexbt.com/search.php?catalog=A3351A3359,Desmopressin,16679-58-6,H05,L1021-02,1069.22,DMSO,C46H64N14O12S2,O=C(C1CSSCCC(NC(CC2=CC=C(O)C=C2)C(NC(CC3=CC=CC=C3)C(NC(CCC(N)=O)C(NC(CC(N)=O)C(N1)=O)=O)=O)=O)=O)N4C(C(NC(C(NCC(N)=O)=O)CCC/N=C(N)\N)=O)CCC4,insoluble in EtOH; ≥106.4 mg/mL in DMSO; ≥119.8 mg/mL in H2O,,GPCR/G protein,Vasopressin Receptor,Hemostatic and anti-diuretic,https://www.apexbt.com/search.php?catalog=A3359A3370,Docetaxel Trihydrate,148408-66-6,H06,L1021-02,861.93,DMSO,C43H59NO17,CC([[C@H](OC([[C@H@](O)([H])[[C@H](NC(OC(C)(C)C)=O)([H])C1=CC=CC=C1)=O)([H])C[[C@H@]2(O)[[C@H](OC(C3=CC=CC=C3)=O)([H])[[C@H@]4([H])[[C@H@]([[C@H](O)([H])C[[C@H]5([H])[[C@H@]4(OC(C)=O)CO5)6C)=C(C(C)2C)[[C@H](O)([H])C6=O.O.O.O,≥43.1 mg/mL in DMSO; insoluble in H2O; ≥87.6 mg/mL in EtOH with gentle warming,Trihydrate,Cell Cycle/Checkpoint,Microtubule/Tubulin,Depolymerisation of microtubules inhibitor,https://www.apexbt.com/search.php?catalog=A3370A3371,Doramectin,117704-25-3,H07,L1021-02,899.11,DMSO,C50H74O14,CC1/C=C/C=C2COC3C\2(O)C(C(OC4CC(OC5(C=CC(C)C(C6CCCCC6)O5)C4)C/C=C(C)/C1OC7CC(OC)C(OC8CC(OC)C(O)C(C)O8)C(C)O7)=O)C=C(C)C3O,≥89.9 mg/mL in DMSO; insoluble in H2O; ≥14.43 mg/mL in EtOH with gentle warming,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=A3371A3374,Dronedarone,141626-36-0,H08,L1021-02,556.77,DMSO,C31H44N2O5S,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,≥27.84 mg/mL in DMSO; insoluble in H2O; ≥49.8 mg/mL in EtOH,Free Base,Metabolism,CYP3A/CYP450,"CYP3A4 and 2D6 inhibitor,moderate",https://www.apexbt.com/search.php?catalog=A3374A3381,Edoxaban,480449-70-5,H09,L1021-02,548.06,DMSO,C24H30ClN7O4S,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,≥27.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Proteases,Thrombin,,https://www.apexbt.com/search.php?catalog=A3381A3383,Edoxaban tosylate monohydrate,1229194-11-9,H10,L1021-02,738.27,DMSO,C31H40ClN7O8S2,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O,≥36.91 mg/mL in DMSO; insoluble in H2O; ≥5.78 mg/mL in EtOH with gentle warming and ultrasonic,tosylate,Proteases,Thrombin,Oral factor Xa inhibitor,https://www.apexbt.com/search.php?catalog=A3383A3384,Elacridar,143664-11-3,H11,L1021-02,563.64,DMSO,C34H33N3O5,COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC,≥56.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Others,Others,BCRP inhibitor,https://www.apexbt.com/search.php?catalog=A3384A3387,Eltrombopag Olamine,496775-62-3,A01,L1021-03,564.63,DMSO,C29H36N6O6,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,insoluble in EtOH; insoluble in H2O; ≥14.12 mg/mL in DMSO with gentle warming,Free Base,Others,Thrombopoietin Receptor,C-mpl agonist,https://www.apexbt.com/search.php?catalog=A3387A3388,EMD-1214063,1100598-32-0,A02,L1021-03,492.57,DMSO,C29H28N6O2,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,>4.9mg/mL in DMSO,Free Base,Tyrosine Kinase,c-MET,"C-Met inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3388A3392,Emodin,518-82-1,A03,L1021-03,270.24,DMSO,C15H10O5,CC1=CC(O)=C2C(C(C3=CC(O)=CC(O)=C3C2=O)=O)=C1,≥27 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Immunology/Inflammation,NF-_B,,https://www.apexbt.com/search.php?catalog=A3392A3397,Erlotinib,183321-74-6,A04,L1021-03,393.44,DMSO,C22H23N3O4,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,insoluble in H2O; ≥19.65 mg/mL in DMSO; ≥30.27 mg/mL in EtOH with gentle warming,Free Base,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3397A3399,Esomeprazole Magnesium trihydrate,217087-09-7,A05,L1021-03,767.17,DMSO,C34H42MgN6O9S2,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.O.O.O.[Mg+2],≥110.6 mg/mL in DMSO; ≥39 mg/mL in EtOH; insoluble in H2O,,Autophagy; Membrane Transporter/Ion Channel,Autophagy; Proton Pump, proton pump inhibitor,https://www.apexbt.com/search.php?catalog=A3399A3403,Etofenamate,30544-47-9,A06,L1021-03,369.34,DMSO,C18H18F3NO4,C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F,insoluble in H2O; ≥108.4 mg/mL in EtOH; ≥16.45 mg/mL in DMSO,,Others,Others,Non-steroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=A3403A3405,Etoricoxib,202409-33-4,A07,L1021-03,358.84,DMSO,C18H15ClN2O2S,CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl,insoluble in H2O; ≥10.85 mg/mL in DMSO; ≥49.4 mg/mL in EtOH with gentle warming,,Neuroscience,COX,Specific COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=A3405A3412,Fenretinide,65646-68-6,A08,L1021-03,391.55,DMSO,C26H33NO2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,insoluble in H2O; ≥19.6 mg/mL in DMSO; ≥47.8 mg/mL in EtOH with gentle warming,,Others,RAR/RXR,,https://www.apexbt.com/search.php?catalog=A3412A3418,Flecainide acetate,54143-56-5,A09,L1021-03,474.39,DMSO,C19H24F6N2O5,CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,≥23.7 mg/mL in H2O with gentle warming and ultrasonic; ≥47.4 mg/mL in DMSO; ≥47.4 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Sodium Channel,Antiarrhythmic drug,https://www.apexbt.com/search.php?catalog=A3418A3419,Fluvastatin,93957-54-1,A10,L1021-03,411.47,DMSO,C24H26FNO4,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,≥20.57 mg/mL in DMSO; ≥32.53 mg/mL in H2O with gentle warming; ≥42.2 mg/mL in EtOH with gentle warming,Free Base,Metabolism,HMG-CoA Reductase,HMGCR inhibitor,https://www.apexbt.com/search.php?catalog=A3419A3421,Fosamprenavir Calcium Salt,226700-81-8,A11,L1021-03,623.67,DMSO,C25H34CaN3O9PS,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2],≥6.66 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,#N/A,Proteases/Proteasome,HIV Protease,Prodrug of antiretroviral protease inhibitor amprenavir,https://www.apexbt.com/search.php?catalog=A3421A3423,Galanthamine,357-70-0,B01,L1021-03,287.35,DMSO,C17H21NO3,[H][[C@H@]([[C@H@]1(C([H])=C2[H])C3=C(C([H])=C4[H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])[H])(C([H])([H])[[C@H@]2([H])O[H])OC3=C4OC([H])([H])[H],≥14.37 mg/mL in DMSO; ≥14.43 mg/mL in H2O with gentle warming; ≥45 mg/mL in EtOH with gentle warming,,Neuroscience,AChR,Acetylcholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=A3423A3433,Gefitinib hydrochloride,184475-55-6,B02,L1021-03,483.36,DMSO,C22H25Cl2FN4O3,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl,insoluble in EtOH; ≥4.28 mg/mL in H2O with gentle warming and ultrasonic; ≥6.9 mg/mL in DMSO with gentle warming,,JAK/STAT Signaling,EGFR,Potent EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3433A3451,Guanfacine hydrochloride,29110-48-3,B03,L1021-03,282.55,DMSO,C9H10Cl3N3O,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl,≥14.13 mg/mL in DMSO; ≥17.17 mg/mL in EtOH with gentle warming and ultrasonic; ≥50.6 mg/mL in H2O with gentle warming,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_2A-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=A3451A3479,Hydroxyfasudil hydrochloride,155558-32-0,B04,L1021-03,343.83,DMSO,C14H18ClN3O3S,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CNC3=O.Cl,insoluble in EtOH; ≥7.88 mg/mL in DMSO with gentle warming; ≥5.04 mg/mL in H2O with gentle warming and ultrasonic,,TGF-_ / Smad Signaling,ROCK,Rho-kinase inhibitor and vasodilator,https://www.apexbt.com/search.php?catalog=A3479A3496,Indacaterol,312753-06-3,B05,L1021-03,392.49,DMSO,C24H28N2O3,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,insoluble in H2O; ≥12.85 mg/mL in DMSO; ≥6.93 mg/mL in EtOH with gentle warming and ultrasonic,,GPCR/G protein,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=A3496A3513,Ixabepilone,219989-84-1,B06,L1021-03,506.7,DMSO,C27H42N2O5S,C[[C@H]([[C@H](O)[[C@@H](C)C(C(C)(C)[[C@@H](O)C1)=O)CCC[[C@H]2(C)[[C@@H](O2)C[[C@@H](/C(C)=C/C3=CSC(C)=N3)NC1=O,≥22.25 mg/mL in DMSO; insoluble in H2O; ≥41.3 mg/mL in EtOH with gentle warming,,Tyrosine Kinase,EGFR,,https://www.apexbt.com/search.php?catalog=A3513A3528,Kinetin,525-79-1,B07,L1021-03,215.21,DMSO,C10H9N5O,C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,insoluble in H2O; insoluble in EtOH; ≥5.38 mg/mL in DMSO with gentle warming,Free Base,Others,Others,Plant growth hormones,https://www.apexbt.com/search.php?catalog=A3528A3543,LDE225 Diphosphate,1218778-77-8,B08,L1021-03,681.49,DMSO,C26H32F3N3O11P2,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F.OP(=O)(O)O.OP(=O)(O)O,≥27.85 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Stem Cell,Smoothened,,https://www.apexbt.com/search.php?catalog=A3543A3546,Ledipasvir,1256388-51-8,B09,L1021-03,889,DMSO,C49H54F2N8O6,CC([[C@H@](/N=C(OC)\O)([H])C(N1CC2(C[[C@H@]1([H])C3=NC=C(N3)C4=CC5=C(C6=C(C5(F)F)C=C(C7=CC(N8)=C(N=C8[[C@H]9([H])[[C@H@]%10([H])CC[[C@H](N9C([[C@H](/N=C(OC)\O)([H])C(C)C)=O)([H])C%10)C=C7)C=C6)C=C4)CC2)=O)C,≥44.45 mg/mL in DMSO; insoluble in H2O; ≥46.9 mg/mL in EtOH with gentle warming,Free Base,Microbiology & Virology,HCV,HCV NS5A protein inhibitor,https://www.apexbt.com/search.php?catalog=A3546A3549,Lesinurad,878672-00-5,B10,L1021-03,404.28,DMSO,C17H14BrN3O2S,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,insoluble in H2O; ≥40.9 mg/mL in EtOH with ultrasonic; ≥92.2 mg/mL in DMSO with ultrasonic,,Membrane Transporter/Ion Channel,URAT1,URAT1 inhibitor,https://www.apexbt.com/search.php?catalog=A3549A3550,Letermovir,917389-32-3,B11,L1021-03,572.55,DMSO,C29H28F4N4O4,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,≥57.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,Microbiology & Virology,CMV,Novel anti-CMV compound,https://www.apexbt.com/search.php?catalog=A3550A3551,Leuprolide Acetate,74381-53-6,C01,L1021-03,1269.45,DMSO,C61H88N16O14,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O,≥126.9 mg/mL in DMSO; ≥102 mg/mL in H2O with gentle warming; ≥31.4 mg/mL in EtOH with gentle warming,,Endocrinology and Hormones,GnRH,Pituitary GnRH receptors agonist,https://www.apexbt.com/search.php?catalog=A3551A3564,Luliconazole,187164-19-8,C02,L1021-03,354.28,DMSO,C14H9Cl2N3S2,C1C(SC(=C(C#N)N2C=CN=C2)S1)C3=C(C=C(C=C3)Cl)Cl,insoluble in H2O; ≥17.71 mg/mL in DMSO; ≥32.53 mg/mL in EtOH with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Azole antifungal agent(interdigital tinea pedis),https://www.apexbt.com/search.php?catalog=A3564A3575,LY2835219 free base,1231929-97-7,C03,L1021-03,506.59,DMSO,C27H32F2N8,CCN1CCN(CC2=CN=C(NC3=NC=C(F)C(C4=CC5=C(N=C(C)N5C(C)C)C(F)=C4)=N3)C=C2)CC1,insoluble in H2O; ≥4.83 mg/mL in DMSO with gentle warming and ultrasonic; ≥6.34 mg/mL in EtOH with gentle warming,,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK inhibitor,https://www.apexbt.com/search.php?catalog=A3575A3583,Matrine,519-02-8,C04,L1021-03,248.36,DMSO,C15H24N2O,O=C1N(C[[C@H@]2([H])[[C@H@]3([H])[[C@H]4([H])CCCN3CCC2)[[C@H]4([H])CCC1,≥12.42 mg/mL in DMSO; ≥47.2 mg/mL in EtOH; ≥50.3 mg/mL in H2O with gentle warming and ultrasonic,#N/A,Apoptosis,Apoptosis Inducers,Alkaloid found in Sophora plant,https://www.apexbt.com/search.php?catalog=A3583A3593,Mefloquine hydrochloride,51773-92-3,C05,L1021-03,414.77,DMSO,C17H17ClF6N2O,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O.Cl,insoluble in H2O; ≥20.74 mg/mL in DMSO; ≥33.67 mg/mL in EtOH,Salt,Microbiology & Virology,Antimalaria,"Quinoline methanol antimalarial agent,",https://www.apexbt.com/search.php?catalog=A3593A3599,Metoclopramide,364-62-5,C06,L1021-03,299.8,DMSO,C14H22ClN3O2,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,insoluble in H2O; ≥14.99 mg/mL in DMSO; ≥24.6 mg/mL in EtOH with gentle warming,Free Base,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3599A3606,Micafungin sodium,208538-73-2,C07,L1021-03,1292.26,DMSO,C56H70N9NaO23S,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)[O-])O)O)C(CC(=O)N)O)C)O)O)O.[Na+],≥64.66 mg/mL in DMSO; insoluble in EtOH; ≥17.5 mg/mL in H2O with gentle warming and ultrasonic,sodium,Others,"_(1,3)-D-Glucan Synthase","Inhibitor of _-(1,3)-D-glucan synthesis;fungicide",https://www.apexbt.com/search.php?catalog=A3606A3617,MK-4827,1038915-60-4,C08,L1021-03,320.39,DMSO,C19H20N4O,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,≥32 mg/mL in DMSO; insoluble in H2O; ≥50.9 mg/mL in EtOH with gentle warming,,Chromatin/Epigenetics,PARP,"PARP-1/-2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3617A3618,MK-5172,1350514-68-9,C09,L1021-03,766.9,DMSO,C38H50N6O9S,COC1=CC2=C(N=C(CCCCC[[C@@H]3C[[C@H]3OC(N[[C@@H](C(C)(C)C)C(N4[[C@H](C(N[[C@H@]5(C(NS(=O)(C6CC6)=O)=O)[[C@H](C5)C=C)=O)C[[C@@H]7C4)=O)=O)C(O7)=N2)C=C1,≥38.35 mg/mL in DMSO; insoluble in H2O; ≥24 mg/mL in EtOH with gentle warming and ultrasonic,,Proteases,NS3/4a protease,HCV NS3/4a protease inhibitor,https://www.apexbt.com/search.php?catalog=A3618A3631,Monomethyl auristatin E,474645-27-7,C10,L1021-03,717.98,DMSO,C39H67N5O7,CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(C)C(C2=CC=CC=C2)O)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)NC,≥35.9 mg/mL in DMSO; insoluble in H2O; ≥48.5 mg/mL in EtOH with gentle warming and ultrasonic,,Cell Cycle/Checkpoint,Microtubule/Tubulin,,https://www.apexbt.com/search.php?catalog=A3631A3653,Nelfinavir Mesylate,159989-65-8,C11,L1021-03,663.89,DMSO,C33H49N3O7S2,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,≥66.4 mg/mL in DMSO; insoluble in H2O; ≥100.4 mg/mL in EtOH with gentle warming,Mesylate,Proteases,HIV Protease,"HIV protease inhibitor,antiretroviral drug for HIV treatment",https://www.apexbt.com/search.php?catalog=A3653A3660,Nilotinib monohydrochloride monohydrate,923288-90-8,D01,L1021-03,583.99,DMSO,C28H25ClF3N7O2,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.O.Cl,≥50 mg/mL in EtOH with gentle warming; insoluble in H2O; ≥210.8 mg/mL in DMSO,,TGF-_ / Smad Signaling,Bcr-Abl,Bcr-Abl inhibitor,https://www.apexbt.com/search.php?catalog=A3660A3664,Nordihydroguaiaretic acid,500-38-9,D02,L1021-03,302.36,DMSO,C18H22O4,CC(C(CC1=CC(O)=C(O)C=C1)C)CC2=CC(O)=C(O)C=C2,insoluble in H2O; ≥107 mg/mL in EtOH; ≥121 mg/mL in DMSO,,PI3K/Akt/mTOR Signaling,mTOR,,https://www.apexbt.com/search.php?catalog=A3664A3681,Olmesartan,144689-24-7,D03,L1021-03,446.5,DMSO,C24H26N6O3,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,≥22.32 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist,https://www.apexbt.com/search.php?catalog=A3681A3683,Olprinone Hydrochloride,119615-63-3,D04,L1021-03,286.72,DMSO,C14H11ClN4O,CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2.Cl,insoluble in EtOH; ≥13.2 mg/mL in H2O with gentle warming; ≥52.1 mg/mL in DMSO with gentle warming,,Metabolism,PDE,"Phosphodiesterase 3 (PDE3) inhibitor, selective",https://www.apexbt.com/search.php?catalog=A3683A3688,Oseltamivir,196618-13-0,D05,L1021-03,312.4,DMSO,C16H28N2O4,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,≥31.2 mg/mL in DMSO; ≥119.4 mg/mL in EtOH with gentle warming; ≥82 mg/mL in H2O with gentle warming,Free Base,Microbiology & Virology,NA,inhibitor of influenza neuraminidase,https://www.apexbt.com/search.php?catalog=A3688A3689,Oseltamivir acid,187227-45-8,D06,L1021-03,284.35,DMSO,C14H24N2O4,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)O,≥14.2 mg/mL in DMSO; ≥46.1 mg/mL in H2O with gentle warming; ≥97 mg/mL in EtOH with gentle warming,,Microbiology & Virology,NA,Influenza neuraminidase inhibitor,https://www.apexbt.com/search.php?catalog=A3689A3707,Pemetrexed disodium hemipenta hydrate,357166-30-4,D07,L1021-03,516.41,H2O,C20H24N5Na2O8.5,O=C(CC[[C@H](NC(C1=CC=C(CCC2=CNC(N=C(N3)N)=C2C3=O)C=C1)=O)C([O-])=O)[O-],≥23.42 mg/mL in H2O with gentle warming; insoluble in EtOH; insoluble in DMSO,Free Base,Apoptosis,Thymidylate Synthase,Antifolate and antimetabolite agent,https://www.apexbt.com/search.php?catalog=A3707A3708,Pentostatin,53910-25-1,D08,L1021-03,268.27,DMSO,C11H16N4O4,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,≥26.8 mg/mL in H2O; insoluble in EtOH; ≥13.4 mg/mL in DMSO,,GPCR/G protein,Adenosine Receptor,Irreversible adenosine deaminase inhibitor,https://www.apexbt.com/search.php?catalog=A3708A3709,Peramivir,330600-85-6,D09,L1021-03,328.41,H2O,C15H28N4O4,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,insoluble in DMSO; ≥5.66 mg/mL in H2O with gentle warming and ultrasonic; ≥7.6 mg/mL in EtOH,Free Base,Microbiology & Virology,NA,Aeuraminidase inhibitor;antiviral drug,https://www.apexbt.com/search.php?catalog=A3709A3722,Phenylpiracetam,77472-70-9,D10,L1021-03,218.25,DMSO,C12H14N2O2,O=C1N(CC(N)=O)CC(C2=CC=CC=C2)C1,≥10.92 mg/mL in DMSO; ≥18.5 mg/mL in H2O with gentle warming and ultrasonic; ≥58.2 mg/mL in EtOH with gentle warming,,Others,Others,Nootropic derivative of piracetam,https://www.apexbt.com/search.php?catalog=A3722A3727,Pitolisant hydrochloride,903576-44-3,D11,L1021-03,332.31,DMSO,C17H27Cl2NO,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl.Cl,≥16.6 mg/mL in DMSO; ≥57.4 mg/mL in H2O; ≥94.2 mg/mL in EtOH,,Neuroscience,Histamine Receptor,Nonimidazole inverse agonist,https://www.apexbt.com/search.php?catalog=A3727A3733,Pramipexole dihydrochloride,104632-25-9,E01,L1021-03,284.25,DMSO,C10H19Cl2N3S,CCCNC1CCC2=C(C1)SC(=N2)N.Cl.Cl,≥105.2 mg/mL in H2O; ≥14.21 mg/mL in DMSO; ≥3.43 mg/mL in EtOH with gentle warming and ultrasonic,,Neuroscience,Dopamine Receptor,Dopamine receptor agonist,https://www.apexbt.com/search.php?catalog=A3733A3738,PSI-7977,1190307-88-0,E02,L1021-03,529.45,DMSO,C22H29FN3O9P,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,insoluble in H2O; ≥183 mg/mL in DMSO; ≥84.4 mg/mL in EtOH with gentle warming,,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agents for chronic HCV infection,https://www.apexbt.com/search.php?catalog=A3738A3740,Puromycin aminonucleoside,58-60-6,E03,L1021-03,294.31,DMSO,C12H18N6O3,CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)N)O,≥14.45 mg/mL in DMSO; ≥29.4 mg/mL in EtOH with gentle warming; ≥29.5 mg/mL in H2O with gentle warming,#N/A,Others,Others,Aminonucleoside portion of the antibiotic puromycin,https://www.apexbt.com/search.php?catalog=A3740A3744,Quetiapine,111974-69-7,E04,L1021-03,383.51,DMSO,C21H25N3O2S,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,insoluble in H2O; ≥19.18 mg/mL in DMSO; ≥29.55 mg/mL in EtOH with gentle warming,Free Base,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3744A3750,Regorafenib hydrochloride,835621-07-3,E05,L1021-03,519.28,DMSO,C21H16Cl2F4N4O3,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.Cl,≥25.95 mg/mL in DMSO; insoluble in H2O; ≥8.75 mg/mL in EtOH with gentle warming and ultrasonic,hydrochloride,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3750A3751,Regorafenib monohydrate,1019206-88-2,E06,L1021-03,500.83,DMSO,C21H17ClF4N4O4,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O,≥25.05 mg/mL in DMSO; insoluble in H2O,,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3751A3758,Retigabine dihydrochloride,150812-13-8,E07,L1021-03,376.25,DMSO,C16H20Cl2FN3O2,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N.Cl.Cl,≥18.8 mg/mL in DMSO; ≥52.4 mg/mL in H2O with gentle warming; ≥8.71 mg/mL in EtOH with gentle warming and ultrasonic,,Membrane Transporter/Ion Channel,GABA Receptor,,https://www.apexbt.com/search.php?catalog=A3758A3763,RG7388,1229705-06-9,E08,L1021-03,616.48,DMSO,C31H29Cl2F2N3O4,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,≥30.82 mg/mL in DMSO; insoluble in H2O; ≥6.96 mg/mL in EtOH with gentle warming,Free Base,Apoptosis,p53,"MDM2 antagonist, oral, selective",https://www.apexbt.com/search.php?catalog=A3763A3765,Rilpivirine,500287-72-9,E09,L1021-03,366.42,DMSO,C22H18N6,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,insoluble in H2O; ≥12.25 mg/mL in DMSO; ≥6.58 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Microbiology & Virology,HIV,Inhibitor of next-generation nonnucleoside reverse transcriptase,https://www.apexbt.com/search.php?catalog=A3765A3767,Riociguat,625115-55-1,E10,L1021-03,422.42,DMSO,C20H19FN8O2,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,insoluble in EtOH; insoluble in H2O; ≥16.95 mg/mL in DMSO,Free Base,Others,Guanylate Cyclase,Soluble guanylate cyclase (sGC) stimulator,https://www.apexbt.com/search.php?catalog=A3767A3768,Rivastigmine,123441-03-2,E11,L1021-03,250.34,DMSO,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,≥12.52 mg/mL in DMSO; ≥23.6 mg/mL in H2O with ultrasonic; ≥92.8 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,AChR,Cholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=A3768A3781,Ruxolitinib phosphate,1092939-17-7,F01,L1021-03,404.36,DMSO,C17H21N6O4P,[HH].C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OOP(=O)=O,≥20.2 mg/mL in DMSO; ≥6.92 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.03 mg/mL in H2O with gentle warming and ultrasonic,,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor,https://www.apexbt.com/search.php?catalog=A3781A3787,Salirasib,162520-00-5,F02,L1021-03,358.54,DMSO,C22H30O2S,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,insoluble in H2O; ≥16.2 mg/mL in EtOH; ≥16.75 mg/mL in DMSO ,Free Base,MAPK Signaling,RasGAP (Ras- P21),Inhibitor of active Ras protein,https://www.apexbt.com/search.php?catalog=A3787A3789,Salmeterol xinafoate,94749-08-3,F03,L1021-03,603.75,DMSO,C36H45NO7,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O,≥30.19 mg/mL in DMSO; insoluble in H2O; ≥15.83 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,_2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=A3789A3791,Saquinavir mesylate,149845-06-7,F04,L1021-03,766.95,DMSO,C39H54N6O8S,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,insoluble in H2O; ≥6.71 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.67 mg/mL in DMSO ,mesylate,Proteases,HIV Protease,HIV Protease Inhibitor,https://www.apexbt.com/search.php?catalog=A3791A3817,Sildenafil,139755-83-2,F05,L1021-03,474.58,DMSO,C22H30N6O4S,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,≥22.65 mg/mL in H2O; insoluble in EtOH; ≥46.3 mg/mL in DMSO with ultrasonic,,Metabolism,PDE,"PDE5 inhibitor, selective",https://www.apexbt.com/search.php?catalog=A3817A3820,Simeprevir,923604-59-5,F06,L1021-03,749.96,DMSO,C38H47N5O7S2,COC1=CC=C(C(O[[C@H]2CC(C(N(C)CCCC/C=C\[[C@H]3C[[C@H@]3(C(NS(=O)(C4CC4)=O)=O)NC5=O)=O)[[C@H]5C2)=CC(C6=NC(C(C)C)=CS6)=N7)C7=C1C,insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL in DMSO ,Free Base,Proteases,HCV Protease,Inhibitor of HCV NS3/4A protease,https://www.apexbt.com/search.php?catalog=A3820A3856,Tamibarotene,94497-51-5,F07,L1021-03,351.44,DMSO,C22H25NO3,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,insoluble in H2O; ≥13.35 mg/mL in DMSO; ≥52.5 mg/mL in EtOH with ultrasonic,Free Base,Others,RARs,RAR_ agonist,https://www.apexbt.com/search.php?catalog=A3856A3863,Tedizolid,856866-72-3,F08,L1021-03,370.34,DMSO,C17H15FN6O3,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,insoluble in EtOH; insoluble in H2O; ≥9.25 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Oxazolidinone for gram-positive infections,https://www.apexbt.com/search.php?catalog=A3863A3865,Teneligliptin hydrobromide,906093-29-6,F09,L1021-03,1257.72,DMSO,C44H65Br5N12O2S2,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.Br.Br.Br.Br.Br,≥62.9 mg/mL in DMSO; ≥104.8 mg/mL in H2O; ≥12.1 mg/mL in EtOH with gentle warming and ultrasonic,hydrobromide,Proteases,DPP-4,Dipeptidyl peptidase-4 inhibitor,https://www.apexbt.com/search.php?catalog=A3865A3872,TH-302,918633-87-1,F10,L1021-03,449.04,DMSO,C9H16Br2N5O4P,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,≥22.45 mg/mL in DMSO; ≥34.2 mg/mL in EtOH with ultrasonic; ≥4.73 mg/mL in H2O with gentle warming and ultrasonic,free base,DNA Damage/DNA Repair,Topoisomerase,"Hypoxia-activated prodrug,inhibits H460/HT29 cell growth",https://www.apexbt.com/search.php?catalog=A3872A3873,Tianeptine,72797-41-2,F11,L1021-03,436.96,DMSO,C21H25ClN2O4S,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,insoluble in H2O; ≥4.08 mg/mL in EtOH with gentle warming and ultrasonic; ≥82.4 mg/mL in DMSO,#N/A,Neuroscience,5-HT Receptor,5-HT facilitator,https://www.apexbt.com/search.php?catalog=A3873A3874,Tiotropium Bromide,136310-93-5,G01,L1021-03,472.42,DMSO,C19H22BrNO4S2,O=C(C(C1=C([H])C([H])=C([H])S1)(C2=C([H])C([H])=C([H])S2)O[H])O[[C@H@]3([H])C([H])([H])[[C@H]4([H])[N+](C([H])([H])[H])(C([H])([H])[H])[[C@H@](C3([H])[H])([H])[[C@H@]5([H])O[[C@H@]45[H].[Br-],≥23.62 mg/mL in DMSO; insoluble in EtOH; ≥33.07 mg/mL in H2O with ultrasonic,Bromide,Neuroscience,AChR,MAChR M antagonist,https://www.apexbt.com/search.php?catalog=A3874A3875,Tipiracil hydrochloride,183204-72-0,G02,L1021-03,279.12,H2O,C9H12Cl2N4O2,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl.Cl,insoluble in DMSO; insoluble in EtOH; ≥13.25 mg/mL in H2O,,Others,Thymidine phosphorylase,Thymidine phosphorylase inhibitor,https://www.apexbt.com/search.php?catalog=A3875A3877,Tirofiban hydrochloride monohydrate,150915-40-5,G03,L1021-03,495.07,DMSO,C22H39ClN2O6S,O=C(O)[[C@@H](NS(=O)(CCCC)=O)CC1=CC=C(OCCCCC2CCNCC2)C=C1.Cl.O,≥24.75 mg/mL in DMSO; ≥105 mg/mL in EtOH with ultrasonic; ≥3.84 mg/mL in H2O with gentle warming and ultrasonic,Hydrochloride,Others,Glycoprotein,Glycoprotein IIb/IIIa inhibitor,https://www.apexbt.com/search.php?catalog=A3877A3887,Trametinib DMSO solvate,1187431-43-1,G04,L1021-03,693.53,DMSO,C28H29FIN5O5S,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5.CS(=O)C,insoluble in EtOH; insoluble in H2O; ≥11.2 mg/mL in DMSO with gentle warming and ultrasonic,,MAPK Signaling,MEK1/2,Allosteric MEK1/MEK2 kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3887A3888,Trelagliptin,865759-25-7,G05,L1021-03,357.38,DMSO,C18H20FN5O2,CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N,≥11.6 mg/mL in DMSO; ≥3.68 mg/mL in EtOH with gentle warming and ultrasonic; ≥93.8 mg/mL in H2O,Free Base,Proteases,DPP-4,"DPP-4 inhibitor,long-acting and selective",https://www.apexbt.com/search.php?catalog=A3888A3891,Triptolide,38748-32-2,G06,L1021-03,360.41,DMSO,C20H24O6,CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C,≥36 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Immunology/Inflammation,NF-_B,,https://www.apexbt.com/search.php?catalog=A3891A3892,Triptonide,38647-11-9,G07,L1021-03,358.39,DMSO,C20H22O6,CC([[C@H]12[[C@@H](O2)[[C@H]3[[C@H@]4(O3)[[C@H]5(CCC6=C([[C@H]5([H])C[[C@H]7[[C@H@]4(O7)C1=O)COC6=O)C)C,insoluble in H2O; insoluble in EtOH; ≥16.35 mg/mL in DMSO ,,Others,dCTP Pyrophosphatase,,https://www.apexbt.com/search.php?catalog=A3892A3893,Troglitazone,97322-87-7,G08,L1021-03,441.54,DMSO,C24H27NO5S,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,insoluble in H2O; ≥20.9 mg/mL in DMSO; ≥3.34 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,PPAR,Selective PPAR_ agonist,https://www.apexbt.com/search.php?catalog=A3893A3900,Umeclidinium bromide,869113-09-7,G09,L1021-03,508.49,DMSO,C29H34BrNO2,C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-],insoluble in H2O; insoluble in EtOH; ≥61.5 mg/mL in DMSO,#N/A,Neuroscience,Muscarinic Receptor,MAChR antagonist,https://www.apexbt.com/search.php?catalog=A3900A3919,Vilazodone Hydrochloride,163521-08-2,G10,L1021-03,477.99,DMSO,C26H28ClN5O2,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.Cl,≥23.9 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Hydrochloride,Neuroscience,5-HT Receptor,Combined SSRI and 5-HT1A receptor partial agonist,https://www.apexbt.com/search.php?catalog=A3919A3920,Vinblastine sulfate,143-67-9,G11,L1021-03,909.05,DMSO,C46H60N4O13S,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,≥28.85 mg/mL in DMSO; insoluble in EtOH; ≥48.2 mg/mL in H2O with ultrasonic,sulfate,Ubiquitination/Proteasome,Autophagy,Anti-mitotic agent,https://www.apexbt.com/search.php?catalog=A3920A3921,Vinorelbine ditartrate,125317-39-7,H01,L1021-03,1079.11,DMSO,C53H66N4O20,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,≥33.7 mg/mL in DMSO; ≥41.9 mg/mL in EtOH with ultrasonic; ≥43 mg/mL in H2O with ultrasonic,ditartrate,Others,Others,Anti-mitotic chemotherapy drug,https://www.apexbt.com/search.php?catalog=A3921A3926,Vortioxetine,508233-74-7,H02,L1021-03,298.45,DMSO,C18H22N2S,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,insoluble in H2O; ≥14.92 mg/mL in DMSO; ≥4.31 mg/mL in EtOH with ultrasonic,,Neuroscience,5-HT Receptor,5-HT receptors antagonist,https://www.apexbt.com/search.php?catalog=A3926A3952,Ziprasidone,146939-27-7,H03,L1021-03,412.94,DMSO,C21H21ClN4OS,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,≥20.65 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,Free Base,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3952A3953,Ziprasidone hydrochloride monohydrate,138982-67-9,H04,L1021-03,467.41,DMSO,C21H24Cl2N4O2S,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,insoluble in H2O; insoluble in EtOH; ≥11.69 mg/mL in DMSO,Hydrochloride,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3953A3966,Doxorubicin,23214-92-8,H05,L1021-03,543.52,DMSO,C27H29NO11,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,≥27.2 mg/mL in DMSO; insoluble in EtOH; ≥24.8 mg/mL in H2O with ultrasonic,Free Base,DNA Damage/DNA Repair,Topoisomerase,"Topo II inhibitor,immunosuppresive antineoplastic antibiotic",https://www.apexbt.com/search.php?catalog=A3966A3967,Lapatinib Ditosylate,388082-77-7,H06,L1021-03,925.46,DMSO,C29H26ClFN4O4S 2C7H8O3S,O=S(CCNCC1=CC=C(C2=CC3=C(NC4=CC=C(OCC5=CC=CC(F)=C5)C(Cl)=C4)N=CN=C3C=C2)O1)(C)=O.O=S(C6=CC=C(C)C=C6)(O)=O.O=S(C7=CC=C(C)C=C7)(O)=O,≥24.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Ditosylate,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3967A4007,MLN9708,1201902-80-8,H07,L1021-03,517.1,DMSO,C20H23BCl2N2O9,B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,insoluble in H2O; ≥20.85 mg/mL in DMSO; ≥4.56 mg/mL in EtOH with gentle warming and ultrasonic,,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor,https://www.apexbt.com/search.php?catalog=A4007A4008,MLN2238,1072833-77-2,H08,L1021-03,361,DMSO,C14H19BCl2N2O4,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,insoluble in H2O; ≥103 mg/mL in EtOH with ultrasonic; ≥16.8 mg/mL in DMSO,Free Base,Ubiquitination/Proteasome,Proteasome,_5 site of the 20S proteasome inhibitor,https://www.apexbt.com/search.php?catalog=A4008A4009,CEP-18770,847499-27-8,H09,L1021-03,413.3,DMSO,C21H28BN3O5,B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O,insoluble in H2O; ≥16.75 mg/mL in DMSO; ≥32.27 mg/mL in EtOH with ultrasonic,Free Base,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor,https://www.apexbt.com/search.php?catalog=A4009A4012,Gabexate mesylate,56974-61-9,H10,L1021-03,417.48,DMSO,C16H23N3O4·CH4O3S,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N.CS(=O)(=O)O,≥102.4 mg/mL in H2O; ≥18.2 mg/mL in DMSO; ≥99.8 mg/mL in EtOH,Mesylate,Proteases,Serine Protease,Trypsin-like serine proteinases inhibitor,https://www.apexbt.com/search.php?catalog=A4012A4013,Aspirin (Acetylsalicylic acid),50-78-2,H11,L1021-03,180.16,DMSO,C9H8O4,CC(=O)OC1=CC=CC=C1C(=O)O,insoluble in H2O; ≥104.2 mg/mL in EtOH with ultrasonic; ≥8.55 mg/mL in DMSO,Free Base,Neuroscience,COX,Cyclooxygenase (COX) inhibitor,https://www.apexbt.com/search.php?catalog=A4013A4014,Artemether (SM-224),71963-77-4,A01,L1021-04,298.4,DMSO,C16H26O5,[H][[C@H]12[[C@H@]3([[C@H@]4([H])CC[[C@H@]2([H])C)[[C@H@](O[[C@H](OC)[[C@H@]4(C)[H])([H])O[[C@H@](OO3)(C)CC1,insoluble in H2O; ≥15.3 mg/mL in DMSO; ≥90.2 mg/mL in EtOH,,Ubiquitination/Proteasome,Proteasome,,https://www.apexbt.com/search.php?catalog=A4014A4015,Disulfiram,97-77-8,A02,L1021-04,296.54,DMSO,C10H20N2S4,CCN(CC)C(=S)SSC(=S)N(CC)CC,insoluble in H2O; ≥12 mg/mL in DMSO; ≥24.2 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,Dopamine _-hydroxylase,Dopamine _-hydroxylase inhibitor,https://www.apexbt.com/search.php?catalog=A4015A4022,BMS-708163 (Avagacestat),1146699-66-2,A03,L1021-04,520.88,DMSO,C20H17ClF4N4O4S,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,insoluble in H2O; ≥177.6 mg/mL in DMSO; ≥47.6 mg/mL in EtOH with ultrasonic,,Proteases,Gamma Secretase,_-secretase inhibitor,https://www.apexbt.com/search.php?catalog=A4022A4024,Danoprevir (RG7227),850876-88-9,A04,L1021-04,731.83,DMSO,C35H46FN5O9S,FC1=CC=CC2=C1CN(C2)C(O[[C@@H]3C[[C@H](C(N[[C@H@]4(C(NS(=O)(C5CC5)=O)=O)[[C@H@](/C=C\CCCCC[[C@@H]6N([H])C(OC(C)(C)C)=O)([H])C4)=O)([H])N(C6=O)C3)=O,≥32.6 mg/mL in DMSO; insoluble in H2O; ≥46.4 mg/mL in EtOH with ultrasonic,,Proteases,HCV Protease,,https://www.apexbt.com/search.php?catalog=A4024A4031,Telaprevir (VX-950),402957-28-2,A05,L1021-04,679.9,DMSO,C36H53N7O6,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,≥32.95 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Proteases,HCV Protease,HCV NS3-4A protease inhibitor,https://www.apexbt.com/search.php?catalog=A4031A4032,"VX-222 (VCH-222, Lomibuvir)",1026785-59-0,A06,L1021-04,445.6,DMSO,C25H35NO4S,CC1CCC(CC1)C(=O)N(C2CCC(CC2)O)C3=C(SC(=C3)C#CC(C)(C)C)C(=O)O,≥44.6 mg/mL in DMSO; insoluble in H2O; ≥97.2 mg/mL in EtOH,,Proteases,HCV Protease,NNI of HCV RNA polymerase,https://www.apexbt.com/search.php?catalog=A4032A4033,Glimepiride,93479-97-1,A07,L1021-04,490.62,DMSO,C24H34N4O5S,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,≥21.45 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,DPP-4,Sulfonylurea compound,https://www.apexbt.com/search.php?catalog=A4033A4034,Linagliptin (BI-1356),668270-12-0,A08,L1021-04,472.5,DMSO,C25H28N8O2,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,insoluble in H2O; insoluble in EtOH; ≥17.85 mg/mL in DMSO,Free Base,Proteases,DPP-4,"DDP-4 inhibitor,highly potent and competitive",https://www.apexbt.com/search.php?catalog=A4034A4036,Sitagliptin phosphate monohydrate,654671-77-9,A09,L1021-04,523.3,DMSO,C16H15F6N5O·H3PO4·H2O,[HH].C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.O.OOP(=O)=O,≥23.8 mg/mL in DMSO; insoluble in EtOH; ≥30.6 mg/mL in H2O with ultrasonic,phosphate,Proteases,DPP-4,Potent DPP-4 inhibitor,https://www.apexbt.com/search.php?catalog=A4036A4037,Vildagliptin (LAF-237),274901-16-5,A10,L1021-04,303.4,DMSO,C17H25N3O2,O[[C@H@]1(C[[C@H]2(NCC(N3[[C@H](C#N)CCC3)=O)C4)C[[C@H](C2)C[[C@H]4C1,≥12.05 mg/mL in DMSO; ≥96.4 mg/mL in EtOH with ultrasonic; ≥96.8 mg/mL in H2O with ultrasonic,Free Base,Proteases,DPP-4,DPP-4 inhibitor,https://www.apexbt.com/search.php?catalog=A4037A4038,Alogliptin (SYR-322),850649-61-5,A11,L1021-04,339.39,DMSO,C18H21N5O2,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,insoluble in H2O; ≥100 mg/mL in EtOH with ultrasonic; ≥14.75 mg/mL in DMSO,Free Base,Proteases,DPP-4,"DPP-4 inhibitor,potent and highly selective",https://www.apexbt.com/search.php?catalog=A4038A4040,Atazanavir sulfate (BMS-232632-05),229975-97-7,B01,L1021-04,802.9,DMSO,C38H52N6O7·H2SO4,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,≥28.7 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥4.05 mg/mL in EtOH with gentle warming and ultrasonic,Sulfate,Proteases,HIV Protease,Protease inhibitor,https://www.apexbt.com/search.php?catalog=A4040A4049,Marimastat,154039-60-8,B02,L1021-04,331.41,DMSO,C15H29N3O5,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,≥2.8 mg/mL in H2O with gentle warming and ultrasonic; ≥20.43 mg/mL in EtOH; ≥80.1 mg/mL in DMSO,Free Base,Proteases,MMP,"MMPs inhibitor,board spectrum",https://www.apexbt.com/search.php?catalog=A4049A4050,GM 6001,142880-36-2,B03,L1021-04,388.46,DMSO,C20H28N4O4,CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC,insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL in DMSO,Free Base,Proteases,MMP,Broad spectrum MMP inhibitor,https://www.apexbt.com/search.php?catalog=A4050A4052,Doxycycline hyclate,24390-14-5,B04,L1021-04,512.94,DMSO,C23H29ClN2O9,O=C(N)C(C1=O)=C([[C@H]([[C@H@]2([[C@H]([[C@H@]3([[C@H](C4=C(C(O)=CC=C4)C(C3=C([[C@H@]21O)O)=O)C)[H])O)[H])N(C)C)O.Cl.[0.5H2O].[0.5C2H6O],≥22.15 mg/mL in DMSO; insoluble in EtOH; ≥49.2 mg/mL in H2O with ultrasonic,Hydrochloride,Others,Others,MMP inhibitor,https://www.apexbt.com/search.php?catalog=A4052A4054,17-AAG (KOS953),75747-14-7,B05,L1021-04,585.7,DMSO,C31H43N3O8,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC,≥24.95 mg/mL in DMSO; insoluble in H2O; ≥9.56 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HSP,Hsp90 inhibitor,https://www.apexbt.com/search.php?catalog=A4054A4056,AT13387,912999-49-6,B06,L1021-04,409.5,DMSO,C24H31N3O3,CC(C)C1=C(C=C(C(=C1)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C)O)O,insoluble in H2O; ≥13.25 mg/mL in DMSO; ≥47.7 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HSP,Hsp90 inhibitor,https://www.apexbt.com/search.php?catalog=A4056A4070,Elvitegravir (GS-9137),697761-98-1,B07,L1021-04,447.9,DMSO,C23H23ClFNO5,CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL in DMSO,Free Base,Proteases,HIV Integrase,"HIV-1 integrase inhibitor,potent",https://www.apexbt.com/search.php?catalog=A4070A4071,Fluorouracil (Adrucil),51-21-8,B08,L1021-04,130.1,DMSO,C4H3FN2O2,C1=C(C(=O)NC(=O)N1)F,insoluble in EtOH; ≥10.04 mg/mL in H2O with gentle warming and ultrasonic; ≥13.04 mg/mL in DMSO,Free Base,Proteases,HIV Integrase,Antitumor agent;inhibitor of thymidylate synthase,https://www.apexbt.com/search.php?catalog=A4071A4073,Raltegravir (MK-0518),518048-05-0,B09,L1021-04,444.4,DMSO,C20H21FN6O5,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL in DMSO ,Free Base,Proteases,HIV Integrase,HIV-1 integrase inhibitor,https://www.apexbt.com/search.php?catalog=A4073A4074,S/GSK1349572,1051375-16-6,B10,L1021-04,419.4,DMSO,C20H19F2N3O5,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,≥41.9 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,HIV Integrase,"HIV integrase inhibitor, novel and potent",https://www.apexbt.com/search.php?catalog=A4074A4078,Captopril,62571-86-2,B11,L1021-04,217.29,DMSO,C9H15NO3S,OC(C1CCCN1C(C(CS)C)=O)=O,≥21.7 mg/mL in DMSO; ≥105.2 mg/mL in EtOH with ultrasonic; ≥48.6 mg/mL in H2O with ultrasonic,,Endocrinology and Hormones,RAAS,,https://www.apexbt.com/search.php?catalog=A4078A4080,Moxonidine,75438-57-2,C01,L1021-04,241.68,DMSO,C9H12ClN5O,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,insoluble in H2O; ≥11.3 mg/mL in DMSO; ≥4.74 mg/mL in EtOH with ultrasonic,Free Base,Others,Imidazoline Receptors,I1R/_2AR agonist,https://www.apexbt.com/search.php?catalog=A4080A4082,Olmesartan medoxomil,144689-63-4,C02,L1021-04,558.6,DMSO,C29H30N6O6,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,≥21.1 mg/mL in DMSO; insoluble in H2O; ≥4.6 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Proteases,ACE,AT1 receptor antagonist,https://www.apexbt.com/search.php?catalog=A4082A4083,Rocilinostat (ACY-1215),1316214-52-4,C03,L1021-04,433.5,DMSO,C24H27N5O3,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,≥21.675 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,HDAC,Selective HDAC6 inhibitor,https://www.apexbt.com/search.php?catalog=A4083A4084,"Vorinostat (SAHA, MK0683)",149647-78-9,C04,L1021-04,264.3,DMSO,C14H20N2O3,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4084A4089,"Mocetinostat (MGCD0103, MG0103)",726169-73-9,C05,L1021-04,396.44,DMSO,C23H20N6O,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,HDAC,"HDAC inhibitor,isotype-selective and potent",https://www.apexbt.com/search.php?catalog=A4089A4092,CUDC-101,1012054-59-9,C06,L1021-04,434.49,DMSO,C24H26N4O4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,≥21.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,DNA Damage/DNA Repair,HDAC,Multitargeted HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4092A4095,Pracinostat (SB939),929016-96-6,C07,L1021-04,358.48,DMSO,C20H30N4O2,ONC(/C=C/C1=CC=C2N(CCN(CC)CC)C(CCCC)=NC2=C1)=O,insoluble in H2O; ≥11.4 mg/mL in DMSO; ≥24.8 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4095A4096,Belinostat (PXD101),414864-00-9,C08,L1021-04,318.35,DMSO,C15H14N2O4S,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,insoluble in H2O; ≥15.92 mg/mL in DMSO; ≥44.1 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,Hydroxamate-type HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4096A4098,PCI-24781 (CRA-024781),783355-60-2,C09,L1021-04,397.42,DMSO,C21H23N3O5,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL in DMSO with gentle warming,Free Base,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4098A4099,Valproic acid sodium salt (Sodium valproate),1069-66-5,C10,L1021-04,166.19,DMSO,C8H15NaO2,CCCC(CCC)C(=O)[O-].[Na+],≥8.35 mg/mL in DMSO; ≥88.2 mg/mL in H2O; ≥90.2 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4099A4107,Sodium Phenylbutyrate,1716-12-7,C11,L1021-04,186.18,DMSO,C10H11O2·Na,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+],≥27.65 mg/mL in H2O; ≥50.9 mg/mL in EtOH with ultrasonic; ≥6.3 mg/mL in DMSO,Sodium,DNA Damage/DNA Repair,HDAC,Histone deacetylase inhibitor,https://www.apexbt.com/search.php?catalog=A4107A4110,MLN8237 (Alisertib),1028486-01-2,D01,L1021-04,518.92,DMSO,C27H20ClFN4O4,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,≥25.95 mg/mL in DMSO; insoluble in H2O; insoluble in ETOH,Free Base,Chromatin/Epigenetics,Aurora Kinase,"Aurora A Kinase inhibitor, Potent and selective",https://www.apexbt.com/search.php?catalog=A4110A4111,"VX-680 (MK-0457,Tozasertib)",639089-54-6,D02,L1021-04,464.59,DMSO,C23H28N8OS,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5,≥23.25 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,Aurora Kinase,Aurora kinase inhibitor,https://www.apexbt.com/search.php?catalog=A4111A4112,Barasertib (AZD1152-HQPA),722544-51-6,D03,L1021-04,507.56,DMSO,C26H30FN7O3,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO,≥25.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,Aurora Kinase,"Aurora Kinase B inhibitor, Potent and selective",https://www.apexbt.com/search.php?catalog=A4112A4135,Tofacitinib (CP-690550) Citrate,540737-29-9,D04,L1021-04,504.49,DMSO,C16H20N6O·C6H8O7,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥25.22 mg/mL in DMSO; insoluble in EtOH; ≥3.4 mg/mL in H2O with gentle warming and ultrasonic,Citrate,Chromatin/Epigenetics,JAK,Potent JAK inhibitor,https://www.apexbt.com/search.php?catalog=A4135A4136,TG101348 (SAR302503),936091-26-8,D05,L1021-04,524.68,DMSO,C27H36N6O3S,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,≥26.23 mg/mL in DMSO; insoluble in H2O; ≥6.69 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Chromatin/Epigenetics,JAK,"JAK-2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A4136A4138,"Tofacitinib (CP-690550,Tasocitinib)",477600-75-2,D06,L1021-04,312.37,DMSO,C16H20N6O,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL in DMSO,Free Base,Chromatin/Epigenetics,JAK,Janus kinase inhibitor,https://www.apexbt.com/search.php?catalog=A4138A4141,"Baricitinib (LY3009104, INCB028050)",1187594-09-7,D07,L1021-04,371.42,DMSO,C16H17N7O2S,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL in DMSO,,Chromatin/Epigenetics,JAK,"JAK1/JAK2 inhibitor,selective orally bioavailable",https://www.apexbt.com/search.php?catalog=A4141A4147,LY2784544,1229236-86-5,D08,L1021-04,469.94,DMSO,C23H25ClFN7O,CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,≥23.5 mg/mL in DMSO; insoluble in H2O; ≥5.65 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Chromatin/Epigenetics,JAK,"JAK2 inhibitor,highly potent and selective",https://www.apexbt.com/search.php?catalog=A4147A4153,BMN 673,1207456-01-6,D09,L1021-04,380.35,DMSO,C19H14F2N6O,FC1=CC2=C3C([[C@H](C4=NC=NN4C)[[C@@H](C(C=C5)=CC=C5F)NC3=C1)=NNC2=O,insoluble in H2O; ≥14.2 mg/mL in EtOH with gentle warming and ultrasonic; ≥19.02 mg/mL in DMSO,,DNA Damage/DNA Repair,PARP,,https://www.apexbt.com/search.php?catalog=A4153A4154,"Olaparib (AZD2281, Ku-0059436)",763113-22-0,D10,L1021-04,434.46,DMSO,C24H23FN4O3,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,≥21.72 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,PARP,Potent PARP1/PARP2 inhibitor,https://www.apexbt.com/search.php?catalog=A4154A4156,"Rucaparib (AG-014699,PF-01367338)",459868-92-9,D11,L1021-04,421.36,DMSO,C19H18FN3O·H3PO4,OP(O)(O)=O.FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1,≥21.08 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Phosphate,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,https://www.apexbt.com/search.php?catalog=A4156A4157,Iniparib (BSI-201),160003-66-7,E01,L1021-04,292.03,DMSO,C7H5IN2O3,C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,insoluble in H2O; ≥103.4 mg/mL in DMSO; ≥24.3 mg/mL in EtOH with gentle warming and ultrasonic,,Chromatin/Epigenetics,PARP,"PARP1 inhibitor,intravenously adminsitered",https://www.apexbt.com/search.php?catalog=A4157A4168,Entacapone,130929-57-6,E02,L1021-04,305.29,DMSO,C14H15N3O5,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,insoluble in H2O; ≥12.65 mg/mL in EtOH with ultrasonic; ≥13.1 mg/mL in DMSO,,Chromatin/Epigenetics,Histone Methyltransferase,COMT inhibitor,https://www.apexbt.com/search.php?catalog=A4168A4176,Thioguanine,154-42-7,E03,L1021-04,167.19,DMSO,C5H5N5S,C1=NC2=C(N1)C(=S)N=C(N2)N,insoluble in EtOH; insoluble in H2O; ≥8.35 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,DNA Methyltransferase,Purine antimetabolite,https://www.apexbt.com/search.php?catalog=A4176A4181,EX 527 (SEN0014196),49843-98-3,E04,L1021-04,248.71,DMSO,C13H13ClN2O,ClC1=CC2=C(C=C1)NC3=C2CCCC3C(N)=O,insoluble in H2O; ≥12.43 mg/mL in DMSO; ≥25.45 mg/mL in EtOH with ultrasonic,Free Base,Chromatin/Epigenetics,Sirtuin,SIRT1 inhibitor,https://www.apexbt.com/search.php?catalog=A4181A4182,Resveratrol,501-36-0,E05,L1021-04,228.24,DMSO,C14H12O3,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,insoluble in H2O; ≥48.2 mg/mL in EtOH with ultrasonic; ≥9.65 mg/mL in DMSO,Free Base,Chromatin/Epigenetics,Sirtuin,SIRT1 activator,https://www.apexbt.com/search.php?catalog=A4182A4187,FG-4592 (ASP1517),808118-40-3,E06,L1021-04,352.34,DMSO,C19H16N2O5,CC1=NC(=C(C2=C1C=C(C=C2)OC3=CC=CC=C3)O)C(=O)NCC(=O)O,insoluble in H2O; ≥17.62 mg/mL in DMSO; ≥2.9 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Angiogenesis,HIF,HIF prolyl-hydroxylase inhibitor,https://www.apexbt.com/search.php?catalog=A4187A4188,2-Methoxyestradiol (2-MeOE2),362-07-2,E07,L1021-04,302.41,DMSO,C19H26O3,CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O,insoluble in H2O; ≥15.25 mg/mL in DMSO; ≥24.25 mg/mL in EtOH with ultrasonic,Free Base,Apoptosis,Apoptosis Inducers,"Apoptotic, antiproliferative and antiangiogenic agent",https://www.apexbt.com/search.php?catalog=A4188A4211,Lenalidomide (CC-5013),191732-72-6,E08,L1021-04,259.3,DMSO,C13H13N3O3,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL in DMSO,Free Base,Apoptosis,TNF-_,"Antineoplastic agent,inhibits angiogenesis",https://www.apexbt.com/search.php?catalog=A4211A4212,Pomalidomide (CC-4047),19171-19-8,E09,L1021-04,273.2,DMSO,C13H11N3O4,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL in DMSO,Free Base,Apoptosis,TNF-_,"Immunomodulator,antumor/anti-angiogenic",https://www.apexbt.com/search.php?catalog=A4212A4216,Thalidomide,50-35-1,E10,L1021-04,258.23,DMSO,C13H10N2O4,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,insoluble in H2O; insoluble in EtOH; ≥11.8 mg/mL in DMSO,Free Base,Apoptosis,TNF-_,"Immunomodulatory agent,sedative drug,angiogenesis inhibitor",https://www.apexbt.com/search.php?catalog=A4216A4219,Birinapant (TL32711),1260251-31-7,E11,L1021-04,806.94,DMSO,C42H56F2N8O6,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,≥40.35 mg/mL in DMSO; insoluble in H2O; ≥46.9 mg/mL in EtOH,Free Base,Apoptosis,IAP,Potent XIAP/cIAP1 antagonist,https://www.apexbt.com/search.php?catalog=A4219A4221,YM155,781661-94-7,F01,L1021-04,443.3,DMSO,C20H19BrN4O3,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-],≥22.15 mg/mL in DMSO; ≥13.49 mg/mL in EtOH with ultrasonic; ≥96.2 mg/mL in H2O with ultrasonic,Free Base,Apoptosis,IAP,"Survivin suppressant,apoptosis inhibitor",https://www.apexbt.com/search.php?catalog=A4221A4227,Tipifarnib (Zarnestra),192185-72-1,F02,L1021-04,489.4,DMSO,C27H22Cl2N4O,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,insoluble in H2O; ≥8.16 mg/mL in DMSO; ≥9.16 mg/mL in EtOH with ultrasonic,,Metabolism,Transferase,,https://www.apexbt.com/search.php?catalog=A4227A4232,Cyclophosphamide monohydrate,6055-19-2,F03,L1021-04,279.1,DMSO,C7H15Cl2N2O2P·H2O,C1CNP(=O)(OC1)N(CCCl)CCCl.O,≥13.95 mg/mL in DMSO; ≥51.5 mg/mL in H2O with gentle warming and ultrasonic; ≥96 mg/mL in EtOH,Monohydrate,Others,Others,"alkylating, cytotoxic agent,antitumor activity",https://www.apexbt.com/search.php?catalog=A4232A4233,Methylprednisolone,83-43-2,F04,L1021-04,374.48,DMSO,C22H30O5,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,insoluble in H2O; ≥15.35 mg/mL in DMSO; ≥9.5 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Glucocorticoid Receptor,"Apoptosis inducer,GR agonist",https://www.apexbt.com/search.php?catalog=A4233A4237,"Amuvatinib (MP-470, HPK 56)",850879-09-3,F05,L1021-04,447.51,DMSO,C23H21N5O3S,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,≥22.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A4237A4240,Abiraterone,154229-19-3,F06,L1021-04,349.52,DMSO,C24H31NO,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,insoluble in EtOH; insoluble in H2O; ≥5.57 mg/mL in DMSO with gentle warming,Free Base,Metabolism,P450,Potent CYP17 inhibitor,https://www.apexbt.com/search.php?catalog=A4240A4302,Rosiglitazone maleate,155141-29-0,F07,L1021-04,473.5,DMSO,C18H19N3O3S·C4H4O4,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O,≥23.7 mg/mL in DMSO; insoluble in H2O; ≥19 mg/mL in EtOH with ultrasonic,Maleate,Metabolism,PPAR,"PPAR_ agonist,high-affinity and selective,potent insulin sensitizer",https://www.apexbt.com/search.php?catalog=A4302A4304,Rosiglitazone,122320-73-4,F08,L1021-04,357.43,DMSO,C18H19N3O3S,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL in DMSO,Free Base,Metabolism,PPAR,Potent PPAR_ agonist,https://www.apexbt.com/search.php?catalog=A4304A4306,Ciprofibrate,52214-84-3,F09,L1021-04,289.15,DMSO,C13H14Cl2O3,CC(C(O)=O)(OC1=CC=C(C2CC2(Cl)Cl)C=C1)C,insoluble in H2O; ≥10.85 mg/mL in DMSO; ≥94.6 mg/mL in EtOH,,Metabolism,PPAR,PPAR_ agonist,https://www.apexbt.com/search.php?catalog=A4306A4310,Rosiglitazone HCl,302543-62-0,F10,L1021-04,393.89,DMSO,C18H20ClN3O3S,CN(C1=CC=CC=N1)CCOC2=CC=C(CC3C(NC(S3)=O)=O)C=C2.Cl,≥39.4 mg/mL in DMSO; ≥2.81 mg/mL in H2O with gentle warming and ultrasonic; ≥51.2 mg/mL in EtOH with ultrasonic,,Metabolism,PPAR,PPAR_ agonist,https://www.apexbt.com/search.php?catalog=A4310A4313,Cobicistat (GS-9350),1004316-88-4,F11,L1021-04,776.02,DMSO,C40H53N7O5S2,CC(C1=NC(CN(C(NC(C(NC(CC2=CC=CC=C2)CCC(NC(OCC3=CN=CS3)=O)CC4=CC=CC=C4)=O)CCN5CCOCC5)=O)C)=CS1)C,insoluble in H2O; ≥150.9 mg/mL in DMSO; ≥102.4 mg/mL in EtOH with ultrasonic,,Metabolism,CYP3A/CYP450,Selective CYP3A inhibitor,https://www.apexbt.com/search.php?catalog=A4313A4316,Ketoconazole,65277-42-1,G01,L1021-04,531.43,DMSO,C26H28Cl2N4O4,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,≥23.4 mg/mL in DMSO; insoluble in H2O; ≥10 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,P450,Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase,https://www.apexbt.com/search.php?catalog=A4316A4317,Apremilast (CC-10004),608141-41-9,G02,L1021-04,460.5,DMSO,C22H24N2O7S,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,≥23.05 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Metabolism,PDE,PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=A4317A4319,Roflumilast,162401-32-3,G03,L1021-04,403.21,DMSO,C17H14Cl2F2N2O3,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,insoluble in H2O; ≥20.2 mg/mL in DMSO; ≥9.94 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,PDE,PDE-4 inhibitor,https://www.apexbt.com/search.php?catalog=A4319A4320,Voriconazole,137234-62-9,G04,L1021-04,349.31,DMSO,C16H14F3N5O,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,≥34.9 mg/mL in DMSO; insoluble in H2O; ≥45 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,CYP3A/CYP450,CYP51 inhibitor,https://www.apexbt.com/search.php?catalog=A4320A4321,Sildenafil Citrate,171599-83-0,G05,L1021-04,666.7,DMSO,C22H30N6O4S·C6H8O7,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥25.35 mg/mL in DMSO; insoluble in EtOH; ≥2.97 mg/mL in H2O with gentle warming and ultrasonic,Citrate,Metabolism,PDE,Treat erectile dysfunction and PAH,https://www.apexbt.com/search.php?catalog=A4321A4322,Clarithromycin,81103-11-9,G06,L1021-04,747.95,DMSO,C38H69NO13,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,≥31.2 mg/mL in DMSO; insoluble in H2O; ≥3.24 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,CYP3A/CYP450,"CYP3A inhibitor, potent",https://www.apexbt.com/search.php?catalog=A4322A4323,Vardenafil HCl Trihydrate,330808-88-3,G07,L1021-04,579.11,DMSO,C23H32N6O4S·HCl·3H2O,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,≥13.3 mg/mL in DMSO; ≥3.42 mg/mL in EtOH with gentle warming and ultrasonic; ≥95 mg/mL in H2O,,Metabolism,PDE,,https://www.apexbt.com/search.php?catalog=A4323A4324,Pioglitazone HCl,112529-15-4,G08,L1021-04,392.9,DMSO,C19H20N2O3S·HCl,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl,insoluble in H2O; ≥19.65 mg/mL in DMSO; ≥7.52 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Metabolism,PPAR,PPAR_ agonist,https://www.apexbt.com/search.php?catalog=A4324A4327,Tadalafil,171596-29-5,G09,L1021-04,389.4,DMSO,C22H19N3O4,O=C1N(C)CC(N([[C@@H]2C(C=C3)=CC4=C3OCO4)[[C@H]1([H])CC5=C2NC6=CC=CC=C56)=O,insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL in DMSO,Free Base,Metabolism,PDE,PDE5 inhibitor,https://www.apexbt.com/search.php?catalog=A4327A4328,Rolipram,61413-54-5,G10,L1021-04,275.34,DMSO,C16H21NO3,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,insoluble in H2O; ≥13 mg/mL in DMSO; ≥24.65 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,PDE,PDE4-inhibitor and an anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=A4328A4329,Cilomilast,153259-65-5,G11,L1021-04,343.42,DMSO,C20H25NO4,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,insoluble in H2O; ≥12.95 mg/mL in DMSO; ≥49.9 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,PDE,Potent PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=A4329A4330,Isotretinoin,4759-48-2,H01,L1021-04,300.44,DMSO,C20H28O2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥24.3 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,Dopamine _-hydroxylase,Dopamine _-hydroxylase activator,https://www.apexbt.com/search.php?catalog=A4330A4334,Avanafil,330784-47-9,H02,L1021-04,483.95,DMSO,C23H26ClN7O3,O=C(C1=CN=C(N2[[C@H](CO)CCC2)N=C1NCC3=CC=C(OC)C(Cl)=C3)NCC4=NC=CC=N4,insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL in DMSO,Free Base,Metabolism,PDE,PDE5 inhibitor,https://www.apexbt.com/search.php?catalog=A4334A4336,Mycophenolate Mofetil,128794-94-5,H03,L1021-04,433.49,DMSO,C23H31NO7,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC,insoluble in H2O; ≥15.68 mg/mL in EtOH with ultrasonic; ≥16.25 mg/mL in DMSO,Free Base,Metabolism,Dehydrogenase,IMPDH inhibitor,https://www.apexbt.com/search.php?catalog=A4336A4337,Cilostazol,73963-72-1,H04,L1021-04,369.46,DMSO,C20H27N5O2,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,insoluble in H2O; ≥15.4 mg/mL in DMSO; ≥3.95 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,PDE,PDE3 inhibitor,https://www.apexbt.com/search.php?catalog=A4337A4338,Rivaroxaban,366789-02-8,H05,L1021-04,435.88,DMSO,C19H18ClN3O5S,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,insoluble in H2O; insoluble in EtOH; ≥13.9 mg/mL in DMSO with gentle warming,Free Base,Metabolism,Factor Xa,Factor Xa inhibitor,https://www.apexbt.com/search.php?catalog=A4338A4340,Pimobendan,74150-27-9,H06,L1021-04,334.37,DMSO,C19H18N4O2,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥19.48 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,PDE,Selective PDE3 inhibitor.Ca2+ channel sensitizer,https://www.apexbt.com/search.php?catalog=A4340A4341,Apixaban,503612-47-3,H07,L1021-04,459.5,DMSO,C25H25N5O4,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,insoluble in H2O; ≥10.64 mg/mL in EtOH with gentle warming and ultrasonic; ≥11.5 mg/mL in DMSO,Free Base,Proteases,Thrombin,Factor Xa inhibitor,https://www.apexbt.com/search.php?catalog=A4341A4342,Gimeracil,103766-25-2,H08,L1021-04,145.54,DMSO,C5H4ClNO2,C1=C(C(=CNC1=O)Cl)O,insoluble in H2O; ≥6.56 mg/mL in EtOH with gentle warming and ultrasonic; ≥6.6 mg/mL in DMSO,Free Base,Metabolism,Dehydrogenase,Dihydropyrimidine dehydrogenase inhibitor,https://www.apexbt.com/search.php?catalog=A4342A4343,Dyphylline,479-18-5,H09,L1021-04,254.24,DMSO,C10H14N4O4,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,≥17.17 mg/mL in H2O; ≥21.96 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.8 mg/mL in DMSO,Free Base,Metabolism,PDE,Pan-PDE inhibitor,https://www.apexbt.com/search.php?catalog=A4343A4344,Ozagrel,82571-53-7,H10,L1021-04,228.25,DMSO,C13H12N2O2,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O,≥10.8 mg/mL in DMSO; ≥13.23 mg/mL in EtOH with gentle warming and ultrasonic; ≥17.03 mg/mL in H2O,Free Base,Metabolism,Factor Xa,Thromboxane A2 synthetase inhibitor,https://www.apexbt.com/search.php?catalog=A4344A4346,Aminophylline,317-34-0,H11,L1021-04,420.43,H2O,C16H24N10O4,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,≥13.48 mg/mL in DMSO with gentle warming and ultrasonic; ≥14.45 mg/mL in H2O with gentle warming; ≥16.933 mg/mL in EtOH with gentle warming and ultrasonic,Ethylenediamine,Metabolism,PDE,Pan-PDE inhibitor,https://www.apexbt.com/search.php?catalog=A4346A4347,Methotrexate,59-05-2,A01,L1021-05,454.44,DMSO,C20H22N8O5,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,≥21.55 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Metabolism,DHFR,"Folate antagonist,inhibits DFHR",https://www.apexbt.com/search.php?catalog=A4347A4348,Trilostane,13647-35-3,A02,L1021-05,329.43,DMSO,C20H27NO3,N#CC1=C([[C@H@]2([H])O[[C@H@]2(C([H])([H])C3([H])[H])[[C@H@](C1([H])[H])(C([H])([H])[H])[[C@H]4([H])[[C@H]3([H])[[C@H@](C([H])([H])C([H])([H])[[C@H]5([H])O[H])([H])[[C@H]5(C([H])([H])[H])C([H])([H])C4([H])[H])O[H],insoluble in H2O; insoluble in EtOH; ≥16.35 mg/mL in DMSO,Free Base,Metabolism,Dehydrogenase,3_-HSD inhibitor,https://www.apexbt.com/search.php?catalog=A4348A4349,S- (+)-Rolipram,85416-73-5,A03,L1021-05,275.34,DMSO,C16H21NO3,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,insoluble in H2O; ≥13.9 mg/mL in DMSO; ≥20.76 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,PDE,CAMP-specific PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=A4349A4350,Pralatrexate,146464-95-1,A04,L1021-05,477.47,DMSO,C23H23N7O5,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,≥23.85 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Metabolism,DHFR,"Antifolate,a folate analog",https://www.apexbt.com/search.php?catalog=A4350A4352,Anagrelide HCl,58579-51-4,A05,L1021-05,292.55,DMSO,C10H8Cl3N3O,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31.Cl,insoluble in EtOH; insoluble in H2O; ≥4.9 mg/mL in DMSO,Hydrochloride,Metabolism,PDE,Thrombocytopenic agent,https://www.apexbt.com/search.php?catalog=A4352A4353,Pyrimethamine,58-14-0,A06,L1021-05,248.71,DMSO,C12H13ClN4,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥10 mg/mL in DMSO with gentle warming; ≥5.23 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,DHFR,DHFR inhibitor,https://www.apexbt.com/search.php?catalog=A4353A4357,Dorzolamide HCl,130693-82-2,A07,L1021-05,360.9,DMSO,C10H16N2O4S3·HCl,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl,insoluble in EtOH; ≥13 mg/mL in H2O; ≥18.67 mg/mL in DMSO with ultrasonic,Hydrochloride,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A4357A4359,Brinzolamide,138890-62-7,A08,L1021-05,383.51,DMSO,C12H21N3O5S3,O=S(C(S1)=CC2=C1S(N(CCCOC)C[[C@@H]2NCC)(=O)=O)(N)=O,insoluble in H2O; ≥15.05 mg/mL in DMSO; ≥8.82 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,Carbonic Anhydrase,CA II inhibitor,https://www.apexbt.com/search.php?catalog=A4359A4360,Topiramate,97240-79-4,A09,L1021-05,339.36,DMSO,C12H21NO8S,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,≥16.95 mg/mL in DMSO; ≥2.22 mg/mL in H2O with ultrasonic; ≥24.1 mg/mL in EtOH,Free Base,Metabolism,Carbonic Anhydrase,"GluR5 receptor antagonist,anticonvulsant",https://www.apexbt.com/search.php?catalog=A4360A4362,Tioxolone,4991-65-5,A10,L1021-05,168.17,DMSO,C7H4O3S,OC1=CC(OC(S2)=O)=C2C=C1,≥63.2 mg/mL in DMSO; ≥2.33 mg/mL in H2O with gentle warming and ultrasonic; ≥22.7 mg/mL in EtOH with ultrasonic,,Metabolism,Carbonic Anhydrase,CAI inhibitor,https://www.apexbt.com/search.php?catalog=A4362A4363,Fluvastatin Sodium,93957-55-2,A11,L1021-05,433.45,DMSO,C24H25FNNaO4,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+],≥16.83 mg/mL in EtOH; ≥18.15 mg/mL in DMSO; ≥8.22 mg/mL in H2O,Sodium,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A4363A4364,Methazolamide,554-57-4,B01,L1021-05,236.27,DMSO,C5H8N4O3S2,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,≥11.18 mg/mL in EtOH with gentle warming and ultrasonic; ≥2.58 mg/mL in H2O with gentle warming and ultrasonic; ≥7.25 mg/mL in DMSO ,Free Base,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A4364A4365,Lovastatin,75330-75-5,B02,L1021-05,404.54,DMSO,C24H36O5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,insoluble in H2O; ≥18.6 mg/mL in EtOH with ultrasonic; ≥20.2 mg/mL in DMSO,Free Base,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A4365A4366,Rasagiline Mesylate,161735-79-1,B03,L1021-05,267.34,DMSO,C12H13N·CH4O3S,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,≥13.37 mg/mL in DMSO; ≥46 mg/mL in EtOH with ultrasonic; ≥95.8 mg/mL in H2O,Mesylate,Metabolism,MAO,Irreversible MAO-B inhibitor,https://www.apexbt.com/search.php?catalog=A4366A4367,Atorvastatin Calcium,134523-03-8,B04,L1021-05,1155.34,DMSO,2(C33H34FN2O5)·Ca,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],≥57.75 mg/mL in DMSO; insoluble in H2O; ≥2.94 mg/mL in EtOH with gentle warming and ultrasonic,Calcium,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A4367A4368,Safinamide Mesylate,202825-46-5,B05,L1021-05,398.45,DMSO,C17H19FN2O2·CH4O3S,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O,≥10.08 mg/mL in EtOH with gentle warming and ultrasonic; ≥16.1 mg/mL in DMSO; ≥84.6 mg/mL in H2O,Mesylate,Metabolism,MAO,"MAO-B inhibitor,potent,selective and reversible",https://www.apexbt.com/search.php?catalog=A4368A4369,Pravastatin sodium,81131-70-6,B06,L1021-05,446.51,DMSO,C23H35O7·Na,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+],≥100.4 mg/mL in EtOH with ultrasonic; ≥13.15 mg/mL in DMSO; ≥98.8 mg/mL in H2O,Free Base,Metabolism,HMG-CoA Reductase,"HMG-CoA reductase inhibitor,highly selective and competitive",https://www.apexbt.com/search.php?catalog=A4369A4370,Moclobemide (Ro 111163),71320-77-9,B07,L1021-05,268.74,DMSO,C13H17ClN2O2,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥48.3 mg/mL in EtOH with ultrasonic; ≥9.85 mg/mL in DMSO,Free Base,Metabolism,MAO,Reversible inhibitor of MAO-A,https://www.apexbt.com/search.php?catalog=A4370A4377,Evacetrapib (LY2484595),1186486-62-3,B08,L1021-05,638.65,DMSO,C31H36F6N6O2,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,≥32.1 mg/mL in DMSO; insoluble in H2O; ≥50.4 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,CETP,"CETP inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A4377A4378,Torcetrapib,262352-17-0,B09,L1021-05,600.47,DMSO,C26H25F9N2O4,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,≥22.4 mg/mL in DMSO; insoluble in H2O; ≥69 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,CETP,CETP inhibitor,https://www.apexbt.com/search.php?catalog=A4378A4379,Lonafarnib,193275-84-2,B10,L1021-05,638.82,DMSO,C27H31Br2ClN4O2,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(C=C(C=C4CCC5=CC(=CN=C35)Br)Cl)Br)C(=O)N,≥31.95 mg/mL in DMSO; insoluble in H2O; ≥96.4 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,Transferase,"Ftase inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A4379A4383,Tolcapone,134308-13-7,B11,L1021-05,273.24,DMSO,C14H11NO5,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],insoluble in H2O; ≥12 mg/mL in DMSO; ≥5.78 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,Transferase,COMT inhibitor,https://www.apexbt.com/search.php?catalog=A4383A4385,Ganetespib (STA-9090),888216-25-9,C01,L1021-05,364.4,DMSO,C20H20N4O3,CC(C)C1=CC(=C2NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)C(=O)C=C1O,insoluble in H2O; ≥18.22 mg/mL in DMSO; ≥6.4 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Proteases,HSP,"Hsp90 inhibitor,non-geldanamycin",https://www.apexbt.com/search.php?catalog=A4385A4390,Pemetrexed,150399-23-8,C02,L1021-05,471.37,DMSO,C20H19N5Na2O6,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],insoluble in EtOH; ≥15.68 mg/mL in DMSO with gentle warming and ultrasonic; ≥30.67 mg/mL in H2O,Free Base,Metabolism,DHFR,"TS, DHFR,GARFT and AICARFT inhibitor",https://www.apexbt.com/search.php?catalog=A4390A4393,Paclitaxel (Taxol),33069-62-4,C03,L1021-05,853.91,DMSO,C47H51NO14,O=C(N[[C@H]([[C@H](C(O[[C@H]1C[[C@H]2(O)C(C)(C)C([[C@@H](OC(C)=O)C([[C@H@]3(C)[[C@H]([[C@H@](CO4)(OC(C)=O)[[C@H]4C[[C@@H]3O)([H])[[C@@H]2OC(C5=CC=CC=C5)=O)=O)=C1C)=O)O)C6=CC=CC=C6)C7=CC=CC=C7,≥42.7 mg/mL in DMSO; insoluble in H2O; insoluble in H2O; ≥29.53 mg/mL in EtOH with ultrasonic; ≥31.6 mg/mL in EtOH with ultrasonic,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Antineoplastic agent,https://www.apexbt.com/search.php?catalog=A4393A4394,Docetaxel,114977-28-5,C04,L1021-05,807.88,DMSO,C43H53NO14,O=C(N[[C@H]([[C@H](C(O[[C@H]1C[[C@H]2(O)C(C)(C)C([[C@@H](O)C([[C@H@]3(C)[[C@H]([[C@H@](CO4)(OC(C)=O)[[C@H@]4([H])C[[C@@H]3O)([H])[[C@@H]2OC(C5=CC=CC=C5)=O)=O)=C1C)=O)O)C6=CC=CC=C6)OC(C)(C)C,≥40.4 mg/mL in DMSO; insoluble in H2O; ≥94.4 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubulin disassembly inhibitor,https://www.apexbt.com/search.php?catalog=A4394A4395,10-DAB (10-Deacetylbaccatin),32981-86-5,C05,L1021-05,544.59,DMSO,C29H36O10,O[[C@H](C(C)(C)C1=C(C)[[C@H]2O)(C2)[[C@H]([[C@@H]([[C@H@](C([[C@H]1O)=O)(C)[[C@@H]3O)[[C@H]4([[C@@H](C3)OC4)OC(C)=O)OC(C5=CC=CC=C5)=O,≥22.25 mg/mL in DMSO; insoluble in H2O; ≥3.96 mg/mL in EtOH with ultrasonic,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Precursor of antitumor compound Palitaxel and Docetaxel,https://www.apexbt.com/search.php?catalog=A4395A4448,Actinomycin D,50-76-0,C06,L1021-05,1255.43,DMSO,C62H86N12O16,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,≥62.75 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Apoptosis,Apoptosis Inducers,,https://www.apexbt.com/search.php?catalog=A4448A4452,Mitomycin C,50-07-7,C07,L1021-05,334.33,DMSO,C15H18N4O5,NC(C1=O)=C(C)C(C2=C1[[C@@H](COC(N)=O)[[C@H]3(OC)N2C[[C@H]4[[C@@H]3N4)=O,insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL in DMSO,Free Base,Apoptosis,Apoptosis Inducers,"Inhibits DNA synthesis,antibiotic and antitumor agent",https://www.apexbt.com/search.php?catalog=A4452A4457,Streptozocin,18883-66-4,C08,L1021-05,265.22,DMSO,C8H15N3O7,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,≥10.3 mg/mL in DMSO; ≥26.5 mg/mL in EtOH with gentle warming; ≥53.2 mg/mL in H2O,Free Base,Apoptosis,Apoptosis Inducers,Antibiotic and antitumor agent,https://www.apexbt.com/search.php?catalog=A4457A4468,Cesium chloride,7647-17-8,C09,L1021-05,168.36,H2O,ClCs,[Cs+].[Cl-],insoluble in EtOH; insoluble in DMSO; ≥90.6 mg/mL in H2O,,Apoptosis,Other Apoptosis,,https://www.apexbt.com/search.php?catalog=A4468A4473,Melphalan,148-82-3,C10,L1021-05,305.2,DMSO,C13H18Cl2N2O2,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,insoluble in H2O; insoluble in EtOH; ≥6.85 mg/mL in DMSO,Free Base,Apoptosis,Other Apoptosis,DNA alkylating agent,https://www.apexbt.com/search.php?catalog=A4473A4601,Empagliflozin (BI 10773),864070-44-0,C11,L1021-05,450.91,DMSO,C23H27ClO7,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,insoluble in H2O; ≥20.75 mg/mL in DMSO; ≥7.06 mg/mL in EtOH with ultrasonic,,Metabolism,SGLT,SGLT-2 inhibitor for oral treatment of type 2 diabetes,https://www.apexbt.com/search.php?catalog=A4601A5010,Asenapine,85650-56-2,D01,L1021-05,401.84,DMSO,C17H16ClNO·C4H4O4,[H][[C@H@]1(C(C=C(Cl)C=C2)=C2OC3=C4C=CC=C3)[[C@H]4([H])CN(C)C1.OC(/C=C/C(O)=O)=O,≥20.09 mg/mL in DMSO; ≥24.75 mg/mL in EtOH with ultrasonic; ≥3.025 mg/mL in H2O with ultrasonic,Free Base,Neuroscience,5-HT Receptor,Inhibits adrenergic receptor/5-HT receptor,https://www.apexbt.com/search.php?catalog=A5010A5047,Ivacaftor (VX-770),873054-44-5,D02,L1021-05,392.49,DMSO,C24H28N2O3,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,insoluble in H2O; ≥19.6 mg/mL in DMSO; ≥2.95 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,CFTR,Potent CFTR potentiator,https://www.apexbt.com/search.php?catalog=A5047A5059,Edaravone,89-25-8,D03,L1021-05,174.2,DMSO,C10H10N2O,CC1=NN(C(=O)C1)C2=CC=CC=C2,insoluble in H2O; ≥47.8 mg/mL in EtOH with ultrasonic; ≥6.45 mg/mL in DMSO,Free Base,Others,Others,A radical scavenger and antioxidant,https://www.apexbt.com/search.php?catalog=A5059A5065,Bicalutamide,90357-06-5,D04,L1021-05,430.37,DMSO,C18H14F4N2O4S,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,≥21.5 mg/mL in DMSO; insoluble in H2O; ≥4.3 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,https://www.apexbt.com/search.php?catalog=A5065A5066,Heparin sodium,9041-08-1,D05,L1021-05,6000-20000,H2O,(C12H16NS2Na3)20,CCC1CC(N[R])C(OC1CO[S]([O-])(=O)=O)OC2C(O)C(O)C(OC3C(CO[R])OC(OC4C(O)C(O[S]([O-])(=O)=O)C(OC5C(O)C(N[S]([O-])(=O)=O)C(C)OC5CO[S]([O-])(=O)=O)OC4C([O-])=O)C(N[S]([O-])(=O)=O)C3[S]([O-])(=O)=O)OC2C([O-])=O,insoluble in EtOH; insoluble in DMSO; ≥12.75 mg/mL in H2O,Free Base,Proteases,Thrombin,Antithrombin III activator,https://www.apexbt.com/search.php?catalog=A5066A5124,Meropenem,96036-03-2,D06,L1021-05,383.46,DMSO,C17H25N3O5S,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,insoluble in EtOH; ≥19.15 mg/mL in DMSO; ≥9.88 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,_-lactam antibiotic of the carbapenem subclass,https://www.apexbt.com/search.php?catalog=A5124A5133,Irinotecan,97682-44-5,D07,L1021-05,586.68,DMSO,C33H38N4O6,O=C(OC1)C(O)(CC)C2=C1C(N(CC3=C4N=C5C(C=C(OC(N6CCC(N7CCCCC7)CC6)=O)C=C5)=C3CC)C4=C2)=O,insoluble in H2O; ≥11.4 mg/mL in DMSO; ≥4.9 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase I inhibitor,https://www.apexbt.com/search.php?catalog=A5133A5143,Finasteride,98319-26-7,D08,L1021-05,372.54,DMSO,C23H36N2O2,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,insoluble in H2O; ≥14.65 mg/mL in DMSO; ≥76.4 mg/mL in EtOH,Free Base,Endocrinology and Hormones,5-alpha Reductase,Inhibitor of Type II 5_-reductase,https://www.apexbt.com/search.php?catalog=A5143A5166,Ondansetron HCl,99614-01-4,D09,L1021-05,329.82,DMSO,C18H19N3O·HCl,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,insoluble in EtOH; insoluble in H2O; ≥25.5 mg/mL in DMSO,Hydrochloride,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,https://www.apexbt.com/search.php?catalog=A5166A5173,Alfuzosin HCl,81403-68-1,D10,L1021-05,425.91,DMSO,C19H27N5O4·HCl,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl,≥19 mg/mL in DMSO; ≥3 mg/mL in EtOH with ultrasonic; ≥47.8 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,"_1 adrenoceptor antagonist,functionally uro-selective",https://www.apexbt.com/search.php?catalog=A5173A5181,Linezolid,165800-03-3,D11,L1021-05,337.35,DMSO,C16H20FN3O4,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,≥16.85 mg/mL in DMSO; ≥2.48 mg/mL in H2O with gentle warming and ultrasonic; ≥9.5 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Antibacterial reagent,https://www.apexbt.com/search.php?catalog=A5181A5183,Clopidogrel,120202-66-6,E01,L1021-05,419.9,DMSO,C16H16ClNO2S·H2SO4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O,≥20.995 mg/mL in DMSO; ≥48.6 mg/mL in H2O; ≥50 mg/mL in EtOH with ultrasonic,Sulfate,Neuroscience,P2 Receptor,P2Y12 receptor antagonist,https://www.apexbt.com/search.php?catalog=A5183A5220,Vecuronium Bromide,50700-72-6,E02,L1021-05,637.73,DMSO,C34H57N2O4·Br,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],≥31.89 mg/mL in DMSO; insoluble in H2O; ≥98.6 mg/mL in EtOH with ultrasonic,Bromide,Neuroscience,AChR,Nonpolarizing neuromuscular relaxant,https://www.apexbt.com/search.php?catalog=A5220A5226,Tigecycline,220620-09-7,E03,L1021-05,585.65,DMSO,C29H39N5O8,CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O,≥29.3 mg/mL in DMSO; insoluble in EtOH; ≥32.47 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Glycylcycline antibiotic,https://www.apexbt.com/search.php?catalog=A5226A5275,Tenofovir,147127-20-6,E04,L1021-05,287.21,DMSO,C9H14N5O4P,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,insoluble in EtOH; insoluble in H2O; ≥4.38 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Reverse Transcriptase,HIV reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A5275A5293,Risedronate Sodium,115436-72-1,E05,L1021-05,305.09,H2O,C7H10NNaO7P2,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+],insoluble in EtOH; insoluble in DMSO; ≥10.17 mg/mL in H2O with gentle warming,,Others,Others,FPP synthase inhibitor,https://www.apexbt.com/search.php?catalog=A5293A5294,Sumatriptan Succinate,103628-48-4,E06,L1021-05,413.49,DMSO,C14H21N3O2S·C4H6O4,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O,insoluble in EtOH; ≥136.8 mg/mL in DMSO; ≥47.2 mg/mL in H2O,,Neuroscience,5-HT Receptor,5-HT1 receptor agonist,https://www.apexbt.com/search.php?catalog=A5294A5300,Ranolazine 2HCl,95635-56-6,E07,L1021-05,500.46,DMSO,C24H33N3O4·2HCl,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O.Cl.Cl,≥20.25 mg/mL in DMSO; ≥3.34 mg/mL in EtOH with ultrasonic; ≥47.2 mg/mL in H2O,Dihydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Partial fatty acid oxidation inhibitor,https://www.apexbt.com/search.php?catalog=A5300A5316,Repaglinide,135062-02-1,E08,L1021-05,452.59,DMSO,C27H36N2O4,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,insoluble in H2O; ≥16.73 mg/mL in EtOH with ultrasonic; ≥17 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 (KATP) channel blocker,https://www.apexbt.com/search.php?catalog=A5316A5318,Prazosin HCl,19237-84-4,E09,L1021-05,419.86,DMSO,C19H21N5O4·HCl,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl,insoluble in H2O; insoluble in EtOH; ≥6.99 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,_1 and _2B-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=A5318A5322,Tianeptine sodium,30123-17-2,E10,L1021-05,458.93,DMSO,C21H24ClN2NaO4S,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)[O-].[Na+],≥22.95 mg/mL in DMSO; ≥16.27 mg/mL in EtOH with ultrasonic; ≥50.3 mg/mL in H2O with ultrasonic,Sodium Salt,Neuroscience,5-HT Receptor,"5-HT uptake facilitator,selective,antidepressant",https://www.apexbt.com/search.php?catalog=A5322A5323,Moxifloxacin HCl,186826-86-8,E11,L1021-05,437.89,DMSO,C21H24FN3O4·HCl,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,insoluble in EtOH; ≥19.15 mg/mL in DMSO; ≥25.4 mg/mL in H2O with gentle warming,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,Fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=A5323A5331,"TSU-68 (SU6668,Orantinib)",252916-29-3,F01,L1021-05,310.35,DMSO,C18H18N2O3,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL in DMSO,Free Base,Tyrosine Kinase,VEGFR,"PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive",https://www.apexbt.com/search.php?catalog=A5331A5343,Ispinesib (SB-715992),336113-53-2,F02,L1021-05,517.06,DMSO,C30H33ClN4O2,CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C,≥25.85 mg/mL in DMSO; insoluble in H2O; ≥48.4 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,Ksp,Kinesin spindle protein (KSP)inhibitor,https://www.apexbt.com/search.php?catalog=A5343A5346,Marbofloxacin,115550-35-1,F03,L1021-05,362.36,DMSO,C17H19FN4O4,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)N(C([H])([H])[H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],insoluble in EtOH; insoluble in H2O; ≥6.18 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Fluoroquinolone antibiotic for veterinary use,https://www.apexbt.com/search.php?catalog=A5346A5350,Ziprasidone HCl,122883-93-6,F04,L1021-05,449.4,DMSO,C21H21ClN4OS·HCl,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl,≥22.47 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Hydrochloride,Neuroscience,5-HT Receptor,Serotonin and dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A5350A5354,Zonisamide,68291-97-4,F05,L1021-05,212.23,DMSO,C8H8N2O3S,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,insoluble in H2O; ≥8.35 mg/mL in DMSO; ≥9.48 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic with anticonvulsant and mechanistic effect,https://www.apexbt.com/search.php?catalog=A5354A5355,Venlafaxine,99300-78-4,F06,L1021-05,313.86,DMSO,C17H27NO2·HCl,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl,≥28.65 mg/mL in DMSO; ≥56.5 mg/mL in H2O; ≥59.7 mg/mL in EtOH,Hydrochloride,Neuroscience,5-HT Receptor,Dual serotonin/noradrenalin re-uptake inhibitor,https://www.apexbt.com/search.php?catalog=A5355A5375,Tranilast,53902-12-8,F07,L1021-05,327.33,DMSO,C18H17NO5,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,≥32.7 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,GPCR/G protein,Angiotensin Receptor,Angiogenesis inhibitor,https://www.apexbt.com/search.php?catalog=A5375A5384,Zileuton,111406-87-2,F08,L1021-05,236.29,DMSO,C11H12N2O2S,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,insoluble in H2O; ≥12.73 mg/mL in EtOH; ≥13.3 mg/mL in DMSO,Free Base,Immunology/Inflammation,5-Lipoxygenase,"5-lipoxygenase (5-LOX) inhibitor, orally active",https://www.apexbt.com/search.php?catalog=A5384A5391,Varenicline Tartrate,375815-87-5,F09,L1021-05,361.35,DMSO,C13H13N3·C4H6O6,O=C([[C@H]([[C@H@](C(O[H])=O)([H])O[H])([H])O[H])O[H].[H][[C@H@]12C([H])([H])C(C([H])([H])N([H])C2([H])[H])([H])C3=C([H])C4=NC([H])=C([H])N=C4C([H])=C13,insoluble in EtOH; ≥18.07 mg/mL in DMSO; ≥96.2 mg/mL in H2O,Tartrate,Neuroscience,AChR,"Subtype-selective agonist of _4_2 nicotinic receptors,orally active",https://www.apexbt.com/search.php?catalog=A5391A5399,Iloperidone,133454-47-4,F10,L1021-05,426.48,DMSO,C24H27FN2O4,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,≥21.32 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Neuroscience,5-HT Receptor,Dopamine (D2) and serotonin (5HT2) receptor antagonist,https://www.apexbt.com/search.php?catalog=A5399A5413,HMN-214,173529-46-9,F11,L1021-05,424.47,DMSO,C22H20N2O5S,CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC,≥21.2 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,#N/A,Cell Cycle/Checkpoint,PLK,"Plk inhibitor,broad-spectrum anti-tumor agent",https://www.apexbt.com/search.php?catalog=A5413A5424,Fludarabine,21679-14-1,G01,L1021-05,285.23,DMSO,C10H12FN5O4,C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F,insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor,https://www.apexbt.com/search.php?catalog=A5424A5467,Ponatinib (AP24534),943319-70-8,G02,L1021-05,532.56,DMSO,C29H27F3N6O,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,≥53.3 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,TGF-_ / Smad Signaling,Bcr-Abl,"pan-BCR-ABL inhibitor,multi-kinase inhibitor",https://www.apexbt.com/search.php?catalog=A5467A5489,Zibotentan (ZD4054),186497-07-4,G03,L1021-05,424.43,DMSO,C19H16N6O4S,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,insoluble in EtOH; insoluble in H2O; ≥7.2 mg/mL in DMSO,Free Base,GPCR/G protein,Endothelin Receptor,"ETA receptor antagonist,potent and specific",https://www.apexbt.com/search.php?catalog=A5489A5511,Ofloxacin,82419-36-1,G04,L1021-05,361.37,DMSO,C18H20FN3O4,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],insoluble in H2O; insoluble in EtOH; ≥12.03 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolones,antibiotics",https://www.apexbt.com/search.php?catalog=A5511A5559,Cefaclor,53994-73-3,G05,L1021-05,367.81,H2O,C15H14ClN3O4S,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,insoluble in EtOH; insoluble in DMSO; ≥3.68 mg/mL in H2O with gentle warming and ultrasonic,,Microbiology & Virology,Antibiotic,Cephalosporin antibiotic inhibiting cell wall synthesis.,https://www.apexbt.com/search.php?catalog=A5559A5566,LY2228820,862507-23-1,G06,L1021-05,612.74,DMSO,C24H29FN6·2CH4O3S,CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N.CS(=O)(=O)O.CS(=O)(=O)O,≥30.65 mg/mL in DMSO; ≥45 mg/mL in H2O with ultrasonic; ≥9.9 mg/mL in EtOH with ultrasonic,Mesylate,MAPK Signaling,p38,P38 MAP kinase inhibitor,https://www.apexbt.com/search.php?catalog=A5566A5573,Pimasertib (AS-703026),1236699-92-5,G07,L1021-05,431.2,DMSO,C15H15FIN3O3,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,≥21.55 mg/mL in DMSO; insoluble in H2O; ≥10.36 mg/mL in EtOH with ultrasonic,Free Base,MAPK Signaling,MEK1/2,MEK1/2 inhibitor,https://www.apexbt.com/search.php?catalog=A5573A5618,Daclatasvir (BMS-790052),1009119-64-5,G08,L1021-05,738.88,DMSO,C40H50N8O6,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,≥36.6 mg/mL in DMSO; insoluble in H2O; ≥23.33 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HCV Protease,HCV NS5A inhibitor,https://www.apexbt.com/search.php?catalog=A5618A5634,SAR245409 (XL765),1349796-36-6,G09,L1021-05,599.66,DMSO,C31H29N5O6S,CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC4=CC=CC=C4N=C3NC5=CC(=CC(=C5)OC)OC)OC,insoluble in H2O; insoluble in EtOH; ≥15 mg/mL in DMSO,Free Base,PI3K/Akt/mTOR Signaling,PI3K,mTOR/PI3K inhibitor,https://www.apexbt.com/search.php?catalog=A5634A5639,BIRB 796 (Doramapimod),285983-48-4,G10,L1021-05,527.66,DMSO,C31H37N5O3,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,≥26.4 mg/mL in DMSO; insoluble in H2O; ≥11.24 mg/mL in EtOH with ultrasonic,Free Base,MAPK Signaling,p38,"P38 MAPK inhibitor,cell permeable and highly selective",https://www.apexbt.com/search.php?catalog=A5639A5710,Tazarotene,118292-40-3,G11,L1021-05,351.46,DMSO,C21H21NO2S,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,insoluble in H2O; ≥11.1 mg/mL in EtOH with ultrasonic; ≥14.85 mg/mL in DMSO,Free Base,Others,RARs,Topical retinoid;antiproliferative;inducer of TIG3 tumor suppressor,https://www.apexbt.com/search.php?catalog=A5710A5734,Fasudil (HA-1077) HCl,105628-07-7,H01,L1021-05,327.83,DMSO,C14H17N3O2S·HCl,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl,≥16.4 mg/mL in DMSO; ≥4.81 mg/mL in EtOH with ultrasonic; ≥50 mg/mL in H2O,Hydrochloride,TGF-_ / Smad Signaling,ROCK,Protein kinase inhibitor,https://www.apexbt.com/search.php?catalog=A5734A5770,Sulfasalazine,599-79-1,H02,L1021-05,398.39,DMSO,C18H14N4O5S,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O,insoluble in ETOH; insoluble in H2O; ≥17.7 mg/mL in DMSO,Free Base,Others,Others,NF-_B activation inhibitor,https://www.apexbt.com/search.php?catalog=A5770A5786,Natamycin,7681-93-8,H03,L1021-05,665.73,DMSO,C33H47NO13,O[[C@H](C1)(C[[C@H](C[[C@H]2O[[C@@H]2/C=C\C(O[[C@H](C)C/C=C\C=C/C=C\C=C/[[C@@H]3O[[C@@H]([[C@H]([[C@H]4N)O)O[[C@H](C)[[C@H]4O)=O)O)O[[C@H](C3)([H])[[C@H](C(O)=O)[[C@H]1O,insoluble in EtOH; insoluble in H2O; ≥16.43 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Antifungal macrolide polyene,https://www.apexbt.com/search.php?catalog=A5786A5790,Cidofovir,113852-37-2,H04,L1021-05,279.19,H2O,C8H14N3O6P,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL in H2O with gentle warming,,Microbiology & Virology,CMV,Anti-CMV drug;inhibitor of viral DNA syntheis,https://www.apexbt.com/search.php?catalog=A5790A5791,Ibuprofen Lysine,57469-77-9,H05,L1021-05,352.47,H2O,C19H32N2O4,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O.C(CCN)CC(C(=O)O)N,insoluble in EtOH; insoluble in DMSO; ≥17.62 mg/mL in H2O,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=A5791A5793,Quizartinib (AC220),950769-58-1,H06,L1021-05,560.67,DMSO,C29H32N6O4S,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,≥28.03 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Tyrosine Kinase,FLT3,"FLT3 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A5793A5854,Dapagliflozin,461432-26-8,H07,L1021-05,408.87,DMSO,C21H25ClO6,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,insoluble in H2O; ≥116.6 mg/mL in EtOH; ≥15.1 mg/mL in DMSO,Free Base,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A5854A5926,Febuxostat,144060-53-7,H08,L1021-05,316.37,DMSO,C16H16N2O3S,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,insoluble in H2O; ≥15.55 mg/mL in DMSO; ≥15.95 mg/mL in EtOH with ultrasonic,,Others,XAO,non-purine selective inhibitor of xanthine oxidase,https://www.apexbt.com/search.php?catalog=A5926A5931,Aztreonam,78110-38-0,H09,L1021-05,435.43,DMSO,C13H17N5O8S2,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,insoluble in EtOH; ≥10.24 mg/mL in H2O with ultrasonic; ≥18.9 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,"Monobactam antibiotic,selectively active against Gram-negative aerobic bacteria",https://www.apexbt.com/search.php?catalog=A5931A5932,Candesartan,139481-59-7,H10,L1021-05,440.45,DMSO,C24H20N6O3,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,insoluble in H2O; ≥14.65 mg/mL in DMSO; ≥3.45 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,RAAS,Angiotensin II receptor 1 (AT1) antagonist,https://www.apexbt.com/search.php?catalog=A5932A5970,Irbesartan,138402-11-6,H11,L1021-05,428.53,DMSO,C25H28N6O,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,insoluble in H2O; ≥11.49 mg/mL in EtOH with ultrasonic; ≥17.4 mg/mL in DMSO,Free Base,GPCR/G protein,Angiotensin Receptor,Angiotensin II inhibitor,https://www.apexbt.com/search.php?catalog=A5970A6743,H-D-Ser-OH,312-84-5,A01,L1021-06,105.09,H2O,C3H7NO3,C(C(C(=O)O)N)O,insoluble in DMSO; insoluble in EtOH; ≥93 mg/mL in H2O,,Others,Others,Endogenous ligand for the glycine site of the N-methyl D-aspartate receptor (NMDAR),https://www.apexbt.com/search.php?catalog=A6743A7132,H-Cys-OH,52-90-4,A02,L1021-06,121.2,H2O,C3H7NO2S,C(C(C(=O)O)N)S,insoluble in EtOH; insoluble in DMSO; ≥40.3 mg/mL in H2O,,Amino Acids & Building Blocks,Amino Acids and Derivatives,,https://www.apexbt.com/search.php?catalog=A7132A7291,H-Ser-OH,56-45-1,A03,L1021-06,105.1,H2O,C3H7NO3,C(C(C(=O)O)N)O,insoluble in DMSO; insoluble in EtOH; ≥107 mg/mL in H2O,,Amino Acids & Building Blocks,Amino Acids and Derivatives,,https://www.apexbt.com/search.php?catalog=A7291A7486,H-Cit-OH,372-75-8,A04,L1021-06,175.2,H2O,C6H13N3O3,C(CC(C(=O)O)N)CNC(=O)N,insoluble in EtOH; insoluble in DMSO; ≥17.5 mg/mL in H2O,,Amino Acids & Building Blocks,Unusual Amino Acids,,https://www.apexbt.com/search.php?catalog=A7486A8010,Biotin,58-85-5,A05,L1021-06,244.31,DMSO,C10H16N2O3S,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,≥24.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Labels and tags,Biotinylation Reagents,Lysine probe coupled to mass spectrometry detection,https://www.apexbt.com/search.php?catalog=A8010A8019,Perindopril Erbumine,107133-36-8,A06,L1021-06,441.6,DMSO,C19H32N2O5·C4H11N,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.CC(C)(C)N,≥111.4 mg/mL in H2O; ≥15.7 mg/mL in EtOH; ≥8.58 mg/mL in DMSO with ultrasonic,t-Butylamine,Endocrinology and Hormones,RAAS,ACE inhibitor,https://www.apexbt.com/search.php?catalog=A8019A8164,Cyclo (-RGDfK),161552-03-0,A07,L1021-06,603.7,DMSO,C27H41N9O7,C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O,≥30.19 mg/mL in DMSO; insoluble in EtOH; ≥59.2 mg/mL in H2O,#N/A,Angiogenesis,Integrin,Inhibitor of _v_3 integrin,https://www.apexbt.com/search.php?catalog=A8164A8167,Rapamycin (Sirolimus),53123-88-9,A08,L1021-06,914.18,DMSO,C51H79NO13,O[[C@H]1[[C@H](OC)C[[C@H](C[[C@@H](C)[[C@H](CC([[C@H](C)/C=C(C)/[[C@H]([[C@@H](OC)C([[C@@H](C[[C@@H](/C=C/C=C/C=C(C)/[[C@@H](OC)C[[C@@H]2CC[[C@@H](C)[[C@H@](C(C(N3[[C@H]4CCCC3)=O)=O)(O)O2)C)C)=O)O)=O)OC4=O)CC1,≥45.7 mg/mL in DMSO; insoluble in H2O; ≥58.9 mg/mL in EtOH with ultrasonic,Free Base,PI3K/Akt/mTOR Signaling,mTOR,Original antifungal antibiotic,https://www.apexbt.com/search.php?catalog=A8167A8169,Everolimus (RAD001),159351-69-6,A09,L1021-06,958.22,DMSO,C53H83NO14,OCCO[[C@H]1[[C@H](OC)C[[C@H](C[[C@H](C)[[C@H](CC([[C@H](C)/C=C(C)/[[C@@H](O)[[C@H]2OC)=O)OC([[C@@H]3CCCCN3C(C([[C@H@]4(O)[[C@H](C)CC[[C@@H](C[[C@H](OC)/C(C)=C/C=C/C=C/[[C@@H](C)C[[C@@H](C)C2=O)O4)=O)=O)=O)CC1,≥47.91 mg/mL in DMSO; insoluble in H2O; ≥122 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor,https://www.apexbt.com/search.php?catalog=A8169A8171,"Entinostat (MS-275,SNDX-275)",209783-80-2,A10,L1021-06,376.4,DMSO,C21H20N4O3,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,insoluble in H2O; ≥18.8 mg/mL in DMSO; ≥7.4 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,HDAC1 and HDAC3 inhibitor,https://www.apexbt.com/search.php?catalog=A8171A8173,"Romidepsin (FK228, depsipeptide)",128517-07-7,A11,L1021-06,540.7,DMSO,C24H36N4O6S2,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,≥27.04 mg/mL in DMSO; insoluble in H2O; ≥35.27 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,"HDAC1/HDAC2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8173A8178,Panobinostat (LBH589),404950-80-7,B01,L1021-06,349.43,DMSO,C21H23N3O2,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A8178A8184,AICAR,2627-69-2,B02,L1021-06,258.23,DMSO,C9H14N4O5,CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C,insoluble in EtOH; ≥12.9 mg/mL in DMSO; ≥52.9 mg/mL in H2O,#N/A,PI3K/Akt/mTOR Signaling,AMPK,AMPK activator,https://www.apexbt.com/search.php?catalog=A8184A8190,Semagacestat (LY450139),425386-60-3,B03,L1021-06,361.44,DMSO,C19H27N3O4,CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O,insoluble in H2O; ≥18.05 mg/mL in DMSO; ≥40.3 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Amyloid _,_-secretase inhibitor,https://www.apexbt.com/search.php?catalog=A8190A8192,Staurosporine,62996-74-1,B04,L1021-06,466.53,DMSO,C28H26N4O3,O=C(NC1)C2=C1C3=C(C4=C2C5=C(C=CC=C5)N4[[C@H]6C[[C@@H](NC)[[C@@H](OC)[[C@H]7(C)O6)N7C8=CC=CC=C83,insoluble in H2O; insoluble in EtOH; ≥11.66 mg/mL in DMSO,#N/A,Tyrosine Kinase,Broad Spectrum Protein Kinase Inhibitor,"Protein kinase inhibitor,potent and cell permeable",https://www.apexbt.com/search.php?catalog=A8192A8194,ABT-199,1257044-40-8,B05,L1021-06,868.44,DMSO,C45H50ClN7O7S,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,≥43.42 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Apoptosis,Bcl-2 Family,"Bcl-2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8194A8200,DAPT (GSI-IX),208255-80-5,B06,L1021-06,432.46,DMSO,C23H26F2N2O4,CC(C(=O)NC(C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F,≥21.62 mg/mL in DMSO; insoluble in H2O; ≥16.36 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Amyloid _,"_-secretase inhibitor,potent and specific",https://www.apexbt.com/search.php?catalog=A8200A8201,Amprenavir (agenerase),161814-49-9,B07,L1021-06,505.63,DMSO,C25H35N3O6S,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,insoluble in H2O; ≥14.85 mg/mL in EtOH; ≥25 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HIV Protease,HIV-1 protease inhibitor,https://www.apexbt.com/search.php?catalog=A8201A8202,Abiraterone acetate,154229-18-2,B08,L1021-06,391.55,DMSO,C26H33NO2,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,insoluble in H2O; ≥11.22 mg/mL in DMSO with gentle warming and ultrasonic; ≥15.7 mg/mL in EtOH,acetate,Metabolism,P450,Cytochrome p450 17a1 inhibitor,https://www.apexbt.com/search.php?catalog=A8202A8203,Ritonavir,155213-67-5,B09,L1021-06,720.9,DMSO,C37H48N6O5S2,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,≥26 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥9.02 mg/mL in EtOH,Free Base,Proteases,HIV Protease,HIV protease inhibitor,https://www.apexbt.com/search.php?catalog=A8203A8204,Lopinavir,192725-17-0,B10,L1021-06,628.81,DMSO,C37H48N4O5,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,≥31.45 mg/mL in DMSO; insoluble in H2O; ≥48.3 mg/mL in EtOH,Free Base,Proteases,HIV Protease,"HIV protease inhibitor,highly potent",https://www.apexbt.com/search.php?catalog=A8204A8205,Atazanavir,198904-31-3,B11,L1021-06,704.9,DMSO,C38H52N6O7,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,≥28.6 mg/mL in DMSO; insoluble in H2O; ≥9.9 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HIV Protease,"HIV protease inhibitor,highly potent",https://www.apexbt.com/search.php?catalog=A8205A8206,Darunavir,206361-99-1,C01,L1021-06,547.66,DMSO,C27H37N3O7S,CC(CN(S(C1=CC=C(N)C=C1)(=O)=O)C[[C@H](O)([H])[[C@H](/N=C(O[[C@H@]2([H])CO[[C@H]3([H])[[C@H@]2([H])CCO3)\O)([H])CC4=CC=CC=C4)C,≥22.65 mg/mL in DMSO; insoluble in H2O; ≥4.94 mg/mL in EtOH with ultrasonic,Ethanolate,Proteases,HIV Protease,HIV-1 protease inhibitor,https://www.apexbt.com/search.php?catalog=A8206A8207,AZD6244 (Selumetinib),606143-52-6,C02,L1021-06,457.69,DMSO,C17H15BrClFN4O3,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,≥22.88 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,MAPK Signaling,MEK1/2,MEK inhibitor,https://www.apexbt.com/search.php?catalog=A8207A8210,GDC-0941,957054-30-7,C03,L1021-06,513.64,DMSO,C23H27N7O3S2,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,≥25.7 mg/mL in DMSO; insoluble in H2O; ≥3.59 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,PI3K/Akt/mTOR Signaling,PI3K,"PI3K inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8210A8218,Lapatinib,231277-92-2,C04,L1021-06,581.06,DMSO,C29H26ClFN4O4S,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,≥29.05 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent,selective and reversible",https://www.apexbt.com/search.php?catalog=A8218A8219,Gefitinib (ZD1839),184475-35-2,C05,L1021-06,446.90,DMSO,C22H24ClFN4O3,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,≥22.34 mg/mL in DMSO; insoluble in H2O; ≥2.48 mg/mL in EtOH with ultrasonic,Free Base,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A8219A8221,EPZ-6438,1403254-99-8,C06,L1021-06,572.74,DMSO,C34H44N4O4,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,≥28.64 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,Chromatin/Epigenetics,Histone Methyltransferase,"EZH2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8221A8232,Nilotinib(AMN-107),641571-10-0,C07,L1021-06,529.53,DMSO,C28H22F3N7O,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,≥26.5 mg/mL in DMSO; insoluble in H2O; ≥5 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,TGF-_ / Smad Signaling,Bcr-Abl,"Bcr-Abl kinase inhibitor,selective",https://www.apexbt.com/search.php?catalog=A8232A8234,Erlotinib Hydrochloride,183319-69-9,C08,L1021-06,429.91,DMSO,C22H24ClN3O4,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL in DMSO with gentle warming,Hydrochloride,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A8234A8235,Embelin,550-24-3,C09,L1021-06,294.39,DMSO,C17H26O4,CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O,insoluble in H2O; ≥4.23 mg/mL in EtOH with ultrasonic; ≥9.6 mg/mL in DMSO,,Apoptosis,IAP,"XIAP inhibitor,cell-permeable",https://www.apexbt.com/search.php?catalog=A8235A8236,Regorafenib,755037-03-7,C10,L1021-06,482.82,DMSO,C21H15ClF4N4O3,O=C(NC)C1=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C(F)=C2)=CC=N1,≥25.04 mg/mL in DMSO; insoluble in H2O; ≥6.25 mg/mL in EtOH with ultrasonic,Free Base,Tyrosine Kinase,c-RET,Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1,https://www.apexbt.com/search.php?catalog=A8236A8245,Sorafenib Tosylate,475207-59-1,C11,L1021-06,637.03,DMSO,C21H16ClF3N4O3·C7H8O3S,CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,≥31.85 mg/mL in DMSO; insoluble in H2O; ≥4.15 mg/mL in EtOH with ultrasonic,Tosylate,Tyrosine Kinase,PDGFR,,https://www.apexbt.com/search.php?catalog=A8245A8247,Afatinib (BIBW2992),439081-18-2,D01,L1021-06,485.94,DMSO,C24H25ClFN5O3,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,≥24.3 mg/mL in DMSO; insoluble in H2O; ≥42.1 mg/mL in EtOH with ultrasonic,Free Base,JAK/STAT Signaling,EGFR,Irreversible EGFR/HER2 inhibitor,https://www.apexbt.com/search.php?catalog=A8247A8252,Nintedanib (BIBF 1120),656247-17-5,D02,L1021-06,539.62,DMSO,C31H33N5O4,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL in DMSO,Free Base,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor,https://www.apexbt.com/search.php?catalog=A8252A8255,Sunitinib malate,341031-54-7,D03,L1021-06,532.56,DMSO,C22H27FN4O2·C4H6O5,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,≥26.65 mg/mL in DMSO; insoluble in EtOH; ≥4.6 mg/mL in H2O with ultrasonic,Malate,Tyrosine Kinase,VEGFR,VEGFR/PDGFR_/ KIT/ FLT3/RET/CSF-1R inhibitor,https://www.apexbt.com/search.php?catalog=A8255A8307,Crenolanib (CP-868596),670220-88-9,D04,L1021-06,443.54,DMSO,C26H29N5O2,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,≥22.2 mg/mL in DMSO; insoluble in H2O; ≥2.5 mg/mL in EtOH with ultrasonic,Free Base,Tyrosine Kinase,PDGFR,"PDGFR-_ inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8307A8309,Perifosine,157716-52-4,D05,L1021-06,461.67,H2O,C25H52NO4P,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,insoluble in DMSO; ≥5.55 mg/mL in EtOH with ultrasonic; ≥5.94 mg/mL in H2O with ultrasonic,,PI3K/Akt/mTOR Signaling,Akt,,https://www.apexbt.com/search.php?catalog=A8309A8311,Maraviroc,376348-65-1,D06,L1021-06,513.67,DMSO,C29H41F2N5O,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,≥25.7 mg/mL in DMSO; insoluble in H2O; ≥48 mg/mL in EtOH,Free Base,Microbiology & Virology,HIV,"Selective CCR5 antagonist,antiretroviral agent",https://www.apexbt.com/search.php?catalog=A8311A8314,Temsirolimus,162635-04-3,D07,L1021-06,1030.29,DMSO,C56H87NO16,CO[[C@@H]1C[[C@H](C[[C@@H](C)[[C@@H](OC([[C@H]2([H])CCCCN2C(C([[C@H]3(O)O[[C@H@](C[[C@H](OC)/C(C)=C/C=C/C=C/[[C@H](C[[C@@H](C)C4=O)C)([H])CC[[C@H]3C)=O)=O)=O)CC([[C@H](C)/C=C(C)/[[C@@H](O)[[C@H]4OC)=O)CC[[C@H]1OC(C(CO)(C)CO)=O,≥51.5 mg/mL in DMSO; insoluble in H2O; ≥11.2 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor,https://www.apexbt.com/search.php?catalog=A8314A8316,PD 0332991 (Palbociclib) HCl,827022-32-2,D08,L1021-06,483.99,H2O,C24H30ClN7O2,O=C1N(C2=NC(NC3=NC=C(C=C3)N4CCNCC4)=NC=C2C(C)=C1C(C)=O)C5CCCC5.Cl,≥14.48 mg/mL in H2O; ≥2.42 mg/mL in DMSO; ≥2.79 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective",https://www.apexbt.com/search.php?catalog=A8316A8317,Fludarabine Phosphate (Fludara),75607-67-9,D09,L1021-06,365.21,DMSO,C10H13FN5O7P,C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,insoluble in EtOH; ≥17.6 mg/mL in DMSO; ≥6.7 mg/mL in H2O with gentle warming and ultrasonic,Phosphate,DNA Damage/DNA Repair,DNA Synthesis,Inhibits STAT1 activation and DNA synthesis,https://www.apexbt.com/search.php?catalog=A8317A8319,"Dacomitinib (PF299804, PF299)",1110813-31-4,D10,L1021-06,469.94,DMSO,C24H25ClFN5O2,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,≥23.5 mg/mL in DMSO; insoluble in H2O; ≥8.76 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,JAK/STAT Signaling,EGFR,HER inhibitor,https://www.apexbt.com/search.php?catalog=A8319A8321,Cisplatin,15663-27-1,D11,L1021-06,300.05,DMSO,Cl2H6N2Pt,N.N.Cl[Pt+2]Cl,insoluble in EtOH; insoluble in H2O; ≥12.5 mg/mL in DMF,Free Base,Apoptosis,Caspase,"Inhibits DNA synthesis,chemotherapy drug",https://www.apexbt.com/search.php?catalog=A8321A8322,Neratinib (HKI-272),698387-09-6,E01,L1021-06,557.04,DMSO,C30H29ClN6O3,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,insoluble in H2O; ≥13.93 mg/mL in DMSO with gentle warming; ≥2.52 mg/mL in EtOH with gentle warming,,JAK/STAT Signaling,EGFR,"HER2/EGFR inhibitor,potent and irreversible",https://www.apexbt.com/search.php?catalog=A8322A8325,Tivantinib (ARQ 197),905854-02-6,E02,L1021-06,369.42,DMSO,C23H19N3O2,O=C([[C@H](C(C1=CC=C2)=CN3C1=C2CCC3)[[C@@H]4C5=CNC6=CC=CC=C56)NC4=O,≥18.47 mg/mL in DMSO; ≥2.29 mg/mL in H2O with gentle warming; ≥4.32 mg/mL in EtOH,Free Base,Tyrosine Kinase,c-MET,"C-Met inhibitor,non-ATP-competitive",https://www.apexbt.com/search.php?catalog=A8325A8327,Verteporfin,129497-78-5,E03,L1021-06,718.79,DMSO,C41H42N4O8,O=C([[C@H]1[[C@H](/C(N=C2/C=C(C(C)=C/3C=C)\NC3=C/C4=N/C(C(CCC(O)=O)=C4C)=C\5)=C/C6=C(C)C(CCC(OC)=O)=C5N6)(C)C2=CC=C1C(OC)=O)OC,insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL in DMSO,,Others,Others,Photosensitizer used in photodynamic therapy,https://www.apexbt.com/search.php?catalog=A8327A8328,LDK378,1032900-25-6,E04,L1021-06,558.14,DMSO,C28H36ClN5O3S,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,insoluble in H2O; ≥13.95 mg/mL in DMSO; ≥4.62 mg/mL in EtOH with gentle warming,Free Base,Tyrosine Kinase,ALK,Potent ALK inhibitor,https://www.apexbt.com/search.php?catalog=A8328A8330,CX-4945 (Silmitasertib),1009820-21-6,E05,L1021-06,349.77,DMSO,C19H12ClN3O2,C1=CC(=CC(=C1)Cl)NC2=C3C=CN=CC3=C4C=CC(=CC4=N2)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥8.74 mg/mL in DMSO,Free Base,PI3K/Akt/mTOR Signaling,CK2,CK2 inhibitor,https://www.apexbt.com/search.php?catalog=A8330A8331,Bleomycin Sulfate,9041-93-4,E06,L1021-06,1512.6,DMSO,C55H85N17O25S4,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-],≥125 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥151.3 mg/mL in H2O with ultrasonic,Sulfate,DNA Damage/DNA Repair,DNA Synthesis,"Chemotherapy agent, induces DNA strand break",https://www.apexbt.com/search.php?catalog=A8331A8332,R788 disodium,1025687-58-4,E07,L1021-06,624.42,DMSO,C23H24FN6Na2O9P,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.[Na+].[Na+],≥62.4 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥2.53 mg/mL in H2O with gentle warming,,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),"Syk inhibitor,ATP competitive and potent",https://www.apexbt.com/search.php?catalog=A8332A8333,Canagliflozin,842133-18-0,E08,L1021-06,444.52,DMSO,C24H25FO5S,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,≥22.25 mg/mL in DMSO; insoluble in H2O; ≥49.5 mg/mL in EtOH,Free Base,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8333A8334,Linsitinib,867160-71-2,E09,L1021-06,421.51,DMSO,C26H23N5O,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,≥21.08 mg/mL in DMSO; insoluble in H2O; ≥2.88 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Tyrosine Kinase,Insulin Receptor,"IGF1R/IR inhibitor,potent and novel",https://www.apexbt.com/search.php?catalog=A8334A8335,Palbociclib (PD0332991) Isethionate,827022-33-3,E10,L1021-06,573.66,DMSO,C24H29N7O2·C2H6O4S,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.C(CS(=O)(=O)O)O,≥28.7 mg/mL in DMSO; insoluble in EtOH; ≥26.8 mg/mL in H2O,,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective",https://www.apexbt.com/search.php?catalog=A8335A8346,BYL-719,1217486-61-7,E11,L1021-06,441.47,DMSO,C19H22F3N5O2S,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,≥22.07 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,PI3K/Akt/mTOR Signaling,PI3K,Selective PI3K_ inhibitor,https://www.apexbt.com/search.php?catalog=A8346A8347,Pazopanib Hydrochloride,635702-64-6,F01,L1021-06,473.98,DMSO,C21H24ClN7O2S,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,≥11.1 mg/mL in H2O; ≥11.85 mg/mL in DMSO; ≥2.88 mg/mL in EtOH,,Tyrosine Kinase,VEGFR,,https://www.apexbt.com/search.php?catalog=A8347A8348,LY2157299,700874-72-2,F02,L1021-06,369.42,DMSO,C22H19N5O,CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,insoluble in H2O; ≥18.45 mg/mL in DMSO; ≥26.15 mg/mL in EtOH,Free Base,TGF-_ / Smad Signaling,TGF-_R1(ALK5),"TGF-_R1 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8348A8351,VX-809,936727-05-8,F03,L1021-06,452.41,DMSO,C24H18F2N2O5,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,≥22.6 mg/mL in DMSO; insoluble in H2O; ≥4.91 mg/mL in EtOH with gentle warming,Free Base,Membrane Transporter/Ion Channel,CFTR,CFTR corrector,https://www.apexbt.com/search.php?catalog=A8351A8355,Arsonic acid,97-44-9,F04,L1021-06,275.09,DMSO,C8H10AsNO5,CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O,insoluble in H2O; insoluble in EtOH; ≥12.95 mg/mL in DMSO with gentle warming,Free Base,Others,Others,An organoarsenic compound,https://www.apexbt.com/search.php?catalog=A8355A8356,Acetylcysteine,616-91-1,F05,L1021-06,163.19,DMSO,C5H9NO3S,CC(=O)NC(CS)C(=O)O,≥44.6 mg/mL in H2O; ≥53.3 mg/mL in EtOH; ≥8.16 mg/mL in DMSO,,Neuroscience,AChR,Antioxidant;mucolytic agent,https://www.apexbt.com/search.php?catalog=A8356A8358,Albendazole,54965-21-8,F06,L1021-06,265.33,DMSO,C12H15N3O2S,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,insoluble in EtOH; insoluble in H2O; ≥8.75 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,treatment of a variety of parasitic worm infestations,https://www.apexbt.com/search.php?catalog=A8358A8359,Alendronate sodium,129318-43-0,F07,L1021-06,271.08,H2O,C4H12NNaO7P2,C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+],insoluble in DMSO; insoluble in EtOH; ≥15 mg/mL in H2O with gentle warming,Sodium,Others,Others,Osteoclast-mediated bone resorption inhibitor,https://www.apexbt.com/search.php?catalog=A8359A8360,Allopurinol,315-30-0,F08,L1021-06,136.11,DMSO,C5H4N4O,C1=C2C(=NC=NC2=O)NN1,insoluble in H2O; insoluble in EtOH; ≥5.15 mg/mL in DMSO with gentle warming,Free Base,Others,XAO,Xanthine oxidase inhibitor,https://www.apexbt.com/search.php?catalog=A8360A8362,Arbidol HCl,131707-23-8,F09,L1021-06,513.88,DMSO,C22H25BrN2O3S·HCl,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3.Cl,≥19.85 mg/mL in DMSO; ≥2.55 mg/mL in H2O with gentle warming; ≥45.1 mg/mL in EtOH,hydrochloride,Microbiology & Virology,Influenza A virus,Antiviral chemical agent,https://www.apexbt.com/search.php?catalog=A8362A8363,Argatroban,74863-84-6,F10,L1021-06,508.63,DMSO,C23H36N6O5S,O=C([[C@H](CCC/N=C(N)/N)NS(=O)(C1=C2NC[[C@H](C)CC2=CC=C1)=O)N3[[C@@H](C(O)=O)C[[C@H](C)CC3,≥25.25 mg/mL in DMSO; insoluble in H2O; ≥2.97 mg/mL in EtOH with gentle warming,Free Base,Proteases,Thrombin,Thrombin mediated fibrinogen cleavage inhibitor,https://www.apexbt.com/search.php?catalog=A8363A8364,ARN-509,956104-40-8,F11,L1021-06,477.43,DMSO,C21H15F4N5O2S,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C(=C4)C(F)(F)F)C#N)F,≥23.85 mg/mL in DMSO; insoluble in H2O; ≥7.33 mg/mL in EtOH,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=A8364A8369,Atropine sulfate monohydrate,5908-99-6,G01,L1021-06,694.83,DMSO,2(C17H23NO3)·H2O·H2SO4,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.O.OS(=O)(=O)O,≥34.74 mg/mL in DMSO; ≥56.5 mg/mL in H2O; ≥59.7 mg/mL in EtOH,sulfate,Neuroscience,AChR,MAChRs antagonist,https://www.apexbt.com/search.php?catalog=A8369A8370,Axitinib (AG 013736),319460-85-0,G02,L1021-06,386.47,DMSO,C22H18N4OS,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,insoluble in H2O; ≥19.3 mg/mL in DMSO; ≥3.52 mg/mL in EtOH,Free Base,Tyrosine Kinase,VEGFR,VEGFR1/ c-Kit inhibitor,https://www.apexbt.com/search.php?catalog=A8370A8376,Bephenium Hydroxynaphthoate,3818-50-6,G03,L1021-06,443.53,DMSO,C28H29NO4,C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CC=C2.C1=CC=C2C=C(C(=CC2=C1)C(=O)O)[O-],insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL in DMSO,hydroxynaphthoa,Others,Others,Anthelmintic agent,https://www.apexbt.com/search.php?catalog=A8376A8377,Betacarotene,7235-40-7,G04,L1021-06,536.87,EtOH,C40H56,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C,insoluble in H2O; insoluble in DMSO; ≥9.6 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=A8377A8378,Betamethasone Dipropionate,5593-20-4,G05,L1021-06,504.59,DMSO,C28H37FO7,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,≥22.75 mg/mL in DMSO; insoluble in H2O; ≥31.03 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=A8378A8379,Betamethasone Valerate,2152-44-5,G06,L1021-06,476.58,DMSO,C27H37FO6,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,insoluble in H2O; ≥19.2 mg/mL in DMSO; ≥28.1 mg/mL in EtOH,Valerate,Others,Others,anti-inflammatory corticosteroid,https://www.apexbt.com/search.php?catalog=A8379A8380,Bexarotene,153559-49-0,G07,L1021-06,348,DMSO,C24H28O2,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,insoluble in H2O; ≥10.35 mg/mL in DMSO; ≥11.34 mg/mL in EtOH,Free Base,Others,Retinoid X Receptors,Retinoid Receptor agonist,https://www.apexbt.com/search.php?catalog=A8380A8381,BIBR-1048,211915-06-9,G08,L1021-06,627.73,DMSO,C34H41N7O5,CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N,≥30 mg/mL in DMSO; insoluble in H2O; ≥22.13 mg/mL in EtOH,Free Base,Proteases,Thrombin,Thrombin inhibitor,https://www.apexbt.com/search.php?catalog=A8381A8384,Blonanserin,132810-10-7,G09,L1021-06,367.5,DMSO,C23H30FN3,CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F,insoluble in H2O; ≥17.67 mg/mL in EtOH; ≥9.19 mg/mL in DMSO,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=A8384A8386,Busulfan,55-98-1,G10,L1021-06,246.3,DMSO,C6H14O6S2,CS(=O)(=O)OCCCCOS(=O)(=O)C,≥12.3 mg/mL in DMSO; ≥2.35 mg/mL in H2O with gentle warming; ≥2.82 mg/mL in EtOH with gentle warming,Free Base,DNA Damage/DNA Repair,DNA Alkylating,DNA alkylating agent,https://www.apexbt.com/search.php?catalog=A8386A8387,Calcium Gluceptate,17140-60-2,G11,L1021-06,490.42,H2O,C14H26CaO16,C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Ca+2],insoluble in EtOH; ≥4.90 mg/mL in DMSO with gentle warming; ≥89.2 mg/mL in H2O,Gluceptate,Others,Others,Calcium supplement,https://www.apexbt.com/search.php?catalog=A8387A8388,Carbadox,6804-07-5,H01,L1021-06,262.22,DMSO,C11H10N4O4,COC(=O)N=NC=C1C=[N+](C2=CC=CC=C2N1O)[O-],insoluble in H2O; insoluble in EtOH; ≥3.78 mg/mL in DMSO with gentle warming,Free Base,Others,Others,antibiotic,https://www.apexbt.com/search.php?catalog=A8388A8389,Carbenoxolone disodium,7421-40-1,H02,L1021-06,614.72,DMSO,C34H48Na2O7,CC1(C2CCC3(C(C2(CCC1OC(=O)CCC(=O)[O-])C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)[O-])C)C)C)C.[Na+].[Na+],≥30.74 mg/mL in DMSO; ≥39.1 mg/mL in EtOH; ≥55.1 mg/mL in H2O,disodium,Neuroscience,Gap Junction,11_-HSD inhibitor,https://www.apexbt.com/search.php?catalog=A8389A8390,Casanthranol,8024-48-4,H03,L1021-06,434.39,DMSO,C21H22O10,C1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(C=C3C2OC4C(C(C(C(O4)CO)O)O)O)CO)O,insoluble in H2O; insoluble in EtOH; ≥20.45 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=A8390A8391,Cefdinir,91832-40-5,H04,L1021-06,395.41,DMSO,C14H13N5O5S2,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,insoluble in EtOH; insoluble in H2O; ≥19.55 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Third generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=A8391A8392,Cefoperazone,62893-19-0,H05,L1021-06,645.66,DMSO,C25H27N9O8S2,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,≥64.6 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Microbiology & Virology,Antibiotic,Third-generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=A8392A8393,CH5424802,1256580-46-7,H06,L1021-06,482.62,DMSO,C30H34N4O2,CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6,insoluble in H2O; ≥2.72 mg/mL in EtOH with gentle warming; ≥4.83 mg/mL in DMSO with gentle warming and ultrasonic,,Tyrosine Kinase,ALK,"ALK inhibitor,potent and ATP-competitive",https://www.apexbt.com/search.php?catalog=A8393A8397,Chlorothiazide,58-94-6,H07,L1021-06,295.72,DMSO,C7H6ClN3O4S2,ClC1=C(C=C2S(=O)(NC=NC2=C1)=O)S(=O)(N)=O,insoluble in H2O; insoluble in EtOH; ≥14.85 mg/mL in DMSO,Free Base,Others,Others,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A8397A8398,Chlorprothixene,113-59-7,H08,L1021-06,315.87,DMSO,C18H18ClNS,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,insoluble in H2O; ≥13.43 mg/mL in DMSO; ≥15.79 mg/mL in EtOH,Free Base,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A8398A8401,Clotrimazole,23593-75-1,H09,L1021-06,344.84,DMSO,C22H17ClN2,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,insoluble in H2O; ≥15.1 mg/mL in EtOH; ≥28.1 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,antifungal compound,https://www.apexbt.com/search.php?catalog=A8401A8402,Conivaptan HCl,168626-94-6,H10,L1021-06,535.04,DMSO,C32H26N4O2·HCl,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl,insoluble in H2O; ≥10.22 mg/mL in EtOH; ≥14.8 mg/mL in DMSO,HCl,GPCR/G protein,Vasopressin Receptor,Vasopressin receptor antagonist,https://www.apexbt.com/search.php?catalog=A8402A8404,Cyproterone Acetate,427-51-0,H11,L1021-06,416.94,DMSO,C24H29ClO4,ClC1=C([H])C(C(C([H])([H])C2([H])[H])([H])C(C2(C(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)(C([H])([H])[H])C([H])([H])C3([H])[H])([H])C3([H])C(C1=C([H])C4=O)(C([H])([H])[H])C5([H])C4([H])C5([H])[H],insoluble in H2O; ≥14.7 mg/mL in DMSO; ≥20.55 mg/mL in EtOH,Acetate,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,https://www.apexbt.com/search.php?catalog=A8404A8405,Cytarabine,147-94-4,A01,L1021-07,243.2,DMSO,C9H13N3O5,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,insoluble in EtOH; ≥28.6 mg/mL in H2O; ≥7.65 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"cytotoxic agent, blocks DNA synthesis",https://www.apexbt.com/search.php?catalog=A8405A8406,Dextrose (D-glucose),50-99-7,A02,L1021-07,180.16,DMSO,C6H12O6,C(C1C(C(C(C(O1)O)O)O)O)O,≥2.6 mg/mL in EtOH with gentle warming and ultrasonic; ≥13.85 mg/mL in DMSO; ≥44.3 mg/mL in H2O,Free Base,Others,Others,Simple sugar (monosaccharide),https://www.apexbt.com/search.php?catalog=A8406A8407,Dibucaine (Cinchocaine) HCl,61-12-1,A03,L1021-07,379.92,DMSO,C20H29N3O2·HCl,CCCCOC1=NC2=CC=CC=C2C(C(NCCN(CC)CC)=O)=C1.Cl,≥11.9 mg/mL in DMSO; ≥40.2 mg/mL in H2O; ≥41.4 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8407A8408,Dichlorphenamide,120-97-8,A04,L1021-07,305.16,DMSO,C6H6Cl2N2O4S2,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,insoluble in H2O; ≥15.3 mg/mL in DMSO; ≥15.6 mg/mL in EtOH with ultrasonic,,Metabolism,Carbonic Anhydrase,,https://www.apexbt.com/search.php?catalog=A8408A8409,Dicyclomine HCl,67-92-5,A05,L1021-07,345.95,DMSO,C19H35NO2·HCl,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl,≥16.05 mg/mL in DMSO with gentle warming; ≥31.25 mg/mL in H2O; ≥65.5 mg/mL in EtOH,Hydrochloride,Others,Others,Anticholinergic drug,https://www.apexbt.com/search.php?catalog=A8409A8410,Didanosine,69655-05-6,A06,L1021-07,236.23,DMSO,C10H12N4O3,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,insoluble in H2O; insoluble in EtOH; ≥10.3 mg/mL in DMSO,Free Base,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8410A8411,Difloxacin HCl,98106-17-3,A07,L1021-07,435.86,DMSO,C21H19F2N3O3 HCl,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F,insoluble in EtOH; ≥7.36 mg/mL in H2O with ultrasonic; ≥9.15 mg/mL in DMSO with gentle warming,hydrochloride,Others,Others,quinolone antimicrobial antibiotic,https://www.apexbt.com/search.php?catalog=A8411A8412,Dinaciclib (SCH727965),779353-01-4,A08,L1021-07,396.49,DMSO,C21H28N6O2,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,insoluble in H2O; ≥10.22 mg/mL in EtOH; ≥17.15 mg/mL in DMSO,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Potent CDK inhibitor,https://www.apexbt.com/search.php?catalog=A8412A8413,Diperodon HCl,537-12-2,A09,L1021-07,433.93,DMSO,C22H27N3O4·HCl,O=C(NC1=CC=CC=C1)OC(COC(NC2=CC=CC=C2)=O)CN3CCCCC3.Cl,insoluble in H2O; ≥16.8 mg/mL in DMSO; ≥19.9 mg/mL in EtOH,hydrochloride,Others,Others,Local anaesthetics,https://www.apexbt.com/search.php?catalog=A8413A8414,Diphemanil Methylsulfate,62-97-5,A10,L1021-07,389.51,DMSO,C20H24N·CH3O4S,C[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C.COS(=O)(=O)[O-],≥10.7 mg/mL in EtOH; ≥7.7 mg/mL in H2O; ≥9.74 mg/mL in DMSO,Methylsulfate,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=A8414A8415,Diphenylpyraline HCl,132-18-3,A11,L1021-07,317.85,DMSO,C19H23NO·HCl,CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,≥12.85 mg/mL in H2O; ≥42 mg/mL in DMSO; ≥54.7 mg/mL in EtOH,hydrochloride,Others,Others,Histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A8415A8416,Docosanol (Abreua),661-19-8,B01,L1021-07,326.6,EtOH,C22H46O,CCCCCCCCCCCCCCCCCCCCCCO,insoluble in DMSO; insoluble in H2O; ≥11.9 mg/mL in EtOH with gentle warming,Free Base,Others,Others,Saturated fatty alcohol,https://www.apexbt.com/search.php?catalog=A8416A8417,Dofetilide,115256-11-6,B02,L1021-07,441.56,DMSO,C19H27N3O5S2,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,≥21.15 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8417A8418,Dovitinib Dilactic acid,852433-84-2,B03,L1021-07,572.59,DMSO,C21H21FN6O·2C3H6O3,CC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,≥57.3 mg/mL in DMSO; insoluble in EtOH; ≥14.7 mg/mL in H2O,Dilactic Acid,Tyrosine Kinase,VEGFR,FLT3 inhibitor,https://www.apexbt.com/search.php?catalog=A8418A8419,Doxapram HCl,7081-53-0,B04,L1021-07,432.98,DMSO,C24H30N2O2·HCl·H2O,CCN1CC(CCN2CCOCC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)C1=O.O.Cl,≥20.05 mg/mL in DMSO with gentle warming; ≥14.27 mg/mL in H2O with ultrasonic; ≥14.6 mg/mL in EtOH,hydrochloride,Others,Others,Potassium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8419A8420,Doxycycline HCl,10592-13-9,B05,L1021-07,480.9,DMSO,C22H24N2O8.HCl,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,>16.4mg/mL in DMSO,,Proteases,MMP,Tetracycline antibiotic;MMP inhibitor;cell selection reagent,https://www.apexbt.com/search.php?catalog=A8420A8421,Duloxetine HCl,136434-34-9,B06,L1021-07,333.88,DMSO,C18H19NOS·HCl,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,insoluble in H2O; ≥16.69 mg/mL in DMSO; ≥27.75 mg/mL in EtOH with ultrasonic,hydrochloride,Neuroscience,5-HT Receptor,5-HT receptor inhibitor,https://www.apexbt.com/search.php?catalog=A8421A8422,Emtricitabine,143491-57-0,B07,L1021-07,247.25,DMSO,C8H10FN3O3S,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,≥10.4 mg/mL in DMSO; ≥50.1 mg/mL in H2O; ≥9.38 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8422A8423,Enoxacin (Penetrex),74011-58-8,B08,L1021-07,320.32,DMSO,C15H17FN4O3,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥18.4 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Topoisomerase inhibitor,https://www.apexbt.com/search.php?catalog=A8423A8424,Eplerenone,107724-20-9,B09,L1021-07,414.49,DMSO,C24H30O6,O=C(C(C1([H])[H])([H])C2([H])C3(C(C([H])([H])C4([H])[H])(C([H])([H])[H])C1=C([H])C4=O)OC3([H])C([H])([H])C5(C([H])([H])[H])C2([H])C([H])([H])C([H])([H])[[C@H@]5(C([H])([H])C6([H])[H])OC6=O)OC([H])([H])[H],insoluble in H2O; insoluble in EtOH; ≥4.6 mg/mL in DMSO with gentle warming,,Others,Mineralocorticoid Receptor,Mineralocorticoid receptor antagonists,https://www.apexbt.com/search.php?catalog=A8424A8425,Estradiol,50-28-2,B10,L1021-07,272.38,DMSO,C18H24O2,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,insoluble in H2O; ≥11.25 mg/mL in EtOH; ≥13.5 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Sex hormone,https://www.apexbt.com/search.php?catalog=A8425A8426,Estrone,53-16-7,B11,L1021-07,270.37,DMSO,C18H22O2,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,insoluble in H2O; ≥9.2 mg/mL in EtOH with gentle warming and ultrasonic; ≥9.75 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogenic hormone,https://www.apexbt.com/search.php?catalog=A8426A8427,Ethambutol HCl,1070-11-7,C01,L1021-07,277.23,DMSO,C10H24N2O2·2HCl,CCC(CO)NCCNC(CC)CO.Cl.Cl,≥12.65 mg/mL in DMSO,Dihydrochloride,Others,Others,Antitubercular agent,https://www.apexbt.com/search.php?catalog=A8427A8428,Ethinyl Estradiol,57-63-6,C02,L1021-07,296.4,DMSO,C20H24O2,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,≥8.7 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral contraceptive,https://www.apexbt.com/search.php?catalog=A8428A8429,Ethionamide,536-33-4,C03,L1021-07,166.24,DMSO,C8H10N2S,CCC1=NC=CC(=C1)C(=S)N,≥7.65 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Anti-tuberculosis antibiotic,https://www.apexbt.com/search.php?catalog=A8429A8430,Ezetimibe,163222-33-1,C04,L1021-07,409.4,DMSO,C24H21F2NO3,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,≥20.45 mg/mL in DMSO,Free Base,Metabolism,Cholesterol absorption,Cholesterol transport inhibitor,https://www.apexbt.com/search.php?catalog=A8430A8431,Famprofazone,22881-35-2,C05,L1021-07,377.52,DMSO,C24H31N3O,CC(C)C1=C(N(N(C1=O)C2=CC=CC=C2)C)CN(C)C(C)CC3=CC=CC=C3,insoluble in H2O; ≥17.35 mg/mL in DMSO with gentle warming; ≥26.45 mg/mL in EtOH,Free Base,Others,Others,Non-steroidal anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=A8431A8432,Fenticonazole Nitrate,73151-29-8,C06,L1021-07,518.41,DMSO,C24H20Cl2N2OS·HNO3,C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-],≥25.4 mg/mL in DMSO; insoluble in H2O; ≥22.25 mg/mL in EtOH,Nitrate,Microbiology & Virology,Anti-infection,Antifungal drug,https://www.apexbt.com/search.php?catalog=A8432A8433,Flucytosine,2022-85-7,C07,L1021-07,129.09,DMSO,C4H4FN3O,C1=NC(=O)NC(=C1F)N,insoluble in EtOH; ≥18.8 mg/mL in H2O; ≥6.4 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Antifungal drug,https://www.apexbt.com/search.php?catalog=A8433A8434,Flurbiprofen,5104-49-4,C08,L1021-07,244.26,DMSO,C15H13FO2,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,insoluble in H2O; ≥11.35 mg/mL in DMSO; ≥51.2 mg/mL in EtOH,,Immunology/Inflammation,PGE synthase,Cyclooxygenase inhibitors,https://www.apexbt.com/search.php?catalog=A8434A8435,Furosemide,54-31-9,C09,L1021-07,330.74,DMSO,C12H11ClN2O5S,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,insoluble in H2O; ≥13.35 mg/mL in EtOH; ≥14.9 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,NKCC,GABAA receptors antagonist,https://www.apexbt.com/search.php?catalog=A8435A8436,Gabapentin,60142-96-3,C10,L1021-07,171.24,H2O,C9H17NO2,C1CCC(CC1)(CC(=O)O)CN,≥2.6 mg/mL in EtOH; ≥25.85 mg/mL in H2O; ≥8.56 mg/mL in DMSO,Free Base,Neuroscience,GABA Receptor,GABA enhancer,https://www.apexbt.com/search.php?catalog=A8436A8437,Gemcitabine,95058-81-4,C11,L1021-07,263.2,DMSO,C9H11F2N3O4,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,≥11.75 mg/mL in H2O with gentle warming; ≥24.8 mg/mL in DMSO; ≥7.54 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,DNA Synthesis,inhibitor of DNA synthesis,https://www.apexbt.com/search.php?catalog=A8437A8438,Glipizide,29094-61-9,D01,L1021-07,445.54,DMSO,C21H27N5O4S,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,insoluble in H2O; ≥16.8 mg/mL in DMSO; ≥2.57 mg/mL in EtOH with gentle warming,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Oral anti-diabetic medication,https://www.apexbt.com/search.php?catalog=A8438A8442,Guaifenesin,93-14-1,D02,L1021-07,198.22,DMSO,C10H14O4,COC1=CC=CC=C1OCC(CO)O,≥12.35 mg/mL in H2O; ≥50 mg/mL in EtOH; ≥8.05 mg/mL in DMSO,Free Base,Others,Others,Expectorant agent,https://www.apexbt.com/search.php?catalog=A8442A8443,Guanethidine Sulfate,60-02-6,D03,L1021-07,494.7,H2O,C20H44N8·H2O4S,OS(O)(=O)=O.N=C(N)NCCN1CCCCCCC1.N=C(N)NCCN2CCCCCCC2,insoluble in DMSO; insoluble in EtOH; ≥159.4 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=A8443A8446,Ibuprofen,15687-27-1,D04,L1021-07,206.28,DMSO,C13H18O2,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,insoluble in H2O; ≥10.31 mg/mL in DMSO; ≥50.2 mg/mL in EtOH,Free Base,Neuroscience,COX,inhibitor of cyclooxygenase 1 and cyclooxygenase 2,https://www.apexbt.com/search.php?catalog=A8446A8447,Imidapril HCl,89396-94-1,D05,L1021-07,441.91,DMSO,C20H27N3O6·HCl,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O.Cl,insoluble in H2O; ≥16.5 mg/mL in DMSO; ≥25.35 mg/mL in EtOH with ultrasonic,hydrochloride,Endocrinology and Hormones,RAAS,RAAS inhibitor,https://www.apexbt.com/search.php?catalog=A8447A8449,Indomethacin,53-86-1,D06,L1021-07,357.79,DMSO,C19H16ClNO4,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,insoluble in H2O; ≥16.97 mg/mL in EtOH with ultrasonic; ≥17.89 mg/mL in DMSO,Free Base,Neuroscience,COX,Cox inhibitor,https://www.apexbt.com/search.php?catalog=A8449A8451,Ipratropium Bromide,22254-24-6,D07,L1021-07,412.37,DMSO,C20H30BrNO3,CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.[Br-],insoluble in H2O; ≥20.62 mg/mL in DMSO; ≥24.65 mg/mL in EtOH with ultrasonic,Bromide,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=A8451A8452,ODM-201,1297538-32-9,D08,L1021-07,398.85,DMSO,C19H19ClN6O2,N#CC1=C(Cl)C=C(C2=NN(C[[C@H](C)NC(C3=NNC(C(O)C)=C3)=O)C=C2)C=C1,insoluble in H2O; ≥12.7 mg/mL in EtOH with ultrasonic; ≥19.95 mg/mL in DMSO,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=A8452A8453,Isradipine (Dynacirc),75695-93-1,D09,L1021-07,371.39,DMSO,C19H21N3O5,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,≥12.55 mg/mL in DMSO; ≥16.43 mg/mL in EtOH with ultrasonic; ≥2.71 mg/mL in H2O with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=A8453A8454,Istradefylline (KW-6002),155270-99-8,D10,L1021-07,384.43,DMSO,C20H24N4O4,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,insoluble in H2O; insoluble in EtOH; ≥8.78 mg/mL in DMSO with gentle warming,,GPCR/G protein,Adenosine Receptor,Selective A2A receptor antagonist,https://www.apexbt.com/search.php?catalog=A8454A8455,Nilvadipine,75530-68-6,D11,L1021-07,385.37,DMSO,C19H19N3O6,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,insoluble in H2O; ≥12.4 mg/mL in DMSO; ≥37.13 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8455A8458,Lamivudine,134678-17-4,E01,L1021-07,229.26,DMSO,C8H11N3O3S,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,≥10.5 mg/mL in DMSO; ≥11.4 mg/mL in EtOH with ultrasonic; ≥89.4 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Reverse Transcriptase,Nucleoside analog reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8458A8459,Laquinimod (ABR-215062),248281-84-7,E02,L1021-07,356.8,DMSO,C19H17ClN2O3,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,insoluble in H2O; ≥17.25 mg/mL in DMSO; ≥3.94 mg/mL in EtOH with ultrasonic,,Others,Others,"Immunomodulator,orally-available,quinolinone-based and broad spectrum",https://www.apexbt.com/search.php?catalog=A8459A8460,Levodopa,59-92-7,E03,L1021-07,197.19,H2O,C9H11NO4,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,insoluble in DMSO; insoluble in EtOH; ≥6.57 mg/mL in H2O with gentle warming,,Neuroscience,Dopamine Receptor,,https://www.apexbt.com/search.php?catalog=A8460A8461,L-Glutamine,56-85-9,E04,L1021-07,146.14,H2O,C5H10N2O3,C(CC(=O)N)C(C(=O)O)N,insoluble in EtOH; insoluble in DMSO; ≥6.2 mg/mL in H2O,,GPCR/G protein,mGluR,Non-essential amino acid,https://www.apexbt.com/search.php?catalog=A8461A8462,Lithium Citrate,6080-58-6,E05,L1021-07,281.98,DMSO,C6H5O7·4H2O·3Li,[Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.O.O.O.O,insoluble in EtOH; ≥14.1 mg/mL in DMSO with gentle warming and ultrasonic; ≥83.6 mg/mL in H2O with ultrasonic,,Others,Others,Mood stabilizer,https://www.apexbt.com/search.php?catalog=A8462A8463,Lithocholic Acid,434-13-9,E06,L1021-07,376.57,DMSO,C24H40O3,CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,insoluble in H2O; ≥12.95 mg/mL in DMSO; ≥26.6 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,"Activator of vitamin D receptor,PXR and FXR",https://www.apexbt.com/search.php?catalog=A8463A8466,Meloxicam (Mobic),71125-38-7,E07,L1021-07,351.4,DMSO,C14H13N3O4S2,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,insoluble in H2O; insoluble in EtOH; ≥17.57 mg/mL in DMSO,Free Base,Neuroscience,COX,Nonsteroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=A8466A8467,Mepenzolate Bromide,76-90-4,E08,L1021-07,420.34,DMSO,C21H26BrNO3,OC(C1=CC=CC=C1)(C(OC2CCC[N+](C)(C)C2)=O)C3=CC=CC=C3.[Br-],≥10.02 mg/mL in EtOH with ultrasonic; ≥20.65 mg/mL in DMSO; ≥6.59 mg/mL in H2O with ultrasonic,bromide,Others,Others,mAChR antagonist,https://www.apexbt.com/search.php?catalog=A8467A8468,Mepiroxol,6968-72-5,E09,L1021-07,125.13,DMSO,C6H7NO2,C1=CC(=C[N+](=C1)[O-])CO,≥45.3 mg/mL in EtOH; ≥5.45 mg/mL in DMSO; ≥51.9 mg/mL in H2O,Free Base,Others,Others,Antihyperlipidemic drug,https://www.apexbt.com/search.php?catalog=A8468A8469,Mesna,19767-45-4,E10,L1021-07,164.18,DMSO,C2H5NaO3S2,C(CS(=O)(=O)[O-])S.[Na+],≥2.25 mg/mL in EtOH with gentle warming; ≥48.4 mg/mL in H2O; ≥8.05 mg/mL in DMSO,Free Base,Others,Others,Chemotherapy adjuvant;potential antioxidant,https://www.apexbt.com/search.php?catalog=A8469A8470,Mestranol,72-33-3,E11,L1021-07,310.44,DMSO,C21H26O2,[H][[C@H]12[[C@H@]([[C@H@](CC[[C@H]3(C#C)O)([H])[[C@H]3(C)CC2)([H])CCC4=C1C=CC(OC)=C4,insoluble in H2O; ≥12.4 mg/mL in DMSO; ≥20.25 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen used in contraceptives,https://www.apexbt.com/search.php?catalog=A8470A8471,Meticrane,1084-65-7,F01,L1021-07,275.34,DMSO,C10H13NO4S2,CC1=C(C=C2C(=C1)CCCS2(=O)=O)S(=O)(=O)N,insoluble in H2O; insoluble in EtOH; ≥12.45 mg/mL in DMSO,Free Base,Others,Others,Peripheral-type benzodiazepine receptor (PBR) inhibitor,https://www.apexbt.com/search.php?catalog=A8471A8472,Methimazole,60-56-0,F02,L1021-07,114.17,DMSO,C4H6N2S,CN1C=CN=C1S,≥49.1 mg/mL in H2O; ≥5.8 mg/mL in DMSO; ≥52.4 mg/mL in EtOH,Free Base,Others,Others,ICAM-1 inhibitor,https://www.apexbt.com/search.php?catalog=A8472A8473,Methyocarbamol,532-03-6,F03,L1021-07,241.24,DMSO,C11H15NO5,COC1=CC=CC=C1OCC(COC(=O)N)O,≥15.65 mg/mL in DMSO; ≥59.7 mg/mL in EtOH; ≥7.7 mg/mL in H2O,Free Base,Others,Others,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A8473A8474,Mirabegron (YM178),223673-61-8,F04,L1021-07,396.51,DMSO,C21H24N4O2S,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,insoluble in H2O; ≥16.13 mg/mL in EtOH; ≥19.83 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,Selective _3-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=A8474A8475,Mitotane (Lsodren),53-19-0,F05,L1021-07,320.04,DMSO,C14H10Cl4,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,insoluble in H2O; ≥12.5 mg/mL in DMSO; ≥25.85 mg/mL in EtOH,Free Base,Others,Others,Antineoplastic agents against adrenocortical carcinoma,https://www.apexbt.com/search.php?catalog=A8475A8478,Monobenzone,103-16-2,F06,L1021-07,200.23,DMSO,C13H12O2,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,insoluble in H2O; ≥55.8 mg/mL in EtOH; ≥9.8 mg/mL in DMSO,Free Base,Others,Others,Skin depigmenting agent,https://www.apexbt.com/search.php?catalog=A8478A8479,Noscapine HCl,912-60-7,F07,L1021-07,449.88,DMSO,C22H23NO7·HCl,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3.Cl,insoluble in H2O; ≥10.38 mg/mL in EtOH with gentle warming; ≥18.47 mg/mL in DMSO,hydrochloride,Others,Others,Multi-action opioid alkaloid,https://www.apexbt.com/search.php?catalog=A8479A8481,Nevirapine,129618-40-2,F08,L1021-07,266.3,DMSO,C15H14N4O,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,insoluble in H2O; ≥13.3 mg/mL in DMSO; ≥3.02 mg/mL in EtOH with gentle warming,Free Base,Microbiology & Virology,Reverse Transcriptase,Non-nucleoside reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8481A8482,Nicotine Difartrate,65-31-6,F09,L1021-07,462.46,DMSO,C18H26N2O12,CN1CCCC1C2=CN=CC=C2.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,insoluble in EtOH; ≥16.1 mg/mL in DMSO; ≥35.5 mg/mL in H2O,ditartrate,Others,Others,Nicotinic acetylcholine receptor (nAChR) agonist,https://www.apexbt.com/search.php?catalog=A8482A8483,Nifenazone,2139-47-1,F10,L1021-07,308.33,DMSO,C17H16N4O2,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C3=CN=CC=C3,Soluble in DMSO,Free Base,Others,Others,Analgesic,https://www.apexbt.com/search.php?catalog=A8483A8484,Nimodipine,66085-59-4,F11,L1021-07,418.45,DMSO,C21H26N2O7,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,≥41.8 mg/mL in EtOH; insoluble in H2O; ≥108 mg/mL in DMSO,Free Base,Ubiquitination/Proteasome,Autophagy,Calcium Channel inhibitor & Autophagy activator,https://www.apexbt.com/search.php?catalog=A8484A8485,Nitazoxanide,55981-09-4,G01,L1021-07,307.28,DMSO,C12H9N3O5S,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],insoluble in H2O; insoluble in EtOH; ≥13.25 mg/mL in DMSO,Free Base,Others,Others,Antiprotozoal agent,https://www.apexbt.com/search.php?catalog=A8485A8486,Nitrofurazone,59-87-0,G02,L1021-07,198.14,DMSO,C6H6N4O4,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,insoluble in EtOH; insoluble in H2O; ≥9.6 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Antibiotic,https://www.apexbt.com/search.php?catalog=A8486A8490,Olsalazine Sodium,6054-98-4,G03,L1021-07,346.2,H2O,C14H8N2O6·2Na,C1=CC(=C(C=C1NN=C2C=CC(=O)C(=C2)C(=O)O)C(=O)[O-])[O-].[Na+].[Na+],insoluble in DMSO; insoluble in EtOH; ≥17.2 mg/mL in H2O,Free Base,Microbiology & Virology,Antibiotic,Anti-inflammatory prodrug,https://www.apexbt.com/search.php?catalog=A8490A8492,Orlistat,96829-58-2,G04,L1021-07,495.73,DMSO,C29H53NO5,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,insoluble in H2O; ≥17.4 mg/mL in DMSO; ≥26.8 mg/mL in EtOH,Free Base,Others,Others,Lipase inhibitor for obesity treatment,https://www.apexbt.com/search.php?catalog=A8492A8493,Oxeladin Citrate,52432-72-1,G05,L1021-07,527.6,DMSO,C20H33NO3·C6H8O7,CCC(CC)(C1=CC=CC=C1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥25 mg/mL in DMSO; ≥24.75 mg/mL in H2O; ≥25.85 mg/mL in EtOH,citrate,Others,Others,Cough suppressant,https://www.apexbt.com/search.php?catalog=A8493A8494,Oxethazaine,126-27-2,G06,L1021-07,467.64,DMSO,C28H41N3O3,CC(C)(CC1=CC=CC=C1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC2=CC=CC=C2,≥23.15 mg/mL in DMSO; insoluble in H2O; ≥50 mg/mL in EtOH,Free Base,Others,Others,Topical anesthetic,https://www.apexbt.com/search.php?catalog=A8494A8495,Oxybutynin,5633-20-5,G07,L1021-07,357.49,DMSO,C22H31NO3,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,insoluble in H2O; ≥17.87 mg/mL in DMSO; ≥48.5 mg/mL in EtOH,Free Base,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=A8495A8496,Paliperidone,144598-75-4,G08,L1021-07,426.48,DMSO,C23H27FN4O3,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,insoluble in H2O; insoluble in EtOH; ≥10.662 mg/mL in DMSO with gentle warming,,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A8496A8497,Pasiniazid,2066-89-9,G09,L1021-07,290.27,DMSO,C6H7N3O·C7H7NO3,C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C(=O)NN,insoluble in H2O; ≥14.5 mg/mL in EtOH; ≥22.75 mg/mL in DMSO,Isonicotinic,Others,Others,Anti-TB and anti-leprosy drug,https://www.apexbt.com/search.php?catalog=A8497A8502,Piromidic Acid,19562-30-2,G10,L1021-07,288.32,DMSO,C14H16N4O3,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥2.88 mg/mL in DMF with gentle warming; ≥3 mg/mL in DMSO with gentle warming,,Others,Others,Quinolone antibiotic,https://www.apexbt.com/search.php?catalog=A8502A8503,Piroxicam,36322-90-4,G11,L1021-07,331.35,DMSO,C15H13N3O4S,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,insoluble in H2O; insoluble in EtOH; ≥16.57 mg/mL in DMSO,Free Base,Neuroscience,COX,Prostaglandin synthesis/Coxinhibitor,https://www.apexbt.com/search.php?catalog=A8503A8504,Pitavastatin Calcium,147526-32-7,H01,L1021-07,880.98,DMSO,C50H46CaF2N2O8,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],≥34.85 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Calcium,Metabolism,HMG-CoA Reductase,Enzyme HMGCR inhibitor,https://www.apexbt.com/search.php?catalog=A8504A8506,Potassium Canrenoate,2181-04-6,H02,L1021-07,396.56,H2O,C22H29KO4,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC4(CCC(=O)[O-])O)C.[K+],insoluble in EtOH; insoluble in DMSO; ≥117.4 mg/mL in H2O,,Others,Others,Aldosterone antagonist,https://www.apexbt.com/search.php?catalog=A8506A8507,Pridinol Methanesulfonate,6856-31-1,H03,L1021-07,391.52,DMSO,C21H29NO4S,CS(=O)(=O)O.C1CCN(CC1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)O,≥10.96 mg/mL in H2O with ultrasonic; ≥16.95 mg/mL in DMSO; ≥40.53 mg/mL in EtOH with ultrasonic,Methanesulfonat,Others,Others,Anticholinergic / antiparkinsonian agent,https://www.apexbt.com/search.php?catalog=A8507A8508,Prochlorperazine,58-38-8,H04,L1021-07,373.94,DMSO,C20H24ClN3S,CN(CC1)CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4,insoluble in H2O; ≥16.5 mg/mL in DMSO; ≥58.5 mg/mL in EtOH,Free Base,Others,Others,Dopamine (D2) receptor antagonist,https://www.apexbt.com/search.php?catalog=A8508A8509,Progesterone,57-83-0,H05,L1021-07,314.46,DMSO,C21H30O2,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,insoluble in H2O; ≥14.65 mg/mL in DMSO; ≥47.3 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progesterone,https://www.apexbt.com/search.php?catalog=A8509A8510,Ranolazine,95635-55-5,H06,L1021-07,427.54,DMSO,C24H33N3O4,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,insoluble in H2O; ≥13.18 mg/mL in EtOH with ultrasonic; ≥17.4 mg/mL in DMSO,Free Base,Others,Others,Anti-ischemic,https://www.apexbt.com/search.php?catalog=A8510A8512,Rifaximin (Xifaxan),80621-81-4,H07,L1021-07,785.88,DMSO,C43H51N3O11,O[[C@@H]([[C@H](C)[[C@H]([[C@H](/C=C/C=C(C)\C(NC1=C2O)=O)C)O)[[C@@H](C)[[C@@H]([[C@H](C)[[C@H](/C=C/O[[C@H@](C3=O)(C)OC4=C3C(C5=C1N(C=CC(C)=C6)C6=N5)=C2C(O)=C4C)OC)OC(C)=O,≥83.33 mg/mL in DMSO; insoluble in H2O; ≥30 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"RNA synthesis inhibitor, PXR activator",https://www.apexbt.com/search.php?catalog=A8512A8513,Riluzole,1744-22-5,H08,L1021-07,234.2,DMSO,C8H5F3N2OS,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,≥23.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel protein inhibitor,https://www.apexbt.com/search.php?catalog=A8513A8514,Risperidone,106266-06-2,H09,L1021-07,410.48,DMSO,C23H27FN4O2,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,insoluble in H2O; ≥11.49 mg/mL in EtOH with ultrasonic; ≥6.84 mg/mL in DMSO with gentle warming,Free Base,Neuroscience,5-HT Receptor,SR-2A inhibitor,https://www.apexbt.com/search.php?catalog=A8514A8515,Rivastigmine Tartrate,129101-54-8,H10,L1021-07,400.42,DMSO,C14H22N2O2·C4H6O6,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.C(C(C(=O)O)O)(C(=O)O)O,≥20.02 mg/mL in DMSO; ≥45.3 mg/mL in H2O; ≥79.4 mg/mL in EtOH,Tartrate,Neuroscience,AChR,AChR inhibitor,https://www.apexbt.com/search.php?catalog=A8515A8516,Rizatriptan Benzoate,145202-66-0,H11,L1021-07,391.47,DMSO,C15H19N5·C7H6O2,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,≥4.12 mg/mL in EtOH with ultrasonic; ≥48.9 mg/mL in H2O with ultrasonic; ≥9.79 mg/mL in DMSO,Benzoate,Neuroscience,5-HT Receptor,5-HT Receptor agonist,https://www.apexbt.com/search.php?catalog=A8516A8518,Rosuvastatin Calcium,147098-20-2,A01,L1021-08,1001.14,DMSO,C44H54F2N6O12S2 Ca,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2],≥28.55 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Endocrinology and Hormones,RAAS,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A8518A8521,Silodosin,160970-54-7,A02,L1021-08,495.53,DMSO,C25H32F3N3O4,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,≥24.78 mg/mL in DMSO; insoluble in H2O; ≥45.5 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,_1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=A8521A8522,Simvastatin (Zocor),79902-63-9,A03,L1021-08,418.6,DMSO,C25H38O5,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,insoluble in H2O; ≥102 mg/mL in EtOH with ultrasonic; ≥20.95 mg/mL in DMSO,Free Base,Metabolism,HMG-CoA Reductase,HMGCR (HMG-CoA reductase) inhibitor,https://www.apexbt.com/search.php?catalog=A8522A8523,Sodium 4-amiropparaty Hyalrate,94-16-6,A04,L1021-08,216.17,DMSO,C9H9N2NaO3,C1=CC(=CC=C1C(=O)NCC(=O)[O-])N.[Na+],≥10.56 mg/mL in EtOH with ultrasonic; ≥129.6 mg/mL in H2O; ≥6.5 mg/mL in DMSO,Sodium,Others,Others,Sodium 4-amiropparaty Hyalrate,https://www.apexbt.com/search.php?catalog=A8523A8525,Sotrastaurin (AEB071),425637-18-9,A05,L1021-08,438.48,DMSO,C25H22N6O2,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,≥21.9 mg/mL in DMSO; insoluble in H2O; ≥2.55 mg/mL in EtOH with ultrasonic,Free Base,TGF-_ / Smad Signaling,PKC,PKC inhibitor,https://www.apexbt.com/search.php?catalog=A8525A8527,Sulfadiazine,68-35-9,A06,L1021-08,250.28,DMSO,C10H10N4O2S,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in EtOH; insoluble in H2O; ≥7.55 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Sulfonamide antibiotic,https://www.apexbt.com/search.php?catalog=A8527A8529,Tebipenempivoxil,161715-24-8,A07,L1021-08,497.63,DMSO,C22H31N3O6S2,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,insoluble in H2O; ≥17.25 mg/mL in DMSO; ≥36.27 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,Carbapenem antibiotic,https://www.apexbt.com/search.php?catalog=A8529A8530,Telbivudine,3424-98-4,A08,L1021-08,242.23,DMSO,C10H14N2O5,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,insoluble in EtOH; ≥11.85 mg/mL in DMSO; ≥9.24 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,HBV,Reverse Transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8530A8531,Telmisattan,144701-48-4,A09,L1021-08,514.62,DMSO,C33H30N4O2,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,insoluble in H2O; insoluble in EtOH; ≥9.6 mg/mL in DMSO with gentle warming,Free Base,Endocrinology and Hormones,RAAS,Angiotensin II receptor antagonist,https://www.apexbt.com/search.php?catalog=A8531A8532,Teniposide,29767-20-2,A10,L1021-08,656.7,DMSO,C32H32O13S,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,≥23.65 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase inhibitor,https://www.apexbt.com/search.php?catalog=A8532A8533,Terbinafine,91161-71-6,A11,L1021-08,291.43,DMSO,C21H25N,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥67.2 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Allylamine antifungal agent,https://www.apexbt.com/search.php?catalog=A8533A8534,Terfenadine,50679-08-8,B01,L1021-08,471.67,DMSO,C32H41NO2,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,insoluble in H2O; ≥18 mg/mL in DMSO; ≥8.06 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Histamine H1-receptor antagonist,https://www.apexbt.com/search.php?catalog=A8534A8536,Thiabendazole,148-79-8,B02,L1021-08,201.25,DMSO,C10H7N3S,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL in DMSO ,Free Base,Others,Others,Fungicide,https://www.apexbt.com/search.php?catalog=A8536A8537,Thioridazine HCl,130-61-0,B03,L1021-08,407,DMSO,C21H26N2S2·HCl,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl,≥12.25 mg/mL in EtOH with ultrasonic; ≥20.35 mg/mL in DMSO; ≥6.78 mg/mL in H2O with ultrasonic,Hydrochloride,Others,Others,Calcium channel protein inhibitor,https://www.apexbt.com/search.php?catalog=A8537A8538,Tiopronin (Thiola),1953-02-2,B04,L1021-08,163.19,DMSO,C5H9NO3S,CC(C(=O)NCC(=O)O)S,≥110.6 mg/mL in H2O; ≥120.6 mg/mL in EtOH; ≥6.8 mg/mL in DMSO,Free Base,Others,Others,Drug for cystinuria treatment,https://www.apexbt.com/search.php?catalog=A8538A8539,Tretinoin (Aberela),302-79-4,B05,L1021-08,300.4,DMSO,C20H28O2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥5.77 mg/mL in EtOH with ultrasonic,Free Base,Others,RARs,"retinoic acid, treats acne vulgaris and keratosis pilaris",https://www.apexbt.com/search.php?catalog=A8539A8540,Triamcinolone Acetonide,76-25-5,B06,L1021-08,434.5,DMSO,C24H31FO6,F[[C@H@]1([[C@H@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[[C@H](C([H])([H])C3([H])[H])([H])[[C@H@]4([H])[[C@H@](C([H])([H])[[C@H]1([H])O[H])(C([H])([H])[H])[[C@H]5(C(C([H])([H])O[H])=O)OC(C([H])([H])[H])(C([H])([H])[H])O[[C@H]5([H])C4([H])[H],insoluble in H2O; ≥14.25 mg/mL in DMSO; ≥8.08 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Antiinflammatory steroid,https://www.apexbt.com/search.php?catalog=A8540A8541,Triciribine,35943-35-2,B07,L1021-08,320.3,DMSO,C13H16N6O4,[H][[C@H](N1C(N=C([H])N=C2N(C([H])([H])[H])N=C3N([H])[H])=C2C3=C1[H])([[C@H]4([H])O[H])O[[C@H@](C([H])([H])O[H])([H])[[C@H@]4([H])O[H],insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL in DMSO,,PI3K/Akt/mTOR Signaling,Akt,"Akt inhibitor,highly selective",https://www.apexbt.com/search.php?catalog=A8541A8542,Triflurdine (Viroptic),70-00-8,B08,L1021-08,296.2,DMSO,C10H11F3N2O5,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,≥14.45 mg/mL in DMSO; ≥17.03 mg/mL in EtOH with ultrasonic; ≥3.72 mg/mL in H2O with ultrasonic,Free Base,Apoptosis,Thymidylate Synthase,Anti-herpesvirus antiviral drug,https://www.apexbt.com/search.php?catalog=A8542A8543,Vitamin D2 (Ergocalciferol),50-14-6,B09,L1021-08,396.65,DMSO,C28H44O,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,insoluble in H2O; ≥11.83 mg/mL in DMSO with ultrasonic; ≥16.8 mg/mL in EtOH,Free Base,Others,Others,DNA Polymerase inhibitor,https://www.apexbt.com/search.php?catalog=A8543A8548,Fingolimod (FTY720),162359-56-0,B10,L1021-08,343.94,DMSO,C19H34ClNO2,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,≥15.3 mg/mL in EtOH; ≥17.2 mg/mL in DMSO; ≥31.3 mg/mL in H2O with ultrasonic,,GPCR/G protein,S1P receptor,S1P receptors agonist,https://www.apexbt.com/search.php?catalog=A8548A8549,LY335979 (Zosuquidar 3HCL),167465-36-3,B11,L1021-08,637.0,DMSO,C32H34Cl3F2N3O2,FC1([[C@H](C2=CC=CC=C23)[[C@@H]1C4=CC=CC=C4[[C@H]3N5CCN(C[[C@H](COC6=C7C(N=CC=C7)=CC=C6)O)CC5)F.Cl.Cl.Cl,insoluble in EtOH; ≥17.1 mg/mL in DMSO; ≥31.9 mg/mL in H2O,,Membrane Transporter/Ion Channel,P-gp,Pgp (P-glycoprotein) inhibitor,https://www.apexbt.com/search.php?catalog=A8549A8553,PTC124 (Ataluren),775304-57-9,C01,L1021-08,284.24,DMSO,C15H9FN2O3,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,insoluble in H2O; ≥10.6 mg/mL in DMSO; ≥2.37 mg/mL in EtOH with gentle warming,,Membrane Transporter/Ion Channel,CFTR,CFTR-G542X nonsense allele inhibitor,https://www.apexbt.com/search.php?catalog=A8553A8555,Vandetanib (ZD6474),443913-73-3,C02,L1021-08,475.35,DMSO,C22H24BrFN4O2,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,insoluble in H2O; ≥11.88 mg/mL in DMSO with gentle warming; ≥8.74 mg/mL in EtOH,,Tyrosine Kinase,VEGFR,VEGFR2/EGFR antagonist,https://www.apexbt.com/search.php?catalog=A8555A8556,GSK2126458,1086062-66-9,C03,L1021-08,505.5,DMSO,C25H17F2N5O3S,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,≥25.3 mg/mL in DMSO; insoluble in H2O; ≥2.29 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,mTOR,PI3K/mTOR inhibitor,https://www.apexbt.com/search.php?catalog=A8556A8558,BI6727 (Volasertib),755038-65-4,C04,L1021-08,618.83,DMSO,C34H50N8O3,CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,insoluble in H2O; ≥10.31 mg/mL in DMSO; ≥56.1 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,PLK,"Plk inhibitor,highly potent",https://www.apexbt.com/search.php?catalog=A8558A8623,TOK-001,851983-85-2,C05,L1021-08,388.56,DMSO,C26H32N2O,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,insoluble in H2O; ≥12.4 mg/mL in DMSO; ≥26.5 mg/mL in EtOH,,Endocrinology and Hormones,Androgen Receptor,CYP17 inhibitor and androgen receptor (AR) antagonist,https://www.apexbt.com/search.php?catalog=A8623A8628,Chloroquine diphosphate,50-63-5,C06,L1021-08,515.86,H2O,C18H26ClN3·2H3PO4,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL in H2O,Phosphate,Ubiquitination/Proteasome,Autophagy,"Antimalarial drug,TLR7 TLR9 inhibitor",https://www.apexbt.com/search.php?catalog=A8628A8639,Deferasirox,201530-41-8,C07,L1021-08,373.37,DMSO,C21H15N3O4,O=C(O)C1=CC=C(N2C(C3=CC=CC=C3O)=NC(C4=CC=CC=C4O)=N2)C=C1,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥2.94 mg/mL in EtOH with ultrasonic,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Oral iron chelator,https://www.apexbt.com/search.php?catalog=A8639A8641,LEE011,1211441-98-3,C08,L1021-08,434.54,DMSO,C23H30N8O,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL in DMSO,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK4/6 inhibitor,https://www.apexbt.com/search.php?catalog=A8641A8644,Acyclovir,59277-89-3,C09,L1021-08,225.21,DMSO,C8H11N5O3,C1=NC2=C(N1COCCO)NC(=NC2=O)N,insoluble in H2O; insoluble in EtOH; ≥11.4 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agent,https://www.apexbt.com/search.php?catalog=A8644A8647,Capecitabine,154361-50-9,C10,L1021-08,359.35,DMSO,C15H22FN3O6,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,≥10.97 mg/mL in H2O with ultrasonic; ≥17.95 mg/mL in DMSO; ≥66.9 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"DNA, RNA and protein synthesis inhibitor",https://www.apexbt.com/search.php?catalog=A8647A8648,Oxaliplatin,61825-94-3,C11,L1021-08,397.29,DMSO,C8H14N2O4Pt,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],insoluble in EtOH; ≥37.25 mg/mL in DMSO; ≥3.94 mg/mL in H2O with gentle warming,,DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent,https://www.apexbt.com/search.php?catalog=A8648A8650,Saxagliptin,361442-04-8,D01,L1021-08,315.41,DMSO,C18H25N3O2,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,≥123 mg/mL in EtOH; ≥14.85 mg/mL in DMSO; ≥8.32 mg/mL in H2O with ultrasonic,,Proteases,DPP-4,Selective DPP4 inhibitor,https://www.apexbt.com/search.php?catalog=A8650A8651,LY2940680,1258861-20-9,D02,L1021-08,512.5,DMSO,C26H24F4N6O,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,insoluble in H2O; ≥5.2 mg/mL in EtOH with ultrasonic; ≥51.3 mg/mL in DMSO with gentle warming and ultrasonic,,Stem Cell,Hedgehog,"Hedgehog/SMO antagonist,inhibits Hh signaling",https://www.apexbt.com/search.php?catalog=A8651A8660,Cilengitide,188968-51-6,D03,L1021-08,588.66,DMSO,C27H40N8O7,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,≥29.43 mg/mL in DMSO; insoluble in H2O; ≥22.56 mg/mL in H2O,Free Base,Angiogenesis,Integrin,Integrin inhibitor for _v_3 and _v_5,https://www.apexbt.com/search.php?catalog=A8660A8686,VX-745,209410-46-8,D04,L1021-08,436.27,DMSO,C19H9Cl2F2N3OS,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,≥21.8 mg/mL in DMSO; insoluble in H2O; ≥2.1 mg/mL in EtOH with gentle warming and ultrasonic,,MAPK Signaling,p38,,https://www.apexbt.com/search.php?catalog=A8686A8701,Mesoridazine Besylate,32672-69-8,D05,L1021-08,544.75,DMSO,C27H32N2O4S3,O=S(C)C1=CC=C2SC3=CC=CC=C3N(C2=C1)CC[[C@H]4N(C)CCCC4.OS(=O)(C5=CC=CC=C5)=O,≥21.5 mg/mL in DMSO; insoluble in H2O; ≥19.55 mg/mL in EtOH,besylate,Others,Others,Phenothiazine dopamine receptor anatagonist,https://www.apexbt.com/search.php?catalog=A8701A8704,Stiripentol,49763-96-4,D06,L1021-08,234.29,DMSO,C14H18O3,OC(C(C)(C)C)/C=C/C1=CC2=C(OCO2)C=C1,insoluble in H2O; ≥46.7 mg/mL in EtOH; ≥9.9 mg/mL in DMSO,,Metabolism,Dehydrogenase,,https://www.apexbt.com/search.php?catalog=A8704A8710,ETC-1002,738606-46-7,D07,L1021-08,344.49,DMSO,C19H36O5,OC(C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O)=O,insoluble in H2O; ≥97.6 mg/mL in DMSO; ≥42.5 mg/mL in EtOH,#N/A,Others,ATP citrate lyase,ACL inhibitor and AMPK activator,https://www.apexbt.com/search.php?catalog=A8710A8802,(S)-Crizotinib,877399-52-5; 1374356-45-2,D08,L1021-08,450.34,DMSO,C21H22Cl2FN5O,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,≥33.33 mg/mL in DMSO; insoluble in H2O; ≥8.58 mg/mL in EtOH with ultrasonic,#N/A,DNA Damage/DNA Repair,MTH1,Potent MTH1 inhibitor,https://www.apexbt.com/search.php?catalog=A8802A8809,Vorapaxar,618385-01-6,D09,L1021-08,492.58,DMSO,C29H33FN2O4,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,≥24.65 mg/mL in DMSO; insoluble in H2O; ≥10.64 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,"PAR-1 antagonist,potent and orally active",https://www.apexbt.com/search.php?catalog=A8809A8893,Rucaparib (free base),283173-50-2,D10,L1021-08,323.36,DMSO,C19H18FN3O,FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1,insoluble in H2O; insoluble in EtOH; ≥16.15 mg/mL in DMSO,#N/A,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,https://www.apexbt.com/search.php?catalog=A8893B1006,Vilanterol trifenatate,503070-58-4,D11,L1021-08,774.77,DMSO,C44H49Cl2NO7,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,insoluble in H2O; ≥158.4 mg/mL in DMSO; ≥7.84 mg/mL in ETOH with gentle warming and ultrasonic,,GPCR/G protein,Adrenergic Receptor,_2-AR agonist,https://www.apexbt.com/search.php?catalog=B1006B1011,Bafetinib (INNO-406),859212-16-1,E01,L1021-08,576.62,DMSO,C30H31F3N8O,CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=C(C=N4)C5=CN=CN=C5,≥57.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,TGF-_ / Smad Signaling,Bcr-Abl,Bcr-Abl/Lyn tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=B1011B1027,2-Deoxy-D-glucose,154-17-6,E02,L1021-08,164.16,DMSO,C6H12O5,[H][[C@H]([[C@H](C1([H])[H])([H])O[H])([[C@H](C([H])([H])O[H])([H])OC1([H])O[H])O[H],≥105 mg/mL in H2O; ≥2.37 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.2 mg/mL in DMSO,,Others,Hexokinase,,https://www.apexbt.com/search.php?catalog=B1027B1037,Alvelestat,848141-11-7,E03,L1021-08,545.53,DMSO,C25H22F3N5O4S,CC(N1C2=CC=CC(C(F)(F)F)=C2)=C(C3=CC=NN3C)C=C(C1=O)C(NCC4=NC=C(S(C)(=O)=O)C=C4)=O,≥27.3 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,Elastase,NE inhibitor,https://www.apexbt.com/search.php?catalog=B1037B1045,Sunitinib,557795-19-4,E04,L1021-08,398.47,DMSO,C22H27FN4O2,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,insoluble in H2O; ≥19.9 mg/mL in DMSO with gentle warming; ≥3.16 mg/mL in EtOH with gentle warming,Free Base,Tyrosine Kinase,PDGFR,RTK inhibitor,https://www.apexbt.com/search.php?catalog=B1045B1049,Ulipristal acetate,126784-99-4,E05,L1021-08,475.62,DMSO,C30H37NO4,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,≥21.3 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥23.23 mg/mL in EtOH,acetate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Novel selective progesterone receptor modulator (SPRM),https://www.apexbt.com/search.php?catalog=B1049B1050,Delavirdine mesylate,147221-93-0,E06,L1021-08,552.67,DMSO,C23H32N6O6S2,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C.CS(=O)(=O)O,insoluble in H2O; insoluble in EtOH; ≥58.3 mg/mL in DMSO,#N/A,Microbiology & Virology,Reverse Transcriptase,Non-nucleoside reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B1050B1054,Resiquimod (R-848),144875-48-9,E07,L1021-08,314.38,DMSO,C17H22N4O2,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,insoluble in H2O; ≥12.65 mg/mL in EtOH with ultrasonic; ≥15.85 mg/mL in DMSO,,Immunology/Inflammation,TLR,,https://www.apexbt.com/search.php?catalog=B1054B1059,Mosapride,112885-41-3,E08,L1021-08,421.89,DMSO,C21H25ClFN3O3,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N,insoluble in H2O; insoluble in EtOH; ≥75.3 mg/mL in DMSO,#N/A,Neuroscience,5-HT Receptor,Selective 5HT4 agonist,https://www.apexbt.com/search.php?catalog=B1059B1063,Tizanidine,51322-75-9,E09,L1021-08,253.71,DMSO,C9H8ClN5S,ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1,insoluble in H2O; ≥11.45 mg/mL in DMSO; ≥9.44 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,_2 adrenergic agonist,https://www.apexbt.com/search.php?catalog=B1063B1070,AHU-377(Sacubitril),149709-62-6,E10,L1021-08,411.49,DMSO,C24H29NO5,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,≥41.1 mg/mL in DMSO; ≥21.45 mg/mL in H2O with ultrasonic; ≥26.85 mg/mL in EtOH with ultrasonic,,GPCR/G protein,Angiotensin Receptor,,https://www.apexbt.com/search.php?catalog=B1070B1072,Losartan,114798-26-4,E11,L1021-08,422.91,DMSO,C22H23ClN6O,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,≥2.48 mg/mL in H2O with gentle warming and ultrasonic; ≥2.9 mg/mL in EtOH with gentle warming; ≥84.6 mg/mL in DMSO,,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist,https://www.apexbt.com/search.php?catalog=B1072B1076,Doripenem,148016-81-3,F01,L1021-08,420.5,DMSO,C15H24N4O6S2,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,≥20.1 mg/mL in DMSO with gentle warming; ≥13.1 mg/mL in H2O with ultrasonic; ≥3.37 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Ultra-broad spectrum injectable antibiotic,https://www.apexbt.com/search.php?catalog=B1076B1092,Salicylic acid,69-72-7,F02,L1021-08,138.12,DMSO,C7H6O3,C1=CC=C(C(=C1)C(=O)O)O,insoluble in H2O; ≥52.6 mg/mL in EtOH; ≥6.91 mg/mL in DMSO,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1092B1100,Cytarabine hydrochloride,69-74-9,F03,L1021-08,279.68,DMSO,C9H14ClN3O5,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl,insoluble in EtOH; ≥14.2 mg/mL in DMSO; ≥64.2 mg/mL in H2O,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor,https://www.apexbt.com/search.php?catalog=B1100B1102,Brexpiprazole,913611-97-9,F04,L1021-08,433.57,DMSO,C25H27N3O2S,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,≥21.68 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,Free Base,Neuroscience,Dopamine Receptor,"5-HT2A, _1B-, and _2C-adrenergic receptors antagonist",https://www.apexbt.com/search.php?catalog=B1102B1104,AZD-9291,1421373-65-0,F05,L1021-08,499.61,DMSO,C28H33N7O2,CN1C=C(C2=NC(NC3=C(OC)C=C(N(CCN(C)C)C)C(NC(C=C)=O)=C3)=NC=C2)C4=C1C=CC=C4,≥24.98 mg/mL in DMSO; insoluble in H2O; ≥8.09 mg/mL in EtOH with ultrasonic,Free Base,JAK/STAT Signaling,EGFR,Mutated forms EGFR inhibitor,https://www.apexbt.com/search.php?catalog=B1104B1106,VRT752271,869886-67-9,F06,L1021-08,433.33,DMSO,C21H22Cl2N4O2,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,≥43.3 mg/mL in DMSO; insoluble in H2O; ≥2.51 mg/mL in EtOH with gentle warming and ultrasonic,,MAPK Signaling,ERK,ERK1/ERK2 inhibitor,https://www.apexbt.com/search.php?catalog=B1106B1114,T 705,259793-96-9,F07,L1021-08,157.1,DMSO,C5H4FN3O2,C1=C(N=C(C(=O)N1)C(=O)N)F,≥2.9 mg/mL in H2O with ultrasonic; ≥6.2 mg/mL in DMSO; ≥8.78 mg/mL in EtOH with ultrasonic,,Microbiology & Virology,HCV,Potent and selective RNA-dependent RNA polymerase inhibitor,https://www.apexbt.com/search.php?catalog=B1114B1119,Efavirenz,154598-52-4,F08,L1021-08,315.68,DMSO,C14H9ClF3NO2,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,insoluble in H2O; ≥15.55 mg/mL in DMSO; ≥48.1 mg/mL in EtOH,Free Base,Microbiology & Virology,HIV,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B1119B1122,Nelfinavir,159989-64-7,F09,L1021-08,567.78,DMSO,C32H45N3O4S,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,insoluble in H2O; ≥16.1 mg/mL in DMSO with ultrasonic; ≥20.45 mg/mL in EtOH,Free Base,Proteases,HIV Integrase,HIV-1 protease inhibitor,https://www.apexbt.com/search.php?catalog=B1122B1123,Rosuvastatin,287714-41-4,F10,L1021-08,481.54,DMSO,C22H28FN3O6S,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,≥48.2 mg/mL in DMSO; ≥10.78 mg/mL in H2O with ultrasonic; ≥12.4 mg/mL in EtOH with ultrasonic,,Metabolism,HMG-CoA Reductase,Competitive inhibitor of HMG-CoA reductase,https://www.apexbt.com/search.php?catalog=B1123B1124,Pitavastatin,147511-69-1,F11,L1021-08,421.46,DMSO,C25H24FNO4,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,≥10.56 mg/mL in H2O with ultrasonic; ≥14.35 mg/mL in DMSO; ≥8.46 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=B1124B1125,Pravastatin,81093-37-0,G01,L1021-08,424.53,DMSO,C23H36O7,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,≥14.05 mg/mL in DMSO,,Metabolism,HMG-CoA Reductase,,https://www.apexbt.com/search.php?catalog=B1125B1130,GLPG0634,1206161-97-8,G02,L1021-08,425.5,DMSO,C21H23N5O3S,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,≥21.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,JAK/STAT Signaling,JAK,JAK1 inhibitor,https://www.apexbt.com/search.php?catalog=B1130B1134,Oxybutynin chloride,1508-65-2,G03,L1021-08,393.95,DMSO,C22H32ClNO3,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,≥19.7 mg/mL in DMSO; ≥70.8 mg/mL in EtOH; ≥73.3 mg/mL in H2O,Chloride,Neuroscience,AChR,Anticholinergic medication,https://www.apexbt.com/search.php?catalog=B1134B1147,Orotic acid,65-86-1,G04,L1021-08,156.1,DMSO,C5H4N2O4,C1=C(NC(=O)NC1=O)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥15.6 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Pyrimidinecarboxylic acid,https://www.apexbt.com/search.php?catalog=B1147B1157,sn-Glycero-3-phosphocholine,28319-77-9,G05,L1021-08,257.22,H2O,C8H20NO6P,C[N+](C)(C)CCOP(=O)([O-])OCC(CO)O,insoluble in DMSO; ≥11.2 mg/mL in H2O; ≥3.25 mg/mL in EtOH,,Others,Others,Nootropic phospholipid,https://www.apexbt.com/search.php?catalog=B1157B1192,Topiroxostat,577778-58-6,G06,L1021-08,248.24,DMSO,C13H8N6,C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N,insoluble in EtOH; insoluble in H2O; ≥10.7 mg/mL in DMSO,,Others,XAO,Xanthine oxidoreductase (XOR) inhibitor,https://www.apexbt.com/search.php?catalog=B1192B1198,Cisapride,81098-60-4,G07,L1021-08,465.95,DMSO,C23H29ClFN3O4,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,≥23.3 mg/mL in DMSO; insoluble in H2O; ≥3.47 mg/mL in EtOH,,Neuroscience,5-HT Receptor,5-HT4 receptor agonist,https://www.apexbt.com/search.php?catalog=B1198B1199,Tandospirone,87760-53-0,G08,L1021-08,383.49,DMSO,C21H29N5O2,O=C([[C@H@]1([H])[[C@H@](C([H])([H])C2([H])[H])([H])C([H])([H])[[C@H@]2([H])[[C@H]13[H])N(C([H])([H])C([H])([H])C([H])([H])C([H])([H])N4C([H])([H])C([H])([H])N(C5=NC([H])=C([H])C([H])=N5)C([H])([H])C4([H])[H])C3=O,≥38.3 mg/mL in DMSO; insoluble in H2O; ≥12.8 mg/mL in EtOH,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=B1199B1204,Ondansetron hydrochloride dihydrate,103639-04-9,G09,L1021-08,365.85,DMSO,C18H24ClN3O3,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.O.O.Cl,≥12.7 mg/mL in EtOH with ultrasonic; ≥7.57 mg/mL in H2O with ultrasonic; ≥9.15 mg/mL in DMSO,hydrochloride,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1204B1206,Pizotifen,15574-96-6,G10,L1021-08,295.44,DMSO,C19H21NS,CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1,insoluble in H2O; ≥14.77 mg/mL in DMSO; ≥21.63 mg/mL in EtOH with ultrasonic,,Neuroscience,5-HT Receptor,Highly selective 5-HT receptor blocking agent,https://www.apexbt.com/search.php?catalog=B1206B1210,Aniracetam,72432-10-1,G11,L1021-08,219.24,DMSO,C12H13NO3,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,insoluble in H2O; ≥10.96 mg/mL in DMSO; ≥11.06 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,AMPAR,Nootropic drug for senile dementia,https://www.apexbt.com/search.php?catalog=B1210B1215,Gatifloxacin hydrochloride,121577-32-0,H01,L1021-08,411.86,H2O,C19H23ClFN3O4,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl,Insoluble in DMSO; insoluble in EtOH; ≥14.8 mg/mL in H2O with ultrasonic,,DNA Damage/DNA Repair,Topoisomerase,potent fluoroquinolone antibiotics,https://www.apexbt.com/search.php?catalog=B1215B1217,Meropenem trihydrate,119478-56-7,H02,L1021-08,437.51,DMSO,C17H31N3O8S,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O.O.O.O,≥20.7 mg/mL in H2O with gentle warming; insoluble in EtOH; ≥49.2 mg/mL in DMSO,trihydrate,Microbiology & Virology,Antibiotic,Broad-spectum _-lactam antibiotic,https://www.apexbt.com/search.php?catalog=B1217B1223,Vancomycin hydrochloride,1404-93-9,H03,L1021-08,1485.72,DMSO,C66H76Cl3N9O24,Cl.CNC(CC(C)C)C(=O)NC1C(O)C2=CC=C(OC3=CC4=CC(=C3OC5OC(CO)C(O)C(O)C5OC6CC(C)(N)C(O)C(C)O6)OC7=CC=C(C=C7Cl)C(O)C8NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)C9=CC(=C(O)C=C9)C%10=C(C=C(O)C=C%10O)C(NC8=O)C(O)=O)C(=C2)Cl,≥55.8 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥22.15 mg/mL in H2O,Hydrochloride,Microbiology & Virology,Antibiotic,Narrow-spectrum glycopeptide antibacterial agent,https://www.apexbt.com/search.php?catalog=B1223B1224,Anidulafungin,166663-25-8,H04,L1021-08,1140.24,DMSO,C58H73N7O17,O[[C@H]1[[C@H](C)CN(C([[C@H]([[C@H](C)O)NC([[C@H]([[C@@H]([[C@@H](C(C=C2)=CC=C2O)O)O)NC([[C@H](C3)N(C([[C@H]([[C@H](C)O)NC4=O)=O)C[[C@@H]3O)=O)=O)=O)[[C@@H]1C(N[[C@H]([[C@@H](C[[C@@H]4NC(C5=CC=C(C6=CC=C(C(C=C7)=CC=C7OCCCCC)C=C6)C=C5)=O)O)O)=O,insoluble in EtOH; insoluble in H2O; ≥20.8 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,Antifungal drug,https://www.apexbt.com/search.php?catalog=B1224B1226,Fluconazole hydrate,155347-36-7,H05,L1021-08,324.29,DMSO,C13H14F2N6O2,FC1=CC(F)=C(C(CN2C=NC=N2)(O)CN3C=NC=N3)C=C1.O,≥16.35 mg/mL in DMSO; ≥28.8 mg/mL in EtOH; ≥3.2 mg/mL in H2O with ultrasonic,hydrate,Microbiology & Virology,Antibiotic,Triazole antifungal drug,https://www.apexbt.com/search.php?catalog=B1226B1239,Parecoxib Sodium,198470-85-8,H06,L1021-08,392.4,DMSO,C19H17N2NaO4S,CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+],≥10.7 mg/mL in EtOH; ≥118.6 mg/mL in DMSO; ≥43.9 mg/mL in H2O,,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1239B1240,(+)-Ketoconazole,142128-59-4,H07,L1021-08,531.43,DMSO,C26H28Cl2N4O4,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,≥25.5 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,Free Base,Metabolism,P450,Potent inhibitor of cytochrome P450c17,https://www.apexbt.com/search.php?catalog=B1240B1242,Haloperidol hydrochloride,1511-16-6,H08,L1021-08,412.33,DMSO,C21H24Cl2FNO2,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F.Cl,insoluble in H2O; ≥10.31 mg/mL in DMSO; ≥2.96 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Neuroscience,Dopamine Receptor,Antipsychotic drug,https://www.apexbt.com/search.php?catalog=B1242B1246,Etomidate hydrochloride,53188-20-8,H09,L1021-08,280.75,DMSO,C14H17ClN2O2,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2.Cl,≥12.35 mg/mL in DMSO; ≥36.65 mg/mL in EtOH; ≥39.45 mg/mL in H2O with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,GABA Receptor,GABAA receptors agonist,https://www.apexbt.com/search.php?catalog=B1246B1248,Beclomethasone dipropionate,5534-09-8,H10,L1021-08,521.04,DMSO,C28H37ClO7,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,insoluble in H2O; ≥12.72 mg/mL in EtOH with ultrasonic; ≥16.95 mg/mL in DMSO,Free Base,GPCR/G protein,Glucocorticoid Receptor,Corticosteroid used for asthma and rhinitis,https://www.apexbt.com/search.php?catalog=B1248B1251,Valproic acid,99-66-1,H11,L1021-08,144.21,DMSO,C8H16O2,CCCC(CCC)C(=O)O,≥12.35 mg/mL in DMSO; ≥29 mg/mL in EtOH; ≥36 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,HDAC,HDAC1 inhibitor,https://www.apexbt.com/search.php?catalog=B1251B1266,Glycopyrrolate,596-51-0,A01,L1021-09,398.33,DMSO,C19H28BrNO3,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],≥19.92 mg/mL in DMSO; ≥57.5 mg/mL in EtOH; ≥85 mg/mL in H2O,Free Base,Neuroscience,AChR,Muscarinic competitive antagonist,https://www.apexbt.com/search.php?catalog=B1266B1270,Reserpine hydrochloride,16994-56-2,A02,L1021-09,645.14,DMSO,C33H41ClN2O9,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.Cl,≥25 mg/mL in DMSO; insoluble in H2O; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Monoamine transporter,Blocker of VMAT,https://www.apexbt.com/search.php?catalog=B1270B1277,Adapalene sodium salt,911110-93-5,A03,L1021-09,434.5,DMSO,C28H27NaO3,COC1=C(C23C[[C@H@]4([H])C[[C@H](C2)([H])C[[C@H](C3)([H])C4)C=C(C5=CC=C6C=C(C([O-])=O)C=CC6=C5)C=C1.[Na+],insoluble in H2O; insoluble in EtOH; ≥4.35 mg/mL in DMSO with gentle warming,sodium salt,Others,Others,Retinoic acid receptor agonist,https://www.apexbt.com/search.php?catalog=B1277B1278,Benazepril,86541-75-5,A04,L1021-09,424.49,DMSO,C24H28N2O5,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,insoluble in EtOH; ≥38.3 mg/mL in H2O; ≥47.6 mg/mL in DMSO,#N/A,Others,Others,ACE inhibitor,https://www.apexbt.com/search.php?catalog=B1278B1280,Prilocaine hydrochloride,1786-81-8,A05,L1021-09,256.77,DMSO,C13H21ClN2O,CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl,≥10.4 mg/mL in DMSO; ≥50.8 mg/mL in H2O; ≥52.7 mg/mL in EtOH,Hydrochloride,Others,Others,Local anesthetic of the amino amide type,https://www.apexbt.com/search.php?catalog=B1280B1283,Prasugrel hydrochloride,389574-19-0,A06,L1021-09,409.9,DMSO,C20H21ClFNO3S,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl,≥18.9 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥10.42 mg/mL in EtOH with ultrasonic,Hydrochloride,GPCR/G protein,P2Y Receptor,P2 Receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1283B1286,AZD7545,252017-04-2,A07,L1021-09,478.87,DMSO,C19H18ClF3N2O5S,CC(C(=O)NC1=C(C=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)N(C)C)Cl)(C(F)(F)F)O,≥21.85 mg/mL in DMSO; insoluble in H2O; ≥15.63 mg/mL in EtOH with ultrasonic,,Others,PDHK,,https://www.apexbt.com/search.php?catalog=B1286B1289,Minoxidil,38304-91-5,A08,L1021-09,209.25,DMSO,C9H15N5O,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,insoluble in H2O; ≥14.35 mg/mL in EtOH with ultrasonic; ≥2.32 mg/mL in DMSO with gentle warming,,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 channel (KATP) activator.,https://www.apexbt.com/search.php?catalog=B1289B1290,Lansoprazole sodium,226904-00-3,A09,L1021-09,391.34,DMSO,C16H13F3N3NaO2S,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCC(F)(F)F.[Na+],insoluble in H2O; ≥15.05 mg/mL in EtOH; ≥58.9 mg/mL in DMSO,sodium,Membrane Transporter/Ion Channel,Proton Pump,PPI/cytochrome P450 inhibitor,https://www.apexbt.com/search.php?catalog=B1290B1296,Glibenclamide,10238-21-8,A10,L1021-09,494,DMSO,C23H28ClN3O5S,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,≥49.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Metabolism,Saccharometabolism,Insulin production modulator,https://www.apexbt.com/search.php?catalog=B1296B1302,Amsacrine,51264-14-3,A11,L1021-09,393.46,DMSO,C21H19N3O3S,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,Soluble in DMSO,,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 2 inhibitor,https://www.apexbt.com/search.php?catalog=B1302B1303,Amsacrine hydrochloride,54301-15-4,B01,L1021-09,429.92,DMSO,C21H20ClN3O3S,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,≥55.56 mg/mL in DMSO; insoluble in H2O; ≥2.83 mg/mL in EtOH with gentle warming and ultrasonic,,DNA Damage/DNA Repair,Topoisomerase,,https://www.apexbt.com/search.php?catalog=B1303B1327,Epinephrine HCl,55-31-2,B02,L1021-09,219.67,DMSO,C9H13NO3·HCl,CNCC(C1=CC(=C(C=C1)O)O)O.Cl,≥44.7 mg/mL in H2O; ≥5.1 mg/mL in EtOH with ultrasonic; ≥9.2 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1327B1328,Terbutaline Sulfate,23031-32-5,B03,L1021-09,548.65,DMSO,C24H38N2O6·H2O4S,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O,≥26.9 mg/mL in H2O; insoluble in EtOH; ≥11.18 mg/mL in H2O,Sulfate,GPCR/G protein,Adrenergic Receptor,Selective _2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1328B1329,Tolazoline HCl,59-97-2,B04,L1021-09,196.68,DMSO,C10H12N2·HCl,C1CN=C(N1)CC2=CC=CC=C2.Cl,≥25.73 mg/mL in EtOH; ≥51.9 mg/mL in H2O; ≥8.65 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,non-selective competitive _-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1329B1330,Acebutolol HCl,34381-68-5,B05,L1021-09,372.89,DMSO,C18H28N2O4·HCl,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl,≥11.76 mg/mL in EtOH with ultrasonic; ≥18.64 mg/mL in DMSO; ≥57.8 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_-adrenergic receptors antagonist,https://www.apexbt.com/search.php?catalog=B1330B1331,Adrenalone HCl,62-13-5,B06,L1021-09,217.65,DMSO,C9H11NO3·HCl,CNCC(=O)C1=CC(=C(C=C1)O)O.Cl,≥10.88 mg/mL in DMSO; ≥2.16 mg/mL in EtOH with gentle warming and ultrasonic; ≥50.2 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1331B1332,Carvedilol,72956-09-3,B07,L1021-09,406.47,DMSO,C24H26N2O4,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,≥40.6 mg/mL in DMSO; insoluble in H2O; ≥2.415 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,Potent _-adrenoceptor and _1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B1332B1333,Clonidine HCl,4205-91-8,B08,L1021-09,266.5,DMSO,C9H9Cl2N3·HCl,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl,≥13.33 mg/mL in DMSO; ≥15.53 mg/mL in EtOH with ultrasonic; ≥19.27 mg/mL in H2O with ultrasonic,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1333B1334,Dexmedetomidine,113775-47-6,B09,L1021-09,200.28,DMSO,C13H16N2,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,insoluble in H2O; ≥55.7 mg/mL in EtOH; ≥9.95 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,_2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1334B1335,Guanabenz Acetate,23256-50-0,B10,L1021-09,291.13,DMSO,C8H8Cl2N4·C2H4O2,CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,insoluble in EtOH; insoluble in H2O; ≥14.56 mg/mL in DMSO,Acetate,GPCR/G protein,Adrenergic Receptor,_2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1335B1336,Isoprenaline HCl,51-30-9,B11,L1021-09,247.72,DMSO,C11H17NO3·HCl,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl,≥12.39 mg/mL in DMSO; ≥16.6 mg/mL in EtOH with gentle warming and ultrasonic; ≥50.2 mg/mL in H2O with gentle warming,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1336B1338,Maprotiline HCl,10347-81-6,C02,L1021-09,313.86,DMSO,C20H23N·HCl,Cl[H].[H]C12C([H])([H])C([H])([H])C(C3=C([H])C([H])=C([H])C([H])=C23)(C([H])([H])C([H])([H])C([H])([H])N([H])C([H])([H])[H])C4=C([H])C([H])=C([H])C([H])=C14,≥13.95 mg/mL in DMSO; ≥2.11 mg/mL in H2O with gentle warming and ultrasonic; ≥5.84 mg/mL in EtOH with ultrasonic,,GPCR/G protein,Adrenergic Receptor,Selective noradrenalin re-uptake inhibitor,https://www.apexbt.com/search.php?catalog=B1338B1339,Metoprolol Tartrate,56392-17-7,C03,L1021-09,684.81,DMSO,2C15H25NO3·C4H6O6,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(C(C(=O)O)O)(C(=O)O)O,≥32.25 mg/mL in DMSO; ≥10.47 mg/mL in EtOH with ultrasonic; ≥108.6 mg/mL in H2O,Tartrate,GPCR/G protein,Adrenergic Receptor,_1-adrenergic blocking agent,https://www.apexbt.com/search.php?catalog=B1339B1340,Naphazoline HCl,550-99-2,C04,L1021-09,246.74,DMSO,C14H14N2·HCl,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl,≥11.13 mg/mL in EtOH with ultrasonic; ≥12.34 mg/mL in DMSO; ≥52.5 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1340B1341,Nebivolol,152520-56-4,C05,L1021-09,441.9,DMSO,C22H26ClF2NO4,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl,≥22.1 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,GPCR/G protein,Adrenergic Receptor,Highly selective _1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B1341B1343,Phenoxybenzamine HCl,63-92-3,C06,L1021-09,340.3,DMSO,C18H22ClNO·HCl,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl,insoluble in H2O; ≥17.02 mg/mL in DMSO; ≥21.2 mg/mL in EtOH with ultrasonic,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1343B1344,Phenylephrine HCl,61-76-7,C07,L1021-09,203.67,DMSO,C9H13NO2·HCl,CNCC(C1=CC(=CC=C1)O)O.Cl,≥10.18 mg/mL in DMSO; ≥17.08 mg/mL in EtOH with ultrasonic; ≥54.2 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Selective _1-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1344B1346,Propranolol HCl,318-98-9,C08,L1021-09,295.8,DMSO,C16H21NO2·HCl,OC(COC1=CC=CC2=CC=CC=C21)CNC(C)C.Cl,≥100 mg/mL in H2O; ≥12.4 mg/mL in DMSO; ≥9.76 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Competitive non-selective beta-adrenergic receptors inhibitor,https://www.apexbt.com/search.php?catalog=B1346B1347,Ritodrine HCl,23239-51-2,C09,L1021-09,323.81,DMSO,C17H21NO3·HCl,CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl,≥16.19 mg/mL in DMSO; ≥23.1 mg/mL in H2O; ≥60.8 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_-2 adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1347B1348,Salbutamol Sulfate,51022-70-9,C10,L1021-09,337.39,DMSO,C13H21NO3·H2SO4,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O,insoluble in EtOH; ≥16.87 mg/mL in H2O; ≥9.64 mg/mL in H2O,Sulfate,GPCR/G protein,Adrenergic Receptor,_-2 adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1348B1349,Tetrahydrozoline HCl,522-48-5,C11,L1021-09,236.74,DMSO,C13H16N2·HCl,C1CC(C2=CC=CC=C2C1)C3=NCCN3.Cl,≥11.33 mg/mL in EtOH; ≥14.7 mg/mL in H2O; ≥5.92 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1349B1350,Timolol Maleate,26921-17-5,D01,L1021-09,432.49,DMSO,C17H28N4O7S,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O,≥21.62 mg/mL in DMSO; ≥10.53 mg/mL in EtOH; ≥11.83 mg/mL in H2O,Maleate,GPCR/G protein,Adrenergic Receptor,"Non-selective, beta-adrenergic receptor antagonist",https://www.apexbt.com/search.php?catalog=B1350B1351,Xylazine HCl,23076-35-9,D02,L1021-09,256.79,DMSO,C12H16N2S·HCl,CC1=C(C(=CC=C1)C)NC2=NCCCS2.Cl,≥12.84 mg/mL in DMSO; ≥24.1 mg/mL in EtOH; ≥24.15 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_2 Adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1351B1352,Betaxolol,63659-18-7,D03,L1021-09,307.43,DMSO,C18H29NO3,CC(NCC(O)COC1=CC=C(CCOCC2CC2)C=C1)C,≥30.7 mg/mL in DMSO; insoluble in H2O; ≥17.7 mg/mL in EtOH,,GPCR/G protein,Adrenergic Receptor,_adrenergic receptor blocker,https://www.apexbt.com/search.php?catalog=B1352B1353,Betaxolol HCl,63659-19-8,D04,L1021-09,343.89,DMSO,C18H29NO3·HCl,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,≥17.19 mg/mL in DMSO; ≥24.9 mg/mL in EtOH; ≥28.05 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_1 adrenergic receptor blocker,https://www.apexbt.com/search.php?catalog=B1353B1354,Bisoprolol fumarate,104344-23-2,D05,L1021-09,441.52,DMSO,C22H35NO8,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O,≥22.08 mg/mL in DMSO; ≥19.83 mg/mL in EtOH; ≥31.15 mg/mL in H2O,Free Base,GPCR/G protein,Adrenergic Receptor,Selective _-adrenergic blocker,https://www.apexbt.com/search.php?catalog=B1354B1355,Cisatracurium Besylate,96946-42-8,D06,L1021-09,1243.48,DMSO,C53H72N2O12·2C6H5O3S,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],≥62.17 mg/mL in DMSO; ≥24.7 mg/mL in H2O; ≥33 mg/mL in EtOH,Besylate,GPCR/G protein,Adrenergic Receptor,Neuromuscular-blocking drug,https://www.apexbt.com/search.php?catalog=B1355B1356,Detomidine HCl,90038-01-0,D07,L1021-09,222.71,DMSO,C12H15ClN2,CC1=C(C(=CC=C1)CC2=CN=CN2)C.Cl,≥11.14 mg/mL in DMSO; ≥25.7 mg/mL in EtOH; ≥27.25 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1356B1357,Dexmedetomidine HCl,145108-58-3,D08,L1021-09,236.74,DMSO,C13H16N2·HCl,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,≥126.2 mg/mL in H2O; ≥11.84 mg/mL in DMSO; ≥27.87 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Highly selective and potent alpha-2 adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1357B1358,Epinephrine Bitartrate,51-42-3,D09,L1021-09,333.29,DMSO,C9H13NO3·C4H6O6,CNCC(C1=CC(=C(C=C1)O)O)O.C(C(C(=O)O)O)(C(=O)O)O,insoluble in EtOH; ≥16.66 mg/mL in DMSO; ≥22.9 mg/mL in H2O,Bitartrate,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1358B1360,Ivabradine HCl,148849-67-6,D10,L1021-09,505.05,DMSO,C27H37ClN2O5,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl,≥25.25 mg/mL in DMSO; ≥15.87 mg/mL in H2O; ≥8.14 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1360B1361,Medetomidine HCl,86347-15-1,D11,L1021-09,236.74,DMSO,C13H16N2·HCl,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,≥11.84 mg/mL in DMSO; ≥51 mg/mL in H2O; ≥65.7 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Selective _2-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1361B1362,Naftopidil,57149-07-2,E01,L1021-09,392.49,DMSO,C24H28N2O3,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,insoluble in H2O; ≥19.62 mg/mL in DMSO; ≥2.48 mg/mL in EtOH with gentle warming,Free Base,GPCR/G protein,Adrenergic Receptor,_1-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1362B1363,Phentolamine Mesylate,65-28-1,E02,L1021-09,377.46,DMSO,C17H19N3O·CH4O3S,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,≥18.87 mg/mL in DMSO; ≥55.6 mg/mL in H2O; ≥59.8 mg/mL in EtOH,Mesylate,GPCR/G protein,Adrenergic Receptor,Alpha 1/2-blocking agent,https://www.apexbt.com/search.php?catalog=B1363B1364,Scopine,498-45-3,E03,L1021-09,155.19,DMSO,C8H13NO2,[H][[C@H]12O[[C@H@]1([H])[[C@H@](C3([H])[H])([H])N(C([H])([H])[H])[[C@H]2([H])C([H])([H])[[C@H@]3([H])O[H],≥4.99 mg/mL in H2O; ≥46.8 mg/mL in EtOH; ≥7.6 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,_1-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1364B1365,Terazosin HCl,70024-40-7,E04,L1021-09,459.92,DMSO,C19H25N5O4·HCl·2H2O,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl,≥23.0 mg/mL in DMSO; ≥4.48 mg/mL in H2O; ≥54.6 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Selective _1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B1365B1367,Sotalol,3930-20-9,E05,L1021-09,272.36,DMSO,C12H20N2O3S,O[[C@H](C(C=C1)=CC=C1NS(=O)(C)=O)CNC(C)C,insoluble in EtOH; ≥15.44 mg/mL in DMSO; ≥50.7 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1367B1368,Tizanidine HCl,64461-82-1,E06,L1021-09,290.17,DMSO,C9H9Cl2N5S,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl,≥14.51 mg/mL in DMSO; ≥3.45 mg/mL in EtOH with gentle warming; ≥48.3 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1368B1369,Indacaterol Maleate,753498-25-8,E07,L1021-09,508.56,DMSO,C24H28N2O3·C4H4O4,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O,insoluble in H2O; ≥10.02 mg/mL in ETOH with gentle warming; ≥51.6 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,Ultra-long-acting _-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1369B1371,Miltefosine,58066-85-6,E08,L1021-09,407.57,H2O,C21H46NO4P,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,≥10.2 mg/mL in H2O; ≥2.115 mg/mL in DMSO with gentle warming and ultrasonic; ≥49.7 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,Akt,PI3K/Akt inhibitor,https://www.apexbt.com/search.php?catalog=B1371B1373,Phenformin HCl,834-28-6,E09,L1021-09,241.72,DMSO,C10H16ClN5,C1=CC=C(C=C1)CCN=C(N)N=C(N)N.Cl,≥12.1 mg/mL in DMSO; ≥17.53 mg/mL in EtOH; ≥24.5 mg/mL in H2O with ultrasonic,Hydrochloride,Others,Others,biguanidine drug with anti-diabetic activity,https://www.apexbt.com/search.php?catalog=B1373B1375,Dehydroepiandrosterone (DHEA),53-43-0,E10,L1021-09,288.42,DMSO,C19H28O2,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,insoluble in H2O; ≥13.7 mg/mL in DMSO; ≥58.6 mg/mL in ETOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Endogenous steroid hormone,https://www.apexbt.com/search.php?catalog=B1375B1376,Flutamide,13311-84-7,E11,L1021-09,276.21,DMSO,C11H11F3N2O3,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,insoluble in H2O; ≥12.5 mg/mL in DMSO; ≥50.4 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonists,https://www.apexbt.com/search.php?catalog=B1376B1377,Megestrol Acetate,595-33-5,F01,L1021-09,384.51,DMSO,C24H32O4,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,insoluble in H2O; ≥2.54 mg/mL in EtOH with gentle warming; ≥3.84 mg/mL in DMSO with gentle warming,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Anti-estrogen agent,https://www.apexbt.com/search.php?catalog=B1377B1378,Spironolactone,52-01-7,F02,L1021-09,416.57,DMSO,C24H32O4S,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,insoluble in H2O; ≥16.23 mg/mL in EtOH; ≥18 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Androgen Receptor,Competitive mineralocorticoid (aldosterone) receptor antagonist,https://www.apexbt.com/search.php?catalog=B1378B1380,Aminoglutethimide,125-84-8,F03,L1021-09,232.28,DMSO,C13H16N2O2,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥7.16 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Aromatase,Aromatase inhibitor,https://www.apexbt.com/search.php?catalog=B1380B1381,Formestane,566-48-3,F04,L1021-09,302.41,DMSO,C19H26O3,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,insoluble in H2O; ≥3.54 mg/mL in EtOH with gentle warming and ultrasonic; ≥30.6 mg/mL in DMSO with ultrasonic,#N/A,Endocrinology and Hormones,Aromatase,Type I steroidal aromatase inhibitor,https://www.apexbt.com/search.php?catalog=B1381B1382,Anastrozole,120511-73-1,F05,L1021-09,293.37,DMSO,C17H19N5,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,insoluble in H2O; ≥14.15 mg/mL in DMSO; ≥8.62 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Aromatase,Aromatase inhibitor,https://www.apexbt.com/search.php?catalog=B1382B1384,Ciclopirox ethanolamine,41621-49-2,F06,L1021-09,268.35,DMSO,C12H17NO2·C2H7NO,CC1=CC(=O)N(C(=C1)C2CCCCC2)O.C(CO)N,≥10.74 mg/mL in EtOH; ≥11.6 mg/mL in H2O; ≥16.4 mg/mL in DMSO,Ethanolamine,Membrane Transporter/Ion Channel,ATPase,"iron chelator, broad-spectrum antifungal agent",https://www.apexbt.com/search.php?catalog=B1384B1386,Milrinone,78415-72-2,F07,L1021-09,211.22,DMSO,C12H9N3O,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,insoluble in H2O; insoluble in EtOH; ≥8.2 mg/mL in DMSO,Free Base,Metabolism,PDE,PDE-3 inhibitor,https://www.apexbt.com/search.php?catalog=B1386B1388,Esomeprazole Sodium,161796-78-7,F08,L1021-09,367.4,DMSO,C17H18N3NaO3S,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=C(C=C3)OC.[Na+],≥140.8 mg/mL in DMSO; ≥22.15 mg/mL in H2O; ≥6.06 mg/mL in EtOH with ultrasonic,,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B1388B1389,Amiodarone HCl,19774-82-4,F09,L1021-09,681.77,DMSO,C25H30ClI2NO3,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl,insoluble in H2O; ≥13.8 mg/mL in DMSO with gentle warming; ≥3.36 mg/mL in EtOH with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Potassium Channel,Anti-arrhythmic drug,https://www.apexbt.com/search.php?catalog=B1389B1390,Carbamazepine,298-46-4,F10,L1021-09,236.27,DMSO,C15H12N2O,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,insoluble in H2O; ≥10.85 mg/mL in DMSO; ≥3.33 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Inhibitor of neuronal voltage-gated Na+ channels,https://www.apexbt.com/search.php?catalog=B1390B1391,Divalproex Sodium,76584-70-8,F11,L1021-09,310.41,DMSO,C8H16O2·C8H15O2·Na,CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+],≥14.2 mg/mL in DMSO; ≥23.9 mg/mL in H2O; ≥29.55 mg/mL in EtOH,Sodium,Ubiquitination/Proteasome,Autophagy,Epilepsy/migraines/bipolar disorder medicine,https://www.apexbt.com/search.php?catalog=B1391B1392,Loperamide HCl,34552-83-5,G01,L1021-09,513.5,DMSO,C29H33ClN2O2.HCl,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,50mg/mL (97.37 mM; Need ultrasonic) in DMSO;1mg/mL (1.95 mM; Need ultrasonic) in H2O,,Neuroscience,"Opioid Receptor,Autophagy","_ opioid receptors agonist, voltage-sensitive sodium channels blocker",https://www.apexbt.com/search.php?catalog=B1392B1393,Nitrendipine,39562-70-4,G02,L1021-09,360.3699,DMSO,C18H20N2O6,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,insoluble in H2O; ≥13.7 mg/mL in DMSO; ≥2.3 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1393B1394,Tamoxifen Citrate,54965-24-1,G03,L1021-09,563.64,DMSO,C32H37NO8,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥28.2 mg/mL in Etoh with gentle warming; insoluble in H2O; ≥97 mg/mL in DMSO,Citrate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Antiestrogen drug,https://www.apexbt.com/search.php?catalog=B1394B1395,Sulfacetamide Sodium,127-56-0,G04,L1021-09,236.22,DMSO,C8H10N2O3S·Na,CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+],≥10.65 mg/mL in H2O; ≥12.45 mg/mL in EtOH with ultrasonic; ≥28.4 mg/mL in DMSO with ultrasonic,Sodium,Ubiquitination/Proteasome,Autophagy,Sulfonamide antibiotic,https://www.apexbt.com/search.php?catalog=B1395B1397,Trifluoperazine 2HCl,440-17-5,G05,L1021-09,480.42,DMSO,C21H24F3N3S·2HCl,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl,≥24.02 mg/mL in DMSO; ≥48 mg/mL in H2O; ≥7.26 mg/mL in EtOH with ultrasonic,Dihydrochloride,Ubiquitination/Proteasome,Autophagy,Dopamine D2 receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1397B1398,Azithromycin,83905-01-5,G06,L1021-09,748.98,DMSO,C38H72N2O12,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,≥30.05 mg/mL in DMSO; insoluble in H2O; ≥102.8 mg/mL in EtOH,Free Base,Microbiology & Virology,Antibiotic,Antibiotic by inhibiting protein synthesis,https://www.apexbt.com/search.php?catalog=B1398B1399,Temozolomide,85622-93-1,G07,L1021-09,194.15,DMSO,C6H6N6O2,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,insoluble in EtOH; insoluble in H2O; ≥29.61 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA Alkylating,"DNA methylating, chemotherapeutic agent",https://www.apexbt.com/search.php?catalog=B1399B1401,Cabozantinib malate (XL184),1140909-48-3,G08,L1021-09,635.59,DMSO,C32H30FN3O10,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O,≥31.8 mg/mL in DMSO; insoluble in H2O; ≥2.5 mg/mL in EtOH with gentle warming and ultrasonic,,Tyrosine Kinase,c-MET,MET andVEGF receptor2 inhibitor,https://www.apexbt.com/search.php?catalog=B1401B1407,Dabrafenib (GSK2118436),1195765-45-7,G09,L1021-09,519.56,DMSO,C23H20F3N5O2S2,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,≥26 mg/mL in DMSO; insoluble in H2O; ≥2.59 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants,https://www.apexbt.com/search.php?catalog=B1407B1409,Benidipine HCl,91599-74-5,G10,L1021-09,542.02,DMSO,C28H31N3O6·HCl,CC1=C(C(C(=C(N1)C)C(=O)OC2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl,≥21.8 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥8.27 mg/mL in EtOH with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1409B1410,Amlodipine,88150-42-9,G11,L1021-09,408.88,DMSO,C20H25ClN2O5,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,insoluble in H2O; ≥17.7 mg/mL in DMSO; ≥49.8 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1410B1411,Amlodipine Besylate,111470-99-6,H01,L1021-09,567.05,DMSO,C20H25ClN2O5·C6H6O3S,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O,≥26.05 mg/mL in DMSO; insoluble in H2O; ≥11.26 mg/mL in EtOH with ultrasonic,Besylate,Membrane Transporter/Ion Channel,Calcium Channel,Block of L-type calcium channel,https://www.apexbt.com/search.php?catalog=B1411B1412,Flunarizine 2HCl,30484-77-6,H02,L1021-09,477.42,DMSO,C26H26F2N2·2HCl,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl,insoluble in H2O; ≥2.21 mg/mL in EtOH with ultrasonic; ≥20.65 mg/mL in DMSO,Dihydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Calcium entry blocker,https://www.apexbt.com/search.php?catalog=B1412B1413,Tetracaine HCl,136-47-0,H03,L1021-09,300.82,DMSO,C15H24N2O2·HCl,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C.Cl,≥10.85 mg/mL in DMSO; ≥30.2 mg/mL in H2O; ≥9.5 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Anaesthetic and allosteric inhibitor,https://www.apexbt.com/search.php?catalog=B1413B1414,Azelnidipine,123524-52-7,H04,L1021-09,582.65,DMSO,C33H34N4O6,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,≥27.15 mg/mL in DMSO; insoluble in H2O; ≥24.2 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker;antihypertensive,https://www.apexbt.com/search.php?catalog=B1414B1415,Clevidipine Butyrate,167221-71-8,H05,L1021-09,456.32,DMSO,C21H23Cl2NO6,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,≥21.4 mg/mL in DMSO; insoluble in H2O; ≥7.45 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Dihydropyridine calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1415B1416,Felodipine,72509-76-3,H06,L1021-09,384.25,DMSO,C18H19Cl2NO4,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,insoluble in H2O; ≥17.65 mg/mL in DMSO; ≥34.55 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Selective L-type Ca2+ channel blocker,https://www.apexbt.com/search.php?catalog=B1416B1417,Lacidipine,103890-78-4,H07,L1021-09,455.54,DMSO,C26H33NO6,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,≥21.25 mg/mL in DMSO; insoluble in H2O; ≥12.96 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1417B1418,Manidipine,89226-50-6,H08,L1021-09,610.7,DMSO,C35H38N4O6,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,≥61.1 mg/mL in DMSO; insoluble in H2O; ≥3.75 mg/mL in EtOH with ultrasonic,,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1418B1419,Manidipine 2HCl,89226-75-5,H09,L1021-09,683.62,DMSO,C35H40Cl2N4O6,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl,insoluble in H2O; ≥69 mg/mL in DMSO with gentle warming; ≥69.2 mg/mL in EtOH with gentle warming,,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1419B1420,Bupivacaine HCl,18010-40-7,H10,L1021-09,324.89,DMSO,C18H28N2O·HCl,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,≥10.25 mg/mL in DMSO; ≥16.23 mg/mL in H2O with ultrasonic; ≥69.2 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,Anaesthetic drug,https://www.apexbt.com/search.php?catalog=B1420B1422,Tasisulam,519055-62-0,H11,L1021-09,415.11,DMSO,C11H6BrCl2NO3S2,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,insoluble in H2O; ≥20.3 mg/mL in DMSO; ≥85.6 mg/mL in EtOH,Free Base,Apoptosis,Caspase,antitumor agent,https://www.apexbt.com/search.php?catalog=B1422B1423,Cinacalcet HCl,364782-34-3,A01,L1021-10,393.87,DMSO,C22H23ClF3N,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,insoluble in H2O; ≥17.85 mg/mL in DMSO; ≥56 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Calcimimetic Agent,Calcium-sensing receptor (CaR) agonist,https://www.apexbt.com/search.php?catalog=B1423B1429,Rimonabant,168273-06-1,A02,L1021-10,463.79,DMSO,C22H21Cl3N4O,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,≥23.19 mg/mL in DMSO; insoluble in H2O; ≥57.1 mg/mL in EtOH,Free Base,GPCR/G protein,Cannabinoid Receptor,CB1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1429B1440,Acemetacin,53164-05-9,A03,L1021-10,415.82,DMSO,C21H18ClNO6,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,insoluble in H2O; ≥20.79 mg/mL in DMSO; ≥3.39 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1440B1441,Lornoxicam,70374-39-9,A04,L1021-10,371.82,DMSO,C13H10ClN3O4S2,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,insoluble in H2O; insoluble in EtOH; ≥18.59 mg/mL in DMSO with gentle warming,,Neuroscience,COX,COX-1/COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1441B1443,Bufexamac,2438-72-4,A05,L1021-10,223.27,DMSO,C12H17NO3,CCCCOC1=CC=C(C=C1)CC(=O)NO,insoluble in EtOH; ≥11.16 mg/mL in DMSO; ≥2.89 mg/mL in H2O with gentle warming and ultrasonic,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1443B1444,Etodolac,41340-25-4,A06,L1021-10,287.35,DMSO,C17H21NO3,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,insoluble in H2O; ≥14.37 mg/mL in DMSO; ≥77.7 mg/mL in EtOH,Free Base,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1444B1445,Flunixin Meglumin,42461-84-7,A07,L1021-10,491.46,DMSO,C14H11F3N2O2·C7H17NO5,CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNCC(C(C(C(CO)O)O)O)O,≥24.55 mg/mL in DMSO; ≥17.75 mg/mL in EtOH; ≥23.2 mg/mL in H2O,Meglumin,Neuroscience,COX,potent cyclooxygenase inhibitor,https://www.apexbt.com/search.php?catalog=B1445B1446,Ketoprofen,22071-15-4,A08,L1021-10,254.28,DMSO,C16H14O3,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,insoluble in H2O; ≥12.71 mg/mL in DMSO; ≥27.8 mg/mL in EtOH,Free Base,Neuroscience,COX,Dual COX1/2 inhibitor,https://www.apexbt.com/search.php?catalog=B1446B1447,Ketorolac tromethamine salt ,74103-07-4,A09,L1021-10,376.4,DMSO,C19H24N2O6,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O,≥13.1 mg/mL in DMSO; ≥9.9 mg/mL in EtOH with ultrasonic; ≥92.8 mg/mL in H2O,,Neuroscience,COX,Non-selective COX inhibitor,https://www.apexbt.com/search.php?catalog=B1447B1448,Licofelone,156897-06-2,A10,L1021-10,379.88,DMSO,C23H22ClNO2,CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C,insoluble in H2O; insoluble in EtOH; ≥6.33 mg/mL in DMSO with gentle warming,,Neuroscience,COX,"COX-1, COX-2 and 5-LOX inhibitor",https://www.apexbt.com/search.php?catalog=B1448B1449,Mefenamic Acid,61-68-7,A11,L1021-10,241.29,DMSO,C15H15NO2,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,insoluble in H2O; ≥12.06 mg/mL in DMSO; ≥5.97 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,Anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=B1449B1450,Nabumetone,42924-53-8,B01,L1021-10,228.29,DMSO,C15H16O2,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,insoluble in H2O; ≥10.8 mg/mL in EtOH with ultrasonic; ≥11.41 mg/mL in DMSO,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1450B1452,Nimesulide,51803-78-2,B02,L1021-10,308.31,DMSO,C13H12N2O5S,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,insoluble in H2O; ≥15.42 mg/mL in DMSO; ≥2.96 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,Non-steroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=B1452B1453,Phenacetin,62-44-2,B03,L1021-10,179.22,DMSO,C10H13NO2,CCOC1=CC=C(C=C1)NC(=O)C,insoluble in H2O; ≥24.32 mg/mL in EtOH with ultrasonic; ≥8.96 mg/mL in DMSO,Free Base,Neuroscience,COX,Non-opioid analgesic,https://www.apexbt.com/search.php?catalog=B1453B1454,Rofecoxib,162011-90-7,B04,L1021-10,314.36,DMSO,C17H14O4S,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,insoluble in H2O; insoluble in EtOH; ≥15.72 mg/mL in DMSO,Free Base,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1454B1455,Tolfenamic Acid,13710-19-5,B05,L1021-10,261.7,DMSO,C14H12ClNO2,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,insoluble in H2O; ≥13.09 mg/mL in DMSO; ≥6.68 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,Non-steroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=B1455B1457,Diclofenac Sodium,15307-79-6,B06,L1021-10,318.13,DMSO,C14H10Cl2NNaO2,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+],≥15.91 mg/mL in DMSO; ≥26.1 mg/mL in H2O with ultrasonic; ≥48.6 mg/mL in EtOH,Sodium Salt,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1457B1458,Lumiracoxib,220991-20-8,B07,L1021-10,293.72,DMSO,C15H13ClFNO2,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,≥29.4 mg/mL in DMSO; insoluble in H2O; ≥27.15 mg/mL in EtOH with ultrasonic,,Neuroscience,COX,,https://www.apexbt.com/search.php?catalog=B1458B1459,Valdecoxib,181695-72-7,B08,L1021-10,314.36,DMSO,C16H14N2O3S,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,insoluble in H2O; ≥15.72 mg/mL in DMSO; ≥5.42 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1459B1460,Zaltoprofen,74711-43-6,B09,L1021-10,298.36,DMSO,C17H14O3S,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O,insoluble in H2O; ≥14.92 mg/mL in DMSO; ≥48.6 mg/mL in EtOH,Free Base,Neuroscience,COX,Cyclooxygenase (COX) inhibitor,https://www.apexbt.com/search.php?catalog=B1460B1461,Triflusal,322-79-2,B10,L1021-10,248.16,DMSO,C10H7F3O4,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O,insoluble in H2O; ≥106 mg/mL in EtOH; ≥12.41 mg/mL in DMSO,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1461B1464,KPT-330,1393477-72-9,B11,L1021-10,443.31,DMSO,C17H11F6N7O,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,insoluble in H2O; ≥11.52 mg/mL in EtOH; ≥15.15 mg/mL in DMSO,,Cell Cycle/Checkpoint,CRM1,"CRM1 inhibitor, orally bioavailable and selective",https://www.apexbt.com/search.php?catalog=B1464B1465,Plerixafor 8HCl (AMD3100 8HCl),155148-31-5,C01,L1021-10,794.47,H2O,C28H62Cl8N8,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl,≥155.4 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,GPCR/G protein,CXCR,CXCR4 antagonist,https://www.apexbt.com/search.php?catalog=B1465B1468,Adenine,73-24-5,C02,L1021-10,135.13,DMSO,C5H5N5,C1=NC2=C(N1)C(=NC=N2)N,insoluble in H2O; insoluble in EtOH; ≥6.75 mg/mL in DMSO with ultrasonic,,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,High affinity adenine receptor agonist,https://www.apexbt.com/search.php?catalog=B1468B1469,Adenine sulfate,321-30-2,C03,L1021-10,368.33,DMSO,2(C5H5N5)·H2SO4,C1=NC2=C(N1)C(=NC=N2)N.C1=NC2=C(N1)C(=NC=N2)N.OS(=O)(=O)O,insoluble in EtOH; ≥66.9 mg/mL in DMSO; ≥8.45 mg/mL in H2O with gentle warming,,DNA Damage/DNA Repair,DNA Synthesis,,https://www.apexbt.com/search.php?catalog=B1469B1470,Procarbazine HCl,366-70-1,C04,L1021-10,257.76,DMSO,C12H19N3O·HCl,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,≥12.82 mg/mL in H2O; ≥2.56 mg/mL in EtOH with ultrasonic; ≥27.3 mg/mL in DMSO,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic chemotherapy drug,https://www.apexbt.com/search.php?catalog=B1470B1471,Adenine HCl,2922-28-3,C05,L1021-10,171.59,DMSO,C5H5N5·HCl,C1=NC2=C(N1)C(=NC=N2)N.Cl,insoluble in EtOH; ≥11.5 mg/mL in DMSO with gentle warming; ≥6.91 mg/mL in H2O with gentle warming,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,Adenine receptor agonist,https://www.apexbt.com/search.php?catalog=B1471B1472,Mizoribine,50924-49-7,C06,L1021-10,259.22,DMSO,C9H13N3O6,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,insoluble in EtOH; ≥88.2 mg/mL in DMSO; ≥27.6 mg/mL in H2O,,Others,IMPDH,DNA/RNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B1472B1473,Uridine,58-96-8,C07,L1021-10,244.2,DMSO,C9H12N2O6,C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,≥71.43 mg/mL in DMSO; ≥3.9 mg/mL in EtOH with gentle warming and ultrasonic; ≥58.6 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,DNA Synthesis,DNA/RNA synthesis chemical,https://www.apexbt.com/search.php?catalog=B1473B1474,FT-207 (NSC 148958),17902-23-7,C08,L1021-10,200.17,DMSO,C8H9FN2O3,C1CC(OC1)N2C=C(C(=O)NC2=O)F,≥100 mg/mL in DMSO; ≥3.23 mg/mL in H2O; ≥3.87 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,DNA/RNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B1474B1475,Flupirtine maleate,75507-68-5,C09,L1021-10,420.39,DMSO,C19H21FN4O6,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O,insoluble in H2O; ≥17.55 mg/mL in DMSO; ≥2.49 mg/mL in EtOH with gentle warming and ultrasonic,,Membrane Transporter/Ion Channel,NMDA Receptor,NMDA receptor antagonist,https://www.apexbt.com/search.php?catalog=B1475B1476,Raltitrexed,112887-68-0,C10,L1021-10,458.49,DMSO,C21H22N4O6S,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,insoluble in H2O; ≥154 mg/mL in DMSO; ≥10.62 mg/mL in EtOH with ultrasonic,,DNA Damage/DNA Repair,DNA Synthesis,Thymidylate synthase inhibitor,https://www.apexbt.com/search.php?catalog=B1476B1477,Lurasidone HCl,367514-88-3,C11,L1021-10,529.14,DMSO,C28H37ClN4O2S,Cl[H].O=C(C1([H])[[C@H](C([H])([H])C2([H])[H])([H])C([H])([H])C2([H])C13[H])N(C([H])([H])C4([H])C(C([H])([H])N5C([H])([H])C([H])([H])N(C6=NSC7=C6C([H])=C([H])C([H])=C7[H])C([H])([H])C5([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])C4([H])[H])C3=O,insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL in DMSO with gentle warming,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=B1477B1479,Amisulpride,71675-85-9,D01,L1021-10,369.48,DMSO,C17H27N3O4S,CCN1C(CCC1)CNC(C2=CC(S(=O)(CC)=O)=C(C=C2OC)N)=O,insoluble in H2O; ≥14.83 mg/mL in EtOH with ultrasonic; ≥18.47 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,Dopamine D2/D3 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1479B1480,Chlorpromazine HCl,69-09-0,D02,L1021-10,355.33,DMSO,C17H19ClN2S·HCl,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,≥17.77 mg/mL in DMSO; ≥71.4 mg/mL in H2O; ≥74.8 mg/mL in EtOH,Hydrochloride,Neuroscience,Dopamine Receptor,dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1480B1481,Domperidone,57808-66-9,D03,L1021-10,425.91,DMSO,C22H24ClN5O2,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,≥21.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Neuroscience,Dopamine Receptor,Drug for gastroparesis,https://www.apexbt.com/search.php?catalog=B1481B1482,Dopamine HCl,62-31-7,D04,L1021-10,189.64,DMSO,C8H11NO2·HCl,C1=CC(=C(C=C1CCN)O)O.Cl,≥24.9 mg/mL in H2O; ≥3.16 mg/mL in EtOH with ultrasonic; ≥9.48 mg/mL in DMSO,Hydrochloride,Neuroscience,Dopamine Receptor,Dopamine D1-5 receptors agonist,https://www.apexbt.com/search.php?catalog=B1482B1483,Fenoldopam,67227-56-9,D05,L1021-10,305.76,DMSO,C16H16ClNO3,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,insoluble in EtOH; ≥12.55 mg/mL in H2O with ultrasonic; ≥15.29 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,D1-like dopamine receptor partial agonist,https://www.apexbt.com/search.php?catalog=B1483B1484,Levosulpiride,23672-07-3,D06,L1021-10,341.43,DMSO,C15H23N3O4S,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,insoluble in H2O; ≥17.07 mg/mL in DMSO; ≥2.35 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Dopamine Receptor,Antipsychotic drug,https://www.apexbt.com/search.php?catalog=B1484B1485,Pergolide mesylate,66104-23-2,D07,L1021-10,410.59,DMSO,C19H26N2S·CH4O3S,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC.CS(=O)(=O)O,insoluble in EtOH; insoluble in H2O; ≥6.84 mg/mL in DMSO,Mesylate,Neuroscience,Dopamine Receptor,Dopaminergic agonist,https://www.apexbt.com/search.php?catalog=B1485B1486,Amantadine HCl,665-66-7,D08,L1021-10,187.7,DMSO,C10H17N·HCl,C1C2CC3CC1CC(C2)(C3)N.Cl,≥22.73 mg/mL in EtOH; ≥31.55 mg/mL in H2O; ≥9.39 mg/mL in DMSO,Hydrochloride,Neuroscience,Dopamine Receptor,Dopamine receptor agonist,https://www.apexbt.com/search.php?catalog=B1486B1487,Pramipexole 2HCl Monohydrate,191217-81-9,D09,L1021-10,302.26,DMSO,C10H17N3S·2HCl·H2O,CCCNC1CCC2=C(C1)SC(=N2)N.O.Cl.Cl,≥15.11 mg/mL in DMSO; ≥2.37 mg/mL in EtOH with ultrasonic; ≥26.2 mg/mL in H2O,Dihydrochloride,Neuroscience,Dopamine Receptor,Novel non-ergoline dopamine receptor agonist,https://www.apexbt.com/search.php?catalog=B1487B1488,Pramipexole,104632-26-0,D10,L1021-10,211.33,DMSO,C10H17N3S,CCCNC1CCC2=C(C1)SC(=N2)N,insoluble in H2O; ≥10.57 mg/mL in DMSO; ≥22.75 mg/mL in EtOH,Free Base,Neuroscience,Dopamine Receptor,Dopamine agonist,https://www.apexbt.com/search.php?catalog=B1488B1489,Benserazide HCl,14919-77-8,D11,L1021-10,293.7,DMSO,C10H15N3O5·HCl,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl,insoluble in EtOH; ≥12.15 mg/mL in DMSO; ≥17.98 mg/mL in H2O,,Metabolism,Decarboxylase,Decarboxylase inhibitor,https://www.apexbt.com/search.php?catalog=B1489B1490,Quetiapine Fumarate,111974-72-2,E01,L1021-10,883.09,DMSO,C46H54N6O8S2,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥11.03 mg/mL in DMSO,Fumarate,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1490B1496,Icotinib,610798-31-7,E02,L1021-10,391.42,DMSO,C22H21N3O4,[H]C1=C2OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC2=C([H])C3=NC([H])=NC(N([H])C4=C([H])C([H])=C([H])C(C#C[H])=C4[H])=C31,insoluble in H2O; ≥129.6 mg/mL in DMSO; ≥14.13 mg/mL in EtOH with ultrasonic,,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=B1496B1501,Estradiol Cypionate,313-06-4,E03,L1021-10,396.56,DMSO,C26H36O3,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O,insoluble in H2O; ≥15 mg/mL in DMSO; ≥52 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1501B1502,Ethisterone,434-03-7,E04,L1021-10,312.45,DMSO,C21H28O2,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C#C)O)C,≥31.2 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,#N/A,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen hormone,https://www.apexbt.com/search.php?catalog=B1502B1503,Altrenogest,850-52-2,E05,L1021-10,310.43,DMSO,C21H26O2,CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(CC=C)O,insoluble in H2O; ≥14.4 mg/mL in DMSO; ≥56 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1503B1504,Clomiphene citrate,50-41-9,E06,L1021-10,598.08,DMSO,C26H28ClNO·C6H8O7,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥23 mg/mL in DMSO; insoluble in H2O; ≥12.93 mg/mL in EtOH with ultrasonic,Citrate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Selective estrogen receptor modulator,https://www.apexbt.com/search.php?catalog=B1504B1505,Epiandrosterone,481-29-8,E07,L1021-10,290.44,DMSO,C19H30O2,CC12CCC(CC1CCC3C2CCC4(C3CCC4=O)C)O,insoluble in H2O; ≥12.35 mg/mL in EtOH; ≥28.27 mg/mL in DMSO,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=B1505B1506,Estradiol valerate,979-32-8,E08,L1021-10,356.5,DMSO,C23H32O3,CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C,insoluble in H2O; ≥15.45 mg/mL in DMSO; ≥41.7 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Androgen Receptor,Estrogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1506B1507,Estriol,50-27-1,E09,L1021-10,288.39,DMSO,C18H24O3,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,insoluble in H2O; ≥10.33 mg/mL in EtOH with ultrasonic; ≥9.25 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor antagonist,https://www.apexbt.com/search.php?catalog=B1507B1508,Ethynodiol diacetate,297-76-7,E10,L1021-10,384.51,DMSO,C24H32O4,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,insoluble in H2O; ≥19.2 mg/mL in DMSO; ≥60.8 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1508B1509,Hexestrol,84-16-2,E11,L1021-10,270.37,DMSO,C18H22O2,CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O,insoluble in H2O; ≥12.65 mg/mL in DMSO; ≥64 mg/mL in EtOH,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1509B1510,Medroxyprogesterone acetate,71-58-9,F01,L1021-10,386.52,DMSO,C24H34O4,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,insoluble in H2O; ≥2.21 mg/mL in EtOH with ultrasonic; ≥9.48 mg/mL in DMSO with gentle warming,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Steroidal progestin,https://www.apexbt.com/search.php?catalog=B1510B1511,Mifepristone,84371-65-3,F02,L1021-10,429.59,DMSO,C29H35NO2,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,≥21.48 mg/mL in DMSO; insoluble in H2O; ≥21.45 mg/mL in EtOH with gentle warming,Free Base,GPCR/G protein,Glucocorticoid Receptor,Progesterone receptor antagonist,https://www.apexbt.com/search.php?catalog=B1511B1512,Pregnenolone,145-13-1,F03,L1021-10,316.48,DMSO,C21H32O2,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,insoluble in H2O; ≥15.82 mg/mL in DMSO with gentle warming; ≥2.42 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,AChR,steroid hormone,https://www.apexbt.com/search.php?catalog=B1512B1513,Toremifene Citrate,89778-27-8,F04,L1021-10,598.08,DMSO,C32H36ClNO8,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥24.15 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Citrate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral selective estrogen receptor modulator (SERM),https://www.apexbt.com/search.php?catalog=B1513B1514,Equol,531-95-3,F05,L1021-10,242.27,DMSO,C15H14O3,C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O,insoluble in H2O; ≥12.1 mg/mL in DMSO; ≥44.8 mg/mL in EtOH,,Endocrinology and Hormones,Estrogen/progestogen Receptor,,https://www.apexbt.com/search.php?catalog=B1514B1515,Raloxifene HCl,82640-04-8,F06,L1021-10,510.04,DMSO,C28H28ClNO4S,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl,≥22.35 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Hydrochloride,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor (ER),https://www.apexbt.com/search.php?catalog=B1515B1516,Dienogest,65928-58-7,F07,L1021-10,311.42,DMSO,C20H25NO2,CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O,insoluble in H2O; ≥14.8 mg/mL in DMSO; ≥2.35 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Orally active synthetic progesterone,https://www.apexbt.com/search.php?catalog=B1516B1517,Gestodene,60282-87-3,F08,L1021-10,310.43,DMSO,C21H26O2,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,insoluble in H2O; ≥12.65 mg/mL in DMSO; ≥13.75 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen hormonal contraceptive,https://www.apexbt.com/search.php?catalog=B1517B1520,Drospirenone,67392-87-4,F09,L1021-10,366.49,DMSO,C24H30O3,O=C1OC2(C([H])([H])C1([H])[H])C3([H])C(C3([H])[H])([H])C4([H])C2(C([H])([H])[H])C([H])([H])C([H])([H])C(C(C([H])([H])C5([H])[H])(C([H])([H])[H])C6=C([H])C5=O)([H])C4([H])C7([H])C6([H])C7([H])[H],insoluble in H2O; ≥10.8 mg/mL in EtOH with ultrasonic; ≥12.35 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Synthetic progestin,https://www.apexbt.com/search.php?catalog=B1520B1521,Bosentan Hydrate,157212-55-0,F10,L1021-10,569.63,DMSO,C27H31N5O7S,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.O,≥28.5 mg/mL in DMSO; insoluble in H2O; ≥2.45 mg/mL in EtOH with gentle warming and ultrasonic,Hydrate,GPCR/G protein,Endothelin Receptor,endothelin receptor antagonist,https://www.apexbt.com/search.php?catalog=B1521B1529,Gabapentin HCl,60142-95-2,F11,L1021-10,207.7,DMSO,C9H18ClNO2,C1CCC(CC1)(CC(=O)O)CN.Cl,≥55.1 mg/mL in EtOH; ≥9.35 mg/mL in H2O; ≥95.4 mg/mL in DMSO,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,GABA analog,https://www.apexbt.com/search.php?catalog=B1529B1530,Niflumic acid,4394-00-7,G01,L1021-10,282.22,DMSO,C13H9F3N2O2,C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F,insoluble in H2O; ≥12.15 mg/mL in DMSO; ≥18.17 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,GABA Receptor,Ca2+-activated Cl- channel blocker,https://www.apexbt.com/search.php?catalog=B1530B1531,(R)-baclofen,69308-37-8,G02,L1021-10,213.66,H2O,C10H12ClNO2,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,insoluble in DMSO; insoluble in EtOH; ≥7.13 mg/mL in H2O with gentle warming,,Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist,https://www.apexbt.com/search.php?catalog=B1531B1532,Nefiracetam,77191-36-7,G03,L1021-10,246.3,DMSO,C14H18N2O2,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,insoluble in H2O; ≥11.15 mg/mL in DMSO; ≥59.4 mg/mL in EtOH,Free Base,Neuroscience,GABA Receptor,GABA receptor activator,https://www.apexbt.com/search.php?catalog=B1532B1539,Tideglusib,865854-05-3,G04,L1021-10,334.39,DMSO,C19H14N2O2S,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL in DMSO with gentle warming,Free Base,PI3K/Akt/mTOR Signaling,GSK-3,non-ATP-competitive GSK-3_ inhibitor,https://www.apexbt.com/search.php?catalog=B1539B1543,Mubritinib (TAK 165),366017-09-6,G05,L1021-10,468.47,DMSO,C25H23F3N4O2,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,insoluble in H2O; ≥76.9 mg/mL in DMSO with gentle warming; ≥3.09 mg/mL in EtOH with gentle warming and ultrasonic,,Tyrosine Kinase,HER2,Potent inhibitor of HER2/ErbB2,https://www.apexbt.com/search.php?catalog=B1543B1545,Brompheniramine hydrogen maleate,980-71-2,G06,L1021-10,435.31,DMSO,C16H19BrN2·C4H4O4,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,≥11.58 mg/mL in EtOH with ultrasonic; ≥12.24 mg/mL in H2O with ultrasonic; ≥21.76 mg/mL in DMSO,Maleate,Neuroscience,Histamine Receptor,Histamine H1 receptors antagonist,https://www.apexbt.com/search.php?catalog=B1545B1547,Cetirizine DiHCl,83881-52-1,G07,L1021-10,461.81,DMSO,C21H27Cl3N2O3,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,insoluble in EtOH; ≥2.66 mg/mL in H2O with gentle warming and ultrasonic; ≥23.09 mg/mL in DMSO with gentle warming,2HCl,Neuroscience,Histamine Receptor,H1 receptor inverse agonist,https://www.apexbt.com/search.php?catalog=B1547B1549,Hydroxyzine 2HCl,2192-20-3,G08,L1021-10,447.83,DMSO,C21H27ClN2O2·2HCl,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,≥10.14 mg/mL in EtOH; ≥21.5 mg/mL in DMSO; ≥9.5 mg/mL in H2O with ultrasonic,Dihydrochloride,Neuroscience,Histamine Receptor,Histamine H1-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1549B1550,Levodropropizine,99291-25-5,G09,L1021-10,236.31,DMSO,C13H20N2O2,C1CN(CCN1CC(CO)O)C2=CC=CC=C2,≥35 mg/mL in DMSO; ≥17.25 mg/mL in EtOH; ≥18.5 mg/mL in H2O,,Neuronal Signaling,Histamine Receptor, histamine receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1550B1551,Mizolastine,108612-45-9,G10,L1021-10,432.49,DMSO,C24H25FN6O,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,insoluble in H2O; ≥21.62 mg/mL in DMSO with ultrasonic; ≥9.8 mg/mL in EtOH with ultrasonic,,Neuroscience,Histamine Receptor,,https://www.apexbt.com/search.php?catalog=B1551B1552,Nizatidine,76963-41-2,G11,L1021-10,331.46,DMSO,C12H21N5O2S2,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,≥16.57 mg/mL in DMSO; ≥2.23 mg/mL in H2O; ≥3.04 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Histamine Receptor,Histamine H2 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1552B1553,Tripelennamine HCl,154-69-8,H01,L1021-10,291.82,H2O,C16H22ClN3,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl,≥86.4 mg/mL in H2O; ≥2.33 mg/mL in DMSO with ultrasonic; ≥3.45 mg/mL in EtOH with ultrasonic,,Neuroscience,Histamine Receptor,H1-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1553B1554,Benztropine mesylate,132-17-2,H02,L1021-10,403.53,DMSO,C21H25NO·CH4SO3,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O,≥20.18 mg/mL in DMSO; ≥29.65 mg/mL in H2O; ≥52.8 mg/mL in EtOH,Mesylate,Neuroscience,Histamine Receptor,Dopamine transporter (DAT) inhibitor,https://www.apexbt.com/search.php?catalog=B1554B1555,Betahistine 2HCl,5579-84-0,H03,L1021-10,209.12,DMSO,C8H12N2·2HCl,CNCCC1=CC=CC=N1.Cl.Cl,≥10.46 mg/mL in DMSO; ≥2.1 mg/mL in H2O with ultrasonic; ≥48.7 mg/mL in EtOH,Dihydrochloride,Neuroscience,Histamine Receptor,Histamine H3 receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1555B1556,Chlorpheniramine Maleate,113-92-8,H04,L1021-10,390.86,DMSO,C16H19ClN2·C4H4O4,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,≥10.68 mg/mL in H2O; ≥19.54 mg/mL in DMSO; ≥3.95 mg/mL in EtOH with ultrasonic,Maleate,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1556B1557,Cimetidine,51481-61-9,H05,L1021-10,252.34,DMSO,C10H16N6S,CC1=C(N=CN1)CSCCNC(=NC)NC#N,≥12.62 mg/mL in DMSO; ≥2.54 mg/mL in H2O with gentle warming and ultrasonic; ≥9.37 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,H2 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1557B1558,Clemastine Fumarate,14976-57-9,H06,L1021-10,459.96,DMSO,C21H26ClNO·C4H4O4,OC(/C=C/C(O)=O)=O.ClC1=CC=C(C=C1)[[C@H](C2=CC=CC=C2)(C)OCC[[C@@H]3N(C)CCC3,insoluble in EtOH; insoluble in H2O; ≥11.58 mg/mL in DMSO,Free Base,Neuroscience,Histamine Receptor,Selective histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1558B1560,Famotidine,76824-35-6,H07,L1021-10,337.45,DMSO,C8H15N7O2S3,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insoluble in H2O; insoluble in EtOH; ≥16.87 mg/mL in DMSO,Free Base,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1560B1561,Histamine 2HCl,56-92-8,H08,L1021-10,184.07,DMSO,C5H9N3·2HCl,C1=C(NC=N1)CCN.Cl.Cl,insoluble in EtOH; ≥117.4 mg/mL in H2O; ≥9.20 mg/mL in DMSO,Dihydrochloride,Neuroscience,Histamine Receptor,Histamine receptor agonist,https://www.apexbt.com/search.php?catalog=B1561B1562,Ketotifen Fumarate,34580-14-8,H09,L1021-10,425.5,DMSO,C23H23NO5S,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1.C(=CC(=O)O)C(=O)O,insoluble in EtOH; ≥21.28 mg/mL in DMSO; ≥3.35 mg/mL in H2O with ultrasonic,Fumarate,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1562B1563,Pemirolast potassium,100299-08-9,H10,L1021-10,266.3,H2O,C10H7N6O·K,CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+],insoluble in EtOH; ≥85.4 mg/mL in H2O; ≥5.37 mg/mL in DMSO with ultrasonic,,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1563B1564,Ranitidine,66357-59-3,H11,L1021-10,350.86,DMSO,C13H22N4O3S·HCl,CN(C)CC1=CC=C(CSCCN/C(NC)=C/[N+]([O-])=O)O1.Cl,≥17.54 mg/mL in DMSO; ≥3.46 mg/mL in EtOH with ultrasonic; ≥99 mg/mL in H2O,Hydrochloride,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1564B1565,Roxatidine Acetate HCl,93793-83-0,A01,L1021-11,384.9,DMSO,C19H28N2O4·HCl,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2.Cl,≥113.4 mg/mL in H2O; ≥19.25 mg/mL in DMSO; ≥20.87 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,Specific and competitive histamin H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1565B1566,Rupatadine Fumarate,182349-12-8,A02,L1021-11,532.03,DMSO,C26H26ClN3·C4H4O4,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2.C(=CC(=O)O)C(=O)O,insoluble in H2O; ≥11.75 mg/mL in DMSO; ≥12.55 mg/mL in EtOH with gentle warming,,Neuroscience,Histamine Receptor,Inhibitor of PAF and histamine (H1) receptor,https://www.apexbt.com/search.php?catalog=B1566B1568,Azelastine HCl,79307-93-0,A03,L1021-11,418.36,DMSO,C22H24ClN3O·HCl,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl,≥20.92 mg/mL in DMSO; ≥5 mg/mL in EtOH with ultrasonic; ≥5.42 mg/mL in H2O with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,"Potent, second-generation, selective, histamine receptor antagonist",https://www.apexbt.com/search.php?catalog=B1568B1569,Bepotastine Besilate,190786-44-8,A04,L1021-11,547.06,DMSO,C27H31ClN2O6S,C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O,≥15.9 mg/mL in H2O with ultrasonic; ≥27.35 mg/mL in DMSO; ≥6.09 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Histamine Receptor,"Non-sedating, selective antagonist of histamine 1 (H1) receptor",https://www.apexbt.com/search.php?catalog=B1569B1571,Desloratadine,100643-71-8,A05,L1021-11,310.82,DMSO,C19H19ClN2,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,insoluble in H2O; ≥15.54 mg/mL in DMSO; ≥53.3 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,High affinity histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1571B1572,Latrepirdine,97657-92-6,A06,L1021-11,392.37,DMSO,C21H25N3·2HCl,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C.Cl.Cl,insoluble in H2O; ≥19.62 mg/mL in DMSO; ≥54.7 mg/mL in EtOH,,Neuroscience,GluR,Brain cell death inhibitor,https://www.apexbt.com/search.php?catalog=B1572B1573,Fexofenadine HCl,153439-40-8,A07,L1021-11,538.12,DMSO,C32H39NO4·HCl,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl,insoluble in H2O; ≥26.91 mg/mL in DMSO; ≥51.2 mg/mL in EtOH,Hydrochloride,Neuroscience,Histamine Receptor,Histamine H1 receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1573B1575,Lafutidine,118288-08-7,A08,L1021-11,431.55,DMSO,C22H29N3O4S,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,insoluble in H2O; ≥21.58 mg/mL in DMSO; ≥3.44 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1575B1576,Olopatadine HCl,140462-76-6,A09,L1021-11,373.87,DMSO,C21H23NO3·HCl,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl,≥18.69 mg/mL in DMSO; ≥2.87 mg/mL in H2O with ultrasonic; ≥3.03 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,Histamine blocker,https://www.apexbt.com/search.php?catalog=B1576B1589,Pacritinib (SB1518),937272-79-2,A10,L1021-11,472.58,DMSO,C28H32N4O3,[H]C1([H])N(C([H])([H])C([H])([H])OC(C([H])=C2[H])=C(C([H])([H])OC([H])([H])/C([H])=C([H])\C([H])([H])OC([H])([H])C3=C([H])C4=C([H])C([H])=C3[H])C([H])=C2N([H])C5=NC([H])=C([H])C4=N5)C([H])([H])C([H])([H])C1([H])[H],insoluble in EtOH; insoluble in H2O; ≥11.05 mg/mL in DMSO with gentle warming,#N/A,JAK/STAT Signaling,"FLT3, JAK",JAK2/FLT3 inhibitor,https://www.apexbt.com/search.php?catalog=B1589B1592,Hexamethonium Bromide,55-97-0,A11,L1021-11,362.19,DMSO,C12H30N2·2Br,C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-],≥36.2 mg/mL in EtOH with gentle warming; ≥36.3 mg/mL in DMSO with gentle warming; ≥36.6 mg/mL in H2O,,Neuroscience,AChR,Selective antagonist of neuronal-type nicotinic AChR,https://www.apexbt.com/search.php?catalog=B1592B1593,Irsogladine,57381-26-7,B01,L1021-11,256.09,DMSO,C9H7Cl2N5,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,insoluble in H2O; insoluble in EtOH; ≥12.80 mg/mL in DMSO,,Metabolism,PDE,PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=B1593B1594,Neostigmine Bromide,114-80-7,B02,L1021-11,303.2,DMSO,C12H19N2O2·Br,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-],≥15.16 mg/mL in H2O; ≥29.2 mg/mL in EtOH; ≥45.3 mg/mL in DMSO,,Neuroscience,AChR,Cholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=B1594B1595,Succinylcholine Chloride Dihydrate,6101-15-1,B03,L1021-11,397.34,DMSO,C14H30N2O4·2Cl·2H2O,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.O.O.[Cl-].[Cl-],≥10.48 mg/mL in EtOH with ultrasonic; ≥19.87 mg/mL in H2O; ≥6.1 mg/mL in DMSO with ultrasonic,Chloride,Neuroscience,AChR,Nicotinic AChR agonist,https://www.apexbt.com/search.php?catalog=B1595B1596,Acetylcholine Chloride,60-31-1,B04,L1021-11,181.66,DMSO,C7H16NO2·Cl,CC(=O)OCC[N+](C)(C)C.[Cl-],≥49.3 mg/mL in DMSO; ≥9.08 mg/mL in H2O; ≥95.6 mg/mL in EtOH,Chloride,Neuroscience,AChR,Major transmitter at many nervous sites,https://www.apexbt.com/search.php?catalog=B1596B1598,Biperiden HCl,1235-82-1,B05,L1021-11,347.92,DMSO,C21H30ClNO,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O.Cl,insoluble in H2O; ≥8.27 mg/mL in EtOH with ultrasonic; ≥8.7 mg/mL in DMSO,,Neuroscience,Muscarinic Receptor,,https://www.apexbt.com/search.php?catalog=B1598B1599,Bethanechol chloride,590-63-6,B06,L1021-11,196.68,DMSO,C7H17N2O2·Cl,CC(C[N+](C)(C)C)OC(=O)N.[Cl-],≥20.47 mg/mL in DMSO with ultrasonic; ≥31.53 mg/mL in EtOH; ≥9.83 mg/mL in H2O,,Neuroscience,AChR,Muscarinic receptor agonist,https://www.apexbt.com/search.php?catalog=B1599B1600,Darifenacin HBr,133099-07-7,B07,L1021-11,507.48,DMSO,C28H31BrN2O2,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br,insoluble in EtOH; insoluble in H2O; ≥20.2 mg/mL in DMSO,HBr,Neuroscience,Muscarinic Receptor,Selective M3 muscarinic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1600B1601,Decamethonium Bromide,541-22-0,B08,L1021-11,418.29,DMSO,C16H38N2·2Br,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-],≥116 mg/mL in H2O; ≥20.91 mg/mL in DMSO; ≥36.47 mg/mL in EtOH,Bromide,Neuroscience,AChR,Nicotinic AChR partial agonist,https://www.apexbt.com/search.php?catalog=B1601B1602,Donepezil HCl,120011-70-3,B09,L1021-11,415.95,H2O,C24H30ClNO3,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl,insoluble in EtOH; insoluble in DMSO; ≥10.4 mg/mL in H2O,Hydrochloride,Chromatin/Epigenetics,Histone Acetyltransferases,AChE inhibitor,https://www.apexbt.com/search.php?catalog=B1602B1603,Homatropine Bromide,51-56-9,B10,L1021-11,356.25,DMSO,C16H21NO3·HBr,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br,insoluble in EtOH; ≥17.81 mg/mL in DMSO; ≥47.4 mg/mL in H2O,Bromide,Neuroscience,AChR,Muscarinic AChR antagonist,https://www.apexbt.com/search.php?catalog=B1603B1604,Homatropine Methylbromide,80-49-9,B11,L1021-11,370.28,DMSO,C17H24NO3·Br,C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-],≥108.2 mg/mL in H2O; ≥17.95 mg/mL in DMSO; ≥23.9 mg/mL in EtOH with ultrasonic,,Neuroscience,AChR,Muscarinic AChR antagonist,https://www.apexbt.com/search.php?catalog=B1604B1605,Hyoscyamine,101-31-5,C01,L1021-11,289.37,DMSO,C17H23NO3,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,≥14.47 mg/mL in DMSO; ≥2.58 mg/mL in H2O with gentle warming and ultrasonic; ≥60.2 mg/mL in EtOH,Free Base,Neuroscience,AChR,AChR inhibitor,https://www.apexbt.com/search.php?catalog=B1605B1606,Orphenadrine Citrate,4682-36-4,C02,L1021-11,461.5,DMSO,C18H23NO·C6H8O7,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥23.07 mg/mL in DMSO; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic; ≥5.74 mg/mL in H2O with ultrasonic,Citrate,Neuroscience,AChR,Antiparkinsonian and analgesic drug,https://www.apexbt.com/search.php?catalog=B1606B1607,Otilonium Bromide,26095-59-0,C03,L1021-11,563.57,DMSO,C29H43BrN2O4,CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC.[Br-],≥28.18 mg/mL in DMSO; ≥55.8 mg/mL in H2O; ≥91 mg/mL in EtOH,Free Base,Neuroscience,AChR,AChR inhibitor,https://www.apexbt.com/search.php?catalog=B1607B1608,Tropicamide,1508-75-4,C04,L1021-11,284.35,DMSO,C17H20N2O2,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,insoluble in H2O; ≥14.22 mg/mL in DMSO; ≥47.4 mg/mL in EtOH,Free Base,Neuroscience,AChR,Antimuscarinic drug,https://www.apexbt.com/search.php?catalog=B1608B1609,Aclidinium Bromide,320345-99-1,C05,L1021-11,564.55,DMSO,C26H30BrNO4S2,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],≥28.23 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Neuroscience,Muscarinic Receptor,LAMAs antagonist,https://www.apexbt.com/search.php?catalog=B1609B1610,Gallamine Triethiodide,65-29-2,C06,L1021-11,891.53,DMSO,C30H60I3N3O3,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],≥44.58 mg/mL in DMSO; insoluble in EtOH; ≥54.6 mg/mL in H2O,,Neuroscience,AChR,Cholinergic receptor blocker,https://www.apexbt.com/search.php?catalog=B1610B1611,Methscopolamine,155-41-9,C07,L1021-11,398.29,DMSO,C18H24BrNO4,O=C(C(C1=C([H])C([H])=C([H])C([H])=C1[H])([H])C([H])([H])O[H])O[[C@H@]2([H])C([H])([H])[[C@H]3([H])[N+](C([H])([H])[H])(C([H])([H])[H])[[C@H@](C2([H])[H])([H])[[C@H@]4([H])O[[C@H@]34[H].[Br-],insoluble in EtOH; ≥19.91 mg/mL in DMSO; ≥59.2 mg/mL in H2O,Bromide,Neuroscience,AChR,Muscarinic acetylcholine receptor blocker,https://www.apexbt.com/search.php?catalog=B1611B1612,Pancuronium dibromide,15500-66-0,C08,L1021-11,732.67,DMSO,C35H60N2O4·2Br,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],≥36.63 mg/mL in DMSO; ≥49.4 mg/mL in H2O; ≥58.1 mg/mL in EtOH,Bromide,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=B1612B1613,Pyridostigmine Bromide,101-26-8,C09,L1021-11,261.12,DMSO,C9H13BrN2O2,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],≥13.06 mg/mL in DMSO; ≥40 mg/mL in EtOH; ≥55.4 mg/mL in H2O,Bromide,Neuroscience,AChE,Reversible cholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=B1613B1614,Solifenacin succinate,242478-38-2,C10,L1021-11,480.55,DMSO,C27H32N2O6,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O,≥24.05 mg/mL in DMSO; ≥23.6 mg/mL in EtOH with ultrasonic; ≥53.6 mg/mL in H2O,Succinate,Neuroscience,Muscarinic Receptor,Muscarinic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1614B1616,Trospium chloride,10405-02-4,C11,L1021-11,427.96,DMSO,C25H30NO3·Cl,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],≥21.4 mg/mL in DMSO; ≥27.65 mg/mL in EtOH with ultrasonic; ≥29.25 mg/mL in H2O,Chloride,Neuroscience,AChR,Antimuscarinic agent,https://www.apexbt.com/search.php?catalog=B1616B1619,Tiotropium Bromide hydrate,139404-48-1,D01,L1021-11,490.43,DMSO,C19H22NO4S2·Br·xH2O,O=C(C(C1=C([H])C([H])=C([H])S1)(C2=C([H])C([H])=C([H])S2)O[H])O[[C@H@]3([H])C([H])([H])[[C@H]4([H])[N+](C([H])([H])[H])(C([H])([H])[H])[[C@H@](C3([H])[H])([H])[[C@H@]5([H])O[[C@H@]45[H].[H]O[H].[Br-],≥18.87 mg/mL in H2O with ultrasonic; ≥3.74 mg/mL in EtOH with ultrasonic; ≥64.7 mg/mL in DMSO,#N/A,Neuroscience,AChR,Muscarinic antagonist,https://www.apexbt.com/search.php?catalog=B1619B1620,Tolterodine tartrate,124937-52-6,D02,L1021-11,475.57,DMSO,C26H37NO7,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(C(C(=O)O)O)(C(=O)O)O,≥23.78 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Tartrate,Neuroscience,Muscarinic Receptor,Competitive muscarinic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1620B1623,Ifenprodil Tartrate,23210-58-4,D03,L1021-11,475.53,DMSO,C21H27NO2·1/2C4H6O6,CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)O)O)(C(=O)O)O,≥23.78 mg/mL in DMSO; insoluble in H2O; ≥42.5 mg/mL in EtOH,,Neuroscience,GluR,NMDA receptor antagonist,https://www.apexbt.com/search.php?catalog=B1623B1628,MPEP,96206-92-7,D04,L1021-11,193.24,DMSO,C14H11N,CC1=CC=CC(=N1)C#CC2=CC=CC=C2,insoluble in H2O; ≥9.95 mg/mL in DMSO; ≥95 mg/mL in EtOH,,GPCR/G protein,mGluR,,https://www.apexbt.com/search.php?catalog=B1628B1634,Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium,168555-66-6,D05,L1021-11,440.29,DMSO,C18H19Na2O8P,COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)([O-])[O-].[Na+].[Na+],insoluble in H2O; insoluble in EtOH; ≥11.7 mg/mL in DMSO,Phosphate,Cell Cycle/Checkpoint,Microtubule/Tubulin,"microtubule destabilizing drug, water-soluble",https://www.apexbt.com/search.php?catalog=B1634B1639,"Ridaforolimus (Deforolimus, MK-8669)",572924-54-0,D06,L1021-11,990.21,DMSO,C53H84NO14P,O=P(C)(C)O[[C@H]1[[C@H](OC)C[[C@H](C[[C@@H](C)[[C@@H](OC([[C@@H]2CCCCN2C(C([[C@H]3([[C@@H](CC[[C@@H](C[[C@H](OC)/C(C)=C/C=C/C=C/[[C@@H](C)C[[C@@H](C)C([[C@H](OC)[[C@@H]4O)=O)O3)C)O)=O)=O)=O)CC([[C@H](C)/C=C4\C)=O)CC1,≥49.5 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,PI3K/Akt/mTOR Signaling,mTOR,,https://www.apexbt.com/search.php?catalog=B1639B1643,Sodium 4-Aminosalicylate,6018-19-5,D07,L1021-11,211.15,DMSO,C7H7NO3·2H2O·Na,C1=CC(=C(C=C1N)O)C(=O)[O-].O.O.[Na+],≥10.65 mg/mL in DMSO; ≥130 mg/mL in H2O; ≥7.85 mg/mL in EtOH with ultrasonic,Sodium,Immunology/Inflammation,NF-_B,NF-_B inhibitor,https://www.apexbt.com/search.php?catalog=B1643B1648,Naltrexone HCl,16676-29-2,D08,L1021-11,377.86,DMSO,C20H24ClNO4,O=C1[C@H]2[C@]3([C@@](O)(CC1)[C@H]4CC5=CC=C(C(O2)=C53)O)CCN4CC6CC6.Cl,14mg/mL(37.05 mM) in DMSO;14mg/mL(37.05 mM) in H2O;Insoluble in Ethanol,,Endocrinology and Hormones,Opioid Receptor,Opioid receptors antagonist,https://www.apexbt.com/search.php?catalog=B1648B1649,Racecadotril,81110-73-8,D09,L1021-11,385.48,DMSO,C21H23NO4S,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,insoluble in H2O; ≥103 mg/mL in DMSO; ≥18.45 mg/mL in EtOH,Free Base,Others,Endopeptidase,Potent enkephalinase inhibitor,https://www.apexbt.com/search.php?catalog=B1649B1650,Trimebutine,39133-31-8,D10,L1021-11,387.47,DMSO,C22H29NO5,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C,insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥26.65 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Opioid Receptor,Antimuscarinic,https://www.apexbt.com/search.php?catalog=B1650B1651,1-Hexadecanol,36653-82-4,D11,L1021-11,242.44,DMSO,C16H34O,CCCCCCCCCCCCCCCCO,insoluble in H2O; ≥10.75 mg/mL in DMSO; ≥12.5 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Fatty alcohol,https://www.apexbt.com/search.php?catalog=B1651B1655,Alverine Citrate,5560-59-8,E01,L1021-11,473.56,DMSO,C20H27N·C6H8O7,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥23.68 mg/mL in DMSO; ≥2.71 mg/mL in H2O with ultrasonic; ≥2.76 mg/mL in EtOH with ultrasonic,Citrate,GPCR/G protein,OX Receptor,Drug used for functional gastrointestinal disorders,https://www.apexbt.com/search.php?catalog=B1655B1656,Amfenac Sodium Monohydrate,61618-27-7,E02,L1021-11,295.27,DMSO,C15H12NO3·H2O·Na,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)[O-])N.O.[Na+],≥10.16 mg/mL in EtOH with ultrasonic; ≥12.65 mg/mL in DMSO; ≥26.15 mg/mL in H2O,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1656B1658,Amikacin disulfate,39831-55-5,E03,L1021-11,781.76,H2O,C22H43N5O13·2H2O4S,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O,insoluble in DMSO; insoluble in EtOH; ≥17.37 mg/mL in H2O,,Microbiology & Virology,Anti-infection,Semisynthetic aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1658B1659,Aminothiazole,96-50-4,E04,L1021-11,100.14,DMSO,C3H4N2S,C1=CSC(=N1)N,≥2.21 mg/mL in H2O with ultrasonic; ≥4.55 mg/mL in DMSO; ≥59.1 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Thyroid inhibitor,https://www.apexbt.com/search.php?catalog=B1659B1660,Amoxapine,14028-44-5,E05,L1021-11,313.78,DMSO,C17H16ClN3O,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,insoluble in H2O; ≥14.2 mg/mL in DMSO with gentle warming; ≥3.26 mg/mL in EtOH with gentle warming and ultrasonic,,Neuroscience,GlyT,GLYT2a transport activity inhibitor,https://www.apexbt.com/search.php?catalog=B1660B1661,Amoxicillin,26787-78-0,E06,L1021-11,365.4,DMSO,C16H19N3O5S,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,insoluble in H2O; insoluble in EtOH; ≥14.3 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,"Moderate-spectrum, bacteriolytic, _-lactam antibiotic",https://www.apexbt.com/search.php?catalog=B1661B1662,Ampicillin Trihydrate,7177-48-2,E07,L1021-11,403.45,DMSO,C16H19N3O4S·3H2O,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C.O.O.O,insoluble in EtOH; ≥16.7 mg/mL in DMSO; ≥2.39 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,_-lactam antibiotic,https://www.apexbt.com/search.php?catalog=B1662B1663,Amprolium HCl,137-88-2,E08,L1021-11,315.24,H2O,C14H19N4·HCl·Cl,CCCC1=NC=C(C(=N1)N)C[N+]2=CC=CC=C2C.Cl.[Cl-],insoluble in DMSO; ≥14.25 mg/mL in H2O; ≥2.52 mg/mL in EtOH with ultrasonic,Hydrochloride,Metabolism,Vitamin,Thiamin antagonist/coccidiostat,https://www.apexbt.com/search.php?catalog=B1663B1664,Antazoline HCl,2508-72-7,E09,L1021-11,301.81,DMSO,C17H19N3·HCl,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.Cl,≥10.6 mg/mL in H2O; ≥13.4 mg/mL in DMSO; ≥2.69 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,Histamine receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1664B1665,Apramycin Sulfate,65710-07-8,E10,L1021-11,637.66,H2O,C21H41N5O11·xH2O4S,CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O.OS(=O)(=O)O,insoluble in EtOH; insoluble in DMSO; ≥64.2 mg/mL in H2O,,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1665B1666,Atracurium Besylate,64228-81-5,E11,L1021-11,1243.48,DMSO,C53H72N2O12·2(C6H5O3S),C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],≥62.17 mg/mL in DMSO; ≥113.8 mg/mL in EtOH; ≥49.7 mg/mL in H2O,,Neuroscience,AChR,Neuromuscular blocking agent,https://www.apexbt.com/search.php?catalog=B1666B1667,Azaguanine-8,134-58-7,F01,L1021-11,152.11,DMSO,C4H4N6O,C12=NNNC1=NC(=NC2=O)N,insoluble in H2O; insoluble in EtOH; ≥3.93 mg/mL in DMSO,Free Base,Others,Others,Purine analogs,https://www.apexbt.com/search.php?catalog=B1667B1668,Azaperone,1649-18-9,F02,L1021-11,327.4,DMSO,C19H22FN3O,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3,insoluble in H2O; ≥10.88 mg/mL in EtOH with ultrasonic; ≥12.75 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,Dopamine antagonist,https://www.apexbt.com/search.php?catalog=B1668B1669,Azithromycin Dihydrate,117772-70-0,F03,L1021-11,785.02,DMSO,C38H72N2O12·2H2O,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O,≥25.85 mg/mL in DMSO; insoluble in H2O; ≥48.6 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Macrolide antibiotic,https://www.apexbt.com/search.php?catalog=B1669B1670,Bacitracin,1405-87-4,F04,L1021-11,1408.67,DMSO,C65H101N17O16S,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,≥2.58 mg/mL in EtOH with ultrasonic; ≥228.9 mg/mL in H2O; ≥26.45 mg/mL in DMSO,,Microbiology & Virology,Anti-infection,Peptide antibiotic,https://www.apexbt.com/search.php?catalog=B1670B1671,Bacitracin Zinc,1405-89-6,F05,L1021-11,1486.06,DMSO,C66H101N17O16SZn,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3C=NC=N3)CC4=CC=CC=C4.[Zn],≥49.53 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=B1671B1672,Bemegride,64-65-3,F06,L1021-11,155.19,DMSO,C8H13NO2,CCC1(CC(=O)NC(=O)C1)C,≥10.66 mg/mL in EtOH with ultrasonic; ≥2.48 mg/mL in H2O with ultrasonic; ≥7.76 mg/mL in DMSO,Free Base,Neuroscience,GABA Receptor,GABA receptor antagonist,https://www.apexbt.com/search.php?catalog=B1672B1673,Benzbromarone,3562-84-3,F07,L1021-11,424.08,DMSO,C17H12Br2O3,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,insoluble in H2O; ≥19.55 mg/mL in DMSO; ≥6.13 mg/mL in EtOH,Free Base,Metabolism,P450,TMEM16A/B calcium-activated chloride channel (CaCC) blocker,https://www.apexbt.com/search.php?catalog=B1673B1674,Benzethonium Chloride,121-54-0,F08,L1021-11,448.08,DMSO,C27H42NO2·Cl,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-],≥22.4 mg/mL in DMSO; ≥30.15 mg/mL in H2O; ≥55.3 mg/mL in EtOH,Chloride,Neuroscience,AChR,Potent inhibitor of nAChRs,https://www.apexbt.com/search.php?catalog=B1674B1675,Benzocaine,94-09-7,F09,L1021-11,165.19,DMSO,C9H11NO2,CCOC(=O)C1=CC=C(C=C1)N,insoluble in H2O; ≥5.05 mg/mL in DMSO; ≥56.8 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1675B1676,Benzoic Acid,65-85-0,F10,L1021-11,122.12,DMSO,C7H6O2,C1=CC=C(C=C1)C(=O)O,insoluble in H2O; ≥4.45 mg/mL in DMSO; ≥55 mg/mL in EtOH,Free Base,Others,Others,Organic aromatic monocarboxylic acid,https://www.apexbt.com/search.php?catalog=B1676B1677,Benzydamine HCl,132-69-4,F11,L1021-11,345.87,DMSO,C19H23N3O·HCl,CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3.Cl,≥17.05 mg/mL in DMSO; ≥28.2 mg/mL in EtOH; ≥54.6 mg/mL in H2O,Hydrochloride,Immunology/Inflammation,PGE synthase,Topical nonsteroidal anti-inflammatory drug (NSAID),https://www.apexbt.com/search.php?catalog=B1677B1678,Penicillin G Sodium,69-57-8,G01,L1021-11,356.37,DMSO,C16H18N2O4S·Na,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Na+],insoluble in EtOH; ≥13.7 mg/mL in DMSO; ≥58.7 mg/mL in H2O,Sodium,Microbiology & Virology,Anti-infection,penicillin antibiotic,https://www.apexbt.com/search.php?catalog=B1678B1679,Betamipron,3440-28-6,G02,L1021-11,193.2,DMSO,C10H11NO3,C1=CC=C(C=C1)C(=O)NCCC(=O)O,insoluble in H2O; ≥30.2 mg/mL in EtOH; ≥5.65 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Parenteral carbapenem antibiotic,https://www.apexbt.com/search.php?catalog=B1679B1680,Bezafibrate,41859-67-0,G03,L1021-11,361.82,DMSO,C19H20ClNO4,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥15 mg/mL in EtOH with ultrasonic; ≥17.25 mg/mL in DMSO,Free Base,Metabolism,PPAR,Lipid-lowering agent,https://www.apexbt.com/search.php?catalog=B1680B1682,Bosentan,147536-97-8,G04,L1021-11,551.63,DMSO,C27H29N5O6S,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,≥26.45 mg/mL in DMSO; insoluble in H2O; ≥14.87 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Endothelin Receptor,Endothelin receptor antagonist,https://www.apexbt.com/search.php?catalog=B1682B1683,Brimonidine Tartrate,70359-46-5,G05,L1021-11,442.22,DMSO,C15H16BrN5O6,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O,≥22.11 mg/mL in DMSO; insoluble in EtOH; ≥10.14 mg/mL in H2O with ultrasonic,Tartrate,GPCR/G protein,Adrenergic Receptor,Highly selective _-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1683B1684,Bromfenac Sodium,91714-93-1,G06,L1021-11,356.15,DMSO,C15H11BrNO3·Na,C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+],insoluble in EtOH; ≥14.7 mg/mL in DMSO; ≥26.85 mg/mL in H2O,Sodium,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1684B1685,Broxyquinoline,521-74-4,G07,L1021-11,302.95,DMSO,C9H5Br2NO,C1=CC2=C(C(=C(C=C2Br)Br)O)N=C1,insoluble in H2O; insoluble in EtOH; ≥9.75 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Antiprotozoal agent,https://www.apexbt.com/search.php?catalog=B1685B1687,Buspirone HCl,33386-08-2,G08,L1021-11,421.96,DMSO,C21H31N5O2·HCl,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl,≥19.55 mg/mL in DMSO; ≥27.65 mg/mL in H2O; ≥8.37 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,5-HT Receptor,Classic 5-HT1A partial agonist,https://www.apexbt.com/search.php?catalog=B1687B1689,Capreomycin Sulfate,1405-37-4,G09,L1021-11,652.71,H2O,C25H44N14O7,O=C([[C@H](C)NC([[C@@H](N)CNC1=O)=O)N[[C@@H](CNC(C[[C@H](CCCN)N)=O)C(N/C(C(N[[C@H]1[[C@H]2N=C(N)NCC2)=O)=C/NC(N)=O)=O,insoluble in EtOH; insoluble in DMSO; ≥251.8 mg/mL in H2O,,Microbiology & Virology,Anti-infection,Cyclic peptide antibiotic,https://www.apexbt.com/search.php?catalog=B1689B1690,Carprofen,53716-49-7,G10,L1021-11,273.71,DMSO,C15 H12ClNO2,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,insoluble in H2O; ≥11.05 mg/mL in DMSO; ≥19.17 mg/mL in EtOH,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1690B1691,Ceftriaxone Sodium Trihydrate,104376-79-6,G11,L1021-11,663.61,DMSO,C18H16N8O7S3·7/2H2O·2Na,OC(C1=C(CSC(N2C)=NC(C(N2)=O)=O)CS[[C@H](N1C3=O)([H])[[C@@H]3NC(/C(C4=CSC(N)=N4)=N\OC)=O)=O.[Na+].[Na+],≥26.3 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥48.4 mg/mL in H2O,Sodium,Microbiology & Virology,Anti-infection,Third-generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=B1691B1692,Cephalexin,15686-71-2,H01,L1021-11,347.39,H2O,C16H17N3O4S,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,insoluble in DMSO; insoluble in EtOH; ≥8.7 mg/mL in H2O,Free Base,Microbiology & Virology,Antibiotic,Antibiotic,https://www.apexbt.com/search.php?catalog=B1692B1693,Cetrimonium Bromide (CTAB),57-09-0,H02,L1021-11,364.45,DMSO,C19H42N·Br,CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-],≥112.6 mg/mL in EtOH; ≥5.33 mg/mL in DMSO; ≥54.3 mg/mL in H2O,Free Base,Microbiology & Virology,Anti-infection,Component of the broad-spectrum antiseptic cetrimide,https://www.apexbt.com/search.php?catalog=B1693B1694,Cetylpyridinium Chloride,123-03-5,H03,L1021-11,339.99,DMSO,C21H38N·Cl,CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-],≥117.8 mg/mL in H2O; ≥123.8 mg/mL in EtOH; ≥16.1 mg/mL in DMSO,Chloride,Microbiology & Virology,Anti-infection,Cationic quaternary ammonium compound used as oropharyngeal antiseptic.,https://www.apexbt.com/search.php?catalog=B1694B1695,Chlorhexidine HCl,3697-42-5,H04,L1021-11,578.37,DMSO,C22H30Cl2N10·2HCl,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.Cl.Cl,≥24 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,,Microbiology & Virology,Anti-infection,Antiseptic,https://www.apexbt.com/search.php?catalog=B1695B1696,Chlorocresol,59-50-7,H05,L1021-11,142.58,DMSO,C7H7ClO,CC1=C(C=CC(=C1)O)Cl,insoluble in H2O; ≥5.3 mg/mL in DMSO; ≥50.4 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Activator of ryanodine receptor,https://www.apexbt.com/search.php?catalog=B1696B1697,Chlorpropamide,94-20-2,H06,L1021-11,276.74,DMSO,C10H13ClN2O3S,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,insoluble in H2O; ≥14 mg/mL in DMSO; ≥27.5 mg/mL in EtOH,Free Base,Others,Others,Oral antihyperglycemic agent,https://www.apexbt.com/search.php?catalog=B1697B1698,Chlorquinaldol,72-80-0,H07,L1021-11,228.07,DMSO,C10H7Cl2NO,CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl,insoluble in H2O; ≥10.55 mg/mL in DMSO; ≥5.57 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,Antifungal and antibacterial,https://www.apexbt.com/search.php?catalog=B1698B1699,Chlortetracycline HCl,64-72-2,H08,L1021-11,515.34,DMSO,C22H23ClN2O8·HCl,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O.Cl,insoluble in EtOH; ≥12.88 mg/mL in H2O with gentle warming and ultrasonic; ≥25.8 mg/mL in DMSO with gentle warming,,Microbiology & Virology,Anti-infection,Tetracycline antibiotic,https://www.apexbt.com/search.php?catalog=B1699B1701,Chlorzoxazone,95-25-0,H09,L1021-11,169.57,DMSO,C7H4ClNO2,C1=CC2=C(C=C1Cl)NC(=O)O2,insoluble in H2O; ≥24.8 mg/mL in EtOH; ≥7.9 mg/mL in DMSO,Free Base,Metabolism,P450,Muscle-relaxing drug,https://www.apexbt.com/search.php?catalog=B1701B1703,Choline Chloride,67-48-1,H10,L1021-11,139.62,DMSO,C5H14NO·Cl,C[N+](C)(C)CCO.[Cl-],≥112 mg/mL in H2O; ≥6.3 mg/mL in DMSO; ≥65.7 mg/mL in EtOH,Chloride,Neuroscience,AChR,Quaternary ammonium salt,https://www.apexbt.com/search.php?catalog=B1703B1704,Chromocarb,4940-39-0,H11,L1021-11,190.15,DMSO,C10H6O4,C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥7.55 mg/mL in DMSO,Free Base,Others,Others,Vasoprotectant,https://www.apexbt.com/search.php?catalog=B1704B1705,Cinchophen,132-60-5,A01,L1021-12,249.26,DMSO,C16H11NO2,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O,insoluble in H2O; ≥2.5 mg/mL in EtOH with ultrasonic; ≥6.65 mg/mL in DMSO,Free Base,Others,Others,Analgesic drug,https://www.apexbt.com/search.php?catalog=B1705B1706,Climbazole,38083-17-9,A02,L1021-12,292.76,DMSO,C15H17ClN2O2,CC(C)(C)C(=O)C(N1C=CN=C1)OC2=CC=C(C=C2)Cl,insoluble in H2O; ≥13.25 mg/mL in DMSO; ≥59.9 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Broad-spectrum imidazole antifungal agent,https://www.apexbt.com/search.php?catalog=B1706B1707,Clindamycin,18323-44-9,A03,L1021-12,424.98,DMSO,C18H33ClN2O5S,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,insoluble in EtOH; ≥15.3 mg/mL in DMSO; ≥50.6 mg/mL in H2O,Free Base,Others,Others,Antibiotic,https://www.apexbt.com/search.php?catalog=B1707B1708,Clindamycin Phosphate,24729-96-2,A04,L1021-12,504.96,H2O,C18H34ClN2O8PS,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl,≥21.7 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO,Phosphate,Microbiology & Virology,Anti-infection,Lincosamide antibiotic,https://www.apexbt.com/search.php?catalog=B1708B1709,Clodronate Disodium,22560-50-5,A05,L1021-12,288.86,H2O,CH2Cl2Na2O6P2,O=P(O)([O-])C(Cl)(Cl)P(O)([O-])=O.[Na+].[Na+],≥28.9 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1709B1710,Clofazimine,2030-63-9,A06,L1021-12,473.4,DMSO,C27H22Cl2N4,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,insoluble in H2O; insoluble in EtOH; ≥7 mg/mL in DMSO with gentle warming,Free Base,Metabolism,Phospholipase,Tuberculosis drug,https://www.apexbt.com/search.php?catalog=B1710B1711,Clofibric Acid,882-09-7,A07,L1021-12,214.65,DMSO,C10H11ClO3,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,insoluble in H2O; ≥123.2 mg/mL in EtOH; ≥9.35 mg/mL in DMSO,Free Base,Metabolism,PPAR,PPAR agonist,https://www.apexbt.com/search.php?catalog=B1711B1713,Clorprenaline HCL,6933-90-0,A08,L1021-12,250.16,DMSO,C11H16ClNO·HCl,CC(C)NCC(C1=CC=CC=C1Cl)O.Cl,≥46.8 mg/mL in H2O; ≥47.8 mg/mL in EtOH; ≥8.35 mg/mL in DMSO,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1713B1714,Closantel,57808-65-8,A09,L1021-12,663.07,DMSO,C22H14Cl2I2N2O2,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2O)I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl,≥29.9 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor,https://www.apexbt.com/search.php?catalog=B1714B1715,Closantel Sodium,61438-64-0,A10,L1021-12,685.06,DMSO,C22 H13 Cl2I2N2O2·Na,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2[O-])I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl.[Na+],≥33.95 mg/mL in DMSO; insoluble in H2O; ≥124.6 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor,https://www.apexbt.com/search.php?catalog=B1715B1716,Colistin Sulfate,1264-72-8,A11,L1021-12,2801.27,H2O,2(C52H98N16O13)·5(H2SO4),O=C([C@H](CCN)NC([C@H](CC(C)C)NC([C@@H](CC(C)C)NC([C@H](CCN)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCN)NC(CCCC(CC)C)=O)=O)[C@H](O)C)=O)CCN)=O)CCN1)=O)=O)=O)=O)N[C@@H](CCN)C(N[C@@H]([C@H](O)C)C1=O)=O.O=S(O)(O)=O.O=S(O)(O)=O.O=S(O)(O)=O.O=S(O)(O)=O.O=S(O)(O,≥42.47 mg/mL in H2O with gentle warming; insoluble in DMSO; insoluble in EtOH,,Microbiology & Virology,Anti-infection,Cationic polypeptide antibiotic,https://www.apexbt.com/search.php?catalog=B1716B1717,Creatinine,60-27-5,B01,L1021-12,113.12,H2O,C4H7N3O,CN1CC(=O)N=C1N,insoluble in EtOH; ≥11.3 mg/mL in H2O; ≥2.5 mg/mL in DMSO with gentle warming and ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1717B1718,Cyclandelate,456-59-7,B02,L1021-12,276.37,DMSO,C17H24O3,CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O,≥12.35 mg/mL in DMSO; ≥2.61 mg/mL in H2O with gentle warming and ultrasonic; ≥52.2 mg/mL in EtOH,Free Base,Others,Others,Inhibitor of rat hepatic acycloenzyme A,https://www.apexbt.com/search.php?catalog=B1718B1719,Cysteamine HCl,156-57-0,B03,L1021-12,113.61,DMSO,C2H7NS·HCl,C(CS)N.Cl,≥24.35 mg/mL in EtOH; ≥52.1 mg/mL in H2O; ≥7.05 mg/mL in DMSO,Hydrochloride,Others,Others,Drug used to treat cystinosis,https://www.apexbt.com/search.php?catalog=B1719B1721,D-Cycloserine,68-41-7,B04,L1021-12,102.09,H2O,C3H6N2O2,C1C(C(=O)NO1)N,insoluble in DMSO; insoluble in EtOH; ≥51 mg/mL in H2O,,Microbiology & Virology,Anti-infection,NMDA receptor (NMDAR) partial agonist,https://www.apexbt.com/search.php?catalog=B1721B1723,Deferiprone,30652-11-0,B05,L1021-12,139.15,H2O,C7H9NO2,CC1=C(C(=O)C=CN1C)O,insoluble in DMSO; insoluble in EtOH; ≥10.96 mg/mL in H2O,,Others,Others,Chelating agent,https://www.apexbt.com/search.php?catalog=B1723B1724,Deoxycorticosterone acetate,56-47-3,B06,L1021-12,372.5,DMSO,C23H32O4,CC(=O)OCC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,insoluble in H2O; insoluble in EtOH; ≥16.4 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,Steroid hormone,https://www.apexbt.com/search.php?catalog=B1724B1725,Dexlansoprazole,138530-94-6,B07,L1021-12,369.36,DMSO,C16H14F3N3O2S,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,insoluble in H2O; ≥12.6 mg/mL in DMSO; ≥46.4 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B1725B1726,Diacerein,13739-02-1,B08,L1021-12,368.29,DMSO,C19H12O8,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C=C(C=C3C2=O)C(=O)O)OC(=O)C,insoluble in EtOH; insoluble in H2O; ≥46.07 mg/mL in DMSO,,Others,IL Receptor,IL receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1726B1727,Dibenzothiophene,132-65-0,B09,L1021-12,184.26,DMSO,C12H8S,C1=CC=C2C(=C1)C3=CC=CC=C3S2,insoluble in EtOH; insoluble in H2O; ≥8.75 mg/mL in DMSO ,Free Base,Others,Others,Intermediate of organic synthesis,https://www.apexbt.com/search.php?catalog=B1727B1728,Difluprednate,23674-86-4,B10,L1021-12,508.55,DMSO,C27H34F2O7,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,insoluble in H2O; insoluble in EtOH; ≥138.6 mg/mL in DMSO,,Others,Others,Corticosteroid,https://www.apexbt.com/search.php?catalog=B1728B1729,Diminazene Aceturate,908-54-3,B11,L1021-12,515.52,DMSO,C14H15N7·2C4H7NO3,CC(=O)NCC(=O)O.CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N,≥24.35 mg/mL in DMSO; insoluble in EtOH; ≥53.7 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1729B1730,Dinitolmide,148-01-6,C01,L1021-12,225.16,DMSO,C8H7N3O5,CC1=C(C=C(C=C1C(=O)N)[N+](=O)[O-])[N+](=O)[O-],≥45 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Microbiology,Anti-infection,broad-spectrum anticoccidial drug,https://www.apexbt.com/search.php?catalog=B1730B1731,Dirithromycin,62013-04-1,C02,L1021-12,835.07,DMSO,C42H78N2O14,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,≥40.5 mg/mL in EtOH; insoluble in H2O; ≥42.3 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Macrolide glycopeptide antibiotic,https://www.apexbt.com/search.php?catalog=B1731B1733,Domiphen Bromide,538-71-6,C03,L1021-12,414.46,DMSO,C22H40NO·Br,CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1.[Br-],≥11.55 mg/mL in DMSO; ≥14.33 mg/mL in H2O with ultrasonic; ≥48.9 mg/mL in EtOH,Free Base,Others,Others,Quaternary ammonium antiseptic,https://www.apexbt.com/search.php?catalog=B1733B1734,Doxofylline,69975-86-6,C04,L1021-12,266.25,DMSO,C11H14N4O4,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3,insoluble in EtOH; ≥11.4 mg/mL in DMSO; ≥8.32 mg/mL in H2O with ultrasonic,Free Base,Metabolism,PDE,PDE inhibitor,https://www.apexbt.com/search.php?catalog=B1734B1735,Doxylamine Succinate,562-10-7,C05,L1021-12,388.46,DMSO,C17H22N2O·C4H6O4,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O,≥117 mg/mL in H2O; ≥14.2 mg/mL in DMSO; ≥46.6 mg/mL in EtOH,Succinate,Neuroscience,Histamine Receptor,Histamine receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1735B1736,Droperidol,548-73-2,C06,L1021-12,379.43,DMSO,C22H22FN3O2,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,insoluble in EtOH; insoluble in H2O; ≥18.97 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,Dopamine-2 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1736B1737,Dropropizine,17692-31-8,C07,L1021-12,236.31,DMSO,C13H20N2O2,C1CN(CCN1CC(CO)O)C2=CC=CC=C2,≥10.3 mg/mL in DMSO; ≥11.7 mg/mL in H2O with ultrasonic; ≥24.9 mg/mL in EtOH,Free Base,Others,Others,Racemic non-opiate antitussive agent,https://www.apexbt.com/search.php?catalog=B1737B1740,Ebastine,90729-43-4,C08,L1021-12,469.66,DMSO,C32H39NO2,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,insoluble in H2O; ≥16.6 mg/mL in EtOH; ≥8.8 mg/mL in DMSO with ultrasonic,Free Base,Neuroscience,Histamine Receptor,Histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1740B1741,Efaproxiral Sodium,170787-99-2,C09,L1021-12,363.38,DMSO,C20H23NO4·Na,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)[O-])C.[Na+],≥12.83 mg/mL in H2O with ultrasonic; ≥18.4 mg/mL in DMSO; ≥18.45 mg/mL in EtOH,,Others,Others,Synthetic allosteric modifier of hemoglobin,https://www.apexbt.com/search.php?catalog=B1741B1742,Enrofloxacin,93106-60-6,C10,L1021-12,359.39,DMSO,C19H22FN3O3,CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F,insoluble in H2O; ≥15 mg/mL in DMSO with gentle warming; ≥2.49 mg/mL in EtOH with gentle warming and ultrasonic,,Microbiology & Virology,Anti-infection,Fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=B1742B1743,Epalrestat,82159-09-9,C11,L1021-12,319.4,DMSO,C15H13NO3S2,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,insoluble in H2O; insoluble in EtOH; ≥6.375 mg/mL in DMSO with gentle warming,,Others,Others,aldose reductase inhibitor,https://www.apexbt.com/search.php?catalog=B1743B1744,Epinastine HCl,108929-04-0,D01,L1021-12,285.77,DMSO,C16H15N3·HCl,Cl[H].[H]C1(C([H])([H])N=C2N([H])[H])N2C3=C([H])C([H])=C([H])C([H])=C3C([H])([H])C4=C([H])C([H])=C([H])C([H])=C14,≥13.4 mg/mL in DMSO; ≥56 mg/mL in H2O; ≥56.8 mg/mL in EtOH,Hydrochloride,Neuroscience,Histamine Receptor,Histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1744B1745,Eprazinone 2HCl,10402-53-6,D02,L1021-12,453.44,H2O,C24H32N2O2·2HCl,CCOC(CN1CCN(CC1)CC(C)C(=O)C2=CC=CC=C2)C3=CC=CC=C3.Cl.Cl,insoluble in EtOH; insoluble in DMSO; ≥37.95 mg/mL in H2O with gentle warming,,Others,Others,Aucolytic,https://www.apexbt.com/search.php?catalog=B1745B1746,Eprosartan Mesylate,144143-96-4,D03,L1021-12,520.62,DMSO,C24H28N2O7S2,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O.CS(=O)(=O)O,≥22.15 mg/mL in DMSO; insoluble in H2O; ≥16.83 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Angiotensin Receptor,Angiotensin AT1 receptor antagonists,https://www.apexbt.com/search.php?catalog=B1746B1747,Erythritol,149-32-6,D04,L1021-12,122.12,DMSO,C4H10O4,C(C(C(CO)O)O)O,insoluble in EtOH; ≥115.6 mg/mL in H2O; ≥6 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1747B1748,Esmolol HCl,81161-17-3,D05,L1021-12,331.83,DMSO,C16H25NO4·HCl,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl,≥102.4 mg/mL in EtOH; ≥104.8 mg/mL in H2O; ≥16.59 mg/mL in DMSO,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1748B1749,Ethacridine lactate monohydrate,6402-23-9,D06,L1021-12,361.39,DMSO,C15H15N3O·C3H6O3·H2O,CCOC1=CC2=C(C3=C(C=C(C=C3)N)N=C2C=C1)N.CC(C(=O)O)O.O,≥17.05 mg/mL in DMSO; ≥25.1 mg/mL in H2O; ≥3.73 mg/mL in EtOH with ultrasonic,Lactate,Microbiology & Virology,Anti-infection,Antiseptic agent,https://www.apexbt.com/search.php?catalog=B1749B1750,Ethamsylate,2624-44-4,D07,L1021-12,263.31,DMSO,C6H6O5S·C4H11N,CCNCC.C1=CC(=C(C=C1O)S(=O)(=O)O)O,≥113.8 mg/mL in H2O; ≥12.5 mg/mL in DMSO; ≥14.83 mg/mL in EtOH with ultrasonic,Free Base,Immunology/Inflammation,Prostaglandin Receptor,Haemostatic drug,https://www.apexbt.com/search.php?catalog=B1750B1752,Etidronate,2809-21-4,D08,L1021-12,206.03,DMSO,C2H8O7P2,CC(O)(P(=O)(O)O)P(=O)(O)O,≥12.71 mg/mL in EtOH; ≥40.8 mg/mL in DMSO; ≥76.2 mg/mL in H2O,,Others,phosphatase,Protein tyrosine phosphatase inhibitor,https://www.apexbt.com/search.php?catalog=B1752B1754,Fenspiride HCl,5053-08-7,D09,L1021-12,296.79,DMSO,C15H21ClN2O2,C1CN(CCC12CNC(=O)O2)CCC3=CC=CC=C3.Cl,≥14.84 mg/mL in DMSO; ≥4.08 mg/mL in EtOH; ≥40.4 mg/mL in H2O,Hydrochloride,Neuroscience,5-HT Receptor,_ adrenergic and H1 histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1754B1755,Fidaxomicin,873857-62-6,D10,L1021-12,1058.04,DMSO,C52H74Cl2O18,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,≥35.27 mg/mL in DMSO; insoluble in H2O; ≥12.25 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA/RNA Synthesis,macrocyclic antibiotic,https://www.apexbt.com/search.php?catalog=B1755B1757,Flopropione,2295-58-1,D11,L1021-12,182.17,DMSO,C9H10O4,CCC(=O)C1=C(C=C(C=C1O)O)O,≥33.1 mg/mL in DMSO; ≥32.5 mg/mL in EtOH; insoluble in H2O,,Neuronal Signaling,5-HT Receptor,5-HT1A receptor antagonist,https://www.apexbt.com/search.php?catalog=B1757B1758,Florfenicol,73231-34-2,E01,L1021-12,358.21,DMSO,C12H14Cl2FNO4S,CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(Cl)Cl)O,insoluble in H2O; ≥10.56 mg/mL in EtOH; ≥15.05 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Antibacterial agent,https://www.apexbt.com/search.php?catalog=B1758B1759,Flubendazole,31430-15-6,E02,L1021-12,313.28,DMSO,C16H12FN3O3,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F,insoluble in H2O; insoluble in EtOH; ≥10.71 mg/mL in DMSO with gentle warming,,Ubiquitination/Proteasome,Autophagy,Autophagy activator,https://www.apexbt.com/search.php?catalog=B1759B1760,Flufenamic acid,530-78-9,E03,L1021-12,281.23,DMSO,C14H10F3NO2,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,insoluble in EtOH; ≥49.6 mg/mL in H2O; ≥50 mg/mL in DMSO,,Immunology/Inflammation,AMPK; Calcium Channel; Chloride Channel; COX; Potassium Channel,TRPC activator,https://www.apexbt.com/search.php?catalog=B1760B1761,Flumethasone,2135-17-3,E04,L1021-12,410.45,DMSO,C22H28F2O5,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,insoluble in H2O; ≥14.3 mg/mL in DMSO with gentle warming; ≥2.97 mg/mL in EtOH with gentle warming,Free Base,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B1761B1763,Fudosteine,13189-98-5,E05,L1021-12,179.24,H2O,C6H13NO3S,C(CO)CSCC(C(=O)O)N,insoluble in EtOH; ≥2.47 mg/mL in DMSO with gentle warming and ultrasonic; ≥6 mg/mL in H2O,,Others,Others,MUC5AC mucin hypersecretion inhibitor,https://www.apexbt.com/search.php?catalog=B1763B1764,Furaltadone HCl,3759-92-0,E06,L1021-12,360.75,DMSO,C13H16N4O6·HCl,C1COCCN1CC2CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-].Cl,insoluble in EtOH; ≥12.4 mg/mL in DMSO with gentle warming; ≥34.35 mg/mL in H2O,Hydrochloride,Microbiology & Virology,Anti-infection,Antibacterial agent,https://www.apexbt.com/search.php?catalog=B1764B1765,Gadodiamide,122795-43-1,E07,L1021-12,591.67,H2O,C16H28GdN5O9,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3],≥29.2 mg/mL in H2O; insoluble in EtOH; ≥8.3 mg/mL in DMSO,Free Base,Others,Others,Gadolinium-based MRI contrast agent,https://www.apexbt.com/search.php?catalog=B1765B1766,Halcinonide,3093-35-4,E08,L1021-12,454.96,DMSO,C24H32ClFO5,ClC([H])([H])C([[C@H@]12OC(C([H])([H])[H])(C([H])([H])[H])O[[C@H]1([H])C([H])([H])[[C@H]([[C@H@](C([H])([H])C3([H])[H])([H])[[C@H]4([[C@H](C([H])([H])C5([H])[H])(C([H])([H])[H])C3=C([H])C5=O)F)([H])[[C@H]2(C([H])([H])[H])C([H])([H])[[C@H]4([H])O[H])=O,≥22.75 mg/mL in DMSO; insoluble in H2O; ≥5.92 mg/mL in EtOH,Free Base,Immunology/Inflammation,Smo,Anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=B1766B1767,Halobetasol Propionate,66852-54-8,E09,L1021-12,484.96,DMSO,C25H31ClF2O5,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl,≥23.25 mg/mL in DMSO; insoluble in H2O; ≥16.7 mg/mL in EtOH,Free Base,Metabolism,Phospholipase,Phospholipase (e.g. PLA) inhibitor,https://www.apexbt.com/search.php?catalog=B1767B1770,Histamine Phosphate,51-74-1,E10,L1021-12,307.14,H2O,C5H9N·2H3O4P,C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O,insoluble in EtOH; insoluble in DMSO; ≥12.1 mg/mL in H2O,phosphate,Neuroscience,Histamine Receptor,Histamine receptor agonist,https://www.apexbt.com/search.php?catalog=B1770B1772,Ibandronate sodium,138926-19-9,E11,L1021-12,360.23,H2O,C9H25NNaO8P2+,CCCCCN(CCC(P(O)(O)=O)(O)P(O)(O)=O)C.[Na+].O,insoluble in EtOH; insoluble in DMSO; ≥10.25 mg/mL in H2O,Sodium,Others,Others,Potent bisphosphonate drug,https://www.apexbt.com/search.php?catalog=B1772B1773,Idoxuridine,54-42-2,F01,L1021-12,354.1,DMSO,C9H11IN2O5,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,insoluble in EtOH; insoluble in H2O; ≥15 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Antiviral agent,https://www.apexbt.com/search.php?catalog=B1773B1774,Isosorbide,652-67-5,F02,L1021-12,146.14,DMSO,C6H10O4,C1[[C@H]([[C@@H]2[[C@H](O1)[[C@H](CO2)O)O,≥55.3 mg/mL in H2O; ≥7 mg/mL in DMSO; ≥87.7 mg/mL in EtOH,Free Base,Others,Others,Diuretic,https://www.apexbt.com/search.php?catalog=B1774B1775,Isovaleramide,541-46-8,F03,L1021-12,101.15,DMSO,C5H11NO,CC(C)CC(=O)N,≥24.45 mg/mL in H2O; ≥28.3 mg/mL in EtOH; ≥3.8 mg/mL in DMSO,Free Base,Metabolism,Dehydrogenase,Dehydrogenase inhibitor,https://www.apexbt.com/search.php?catalog=B1775B1777,(-)-Tetramisole,16595-80-5,F04,L1021-12,240.75,DMSO,C11H12N2S·HCl,C1CSC2=NC(CN21)C3=CC=CC=C3.Cl,insoluble in H2O; insoluble in DMSO; ≥24.1 mg/mL in EtOH,,Immunology/Inflammation,Parasite,Inhibitor of alkaline phosphatase,https://www.apexbt.com/search.php?catalog=B1777B1778,Levobetaxolol HCl,116209-55-3,F05,L1021-12,343.89,DMSO,C18H29NO3·HCl,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,≥17.15 mg/mL in DMSO; ≥66.5 mg/mL in H2O; ≥78.2 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1778B1779,Liothyronine Sodium,55-06-1,F06,L1021-12,672.96,DMSO,C15H12I3NO4·Na,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.[Na+],insoluble in H2O; insoluble in EtOH; ≥23.47 mg/mL in DMSO with gentle warming and ultrasonic,,Others,Others,Potent agonist of both thyroid hormone receptors TR_ and TR_,https://www.apexbt.com/search.php?catalog=B1779B1781,Lomefloxacin HCl,98079-52-8,F07,L1021-12,387.81,H2O,C17H19F2N3O3·HCl,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O.Cl,insoluble in EtOH; insoluble in DMSO; ≥6.33 mg/mL in H2O with gentle warming,Hydrochloride,Microbiology & Virology,Anti-infection,Fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=B1781B1782,Lomerizine HCl,101477-54-7,F08,L1021-12,541.46,DMSO,C27H30F2N2O3·2HCl,COC1=C(C(=C(C=C1)CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OC)OC.Cl.Cl,≥24.1 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥47.2 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1782B1783,Loxapine Succinate,27833-64-3,F09,L1021-12,445.9,DMSO,C18H18ClN3O·C4H6O4,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O,≥22.29 mg/mL in DMSO; insoluble in H2O; ≥13.68 mg/mL in EtOH with ultrasonic,Succinate,Neuroscience,"5-HT Receptor, Dopamine Receptor",Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1783B1784,Levobupivacaine HCl,27262-48-2,F10,L1021-12,324.89,DMSO,C18H28N2O·HCl,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,≥15.95 mg/mL in DMSO; ≥28.5 mg/mL in EtOH; ≥48.7 mg/mL in H2O,Salt,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1784B1785,Mechlorethamine HCl,55-86-7,F11,L1021-12,192.51,DMSO,C5H11Cl2N·HCl,CN(CCCl)CCCl.Cl,≥47.5 mg/mL in EtOH; ≥57.3 mg/mL in H2O; ≥9.65 mg/mL in DMSO,Hydrochloride,DNA Damage/DNA Repair,DNA/RNA Synthesis,DNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B1785B1786,Meclizine 2HCl,1104-22-9,G01,L1021-12,463.87,DMSO,C25H27Cl2N2·2HCl,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl.Cl,insoluble in H2O; ≥2.93 mg/mL in EtOH with ultrasonic; ≥48.9 mg/mL in DMSO with ultrasonic,,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1786B1787,Methyldopa,555-30-6,G02,L1021-12,211.21,DMSO,C10H13NO4,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,insoluble in H2O; insoluble in EtOH; ≥2.11 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,alpha-2 adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1787B1788,Mevastatin,73573-88-3,G03,L1021-12,390.51,DMSO,C23H34O5,CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O,insoluble in H2O; ≥15.95 mg/mL in DMSO; ≥3.29 mg/mL in EtOH,Free Base,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=B1788B1789,Mexiletine HCl,5370-01-4,G04,L1021-12,215.72,DMSO,C11H17NO·HCl,CC1=C(C(=CC=C1)C)OCC(C)N.Cl,≥10.2 mg/mL in DMSO; ≥50.7 mg/mL in H2O; ≥61.7 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1789B1790,Mezlocillin Sodium,42057-22-7,G05,L1021-12,561.56,DMSO,C21H25N5O8S2·Na,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C.[Na],≥19.75 mg/mL in DMSO; ≥2.49 mg/mL in EtOH with ultrasonic; ≥28.55 mg/mL in H2O,Sodium,Microbiology & Virology,Anti-infection,Penicillin beta-lactam antibiotic,https://www.apexbt.com/search.php?catalog=B1790B1791,Minocycline HCl,13614-98-7,G06,L1021-12,493.94,DMSO,C23H28ClN3O7,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl,insoluble in EtOH; ≥60.7 mg/mL in DMSO with gentle warming; ≥7.86 mg/mL in H2O with gentle warming,,Microbiology & Virology,Antibiotic,Tetracycline antibiotic,https://www.apexbt.com/search.php?catalog=B1791B1792,Montelukast Sodium,151767-02-1,G07,L1021-12,608.17,DMSO,C35H35ClNNaO3S,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+],≥28.7 mg/mL in DMSO; ≥43.6 mg/mL in EtOH; ≥47.5 mg/mL in H2O,Sodium,GPCR/G protein,CysLT1 receptor,Leukotriene receptor antagonist,https://www.apexbt.com/search.php?catalog=B1792B1793,NAD+,53-84-9,G08,L1021-12,663.43,DMSO,C21H27N7O14P2,C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C4N=CN=C5N)O)O)O)O)C(=O)N,≥28.55 mg/mL in H2O; insoluble in EtOH; ≥26.05 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1793B1794,Nefopam HCl,23327-57-3,G09,L1021-12,289.8,DMSO,C17H19NO·HCl,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl,≥9.94mg/mL in DMSO with ultrasonic; ≥2.3 mg/mL in EtOH (Need ultrasonic and warming); ≥12.77 mg/mL in H2O with ultrasonic,,Transmembrane Transporters,Sodium Channel,Centrally acting but non-opioid analgesics,https://www.apexbt.com/search.php?catalog=B1794B1795,Neomycin sulfate,1405-10-3,G10,L1021-12,712.72,H2O,C23H46N6O13·H2SO4,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,≥33.75 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Sulfate,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1795B1796,Netilmicin Sulfate,56391-57-2,G11,L1021-12,1441.55,H2O,2C21H41N5O7·2.5H2O4S,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,≥66.05 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Sulfate,Microbiology & Virology,Anti-infection,Active aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1796B1797,Nicaraven,79455-30-4,H01,L1021-12,284.31,DMSO,C15H16N4O2,CC(CNC(=O)C1=CN=CC=C1)NC(=O)C2=CN=CC=C2,insoluble in H2O; insoluble in EtOH; ≥14.5 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1797B1798,Nicardipine HCl,54527-84-3,H02,L1021-12,515.99,DMSO,C26H29N3O6·HCl,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl,≥25.9 mg/mL in DMSO; insoluble in H2O; ≥39.7 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1798B1799,Nifuroxazide,965-52-6,H03,L1021-12,275.22,DMSO,C12H9N3O5,C1=CC(=CC=C1C(=O)NN=CC2=CC=C(O2)[N+](=O)[O-])O,≥27.5 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,JAK/STAT Signaling,STAT,STAT inhibitor,https://www.apexbt.com/search.php?catalog=B1799B1800,Nithiamide,140-40-9,H04,L1021-12,187.18,DMSO,C5H5N3O3S,CC(=O)NC1=NC=C(S1)[N+](=O)[O-],insoluble in EtOH; insoluble in H2O; ≥8.15 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Antibiotic used in veterinary,https://www.apexbt.com/search.php?catalog=B1800B1803,Oseltamivir phosphate,204255-11-8,H05,L1021-12,410.4,DMSO,C16H31N2O8P,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O,≥20.3 mg/mL in DMSO with gentle warming; ≥110 mg/mL in H2O; ≥2.79 mg/mL in EtOH with gentle warming and ultrasonic,phosphate,Microbiology & Virology,NA,Potent and selective inhibitor of the neuraminidase,https://www.apexbt.com/search.php?catalog=B1803B1804,Oxaprozin,21256-18-8,H06,L1021-12,293.32,DMSO,C18H15NO3,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,insoluble in H2O; ≥11.3 mg/mL in DMSO; ≥18.4 mg/mL in EtOH,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1804B1805,Oxybuprocaine HCl,5987-82-6,H07,L1021-12,344.88,DMSO,C17H28N2O3·HCl,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N.Cl,≥13.65 mg/mL in DMSO; ≥18.67 mg/mL in EtOH; ≥91.6 mg/mL in H2O,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,Local anesthetic,https://www.apexbt.com/search.php?catalog=B1805B1807,Pamidronate,40391-99-9,H08,L1021-12,235.07,H2O,C3H11NO7P2,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,insoluble in DMSO; insoluble in EtOH; ≥2.35 mg/mL in H2O with gentle warming,,Stem Cell,Wnt/_-catenin,Supportive care drug in the category of bisphosphonates,https://www.apexbt.com/search.php?catalog=B1807B1808,Paromomycin Sulfate,1263-89-4,H09,L1021-12,713.71,H2O,C23H45N5O14·xH2O4S,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,≥26.55 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Sulfate ,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1808B1809,Penciclovir,39809-25-1,H10,L1021-12,253.26,DMSO,C10H15N5O3,C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N,insoluble in H2O; insoluble in EtOH; ≥11.95 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,HSV-1 DNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B1809B1810,Penfluridol,26864-56-2,H11,L1021-12,523.97,DMSO,C28H27ClF5NO,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,insoluble in H2O; ≥107 mg/mL in EtOH; ≥13.7 mg/mL in DMSO,,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1810B1811,Pentoxyverine Citrate,23142-01-0,A01,L1021-13,525.59,DMSO,C20H31NO3·C6H8O7,CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥21.75 mg/mL in DMSO; ≥17.3 mg/mL in EtOH; ≥52.2 mg/mL in H2O,,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=B1811B1812,Phenazopyridine HCl,136-40-3,A02,L1021-13,249.7,DMSO,C11H11N5·HCl,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl,insoluble in EtOH; insoluble in H2O; ≥12.5 mg/mL in DMSO,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,Local analgesic,https://www.apexbt.com/search.php?catalog=B1812B1813,Phenindione,83-12-5,A03,L1021-13,222.24,DMSO,C15H10O2,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,insoluble in H2O; ≥10.75 mg/mL in DMSO; ≥6.97 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,Vitamin,Anticoagulant,https://www.apexbt.com/search.php?catalog=B1813B1814,Pheniramine Maleate,132-20-7,A04,L1021-13,356.42,DMSO,C16H20N2·C4H4O4,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,≥104.6 mg/mL in H2O; ≥14.6 mg/mL in DMSO; ≥54.4 mg/mL in EtOH,Maleate,Neuroscience,Histamine Receptor,Histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1814B1816,Pilocarpine HCl,54-71-7,A05,L1021-13,244.72,DMSO,C11H16N2O2·HCl,Cl[H].O=C1OC([H])([H])[[C@H@](C([H])([H])C2=C([H])N=C([H])N2C([H])([H])[H])([H])[[C@H]1([H])C([H])([H])C([H])([H])[H],≥101 mg/mL in H2O; ≥18.57 mg/mL in EtOH; ≥8.35 mg/mL in DMSO,,Neuroscience,AChR,Nonselective muscarinic acetylcholine receptor agonist,https://www.apexbt.com/search.php?catalog=B1816B1817,Pimecrolimus,137071-32-0,A06,L1021-13,810.45,DMSO,C43H68ClNO11,CO[[C@@H]1C[[C@H](/C=C(C)/[[C@@H](OC([[C@H]2([H])CCCCN2C(C([[C@H]3(O)O[[C@H]([[C@@H](OC)C[[C@H](C/C(C)=C/4)C)[[C@@H](OC)C[[C@H]3C)=O)=O)=O)[[C@H](C)[[C@H](CC([[C@@H]4CC)=O)O)CC[[C@@H]1Cl,≥32.05 mg/mL in DMSO; insoluble in H2O; ≥2.12 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Immunology/Inflammation,,"inhibitor of inflammatory cytokines secretion, cell-selective",https://www.apexbt.com/search.php?catalog=B1817B1818,Piperacillin Sodium,59703-84-3,A07,L1021-13,539.54,DMSO,C23H27N5O7S·Na,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+],≥12.68 mg/mL in H2O; ≥18.6 mg/mL in DMSO; ≥27.75 mg/mL in EtOH,Sodium,Microbiology & Virology,Anti-infection,"Semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic",https://www.apexbt.com/search.php?catalog=B1818B1819,Pramoxine HCl,637-58-1,A08,L1021-13,329.86,DMSO,C17H27NO3·HCl,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl,≥15.6 mg/mL in DMSO; ≥24.7 mg/mL in H2O; ≥29.65 mg/mL in EtOH,Hydrochloride,Others,Others,Local anesthetic,https://www.apexbt.com/search.php?catalog=B1819B1820,Primaquine Diphosphate,63-45-6,A09,L1021-13,455.34,DMSO,C15H21N3O·2H3O4P,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2.OP(=O)(O)O.OP(=O)(O)O,insoluble in EtOH; ≥18.85 mg/mL in DMSO; ≥27.65 mg/mL in H2O,Diphosphate,Microbiology & Virology,Antimalaria,"antimalarial agent,blocks protein synthesis",https://www.apexbt.com/search.php?catalog=B1820B1821,Proflavine Hemisulfate,1811-28-5,A10,L1021-13,258.25,DMSO,C13H11N3·1/2H2O4S,C1=CC(=CC2=NC3=C(C=CC(=C3)[NH3+])C=C21)N.C1=CC(=CC2=NC3=C(C=CC(=C3)[NH3+])C=C21)N.[O-]S(=O)(=O)[O-],insoluble in EtOH; ≥10.8 mg/mL in DMSO; ≥2.6 mg/mL in H2O,Hemisulfate,Microbiology & Virology,Anti-infection,Slow-acting disinfectant with bacteriostatic action,https://www.apexbt.com/search.php?catalog=B1821B1823,Quinacrine 2HCl,69-05-6,A11,L1021-13,472.88,DMSO,C23H30ClN3O·2HCl,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,≥23.65 mg/mL in H2O; insoluble in DMSO; ≥9.48 mg/mL in EtOH with ultrasonic,,Metabolism,Phospholipase,,https://www.apexbt.com/search.php?catalog=B1823B1825,Ribostamycin Sulfate,53797-35-6,B01,L1021-13,552.55,H2O,C17H34N4O10·H2O4S,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N.OS(=O)(=O)O,≥24.6 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,Microbiology & Virology,Anti-infection,aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1825B1827,Salicylanilide,87-17-2,B02,L1021-13,213.23,DMSO,C13H11NO2,C1=CC=C(C=C1)NC(=O)C2=CC=CC=C2O,insoluble in H2O; ≥8.7 mg/mL in EtOH with ultrasonic; ≥8.8 mg/mL in DMSO,Free Base,Microbiology & Virology,"Reverse Transcriptase, Integrase, Anti-infection","Antiviral,antibacterial,antifungal reagent",https://www.apexbt.com/search.php?catalog=B1827B1829,Sasapyrine,552-94-3,B03,L1021-13,258.23,DMSO,C14H10O5,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,insoluble in H2O; ≥11 mg/mL in DMSO; ≥33.3 mg/mL in EtOH,Free Base,Immunology/Inflammation,Reactive Oxygen Species,Nonsteroidal oral anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=B1829B1830,Serotonin HCl,153-98-0,B04,L1021-13,212.68,DMSO,C10H12N2O·HCl,C1=CC2=C(C=C1O)C(=CN2)CCN.Cl,≥11.12 mg/mL in EtOH with ultrasonic; ≥22.35 mg/mL in H2O; ≥8.2 mg/mL in DMSO,Hydrochloride,Neuroscience,5-HT Receptor,Endogenous 5-HT receptor agonist,https://www.apexbt.com/search.php?catalog=B1830B1831,Sertaconazole nitrate,99592-39-9,B05,L1021-13,500.78,DMSO,C20H15Cl3N2OS·HNO3,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-],≥22.2 mg/mL in DMSO; insoluble in H2O; ≥2.38 mg/mL in EtOH with gentle warming and ultrasonic,Nitrate,Microbiology & Virology,Anti-infection,Broad-spectrum antifungal,https://www.apexbt.com/search.php?catalog=B1831B1834,Sodium ascorbate,134-03-2,B06,L1021-13,198.11,H2O,C6H7NaO6,O=C1C(O)=C([O-])[[C@@H]([[C@@H](O)CO)O1.[Na+],insoluble in EtOH; insoluble in DMSO; ≥9.1 mg/mL in H2O,Sodium Salt,Metabolism,Vitamin,mineral salts of ascorbic acid,https://www.apexbt.com/search.php?catalog=B1834B1835,Sodium butyrate,156-54-7,B07,L1021-13,110.09,H2O,C4H7NaO2,CCCC(=O)[O-].[Na+],insoluble in DMSO; ≥4 mg/mL in H2O; ≥5.87 mg/mL in EtOH,Butyrate,DNA Damage/DNA Repair,HDAC,Histone deacetylase inhibitor,https://www.apexbt.com/search.php?catalog=B1835B1837,Sodium Monofluorophosphate,10163-15-2,B08,L1021-13,143.95,H2O,FNa2O3P,[O-]P(=O)([O-])F.[Na+].[Na+],insoluble in EtOH; insoluble in DMSO; ≥7.75 mg/mL in H2O,Free Base,Others,phosphatase,Pyruvate kinase/alkaline phosphatase inhibitor,https://www.apexbt.com/search.php?catalog=B1837B1838,Sodium Nitrite,7632-00-0,B09,L1021-13,69,DMSO,HNO2·Na,N(=O)[O-].[Na+],insoluble in EtOH; ≥3.75 mg/mL in DMSO; ≥44.1 mg/mL in H2O,Sodium Salt,Immunology/Inflammation,ROS,myeloperoxidase inhibitor,https://www.apexbt.com/search.php?catalog=B1838B1839,Spiramycin,8025-81-8,B10,L1021-13,843.058,DMSO,C43H74N2O14,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,≥31.25 mg/mL in DMSO; ≥4.71 mg/mL in H2O with ultrasonic; ≥46.1 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,16-membered ring macrolide (antibiotic),https://www.apexbt.com/search.php?catalog=B1839B1840,Sucralose,56038-13-2,B11,L1021-13,397.63,DMSO,C12H19Cl3O8,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CCl)O)O)CCl)O)O)Cl)O,≥15.8 mg/mL in DMSO; ≥2.73 mg/mL in EtOH with gentle warming and ultrasonic; ≥28.6 mg/mL in H2O,Free Base,Others,Others,artificial sweetener and sugar substitute,https://www.apexbt.com/search.php?catalog=B1840B1841,Sulfadoxin,2447-57-6,C01,L1021-13,310.33378,DMSO,C12H14N4O4S,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,Limited solubility,,Microbiology & Virology,Anti-infection,synthetic analog of para-aminobenzoic acid (PABA),https://www.apexbt.com/search.php?catalog=B1841B1842,Sulfaguanidine,57-67-0,C02,L1021-13,214.24,DMSO,C7 H10N4O2S,C1=CC(=CC=C1N)S(=O)(=O)N=C(N)N,≥2.66 mg/mL in H2O with gentle warming and ultrasonic; ≥2.67 mg/mL in EtOH with gentle warming and ultrasonic; ≥9.6 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,sulfonamide antibiotic,https://www.apexbt.com/search.php?catalog=B1842B1844,Sulfapyridine,144-83-2,C03,L1021-13,249.29,DMSO,C11H11N3O2S,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in H2O; insoluble in EtOH; ≥2.49 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,short-acting sulfonamide antibiotic,https://www.apexbt.com/search.php?catalog=B1844B1846,Taurine,107-35-7,C04,L1021-13,125.15,H2O,C2H7NO3S,C(CS(=O)(=O)O)N,insoluble in DMSO; insoluble in EtOH; ≥5.9 mg/mL in H2O,Free Base,Others,Others,Glycine receptor agonist,https://www.apexbt.com/search.php?catalog=B1846B1847,Teicoplanin,61036-62-2,C05,L1021-13,1709.39,H2O,C77H77N9O31Cl2&middot;R,CCCCCCCCCC(C)=O.CCCCC\C=C\CCC(C)=O.CCC(C)CCCCCCC(C)=O.CC(C)CCCCCCCC(C)=O.CC(C)CCCCCCC(C)=O.CC(=O)NC1C(O)C(O)C(CO)OC1OC2C3NC(=O)C(NC(=O)C4NC(=O)C5NC(=O)C(CC6=CC=C(OC7=C(OC8OC(CO)C(O)C(O)C8N[R])C(=CC4=C7)OC9=C(Cl)C=C2C=C9)C(=C6)Cl)NC(=O)C(N)C%10=CC(=C(O)C=C%10)OC%11=CC5=CC(=C%11)O)C%12=CC(=C(O)C=C%12)C%13=C(OC%14OC(CO)C(O)C(O)C%14O)C=C(O)C=C%13C(NC3=O)C(O)=O,insoluble in EtOH; insoluble in DMSO; ≥23.5 mg/mL in H2O,#N/A,,,glycopeptide antibiotic,https://www.apexbt.com/search.php?catalog=B1847B1849,Tenoxicam,59804-37-4,C06,L1021-13,337.37832,DMSO,C13H11N3O4S2,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3,insoluble in EtOH; insoluble in H2O; ≥10.5 mg/mL in DMSO,Free Base,Immunology/Inflammation,,antiinflammatory agent,https://www.apexbt.com/search.php?catalog=B1849B1850,Teriflunomide,108605-62-5,C07,L1021-13,270.21,DMSO,C12H9F3N2O2,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,insoluble in H2O; ≥13.5 mg/mL in DMSO; ≥2.54 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Others,DHODH,Inhibitor of dihydroorotate dehydrogenase,https://www.apexbt.com/search.php?catalog=B1850B1852,Thiamine HCl (Vitamin B1),67-03-8,C08,L1021-13,337.27,H2O,C12 H17N4OS·HCl,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-],insoluble in EtOH; ≥10.9 mg/mL in H2O; ≥2.52 mg/mL in DMSO with ultrasonic,Hydrochloride,Metabolism,Vitamin,hydrochloride salt form of thiamine,https://www.apexbt.com/search.php?catalog=B1852B1853,Thiamphenicol,15318-45-3,C09,L1021-13,356.22,DMSO,C12H15Cl2NO5S,CS(=O)(=O)C1=CC=C(C=C1)C(C(CO)NC(=O)C(Cl)Cl)O,insoluble in H2O; ≥15.55 mg/mL in DMSO; ≥7.09 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,antimicrobial antibiotic,https://www.apexbt.com/search.php?catalog=B1853B1854,Ticarcillin sodium,29457-07-6,C10,L1021-13,430.41,DMSO,C15H16N2O6S2·2Na,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],≥18.8 mg/mL in DMSO; ≥3.35 mg/mL in EtOH with ultrasonic; ≥91.4 mg/mL in H2O,,Microbiology & Virology,Anti-infection,semisynthetic antibiotic,https://www.apexbt.com/search.php?catalog=B1854B1855,Tiratricol,51-24-1,C11,L1021-13,621.93,DMSO,C14H9I3O4,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O,≥29.5 mg/mL in DMSO; insoluble in H2O; ≥120.8 mg/mL in EtOH,Free Base,Others,Others,thyroid hormone analogue,https://www.apexbt.com/search.php?catalog=B1855B1856,Tobramycin,32986-56-4,D01,L1021-13,467.52369,H2O,C18H37N5O9,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,≥46.8 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Free Base,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1856B1857,Tolperisone HCl,3644-61-9,D02,L1021-13,281.82,DMSO,C16H23NO·HCl,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2.Cl,≥10.55 mg/mL in DMSO; ≥102 mg/mL in H2O; ≥98.4 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1857B1858,Tranexamic Acid,1197-18-8,D03,L1021-13,157.21,H2O,C8H15NO2,C1CC(CCC1CN)C(=O)O,insoluble in EtOH; insoluble in DMSO; ≥6.6 mg/mL in H2O,Free Base,Others,Others,competitive inhibitor of plasminogen activation,https://www.apexbt.com/search.php?catalog=B1858B1859,Triamcinolone,124-94-7,D04,L1021-13,394.43,DMSO,C21H27FO6,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,insoluble in H2O; insoluble in EtOH; ≥11.95 mg/mL in DMSO ,Free Base,GPCR/G protein,Glucocorticoid Receptor,synthetic glucocorticoid agonist,https://www.apexbt.com/search.php?catalog=B1859B1860,Triclabendazole,68786-66-3,D05,L1021-13,359.66,DMSO,C14 H9Cl3N2OS,CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,insoluble in H2O; ≥15.7 mg/mL in DMSO; ≥34.67 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,Microtubule Associated,Microtubule associated inhibitor,https://www.apexbt.com/search.php?catalog=B1860B1861,Trometamol,77-86-1,D06,L1021-13,121.14,DMSO,C4H11NO3,C(C(CO)(CO)N)O,≥2.76 mg/mL in EtOH with gentle warming and ultrasonic; ≥28.05 mg/mL in DMSO; ≥4 mg/mL in H2O with gentle warming,Free Base,Neuroscience,COX,proton acceptor used to treat acidemia,https://www.apexbt.com/search.php?catalog=B1861B1862,Troxipide,30751-05-4,D07,L1021-13,294.35,DMSO,C15H22N2O4,COC1=CC(=CC(=C1OC)OC)C(=O)NC2CCCNC2,insoluble in H2O; ≥10.95 mg/mL in DMSO with gentle warming; ≥4.74 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Gastric cytoprotective agent,https://www.apexbt.com/search.php?catalog=B1862B1863,Uracil,66-22-8,D08,L1021-13,112.09,DMSO,C4H4N2O2,C1=CNC(=O)NC1=O,insoluble in H2O; insoluble in EtOH; ≥5.85 mg/mL in DMSO,Free Base,Others,Others,antineoplastic agent,https://www.apexbt.com/search.php?catalog=B1863B1864,Valganciclovir HCl,175865-59-5,D09,L1021-13,390.82,DMSO,C14H23ClN6O5,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N.Cl,insoluble in EtOH; ≥11.4 mg/mL in DMSO; ≥48.4 mg/mL in H2O,Hydrochloride,Microbiology & Virology,CMV,prodrug for ganciclovir,https://www.apexbt.com/search.php?catalog=B1864B1865,Valnemulin HCl,133868-46-9,D10,L1021-13,601.28,DMSO,C31H52N2O5S·HCl,O[[C@H]([[C@H](C)(C=C)C1)[[C@H](C)[[C@H]2(CCC3=O)[[C@@H]3[[C@H@]([[C@@H]1OC(CSC(C)(C)CNC([[C@@H](C(C)C)N)=O)=O)(C)[[C@H](C)CC2.Cl,≥25.65 mg/mL in DMSO; ≥48.4 mg/mL in EtOH; ≥59 mg/mL in H2O,Hydrochloride,Microbiology & Virology,Anti-infection,pleuromutilin antibiotic,https://www.apexbt.com/search.php?catalog=B1865B1867,Verapamil HCl,152-11-4,D11,L1021-13,491.06,DMSO,C27H39ClN2O4,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl,≥14.45 mg/mL in DMSO; ≥6.41 mg/mL in H2O with ultrasonic; ≥8.95 mg/mL in EtOH with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1867B1868,Vitamin A Acetate,127-47-9,E01,L1021-13,328.49,DMSO,C22H32O2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C,insoluble in H2O; ≥16.3 mg/mL in EtOH; ≥16.8 mg/mL in DMSO,,Metabolism,Vitamin,Unsaturated nutritional hydrocarbons,https://www.apexbt.com/search.php?catalog=B1868B1869,Retinyl (Vitamin A) Palmitate,79-81-2,E02,L1021-13,524.86,DMSO,C36H60O2,CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,insoluble in H2O; ≥17.73 mg/mL in EtOH; ≥18.4 mg/mL in DMSO,Free Base,Metabolism,Vitamin,ester of retinol (vitamin A) and palmitic acid,https://www.apexbt.com/search.php?catalog=B1869B1870,Voglibose,83480-29-9,E03,L1021-13,267.28,DMSO,C10H21NO7,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,insoluble in EtOH; ≥12.95 mg/mL in DMSO with gentle warming; ≥25.65 mg/mL in H2O,Free Base,Others,Others,_-glucosidases inhibitor,https://www.apexbt.com/search.php?catalog=B1870B1871,Zoxazolamine,61-80-3,E04,L1021-13,168.58,DMSO,C7H5ClN2O,C1=CC2=C(C=C1Cl)N=C(O2)N,insoluble in H2O; ≥26.25 mg/mL in EtOH with ultrasonic; ≥7.55 mg/mL in DMSO,Free Base,Others,Others,uricosuric and muscle relaxant,https://www.apexbt.com/search.php?catalog=B1871B1872,2-Thiouracil,141-90-2,E05,L1021-13,128.15,DMSO,C4H4N2OS,C1=CNC(=S)NC1=O,insoluble in EtOH; insoluble in H2O; ≥5.25 mg/mL in DMSO,Free Base,Others,Others,antihyperthyroid agent,https://www.apexbt.com/search.php?catalog=B1872B1873,4-Aminohippuric Acid,61-78-9,E06,L1021-13,194.19,DMSO,C9H10N2O3,C1=CC(=CC=C1C(=O)NCC(=O)O)N,insoluble in H2O; insoluble in EtOH; ≥48.6 mg/mL in DMSO,#N/A,Others,Others,typical substrate of organic anion transport systems,https://www.apexbt.com/search.php?catalog=B1873B1875,Acesulfame Potassium,55589-62-3,E07,L1021-13,202.25,DMSO,C4H5NO4S·K,CC1=CC(=O)[N-]S(=O)(=O)O1.[K+],insoluble in EtOH; ≥29.3 mg/mL in H2O; ≥32.1 mg/mL in DMSO,#N/A,,,non-nutritive sweetener,https://www.apexbt.com/search.php?catalog=B1875B1877,Adenosine,58-61-7,E08,L1021-13,267.24,DMSO,C10H13N5O4,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,insoluble in EtOH; insoluble in H2O; ≥12.75 mg/mL in DMSO with gentle warming,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,nucleoside,https://www.apexbt.com/search.php?catalog=B1877B1878,Adiphenine HCl,50-42-0,E09,L1021-13,347.88,DMSO,C20H25NO2·HCl,CCN(CC)CCOC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2.Cl,insoluble in EtOH; ≥17.39 mg/mL in DMSO; ≥57.1 mg/mL in H2O,Hydrochloride,Neuroscience,AChR,nicotinic receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1878B1880,Albendazole Oxide,54029-12-8,E10,L1021-13,281.33,DMSO,C12H15N3O3S,CCCS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC,insoluble in EtOH; insoluble in H2O; ≥6.55 mg/mL in DMSO with gentle warming,Free Base,Cell Cycle/Checkpoint,Microtubule Associated,Microtubule associated inhibitor,https://www.apexbt.com/search.php?catalog=B1880B1881,Alibendol,26750-81-2,E11,L1021-13,251.28,DMSO,C13H17NO4,COC1=C(C(=CC(=C1)CC=C)C(=O)NCCO)O,insoluble in H2O; ≥12.45 mg/mL in DMSO; ≥49.8 mg/mL in EtOH,Free Base,Others,Others,"antispasmodic,choleretic,cholekinetic",https://www.apexbt.com/search.php?catalog=B1881B1882,Allylthiourea,109-57-9,F01,L1021-13,116.18,DMSO,C4H8N2S,C=CCNC(=S)N,≥17.7 mg/mL in H2O; ≥24.75 mg/mL in EtOH; ≥5.8 mg/mL in DMSO,Free Base,Others,Others,Selective inhibitor of ammonia oxidation,https://www.apexbt.com/search.php?catalog=B1882B1883,Amidopyrine,58-15-1,F02,L1021-13,231.29,DMSO,C13H17N3O,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C,≥10.05 mg/mL in DMSO; ≥18.23 mg/mL in H2O; ≥49 mg/mL in EtOH,Free Base,,,analgesic_antipyretic,https://www.apexbt.com/search.php?catalog=B1883B1884,Amiloride HCl,2016-88-8,F03,L1021-13,266.09,DMSO,C6H8ClN7O·HCl,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl,≥13.3 mg/mL in DMSO; ≥2.48 mg/mL in H2O with ultrasonic; ≥2.57 mg/mL in EtOH with ultrasonic,,Membrane Transporter/Ion Channel,"Sodium Channel, Calcium Channel","epithelial sodium channel (ENaC) inhibitor, selective",https://www.apexbt.com/search.php?catalog=B1884B1885,Amphotericin B,1397-89-3,F04,L1021-13,924.08,DMSO,C47H73NO17,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,≥46.2 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Microbiology & Virology,Antibiotic,amphipathic polyene antibiotic,https://www.apexbt.com/search.php?catalog=B1885B1886,Antipyrine,60-80-0,F05,L1021-13,188.23,DMSO,C11H12N2O,CC1=CC(=O)N(N1C)C2=CC=CC=C2,≥45.8 mg/mL in EtOH; ≥5.5 mg/mL in DMSO; ≥66.3 mg/mL in H2O,Free Base,Others,Others,analgesic and antipyretic agent,https://www.apexbt.com/search.php?catalog=B1886B1887,Articaine HCl,23964-57-0,F06,L1021-13,320.84,DMSO,C13H20N2O3S·HCl,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC.Cl,≥13.35 mg/mL in DMSO; ≥47.8 mg/mL in EtOH; ≥48 mg/mL in H2O,Hydrochloride,Others,Others,dental local anesthetic,https://www.apexbt.com/search.php?catalog=B1887B1888,Aspartame,22839-47-0,F07,L1021-13,294.3,DMSO,C14H18N2O5,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,insoluble in EtOH; ≥11.8 mg/mL in DMSO; ≥2.24 mg/mL in H2O with ultrasonic,Free Base,Others,Others,non-saccharide sweetener,https://www.apexbt.com/search.php?catalog=B1888B1889,Buflomedil HCl,35543-24-9,F08,L1021-13,343.85,DMSO,C17H25NO4·HCl,COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC.Cl,≥14.65 mg/mL in DMSO; ≥5.54 mg/mL in EtOH with ultrasonic; ≥60.5 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,vasodilator,https://www.apexbt.com/search.php?catalog=B1889B1891,Azacyclonol,115-46-8,F09,L1021-13,267.37,DMSO,C18H21NO,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O,insoluble in H2O; ≥13.2 mg/mL in DMSO; ≥22.8 mg/mL in EtOH,Free Base,Neuroscience,5-HT Receptor,tranquilizer_antipsychotic,https://www.apexbt.com/search.php?catalog=B1891B1892,Azathioprine,446-86-6,F10,L1021-13,277.26,DMSO,C9H7N7O2S,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],≥55.56 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,DNA Damage/DNA Repair,DNA Synthesis,purine synthesis and GTP-binding protein Rac1 activation inhibitor,https://www.apexbt.com/search.php?catalog=B1892B1893,Azlocillin sodium salt,37091-65-9,F11,L1021-13,484.48,DMSO,C20H23N5NaO6S+,O=C([[C@H](NC(N1CCNC1=O)=O)C2=CC=CC=C2)NC3C(SC(C)(C)C4C(O)=O)N4C3=O.[Na+],≥10.18 mg/mL in EtOH with ultrasonic; ≥15.5 mg/mL in DMSO; ≥53 mg/mL in H2O,Sodium Salt,Microbiology & Virology,Anti-infection,semisynthetic penicillin and _-lactam antibiotic,https://www.apexbt.com/search.php?catalog=B1893B1895,Besifloxacin HCl,405165-61-9,G01,L1021-13,430.3,H2O,C19H22Cl2FN3O3,C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl,insoluble in EtOH; insoluble in DMSO; ≥4.3 mg/mL in H2O with gentle warming and ultrasonic,,Microbiology & Virology,Antibiotic,fourth-generation fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=B1895B1896,Betamethasone,378-44-9,G02,L1021-13,392.46,DMSO,C22H29FO5,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,insoluble in H2O; ≥19.6 mg/mL in DMSO; ≥4.37 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B1896B1897,Bifonazole,60628-96-8,G03,L1021-13,310.39,DMSO,C22H18N2,C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=CC=C3)N4C=CN=C4,insoluble in H2O; ≥10.95 mg/mL in DMSO; ≥5.63 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,imidazole antifungal drug,https://www.apexbt.com/search.php?catalog=B1897B1898,Bisacodyl,603-50-9,G04,L1021-13,361.39,DMSO,C22H19NO4,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,insoluble in H2O; ≥15.25 mg/mL in DMSO; ≥2.84 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,stimulant laxative drug,https://www.apexbt.com/search.php?catalog=B1898B1899,Bromhexine HCl,611-75-6,G05,L1021-13,412.59,DMSO,C14H20Br2N2·HCl,CN(CC1=CC(=CC(=C1N)Br)Br)C2CCCCC2.Cl,insoluble in H2O; ≥2.44 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.33 mg/mL in DMSO with gentle warming,Hydrochloride,Others,Others,bronchial mucolytic agent,https://www.apexbt.com/search.php?catalog=B1899B1900,Budesonide,51333-22-3,G06,L1021-13,430.53,DMSO,C25H34O6,O=C(C([H])([H])O[H])[[C@H@]12OC(C([H])([H])C([H])([H])C([H])([H])[H])([H])O[[C@H]1([H])C([H])([H])[[C@H]([[C@H@](C([H])([H])C3([H])[H])([H])[[C@H@]4([H])[[C@H@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[[C@H]2(C([H])([H])[H])C([H])([H])[[C@H]4([H])O[H],insoluble in H2O; ≥18.13 mg/mL in EtOH; ≥20.2 mg/mL in DMSO,Free Base,GPCR/G protein,Glucocorticoid Receptor,Anti-inflammatory corticosteroid,https://www.apexbt.com/search.php?catalog=B1900B1901,Butenafine HCl,101827-46-7,G07,L1021-13,353.93,DMSO,C23H28ClN,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32.Cl,insoluble in H2O; ≥17.55 mg/mL in DMSO; ≥23.6 mg/mL in EtOH,Hydrochloride,Microbiology & Virology,Antibiotic,synthetic benzylamine antifungal,https://www.apexbt.com/search.php?catalog=B1901B1902,Butoconazole nitrate,64872-77-1,G08,L1021-13,474.79,DMSO,C19H17Cl3N2S·HNO3,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl.[N+](=O)(O)[O-],≥24.65 mg/mL in DMSO; insoluble in H2O; ≥3.79 mg/mL in EtOH with ultrasonic,Nitrate,Microbiology & Virology,Anti-infection,Antifungal agent,https://www.apexbt.com/search.php?catalog=B1902B1903,Carbazochrome sodium sulfonate (AC-17),51460-26-5,G09,L1021-13,322.27,DMSO,C10H11N4NaO5S,CN1C(CC2=CC(=NNC(=O)N)C(=O)C=C21)S(=O)(=O)[O-].[Na+],≥10 mg/mL in H2O with ultrasonic; ≥17 mg/mL in DMSO; ≥2.34 mg/mL in EtOH with gentle warming and ultrasonic,Sodium,Others,Others,antihemorrhagic agent,https://www.apexbt.com/search.php?catalog=B1903B1904,Carbidopa,28860-95-9,G10,L1021-13,226.23,DMSO,C10H14N2O4,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,insoluble in H2O; insoluble in EtOH; ≥6.88 mg/mL in DMSO with gentle warming,,Metabolism,Decarboxylase,Decarboxylase inhibitor,https://www.apexbt.com/search.php?catalog=B1904B1905,Carbimazole,22232-54-8,G11,L1021-13,186.23,DMSO,C7H10N2O2S,CCOC(=O)N1C=CN(C1=S)C,insoluble in H2O; ≥5.57 mg/mL in EtOH with ultrasonic; ≥9.3 mg/mL in DMSO,Free Base,Others,Others,imidazole antithyroid agent,https://www.apexbt.com/search.php?catalog=B1905B1906,Cefoselis Sulfate,122841-12-7,H01,L1021-13,620.64,DMSO,C19H24N8O10S3,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CN4C=CC(=N)N4CCO)C(=O)O.OS(=O)(=O)O,≥62.1 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥2.3 mg/mL in H2O,,Microbiology & Virology,Antibiotic,beta-lactam antibiotic,https://www.apexbt.com/search.php?catalog=B1906B1907,Ceftiofur HCl,103980-44-5,H02,L1021-13,560.02,DMSO,C19H18ClN5O7S3,OC(C1=C(CSC(C2=CC=CO2)=O)CS[[C@H](N31)([H])[[C@H]([H])(NC(/C(C4=CSC(N)=N4)=N/OC)=O)C3=O)=O.Cl,≥21.8 mg/mL in DMSO; insoluble in H2O; ≥9.44 mg/mL in EtOH with ultrasonic,Hydrochloride,Microbiology & Virology,Anti-infection,cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=B1907B1908,Chenodeoxycholic Acid,474-25-9,H03,L1021-13,392.57,DMSO,C24H40O4,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,insoluble in H2O; ≥13.05 mg/mL in DMSO; ≥60.7 mg/mL in EtOH,Free Base,Others,FXR,nuclear receptors(FXR) activator,https://www.apexbt.com/search.php?catalog=B1908B1909,Chlormezanone,80-77-3,H04,L1021-13,273.74,DMSO,C11H12ClNO3S,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥7.9 mg/mL in DMSO; ≥8.74 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Anxiolytic and skeletal muscle relaxant,https://www.apexbt.com/search.php?catalog=B1909B1910,Chloroxine,773-76-2,H05,L1021-13,214.05,DMSO,C9H5Cl2NO,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,insoluble in H2O; ≥2.73 mg/mL in EtOH with gentle warming and ultrasonic; ≥9.7 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,synthetic antibacterial compound,https://www.apexbt.com/search.php?catalog=B1910B1911,Cinepazide maleate,26328-04-1,H06,L1021-13,533.57,DMSO,C22H31N3O5·C4H4O4,COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCN(CC2)CC(=O)N3CCCC3.C(=CC(=O)O)C(=O)O,≥16.85 mg/mL in DMSO; ≥2.48 mg/mL in EtOH; ≥53.9 mg/mL in H2O,Maleate,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1911B1913,Clindamycin HCl,21462-39-5,H07,L1021-13,461.44,DMSO,C18H33ClN2O5S·HCl,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl,≥15.35 mg/mL in DMSO; ≥2.95 mg/mL in EtOH with gentle warming and ultrasonic; ≥53.1 mg/mL in H2O,Hydrochloride,Microbiology & Virology,Anti-infection,Lincosamide antibiotic,https://www.apexbt.com/search.php?catalog=B1913B1915,Clobetasol propionate,25122-46-7,H08,L1021-13,466.97,DMSO,C25H32ClFO5,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,insoluble in H2O; ≥20.05 mg/mL in DMSO; ≥22.1 mg/mL in EtOH,Propionate,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B1915B1917,Clorsulon,60200-06-8,H09,L1021-13,380.66,DMSO,C8H8Cl3N3O4S2,C1=C(C(=CC(=C1N)S(=O)(=O)N)S(=O)(=O)N)C(=C(Cl)Cl)Cl,insoluble in H2O; ≥17.05 mg/mL in DMSO; ≥21.55 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Anthelmintic agent,https://www.apexbt.com/search.php?catalog=B1917B1918,Cloxacillin Sodium,7081-44-9,H10,L1021-13,475.88,DMSO,C19H19ClN3NaO6S,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],≥14.85 mg/mL in DMSO; ≥18.43 mg/mL in EtOH with ultrasonic; ≥48.8 mg/mL in H2O,Sodium Salt,Microbiology & Virology,Anti-infection,semisynthetic beta-lactamase resistant penicillin antibiotic,https://www.apexbt.com/search.php?catalog=B1918B1919,Cortisone acetate,50-04-4,H11,L1021-13,402.48,DMSO,C23H30O6,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,insoluble in H2O; insoluble in EtOH; ≥7.03 mg/mL in DMSO with gentle warming,Free Base,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B1919B1920,Crystal Violet,548-62-9,A01,L1021-14,407.98,DMSO,C25H30ClN3,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],>19.7mg/mL in DMSO,chloride,Others,Others,triarylmethane dye,https://www.apexbt.com/search.php?catalog=B1920B1921,Cyclamic acid,100-88-9,A02,L1021-14,179.24,DMSO,C17H15F2IN4O4,C1CCC(CC1)NS(=O)(=O)O,≥5.85 mg/mL in DMSO; ≥53.1 mg/mL in EtOH; ≥59.2 mg/mL in H2O,Free Base,Others,Others,artificial sweetening agent,https://www.apexbt.com/search.php?catalog=B1921B1922,Cyclosporin A,59865-13-3,A03,L1021-14,1202.61,DMSO,C62H111N11O12,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,≥60.15 mg/mL in DMSO; insoluble in H2O; ≥50.8 mg/mL in EtOH,Free Base,Immunology/Inflammation,,Immunosuppressive agent,https://www.apexbt.com/search.php?catalog=B1922B1923,Cytidine,65-46-3,A04,L1021-14,243.22,DMSO,C9H13N3O5,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,insoluble in EtOH; ≥11.85 mg/mL in DMSO; ≥62.9 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,pyrimidine nucleoside,https://www.apexbt.com/search.php?catalog=B1923B1924,Deflazacort,14484-47-0,A05,L1021-14,441.52,DMSO,C25H31NO6,O=C(C([H])([H])OC(C([H])([H])[H])=O)[[C@H@]12N=C(C([H])([H])[H])O[[C@H]1([H])C([H])([H])[[C@H]([[C@H@](C([H])([H])C3([H])[H])([H])[[C@H@]4([H])[[C@H@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[[C@H]2(C([H])([H])[H])C([H])([H])[[C@H]4([H])O[H],insoluble in H2O; ≥10.52 mg/mL in EtOH with ultrasonic; ≥18.75 mg/mL in DMSO,Free Base,GPCR/G protein,Glucocorticoid Receptor,anti-inflammatory and immunosuppressant,https://www.apexbt.com/search.php?catalog=B1924B1925,Deoxyarbutin,53936-56-4,A06,L1021-14,194.23,DMSO,C11H14O3,C1CCOC(C1)OC2=CC=C(C=C2)O,insoluble in H2O; ≥56.8 mg/mL in EtOH; ≥8.05 mg/mL in DMSO,Free Base,Proteases,Tyrosinase,Tyrosinase inhibitor,https://www.apexbt.com/search.php?catalog=B1925B1926,Dexamethasone acetate,1177-87-3,A07,L1021-14,434.5,DMSO,C24H31FO6,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C,insoluble in H2O; ≥13.35 mg/mL in DMSO; ≥49.7 mg/mL in EtOH,Free Base,GPCR/G protein,Glucocorticoid Receptor,IL Receptor modulator,https://www.apexbt.com/search.php?catalog=B1926B1927,Diclazuril,101831-37-2,A08,L1021-14,407.64,DMSO,C17H9Cl3N4O2,C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)Cl,insoluble in EtOH; ≥19.4 mg/mL in DMSO; ≥2.54 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,anti-coccidial drug,https://www.apexbt.com/search.php?catalog=B1927B1928,Diclofenac Diethylamine,78213-16-8,A09,L1021-14,369.29,DMSO,C14H11Cl2NO2·C4H11N,CCNCC.C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,≥17.05 mg/mL in DMSO; ≥2.55 mg/mL in H2O with gentle warming and ultrasonic; ≥65.5 mg/mL in EtOH,Diethylamine,Neuroscience,COX,non-selective COX inhibitor,https://www.apexbt.com/search.php?catalog=B1928B1929,Diclofenac Potassium,15307-81-0,A10,L1021-14,334.24,DMSO,C14H10Cl2KNO2,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+],≥13.42 mg/mL in H2O; ≥14.95 mg/mL in DMSO; ≥4.85 mg/mL in EtOH,Potassium,Immunology/Inflammation,,nonsteroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=B1929B1931,Dimethyl Fumarate,624-49-7,A11,L1021-14,144.13,DMSO,C6H8O4,COC(=O)C=CC(=O)OC,insoluble in H2O; ≥6.7 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.1 mg/mL in DMSO,Fumarate,Immunology/Inflammation,KEAP1-Nrf2,nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator,https://www.apexbt.com/search.php?catalog=B1931B1932,Diphenhydramine HCl,147-24-0,B01,L1021-14,291.82,DMSO,C17H21NO·HCl,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,≥12.15 mg/mL in DMSO; ≥42 mg/mL in H2O; ≥45.6 mg/mL in EtOH,Hydrochloride,Neuroscience,Histamine Receptor,H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1932B1933,Dipyridamole,58-32-2,B02,L1021-14,504.63,DMSO,C24H40N8O4,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,insoluble in H2O; ≥15.55 mg/mL in DMSO; ≥8.54 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,PDE,PDE inhibitor,https://www.apexbt.com/search.php?catalog=B1933B1934,DL-Carnitine HCl,461-05-2,B03,L1021-14,197.66,DMSO,C7H15NO3·HCl,C[N+](C)(C)CC(CC(=O)O)O.[Cl-],insoluble in EtOH; ≥36.35 mg/mL in H2O; ≥9.5 mg/mL in DMSO with gentle warming,Hydrochloride,Others,Others,quaternary ammonium compound,https://www.apexbt.com/search.php?catalog=B1934B1935,Dronedarone HCl,141625-93-6,B04,L1021-14,593.22,DMSO,C31H45ClN2O5S,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl,≥28.25 mg/mL in DMSO; insoluble in H2O; ≥12.8 mg/mL in EtOH with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Potassium Channel,Antiarrhythmic drugs,https://www.apexbt.com/search.php?catalog=B1935B1936,Dyclonine HCl,536-43-6,B05,L1021-14,325.87,DMSO,C18H27NO2·HCl,CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2.Cl,≥11.32 mg/mL in DMSO with ultrasonic; ≥14.6 mg/mL in EtOH; ≥8.58 mg/mL in H2O with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,local anesthetic,https://www.apexbt.com/search.php?catalog=B1936B1937,Econazole nitrate,24169-02-6,B06,L1021-14,444.7,DMSO,C18H15Cl3N2O·HNO3,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],insoluble in H2O; ≥20.35 mg/mL in DMSO; ≥9.6 mg/mL in EtOH with ultrasonic,Nitrate,Membrane Transporter/Ion Channel,"Anti-infection,Calcium Channel",Calcium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1937B1938,Erdosteine,84611-23-4,B07,L1021-14,249.31,DMSO,C8H11NO4S2,C1CSC(=O)C1NC(=O)CSCC(=O)O,insoluble in H2O; ≥10.6 mg/mL in DMSO; ≥2.19 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Others,Others,mucolytic,https://www.apexbt.com/search.php?catalog=B1938B1939,Erythromycin,114-07-8,B08,L1021-14,733.93,DMSO,C37H67NO13,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,≥29.5 mg/mL in DMSO; insoluble in H2O; ≥61.2 mg/mL in EtOH,Free Base,Microbiology & Virology,Antibiotic,macrolide antibiotic,https://www.apexbt.com/search.php?catalog=B1939B1940,Erythromycin Ethylsuccinate,1264-62-6,B09,L1021-14,862.05,DMSO,C43H75NO16,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,≥30.35 mg/mL in DMSO; insoluble in H2O; ≥46.4 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Macrolide antibiotic,https://www.apexbt.com/search.php?catalog=B1940B1941,Estradiol Benzoate,50-50-0,B10,L1021-14,376.49,DMSO,C25H28O3,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5,insoluble in H2O; ≥12.15 mg/mL in DMSO; ≥9.6 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen/progestogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1941B1942,Famciclovir,104227-87-4,B11,L1021-14,321.33,DMSO,C14H19N5O4,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,≥17.83 mg/mL in H2O with ultrasonic; ≥32.7 mg/mL in EtOH; ≥8.8 mg/mL in DMSO,Free Base,Microbiology & Virology,HSV,Anti-herpesvirus oral prodrug of penciclovir,https://www.apexbt.com/search.php?catalog=B1942B1943,Fenofibrate,49562-28-9,C01,L1021-14,360.83,DMSO,C20H21ClO4,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥12.75 mg/mL in DMSO; ≥18.57 mg/mL in EtOH,Free Base,Metabolism,PPAR,PPAR_ agonist,https://www.apexbt.com/search.php?catalog=B1943B1944,Fenoprofen Calcium,34597-40-5,C02,L1021-14,522.6,DMSO,C30H26CaO6,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].[Ca+2],insoluble in H2O; ≥14.7 mg/mL in DMSO; ≥29.8 mg/mL in EtOH,Free Base,Immunology/Inflammation,,"nonsteroidal, anti-inflammatory antiarthritic agent",https://www.apexbt.com/search.php?catalog=B1944B1945,Fenoprofen calcium hydrate,71720-56-4,C03,L1021-14,558.63,DMSO,C30H30CaO8,CC(C(O[Ca]OC(C(C)C1=CC=CC(OC2=CC=CC=C2)=C1)=O)=O)C3=CC=CC(OC4=CC=CC=C4)=C3.O.O,≥11.45 mg/mL in DMSO; ≥2.46 mg/mL in H2O with gentle warming and ultrasonic; ≥23.85 mg/mL in EtOH,Free Base,Immunology/Inflammation,,"nonsteroidal, anti-inflammatory antiarthritic agent",https://www.apexbt.com/search.php?catalog=B1945B1946,Foscarnet Sodium,63585-09-1,C04,L1021-14,191.95,H2O,CNa3O5P,C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+],insoluble in DMSO; insoluble in EtOH; ≥24.9 mg/mL in H2O,,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B1946B1947,Gemfibrozil,25812-30-0,C05,L1021-14,250.33,DMSO,C15H22O3,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,≥10.15 mg/mL in DMSO; ≥2.53 mg/mL in H2O with gentle warming and ultrasonic; ≥60.1 mg/mL in EtOH,Free Base,Metabolism,PPAR,PPAR_ activator,https://www.apexbt.com/search.php?catalog=B1947B1949,Guanidine HCl,50-01-1,C06,L1021-14,95.53,DMSO,CH6ClN3,C(=N)(N)N.Cl,≥19.2 mg/mL in EtOH; ≥27.2 mg/mL in DMSO; ≥4.4 mg/mL in H2O,Hydrochloride,Others,Others,Protein denaturant,https://www.apexbt.com/search.php?catalog=B1949B1950,Hydrochlorothiazide,58-93-5,C07,L1021-14,297.74,DMSO,C7H8ClN3O4S2,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,insoluble in H2O; insoluble in EtOH; ≥10.7 mg/mL in DMSO,Free Base,Others,Others,diuretic drug of the thiazide class,https://www.apexbt.com/search.php?catalog=B1950B1951,Hydrocortisone,50-23-7,C08,L1021-14,362.46,DMSO,C21H30O5,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,insoluble in H2O; insoluble in EtOH; ≥13.3 mg/mL in DMSO,Free Base,GPCR/G protein,Glucocorticoid Receptor,steroid hormone or glucocorticoid,https://www.apexbt.com/search.php?catalog=B1951B1953,Indapamide,26807-65-8,C09,L1021-14,365.83,DMSO,C16H16ClN3O3S,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,insoluble in H2O; ≥12.95 mg/mL in DMSO; ≥30.3 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,thiazide-like diuretic drug,https://www.apexbt.com/search.php?catalog=B1953B1954,Inulin,9005-80-5,C10,L1021-14,504.43708,H2O,C6nH10n+2O5n+1,OCC1OC(OC2(CO)OC(CO)C(O)C2O)C(O)C(O)C1O,insoluble in EtOH; insoluble in DMSO; ≥26.3 mg/mL in H2O,,Others,Others,starchy substance,https://www.apexbt.com/search.php?catalog=B1954B1956,Isoconazole nitrate,24168-96-5,C11,L1021-14,479.14,DMSO,C18H14Cl4N2O·HNO3,C1=CC(=C(C(=C1)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],insoluble in H2O; insoluble in EtOH; ≥15.05 mg/mL in DMSO,Nitrate,Microbiology & Virology,Anti-infection,azole antifungal reagent,https://www.apexbt.com/search.php?catalog=B1956B1957,Isoniazid,54-85-3,D01,L1021-14,137.14,DMSO,C6H7N3O,C1=CN=CC=C1C(=O)NN,insoluble in EtOH; ≥50.9 mg/mL in H2O; ≥6.3 mg/mL in DMSO,Free Base,Metabolism,Fatty Acid Synthase,antibiotic used for the treatment of tuberculosis,https://www.apexbt.com/search.php?catalog=B1957B1959,Levofloxacin,100986-85-4,D02,L1021-14,361.37,DMSO,C18H20FN3O4,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)[[C@H](C([H])([H])[H])([H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],insoluble in H2O; ≥11.4 mg/mL in DMSO; ≥2.82 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,synthetic fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=B1959B1960,Levonorgestrel,797-63-7,D03,L1021-14,312.45,DMSO,C21H28O2,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥2.44 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen/progestogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1960B1961,Levosimendan,141505-33-1,D04,L1021-14,280.28,DMSO,C14H12N6O,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,insoluble in EtOH; insoluble in H2O; ≥9.75 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,calcium sensitiser,https://www.apexbt.com/search.php?catalog=B1961B1962,Lincomycin HCl,859-18-7,D05,L1021-14,443,DMSO,C18H34N2O6S·HCl,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O.Cl,insoluble in EtOH; ≥35.3 mg/mL in H2O; ≥40.6 mg/mL in DMSO with ultrasonic,#N/A,,,lincosamide antibiotic,https://www.apexbt.com/search.php?catalog=B1962B1963,Lomustine,13010-47-4,D06,L1021-14,233.7,DMSO,C9H16ClN3O2,C1CCC(CC1)NC(=O)N(CCCl)N=O,insoluble in H2O; ≥23.41 mg/mL in DMSO; ≥23.9 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA Alkylating,Antineoplastic drug,https://www.apexbt.com/search.php?catalog=B1963B1964,Lonidamine,50264-69-2,D07,L1021-14,321.16,DMSO,C15H10Cl2N2O2,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥11.1 mg/mL in DMSO,Free Base,Others,Others,hexokinase inactivator,https://www.apexbt.com/search.php?catalog=B1964B1965,Meglumine,6284-40-8,D08,L1021-14,195.21,DMSO,C7H17NO5,CNCC(C(C(C(CO)O)O)O)O,insoluble in EtOH; ≥5.8 mg/mL in DMSO; ≥54.7 mg/mL in H2O,Free Base,Others,Others,amino sugar,https://www.apexbt.com/search.php?catalog=B1965B1966,Menadione,58-27-5,D09,L1021-14,172.18,DMSO,C11H8O2,CC1=CC(=O)C2=CC=CC=C2C1=O,insoluble in H2O; ≥5.15 mg/mL in DMSO; ≥9.86 mg/mL in EtOH with ultrasonic,Free Base,Others,"DNA/RNA Synthesis,phosphatase",precursor to vitamin K2,https://www.apexbt.com/search.php?catalog=B1966B1967,Mepivacaine HCl,1722-62-9,D10,L1021-14,282.81,DMSO,C15H22N2O·HCl,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl,≥10.2 mg/mL in EtOH with ultrasonic; ≥24.2 mg/mL in DMSO; ≥5.8 mg/mL in H2O,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,local anesthetic,https://www.apexbt.com/search.php?catalog=B1967B1968,Mequinol,150-76-5,D11,L1021-14,124.14,DMSO,C7H8O2,COC1=CC=C(C=C1)O,≥24.25 mg/mL in EtOH; ≥27.25 mg/mL in H2O; ≥6.2 mg/mL in DMSO,Free Base,Others,Others,depigmentation agent,https://www.apexbt.com/search.php?catalog=B1968B1969,Mesalamine,89-57-6,E01,L1021-14,153.14,DMSO,C7H7NO3,C1=CC(=C(C=C1N)C(=O)O)O,insoluble in EtOH; insoluble in H2O; ≥7.65 mg/mL in DMSO,Free Base,Immunology/Inflammation,PGE synthase,IKK inhibitor,https://www.apexbt.com/search.php?catalog=B1969B1970,Metformin HCl,1115-70-4,E02,L1021-14,165.62,DMSO,C4H12ClN5,CN(C)C(=N)N=C(N)N.Cl,insoluble in EtOH; ≥30.7 mg/mL in H2O; ≥8.3 mg/mL in DMSO,Hydrochloride,Others,Others,Anti-diabetic drug,https://www.apexbt.com/search.php?catalog=B1970B1971,Methacycline HCl,3963-95-9,E03,L1021-14,478.88,DMSO,C22H22N2O8·HCl,CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O.Cl,insoluble in EtOH; ≥51.73 mg/mL in DMSO; ≥7.09 mg/mL in H2O,,Microbiology & Virology,Anti-infection,tetracycline antibiotic,https://www.apexbt.com/search.php?catalog=B1971B1972,Methenamine,100-97-0,E04,L1021-14,140.19,DMSO,C6H12N4,[H]C1([H])N(C2([H])[H])C([H])([H])N3C([H])([H])N2C([H])([H])N1C3([H])[H],≥2.56 mg/mL in EtOH with gentle warming and ultrasonic; ≥2.83 mg/mL in DMSO; ≥57.4 mg/mL in H2O,Free Base,Microbiology & Virology,Anti-infection,antibiotic,https://www.apexbt.com/search.php?catalog=B1972B1974,Methylthiouracil,56-04-2,E05,L1021-14,142.18,DMSO,C5H6N2OS,CC1=CC(=O)NC(=S)N1,insoluble in EtOH; insoluble in H2O; ≥6.65 mg/mL in DMSO,Free Base,Others,Others,antithyroid preparation,https://www.apexbt.com/search.php?catalog=B1974B1975,Metolazone,17560-51-9,E06,L1021-14,365.83,DMSO,C16H16ClN3O3S,ClC1=C(C=C2C(NC(C)N(C3=CC=CC=C3C)C2=O)=C1)S(=O)(N)=O,insoluble in H2O; ≥108.2 mg/mL in DMSO; ≥3.31 mg/mL in EtOH with ultrasonic,,Others,Others,thiazide-like diuretic,https://www.apexbt.com/search.php?catalog=B1975B1976,Metronidazole,443-48-1,E07,L1021-14,171.15,DMSO,C6H9N3O3,CC1=NC=C(N1CCO)[N+](=O)[O-],≥11.54 mg/mL in EtOH with ultrasonic; ≥3.13 mg/mL in H2O with ultrasonic; ≥8.55 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA/RNA Synthesis,nitroimidazole antibiotic,https://www.apexbt.com/search.php?catalog=B1976B1977,Miconazole,22916-47-8,E08,L1021-14,416.13,DMSO,C18H14Cl4N2O,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,insoluble in H2O; ≥115.8 mg/mL in EtOH; ≥16.2 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,imidazole antifungal agent,https://www.apexbt.com/search.php?catalog=B1977B1978,Miconazole Nitrate,22832-87-7,E09,L1021-14,479.14,DMSO,C18H14Cl4N2O·HNO3,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-],≥23.65 mg/mL in DMSO; insoluble in H2O; ≥2.64 mg/mL in EtOH with gentle warming and ultrasonic,Nitrate,Microbiology & Virology,Anti-infection,Antifungal agent,https://www.apexbt.com/search.php?catalog=B1978B1979,Mometasone furoate,83919-23-7,E10,L1021-14,521.43,DMSO,C27H30Cl2O6,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,insoluble in H2O; ≥14.25 mg/mL in DMSO; ≥5.46 mg/mL in EtOH with ultrasonic,Furoate,GPCR/G protein,Glucocorticoid Receptor,glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B1979B1980,Moroxydine HCl,3160-91-6,E11,L1021-14,207.66,DMSO,C6H13N5O·HCl,C1COCCN1C(=N)N=C(N)N.Cl,≥52.2 mg/mL in H2O; ≥6.65 mg/mL in DMSO; ≥8.73 mg/mL in EtOH with ultrasonic,Hydrochloride,Microbiology & Virology,Anti-infection,synthetic antiviral compound,https://www.apexbt.com/search.php?catalog=B1980B1981,Mycophenolic acid,24280-93-1,F01,L1021-14,320.34,DMSO,C17H20O6,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC,insoluble in H2O; ≥10.85 mg/mL in DMSO; ≥19.2 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,Dehydrogenase,Dehydrogenase inhibitor,https://www.apexbt.com/search.php?catalog=B1981B1982,Nadifloxacin,124858-35-1,F02,L1021-14,360.38,DMSO,C19H21FN2O4,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])C2([H])[H])N(C([H])([H])C4([H])[H])C([H])([H])C([H])([H])C4([H])O[H],insoluble in H2O; insoluble in EtOH; ≥14.3 mg/mL in DMSO ,Free Base,Microbiology & Virology,Anti-infection,topical fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=B1982B1983,Nafcillin Sodium,7177-50-6,F03,L1021-14,454.47,DMSO,C21H21N2O5S·H2O·Na,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],≥15.5 mg/mL in DMSO; ≥19.63 mg/mL in EtOH with ultrasonic; ≥46.1 mg/mL in H2O,Free Base,Microbiology & Virology,Anti-infection,"narrow-spectrum, beta-lactam antibiotic",https://www.apexbt.com/search.php?catalog=B1983B1984,Naftifine HCl,65473-14-5,F04,L1021-14,323.86,DMSO,C21H21N·HCl,CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl,≥32.4 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥17.23 mg/mL in EtOH with ultrasonic,,Microbiology & Virology,Fungal,Allylamine antifungal agent,https://www.apexbt.com/search.php?catalog=B1984B1985,Nalidixic acid,389-08-2,F05,L1021-14,232.24,DMSO,C12H12N2O3,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,insoluble in EtOH; insoluble in H2O; ≥9.45 mg/mL in DMSO with gentle warming,Free Base,DNA Damage/DNA Repair,Topoisomerase,synthetic quinolone antibiotic,https://www.apexbt.com/search.php?catalog=B1985B1986,Nedaplatin,95734-82-0,F06,L1021-14,303.17,H2O,C2H8N2O3Pt,C(C(=O)O)O.[NH2-].[NH2-].[Pt+2],insoluble in DMSO; insoluble in EtOH; ≥9.8 mg/mL in H2O,Free Base,GPCR/G protein,Adrenergic Receptor,DNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B1986B1987,Nicotinic Acid,59-67-6,F07,L1021-14,123.11,DMSO,C6H5NO2,C1=CC(=CN=C1)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥5.95 mg/mL in DMSO,Free Base,Others,Others,water-soluble vitamin belonging to the vitamin B family,https://www.apexbt.com/search.php?catalog=B1987B1988,Nifedipine,21829-25-4,F08,L1021-14,346.33,DMSO,C17H18N2O6,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,insoluble in H2O; ≥15.75 mg/mL in DMSO; ≥7.14 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1988B1989,Nisoldipine,63675-72-9,F09,L1021-14,388.41,DMSO,C20H24N2O6,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,insoluble in H2O; ≥10.62 mg/mL in EtOH; ≥11.55 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1989B1990,Noradrenaline bitartrate monohydrate,108341-18-0,F10,L1021-14,337.28,DMSO,C8H11NO3·C4H6O6·H2O,C1=CC(=C(C=C1C(CN)O)O)O.C(C(C(=O)O)O)(C(=O)O)O.O,insoluble in EtOH; ≥11.35 mg/mL in DMSO; ≥51 mg/mL in H2O,Monohydrate,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1990B1991,Norethindrone,68-22-4,F11,L1021-14,298.42,DMSO,C20H26O2,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,insoluble in EtOH; insoluble in H2O; ≥13.55 mg/mL in DMSO,Free Base,Others,Others,synthetic progestin,https://www.apexbt.com/search.php?catalog=B1991B1992,Novobiocin Sodium,1476-53-5,G01,L1021-14,634.61,DMSO,C31H35N2O11·Na,CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)[O-])CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O.[Na+],≥29.35 mg/mL in DMSO; ≥15.3 mg/mL in H2O; ≥26.9 mg/mL in EtOH,,DNA Damage/DNA Repair,Topoisomerase,aminocoumarin antibiotic,https://www.apexbt.com/search.php?catalog=B1992B1993,Nystatin (Fungicidin),1400-61-9,G02,L1021-14,926.09,DMSO,C47H75NO17,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,≥30.45 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Microbiology & Virology,Antibiotic,antifungal antibiotic,https://www.apexbt.com/search.php?catalog=B1993B1995,"(+,-)-Octopamine HCl",770-05-8,G03,L1021-14,189.64,DMSO,C8H11NO2·HCl,C1=CC(=CC=C1C(CN)O)O.Cl,≥10.98 mg/mL in EtOH with ultrasonic; ≥44.8 mg/mL in H2O; ≥9.48 mg/mL in DMSO,Hydrochloride,Neuroscience,Dopamine Receptor,adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1995B1996,Ornidazole,16773-42-5,G04,L1021-14,219.63,DMSO,C7H10ClN3O3,CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-],≥10.66 mg/mL in H2O; ≥11 mg/mL in DMSO; ≥48.1 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,anti-bacterial and anti-protozoal drug,https://www.apexbt.com/search.php?catalog=B1996B1997,Oxacillin sodium monohydrate,7240-38-2,G05,L1021-14,441.43,DMSO,C19H18N3O5S·Na·H2O,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],insoluble in EtOH; ≥11.55 mg/mL in H2O; ≥16.9 mg/mL in DMSO,sodium,Microbiology & Virology,Anti-infection,an antibiotic used in resistant staphylococci infections,https://www.apexbt.com/search.php?catalog=B1997B1998,Oxfendazole,53716-50-0,G06,L1021-14,315.35,DMSO,C15H13N3O3S,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,insoluble in EtOH; insoluble in H2O; ≥15.75 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,broad spectrum benzimidazole anthelmintic,https://www.apexbt.com/search.php?catalog=B1998B1999,Oxibendazole,20559-55-1,G07,L1021-14,249.27,DMSO,C12H15N3O3,CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,insoluble in EtOH; insoluble in H2O; ≥2.49 mg/mL in DMSO,,Microbiology & Virology,Anti-infection,,https://www.apexbt.com/search.php?catalog=B1999B2000,Oxytetracycline (Terramycin),79-57-2,G08,L1021-14,460.43,DMSO,C22H24N2O9,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,insoluble in EtOH; insoluble in H2O; ≥15.55 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,broad-spectrum tetracycline antibiotic,https://www.apexbt.com/search.php?catalog=B2000B2001,Oxytetracycline Dihydrate,6153-64-6,G09,L1021-14,496.46,DMSO,C22H24N2O9·2H2O,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.O.O,insoluble in H2O; insoluble in EtOH; ≥18.4 mg/mL in DMSO with gentle warming,Dihydrate,Microbiology & Virology,Anti-infection,prescription antibiotic,https://www.apexbt.com/search.php?catalog=B2001B2003,Pefloxacin Mesylate,70458-95-6,G10,L1021-14,429.46,DMSO,C18H24FN3O6S,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O,insoluble in EtOH; ≥53.5 mg/mL in H2O; ≥6.83 mg/mL in DMSO,Mesylate,Microbiology & Virology,Antibiotic,synthetic chemotherapeutic agent_ antibacterial agent,https://www.apexbt.com/search.php?catalog=B2003B2004,Phenylbutazone,50-33-9,G11,L1021-14,308.37,DMSO,C19H20N2O2,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,insoluble in H2O; ≥11.55 mg/mL in DMSO; ≥6.41 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,non-steroidal anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=B2004B2005,Pidotimod,121808-62-6,H01,L1021-14,244.27,DMSO,C9H12N2O4S,C1CC(=O)NC1C(=O)N2CSCC2C(=O)O,insoluble in EtOH; ≥10.5 mg/mL in H2O with ultrasonic; ≥11.3 mg/mL in DMSO,Free Base,Immunology/Inflammation,,immunostimulant,https://www.apexbt.com/search.php?catalog=B2005B2007,Pizotifen Malate,5189-11-7,H02,L1021-14,429.53,DMSO,C23H27NO5S,CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1.C(C(C(=O)O)O)C(=O)O,≥21.48 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Malate,Neuroscience,5-HT Receptor,5-HT receptor antagonist,https://www.apexbt.com/search.php?catalog=B2007B2008,Potassium Iodide,7681-11-0,H03,L1021-14,166,DMSO,K+I-,[K+].[I-],≥3.71 mg/mL in EtOH with gentle warming and ultrasonic; ≥4.7 mg/mL in DMSO; ≥69.4 mg/mL in H2O,Inorganic salt,Others,Others,metal halide with thyroid protecting and expectorant properties,https://www.apexbt.com/search.php?catalog=B2008B2009,Pranlukast,103177-37-3,H04,L1021-14,481.5,DMSO,C27H23N5O4,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,insoluble in EtOH; insoluble in H2O; ≥13.8 mg/mL in DMSO,Free Base,Immunology/Inflammation,Leukotriene Receptor,"selective antagonist of the cysteinyl leukotrienes (LT) C(4), LTD(4) and LTE(4),",https://www.apexbt.com/search.php?catalog=B2009B2010,Pranoprofen,52549-17-4,H05,L1021-14,255.27,DMSO,C15H13NO3,CC(C1=CC2=C(C=C1)OC3=C(C2)C=CC=N3)C(=O)O,insoluble in H2O; ≥11.5 mg/mL in DMSO; ≥2.23 mg/mL in EtOH with gentle warming and ultrasonic,,Neuroscience,COX,non-steroidal COX inhibitor,https://www.apexbt.com/search.php?catalog=B2010B2011,Praziquantel,55268-74-1,H06,L1021-14,312.41,DMSO,C19H24N2O2,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,insoluble in H2O; ≥14.35 mg/mL in DMSO; ≥30.35 mg/mL in EtOH,Free Base,Microbiology & Virology,Antibiotic,anthelmintic,https://www.apexbt.com/search.php?catalog=B2011B2012,Prednisolone,50-24-8,H07,L1021-14,360.44,DMSO,C21H28O5,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥3.25 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Glucocorticoid Receptor,synthetic glucocorticoid,https://www.apexbt.com/search.php?catalog=B2012B2013,Prednisolone Acetate,52-21-1,H08,L1021-14,402.48,DMSO,C23H30O6,CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O,insoluble in H2O; ≥10.95 mg/mL in DMSO; ≥2.57 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Glucocorticoid Receptor,synthetic corticosteroid drug,https://www.apexbt.com/search.php?catalog=B2013B2014,Probenecid,57-66-9,H09,L1021-14,285.36,DMSO,C13H19NO4S,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,insoluble in H2O; ≥13.66 mg/mL in EtOH; ≥8.7 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,TRPV,"inhibitor of organic anion transport, MRP and pannexin-1 channel",https://www.apexbt.com/search.php?catalog=B2014B2015,Probucol,23288-49-5,H10,L1021-14,516.84,DMSO,C31H48O2S2,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,insoluble in H2O; ≥17.45 mg/mL in DMSO; ≥64.2 mg/mL in EtOH,Free Base,Metabolism,LDL,"Antioxidant, anti-inflammatory and hypocholesterolemic agent",https://www.apexbt.com/search.php?catalog=B2015B2016,Protionamide,14222-60-7,H11,L1021-14,180.27,DMSO,C9H12N2S,CCCC1=NC=CC(=C1)C(=S)N,insoluble in H2O; ≥5.95 mg/mL in DMSO; ≥54.5 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,thioamide derivative with antitubercular activity,https://www.apexbt.com/search.php?catalog=B2016B2017,Pyridoxine HCl,58-56-0,A01,L1021-15,205.64,DMSO,C8H11NO3 ·HCl,CC1=NC=C(C(=C1O)CO)CO.Cl,insoluble in EtOH; ≥50.3 mg/mL in H2O; ≥9.3 mg/mL in DMSO,Hydrochloride,Metabolism,Vitamin,a form of vitamin B6,https://www.apexbt.com/search.php?catalog=B2017B2018,Rebamipide,90098-04-7,A02,L1021-15,370.79,DMSO,C19H15ClN2O4,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,insoluble in H2O; insoluble in EtOH; ≥10.25 mg/mL in DMSO,Free Base,Others,Others,cholecystokinin type 1 (CCK1) receptor inhibitor,https://www.apexbt.com/search.php?catalog=B2018B2019,Retapamulin,224452-66-8,A03,L1021-15,517.76,DMSO,C30H47NO4S,O[[C@H]([[C@H](C)(C=C)C1)[[C@H](C)[[C@H]2(CCC3=O)[[C@H]3([H])[[C@H@]([[C@@H]1OC(CSC4C[[C@H](CC5)([H])N(C)[[C@H]5([H])C4)=O)(C)[[C@H](C)CC2,insoluble in H2O; ≥114.8 mg/mL in EtOH; ≥16.15 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,"Pleuromutilin antibiotic,protein synthesis inhibitor",https://www.apexbt.com/search.php?catalog=B2019B2021,Rifampin,13292-46-1,A04,L1021-15,822.94,DMSO,C43H58N4O12,O[[C@H]([[C@H](C)[[C@H]([[C@H](/C=C/C=C(C)/C(NC1=C2O)=O)C)O)[[C@@H](C)[[C@@H]([[C@H](C)[[C@H](/C=C/O[[C@H@]3(C)OC4=C(C)C(O)=C2C(C(/C1=C/NN5CCN(C)CC5)=O)=C4C3=O)OC)OC(C)=O,≥26.25 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Microbiology & Virology,Antibiotic,DNA-dependent RNA polymerase inhibitor,https://www.apexbt.com/search.php?catalog=B2021B2022,Ronidazole,7681-76-7,A05,L1021-15,200.15,DMSO,C6H8N4O4,CN1C(=CN=C1COC(=O)N)[N+](=O)[O-],insoluble in H2O; insoluble in EtOH; ≥6.5 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,antiprotozoal agent,https://www.apexbt.com/search.php?catalog=B2022B2023,Ropivacaine HCl,98717-15-8,A06,L1021-15,310.86,DMSO,C17H26N2O·HCl,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,≥10.1 mg/mL in H2O; ≥42.6 mg/mL in DMSO; ≥50.2 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B2023B2024,Roxithromycin,80214-83-1,A07,L1021-15,837.06727,DMSO,C41H76N2O15,CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,≥27.75 mg/mL in DMSO; insoluble in H2O; ≥44.9 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,semi-synthetic macrolide antibiotic,https://www.apexbt.com/search.php?catalog=B2024B2026,Sodium Nitroprusside,14402-89-2,A08,L1021-15,261.92,DMSO,C5FeN6Na2O,N#C[Fe-2](N=O)(C#N)(C#N)(C#N)C#N.[Na+].[Na+],insoluble in EtOH; ≥11.2 mg/mL in DMSO; ≥51.6 mg/mL in H2O,Free Base,Others,Others,nitric oxide (NO) donor,https://www.apexbt.com/search.php?catalog=B2026B2027,Sodium Picosulfate,10040-45-6,A09,L1021-15,481.41,DMSO,C18H15NO8S2·2Na,C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+],≥13.05 mg/mL in DMSO; ≥2.69 mg/mL in EtOH; ≥50.3 mg/mL in H2O,Sodium Salt,Others,Others,laxative,https://www.apexbt.com/search.php?catalog=B2027B2028,Sodium salicylate,54-21-7,A10,L1021-15,160.1,DMSO,C7H5NaO3,C1=CC=C(C(=C1)C(=O)[O-])O.[Na+],≥14.63 mg/mL in EtOH with ultrasonic; ≥64.8 mg/mL in H2O; ≥7.1 mg/mL in DMSO,Salicylate,Immunology/Inflammation,NF-_B,NF-_B inhibitor,https://www.apexbt.com/search.php?catalog=B2028B2029,Sorbitol,50-70-4,A11,L1021-15,182.17,DMSO,C6H14O6,C(C(C(C(C(CO)O)O)O)O)O,insoluble in EtOH; ≥7.8 mg/mL in DMSO; ≥9.2 mg/mL in H2O,Free Base,Others,Others,sugar alcohol,https://www.apexbt.com/search.php?catalog=B2029B2030,Sparfloxacin,110871-86-8,B01,L1021-15,392.4,DMSO,C19H22F2N4O3,CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F,insoluble in EtOH; insoluble in H2O; ≥10.52 mg/mL in DMSO with ultrasonic,#N/A,,,fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=B2030B2034,Streptomycin sulfate,3810-74-0,B02,L1021-15,1457.38,H2O,2C21H39N7O12·3H2SO4,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,≥69.35 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO,sulfate,Microbiology & Virology,Anti-infection,aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B2034B2035,Sulbactam sodium,69388-84-7,B03,L1021-15,255.22,H2O,C8H10NO5S·Na,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+],insoluble in EtOH; ≥10.75 mg/mL in H2O; ≥2.55 mg/mL in DMSO with ultrasonic,Sodium,Microbiology & Virology,Anti-infection,irreversible _-lactamase inhibitor,https://www.apexbt.com/search.php?catalog=B2035B2036,Sulconazole Nitrate,61318-91-0,B04,L1021-15,460.76,DMSO,C18H15Cl3N2S·HNO3,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],insoluble in EtOH; insoluble in H2O; ≥16.1 mg/mL in DMSO,Nitrate,Microbiology & Virology,Anti-infection,imidazole derivative with broad-spectrum antifungal activity,https://www.apexbt.com/search.php?catalog=B2036B2037,Sulfamerazine,127-79-7,B05,L1021-15,264.3,DMSO,C11H12N4O2S,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in H2O; insoluble in EtOH; ≥10.15 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,sulfonamide antibacterial,https://www.apexbt.com/search.php?catalog=B2037B2038,Sulfameter,651-06-9,B06,L1021-15,280.3,DMSO,C11H12N4O3S,COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in EtOH; insoluble in H2O; ≥9.3 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,long-acting sulfonamide antibacterial,https://www.apexbt.com/search.php?catalog=B2038B2039,Sulfamethizole,144-82-1,B07,L1021-15,270.33,DMSO,C9H10N4O2S2,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in H2O; insoluble in EtOH; ≥9.9 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,sulfathiazole antibacterial agent,https://www.apexbt.com/search.php?catalog=B2039B2040,Sulfamethoxazole,723-46-6,B08,L1021-15,253.28,DMSO,C10H11N3O3S,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in H2O; ≥7.75 mg/mL in DMSO; ≥9.62 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,sulfonamide bacteriostatic antibiotic,https://www.apexbt.com/search.php?catalog=B2040B2041,Sulfanilamide,63-74-1,B09,L1021-15,172.2,DMSO,C6H8N2O2S,C1=CC(=CC=C1N)S(=O)(=O)N,insoluble in H2O; ≥2.49 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.7 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,competitive inhibitor for bacterial enzyme dihydropteroate synthetase,https://www.apexbt.com/search.php?catalog=B2041B2042,Sulfathiazole,72-14-0,B10,L1021-15,255.32,DMSO,C9H9N3O2S2,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,insoluble in EtOH; insoluble in H2O; ≥10.35 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,short-acting sulfa drug,https://www.apexbt.com/search.php?catalog=B2042B2043,Sulfisoxazole,127-69-5,B11,L1021-15,267.3,DMSO,C11H13N3O3S,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in H2O; ≥10.65 mg/mL in DMSO; ≥11.54 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,selective ETA endothelin receptor antagonist,https://www.apexbt.com/search.php?catalog=B2043B2044,Sulindac,38194-50-2,C01,L1021-15,356.41,DMSO,C20H17FO3S,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,insoluble in H2O; ≥12.05 mg/mL in DMSO; ≥4.41 mg/mL in EtOH,Free Base,Neuroscience,COX,Anti-inflammatory agent;COX inhibitor,https://www.apexbt.com/search.php?catalog=B2044B2047,Terbinafine HCl,78628-80-5,C02,L1021-15,327.89,DMSO,C21H26ClN,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl,insoluble in H2O; ≥16.3 mg/mL in DMSO; ≥9.66 mg/mL in EtOH,Hydrochloride,Others,Squalene epoxidase,Potent non-competitive inhibitor of squalene epoxidase,https://www.apexbt.com/search.php?catalog=B2047B2049,Tilmicosin,108050-54-0,C03,L1021-15,869.13,H2O,C46H80N2O13,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)O)N(C)C)O)CCN3CC(CC(C3)C)C)C)C)COC4C(C(C(C(O4)C)O)OC)OC,insoluble in EtOH; insoluble in DMSO; ≥86.9 mg/mL in H2O with gentle warming,,Microbiology & Virology,Anti-infection,macrolide antibiotic,https://www.apexbt.com/search.php?catalog=B2049B2050,Tinidazole,19387-91-8,C04,L1021-15,247.27,DMSO,C8H13N3O4S,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,≥11.25 mg/mL in DMSO; ≥2.57 mg/mL in H2O with gentle warming and ultrasonic; ≥2.8 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Microbiology & Virology,Antibiotic,anti-parasitic drug,https://www.apexbt.com/search.php?catalog=B2050B2051,Tioconazole,65899-73-2,C05,L1021-15,387.71,DMSO,C16H13Cl3N2OS,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,≥11.55 mg/mL in DMSO; ≥2.83 mg/mL in H2O with gentle warming and ultrasonic; ≥25.4 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,antifungal medication,https://www.apexbt.com/search.php?catalog=B2051B2053,Tolnaftate,2398-96-1,C06,L1021-15,307.41,DMSO,C19H17NOS,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,≥12.7 mg/mL in DMSO; ≥2.42 mg/mL in EtOH with gentle warming and ultrasonic; ≥2.64 mg/mL in H2O with gentle warming and ultrasonic,Free Base,Microbiology & Virology,Anti-infection,anti-fungal agent,https://www.apexbt.com/search.php?catalog=B2053B2054,Toltrazuril,69004-03-1,C07,L1021-15,425.38,DMSO,C18H14F3N3O4S,CC1=C(C=CC(=C1)N2C(=O)NC(=O)N(C2=O)C)OC3=CC=C(C=C3)SC(F)(F)F,insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,antiprotozoal agent,https://www.apexbt.com/search.php?catalog=B2054B2055,Torsemide,56211-40-6,C08,L1021-15,348.42,DMSO,C16H20N4O3S,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,insoluble in H2O; insoluble in EtOH; ≥5.08 mg/mL in DMSO,Free Base,Others,Others,pyridine-sulfonyl urea type loop diuretic,https://www.apexbt.com/search.php?catalog=B2055B2056,Trichlormethiazide,133-67-5,C09,L1021-15,380.66,DMSO,C8H8Cl3N3O4S2,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,insoluble in H2O; ≥10.75 mg/mL in DMSO; ≥2.62 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,thiazide diuretic,https://www.apexbt.com/search.php?catalog=B2056B2057,Trimethoprim,738-70-5,C10,L1021-15,290.32,DMSO,C14H18N4O3,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,insoluble in EtOH; insoluble in H2O; ≥12.25 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,bacteriostatic antibiotic,https://www.apexbt.com/search.php?catalog=B2057B2059,Tylosin tartrate,74610-55-2,C11,L1021-15,1066.19,DMSO,C46H77NO17·C4H6O6,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC.C(C(C(=O)O)O)(C(=O)O)O,≥36.85 mg/mL in DMSO; ≥20.85 mg/mL in H2O; ≥41.4 mg/mL in EtOH,Tartrate,Microbiology & Virology,Anti-infection,macrolide antibiotic,https://www.apexbt.com/search.php?catalog=B2059B2061,Valaciclovir HCl,124832-27-5,D01,L1021-15,360.8,DMSO,C13H20N6O4·HCl,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N.Cl,insoluble in EtOH; ≥15.7 mg/mL in DMSO; ≥97 mg/mL in H2O,Hydrochloride,Microbiology & Virology,Anti-infection,antiviral drug for herpes viruses,https://www.apexbt.com/search.php?catalog=B2061B2062,Vidarabine,5536-17-4,D02,L1021-15,267.24,DMSO,C10H13N5O4,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,insoluble in H2O; insoluble in EtOH; ≥12.35 mg/mL in DMSO,Free Base,Microbiology & Virology,HSV,antiviral drug for herpes viruses,https://www.apexbt.com/search.php?catalog=B2062B2063,Vitamin B12,68-19-9,D03,L1021-15,1355.37,DMSO,C63H88CoN14O14P,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],≥45.65 mg/mL in DMSO; ≥11.22 mg/mL in EtOH with ultrasonic; ≥18.32 mg/mL in H2O with ultrasonic,Free Base,Metabolism,Vitamin,water soluble vitamin,https://www.apexbt.com/search.php?catalog=B2063B2064,Vitamin C,50-81-7,D04,L1021-15,176.12,DMSO,C6H8O6,O=C1OC(C(O[H])=C1O[H])([H])C(C([H])([H])O[H])([H])O[H],≥12.2 mg/mL in EtOH with ultrasonic; ≥5.8 mg/mL in DMSO; ≥57.9 mg/mL in H2O,Free Base,Others,Others,water soluble vitamin,https://www.apexbt.com/search.php?catalog=B2064B2065,Vitamin D3,67-97-0,D05,L1021-15,384.64,DMSO,C27H44O,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,insoluble in H2O; ≥51.6 mg/mL in DMSO; ≥77.2 mg/mL in EtOH,,Vitamin D Related,VD/VDR,Fat-soluble secosteroids,https://www.apexbt.com/search.php?catalog=B2065B2066,Xylometazoline HCl,1218-35-5,D06,L1021-15,280.84,DMSO,C16H24N2·HCl,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl,≥14.04 mg/mL in DMSO; ≥50 mg/mL in H2O; ≥59.8 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,_1 and _2 adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B2066B2067,Xylose,25990-60-7,D07,L1021-15,150.13,DMSO,C5H10O5,C(C(C(C(C=O)O)O)O)O,≥113.8 mg/mL in H2O; ≥3.44 mg/mL in EtOH with ultrasonic; ≥7.5 mg/mL in DMSO,Free Base,Others,Others,monosaccharide of the aldopentose type,https://www.apexbt.com/search.php?catalog=B2067B2068,Zafirlukast,107753-78-6,D08,L1021-15,575.68,DMSO,C31H33N3O6S,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,≥23.9 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,GPCR/G protein,Leukotriene Receptor,oral leukotriene receptor antagonist,https://www.apexbt.com/search.php?catalog=B2068B2070,5-Aminolevulinic acid HCl,5451-09-2,D09,L1021-15,167.59,DMSO,C5H9NO3·HCl,NCC(CCC(O)=O)=O.Cl,insoluble in EtOH; ≥111.4 mg/mL in H2O; ≥7.75 mg/mL in DMSO,Hydrochloride,Others,Others,photosensitizing agent_ antineoplastic agent,https://www.apexbt.com/search.php?catalog=B2070B2071,Acetanilide,103-84-4,D10,L1021-15,135.16,DMSO,C8H9NO,CC(=O)NC1=CC=CC=C1,insoluble in H2O; ≥5.1 mg/mL in DMSO; ≥59.6 mg/mL in EtOH,Free Base,Others,Others,aniline derivative,https://www.apexbt.com/search.php?catalog=B2071B2072,Acipimox,51037-30-0,D11,L1021-15,154.12,DMSO,C6H6N2O3,CC1=CN=C(C=[N+]1[O-])C(=O)O,≥15.9 mg/mL in H2O with ultrasonic; ≥2.64 mg/mL in EtOH with gentle warming and ultrasonic; ≥5.6 mg/mL in DMSO,Free Base,Others,Others,Antilipolytic agent,https://www.apexbt.com/search.php?catalog=B2072B2073,Alendronate,121268-17-5,E01,L1021-15,325.12,H2O,C4H18NNaO10P2,[O-]P(O[H])(C(O[H])(C([H])([H])C([H])([H])C([H])([H])N([H])[H])P(O[H])(O[H])=O)=O.[H]O[H].[H]O[H].[H]O[H].[Na+],insoluble in DMSO; insoluble in EtOH; ≥5.57 mg/mL in H2O,,Others,Farnesyl Diphosphate Synthase,Bone resorption inhibitor,https://www.apexbt.com/search.php?catalog=B2073B2075,Ambrisentan,177036-94-1,E02,L1021-15,378.42,DMSO,C22H22N2O4,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,insoluble in H2O; ≥18.92 mg/mL in DMSO; ≥2.85 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Dopamine Receptor,ETA-receptor antagonist,https://www.apexbt.com/search.php?catalog=B2075B2076,(6-)_-Aminocaproic acid,60-32-2,E03,L1021-15,131.17,H2O,C6H13NO2,C(CCC(=O)O)CCN,insoluble in EtOH; ≥5 mg/mL in DMSO; ≥54.5 mg/mL in H2O,Free Base,Others,Others,antifibrinolytic agent,https://www.apexbt.com/search.php?catalog=B2076B2077,Amorolfine HCl,78613-38-4,E04,L1021-15,353.97,DMSO,C21H36ClNO,CCC(C)(C)C1=CC=C(C=C1)CC(C)CN2CC(OC(C2)C)C.Cl,insoluble in H2O; ≥6.25 mg/mL in DMSO; ≥9.54 mg/mL in EtOH,Hydrochloride,Microbiology & Virology,Antibiotic,antifungal reagent,https://www.apexbt.com/search.php?catalog=B2077B2078,Atovaquone,95233-18-4,E05,L1021-15,366.84,DMSO,C22H19ClO3,ClC1=C([H])C([H])=C(C([H])=C1[H])C2([H])C([H])([H])C([H])([H])C(C(C3=O)=C(C4=C([H])C([H])=C([H])C([H])=C4C3=O)O[H])([H])C([H])([H])C2([H])[H],insoluble in EtOH; insoluble in H2O; ≥17.03 mg/mL in DMSO,,Microbiology & Virology,Anti-infection,unique naphthoquinone with broad-spectrum antiprotozoal activity,https://www.apexbt.com/search.php?catalog=B2078B2079,Avobenzone,70356-09-1,E06,L1021-15,310.39,DMSO,C20H22O3,CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC,insoluble in H2O; ≥13.3 mg/mL in DMSO; ≥9.66 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,"topical, broad range UV protector",https://www.apexbt.com/search.php?catalog=B2079B2082,Camostat Mesilate,59721-29-8,E07,L1021-15,494.52,DMSO,C20H22N4O5·CH4O3S,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O,insoluble in EtOH; ≥160.6 mg/mL in DMSO; ≥32.15 mg/mL in H2O,,Membrane Transporter/Ion Channel,Sodium Channel,Trypsin-like protease inhibitor,https://www.apexbt.com/search.php?catalog=B2082B2083,Caspofungin Acetate,179463-17-3,E08,L1021-15,1213.42,DMSO,C56H96N10O19,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O,≥60.67 mg/mL in DMSO; insoluble in EtOH; ≥21.5 mg/mL in H2O,Free Base,Others,"_(1,3)-D-Glucan Synthase",lipopeptide antifungal drug,https://www.apexbt.com/search.php?catalog=B2083B2086,Cefditoren Pivoxil,117467-28-4,E09,L1021-15,620.72,DMSO,C25H28N6O7S3,CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C,insoluble in EtOH; insoluble in H2O; ≥20.05 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=B2086B2087,Ciclopirox,29342-05-0,E10,L1021-15,207.27,DMSO,C12H17NO2,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,insoluble in H2O; ≥11.2 mg/mL in DMSO; ≥22.1 mg/mL in EtOH,,Membrane Transporter/Ion Channel,"ATPase,Anti-infection",broad-spectrum antifungal agent,https://www.apexbt.com/search.php?catalog=B2087B2088,Diethylstilbestrol,56-53-1,E11,L1021-15,268.35,DMSO,C18H20O2,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,insoluble in H2O; ≥21.95 mg/mL in EtOH; ≥7.9 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,synthetic nonsteroidal estrogen,https://www.apexbt.com/search.php?catalog=B2088B2089,Diltiazem HCl,33286-22-5,F01,L1021-15,450.98,DMSO,C22H26N2O4S·HCl,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl,≥100 mg/mL in H2O; ≥12.4 mg/mL in DMSO; ≥2.56 mg/mL in EtOH with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,inhibitor of L-type Ca2+ channels,https://www.apexbt.com/search.php?catalog=B2089B2090,D-Mannitol,69-65-8,F02,L1021-15,182.17,DMSO,C6H14O6,C(C(C(C(C(CO)O)O)O)O)O,insoluble in EtOH; ≥26.9 mg/mL in H2O; ≥6.95 mg/mL in DMSO,Free Base,Others,Others,osmotic diuretic agent_weak renal vasodilator.,https://www.apexbt.com/search.php?catalog=B2090B2091,Doxercalciferol,54573-75-0,F03,L1021-15,412.66,DMSO,C28H44O2,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,insoluble in H2O; ≥11.5 mg/mL in DMSO; ≥51.7 mg/mL in EtOH,Free Base,Vitamin D Related,VD/VDR,Vitamin D receptor activator,https://www.apexbt.com/search.php?catalog=B2091B2092,Doxifluridine,3094-09-5,F04,L1021-15,246.19,DMSO,C9H11FN2O5,CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O,insoluble in EtOH; ≥10 mg/mL in DMSO; ≥11.66 mg/mL in H2O with ultrasonic,Free Base,Apoptosis,Thymidylate Synthase,oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU),https://www.apexbt.com/search.php?catalog=B2092B2093,Felbamate,25451-15-4,F05,L1021-15,238.24,DMSO,C11H14N2O4,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,insoluble in H2O; ≥11.91 mg/mL in DMSO; ≥5.07 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,NMDA Receptor,antagonist at the NMDA-associated glycine binding site,https://www.apexbt.com/search.php?catalog=B2093B2094,Fluconazole,86386-73-4,F06,L1021-15,306.27,DMSO,C13H12F2N6O,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,insoluble in H2O; ≥10.9 mg/mL in DMSO; ≥60.9 mg/mL in EtOH,Free Base,Microbiology & Virology,Antibiotic,Triazole antifungal agent,https://www.apexbt.com/search.php?catalog=B2094B2095,Fluocinolone Acetonide,67-73-2,F07,L1021-15,452.4999,DMSO,C24H30F2O6,F[[C@H@]1([[C@H@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[[C@H](C([H])([H])[[C@H]3([H])F)([H])[[C@H@]4([H])[[C@H@](C([H])([H])[[C@H]1([H])O[H])(C([H])([H])[H])[[C@H]5(C(C([H])([H])O[H])=O)OC(C([H])([H])[H])(C([H])([H])[H])O[[C@H]5([H])C4([H])[H],insoluble in H2O; insoluble in EtOH; ≥14.55 mg/mL in DMSO,Free Base,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B2095B2096,Fluticasone propionate,80474-14-2,F08,L1021-15,500.57,DMSO,C25H31F3O5S,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF,insoluble in H2O; insoluble in EtOH; ≥18.5 mg/mL in DMSO,Propionate,GPCR/G protein,Glucocorticoid Receptor,"High affinity, selective glucocorticoid receptor agonist",https://www.apexbt.com/search.php?catalog=B2096B2097,Ganciclovir,82410-32-0,F09,L1021-15,255.23,DMSO,C9H13N5O4,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N,insoluble in ETOH; ≥25.6 mg/mL in H2O with gentle warming; ≥6.95 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,HSV,Antiviral drug for CMV infections,https://www.apexbt.com/search.php?catalog=B2097B2099,Haloperidol,52-86-8,F10,L1021-15,375.86,DMSO,C21H23ClFNO2,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,insoluble in H2O; ≥18.79 mg/mL in DMSO; ≥2.52 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Neuroscience,Dopamine Receptor,Antipsychotic drug,https://www.apexbt.com/search.php?catalog=B2099B2101,Hydralazine HCl,304-20-1,F11,L1021-15,196.64,H2O,C8H8N4·HCl,C1=CC=C2C(=C1)C=NN=C2NN.Cl,insoluble in DMSO; insoluble in EtOH; ≥35.3 mg/mL in H2O,,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel activator,https://www.apexbt.com/search.php?catalog=B2101B2102,Hydroxyurea,127-07-1,G01,L1021-15,76.05,DMSO,CH4N2O2,C(=O)(N)NO,insoluble in EtOH; ≥21.13 mg/mL in H2O with ultrasonic; ≥3.7 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA/RNA Synthesis,DNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B2102B2103,Idebenone,58186-27-9,G02,L1021-15,338.44,DMSO,C19H30O5,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,insoluble in H2O; ≥51.9 mg/mL in EtOH; ≥9.85 mg/mL in DMSO,Free Base,Immunology/Inflammation,ROS,synthetic analog of coenzyme Q10 (CoQ10),https://www.apexbt.com/search.php?catalog=B2103B2104,Itraconazole,84625-61-6,G03,L1021-15,705.63,DMSO,C35H38Cl2N8O4,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,insoluble in EtOH; insoluble in H2O; ≥8.83 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,antifungal agent,https://www.apexbt.com/search.php?catalog=B2104B2106,Loteprednol etabonate,82034-46-6,G04,L1021-15,466.95,DMSO,C24H31ClO7,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,insoluble in H2O; insoluble in EtOH; ≥16.95 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,potent glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B2106B2107,L-Thyroxine,51-48-9,G05,L1021-15,776.87,DMSO,C15H11I4NO4,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,≥27.35 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Others,Others,Iodine containing hormone,https://www.apexbt.com/search.php?catalog=B2107B2108,Lubiprostone,136790-76-6,G06,L1021-15,390.46,DMSO,C20H32F2O5,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,≥39 mg/mL in DMSO; insoluble in H2O; ≥52.2 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Chloride Channel,activator of ClC-2 chloride channels,https://www.apexbt.com/search.php?catalog=B2108B2109,Mecarbinate,15574-49-9,G07,L1021-15,233.26,DMSO,C13H15NO3,CCOC(=O)C1=C(N(C2=C1C=C(C=C2)O)C)C,insoluble in H2O; insoluble in EtOH; ≥7.1 mg/mL in DMSO,Free Base,Others,Others,chemical intermediate of arbidol hydrochloride,https://www.apexbt.com/search.php?catalog=B2109B2110,Meptazinol HCl,59263-76-2,G08,L1021-15,269.81,DMSO,C15H24ClNO,CCC1(CCCCN(C1)C)C2=CC(=CC=C2)O.Cl,≥13.49 mg/mL in DMSO; ≥15.67 mg/mL in EtOH; ≥52.9 mg/mL in H2O,Hydrochloride,Endocrinology and Hormones,Opioid Receptor,Partial agonist at the _1 opioid receptor,https://www.apexbt.com/search.php?catalog=B2110B2111,Miglitol,72432-03-2,G09,L1021-15,207.22,DMSO,C8H17NO5,C1C(C(C(C(N1CCO)CO)O)O)O,insoluble in EtOH; ≥10.1 mg/mL in DMSO; ≥28.3 mg/mL in H2O,Free Base,Others,Others,Inhibitor of _-glucosidase,https://www.apexbt.com/search.php?catalog=B2111B2112,Milnacipran HCl,101152-94-7,G10,L1021-15,282.81,DMSO,C15H23ClN2O,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl,≥28.75 mg/mL in EtOH; ≥70.4 mg/mL in H2O; ≥77 mg/mL in DMSO,Hydrochloride,Neuroscience,SSRIs,Orally active 5-HT and noradrenalin re-uptake inhibitor,https://www.apexbt.com/search.php?catalog=B2112B2113,Mirtazapine,85650-52-8,G11,L1021-15,265.35,DMSO,C17H19N3,[H]C1(C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C3=C4N=C([H])C([H])=C3[H])N4C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H],insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥45.4 mg/mL in EtOH,Free Base,Neuroscience,5-HT Receptor,"5-HT2, 5-HT3, histamine H1 receptor and  _2-adrenoceptor antagonist",https://www.apexbt.com/search.php?catalog=B2113B2114,Mitoxantrone HCl,70476-82-3,H01,L1021-15,517.4,DMSO,C22H29ClN4O6·HCl,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl,insoluble in EtOH; ≥18.2 mg/mL in DMSO; ≥2.97 mg/mL in H2O with ultrasonic,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,"Topoisomerase II inhibitor, anti-neoplastic drug",https://www.apexbt.com/search.php?catalog=B2114B2115,Moguisteine,119637-67-1,H02,L1021-15,339.41,DMSO,C16H21NO5S,CCOC(=O)CC(=O)N1CCSC1COC2=CC=CC=C2OC,insoluble in H2O; ≥16.95 mg/mL in DMSO; ≥19.2 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,novel peripheral non-narcotic antitussive drug,https://www.apexbt.com/search.php?catalog=B2115B2116,Ozagrel HCl,78712-43-3,H03,L1021-15,264.71,DMSO,C13H12N2O2·HCl,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O.Cl,≥11.88 mg/mL in EtOH with ultrasonic; ≥22 mg/mL in H2O; ≥8.45 mg/mL in DMSO,Hydrochloride,Metabolism,P450 (e.g. CYP17),Potent and selective inhibitor of thromboxane (TXA2) synthetase,https://www.apexbt.com/search.php?catalog=B2116B2117,Pioglitazone,111025-46-8,H04,L1021-15,356.44,DMSO,C19H20N2O3S,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,insoluble in H2O; insoluble in EtOH; ≥14.3 mg/mL in DMSO ,Free Base,Metabolism,PPAR,PPAR agonist,https://www.apexbt.com/search.php?catalog=B2117B2118,Pramiracetam,68497-62-1,H05,L1021-15,269.38,DMSO,C14H27N3O2,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,≥10.3 mg/mL in DMSO; ≥11 mg/mL in H2O; ≥25.2 mg/mL in EtOH,Free Base,Others,Others,nootropic drug,https://www.apexbt.com/search.php?catalog=B2118B2119,Prilocaine,721-50-6,H06,L1021-15,220.31,DMSO,C13H20N2O,CCCNC(C)C(=O)NC1=CC=CC=C1C,≥3.5 mg/mL in H2O with gentle warming and ultrasonic; ≥64.4 mg/mL in EtOH; ≥8.25 mg/mL in DMSO,Free Base,Others,Others,local anesthetic of the amino amide type,https://www.apexbt.com/search.php?catalog=B2119B2120,Primidone,125-33-7,H07,L1021-15,218.25,DMSO,C12H14N2O2,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,insoluble in H2O; ≥10.91 mg/mL in DMSO; ≥3.1 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,anticonvulsant of the pyrimidinedione class,https://www.apexbt.com/search.php?catalog=B2120B2121,Propylthiouracil,51-52-5,H08,L1021-15,170.23,DMSO,C7H10N2OS,CCCC1=CC(=O)NC(=S)N1,insoluble in H2O; ≥4.47 mg/mL in EtOH with ultrasonic; ≥5.4 mg/mL in DMSO,Free Base,Others,Others,thyroperoxidase and 5'-deiodinase inhibitor,https://www.apexbt.com/search.php?catalog=B2121B2122,Pyrazinamide,98-96-4,H09,L1021-15,123.11,DMSO,C5H5N3O,C1=CN=C(C=N1)C(=O)N,≥2.94 mg/mL in EtOH with gentle warming and ultrasonic; ≥5.35 mg/mL in DMSO; ≥7.45 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,antitubercular agent,https://www.apexbt.com/search.php?catalog=B2122B2123,Quinine HCl Dihydrate,6119-47-7,H10,L1021-15,396.91,DMSO,C20H24N2O2·HCl·2H2O,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.O.O.Cl,≥19.45 mg/mL in DMSO; ≥7.14 mg/mL in EtOH with ultrasonic; ≥7.29 mg/mL in H2O with ultrasonic,,Membrane Transporter/Ion Channel,Potassium Channel,,https://www.apexbt.com/search.php?catalog=B2123B2124,Reboxetine mesylate,98769-84-7,H11,L1021-15,409.5,DMSO,C19H23NO3·CH4O3S,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3.CS(=O)(=O)O,≥41 mg/mL in DMSO; ≥5.32 mg/mL in EtOH with ultrasonic; ≥56.4 mg/mL in H2O,,Others,Others,Potent and selective inhibitor of noradrenalin uptake,https://www.apexbt.com/search.php?catalog=B2124B2125,Ribavirin,36791-04-5,A01,L1021-16,244.20864,DMSO,C8H12N4O5,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,insoluble in EtOH; ≥12.2 mg/mL in DMSO; ≥54.4 mg/mL in H2O,Free Base,Microbiology & Virology,Anti-infection,Antiviral guanosine ribonucleoside analog,https://www.apexbt.com/search.php?catalog=B2125B2126,Rifabutin,72559-06-9,A02,L1021-16,847,DMSO,C46H62N4O11,O[[C@H]([[C@H](C)[[C@@H](O)[[C@@H](C)/C=C/C=C(C)\C(NC1=C2C3=NC4(CCN(CC(C)C)CC4)N2)=O)[[C@@H](C)[[C@H](OC(C)=O)[[C@H](C)[[C@@H](OC)/C=C/O[[C@H@]5(C)OC6=C(C5=O)C3=C(C(O)=C6C)C1=O,≥42.35 mg/mL in DMSO; insoluble in H2O; ≥47.5 mg/mL in EtOH,Free Base,Microbiology & Virology,Antibiotic,anti-TB(tuberculosis) medicine,https://www.apexbt.com/search.php?catalog=B2126B2127,Rifapentine,61379-65-5,A03,L1021-16,877.03,DMSO,C47H64N4O12,O[[C@H]([[C@H](C)[[C@@H](O)[[C@@H](C)/C=C/C=C1/C)[[C@@H](C)[[C@H@](OC(C)=O)([H])[[C@H](C)[[C@@H](OC)/C=C/O[[C@H@]2(C)OC3=C(C2=O)C(C(O)=C4/C=N/N5CCN(C6CCCC6)CC5)=C(C(O)=C3C)C(O)=C4NC1=O,≥30.25 mg/mL in DMSO; insoluble in H2O; ≥2.87 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,antibiotic drug used in the treatment of tuberculosis,https://www.apexbt.com/search.php?catalog=B2127B2129,Ropinirole HCl,91374-20-8,A04,L1021-16,296.84,H2O,C16H24N2O·HCl,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1.Cl,≥14.95 mg/mL in H2O; ≥2.5 mg/mL in EtOH with gentle warming and ultrasonic; ≥6.73 mg/mL in DMSO with ultrasonic,Hydrochloride,Neuroscience,Dopamine Receptor,selective dopamine D2-receptor agonist,https://www.apexbt.com/search.php?catalog=B2129B2131,Sulbactam,68373-14-8,A05,L1021-16,233.24,DMSO,C8H11NO5S,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)C,≥11.1 mg/mL in DMSO; ≥26.35 mg/mL in H2O; ≥54.8 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,irreversible _-lactamase inhibitor,https://www.apexbt.com/search.php?catalog=B2131B2132,Sulfamethazine,57-68-1,A06,L1021-16,278.33,DMSO,C12H14N4O2S,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C,insoluble in H2O; ≥2.58 mg/mL in EtOH with gentle warming and ultrasonic; ≥9.9 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,sulfonamide antibacterial,https://www.apexbt.com/search.php?catalog=B2132B2133,Suprofen,40828-46-4,A07,L1021-16,260.31,DMSO,C14H12O3S,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,insoluble in H2O; ≥82.8 mg/mL in DMSO; ≥52.3 mg/mL in EtOH,,Immunology/Inflammation,TLR,dual COX-1/COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B2133B2134,Ulipristal,159811-51-5,A08,L1021-16,433.58,DMSO,C28H35NO3,CC([[C@H@]1(O)CC[[C@H@]2([H])[[C@H]3([H])CCC4=CC(CCC4=C3[[C@H](C5=CC=C(N(C)C)C=C5)([H])C[[C@H@]21C)=O)=O,≥21.7 mg/mL in DMSO; insoluble in H2O; ≥19.73 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,progestogen receptor modulator,https://www.apexbt.com/search.php?catalog=B2134B2135,Ursodiol,128-13-2,A09,L1021-16,392.57,DMSO,C24H40O4,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,insoluble in H2O; ≥16 mg/mL in DMSO; ≥50.5 mg/mL in EtOH,Free Base,Others,Others,Bile acids for PBC treatment,https://www.apexbt.com/search.php?catalog=B2135B2136,Zanamivir,139110-80-8,A10,L1021-16,332.31,H2O,C12H20N4O7,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,insoluble in DMSO; insoluble in EtOH; ≥8.99 mg/mL in H2O,Free Base,Microbiology & Virology,NA,Influenza A/B virus neuraminidases inhibitor,https://www.apexbt.com/search.php?catalog=B2136B2139,Bimatoprost,155206-00-1,A11,L1021-16,415.57,DMSO,C25H37NO4,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,≥21.25 mg/mL in DMSO; insoluble in H2O; ≥73.2 mg/mL in EtOH,Free Base,GPCR/G protein,Prostaglandin Receptor,prostaglandin analog,https://www.apexbt.com/search.php?catalog=B2139B2140,Calcifediol,19356-17-3,B01,L1021-16,400.64,DMSO,C27H44O2,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,insoluble in H2O; ≥13.65 mg/mL in DMSO; ≥41.2 mg/mL in EtOH,,Vitamin D Related,VD/VDR,Major circulating form of vitamin D3,https://www.apexbt.com/search.php?catalog=B2140B2141,Calcitriol,32222-06-3,B02,L1021-16,416.64,DMSO,C27H44O3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,insoluble in H2O; ≥20.83 mg/mL in DMSO; ≥43.5 mg/mL in EtOH,Free Base,Vitamin D Related,VD/VDR,Active metabolite of vitamin D3,https://www.apexbt.com/search.php?catalog=B2141B2142,Cefprozil hydrate,121123-17-9,B03,L1021-16,407.44,DMSO,C18H19N3O5S·H2O,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,≥20.35 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,,Microbiology & Virology,Bacterial,,https://www.apexbt.com/search.php?catalog=B2142B2143,Tacrolimus (FK506),104987-11-3,B04,L1021-16,804.02,DMSO,C44H69NO12,CO[[C@@H]1C[[C@H](/C=C(C)/[[C@@H](OC([[C@H]2([H])CCCCN2C(C([[C@H]3(O)O[[C@H]([[C@@H](OC)C[[C@H](C/C(C)=C/4)C)[[C@@H](OC)C[[C@H]3C)=O)=O)=O)[[C@H](C)[[C@H](CC([[C@@H]4CC=C)=O)O)CC[[C@H]1O,≥26.6 mg/mL in DMSO; insoluble in H2O; ≥84.5 mg/mL in EtOH,Free Base,Microbiology & Virology,Antibiotic,"Macrolide calcineurin inhibitor,immunosuppressant",https://www.apexbt.com/search.php?catalog=B2143B2144,Fluocinonide,356-12-7,B05,L1021-16,494.52,DMSO,C26H32F2O7,F[[C@H@]1([[C@H@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[[C@H](C([H])([H])[[C@H]3([H])F)([H])[[C@H@]4([H])[[C@H@](C([H])([H])[[C@H]1([H])O[H])(C([H])([H])[H])[[C@H]5(C(C([H])([H])OC(C([H])([H])[H])=O)=O)OC(C([H])([H])[H])(C([H])([H])[H])O[[C@H]5([H])C4([H])[H],insoluble in H2O; insoluble in EtOH; ≥13.25 mg/mL in DMSO ,Free Base,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B2144B2145,Fosaprepitant dimeglumine salt,265121-04-8,B06,L1021-16,1004.83,DMSO,C37H56F7N6O16P,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O,≥50.24 mg/mL in DMSO; insoluble in EtOH; ≥13.16 mg/mL in H2O with ultrasonic,Salt,Neuroscience,Substance P/NK1 Receptor,Neurokinin-1 antagonist,https://www.apexbt.com/search.php?catalog=B2145B2147,Peramivir Trihydrate,1041434-82-5,B07,L1021-16,382.45,H2O,C15H34N4O7,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C.O.O.O,insoluble in DMSO; ≥19.1 mg/mL in H2O with gentle warming; ≥9.56 mg/mL in EtOH,,Microbiology & Virology,NA,"potent, specific influenza viral neuraminidase inhibitor",https://www.apexbt.com/search.php?catalog=B2147B2148,Prednisone,53-03-2,B08,L1021-16,358.43,DMSO,C21H26O5,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,insoluble in H2O; insoluble in EtOH; ≥15.35 mg/mL in DMSO,Free Base,Others,Others,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=B2148B2149,Pyrantel Pamoate,22204-24-6,B09,L1021-16,594.692,DMSO,C23H16O6·C11H14N2S,CN1CCCN=C1C=CC2=CC=CS2.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Anti-infection,anthelmintic agent,https://www.apexbt.com/search.php?catalog=B2149B2150,Sitafloxacin Hydrate,163253-35-8,B10,L1021-16,436.84,DMSO,C19H18ClF2N3O3·3/2H2O,C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F.O,insoluble in H2O; insoluble in EtOH; ≥6.6 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,"new-generation, broad-spectrum oral fluoroquinolone antibiotic",https://www.apexbt.com/search.php?catalog=B2150B2153,Alfacalcidol,41294-56-8,B11,L1021-16,400.65,DMSO,C27H44O2,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,insoluble in H2O; ≥20.05 mg/mL in DMSO; ≥21.6 mg/mL in EtOH,Free Base,Vitamin D Related,VD/VDR,Bone resorption inhibitor,https://www.apexbt.com/search.php?catalog=B2153B2154,Alprostadil,745-65-3,C01,L1021-16,354.48,DMSO,C20H34O5,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,insoluble in H2O; ≥13.4 mg/mL in DMSO; ≥47.1 mg/mL in EtOH,Free Base,GPCR/G protein,Prostaglandin Receptor,vasodilator,https://www.apexbt.com/search.php?catalog=B2154B2156,Bindarit,130641-38-2,C02,L1021-16,324.37,DMSO,C19H20N2O3,CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥2.96 mg/mL in EtOH,Free Base,Immunology/Inflammation,CCR,"CCL2, CCL7 and CCL8 inhibitor",https://www.apexbt.com/search.php?catalog=B2156B2157,Cabazitaxel,183133-96-2,C03,L1021-16,835.93,DMSO,C45H57NO14,CO[[C@H]1C[[C@H]2([H])[[C@H](CO2)(OC(C)=O)[[C@H]3([H])[[C@H]1(C)C([[C@H](OC)C4=C(C)[[C@@H](OC([[C@H](O)[[C@H](C5=CC=CC=C5)NC(OC(C)(C)C)=O)=O)C[[C@H]([[C@H]3OC(C6=CC=CC=C6)=O)(O)C4(C)C)=O,≥22.3 mg/mL in DMSO; insoluble in H2O; ≥26.6 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule associated inhibitor,https://www.apexbt.com/search.php?catalog=B2157B2158,Desonide,638-94-8,C04,L1021-16,416.51,DMSO,C24H32O6,O=C(C([H])([H])O[H])[[C@H@]12OC(C([H])([H])[H])(C([H])([H])[H])O[[C@H]1([H])C([H])([H])[[C@H]([[C@H@](C([H])([H])C3([H])[H])([H])[[C@H@]4([H])[[C@H@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[[C@H]2(C([H])([H])[H])C([H])([H])[[C@H]4([H])O[H],insoluble in H2O; ≥11.32 mg/mL in EtOH; ≥20.85 mg/mL in DMSO,Free Base,GPCR/G protein,Glucocorticoid Receptor,nonfluorinated corticosteroid anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=B2158B2159,Eltrombopag,496775-61-2,C05,L1021-16,442.47,DMSO,C25H22N4O4,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,insoluble in H2O; ≥13.2 mg/mL in DMSO; ≥2.39 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Others,Thrombopoietin Receptor,nonpeptide agonist of the thrombopoietin receptor,https://www.apexbt.com/search.php?catalog=B2159B2162,Secnidazole,3366-95-8,C06,L1021-16,185.18,DMSO,C7H11N3O3,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],≥19.8 mg/mL in H2O; ≥47 mg/mL in EtOH; ≥5 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,nitroimidazole anti-infective,https://www.apexbt.com/search.php?catalog=B2162B2164,Ticlopidine HCl,53885-35-1,C07,L1021-16,300.25,H2O,C14H15Cl2NS,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl,≥10.12 mg/mL in EtOH; ≥15.35 mg/mL in H2O; ≥2.33 mg/mL in DMSO with gentle warming and ultrasonic,Hydrochloride,GPCR/G protein,Adenosine Receptor,Purinergic (P2Y) receptor antagonist,https://www.apexbt.com/search.php?catalog=B2164B2166,Ticagrelor,274693-27-5,C08,L1021-16,522.57,DMSO,C23H28F2N6O4S,CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO,≥26.15 mg/mL in DMSO; insoluble in H2O; ≥20.4 mg/mL in EtOH,Free Base,GPCR/G protein,P2Y Receptor,P2Y12 receptor antagonist,https://www.apexbt.com/search.php?catalog=B2166B2171,Imatinib (STI571),152459-95-5,C09,L1021-16,493.6,DMSO,C29H31N7O,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,≥24.68 mg/mL in DMSO; insoluble in H2O; ≥2.48 mg/mL in EtOH with ultrasonic,Free Base,Tyrosine Kinase,c-Kit,Protein-tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=B2171B2193,Mitiglinide Calcium,145525-41-3,C10,L1021-16,668.88,DMSO,C38H48CaN2O6,C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)[O-].C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)[O-].[Ca+2],≥33.45 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥10.14 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor,https://www.apexbt.com/search.php?catalog=B2193B2194,Tolbutamide,64-77-7,C11,L1021-16,270.35,DMSO,C12H18N2O3S,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,insoluble in H2O; ≥10.05 mg/mL in DMSO; ≥15.83 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,first generation potassium channel blocker,https://www.apexbt.com/search.php?catalog=B2194B2195,Gliclazide,21187-98-4,D01,L1021-16,323.41,DMSO,C15H21N3O3S,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,insoluble in H2O; ≥15.6 mg/mL in DMSO; ≥2.89 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor,https://www.apexbt.com/search.php?catalog=B2195B2196,Gliquidone,33342-05-1,D02,L1021-16,527.63,DMSO,C27H33N3O6S,CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C,≥22.4 mg/mL in DMSO; insoluble in H2O; ≥2.455 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,ATP-sensitive K+ channel antagonist,https://www.apexbt.com/search.php?catalog=B2196B2197,Nicorandil,65141-46-0,D03,L1021-16,211.17,DMSO,C8H9N3O4,C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-],≥21.1 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel activator,https://www.apexbt.com/search.php?catalog=B2197B2198,Nateglinide,105816-04-4,D04,L1021-16,317.42,DMSO,C19H27NO3,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,insoluble in H2O; ≥10.04 mg/mL in EtOH with ultrasonic; ≥16.4 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Insulin secretagog agent,https://www.apexbt.com/search.php?catalog=B2198B2200,Esomeprazole Magnesium,161973-10-0,D05,L1021-16,713.12,DMSO,C34H36MgN6O6S2,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2],insoluble in H2O; ≥11.48 mg/mL in EtOH with ultrasonic; ≥20.15 mg/mL in DMSO,Magnesium Salt,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B2200B2201,Zinc Pyrithione,13463-41-7,D06,L1021-16,317.7,DMSO,C10H8N2O2S2Zn,C1=CC(=S)N(C=C1)[O-].C1=CC(=S)N(C=C1)[O-].[Zn+2],insoluble in EtOH; insoluble in H2O; ≥13.45 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B2201B2203,Candesartan Cilexetil,145040-37-5,D07,L1021-16,610.66,DMSO,C33H34N6O6,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6,≥24 mg/mL in DMSO; insoluble in H2O; ≥2.1 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,RAAS,Prodrug of the angiotensin II receptor 1 (AT1) antagonist candesartan,https://www.apexbt.com/search.php?catalog=B2203B2205,Enalapril Maleate,76095-16-4,D08,L1021-16,492.52,DMSO,C20H28N2O5·C4H4O4,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O,≥23.15 mg/mL in DMSO; ≥2.12 mg/mL in EtOH with ultrasonic; ≥3.07 mg/mL in H2O with gentle warming and ultrasonic,,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor,https://www.apexbt.com/search.php?catalog=B2205B2207,Quinapril HCl,82586-55-8,D09,L1021-16,474.98,DMSO,C25H30N2O5·HCl,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl,≥19.6 mg/mL in DMSO; ≥21.2 mg/mL in H2O; ≥49.4 mg/mL in EtOH,Hydrochloride,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor,https://www.apexbt.com/search.php?catalog=B2207B2208,Ramipril,87333-19-5,D10,L1021-16,416.51,DMSO,C23H32N2O5,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,insoluble in H2O; ≥17.55 mg/mL in DMSO; ≥27.4 mg/mL in EtOH,Free Base,Proteases,ACE,angiotensin-converting enzyme (ACE) inhibitor,https://www.apexbt.com/search.php?catalog=B2208B2210,Azilsartan,147403-03-0,D11,L1021-16,456.45,DMSO,C25H20N4O5,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)O,insoluble in EtOH; insoluble in H2O; ≥16.95 mg/mL in DMSO ,Free Base,GPCR/G protein,Angiotensin Receptor,Potent angiotensin II type 1 (AT1) receptor inverse agonist,https://www.apexbt.com/search.php?catalog=B2210B2213,Temocapril HCl,110221-44-8,E01,L1021-16,513.07,DMSO,C23H28N2O5S2·HCl,CCOC(=O)C(CCC1=CC=CC=C1)NC2CSC(CN(C2=O)CC(=O)O)C3=CC=CS3.Cl,insoluble in H2O; ≥13.25 mg/mL in DMSO; ≥39.4 mg/mL in EtOH,Hydrochloride,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor,https://www.apexbt.com/search.php?catalog=B2213B2214,Valsartan,137862-53-4,E02,L1021-16,435.52,DMSO,C24H29N5O3,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,insoluble in H2O; ≥108.8 mg/mL in EtOH; ≥19.65 mg/mL in DMSO,Free Base,GPCR/G protein,Adenosine Receptor,Angiotensin II AT1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B2214B2215,Aliskiren Hemifumarate,173334-58-2,E03,L1021-16,1219.59,DMSO,C64H110N6O16,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=CC(=O)O)C(=O)O,≥58.5 mg/mL in DMSO; ≥121.9 mg/mL in EtOH with gentle warming; ≥122 mg/mL in H2O with gentle warming,Free Base,Others,Renin,renin inhibitor,https://www.apexbt.com/search.php?catalog=B2215B2216,Benazepril HCl,86541-74-4,E04,L1021-16,460.95,DMSO,C24H29ClN2O5,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl,≥18.1 mg/mL in H2O with ultrasonic; ≥18.2 mg/mL in DMSO; ≥55.4 mg/mL in EtOH,Hydrochloride,Others,Others,angiotensin-converting enzyme (ACE) inhibitor,https://www.apexbt.com/search.php?catalog=B2216B2218,Azilsartan Medoxomil,863031-21-4,E05,L1021-16,568.53,DMSO,C30H24N4O8,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)OCC6=C(OC(=O)O6)C,≥24.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor type 1 antagonist,https://www.apexbt.com/search.php?catalog=B2218B2220,Abacavir sulfate,188062-50-2,E06,L1021-16,384.41,H2O,C14H20N6O5S,C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O,insoluble in EtOH; ≥12.3 mg/mL in H2O; ≥8.63 mg/mL in DMSO with ultrasonic,sulfate,Others,Others,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B2220B2221,Zidovudine,30516-87-1,E07,L1021-16,267.24,DMSO,C10H13N5O4,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],≥17.6 mg/mL in H2O with gentle warming and ultrasonic; ≥26.5 mg/mL in EtOH with gentle warming; ≥8.35 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B2221B2222,Adefovir Dipivoxil,142340-99-6,E08,L1021-16,501.47,DMSO,C20H32N5O8P,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,insoluble in H2O; ≥104.2 mg/mL in EtOH; ≥18.7 mg/mL in DMSO,Free Base,Microbiology & Virology,CMV,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B2222B2223,Zalcitabine,7481-89-2,E09,L1021-16,211.22,DMSO,C9H13N3O3,C1CC(OC1CO)N2C=CC(=NC2=O)N,insoluble in EtOH; ≥10.65 mg/mL in DMSO with gentle warming; ≥15.87 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B2223B2224,Etravirine (TMC125),269055-15-4,E10,L1021-16,435.28,DMSO,C20H15BrN6O,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,insoluble in EtOH; insoluble in H2O; ≥19.35 mg/mL in DMSO,Free Base,Microbiology & Virology,HIV,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B2224B2225,Stavudine (d4T),3056-17-5,E11,L1021-16,224.21,DMSO,C10H12N2O4,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,≥51.3 mg/mL in H2O; ≥8.4 mg/mL in DMSO; ≥9.72 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,HIV,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B2225B2229,Palonosetron HCl,135729-62-3,F01,L1021-16,332.87,H2O,C19H25ClN2O,C1CC2CN(C(=O)C3=C2C(=CC=C3)C1)C4CN5CCC4CC5.Cl,insoluble in EtOH; ≥16.6435 mg/mL in DMSO; ≥32.3 mg/mL in H2O,Hydrochloride,Neuroscience,5-HT Receptor,5-HT receptor antagonist,https://www.apexbt.com/search.php?catalog=B2229B2230,Trazodone HCl,25332-39-2,F02,L1021-16,408.32,DMSO,C19H22ClN5O·HCl,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl,insoluble in EtOH; insoluble in H2O; ≥20.42 mg/mL in DMSO,Hydrochloride,Neuroscience,5-HT Receptor,5-HT receptor antagonist,https://www.apexbt.com/search.php?catalog=B2230B2231,Amitriptyline HCl,549-18-8,F03,L1021-16,313.86,DMSO,C20H23N·HCl,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl,≥15.69 mg/mL in DMSO; ≥43.9 mg/mL in H2O; ≥50 mg/mL in EtOH,Hydrochloride,Neuroscience,5-HT Receptor,Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor,https://www.apexbt.com/search.php?catalog=B2231B2232,Aripiprazole,129722-12-9,F04,L1021-16,448.39,DMSO,C23H27Cl2N3O2,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,≥22.4 mg/mL in DMSO; insoluble in H2O; ≥2.27 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Dopamine Receptor,5-HT receptor partial agonist,https://www.apexbt.com/search.php?catalog=B2232B2234,Clomipramine HCl,17321-77-6,F05,L1021-16,351.31,DMSO,C19H23ClN2·HCl,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl,≥17.57 mg/mL in DMSO; ≥31.1 mg/mL in H2O; ≥43.3 mg/mL in EtOH,Hydrochloride,Neuroscience,5-HT Receptor,SERT/NET dopamine transporter (DAT) blocker,https://www.apexbt.com/search.php?catalog=B2234B2235,Clozapine,5786-21-0,F06,L1021-16,326.82,DMSO,C18H19ClN4,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,insoluble in H2O; ≥14.95 mg/mL in DMSO; ≥2.7 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Neuroscience,Dopamine Receptor,5-HT receptor antagonist,https://www.apexbt.com/search.php?catalog=B2235B2236,Desvenlafaxine,93413-62-8,F07,L1021-16,263.38,DMSO,C16H25NO2,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,insoluble in EtOH; ≥13.2 mg/mL in DMSO; ≥2.45 mg/mL in EtOH,Free Base,Neuroscience,5-HT Receptor,serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor,https://www.apexbt.com/search.php?catalog=B2236B2237,Eletriptan HBr,177834-92-3,F08,L1021-16,463.43,DMSO,C22H27BrN2O2S,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br,≥23.17 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,HBr,Neuroscience,5-HT Receptor,selective 5-HT1B and 5-HT1D receptor agonist,https://www.apexbt.com/search.php?catalog=B2237B2238,Escitalopram Oxalate,219861-08-2,F09,L1021-16,414.43,DMSO,C22H23FN2O5,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O,≥10.6 mg/mL in H2O; ≥2.31 mg/mL in EtOH with ultrasonic; ≥20.72 mg/mL in DMSO,Oxalate,Neuroscience,SSRIs,Selective 5-HT reuptake inhibitor,https://www.apexbt.com/search.php?catalog=B2238B2240,Olanzapine,132539-06-1,F10,L1021-16,312.43,DMSO,C17H20N4S,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,insoluble in H2O; ≥15.6 mg/mL in DMSO; ≥2.41 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Neuroscience,5-HT Receptor,Antagonist of 5-HT2A and dopamine D2 receptors,https://www.apexbt.com/search.php?catalog=B2240B2241,Ondansetron,99614-02-5,F11,L1021-16,293.36,DMSO,C18H19N3O,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,insoluble in EtOH; insoluble in H2O; ≥7.33 mg/mL in DMSO,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=B2241B2242,Urapidil HCl,64887-14-5,G01,L1021-16,423.94,DMSO,C20H29N5O3·HCl,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC.Cl,insoluble in EtOH; ≥65.3 mg/mL in DMSO; ≥10.6 mg/mL in H2O,,Neuroscience,5-HT Receptor,_1-adrenoceptor antagonist and 5-HT1A receptor agonist,https://www.apexbt.com/search.php?catalog=B2242B2243,Almotriptan Malate,181183-52-8,G02,L1021-16,469.55,DMSO,C17H25N3O2S·C4H6O5,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O,insoluble in EtOH; ≥19 mg/mL in DMSO; ≥8.5 mg/mL in H2O,Malate,Neuroscience,5-HT Receptor,5-HT1B/1D-receptor agonist,https://www.apexbt.com/search.php?catalog=B2243B2244,Atomoxetine HCl,82248-59-7,G03,L1021-16,291.82,DMSO,C17H22ClNO,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2.Cl,insoluble in H2O; ≥14.35 mg/mL in DMSO; ≥2.94 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Neuroscience,5-HT Receptor,Noradrenalin re-uptake inhibitor,https://www.apexbt.com/search.php?catalog=B2244B2246,Desvenlafaxine Succinate,386750-22-7,G04,L1021-16,381.46,DMSO,C16H25NO2·C4H6O4·H2O,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O,≥18.55 mg/mL in DMSO; ≥2.04 mg/mL in H2O with gentle warming and ultrasonic; ≥2.6 mg/mL in EtOH with gentle warming and ultrasonic,Succinate ,Neuroscience,5-HT Receptor,serotonin (5-HT) transporter and norepinephrine (NE) transporter reuptake inhibitor,https://www.apexbt.com/search.php?catalog=B2246B2248,Ketanserin,74050-98-9,G05,L1021-16,395.43,DMSO,C22H22FN3O3,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,≥39.5 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,,Neuroscience,5-HT Receptor,specific 5-HT2A serotonin receptor antagonist,https://www.apexbt.com/search.php?catalog=B2248B2249,Lamotrigine,84057-84-1,G06,L1021-16,256.09,DMSO,C9H7Cl2N5,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,insoluble in H2O; ≥12.3 mg/mL in DMSO; ≥2.18 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,5-HT inhibitor_ sodium channel blocker,https://www.apexbt.com/search.php?catalog=B2249B2251,Naratriptan,143388-64-1,G07,L1021-16,371.93,DMSO,C17H26ClN3O2S,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C.Cl,insoluble in H2O; ≥61.1 mg/mL in DMSO; ≥2.77 mg/mL in EtOH with gentle warming and ultrasonic,,Neuroscience,5-HT Receptor,selective 5-HT1 receptor subtype agonist,https://www.apexbt.com/search.php?catalog=B2251B2252,Paroxetine HCl,78246-49-8,G08,L1021-16,365.83,DMSO,C19H20FNO3·HCl,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl,insoluble in H2O; ≥17.8 mg/mL in EtOH; ≥18.29 mg/mL in DMSO,Hydrochloride,Neuroscience,AChR,Antidepressant agents,https://www.apexbt.com/search.php?catalog=B2252B2253,Prucalopride,179474-81-8,G09,L1021-16,367.87,DMSO,C18H26ClN3O3,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,insoluble in H2O; ≥18.39 mg/mL in DMSO; ≥2.68 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Neuroscience,5-HT Receptor,5-HT4A and 5-HT4B receptor agonist,https://www.apexbt.com/search.php?catalog=B2253B2257,Sertraline HCl,79559-97-0,G10,L1021-16,342.69,DMSO,C17H18Cl3N,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,insoluble in H2O; ≥17.13 mg/mL in DMSO; ≥2.36 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Neuroscience,SSRIs,selective serotonin re-uptake inhibitor (SSRI),https://www.apexbt.com/search.php?catalog=B2257B2258,Tropisetron,105826-92-4,G11,L1021-16,320.81,DMSO,C17H21ClN2O2,O=C(O[[C@H]1C[[C@@H]2CC[[C@H](C1)N2C)[[C@@H]3C4=C(N=C3)C=CC=C4.Cl,≥28.4 mg/mL in DMSO; insoluble in EtOH; ≥9.7 mg/mL in H2O,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=B2258B2261,Zolmitriptan,139264-17-8,H01,L1021-16,287.36,DMSO,C16H21N3O2,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,insoluble in H2O; ≥14.37 mg/mL in DMSO; ≥28.55 mg/mL in EtOH,Free Base,Neuroscience,5-HT Receptor,Potent 5-HT1B/1D/1F agonist,https://www.apexbt.com/search.php?catalog=B2261B2262,Agomelatine,138112-76-2,H02,L1021-16,243.3,DMSO,C15H17NO2,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,insoluble in H2O; ≥117.6 mg/mL in EtOH; ≥12.17 mg/mL in DMSO,Free Base,Neuroscience,5-HT Receptor,MT1/MT2 / 5-HT2C agonist,https://www.apexbt.com/search.php?catalog=B2262B2264,Dapoxetine HCl,129938-20-1,H03,L1021-16,341.87,DMSO,C21H23NO·HCl,CN(C)C(CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3.Cl,≥17.09 mg/mL in DMSO; ≥39.6 mg/mL in H2O; ≥55 mg/mL in EtOH,Hydrochloride,Neuroscience,5-HT Receptor,Selective serotonin reuptake inhibitor,https://www.apexbt.com/search.php?catalog=B2264B2266,"LDE225 (NVP-LDE225,Erismodegib)",956697-53-3,H04,L1021-16,485.5,DMSO,C26H26F3N3O3,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,≥24.3 mg/mL in DMSO; insoluble in H2O; ≥23 mg/mL in EtOH with ultrasonic,Free Base,Stem Cell,Smoothened,"Smoothened inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=B2266B2267,Ambroxol HCl,23828-92-4,H05,L1021-16,414.56,DMSO,C13H18Br2N2O·HCl,C1CC(CCC1NCC2=CC(=CC(=C2N)Br)Br)O.Cl,insoluble in EtOH; ≥164.6 mg/mL in DMSO; ≥6.03 mg/mL in H2O with ultrasonic,,Membrane Transporter/Ion Channel,Sodium Channel,TTX-resistant Na+ currents inhibitor,https://www.apexbt.com/search.php?catalog=B2267B2268,Amiloride HCl dihydrate,17440-83-4,H06,L1021-16,302.12,DMSO,C6H8ClN7O·HCl·2H2O,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.O.O.Cl,insoluble in EtOH; insoluble in H2O; ≥14.05 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,potent epithelial sodium channel (ENaC) blocker,https://www.apexbt.com/search.php?catalog=B2268B2270,Ouabain,630-60-4,H07,L1021-16,728.77,DMSO,C29H44O12·8H2O,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,≥72.9 mg/mL in DMSO,,Membrane Transporter/Ion Channel,Sodium Channel,selective Na+/K+-ATPase inhibitor,https://www.apexbt.com/search.php?catalog=B2270B2271,Phenytoin,57-41-0,H08,L1021-16,252.27,DMSO,C15H12N2O2,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,insoluble in H2O; ≥11 mg/mL in DMSO; ≥3.44 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,inactive voltage-gated sodium channel stabilizer,https://www.apexbt.com/search.php?catalog=B2271B2272,Phenytoin sodium,630-93-3,H09,L1021-16,274.25,DMSO,C15H11N2NaO2,C1=CC=C(C=C1)C2(C(=O)NC(=N2)[O-])C3=CC=CC=C3.[Na+],insoluble in H2O; insoluble in EtOH; ≥11.55 mg/mL in DMSO,Sodium Salt,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel stabilizer,https://www.apexbt.com/search.php?catalog=B2272B2274,Proparacaine HCl,5875-06-9,H10,L1021-16,330.85,DMSO,C16H26N2O3·HCl,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl,insoluble in EtOH; ≥14.9 mg/mL in DMSO; ≥17.73 mg/mL in H2O with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,voltage-gated sodium channels antagonist,https://www.apexbt.com/search.php?catalog=B2274B2275,Triamterene,396-01-0,H11,L1021-16,253.26,DMSO,C12H11N7,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,insoluble in EtOH; insoluble in H2O; ≥7.85 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B2275B2276,Vinpocetine,42971-09-5,A01,L1021-17,350.45,DMSO,C22H26N2O2,O=C(C(N1C2=C(C3=C([H])C([H])=C([H])C([H])=C13)C([H])([H])C4([H])[H])=C([H])[[C@H@]5(C([H])([H])C([H])([H])[H])[[C@H]2([H])N4C([H])([H])C([H])([H])C5([H])[H])OC([H])([H])C([H])([H])[H],≥2.59 mg/mL in H2O with gentle warming and ultrasonic; ≥2.99 mg/mL in EtOH with ultrasonic; ≥5.83 mg/mL in DMSO,Free Base,Metabolism,PDE,PDE inhibitor,https://www.apexbt.com/search.php?catalog=B2276B2278,Ibutilide Fumarate,122647-32-9,A02,L1021-17,885.23,DMSO,(C20H36N2O3S)2·C4H4O4,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O,≥25.6 mg/mL in DMSO; ≥16.4 mg/mL in H2O with ultrasonic; ≥2.69 mg/mL in EtOH with ultrasonic,Fumarate,Membrane Transporter/Ion Channel,Sodium Channel,Class III antiarrhythmic agent,https://www.apexbt.com/search.php?catalog=B2278B2279,Oxcarbazepine,28721-07-5,A03,L1021-17,252.27,DMSO,C15H12N2O2,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,insoluble in H2O; insoluble in EtOH; ≥9.1 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,BTX inhibitor,https://www.apexbt.com/search.php?catalog=B2279B2280,Rufinamide,106308-44-5,A04,L1021-17,238.19,DMSO,C10H8F2N4O,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,insoluble in H2O; insoluble in EtOH; ≥11.25 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,GABA Receptor,voltage-gated sodium channel blocker,https://www.apexbt.com/search.php?catalog=B2280B2281,Propafenone HCl,34183-22-7,A05,L1021-17,377.9,DMSO,C21H27NO3·HCl,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl,insoluble in H2O; ≥18.6 mg/mL in DMSO; ≥2.99 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,classic anti-arrhythmic medication,https://www.apexbt.com/search.php?catalog=B2281B2283,Niclosamide,50-65-7,A06,L1021-17,327.12,DMSO,C13H8Cl2N2O4,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,insoluble in H2O; ≥12.75 mg/mL in EtOH with gentle warming; ≥8.2 mg/mL in DMSO with gentle warming and ultrasonic,,JAK/STAT Signaling,STAT,Inhibitor of the STAT3 signaling pathway,https://www.apexbt.com/search.php?catalog=B2283B2284,Fostamatinib (R788),901119-35-5,A07,L1021-17,580.46,DMSO,C23H26FN6O9P,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,insoluble in H2O; ≥100.4 mg/mL in DMSO; ≥3.05 mg/mL in EtOH with gentle warming and ultrasonic,,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),Spleen tyrosine kinase (Syk) inhibitor,https://www.apexbt.com/search.php?catalog=B2284B2285,Daunorubicin HCl,23541-50-6,A08,L1021-17,563.98,DMSO,C27H30ClNO10,Cl[H].O=C(C([H])([H])[H])[[C@H@](C([H])([H])[[C@H]1([H])O[[C@H](C([H])([H])[[C@H]2([H])N([H])[H])([H])O[[C@H](C([H])([H])[H])([H])[[C@H@]2([H])O[H])(C([H])([H])C3=C1C(O[H])=C(C(C4=C5C([H])=C([H])C([H])=C4OC([H])([H])[H])=O)C(C5=O)=C3O[H])O[H],≥28.2 mg/mL in DMSO; insoluble in H2O; ≥2.07 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Microbiology & Virology,Antibiotic,DNA topoisomerase II inhibitor,https://www.apexbt.com/search.php?catalog=B2285B2288,Pirfenidone,53179-13-8,A09,L1021-17,185.22,DMSO,C12H11NO,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,≥36 mg/mL in EtOH; ≥38.4 mg/mL in DMSO; ≥7.68 mg/mL in H2O with gentle warming,Free Base,TGF-_ / Smad Signaling,SMAD,TGF-_ production inhibitor,https://www.apexbt.com/search.php?catalog=B2288B2291,Pefloxacin Mesylate Dihydrate,149676-40-4,A10,L1021-17,465.49,DMSO,C18H28FN3O8S,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O.O.O,insoluble in EtOH; ≥11.28 mg/mL in DMSO with gentle warming; ≥33.1 mg/mL in H2O,,Microbiology & Virology,Antibiotic,third generation of fluoroquinolone class of antibacterials,https://www.apexbt.com/search.php?catalog=B2291B2292,Flumequine,42835-25-6,A11,L1021-17,261.25,DMSO,C14H12FNO3,FC1=C([H])C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])C2([H])[H],insoluble in EtOH; insoluble in H2O; ≥9.35 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,Topoisomerase,DNA topoisomerase II inhibitor_synthetic chemotherapeutic antibiotic,https://www.apexbt.com/search.php?catalog=B2292B2293,Irinotecan HCl Trihydrate,136572-09-3,B01,L1021-17,677.18,DMSO,C33H45ClN4O9,O=C(N1CCC(CC1)N2CCCCC2)OC3=CC4=C(CC)C5=C(C(N6C5)=CC(C7(CC)O)=C(COC7=O)C6=O)N=C4C=C3.Cl.O.O.O,≥23.1 mg/mL in DMSO; insoluble in EtOH; ≥2.5 mg/mL in H2O with gentle warming and ultrasonic,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor,https://www.apexbt.com/search.php?catalog=B2293B2295,Pirarubicin,72496-41-4,B02,L1021-17,627.64,DMSO,C32H37NO12,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)OC6CCCCO6,insoluble in H2O; insoluble in EtOH; ≥7.65 mg/mL in DMSO,,DNA Damage/DNA Repair,Topoisomerase,,https://www.apexbt.com/search.php?catalog=B2295B2296,Topotecan HCl,119413-54-6,B03,L1021-17,457.91,DMSO,C23H24ClN3O5,Cl[H].O=C1N(C([H])([H])C2=C([H])C(C(C([H])([H])N(C([H])([H])[H])C([H])([H])[H])=C3O[H])=C(C([H])=C3[H])N=C42)C4=C([H])C([[C@H@](C([H])([H])C([H])([H])[H])5O[H])=C1C([H])([H])OC5=O,≥22.9 mg/mL in DMSO; insoluble in EtOH; ≥2.14 mg/mL in H2O with gentle warming and ultrasonic,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor,https://www.apexbt.com/search.php?catalog=B2296B2300,Tolvaptan,150683-30-0,B04,L1021-17,448.94,DMSO,C26H25ClN2O3,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,insoluble in H2O; ≥17.8 mg/mL in DMSO; ≥2.71 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Vasopressin Receptor,AVP V2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B2300B3209,Triapine,200933-27-3,B06,L1021-17,195.24,DMSO,C7H9N5S,C1=CC(=C(N=C1)C=NNC(=S)N)N,≥83.33 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,DNA Damage/DNA Repair,DNA Synthesis,Ribonucleotide reductase inhibitor,https://www.apexbt.com/search.php?catalog=B3209B3225,BAF312 (Siponimod),1230487-00-9,B07,L1021-17,516.6,DMSO,C29H35F3N2O3,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,insoluble in EtOH; insoluble in H2O; ≥194.8 mg/mL in DMSO,,GPCR/G protein,S1P receptor,"S1P agonist,potent and selective",https://www.apexbt.com/search.php?catalog=B3225B3234,Betrixaban,330942-05-7,B08,L1021-17,451.91,DMSO,C23H22ClN5O3,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,≥45.2 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Metabolism,Factor Xa,,https://www.apexbt.com/search.php?catalog=B3234B3255,Meisoindigo,97207-47-1,B09,L1021-17,276.29,DMSO,C17H12N2O2,CN1C2=CC=CC=C2C(=C3C4=CC=CC=C4NC3=O)C1=O,insoluble in H2O; insoluble in EtOH; ≥25.85 mg/mL in DMSO with ultrasonic,#N/A,Apoptosis,Apoptosis Inducers,Apoptosis inducer;potential agent for AML,https://www.apexbt.com/search.php?catalog=B3255B3263,Ipragliflozin,761423-87-4,B10,L1021-17,404.45,DMSO,C21H21FO5S,C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)F,insoluble in H2O; ≥63.4 mg/mL in EtOH; ≥72.7 mg/mL in DMSO,#N/A,,,SGLT2 inhibitor,https://www.apexbt.com/search.php?catalog=B3263B3267,AHU-377 hemicalcium salt,1369773-39-6,B11,L1021-17,430.52,DMSO,C24H28Ca0·5NO5,O=C(OCC)[[C@@H](C)C[[C@@H](NC(CCC([O-])=O)=O)CC1=CC=C(C2=CC=CC=C2)C=C1.[0.5Ca2+],≥17.9 mg/mL in DMSO; ≥20.95 mg/mL in H2O with gentle warming and ultrasonic; ≥21.35 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,Neprilysin,,https://www.apexbt.com/search.php?catalog=B3267B3283,PF-04449913,1095173-27-5,C01,L1021-17,374.44,DMSO,C21H22N6O,N#CC1=CC=C(NC(N[[C@@H]2CCN(C)[[C@@H](C3=NC4=CC=CC=C4N3)C2)=O)C=C1,insoluble in H2O; insoluble in EtOH; ≥20.15 mg/mL in DMSO,,Stem Cell,Smoothened,,https://www.apexbt.com/search.php?catalog=B3283B3290,Lisinopril dihydrate,83915-83-7,C02,L1021-17,441.52,H2O,C21H35N3O7,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O.O.O,<2.69 mg/mL in H2O insoluble in; insoluble in DMSO; insoluble in EtOH,,Endocrinology and Hormones,RAAS,ACE inhibitor,https://www.apexbt.com/search.php?catalog=B3290B3300,Cromolyn sodium,15826-37-6,C03,L1021-17,512.33,DMSO,C23H14Na2O11,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+],insoluble in EtOH; insoluble in H2O; ≥5.12 mg/mL in DMSO,,Membrane Transporter/Ion Channel,Calcium Channel,Mast cell membrane stabilizer,https://www.apexbt.com/search.php?catalog=B3300B3301,Sulfadimethoxine,122-11-2,C04,L1021-17,310.33,DMSO,C12H14N4O4S,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,insoluble in H2O; ≥13.6 mg/mL in DMSO; insoluble in EtOH,Free Base,Microbiology & Virology,Anti-infection,Antimicrobial agent,https://www.apexbt.com/search.php?catalog=B3301B3304,ATP disodium salt,987-65-5,C05,L1021-17,551.14,H2O,C10H14N5Na2O13P3,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)([O-])[O-])O)O.[Na+].[Na+],insoluble in DMSO; ≥19 mg/mL in H2O; insoluble in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=B3304B3308,Memantine hydrochloride,41100-52-1,C06,L1021-17,215.76,DMSO,C12H22ClN,CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl,≥12.59 mg/mL in DMSO; ≥2.46 mg/mL in EtOH; ≥9.4 mg/mL in H2O,Hydrochloride,Neuroscience,"P450, AMPA Receptor-kainate Receptor-NMDA Receptor",NMDA receptor antagonist,https://www.apexbt.com/search.php?catalog=B3308B3309,Cyproheptadine hydrochloride,969-33-5,C07,L1021-17,323.86,DMSO,C21H22ClN,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl,insoluble in H2O; ≥14.15 mg/mL in DMSO; ≥27.15 mg/mL in EtOH,Hydrochloride,Neuroscience,Histamine Receptor,serotonin and histamine antagonist as well as antimuscarinic reagent,https://www.apexbt.com/search.php?catalog=B3309B3326,Bupropion hydrochloride,31677-93-7,C08,L1021-17,276.2,DMSO,C13H19Cl2NO,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl,≥12.85 mg/mL in DMSO; ≥21.57 mg/mL in H2O; ≥52.4 mg/mL in EtOH,Hydrochloride,Neuroscience,"AChR,Dopamine Receptor",Dopamine/norepinephrine inhibitor,https://www.apexbt.com/search.php?catalog=B3326B3341,Sotalol hydrochloride,959-24-0,C09,L1021-17,308.82,DMSO,C12H21ClN2O3S,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl,≥15.44 mg/mL in DMSO; ≥2.86 mg/mL in EtOH; ≥55.7 mg/mL in H2O,,GPCR/G protein,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=B3341B3342,Spectinomycin dihydrochloride,21736-83-4,C10,L1021-17,405.27,H2O,C14H26Cl2N2O7,Cl[H].Cl[H].O=C1[[C@H]2(O[H])O[[C@H@]([[C@H@]([[C@H@]3([H])O[H])([H])N([H])C([H])([H])[H])([H])[[C@H]([[C@H@]([[C@H]3([H])N([H])C([H])([H])[H])([H])O[H])([H])O[[C@H]2([H])O[[C@H@](C([H])([H])[H])([H])C1([H])[H],insoluble in EtOH; insoluble in DMSO; ≥22.95 mg/mL in H2O,,Microbiology & Virology,Anti-infection,new parenteral antibiotic,https://www.apexbt.com/search.php?catalog=B3342B3343,Vardenafil,224785-90-4,C11,L1021-17,488.6,DMSO,C23H32N6O4S,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,≥22.5 mg/mL in DMSO; insoluble in H2O; ≥59.7 mg/mL in EtOH,Free Base,Metabolism,PDE,PDE5 inhibitor,https://www.apexbt.com/search.php?catalog=B3343B3344,Xylazine,7361-61-7,D01,L1021-17,220.33,DMSO,C12H16N2S,CC1=C(C(=CC=C1)C)NC2=NCCCS2,insoluble in EtOH; insoluble in H2O; ≥9.8 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=B3344B3361,Amoxicillin trihydrate,61336-70-7,D02,L1021-17,419.45,DMSO,C16H25N3O8S,N[[C@H](C(N[[C@H]1C(N2[[C@@H]1SC(C)(C)[[C@@H]2C(O)=O)=O)=O)C3=CC=C(O)C=C3.O.O.O,insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL in DMSO,,Microbiology & Virology,Anti-infection,Broad spectrum antibiotic,https://www.apexbt.com/search.php?catalog=B3361B3370,Arecoline hydrobromide,300-08-3,D03,L1021-17,236.11,DMSO,C8H14BrNO2,CN1CCC=C(C1)C(=O)OC.Br,≥11.81 mg/mL in DMSO; ≥2.73 mg/mL in EtOH with gentle warming and ultrasonic; ≥59.1 mg/mL in H2O,hydrobromide,Neuroscience,AChR,muscarinic acetylcholine receptor agonist,https://www.apexbt.com/search.php?catalog=B3370B3373,Dibucaine,85-79-0,D04,L1021-17,343.46,DMSO,C20H29N3O2,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,insoluble in H2O; ≥16.45 mg/mL in DMSO; ≥27.1 mg/mL in EtOH,Free Base,Others,Others,Local anesthetic,https://www.apexbt.com/search.php?catalog=B3373B3377,Ropivacaine hydrochloride monohydrate,132112-35-7,D05,L1021-17,328.88,DMSO,C17H29ClN2O2,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.O.Cl,≥10.14 mg/mL in EtOH; ≥58.6 mg/mL in DMSO; ≥9.8 mg/mL in H2O,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,"anaesthetic, long-acting and local",https://www.apexbt.com/search.php?catalog=B3377B3379,Verbascoside,61276-17-3,D06,L1021-17,624.59,DMSO,C29H36O15,CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O,insoluble in H2O; ≥30.95 mg/mL in DMSO; ≥63.6 mg/mL in EtOH,#N/A,,,PKC/NF-_B inhibitor,https://www.apexbt.com/search.php?catalog=B3379B3399,Tirapazamine,27314-97-2,D07,L1021-17,178.15,DMSO,C7H6N4O2,C1=CC=C2C(=C1)N(C(=N)N=[N+]2[O-])O,insoluble in H2O; insoluble in EtOH; ≥8.9 mg/mL in DMSO,#N/A,Others,Others,Anticancer drug,https://www.apexbt.com/search.php?catalog=B3399B3404,Methylcobalamin,13422-55-4,D08,L1021-17,1344.38,DMSO,C63H91CoN13O14P+,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],≥53.5 mg/mL in DMSO; insoluble in H2O; ≥2.75 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,a form of vitamin B12,https://www.apexbt.com/search.php?catalog=B3404B3407,Dexrazoxane,24584-09-6,D09,L1021-17,268.27,DMSO,C11H16N4O4,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,insoluble in H2O; insoluble in EtOH; ≥12 mg/mL in DMSO,Free Base,Others,Others,cardioprotective agent,https://www.apexbt.com/search.php?catalog=B3407B3409,Ketorolac,74103-06-3,D10,L1021-17,255.27,DMSO,C15H13NO3,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,insoluble in EtOH; ≥12.76 mg/mL in DMSO; ≥43.2 mg/mL in H2O,#N/A,Neuroscience,COX,non-selective COX inhibitor,https://www.apexbt.com/search.php?catalog=B3409B3411,Latanoprost,130209-82-4,D11,L1021-17,432.59,DMSO,C26H40O5,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,≥43.3 mg/mL in DMSO; ≥10.12 mg/mL in H2O with ultrasonic; ≥45.5 mg/mL in EtOH,,Others,Others,FP prostaglandin receptor agonist,https://www.apexbt.com/search.php?catalog=B3411B3431,Amikacin,37517-28-5,E01,L1021-17,585.6,H2O,C22H43N5O13,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,insoluble in EtOH; insoluble in DMSO; ≥5.86 mg/mL in H2O,Free Base,Microbiology & Virology,Antibiotic,aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B3431B3433,Flavoxate hydrochloride,3717-88-2,E02,L1021-17,427.92,DMSO,C24H26ClNO4,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl,insoluble in H2O; insoluble in EtOH; ≥7.13 mg/mL in DMSO with gentle warming,Hydrochloride,Neuroscience,AChR,muscarinic AChR antagonist,https://www.apexbt.com/search.php?catalog=B3433B3435,Procaine,59-46-1,E03,L1021-17,236.31,DMSO,C13H20N2O2,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,insoluble in EtOH; ≥17 mg/mL in H2O; ≥8.7 mg/mL in DMSO with gentle warming,Free Base,Others,Others,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B3435B3436,Ouabain Octahydrate,11018-89-6,E04,L1021-17,728.77,DMSO,C29H60O20,O[[C@H]1[[C@@H](O)[[C@H](O[[C@@H]2C[[C@H]3(O)[[C@H@]([[C@H](O)C2)(CO)[[C@H]4([H])[[C@H@]([[C@H](CC[[C@@H]5C6=CC(OC6)=O)(O)[[C@H]5(C)C[[C@H]4O)([H])CC3)O[[C@@H](C)[[C@@H]1O,≥19.5 mg/mL in H2O with gentle warming and ultrasonic,,Others,Others,selective Na+/K+-ATPase inhibitor,https://www.apexbt.com/search.php?catalog=B3436B3439,Udenafil,268203-93-6,E05,L1021-17,516.66,DMSO,C25H36N6O4S,CCCC(C(N=C(N1)C2=C(OCCC)C=CC(S(NCCC3CCCN3C)(=O)=O)=C2)=C4C1=O)=NN4C,insoluble in H2O; ≥117.2 mg/mL in DMSO; ≥22.48 mg/mL in EtOH with ultrasonic,#N/A,Metabolism,PDE,PDE5 inhibitor,https://www.apexbt.com/search.php?catalog=B3439B3440,Nicergoline,27848-84-6,E06,L1021-17,484.39,DMSO,C24H26BrN3O3,CN1C=C2C[[C@H]3([H])[[C@H](C4=C2C1=CC=C4)(OC)C[[C@H](COC(C5=CC(Br)=CN=C5)=O)([H])CN3C,insoluble in H2O; ≥32.2 mg/mL in EtOH; ≥52.6 mg/mL in DMSO,,GPCR/G protein,Adenosine Receptor,vasodilator,https://www.apexbt.com/search.php?catalog=B3440B3443,Tiagabine hydrochloride,145821-59-6,E07,L1021-17,412.01,DMSO,C20H26ClNO2S2,CC(C=CS1)=C1/C(C2=C(C=CS2)C)=C/CCN3CCC[[C@H](C(O)=O)([H])C3.Cl,≥16.6 mg/mL in DMSO; ≥20.95 mg/mL in H2O; ≥21.35 mg/mL in EtOH,Free Base,Neuroscience,GABA Receptor,GABA uptake inhibitor,https://www.apexbt.com/search.php?catalog=B3443B3448,Dapsone,80-08-0,E08,L1021-17,248.3,DMSO,C12H12N2O2S,NC1=CC=C(S(C2=CC=C(N)C=C2)(=O)=O)C=C1,insoluble in H2O; ≥8.17 mg/mL in EtOH with ultrasonic; ≥8.35 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,sulfone antibiotic,https://www.apexbt.com/search.php?catalog=B3448B3449,Warfarin,81-81-2,E09,L1021-17,308.33,DMSO,C19H16O4,CC(CC(C1=C(O)C2=CC=CC=C2OC1=O)C3=CC=CC=C3)=O,≥30.8 mg/mL in Etoh with gentle warming; insoluble in H2O; ≥24.7 mg/mL in DMSO,,Others,Others,anticoagulant drug,https://www.apexbt.com/search.php?catalog=B3449B3455,Metaxalone,1665-48-1,E10,L1021-17,221.25,DMSO,C12H15NO3,CC1=CC(C)=CC(OCC(O2)CN=C2O)=C1,insoluble in H2O; ≥17.93 mg/mL in EtOH with ultrasonic; ≥9.75 mg/mL in DMSO,Free Base,Others,Others,muscle relaxant,https://www.apexbt.com/search.php?catalog=B3455B3460,Balsalazide,80573-04-2,E11,L1021-17,357.32,DMSO,C17H15N3O6,OC1=C(C(O)=O)C=C(/N=N/C2=CC=C(C(NCCC(O)=O)=O)C=C2)C=C1,insoluble in EtOH; ≥13.9 mg/mL in DMSO; ≥24.55 mg/mL in H2O,Free Base,Ubiquitination/Proteasome,Interleukin Related; STAT,anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=B3460B3464,Eicosapentaenoic Acid,10417-94-4,F01,L1021-17,302.45,DMSO,C20H30O2,CC/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\CCCC(O)=O,≥116.8 mg/mL in DMSO; ≥49.3 mg/mL in H2O; ≥52.5 mg/mL in EtOH,,Immunology/Inflammation,Immunology & Inflamm,EPA_omega-3 fatty acid,https://www.apexbt.com/search.php?catalog=B3464B3465,"UK 14,304",59803-98-4,F02,L1021-17,292.13,DMSO,C11H10BrN5,BrC1=C(NC2=NCCN2)C=CC3=C1N=CC=N3,insoluble in H2O; insoluble in EtOH; ≥25.7 mg/mL in DMSO with ultrasonic,,GPCR/G protein,Adenosine Receptor,full _2-adrenergic receptor (_2-AR) agonist,https://www.apexbt.com/search.php?catalog=B3465B3466,Rabeprazole sodium,117976-90-6,F03,L1021-17,381.42,DMSO,C18H20N3NaO3S,O=S(CC1=NC=CC(OCCCOC)=C1C)C2=NC3=CC=CC=C3N2[Na],≥15.5 mg/mL in DMSO; ≥30.5 mg/mL in EtOH; ≥7.24 mg/mL in H2O with ultrasonic,Sodium,Membrane Transporter/Ion Channel,Proton Pump,proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B3466B3467,Rabeprazole,117976-89-3,F04,L1021-17,359.44,DMSO,C18H21N3O3S,CC(C(OCCCOC)=CC=N1)=C1CS(C2=NC3=CC=CC=C3N2)=O,≥11.26 mg/mL in H2O with ultrasonic; ≥12.65 mg/mL in DMSO; ≥2.62 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Proton Pump,proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B3467B3470,Etonogestrel,54048-10-1,F05,L1021-17,324.46,DMSO,C22H28O2,CC[[C@H@]1([[C@H@]([[C@H]2([H])CCC3=CC(CC[[C@H]3([H])[[C@H@]42[H])=O)([H])CC[[C@H@]1(O)C#C)CC4=C,insoluble in H2O; ≥15.05 mg/mL in DMSO; ≥2.78 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,steroidal progestin,https://www.apexbt.com/search.php?catalog=B3470B3471,Medroxyprogesterone,520-85-4,F06,L1021-17,344.49,DMSO,C22H32O3,C[[C@H@](C1=CC(CC[[C@H]21C)=O)([H])C[[C@H]([[C@H]3([H])CC[[C@H]4(O)C(C)=O)([H])[[C@H]2([H])CC[[C@H@]34C,≥34.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Endocrinology and Hormones,Estrogen/progestogen Receptor,potent progesterone receptor agonist,https://www.apexbt.com/search.php?catalog=B3471B3474,Amifostine,20537-88-6,F07,L1021-17,214.22,H2O,C5H15N2O3PS,NCCCNCCSP(O)(O)=O,insoluble in DMSO; insoluble in EtOH; ≥8.05 mg/mL in H2O,,Others,Others,cytoprotective adjuvant,https://www.apexbt.com/search.php?catalog=B3474B3477,Ciclesonide,126544-47-6,F08,L1021-17,540.69,DMSO,C32H44O7,CC(C(OCC([[C@H@]12[[C@H@](O[[C@H@](O2)([H])C3CCCCC3)([H])C[[C@H@]4([H])[[C@H]([[C@H]5([H])[[C@H](O)([H])C[[C@H@]41C)([H])CCC6=CC(C=C[[C@H@]65C)=O)=O)=O)C,insoluble in H2O; ≥15.8 mg/mL in DMSO; ≥50.6 mg/mL in EtOH,Free Base,GPCR/G protein,Glucocorticoid Receptor,glucocorticoid,https://www.apexbt.com/search.php?catalog=B3477B3480,Mafenide Acetate,13009-99-9,F09,L1021-17,246.28,DMSO,C9H14N2O4S,NCC1=CC=C(S(N)(=O)=O)C=C1.CC(O)=O,≥22.9 mg/mL in DMSO; ≥5.6 mg/mL in EtOH with ultrasonic; ≥36.7 mg/mL in H2O,,Metabolism,Carbonic Anhydrase,carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=B3480B3484,Misoprostol,59122-46-2,F10,L1021-17,382.53,DMSO,C22H38O5,CCCCC(C/C([H])=C([H])/[[C@H]1([H])[[C@H@](C(C[[C@H@]1([H])O)=O)([H])CCCCCCC(OC)=O)(O)C,insoluble in EtOH; insoluble in H2O; ≥11.05 mg/mL in DMSO,Free Base,GPCR/G protein,Prostaglandin Receptor,synthetic prostaglandin E1 (PGE1) analog,https://www.apexbt.com/search.php?catalog=B3484B3487,Eslicarbazepine acetate,236395-14-5,F11,L1021-17,296.32,DMSO,C17H16N2O3,CC(O[[C@H@]1([H])CC2=CC=CC=C2N(C(O)=N)C3=CC=CC=C31)=O,insoluble in H2O; ≥14.85 mg/mL in DMSO; ≥2.77 mg/mL in EtOH with gentle warming and ultrasonic,acetate,Others,Others,antiepileptic drug,https://www.apexbt.com/search.php?catalog=B3487B3488,Tiagabine,115103-54-3,G01,L1021-17,375.55,DMSO,C20H25NO2S2,CC(C=CS1)=C1/C(C2=C(C=CS2)C)=C/CCN3CCC[[C@H](C(O)=O)([H])C3,≥13.5 mg/mL in H2O; ≥2.46 mg/mL in EtOH with gentle warming and ultrasonic; ≥9.4 mg/mL in DMSO,Free Base,Neuroscience,GABA Receptor,selective gamma-aminobutyric acid (GABA) reuptake inhibitor,https://www.apexbt.com/search.php?catalog=B3488B3489,Carmustine,154-93-8,G02,L1021-17,214.05,DMSO,C5H9Cl2N3O2,ClCC/N=C(O)/N(N=O)CCCl,insoluble in H2O; ≥21.51 mg/mL in DMSO; ≥27.15 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA Alkylating,cell-cycle phase nonspecific alkylating antineoplastic agent,https://www.apexbt.com/search.php?catalog=B3489B3490,Eptifibatide,188627-80-7,G03,L1021-17,831.96,DMSO,C35H49N11O9S2,O=C([[C@H@](C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12)([H])N([H])C([[C@H@](C([H])([H])C(O[H])=O)([H])N([H])C(C([H])([H])N([H])C3=O)=O)=O)N4[[C@H@](C(N([H])[[C@H@](C(N([H])[H])=O)([H])C([H])([H])SSC([H])([H])C([H])([H])C(N([H])[[C@H@]3([H])C([H])([H,≥28.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Angiogenesis,Integrin,Glycoprotein (GP) IIb/IIIa inhibitor,https://www.apexbt.com/search.php?catalog=B3490B3491,Bedaquiline fumarate,845533-86-0,G04,L1021-17,671.58,DMSO,C36H35BrN2O6,CN(CC[[C@H@]([[C@H](C1=CC2=CC(Br)=CC=C2N=C1OC)([H])C3=CC=CC=C3)(O)C4=CC=CC5=CC=CC=C54)C.O=C(O)/C([H])=C([H])/C(O)=O,≥23.45 mg/mL in DMSO; insoluble in H2O; ≥2.24 mg/mL in EtOH with gentle warming and ultrasonic,fumarate,Microbiology & Virology,Antibiotic,anti-tuberculosis drug,https://www.apexbt.com/search.php?catalog=B3491B3492,Bedaquiline,843663-66-1,G05,L1021-17,525.5,DMSO,C31H29BrN2O,CN(C)CC[[C@H@]([[C@H](C1=CC=CC=C1)C2=CC3=CC(Br)=CC=C3N=C2)(O)C4=CC=CC5=C4C=CC=C5,≥22.05 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,Free Base,Microbiology & Virology,Antibiotic,anti-tuberculosis drug,https://www.apexbt.com/search.php?catalog=B3492B3494,Sarpogrelate hydrochloride,135159-51-2,G06,L1021-17,465.97,DMSO,C24H32ClNO6,O=C(CCC(O)=O)OC(CN(C)C)COC1=CC=CC=C1CCC2=CC(OC)=CC=C2.Cl,≥23.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,GPCR/G protein,5-HT Receptor,5-HT2A receptor inhibitor,https://www.apexbt.com/search.php?catalog=B3494B3505,Diclofenac,15307-86-5,G07,L1021-17,296.15,DMSO,C14H11Cl2NO2,ClC1=C(NC2=CC=CC=C2CC(O)=O)C(Cl)=CC=C1,insoluble in H2O; ≥14.81 mg/mL in DMSO; ≥18.87 mg/mL in EtOH,Free Base,Neuroscience,COX,non-selective COX inhibitor,https://www.apexbt.com/search.php?catalog=B3505B3513,Ademetionine,29908-03-0,G08,L1021-17,398.44,DMSO,C15H22N6O5S,C[S+](C[[C@H](O1)([H])[[C@H](O)([H])[[C@H](O)([H])[[C@H]1([H])N2C=NC(C2=NC=N3)=C3N)CC[[C@H@](N)([H])C([O-])=O,insoluble in EtOH; ≥108 mg/mL in H2O; ≥110.8 mg/mL in DMSO,,Others,Others,"S-adenosylmethionine, PDE4B inhibitor",https://www.apexbt.com/search.php?catalog=B3513B3518,Alcaftadine,147084-10-4,G09,L1021-17,307.39,DMSO,C19H21N3O,CN1CC/C(CC1)=C2C3=CC=CC=C3CCN4C(C=O)=CN=C/24,insoluble in H2O; ≥15.37 mg/mL in DMSO; ≥9.1 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,H1 histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B3518B3519,Cefepime Dihydrochloride Monohydrate,123171-59-5,G10,L1021-17,570.5,DMSO,C20H29Cl2N5O6S2,NC1=NC(/C(C(N[[C@H]2[[C@H]3([H])C(C(C([O-])=O)=C(C[N+]4(C)CCCC4)CS3)C2=O)=O)=N/OC)=CS1.Cl.Cl.O,≥57.1 mg/mL in DMSO; insoluble in EtOH; ≥30.2 mg/mL in H2O,,Microbiology & Virology,Antibiotic,broad-spectrum cephalosporin,https://www.apexbt.com/search.php?catalog=B3519B3525,Chlorhexidine digluconate,18472-51-0,G11,L1021-17,897.76,DMSO,C34H54Cl2N10O14,ClC1=CC=C(NC(NC(NCCCCCCNC(NC(NC2=CC=C(Cl)C=C2)=N)=N)=N)=N)C=C1.OC[[C@H](O)([H])[[C@H](O)([H])[[C@H@](O)([H])[[C@H](O)([H])C(O)=O.OC[[C@H](O)([H])[[C@H](O)([H])[[C@H@](O)([H])[[C@H](O)([H])C(O)=O,≥36.4 mg/mL in DMSO; insoluble in EtOH; ≥45.7 mg/mL in H2O,Free Base,Microbiology & Virology,Antibiotic,antiseptic,https://www.apexbt.com/search.php?catalog=B3525B3527,Nitisinone,104206-65-7,H01,L1021-17,329.23,DMSO,C14H10F3NO5,FC(F)(F)C1=CC(N(=O)=O)=C(C(C2C(CCCC2=O)=O)=O)C=C1,insoluble in H2O; ≥13.55 mg/mL in DMSO; ≥2.62 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Others,Others,inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase,https://www.apexbt.com/search.php?catalog=B3527B3530,4-Aminopyridine,504-24-5,H02,L1021-17,94.11,H2O,C5H6N2,NC1=CC=NC=C1,≥11.54 mg/mL in EtOH; ≥12.46 mg/mL in DMSO with ultrasonic; ≥6 mg/mL in H2O,,Membrane Transporter/Ion Channel,Potassium Channel,potassium channel-blocking agent,https://www.apexbt.com/search.php?catalog=B3530B3532,Acetaminophen,103-90-2,H03,L1021-17,151.16,DMSO,C8H9NO2,C/C(O)=N/C1=CC=C(O)C=C1,insoluble in H2O; ≥29.4 mg/mL in EtOH; ≥7.56 mg/mL in DMSO,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B3532B3538,Iohexol,66108-95-0,H04,L1021-17,821.14,DMSO,C19H26I3N3O9,CC(N(C1=C(I)C(/C(O)=N/CC(O)CO)=C(I)C(/C(O)=N/CC(O)CO)=C1I)CC(O)CO)=O,≥31.85 mg/mL in DMSO; ≥2.52 mg/mL in EtOH with ultrasonic; ≥48.8 mg/mL in H2O,Free Base,Ubiquitination/Proteasome,Autophagy; Mitophagy,contrast agent,https://www.apexbt.com/search.php?catalog=B3538B3539,Ceftazidime,72558-82-8,H05,L1021-17,546.58,DMSO,C22H22N6O7S2,CC(C([O-])=O)(O/N=C(\C(O)=N\[[C@H]([[C@H]1([H])N2C(C(O)=O)=C(CS1)C[N+]3=CC=CC=C3)([H])C2=O)C(N4)=CSC4=N)C,≥21.25 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Microbiology & Virology,Antibiotic,third-generation cephalosporin,https://www.apexbt.com/search.php?catalog=B3539B3540,Trandolapril,87679-37-6,H06,L1021-17,430.54,DMSO,C24H34N2O5,O=C([[C@@H](N[[C@H](C(OCC)=O)CCC1=CC=CC=C1)C)N2[[C@H](C(O)=O)C[[C@H@]3([H])CCCC[[C@H@]32[H],insoluble in H2O; ≥10.92 mg/mL in EtOH with ultrasonic; ≥9.65 mg/mL in DMSO,Free Base,Proteases,ACE,angiotensin-converting enzyme (ACE) inhibitor,https://www.apexbt.com/search.php?catalog=B3540B3542,Tetrabenazine,58-46-8,H07,L1021-17,317.42,DMSO,C19H27NO3,CC(CC1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1=O)C,insoluble in H2O; ≥9 mg/mL in DMSO; ≥9.36 mg/mL in EtOH with ultrasonic,,Neuroscience,Dopamine Receptor,VMAT-inhibitor,https://www.apexbt.com/search.php?catalog=B3542B3553,GS-9973,1229208-44-9,H08,L1021-17,411.46,DMSO,C23H21N7O,C12=NC=CN1C=C(C3=CC=C(C=NN4)C4=C3)N=C2NC5=CC=C(N6CCOCC6)C=C5,insoluble in EtOH; insoluble in H2O; ≥20.55 mg/mL in DMSO,Free Base,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),"Syk inhibitor, orally bioavailable and selective",https://www.apexbt.com/search.php?catalog=B3553B3608,Crizotinib hydrochloride,1415560-69-8,H09,L1021-17,486.8,DMSO,C21H23Cl3FN5O,C[[C@H](OC(C=C(C(C=N1)=CN1C2CCNCC2)C=N3)=C3N)([H])C4=C(Cl)C=CC(F)=C4Cl.Cl,≥100.4 mg/mL in DMSO; ≥101.4 mg/mL in EtOH; ≥52.2 mg/mL in H2O,,Tyrosine Kinase,ALK,inhibitor of the c-Met kinase and the NPM-ALK,https://www.apexbt.com/search.php?catalog=B3608B3610,Clofibrate,637-07-0,H10,L1021-17,242.7,DMSO,C12H15ClO3,ClC1=CC=C(C=C1)OC(C)(C)C(OCC)=O,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥114.2 mg/mL in EtOH,,Metabolism,PPAR,PPAR agonist,https://www.apexbt.com/search.php?catalog=B3610B3611,Moxidectin,113507-06-5,H11,L1021-17,639.82,DMSO,C37H53NO8,CC(/C([H])=C([[C@H](O1)([H])[[C@H@](/C(C[[C@H@]21C[[C@H](O3)([H])C[[C@H@](O2)([H])C/C([H])=C(C[[C@H@](/C([H])=C([H])/C([H])=C([[C@H@]45O)\CO[[C@H]5([H])[[C@H@](O)([H])C(C)=C[[C@H@]4([H])C3=O)([H])C)\C)=N\OC)([H])C)\C)C,≥128 mg/mL in EtOH; ≥129.4 mg/mL in DMSO; ≥3.27 mg/mL in H2O with gentle warming and ultrasonic,,Microbiology & Virology,Antibiotic,anthelmintic drug,https://www.apexbt.com/search.php?catalog=B3611B3662,Artesunate,88495-63-0,A01,L1021-18,384.42,DMSO,C19H28O8,O=C(CCC(O)=O)O[[C@H]1O[[C@@H]2O[[C@H@]3(C)OO[[C@H]42[[C@@H](CC3)[[C@H](C)CC[[C@H]4[[C@H]1C,insoluble in H2O; ≥16.3 mg/mL in DMSO; ≥54.6 mg/mL in EtOH,,Others,Others,derivative of the natural product artemisinin,https://www.apexbt.com/search.php?catalog=B3662B3664,Cinchonidine,485-71-2,A02,L1021-18,294.39,DMSO,C19H22N2O,O[[C@H](C1=CC=NC2=CC=CC=C12)[[C@H]3[[C@H@]4C[[C@@H](C=C)[[C@@H](CC4)C3,insoluble in H2O; ≥14.9 mg/mL in EtOH; ≥17.33 mg/mL in DMSO,,Others,Others,alkaloid,https://www.apexbt.com/search.php?catalog=B3664B3668,Sodium Monensin,22373-78-0,A03,L1021-18,692.85,EtOH,C36H61NaO11,O[[C@H]1C[[C@H]2(O[[C@H]([[C@H](C)[[C@@H]([[C@@H](C([O-])=O)C)OC)[[C@@H]1C)O[[C@H@](CC2)(C)[[C@@H]3O[[C@H](CC3)(CC)[[C@H]4O[[C@H]([[C@H]([[C@@H](C)C[[C@H]5C)O[[C@H]5(CO)O)C[[C@H]4C.[Na+],insoluble in H2O; insoluble in DMSO; ≥69.3 mg/mL in EtOH with ultrasonic,,Others,Others,naturally polyether ionophore antibiotic,https://www.apexbt.com/search.php?catalog=B3668B3674,Hypoxanthine,68-94-0,A04,L1021-18,136.11,DMSO,C5H4N4O,O=C1N=CNC2=C1NC=N2,insoluble in EtOH; insoluble in H2O; ≥1.36 mg/mL in DMSO with ultrasonic; ≥5.89 mg/mL in EtOH with ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=B3674B3676,Rotundine,483-14-7,A05,L1021-18,355.43,DMSO,C21H25NO4,COC1=CC=C2C(CN3CCC4=CC(OC)=C(C=C4[[C@H@]3(C2)[H])OC)=C1OC,insoluble in H2O; ≥16 mg/mL in DMSO; ≥2.95 mg/mL in EtOH with gentle warming and ultrasonic,,Neuroscience,Dopamine Receptor,"Dopamine D1 receptor antagonist,potent and selective",https://www.apexbt.com/search.php?catalog=B3676B3677,Inosine,58-63-9,A06,L1021-18,268.23,DMSO,C10H12N4O5,O[[C@H]1[[C@H](N2C(NC=NC3=O)=C3N=C2)O[[C@H](CO)[[C@H]1O,insoluble in EtOH; ≥13.4 mg/mL in DMSO with gentle warming; ≥4.5 mg/mL in H2O with ultrasonic,,Others,Others,endogenous purine nucleoside,https://www.apexbt.com/search.php?catalog=B3677B3679,Vanillin,121-33-5,A07,L1021-18,152.15,DMSO,C8H8O3,OC1=C(C=C(C=O)C=C1)OC,insoluble in H2O; ≥31.1 mg/mL in DMSO; ≥41.3 mg/mL in EtOH,,Others,Others,flavorant,https://www.apexbt.com/search.php?catalog=B3679B3680,Griseofulvin,126-07-8,A08,L1021-18,352.77,DMSO,C17H17ClO6,ClC(C(O[[C@H]1(C(OC)=C2)[[C@H](C)CC2=O)=C(C(OC)=C3)C1=O)=C3OC,insoluble in EtOH; insoluble in H2O; ≥10.45 mg/mL in DMSO,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule associated inhibitor,https://www.apexbt.com/search.php?catalog=B3680B3681,Cyromazine,66215-27-8,A09,L1021-18,166.18,DMSO,C6H10N6,NC1=NC(NC2CC2)=NC(N)=N1,insoluble in H2O; ≥2.3 mg/mL in EtOH with gentle warming and ultrasonic; ≥5.7 mg/mL in DMSO,Free base,Others,Others,"insecticide, acaricide",https://www.apexbt.com/search.php?catalog=B3681B3709,Midostaurin (PKC412),120685-11-2,A10,L1021-18,570.64,DMSO,C35H30N4O4,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,≥57.1 mg/mL in DMSO with ultrasonic; insoluble in H2O; ≥1.8 mg/mL in EtOH with gentle warming and ultrasonic,,TGF-_ / Smad Signaling,PKC,PKC inhibitor,https://www.apexbt.com/search.php?catalog=B3709B3716,Chlorambucil,305-03-3,A11,L1021-18,304.21,DMSO,C14H19Cl2NO2,ClCCN(CCCl)C(C=C1)=CC=C1CCCC(O)=O,insoluble in H2O; ≥12.15 mg/mL in DMSO; ≥17.7 mg/mL in EtOH,Free Base,Others,Others,nitrogen mustard alkylating agent,https://www.apexbt.com/search.php?catalog=B3716B3742,Thio-TEPA,52-24-4,B01,L1021-18,189.22,DMSO,C6H12N3PS,S=P(N1CC1)(N2CC2)N3CC3,insoluble in H2O; ≥54.3 mg/mL in EtOH with ultrasonic; ≥7.5 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA Alkylating,alkylating agent used to treat cancer,https://www.apexbt.com/search.php?catalog=B3742B4620,Losmapimod,585543-15-3,B02,L1021-18,383.46,DMSO,C22H26FN3O2,FC1=C(C)C(C(C=C2)=NC=C2C(NCC(C)(C)C)=O)=CC(C(NC3CC3)=O)=C1,insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL in DMSO,Free Base,MAPK Signaling,p38,"p38 MAPK inhibitor, orally active",https://www.apexbt.com/search.php?catalog=B4620B4669,Vidofludimus,717824-30-1,B03,L1021-18,355.36,DMSO,C20H18FNO4,FC1=CC(C2=CC=CC(OC)=C2)=CC=C1NC(C3=C(C(O)=O)CCC3)=O,insoluble in H2O; insoluble in EtOH; ≥103 mg/mL in DMSO,,Metabolism,Dehydrogenase,DHODH inhibitor,https://www.apexbt.com/search.php?catalog=B4669B4720,Pantoprazole,102625-70-7,B04,L1021-18,383.37,DMSO,C16H15F2N3O4S,COC1=C(OC)C(=NC=C1)C[S](=O)C2=NC3=CC=C(OC(F)F)C=C3[NH]2,≥17.95 mg/mL in DMSO; ≥29.05 mg/mL in EtOH; ≥4.17 mg/mL in H2O,Free Base,Membrane Transporter/Ion Channel,Proton Pump,H+/K+-ATPase inhibitor,https://www.apexbt.com/search.php?catalog=B4720B4721,2'-Deoxyguanosine,961-07-9,B05,L1021-18,267.24,DMSO,C10H13N5O4,NC1=NC2=C(N=C[N]2C3CC(O)C(CO)O3)C(=O)N1,insoluble in EtOH; insoluble in H2O; ≥6440 mg/mL in DMSO,,Others,Others,2'-Deoxyguanosine,https://www.apexbt.com/search.php?catalog=B4721B4723,Oxytocin,50-56-6,B06,L1021-18,1007.19,DMSO,C43H66N12O12S2,CCC(C)C1NC(=O)C(CC2=CC=C(O)C=C2)NC(=O)C(N)CSSCC(NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(N)=O.CC(O)=O,≥182.8 mg/mL in DMSO; ≥14.93 mg/mL in EtOH; ≥44.1 mg/mL in H2O,,Others,Others,mammalian neurohypophysial hormone,https://www.apexbt.com/search.php?catalog=B4723B4724,Pneumocandin B0,135575-42-7,B07,L1021-18,1065.21,DMSO,C50H80N8O17,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(O)C(O)NC(=O)C2C(O)CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(O)CN3C(=O)C(NC1=O)C(C)O)C(O)C(O)C4=CC=C(O)C=C4)C(O)CC(N)=O,insoluble in H2O; ≥56.2 mg/mL in EtOH with ultrasonic; ≥94.6 mg/mL in DMSO,#N/A,Microbiology & Virology,Antibiotic,"potent antifungal and inhibitor of ß-(1,3)-D-glucan synthesis",https://www.apexbt.com/search.php?catalog=B4724B4737,Oxybenzone,131-57-7,B08,L1021-18,228.24,DMSO,C14H12O3,COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,insoluble in H2O; ≥8.2 mg/mL in DMSO; ≥9 mg/mL in EtOH,Free Base,Others,Others,sunscreen agent,https://www.apexbt.com/search.php?catalog=B4737B4745,(S)-10-Hydroxycamptothecin,19685-09-7,B09,L1021-18,364.35,DMSO,C20H16N2O5,CC[[C@H]1(O)C(C=C2C3=C(CN2C4=O)C=C5C=C(O)C=CC5=N3)=C4COC1=O,≥23.8 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,,DNA Damage/DNA Repair,Topoisomerase,,https://www.apexbt.com/search.php?catalog=B4745B4748,Oxiracetam,62613-82-5,B10,L1021-18,158.16,DMSO,C6H10N2O3,N=C(O)CN1CC(O)CC1=O,insoluble in EtOH; ≥27.4 mg/mL in DMSO; ≥42.3 mg/mL in H2O,,Others,Others,cyclic derivative of gamma-aminobutyric acid (GABA),https://www.apexbt.com/search.php?catalog=B4748B4783,Diphenidol HCl,3254-89-5,B11,L1021-18,345.91,DMSO,C21H28ClNO,OC(C1=CC=CC=C1)(C2=CC=CC=C2)CCCN3CCCCC3.Cl,≥17.05 mg/mL in DMSO; ≥2.61 mg/mL in H2O with ultrasonic; ≥4.84 mg/mL in EtOH,,Neuroscience,AChR,antagonist of muscarinic M2 and M3 receptor,https://www.apexbt.com/search.php?catalog=B4783B4784,Promethazine HCl,58-33-3,C01,L1021-18,320.88,DMSO,C17H21ClN2S,CC(N(C)C)CN1C2=CC=CC=C2SC3=CC=CC=C31.Cl,≥14.2 mg/mL in DMSO; ≥17.57 mg/mL in H2O; ≥5.38 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B4784B4795,Labetalol HCl,32780-64-6,C02,L1021-18,364.87,DMSO,C19H25ClN2O3,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl,insoluble in H2O; ≥18.24 mg/mL in DMSO; ≥2.98 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,GPCR/G protein,Adrenergic Receptor,mixed alpha/beta adrenergic antagonist,https://www.apexbt.com/search.php?catalog=B4795B4796,Meclofenamate Sodium,6385-02-0,C03,L1021-18,318.13,DMSO,C14H11Cl2NO2·Na,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+],insoluble in H2O; ≥15.91 mg/mL in DMSO; ≥47.5 mg/mL in EtOH,Sodium,Neuroscience,COX,dual COX-1/COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B4796B4798,Procainamide HCl,614-39-1,C04,L1021-18,271.79,DMSO,C13H22ClN3O,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl,≥13.65 mg/mL in DMSO; ≥22.65 mg/mL in EtOH; ≥46.4 mg/mL in H2O,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,sodium channel blocker,https://www.apexbt.com/search.php?catalog=B4798B4800,Defactinib,1073154-85-4,C05,L1021-18,510.49,DMSO,C20H21F3N8O3S,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,insoluble in EtOH; insoluble in H2O; ≥160.2 mg/mL in DMSO,,Tyrosine Kinase,FAK,FAK phosphorylation inhibitor,https://www.apexbt.com/search.php?catalog=B4800B4806,Brivaracetam,357336-20-0,C06,L1021-18,703.83,DMSO,C33H41N3O10S2,CCC[C@@H]1CC(N(C1)[C@H](CC)C(N)=O)=O,16mg/mL in ethanol;20mg/mL in DMSO;14mg/mL in dimethyl formamide,,,,High-affinity ligand for synaptic vesicle glycoprotein 2A (SV2A),https://www.apexbt.com/search.php?catalog=B4806B4809,K-115,887375-67-9,C07,L1021-18,395.88,H2O,C15H23ClFN3O4S,CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F.O.O.Cl,insoluble in EtOH; ≥123.2 mg/mL in DMSO; ≥41.7 mg/mL in H2O,,Cell Cycle/Checkpoint,Rho,Selective Rho kinase inhibitor,https://www.apexbt.com/search.php?catalog=B4809B4811,Afuresertib,1047644-62-1,C08,L1021-18,427.32,DMSO,C18H17Cl2FN4OS,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,≥2.71 mg/mL in H2O; ≥6.25 mg/mL in EtOH; ≥96 mg/mL in DMSO,,PI3K/Akt/mTOR Signaling,PKB,pan-AKT inhibitor,https://www.apexbt.com/search.php?catalog=B4811B4815,LCZ696,936623-90-4,C09,L1021-18,956.99,DMSO,C48H54N6Na3O8·2.5H2O,CCCCC(N([[C@H@](C([O-])=O)([H])C(C)C)CC1=CC=C(C2=CC=CC=C2C3=N[N-]N=N3)C=C1)=O.CCOC([[C@H](C[[C@H@](/N=C([O-])/CCC([O-])=O)([H])CC4=CC=C(C5=CC=CC=C5)C=C4)([H])C)=O.[3Na+].[2.5H2O],≥45.05 mg/mL in DMSO; ≥11.28 mg/mL in H2O; ≥28.5 mg/mL in EtOH,Free Base,GPCR/G protein,Angiotensin Receptor,A first in class ARNi (angiotensin receptor neprilysin inhibitor),https://www.apexbt.com/search.php?catalog=B4815B4826,Isavuconazole,241479-67-4,C10,L1021-18,437.47,DMSO,C22H17F2N5OS,CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,insoluble in H2O; ≥19.8 mg/mL in DMSO; ≥21.07 mg/mL in EtOH,,Microbiology & Virology,Antifungal,triazole antifungal drug,https://www.apexbt.com/search.php?catalog=B4826B4834,Efinaconazole,164650-44-6,C11,L1021-18,348.39,DMSO,C18H22F2N4O,CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3,insoluble in H2O; ≥13.95 mg/mL in DMSO; ≥53.3 mg/mL in EtOH,Free Base,Microbiology & Virology,Antifungal,novel triazole antifungal drug,https://www.apexbt.com/search.php?catalog=B4834B4869,Cyclocytidine HCl,10212-25-6,D01,L1021-18,261.66,DMSO,C9H12ClN3O4,C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=N.Cl,≥16.6mg/mL in DMSO with ultrasonic; insoluble in EtOH; ≥46.2 mg/mL in H2O,,DNA Damage,DNA/RNA Synthesis,pyrimidine nucleoside analogues that inhibit DNA synthesis,https://www.apexbt.com/search.php?catalog=B4869B4871,Ospemifene,128607-22-7,D02,L1021-18,378.89,DMSO,C24H23ClO2,C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl,insoluble in H2O; ≥11.14 mg/mL in EtOH; ≥15.4 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,non-hormonal selective estrogen receptor modulator (SERM),https://www.apexbt.com/search.php?catalog=B4871B4872,Mupirocin,12650-69-0,D03,L1021-18,500.62,DMSO,C26H44O9,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,≥100 mg/mL in DMSO; insoluble in H2O; ≥5.69 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,isoleucyl t-RNA synthetase inhibitor,https://www.apexbt.com/search.php?catalog=B4872B4874,Hydroxychloroquine Sulfate,747-36-4,D04,L1021-18,433.95,H2O,C18H28ClN3O5S,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O,insoluble in DMSO; insoluble in EtOH; ≥17.6 mg/mL in H2O,Sulfate,Others,Others,Autophagy inhibitor,https://www.apexbt.com/search.php?catalog=B4874B4882,PF-06463922,1454846-35-5,D05,L1021-18,406.41,DMSO,C21H19FN6O2,FC1=CC([[C@H](OC2=C(N)N=CC(C3=C(C#N)N(C)N=C3CN4C)=C2)C)=C(C4=O)C=C1,insoluble in H2O; ≥20.3 mg/mL in DMSO; ≥5.85 mg/mL in EtOH,,Tyrosine Kinase,ALK,,https://www.apexbt.com/search.php?catalog=B4882B4883,Abscisic Acid (Dormin),21293-29-8,D06,L1021-18,264.32,DMSO,C15H20O4,CC1=CC(=O)CC(C1(C=CC(=CC(=O)O)C)O)(C)C,insoluble in H2O; ≥8.9 mg/mL in DMSO; ≥9.6 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=B4883B4885,Lomitapide,182431-12-5,D07,L1021-18,692.71,DMSO,C39H37F6N3O2,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,≥22.4 mg/mL in DMSO,Free Base,Others,Others,"MTP inhibitor, orally active",https://www.apexbt.com/search.php?catalog=B4885B4888,Obeticholic Acid,459789-99-2,D08,L1021-18,420.63,DMSO,C26H44O4,CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O,≥21.5 mg/mL in DMSO; insoluble in H2O; ≥21.3 mg/mL in EtOH,Free Base,Others,FXR,FXR agonist with anticholeretic activity,https://www.apexbt.com/search.php?catalog=B4888B4950,Darunavir Ethanolate,635728-49-3,D09,L1021-18,593.73,DMSO,C29H43N3O8S,O[[C@H](CN(CC(C)C)S(=O)(C(C=C1)=CC=C1N)=O)[[C@H](CC2=CC=CC=C2)NC(O[[C@@H]3[[C@H]4[[C@H](OCC4)OC3)=O.OCC,≥21 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Proteases,HIV Protease,,https://www.apexbt.com/search.php?catalog=B4950B4953,Methylprednisolone Sodium Succinate,2375-03-3,D10,L1021-18,496.53,DMSO,C26H33NaO8,O[[C@H@]1(C(COC(CCC([O-])=O)=O)=O)[[C@H](C2)(C)[[C@@H](CC1)[[C@H](C[[C@@H]3C)[[C@@H]([[C@H@](C)(C=C4)C3=CC4=O)[[C@H]2O.[Na+],≥49.7 mg/mL in DMSO; ≥13.1 mg/mL in EtOH; ≥2.94 mg/mL in H2O,,GPCR/G protein,Glucagon Receptor,glucocorticoid,https://www.apexbt.com/search.php?catalog=B4953B4954,Sulfisoxazole Acetyl,80-74-0,D11,L1021-18,309.34,DMSO,C13H15N3O4S,O=S(C1=CC=C(N([H])[H])C=C1)(N(C(C)=O)C2=C(C)C(C)=NO2)=O,insoluble in H2O; insoluble in EtOH; ≥14.15 mg/mL in DMSO,Free Base,Microbiology & Virology,Bacterial; Endothelin Receptor,sulfonamide antibacterial,https://www.apexbt.com/search.php?catalog=B4954B4962,Thonzonium Bromide,553-08-2,E01,L1021-18,591.71,DMSO,C32H55BrN4O,C[N+](CCN(C1=NC=CC=N1)CC(C=C2)=CC=C2OC)(C)CCCCCCCCCCCCCCCC.[Br-],≥53.5 mg/mL in DMSO; ≥121.2 mg/mL in EtOH; ≥62.1 mg/mL in H2O,,Microbiology & Virology,Bacterial,surface active agent and inhibitor of V-ATPase proton transport,https://www.apexbt.com/search.php?catalog=B4962B4964,(-)-epicatechin,490-46-0,E02,L1021-18,290.27,DMSO,C15H14O6,O[[C@@H]1CC2=C(C=C(O)C=C2O)O[[C@@H]1C3=CC=C(O)C(O)=C3,insoluble in H2O; insoluble in EtOH; ≥14.5 mg/mL in DMSO ,,TGF-_ / Smad Signaling,PKC,,https://www.apexbt.com/search.php?catalog=B4964B4965,(-)-epicatechin gallate,1257-08-5,E03,L1021-18,442.37,DMSO,C22H18O10,OC1=CC(C(O[[C@@H]2CC3=C(C=C(O)C=C3O)O[[C@@H]2C4=CC=C(O)C(O)=C4)=O)=CC(O)=C1O,≥22.1 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,TGF-_ / Smad Signaling,PKC,,https://www.apexbt.com/search.php?catalog=B4965B4968,Rilmenidine Phosphate,85409-38-7,E04,L1021-18,278.24,DMSO,C10H19N2O5P,OP(O)(O)=O.C1(NC(C2CC2)C3CC3)=NCCO1,insoluble in EtOH; ≥30.15 mg/mL in H2O; ≥5.68 mg/mL in DMSO,,Others,Imidazoline Receptors,,https://www.apexbt.com/search.php?catalog=B4968B4972,Caspofungin,162808-62-0,E05,L1021-18,1092.33,DMSO,C53H89N9O15,O=C([[C@@H]1C[[C@@H](O)CN1C([[C@@H](NC(C2CC(CCCCCCCCC(C)CC(CC)C)=O)=O)[[C@@H](C)O)=O)N[[C@@H]([[C@H](O)[[C@@H](O)C3=CC=C(O)C=C3)C(N[[C@@H]([[C@H](O)CCN)C(N4CC[[C@H](O)[[C@H]4C(N[[C@@H](NCCN)[[C@H](O)C2)=O)=O)=O,≥48.1 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,lipopeptide antifungal drug,https://www.apexbt.com/search.php?catalog==B4972B4973,Cefpodoxime Proxetil,87239-81-4,E06,L1021-18,557.60,DMSO,C21H27N5O9S2,CC(C)OC(OC(C)OC(C1=C(COC)CS[[C@H]([H])([[C@@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O)N1C2=O)=O)=O,≥22.1 mg/mL in DMSO; insoluble in H2O; ≥17.1 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=B4973B4974,Cefprozil,92665-29-7,E07,L1021-18,389.43,DMSO,C18H19N3O5S,OC1=CC=C([[C@@H](N)C(N[[C@@H]2C(N3[[C@H@]2([H])SCC(/C=C/C)=C3C(O)=O)=O)=O)C=C1,insoluble in EtOH; ≥4.5 mg/mL in DMSO with gentle warming; ≥5.54 mg/mL in H2O,Free Base,Microbiology & Virology,Bacterial,antibiotic,https://www.apexbt.com/search.php?catalog=B4974B4975,Cetrorelix,120287-85-6,E08,L1021-18,1431.04,DMSO,C70H92ClN17O14,"C[C@H](C(=O)N)NC(=O)C1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=
O)[C@@H](CCCNC(=O)N)NC(=O)[C@@H](CC2=CC=C(C=C2)O)NC(=O)[C@@H](CO)NC(=O)
[C@@H](CC3=CN=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=
CC=CC=C6C=C5)NC(=O)C",≥30.9 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,Free Base,GPCR/G Protein,GNRH Receptor,gonadotropin-releasing hormone (GnRH) antagonist,https://www.apexbt.com/search.php?catalog=B4975B4976,Desogestrel,54024-22-5,E09,L1021-18,310.47,DMSO,C22H30O,O)[C@@H](CCCNC(=O)N)NC(=O)[C@@H](CC2=CC=C(C=C2)O)NC(=O)[C@@H](CO)NC(=O),insoluble in H2O; ≥13.7 mg/mL in DMSO; ≥9.42 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,progestin used in hormonal contraceptives,https://www.apexbt.com/search.php?catalog=B4976B4979,Octreotide acetate,83150-76-9,E10,L1021-18,1079.29,DMSO,C51H70N10O12S2,[C@@H](CC3=CN=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=,≥53.96 mg/mL in DMSO; ≥10.04 mg/mL in EtOH; ≥28.85 mg/mL in H2O,acetate,GPCR/G protein,Somatostatin Receptor,octapeptide congener of native somatostatin,https://www.apexbt.com/search.php?catalog=B4979B4980,Pentamidine isethionate,140-64-7,E11,L1021-18,592.68,DMSO,C19H24N4O2·2C2H6O4S,CC=CC=C6C=C5)NC(=O)C,≥22.6 mg/mL in DMSO; insoluble in EtOH; ≥10.54 mg/mL in H2O,isethionate,Microbiology & Virology,Antibiotic,Drug to treat protozoal diseases,https://www.apexbt.com/search.php?catalog=B4980B4981,Sumatriptan,103628-46-2,F01,L1021-18,295.40,DMSO,C14H21N3O2S,CNS(CC1=CC(C(CCN(C)C)=CN2)=C2C=C1)(=O)=O,≥14.77 mg/mL in DMSO,Free Base,Neuroscience,5-HT Receptor,5-HT1 receptor agonist,https://www.apexbt.com/search.php?catalog=B4981B4982,Topotecan,123948-87-8,F02,L1021-18,421.45,DMSO,C23H23N3O5,CC[[C@H]1(O)C(C=C2C3=NC4=CC=C(O)C(CN(C)C)=C4C=C3CN2C5=O)=C5COC1=O,≥21.1 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor,https://www.apexbt.com/search.php?catalog=B4982B5462,Rotenone,83-79-4,F03,L1021-18,394.42,DMSO,C23H22O6,O=C1[[C@H](C2=CC(OC)=C3OC)[[C@@H](COC2=C3)OC4=C1C=CC5=C4C[[C@H](C(C)=C)O5,insoluble in EtOH; insoluble in H2O; ≥77.6 mg/mL in DMSO,#N/A,Metabolism,Oxidative Phosphorylation,inhibitor of the mitochondrial complex I electron transport chain,https://www.apexbt.com/search.php?catalog=B5462B5736,Carbetocin,37025-55-1,F04,L1021-18,988.16,DMSO,C45H69N11O12S,O=C([C@H](CSCCCC(N[C@H](C1=O)CC2=CC=C(OC)C=C2)=O)NC([C@@H](NC([C@](NC([C@](N1)([H])[C@@H](C)CC)=O)([H])CCC(N)=O)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CC(C)C)C(NCC(N)=O)=O)=O,≥261.4 mg/mL in DMSO; ≥50.9 mg/mL in H2O; ≥57.8 mg/mL in EtOH,,Others,Others,oxytocin receptor agonist,https://www.apexbt.com/search.php?catalog=B5736B5827,Poziotinib,1092364-38-9,F05,L1021-18,491.34,DMSO,C23H21Cl2FN4O3,C=CC(N1CCC(OC2=C(OC)C=C3C(C(NC4=C(F)C(Cl)=C(Cl)C=C4)=NC=N3)=C2)CC1)=O,insoluble in EtOH; insoluble in H2O; ≥94.2 mg/mL in DMSO,,Tyrosine Kinase,HER2,irreversible pan-HER inhibitor,https://www.apexbt.com/search.php?catalog=B5827B5846,Radotinib(IY-5511),926037-48-1,F06,L1021-18,530.5,DMSO,C27H21F3N8O,CC1=C(NC2=NC=CC(C3=CN=CC=N3)=N2)C=C(/C(O)=N/C4=CC(N(C=N5)C=C5C)=CC(C(F)(F)F)=C4)C=C1,≥26.55 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Apoptosis,Bcl-2 Family,Bcr-Abl tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=B5846B5854,Pexidartinib (PLX3397),1029044-16-3,F07,L1021-18,417.81,DMSO,C20H15ClF3N5,ClC(C=N1)=CC2=C1NC=C2CC3=CN=C(NCC4=CN=C(C(F)(F)F)C=C4)C=C3,insoluble in EtOH; insoluble in H2O; ≥20.9 mg/mL in DMSO,Free Base,Tyrosine Kinase,CSF-1R,CSF-1R inhibitor,https://www.apexbt.com/search.php?catalog=B5854B5856,GSK1349572 sodiuM salt,1051375-19-9,F08,L1021-18,441.36,DMSO,C20H18F2N3NaO5,C[[C@H](N12)([H])CCO[[C@H@]1([H])CN(C(C2=O)=C3[O-])C=C(/C(O)=N/CC4=C(F)C=C(F)C=C4)C3=O.[Na+],insoluble in H2O; insoluble in EtOH; ≥8.06 mg/mL in DMSO with gentle warming,,Proteases,HIV Integrase,Next-generation HIV integrase (IN) inhibitor,https://www.apexbt.com/search.php?catalog=B5856B5859,Entrectinib,1108743-60-7,F09,L1021-18,560.64,DMSO,C31H34F2N6O2,CN1CCN(C2=CC(NC3CCOCC3)=C(C(/N=C4C5=C(NN/4)C=CC(CC6=CC(F)=CC(F)=C6)=C5)=O)C=C2)CC1,≥28.05 mg/mL in DMSO; insoluble in H2O; ≥9.82 mg/mL in EtOH with ultrasonic,Free Base,Tyrosine Kinase,ALK,Orally active inhibitor of ALK kinase,https://www.apexbt.com/search.php?catalog=B5859B5861,Molidustat (BAY85-3934),1154028-82-6,F10,L1021-18,314.3,DMSO,C13H14N8O2,O=C1C(N2C=CN=N2)=CNN1C3=NC=NC(N4CCOCC4)=C3,insoluble in EtOH; insoluble in H2O; ≥5.68 mg/mL in DMF,Free Base,Chromatin/Epigenetics,HIF,Novel HIF-PH inhibitor,https://www.apexbt.com/search.php?catalog=B5861B5864,Fruquintinib(HMPL-013),1194506-26-7,F11,L1021-18,393.39,DMSO,C21H19N3O5,CC(O1)=C(/C(O)=N/C)C2=C1C=C(OC3=NC=NC4=CC(OC)=C(OC)C=C43)C=C2,insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL in DMSO,,Tyrosine Kinase,VEGFR,,https://www.apexbt.com/search.php?catalog=B5864B5868,MK3102,1226781-44-7,G01,L1021-18,398.43,DMSO,C17H20F2N4O3S,CS(N1C=C2CN([[C@H](CO3)([H])C[[C@H@](N)([H])[[C@H@]3([H])C4=C(F)C=CC(F)=C4)CC2=N1)(=O)=O,insoluble in EtOH; insoluble in H2O; ≥17.15 mg/mL in DMSO,,Proteases,DPP-4,Novel long-acting DPP-4 inhibitor,https://www.apexbt.com/search.php?catalog=B5868B5888,Retigabine,150812-12-7,G02,L1021-18,303.33,DMSO,C16H18FN3O2,CCO/C(O)=N/C1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,insoluble in H2O; ≥11.1 mg/mL in EtOH with ultrasonic; ≥12.95 mg/mL in DMSO,,Membrane Transporter/Ion Channel,Potassium Channel,,https://www.apexbt.com/search.php?catalog=B5888B5904,Regadenoson,313348-27-5,G03,L1021-18,390.35,DMSO,C15H18N8O5,C/N=C(O)/C(C=N1)=CN1C2=NC(N)=C(N=CN3[[C@H@]4([H])[[C@H@](O)([H])[[C@H@](O)([H])[[C@H@](O4)([H])CO)C3=N2,insoluble in H2O; insoluble in EtOH; ≥18.05 mg/mL in DMSO,,GPCR/G protein,Adenosine Receptor,Highly selective and low affinity A2A adenosine agonist,https://www.apexbt.com/search.php?catalog=B5904B5912,Chlorotrianisene,569-57-3,G04,L1021-18,380.86,DMSO,C23H21ClO3,COC1=CC=C(/C(C2=CC=C(OC)C=C2)=C(Cl)/C3=CC=C(OC)C=C3)C=C1,insoluble in H2O; insoluble in EtOH; ≥16.1 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen agonist,https://www.apexbt.com/search.php?catalog=B5912B5944,Carteolol HCl,51781-21-6,G05,L1021-18,328.83,DMSO,C16H25ClN2O3,CC(C)(NCC(O)COC1=CC=CC2=C1CCC(O)=N2)C.Cl,insoluble in EtOH; ≥16.44 mg/mL in DMSO; ≥22.25 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Non-selective beta-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B5944B5953,Dovitinib (TKI258) Lactate,915769-50-5,G06,L1021-18,500.52,H2O,C24H29FN6O5,FC1=C(C(N)=C(C2=O)C3=NC4=C(N3)C=C(N5CCN(C)CC5)C=C4)C(N2)=CC=C1.CC(O)C(O)=O.O,insoluble in EtOH; ≥10.62 mg/mL in DMSO; ≥168.2 mg/mL in H2O,,Tyrosine Kinase,VEGFR,"Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).",https://www.apexbt.com/search.php?catalog=B5953B5954,Dasatinib Monohydrate,863127-77-9,G07,L1021-18,506.02,DMSO,C22H28ClN7O3S,CC1=C(/N=C(O)/C(S2)=CN=C2NC3=CC(N4CCN(CCO)CC4)=NC(C)=N3)C(Cl)=CC=C1.O,≥25.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,TGF-_ / Smad Signaling,Bcr-Abl,,https://www.apexbt.com/search.php?catalog=B5954B5958,Oltipraz,64224-21-1,G08,L1021-18,226.34,DMSO,C8H6N2S3,CC(C1=S)=C(SS1)C2=CN=CC=N2,≥22.6 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Immunology/Inflammation,Nrf2,Nrf2 activator;An antischistosomal agent,https://www.apexbt.com/search.php?catalog=B5958B5965,Tamoxifen,10540-29-1,G09,L1021-18,371.51,DMSO,C26H29NO,CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3,insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL in DMSO,Free Base,TGF-_ / Smad Signaling,Autophagy; Estrogen Receptor/ERR; HSP,TGF-_ modulatory and PKC inhibitory effects,https://www.apexbt.com/search.php?catalog=B5965B5970,Sanguinarine chloride,5578-73-4,G10,L1021-18,367.78,DMSO,C20H14ClNO4,C[N+]1=C2C(C=CC3=CC(OCO4)=C4C=C32)=C5C=CC(OCO6)=C6C5=C1.[Cl-],insoluble in H2O; insoluble in EtOH; ≥3.68 mg/mL in DMSO with gentle warming,,Chromatin/Epigenetics,Protein Ser/Thr Phosphatases,Inhibitor of PP2C and MKP-1,https://www.apexbt.com/search.php?catalog=B5970B5984,Naproxen Sodium,26159-34-2,G11,L1021-18,252.24,H2O,C14H13NaO3,C[[C@H@](C([O-])=O)([H])C1=CC2=CC=C(OC)C=C2C=C1.[Na+],insoluble in DMSO; ≥2.25 mg/mL in EtOH with gentle warming and ultrasonic; ≥6.306 mg/mL in H2O,Sodium,Neuroscience,COX,cyclooxygenase inhibitor,https://www.apexbt.com/search.php?catalog=B5984B5986,Enoxolone,471-53-4,H01,L1021-18,470.68,DMSO,C30H46O4,CC([[C@H]1([H])CC[[C@H]23C)([[C@H](O)([H])CC[[C@H@]1([[C@H@]2([H])C(C=C4[[C@H]5([H])C[[C@H](CC[[C@H](CC[[C@H]43C)5C)(C(O)=O)C)=O)C)C,insoluble in H2O; ≥19.3 mg/mL in DMSO; ≥26.5 mg/mL in EtOH,,Others,Others,major component of licorice,https://www.apexbt.com/search.php?catalog=B5986B5988,Troxerutin,7085-55-4,H02,L1021-18,742.68,DMSO,C33H42O19,C[[C@H@](O1)([H])[[C@H@](O)([H])[[C@H](O)([H])[[C@H](O)([H])[[C@H]1([H])OC[[C@H]2([H])[[C@H](O)([H])[[C@H@](O)([H])[[C@H](O)([H])[[C@H@](OC(C(C3=C(O)C=C(OCCO)C=C3O4)=O)=C4C5=CC(OCCO)=C(OCCO)C=C5)([H])O2,≥74.3 mg/mL in DMSO; insoluble in EtOH; ≥31.8 mg/mL in H2O,,Others,Antioxidants,flavonoid,https://www.apexbt.com/search.php?catalog=B5988B5990,Diosmetin,520-34-3,H03,L1021-18,300.26,DMSO,C16H12O6,COC1=C(O)C=C(C2=CC(C3=C(O)C=C(O)C=C3O2)=O)C=C1,insoluble in H2O; ≥13.65 mg/mL in DMSO; ≥2.4 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,CYP3A/CYP450,CYP1A1 inhibitor,https://www.apexbt.com/search.php?catalog=B5990B5994,Cyclobenzaprine HCl,6202-23-9,H04,L1021-18,311.85,DMSO,C20H22ClN,CN(CC/C=C1C2=CC=CC=C2C=CC3=CC=CC=C3\1)C.Cl,≥15.59 mg/mL in DMSO; ≥5.32 mg/mL in EtOH; ≥54.3 mg/mL in H2O,Hydrochloride,GPCR/G protein,5-HT Receptor,5-HT2 receptor antagonist,https://www.apexbt.com/search.php?catalog=B5994B5995,Calcium D-Panthotenate,137-08-6,H05,L1021-18,476.53,DMSO,C18H32CaN2O10,CC(CO)([[C@H](O)([H])/C([O-])=N/CCC([O-])=O)C.CC(CO)([[C@H](O)([H])/C(O)=N/CCC(O)=O)C.[Ca+2],insoluble in EtOH; ≥24.65 mg/mL in H2O with ultrasonic; ≥9 mg/mL in DMSO,,Metabolism,Vitamin,"water-soluble vitamin, precursor in the biosynthesis of coenzyme A",https://www.apexbt.com/search.php?catalog=B5995B5996,Motolimod (VTX-2337),926927-61-9,H06,L1021-18,458.6,DMSO,C28H34N4O2,CCCN(C(C(CC1=N)=CC2=C(N1)C=C(C3=CC=C(C(N4CCCC4)=O)C=C3)C=C2)=O)CCC,insoluble in H2O; ≥15.7 mg/mL in DMSO; ≥45.8 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Immunology/Inflammation,TLR,TLR8 agonist,https://www.apexbt.com/search.php?catalog=B5996B6001,4-Methylumbelliferone (4-MU),90-33-5,H07,L1021-18,176.17,DMSO,C10H8O3,CC(C1=C(O2)C=C(O)C=C1)=CC2=O,insoluble in H2O; ≥2.45 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.8 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=B6001B6012,Pexmetinib (ARRY-614),945614-12-0,H08,L1021-18,556.64,DMSO,C31H33FN6O3,CC1=CC=C(N2C(NC(NCC3=CC(F)=CC=C3OC4=CC=C5C(C=NN5CCO)=C4)=O)=CC(C(C)(C)C)=N2)C=C1,insoluble in H2O; ≥107.6 mg/mL in DMSO; ≥113 mg/mL in EtOH,,MAPK Signaling,p38,dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase,https://www.apexbt.com/search.php?catalog=B6012B6015,Cyclo(RGDyK),250612-42-1,H09,L1021-18,847.72,DMSO,C31H43F6N9O12,NCCCC[[C@H@]1([H])/C(O)=N/[[C@H@](/C(O)=N/C/C(O)=N/[[C@H@](/C(O)=N/[[C@H](/C(O)=N/1)([H])CC2=CC=C(O)C=C2)([H])CC(O)=O)([H])CCCNC(N)=N.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O,insoluble in EtOH; ≥50.2 mg/mL in H2O with ultrasonic; ≥6.347 mg/mL in DMSO with gentle warming and ultrasonic,,Angiogenesis,Integrin,_V_3 integrin inhibitor,https://www.apexbt.com/search.php?catalog=B6015B6019,Sodium Tauroursodeoxycholate (TUDC),35807-85-3,H10,L1021-18,521.69,DMSO,C26H44NNaO6S,C[[C@H]([[C@H@]1([H])CC[[C@H@]2([H])[[C@H@]([[C@H](O)([H])C[[C@H]3([H])C[[C@H@](O)([H])CC[[C@H@]34C)([H])[[C@H]4([H])CC[[C@H]12C)([H])CC/C([O-])=N/CCS(O)(=O)=O.[Na+],≥26.1 mg/mL in DMSO; ≥2.61 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.42 mg/mL in H2O,,Others,Others,water soluble bile salt,https://www.apexbt.com/search.php?catalog=B6019B6022,Metoprolol Succinate,98418-47-4,H11,L1021-18,652.82,DMSO,C34H56N2O10,OC(COC(C=C1)=CC=C1CCOC)CNC(C)C.OC(COC(C=C2)=CC=C2CCOC)CNC(C)C.OC(CCC(O)=O)=O,≥24.75 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥2.63 mg/mL in H2O with ultrasonic,,GPCR/G protein,Adrenergic Receptor,beta-1 selective adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B6022B6029,Napabucasin,83280-65-3,A01,L1021-19,240.21,DMSO,C14H8O4,CC(C(O1)=CC2=C1C(C3=CC=CC=C3C2=O)=O)=O,insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL in DMSO ,,JAK/STAT Signaling,STAT,STAT3 inhibitor,https://www.apexbt.com/search.php?catalog=B6029B6032,CB-5083,1542705-92-9,A02,L1021-19,413.47,DMSO,C24H23N5O2,O=C(N)C1=CC=CC2=C1C=C(C)N2C3=NC(NCC4=CC=CC=C4)=C5COCCC5=N3,insoluble in H2O; ≥20.65 mg/mL in DMSO; ≥4.4 mg/mL in EtOH,,Ubiquitination/Proteasome,p97,,https://www.apexbt.com/search.php?catalog=B6032B6036,INCB-024360,1204669-58-8,A03,L1021-19,438.23,DMSO,C11H13BrFN7O4S,BrC1=C(F)C=CC(/N=C(NO)\C2=NON=C2NCCNS(N)(=O)=O)=C1,insoluble in H2O; ≥17.1 mg/mL in DMSO; ≥2.96 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,IDO,potent and selective inhibitor of IDO1,https://www.apexbt.com/search.php?catalog=B6036B6038,Ozanimod (RPC1063),1306760-87-1,A04,L1021-19,404.46,DMSO,C23H24N4O3,CC(OC1=C(C#N)C=C(C2=NC(C3=CC=CC4=C3CC[[C@H]4([H])NCCO)=NO2)C=C1)C,≥40.4 mg/mL in DMSO; insoluble in H2O; ≥2.25 mg/mL in EtOH with ultrasonic,,GPCR/G protein,S1P receptor,agonist of the sphingosine-1-phosphate receptor subtypes 1 and 5,https://www.apexbt.com/search.php?catalog=B6038B6049,Tedizolid HCl,856866-72-3,A05,L1021-19,406.80,DMSO,C17H16ClFN6O3,FC1=CC(N2C[[C@H](CO)OC2=O)=CC=C1C3=CC=C(C4=NN(C)N=N4)N=C3.Cl,insoluble in H2O; insoluble in EtOH; ≥13.57 mg/mL in DMSO with gentle warming,#N/A,Microbiology & Virology,Antibiotic,Oxazolidinone for gram-positive infections,https://www.apexbt.com/search.php?catalog=B6049B6068,Deferoxamine mesylate,138-14-7,A06,L1021-19,656.79,DMSO,C26H52N6O11S,CC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCCN)=O)=O)=O.CS(O)(=O)=O,≥65.7 mg/mL in H2O; insoluble in EtOH; ≥29.8 mg/mL in DMSO,,Others,Others,iron-chelating agent,https://www.apexbt.com/search.php?catalog=B6068B6073,Sildenafil mesylate,1308285-21-3,A07,L1021-19,570.68,DMSO,C23H34N6O7S2,CCCC(C(N=C(N1)C2=C(OCC)C=CC(S(N3CCN(CC3)C)(=O)=O)=C2)=C4C1=O)=NN4C.CS(O)(=O)=O,≥57.1 mg/mL in DMSO; insoluble in EtOH; ≥25.95 mg/mL in H2O,,Metabolism,PDE,,https://www.apexbt.com/search.php?catalog=B6073B6098,Resazurin sodium salt,62758-13-8,A08,L1021-19,251.17,DMSO,C12H6NNaO4,O=C1C=C2OC3=CC([O-])=CC=C3[N+]([O-])=C2C=C1.[Na+],≥25.1 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,Others,Others,fluorogenic oxidation-reduction indicator,https://www.apexbt.com/search.php?catalog=B6098B6124,Fomepizole,7554-65-6,A09,L1021-19,82.1,H2O,C4H6N2,CC1=CNN=C1,≥123.4 mg/mL in EtOH; ≥127 mg/mL in DMSO; ≥8.2 mg/mL in H2O,,Metabolism,Dehydrogenase,competitive inhibitor of the enzyme alcohol dehydrogenase,https://www.apexbt.com/search.php?catalog=B6124B6125,Acetazolamide,59-66-5,A10,L1021-19,222.25,DMSO,C4H6N4O3S2,C/C(O)=N/C1=NN=C(S(N)(=O)=O)S1,insoluble in EtOH; insoluble in H2O; ≥22.2 mg/mL in DMSO,,Metabolism,Carbonic Anhydrase,carbonic anhydrase (CA) inhibitor,https://www.apexbt.com/search.php?catalog=B6125B6126,17-Hydroxyprogesterone,68-96-2,A11,L1021-19,330.46,DMSO,C21H30O3,CC([[C@H@]1(O)CC[[C@H@]2([H])[[C@H]([[C@H]3([H])CC[[C@H@]21C)([H])CCC4=CC(CC[[C@H@]43C)=O)=O,insoluble in H2O; ≥16 mg/mL in EtOH with gentle warming; ≥31.6 mg/mL in DMSO,,Endocrinology and Hormones,Estrogen/progestogen Receptor,endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones,https://www.apexbt.com/search.php?catalog=B6126B6128,Fenofibric acid,42017-89-0,B01,L1021-19,318.75,DMSO,C17H15ClO4,CC(C(O)=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C,≥31.9 mg/mL in DMSO; insoluble in H2O; ≥18.67 mg/mL in EtOH,,Metabolism,PPAR,ppar inhibitor_ lipid-lowering agent,https://www.apexbt.com/search.php?catalog=B6128B6132,Fluphenazine dihydrochloride,146-56-5,B02,L1021-19,510.44,DMSO,C22H28Cl2F3N3OS,FC(F)(F)C1=CC(N(C2=CC=CC=C2S3)CCCN4CCN(CCO)CC4)=C3C=C1.Cl.Cl,≥114.2 mg/mL in DMSO; ≥3.65 mg/mL in EtOH; ≥72.4 mg/mL in H2O,#N/A,Neuroscience,Dopamine Receptor,phenothiazine-class D1DR and D2DR inhibitor,https://www.apexbt.com/search.php?catalog=B6132B6134,Amodiaquine dihydrochloride dihydrate,6398-98-7,B03,L1021-19,464.81,DMSO,C20H28Cl3N3O3,CCN(CC1=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=CC=C1O)CC.Cl.Cl.O.O,≥18.03 mg/mL in H2O with ultrasonic; ≥5.9 mg/mL in EtOH with ultrasonic; ≥70.4 mg/mL in DMSO,,Metabolism,Transferase,histamine N-methyl transferase inhibitor,https://www.apexbt.com/search.php?catalog=B6134B6135,Nitroxoline,4008-48-4,B04,L1021-19,190.16,DMSO,C9H6N2O3,OC1=C2C(C=CC=N2)=C([N+]([O-])=O)C=C1,insoluble in EtOH; insoluble in H2O; ≥118.4 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,antibacterial agent,https://www.apexbt.com/search.php?catalog=B6135B6137,Diflunisal,22494-42-4,B05,L1021-19,250.2,DMSO,C13H8F2O3,FC1=CC(F)=C(C2=CC(C(O)=O)=C(O)C=C2)C=C1,insoluble in H2O; ≥19.7 mg/mL in EtOH; ≥49 mg/mL in DMSO,,Neuroscience,COX,"COX inhibitor, nonsteroidal anti-inflammatory drug (NSAID)",https://www.apexbt.com/search.php?catalog=B6137B6139,(+/-)-Sulfinpyrazone,57-96-5,B06,L1021-19,404.48,DMSO,C23H20N2O3S,O=C(N1C2=CC=CC=C2)C(C(N1C3=CC=CC=C3)=O)CCS(C4=CC=CC=C4)=O,insoluble in H2O; ≥17.537 mg/mL in EtOH; ≥47.6 mg/mL in DMSO,,Neuroscience,COX,platelet COX inhibitor,https://www.apexbt.com/search.php?catalog=B6139B6140,Hexachlorophene,70-30-4,B07,L1021-19,406.9,DMSO,C13H6Cl6O2,ClC1=CC(Cl)=C(Cl)C(CC2=C(Cl)C(Cl)=CC(Cl)=C2O)=C1O,≥40.7 mg/mL in DMSO; insoluble in H2O; ≥54.2 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Potassium Channel,KCNQ1/KCNE1 potassium channel activator,https://www.apexbt.com/search.php?catalog=B6140B6148,Etretinate,54350-48-0,B08,L1021-19,354.48,DMSO,C23H30O3,CCOC(/C=C(/C=C/C=C(/C=C/C1=C(C=C(OC)C(C)=C1C)C)C)C)=O,insoluble in H2O; insoluble in EtOH; ≥17.7 mg/mL in DMSO with gentle warming and ultrasonic,,Others,Retinoid X Receptors,retinoid receptor agonist,https://www.apexbt.com/search.php?catalog=B6148B6149,Eugenol,97-53-0,B09,L1021-19,164.2,DMSO,C10H12O2,C=CCC1=CC(OC)=C(O)C=C1,insoluble in H2O; ≥59.2 mg/mL in DMSO; ≥62.2 mg/mL in EtOH,,Others,Others,naturally occuring scent chemical,https://www.apexbt.com/search.php?catalog=B6149B6153,Isatin,91-56-5,B10,L1021-19,147.13,DMSO,C8H5NO2,O=C(C1=O)C2=C(N1)C=CC=C2,insoluble in H2O; ≥113.4 mg/mL in DMSO; ≥7.29 mg/mL in EtOH with ultrasonic,,Metabolism,MAO,endogenous monoamine oxidase inhibitor,https://www.apexbt.com/search.php?catalog=B6153B6154,Benzenesulfonamide,98-10-2,B11,L1021-19,157.19,DMSO,C6H7NO2S,NS(C1=CC=CC=C1)(=O)=O,≥1.27 mg/mL in H2O with ultrasonic; ≥22.3 mg/mL in EtOH; ≥23.6 mg/mL in DMSO,#N/A,Metabolism,Carbonic Anhydrase,carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=B6154B6155,Lauric Acid,143-07-7,C01,L1021-19,200.32,DMSO,C12H24O2,CCCCCCCCCCCC(O)=O,insoluble in H2O; ≥40.2 mg/mL in DMSO; ≥40.4 mg/mL in EtOH,,Metabolism,Lipid Metabolism,saturated medium-chain fatty acid,https://www.apexbt.com/search.php?catalog=B6155B6156,Cinnarizine,298-57-7,C02,L1021-19,368.51,DMSO,C26H28N2,C1(/C=C/CN2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=CC=CC=C1,insoluble in H2O; ≥5.13 mg/mL in DMSO with ultrasonic; ≥7.13 mg/mL in EtOH with ultrasonic,,Neuroscience,Histamine Receptor,antihistamine and calcium channel blocker,https://www.apexbt.com/search.php?catalog=B6156B6157,Perphenazine,58-39-9,C03,L1021-19,403.97,DMSO,C21H26ClN3OS,ClC1=CC(N(C2=CC=CC=C2S3)CCCN4CCN(CCO)CC4)=C3C=C1,insoluble in H2O; ≥104.6 mg/mL in EtOH; ≥111.6 mg/mL in DMSO,,Neuroscience,Dopamine Receptor,dopamine antagonist,https://www.apexbt.com/search.php?catalog=B6157B6176,LOXO-101,1223405-08-0,C04,L1021-19,526.51,DMSO,C21H24F2N6O6S,O=S(O)(O)=O.O=C(N1C[[C@@H](O)CC1)NC2=C3N=C(N4[[C@@H](C5=CC(F)=CC=C5F)CCC4)C=CN3N=C2,≥18.47 mg/mL in DMSO; ≥2.14 mg/mL in EtOH; ≥29.65 mg/mL in H2O,,Tyrosine Kinase,Trk,,https://www.apexbt.com/search.php?catalog=B6176B6185,ACP-196,1420477-60-6,C05,L1021-19,465.51,DMSO,C26H23N7O2,O=C(NC1=NC=CC=C1)C2=CC=C(C3=C4C(N)=NC=CN4C([[C@H]5N(C(C#CC)=O)CCC5)=N3)C=C2,≥46.6 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥13.86 mg/mL in EtOH,,Angiogenesis,BTK,irreversible BTK inhibitor,https://www.apexbt.com/search.php?catalog=B6185B6189,Sivelestat (ONO-5046),127373-66-4,C06,L1021-19,434.46,DMSO,C20H22N2O7S,O=C(O)CNC(C1=CC=CC=C1NS(=O)(C2=CC=C(OC(C(C)(C)C)=O)C=C2)=O)=O,≥43.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Proteases,Elastase,neutrophil elastase inhibitor,https://www.apexbt.com/search.php?catalog=B6189B6298,Bromocriptine mesylate,22260-51-1,C07,L1021-19,750.7,DMSO,C32H40BrN5O5·CH3SO3H,BrC(NC1=CC=CC2=C31)=C3C[[C@H](C2=C4)N(C)C[[C@@H]4C(N[[C@H]5(C(C)C)O[[C@H@]6(N(C5=O)[[C@@H](CC(C)C)C(N7[[C@H]6CCC7)=O)O)=O.OS(=O)(C)=O,insoluble in H2O; insoluble in EtOH; ≥20.05 mg/mL in DMSO,,Neuroscience,Dopamine Receptor,D2-like dopamine receptor agonist,https://www.apexbt.com/search.php?catalog=B6298B6329,"Dantrolene, sodium salt",14663-23-1,C08,L1021-19,336.23,DMSO,C14H9N4NaO5,O=C1N=C(N(C1)/N=C/C2=CC=C(C(C=C3)=CC=C3[N+]([O-])=O)O2)[O-].[Na+],insoluble in EtOH; insoluble in H2O; ≥12.2 mg/mL in DMSO,sodium salt,Membrane Transporter/Ion Channel,Calcium Channel,ryanodine receptor (RYR) channels inhibitor,https://www.apexbt.com/search.php?catalog=B6329B6396,Mepyramine maleate,59-33-6,C09,L1021-19,401.46,DMSO,C17H23N3O·C4H4O4,CN(C)CCN(C1=NC=CC=C1)CC(C=C2)=CC=C2OC.OC(/C=C\C(O)=O)=O,≥10.18 mg/mL in EtOH; ≥20.073 mg/mL in DMSO; ≥26.5 mg/mL in H2O,maleate,Neuroscience,Histamine Receptor,inverse agonist for the H1 receptor,https://www.apexbt.com/search.php?catalog=B6396B6452,Aminoguanidine hydrochloride,1937-19-5,C10,L1021-19,110.55,DMSO,CH6N4·HCl,N/C(N)=N\N.Cl,insoluble in EtOH; ≥4.45 mg/mL in DMSO; ≥9.62 mg/mL in H2O,,Others,iNOS,iNOS inhibitor,https://www.apexbt.com/search.php?catalog=B6452B6466,(S)-(-)-Propranolol hydrochloride,4199-10-4,C11,L1021-19,295.81,DMSO,C16H21NO2·HCl,O[[C@H](COC1=CC=CC2=CC=CC=C12)CNC(C)C.Cl,≥15.65 mg/mL in H2O; ≥2.9 mg/mL in EtOH with gentle warming and ultrasonic; ≥57.5 mg/mL in DMSO,#N/A,GPCR/G protein,Adrenergic Receptor,_-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B6466B6472,Evans Blue tetrasodium salt,314-13-6,D01,L1021-19,960.82,H2O,C34H24N6Na4O14S4,O=C1C(C(C=C/C1=N/NC(C(C)=C2)=CC=C2C3=CC=C(C(C)=C3)N/N=C4C(C(C(C=C\4)=C5S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C5)N)=O)=C6S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C6)N.[Na+].[Na+].[Na+].[Na+],insoluble in EtOH; ≥192.4 mg/mL in DMSO; ≥213.8 mg/mL in H2O,,Membrane Transporter/Ion Channel,Glutamate (EAAT) Transporters,L-glutamate uptake inhibitor,https://www.apexbt.com/search.php?catalog=B6472B6492,(RS)-(±)-Sulpiride,15676-16-1,D02,L1021-19,341.42,DMSO,C15H23N3O4S,O=C(C(C=C1S(=O)(N)=O)=C(C=C1)OC)NC[[C@@H]2N(CC)CCC2,insoluble in H2O; insoluble in EtOH; ≥58 mg/mL in DMSO,,Neuroscience,Dopamine Receptor,D2-like dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B6492B6522,Spermine tetrahydrochloride,306-67-2,D03,L1021-19,348.19,H2O,C10H26N4·4HCl,NCCCNCCCCNCCCN.Cl.Cl.Cl.Cl,≥34.8 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO,,Membrane Transporter/Ion Channel,NMDA Receptor,,https://www.apexbt.com/search.php?catalog=B6522B6526,Diazoxide,364-98-7,D04,L1021-19,230.67,DMSO,C8H7ClN2O2S,ClC1=CC=C2NC(C)=NS(=O)(C2=C1)=O,insoluble in EtOH; insoluble in H2O; ≥10.4 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,AMPAR,positive allosteric modulator of the AMPA and kainate receptors,https://www.apexbt.com/search.php?catalog=B6526B6527,Tacrine hydrochloride,1684-40-8,D05,L1021-19,234.73,DMSO,C13H14N2·HCl,NC1=C2CCCCC2=NC3=CC=CC=C13.Cl,≥10.15 mg/mL in H2O; ≥10.68 mg/mL in EtOH; ≥10.78 mg/mL in DMSO,Hydrochloride,Neuroscience,AChE,cholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=B6527B6586,(-)-Lobeline hydrochloride,134-63-4,D06,L1021-19,373.92,DMSO,C22H27NO2·HCl,O[[C@H](C1=CC=CC=C1)C[[C@H]2N(C)[[C@H](CC(C3=CC=CC=C3)=O)CCC2.Cl,≥37.5 mg/mL in EtOH with ultrasonic; ≥37.8 mg/mL in H2O with gentle warming and ultrasonic; ≥74.8 mg/mL in DMSO,,Neuroscience,Nicotinic Receptor,nicotinic receptor partial agonist,https://www.apexbt.com/search.php?catalog=B6586B6643,2-APB,524-95-8,D07,L1021-19,225.1,DMSO,C14H16BNO,NCCOB(C1=CC=CC=C1)C2=CC=CC=C2,insoluble in H2O; ≥27.85 mg/mL in EtOH; ≥9.4 mg/mL in DMSO,#N/A,Membrane Transporter/Ion Channel,Calcium Channel,"antagonist of Ins(1,4,5) P3-induced Ca2+ release",https://www.apexbt.com/search.php?catalog=B6643B6736,Citalopram hydrobromide,59729-32-7,D08,L1021-19,405.31,DMSO,C20H21FN2O·HBr,FC1=CC=C(C=C1)[[C@H@]2(CCCN(C)C)OCC3=CC(C#N)=CC=C23.Br,≥2.36 mg/mL in EtOH with gentle warming and ultrasonic; ≥20.27 mg/mL in DMSO; ≥9.46 mg/mL in H2O,Hydrobromide,Neuroscience,5-HT Receptor,5-HT uptake inhibitor,https://www.apexbt.com/search.php?catalog=B6736B6752,Suramin hexasodium salt,129-46-4,D09,L1021-19,1429.15,DMSO,C51H34N6Na6O23S6,[O-]S(=O)(C1=C(C(NC(C2=CC=C(C)C(NC(C3=CC=CC(NC(NC4=CC(C(NC5=CC(C(NC(C(C6=CC(S([O-])(=O)=O)=C7)=C7S([O-])(=O)=O)=CC=C6S([O-])(=O)=O)=O)=CC=C5C)=O)=CC=C4)=O)=C3)=O)=C2)=O)=CC=C8S([O-])(=O)=O)C8=CC(S([O-])(=O)=O)=C1)=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],≥71.45 mg/mL in H2O; insoluble in EtOH; ≥21 mg/mL in DMSO,,Membrane Transporter/Ion Channel,P2X purinergic receptor,,https://www.apexbt.com/search.php?catalog=B6752B6764,Combretastatin A4,117048-59-6,D10,L1021-19,316.35,DMSO,C18H20O5,OC1=CC(/C=C\C2=CC(OC)=C(C(OC)=C2)OC)=CC=C1OC,insoluble in H2O; ≥19 mg/mL in EtOH with ultrasonic; ≥34.3 mg/mL in DMSO,#N/A,Angiogenesis,Antiangiogenics,tubulin polymerization inhibitor,https://www.apexbt.com/search.php?catalog=B6764B7005,Prostaglandin E2,363-24-6,D11,L1021-19,352.47,DMSO,C20H32O5,O[[C@H](C1)[[C@H](/C=C/[[C@H](CCCCC)O)[[C@@H](C/C=C\CCCC(O)=O)C1=O,≥35.2 mg/mL in EtOH; insoluble in H2O; ≥42.8 mg/mL in DMSO,,GPCR/G protein,Prostanoid Receptors,,https://www.apexbt.com/search.php?catalog=B7005B7099,6-Hydroxydopamine hydrobromide,636-00-0,E01,L1021-19,250.09,DMSO,C8H11NO3·HBr,OC(C(CCN)=C1)=CC(O)=C1O.Br,insoluble in EtOH; ≥25 mg/mL in DMSO with ultrasonic; ≥45.4 mg/mL in H2O,#N/A,Neuroscience,Dopamine Receptor,neurotoxin that destroys dopaminergic and noradrenergic (catecholaminergic) neurons,https://www.apexbt.com/search.php?catalog=B7099B7152,Pentylenetetrazole,54-95-5,E02,L1021-19,138.17,DMSO,C6H10N4,N12N=NN=C1CCCCC2,≥15.38 mg/mL in EtOH; ≥6.3 mg/mL in DMSO; ≥83.2 mg/mL in H2O,#N/A,Membrane Transporter/Ion Channel,GABA Receptor,CNS stimulant,https://www.apexbt.com/search.php?catalog=B7152B7174,DCA,2156-56-1,E03,L1021-19,150.92,DMSO,C2HCl2NaO2,ClC(C([O-])=O)Cl.[Na+],≥15.1 mg/mL in DMSO with gentle warming; ≥46.3 mg/mL in EtOH; ≥62.7 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=B7174B7196,Carbamoylcholine chloride,51-83-2,E04,L1021-19,182.65,DMSO,C6H15ClN2O2,O=C(N)OCC[N+](C)(C)C.[Cl-],insoluble in EtOH; ≥4.57 mg/mL in DMSO; ≥52.3 mg/mL in H2O,,Neuroscience,Nicotinic Receptor,Cholinergic receptor agonist,https://www.apexbt.com/search.php?catalog=B7196B7201,_-Estradiol,57-91-0,E05,L1021-19,272.38,DMSO,C18H24O2,O[[C@H]1[[C@H]2(C)[[C@@H](CC1)[[C@H](CCC3=C4C=CC(O)=C3)[[C@@H]4CC2,insoluble in H2O; ≥13.15 mg/mL in EtOH; ≥23.25 mg/mL in DMSO with ultrasonic,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Endogenous estrogen receptor ligand,https://www.apexbt.com/search.php?catalog=B7201B7205,Mecamylamine hydrochloride,826-39-1,E06,L1021-19,203.75,DMSO,C11H21N·HCl,CC([[C@@H]1C[[C@H]2CC1)(C)[[C@H@]2(C)NC.Cl,insoluble in H2O; ≥20.4 mg/mL in EtOH; ≥20.6 mg/mL in DMSO,,Neuroscience,Nicotinic Receptor,nicotinic acetylcholine receptor antagonist,https://www.apexbt.com/search.php?catalog=B7205B7226,Atipamezole hydrochloride,104075-48-1,E07,L1021-19,248.75,DMSO,C14H16N2·HCl,CCC1(C2=CN=CN2)CC3=CC=CC=C3C1.Cl,≥2.39 mg/mL in DMSO with gentle warming and ultrasonic; ≥24.9 mg/mL in EtOH with ultrasonic; ≥9.68 mg/mL in H2O with ultrasonic,,GPCR/G protein,Adrenergic Receptor,_2-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B7226B7261,Desipramine hydrochloride,58-28-6,E08,L1021-19,302.84,DMSO,C18H22N2·HCl,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C13.Cl,≥119.6 mg/mL in DMSO; ≥15.73 mg/mL in H2O with ultrasonic; ≥2.9 mg/mL in EtOH with gentle warming and ultrasonic,,GPCR/G protein,Adrenergic Transporters,noradrenalin transporters inhibitor,https://www.apexbt.com/search.php?catalog=B7261B7262,Tetraethylammonium chloride,56-34-8,E09,L1021-19,165.2,EtOH,C8H20ClN,CC[N+](CC)(CC)CC.[Cl-],≥12.1 mg/mL in DMSO with ultrasonic; ≥16.5 mg/mL in EtOH; ≥29.1 mg/mL in H2O,#N/A,Membrane Transporter/Ion Channel,Potassium Channel,K+ channel blocker,https://www.apexbt.com/search.php?catalog=B7262B7293,Sodium phosphate dibasic,7558-79-4,E10,L1021-19,141.96,H2O,Na2HPO4,OP([O-])([O-])=O.[Na+].[Na+],insoluble in DMSO; insoluble in EtOH; ≥14.2 mg/mL in H2O,,Others,Reagents,Commonly used in biological assay buffers,https://www.apexbt.com/search.php?catalog=B7293B7294,DL-Dithiothreitol,3483-12-3,E11,L1021-19,154.25,H2O,C4H10O2S2,SC[[C@H]([[C@@H](CS)O)O,≥15.4 mg/mL in H2O; ≥34 mg/mL in DMSO; ≥37.4 mg/mL in EtOH,#N/A,Others,Reagents,Reagent for maintaining SH groups in the reduced state,https://www.apexbt.com/search.php?catalog=B7294B7297,Citric acid,77-92-9,F01,L1021-19,192.12,H2O,C6H8O7,OC(CC(O)=O)(C(O)=O)CC(O)=O,insoluble in DMSO; ≥19.2 mg/mL in H2O; ≥24.1 mg/mL in EtOH,,Others,Reagents,Commonly used laboratory reagent,https://www.apexbt.com/search.php?catalog=B7297B7336,Thiostrepton,1393-48-2,F02,L1021-19,1664.89,DMSO,C72H85N19O18S5,CCC(C)C1NC2C=CC3=C(C=C(N=C3C2O)C(=O)OC(C)C4NC(=O)C5=CSC(=N5)C(NC(=O)C6CSC(=N6)\C(NC(=O)C(NC(=O)C7=CSC(=N7)C8(CCC(=NC8C9=CSC4=N9)C%10=NC(=CS%10)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C\C)C(C)(O)C(C)O)C(C)O,insoluble in EtOH; insoluble in H2O; ≥14.4 mg/mL in DMSO,,DNA Damage/DNA Repair,DNA Synthesis,,https://www.apexbt.com/search.php?catalog=B7336B7341,Canrenone,976-71-6,F03,L1021-19,340.46,DMSO,C22H28O3,O=C1O[[C@H]2(CC1)[[C@H]3(C)[[C@@H](CC2)[[C@H](C=C4)[[C@@H]([[C@H](CC5)(C)C4=CC5=O)CC3,insoluble in H2O; ≥21.15 mg/mL in EtOH; ≥51.1 mg/mL in DMSO,,Others,Mineralocorticoid Receptor,Mineralocorticoid receptor antagonist,https://www.apexbt.com/search.php?catalog=B7341B7347,Metyrapone,54-36-4,F04,L1021-19,226.27,DMSO,C14H14N2O,O=C(C1=CC=CN=C1)C(C)(C)C2=CC=CN=C2,≥13.45 mg/mL in H2O; ≥42.1 mg/mL in DMSO; ≥59.1 mg/mL in EtOH,,Others,Hydroxylases,11-_ hydroxylase (CYP11B1) inhibitor,https://www.apexbt.com/search.php?catalog=B7347B7409,Astemizole,68844-77-9,F05,L1021-19,458.57,DMSO,C28H31FN4O,FC1=CC=C(C=C1)CN2C(NC3CCN(CCC(C=C4)=CC=C4OC)CC3)=NC5=CC=CC=C25,insoluble in H2O; ≥11.46 mg/mL in DMSO with gentle warming; ≥12.46 mg/mL in EtOH,#N/A,Neuroscience,Histamine Receptor,"anti-histamine compound, potent",https://www.apexbt.com/search.php?catalog=B7409B7438,Estropipate,7280-37-7,F06,L1021-19,436.56,DMSO,C18H22O5S·C4H10N2,O=C1[[C@H@]2(C)[[C@H](CC1)[[C@H](CCC3=CC(OS(O)(=O)=O)=CC=C43)[[C@H]4CC2.N5CCNCC5,insoluble in H2O; insoluble in EtOH; ≥20.7 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor agonist,https://www.apexbt.com/search.php?catalog=B7438B7446,Tramiprosate,3687-18-1,F07,L1021-19,139.17,H2O,C3H9NO3S,OS(=O)(CCCN)=O,insoluble in DMSO; insoluble in EtOH; ≥5.65 mg/mL in H2O,,Neuroscience,Amyloid _,,https://www.apexbt.com/search.php?catalog=B7446B7456,Allopregnanolone,516-54-1,F08,L1021-19,318.49,DMSO,C21H34O2,O[[C@H]1C[[C@H]2[[C@H@](CC1)(C)[[C@@H]3[[C@@H](CC2)[[C@H]4[[C@H]([[C@@H](C(C)=O)CC4)(C)CC3,insoluble in H2O; ≥27.3 mg/mL in DMSO; ≥28.2 mg/mL in EtOH,,Membrane Transporter/Ion Channel,GABA Receptor,GABAA receptor positive allosteric modulator,https://www.apexbt.com/search.php?catalog=B7456B7469,Corticosterone,50-22-6,F09,L1021-19,346.46,DMSO,C21H30O4,O[[C@@H]1[[C@H]([[C@H](CC2)(C)C3=CC2=O)[[C@@H](CC3)[[C@H]4[[C@H]([[C@@H](C(CO)=O)CC4)(C)C1,insoluble in H2O; insoluble in EtOH; ≥14.5 mg/mL in DMSO ,,GPCR/G protein,Glucocorticoid Receptor,,https://www.apexbt.com/search.php?catalog=B7469B7514,Tranylcypromine hydrochloride,1986-47-6,F10,L1021-19,169.65,DMSO,C9H11N·HCl,N[[C@H]1[[C@H](C2=CC=CC=C2)C1.Cl,≥54.3 mg/mL in H2O; ≥54.9 mg/mL in EtOH; ≥7.8 mg/mL in DMSO,,Chromatin/Epigenetics,Histone Demethylases,LSD1/BHC110 and monoamine oxidase (MAO) inhibitor,https://www.apexbt.com/search.php?catalog=B7514B7587,Puromycin dihydrochloride,58-58-2,F11,L1021-19,544.43,DMSO,C22H29N7O5·2HCl,O[[C@H]1[[C@H]([[C@@H](CO)O[[C@H]1N2C3=NC=NC(N(C)C)=C3N=C2)NC([[C@H](CC(C=C4)=CC=C4OC)N)=O.Cl.Cl,≥27.2 mg/mL in DMSO; ≥3.27 mg/mL in EtOH with ultrasonic; ≥99.4 mg/mL in H2O,Salt,DNA Damage/DNA Repair,DNA Synthesis,allows selection for cells expressing the resistance gene puromycin N-acetyl-transferase (PAC) and successful Cas9-induced knock-in with puromycin resistance gene.,https://www.apexbt.com/search.php?catalog=B7587B7590,Quinidine,56-54-2,G01,L1021-19,324.42,DMSO,C20H24N2O2,O[[C@H](C(C1=C2)=CC=NC1=CC=C2OC)[[C@@H]3[[C@H@]4C[[C@@H](C=C)[[C@@H](CC4)C3,insoluble in H2O; ≥10.32 mg/mL in EtOH with ultrasonic; ≥11.95 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Other Channel Modulators,reduces both Na+ and K+ channel currents,https://www.apexbt.com/search.php?catalog=B7590B7617,Prostaglandin F2_,38562-01-5,G02,L1021-19,475.62,H2O,C20H34O5·C4H11NO3,O[[C@@H](C1)[[C@H](C/C=C\CCCC(O)=O)[[C@@H](/C=C/[[C@H](CCCCC)O)[[C@@H]1O.OCC(CO)(CO)N,≥92.9 mg/mL in H2O; ≥106 mg/mL in DMSO; ≥49.6 mg/mL in EtOH,,GPCR/G protein,Prostanoid Receptors,Prostaglandin E2 and F2_ receptor agonist,https://www.apexbt.com/search.php?catalog=B7617B7648,Phosphocreatine disodium salt,922-32-7,G03,L1021-19,255.08,H2O,C4H8N3Na2O5P,OC(CN(C)/C(N)=N/P([O-])([O-])=O)=O.[Na+].[Na+],insoluble in ETOH; insoluble in DMSO; ≥54.6 mg/mL in H2O,,Others,Miscellaneous Compounds,used to regenerate ATP during skeletal muscle contraction,https://www.apexbt.com/search.php?catalog=B7648B7684,Digoxin,20830-75-5,G04,L1021-19,780.94,DMSO,C41H64O14,O[[C@H]1([[C@H]([[C@@H](C2=CC(OC2)=O)CC1)(C)[[C@@H]3O)[[C@H]4[[C@H](C3)[[C@H](CC[[C@@H]5O[[C@@H](C[[C@@H]6O)O[[C@H](C)[[C@H]6O[[C@@H](C[[C@@H]7O)O[[C@H](C)[[C@H]7O[[C@@H](C[[C@@H]8O)O[[C@H](C)[[C@H]8O)(C)[[C@@H](C5)CC4,≥33.25 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Membrane Transporter/Ion Channel,ATPase,Na+/K+ ATPase pump inhibitor,https://www.apexbt.com/search.php?catalog=B7684B7687,Auranofin,34031-32-8,G05,L1021-19,678.48,DMSO,C20H34AuO9PS,O=C(C)OC1C(OC(C)=O)C(OC(C)=O)C(COC(C)=O)OC1[S-].CCP(CC)CC.[Au+],≥67.8 mg/mL in DMSO; insoluble in H2O; ≥31.6 mg/mL in EtOH,,Others,Reductases,thioredoxin reductase (TrxR) inhibitor,https://www.apexbt.com/search.php?catalog=B7687B7705,Lithium carbonate,554-13-2,G06,L1021-19,73.89,H2O,Li2CO3,[O-]C([O-])=O.[Li+].[Li+],insoluble in EtOH; ≥2.74 mg/mL in DMSO with ultrasonic; ≥3.95 mg/mL in H2O,,Membrane Transporter/Ion Channel,ATPase,,https://www.apexbt.com/search.php?catalog=B7705B7775,L-Glutathione Reduced,70-18-8,G07,L1021-19,307.32,H2O,C10H17N3O6S,SC[[C@@H](C(NCC(O)=O)=O)NC(CC[[C@@H](C(O)=O)N)=O,insoluble in EtOH; insoluble in DMSO; ≥14.25 mg/mL in H2O,,Others,Antioxidants,used to elute glutathione S-transferase (GST) from glutathione agarose.,https://www.apexbt.com/search.php?catalog=B7775B7781,Urea,57-13-6,G08,L1021-19,60.06,DMSO,CH4N2O,O=C(N)N,≥19.27 mg/mL in EtOH with ultrasonic; ≥55.7 mg/mL in H2O; ≥6 mg/mL in DMSO,,Others,Reagents,organic compound,https://www.apexbt.com/search.php?catalog=B7781B7804,AG-221 (Enasidenib),1446502-11-9,G09,L1021-19,473.37,DMSO,C19H17F6N7O,CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1,≥47.3 mg/mL in DMSO; insoluble in H2O; ≥22.9 mg/mL in EtOH,,Metabolism,Dehydrogenase,mutant isocitrate dehydrogenase 2 (IDH2) inhibitor,https://www.apexbt.com/search.php?catalog=B7804B7805,AG-120,1448347-49-6,G10,L1021-19,582.96,DMSO,C28H22ClF3N6O3,O=C([[C@H](CC1)N(C2=NC=CC(C#N)=C2)C1=O)N([[C@@H](C3=CC=CC=C3Cl)C(NC4CC(F)(F)C4)=O)C5=CC(F)=CN=C5,≥58.3 mg/mL in DMSO; insoluble in H2O; ≥63.3 mg/mL in EtOH,,Metabolism,Dehydrogenase,,https://www.apexbt.com/search.php?catalog=B7805B7813,"Olmutinib (HM61713, BI 1482694)",1353550-13-6,G11,L1021-19,486.59,DMSO,C26H26N6O2S,C=CC(NC1=CC=CC(OC2=C3C(C=CS3)=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=N2)=C1)=O,insoluble in H2O; ≥9.11 mg/mL in EtOH with ultrasonic; ≥96.6 mg/mL in DMSO,#N/A,Tyrosine Kinase,EGFR,EGFR mutant-specific inhibitor,https://www.apexbt.com/search.php?catalog=B7813B7845,Imidazole,288-32-4,H01,L1021-19,68.08,H2O,C3H4N2,C1=CN=CN1,≥46.6 mg/mL in DMSO; ≥54.5 mg/mL in EtOH; ≥6.8 mg/mL in H2O,,Metabolism,phosphatases,,https://www.apexbt.com/search.php?catalog=B7845B7846,sodium fluoride ,7681-49-4,H02,L1021-19,41.99,H2O,FNa,[F-].[Na+],insoluble in DMSO; insoluble in EtOH; ≥4.2 mg/mL in H2O,,Metabolism,phosphatases,,https://www.apexbt.com/search.php?catalog=B7846B7849,Rimantadine Hydrochloride,1501-84-4,H03,L1021-19,215.76,DMSO,C12H22ClN,N[[C@H](C)[[C@H]1(C[[C@H]2C3)C[[C@@H](C2)C[[C@H]3C1.Cl,≥21.6 mg/mL in DMSO; ≥9.24 mg/mL in H2O; ≥9.88 mg/mL in EtOH,,Microbiology & Virology,Influenza A virus,anti-influenza virus drug,https://www.apexbt.com/search.php?catalog=B7849B7854,o-Phenanthroline,66-71-7,H04,L1021-19,180.21,DMSO,C12H8N2,C(C=CC=N1)(C=C2)=C1C3=C2C=CC=N3,insoluble in H2O; ≥360.42 mg/mL in DMSO; ≥58.9 mg/mL in EtOH,#N/A,Proteases,Other Proteases,metalloprotease inhibitor,https://www.apexbt.com/search.php?catalog=B7854B7864,2-Deoxy-D-ribose,533-67-5,H05,L1021-19,134.13,DMSO,C5H10O4+adduct,O=CC[[C@H@](O)([H])[[C@H@](O)([H])CO,≥10.56 mg/mL in EtOH with gentle warming and ultrasonic; ≥13.4 mg/mL in DMSO; ≥49.3 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=B7864B7866,2-Deoxyuridine,951-78-0,H06,L1021-19,228.2,DMSO,C9H12N2O5,OC[[C@H](O1)([H])[[C@H](O)([H])C[[C@H]1([H])N2C=CC(O)=NC2=O,≥22.8 mg/mL in DMSO; insoluble in EtOH; ≥17.57 mg/mL in H2O,,Others,kinase,"Rutin metabolite, antioxidant",https://www.apexbt.com/search.php?catalog=B7866B7869,4-Aminobenzoic acid,150-13-0,H07,L1021-19,137.14,DMSO,C7H7NO2,NC1=CC=C(C(O)=O)C=C1,insoluble in H2O; ≥13.7 mg/mL in DMSO; ≥25.25 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=B7869B7870,4-Hydroxybenzoic acid,99-96-7,H08,L1021-19,138.12,DMSO,C7H6O3,OC1=CC=C(C(O)=O)C=C1,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥30.5 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=B7870B7872,5-Methoxytryptamine,608-07-1,H09,L1021-19,190.24,DMSO,C11H14N2O,COC1=CC(C(CCN)=CN2)=C2C=C1,insoluble in H2O; ≥19 mg/mL in DMSO; ≥28.05 mg/mL in EtOH,,Neuroscience,5-HT Receptor,"Full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors but has no affinity for the 5-HT3 receptor",https://www.apexbt.com/search.php?catalog=B7872B7876,Adenosine 5-triphosphate,34369-07-8,H10,L1021-19,507.18,H2O,C10H16N5O13P3,NC1=C(N=CN2[[C@H@]3([H])[[C@H@](O)([H])[[C@H@](O)([H])[[C@H@](O3)([H])COP(O)(OP(O)(OP(O)(O)=O)=O)=O)C2=NC=N1,≥50.7 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO,,Others,Others,Purinergic P2 receptor agonist,https://www.apexbt.com/search.php?catalog=B7876B7879,Cellobiose,528-50-7,H11,L1021-19,342.3,H2O,C12H22O11,OC[[C@H]1([H])[[C@H](O)([H])[[C@H@](O)([H])[[C@H](O)([H])[[C@H@](O[[C@H]([[C@H@](O)([H])[[C@H](O)([H])[[C@H]2([H])O)([H])[[C@H@](O2)([H])CO)([H])O1,≥34.2 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=B7879B7894,L-Arabinose,5328-37-0,A01,L1021-20,150.13,DMSO,C5H10O5,O[[C@H@]1([H])COC(O)([H])[[C@H@](O)([H])[[C@H@]1([H])O,insoluble in EtOH; ≥15 mg/mL in DMSO; ≥46.5 mg/mL in H2O,,Others,Others,"Aldopentose,component of biopolymers like hemicellulose and pectin",https://www.apexbt.com/search.php?catalog=B7894B7900,Malonic acid,141-82-2,A02,L1021-20,104.06,DMSO,C3H4O4,O=C(O)CC(O)=O,≥10.4 mg/mL in DMSO; ≥104 mg/mL in H2O; ≥119.8 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=B7900B7901,Melibiose,585-99-9,A03,L1021-20,342.3,DMSO,C12H22O11,O=C[[C@H@](O)([H])[[C@H](O)([H])[[C@H@](O)([H])[[C@H@](O)([H])CO[[C@H]1([H])[[C@H@](O)([H])[[C@H](O)([H])[[C@H](O)([H])[[C@H@](O1)([H])CO,insoluble in EtOH; ≥29.1 mg/mL in H2O; ≥53.6 mg/mL in DMSO,,Others,Others,"Reducing disaccharide, carbon substrate",https://www.apexbt.com/search.php?catalog=B7901B7902,m-Hydroxybenzoic acid,99-06-9,A04,L1021-20,138.12,DMSO,C7H6O3,OC1=CC=CC(C(O)=O)=C1,≥48 mg/mL in EtOH; ≥6.9 mg/mL in H2O with gentle warming and ultrasonic; ≥60.5 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=B7902B7903,myo-Inositol,87-89-8,A05,L1021-20,180.16,DMSO,C6H12O6+adduct,OC1C(O)C(O)C(O)C(O)C1O,insoluble in EtOH; ≥42.35 mg/mL in H2O; ≥9 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=B7903B7905,N-Acetylneuraminic acid,131-48-6,A06,L1021-20,309.27,H2O,C11H19NO9,C/C(O)=N/[[C@H]([[C@H](O1)([H])[[C@H@](O)([H])[[C@H@](O)([H])CO)([H])[[C@H](O)([H])C[[C@H@]1(O)C(O)=O,≥30.9 mg/mL in H2O; insoluble in EtOH; ≥2.3 mg/mL in DMSO with gentle warming and ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=B7905B7907,N-Carbamyl-L-glutamic acid,1188-38-1,A07,L1021-20,190.15,DMSO,C6H10N2O5,N=C(O)N[[C@H@](C(O)=O)([H])CCC(O)=O,insoluble in EtOH; ≥19 mg/mL in DMSO; ≥8.64 mg/mL in H2O with ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=B7907B7910,Pyridoxal 5 phosphate,54-47-7,A08,L1021-20,247.14,DMSO,C8H10NO6P,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=N1,insoluble in EtOH; insoluble in H2O; ≥12.35 mg/mL in DMSO with gentle warming and ultrasonic,,Metabolism,Vitamin,,https://www.apexbt.com/search.php?catalog=B7910B7911,Pyridoxal hydrochloride,65-22-5,A09,L1021-20,203.62,DMSO,C8H9NO3,CC1=C(O)C(C=O)=C(CO)C=N1.Cl,≥20.4 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥46.4 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=B7911B7912,Pyridoxine,65-23-6,A10,L1021-20,169.18,DMSO,C8H11NO3,CC1=C(O)C(CO)=C(CO)C=N1,insoluble in EtOH; ≥16.9 mg/mL in DMSO; ≥57.9 mg/mL in H2O,,Metabolism,Vitamin,,https://www.apexbt.com/search.php?catalog=B7912B7917,Vanillic acid,121-34-6,A11,L1021-20,168.15,DMSO,C8H8O4,COC1=C(O)C=CC(C(O)=O)=C1,≥22.45 mg/mL in DMSO; ≥5.6 mg/mL in H2O with gentle warming and ultrasonic; ≥9.14 mg/mL in EtOH,,Others,Others,Used as a precursor in the synthesis of a wide range of bio-based epoxy resins and polyesters,https://www.apexbt.com/search.php?catalog=B7917B7936,Flavin adenine dinucleotide disodium,84366-81-4,B01,L1021-20,829.51,H2O,C27H31N9Na2O15P2,CC1=CC(N=C(C([O-])=N2)C3=NC2=O)=C(N3C[[C@H@](O)([H])[[C@H@](O)([H])[[C@H@](O)([H])COP([O-])(OP(O)(OC[[C@H](O4)([H])[[C@H](O)([H])[[C@H](O)([H])[[C@H]4([H])N5C=NC(C5=NC=N6)=C6N)=O)=O)C=C1C.[Na+].[Na+],insoluble in DMSO; insoluble in EtOH; ≥207.5 mg/mL in H2O,,Metabolism,Endogenous Metabolite,"Redox cofactor (electron carrier), involved in several important enzymatic reactions in metabolism",https://www.apexbt.com/search.php?catalog=B7936B7960,Vadadustat,1000025-07-9,B02,L1021-20,306.7,DMSO,C14H11ClN2O4,OC1=CC(C2=CC=CC(Cl)=C2)=CN=C1C(NCC(O)=O)=O,insoluble in H2O; ≥57.7 mg/mL in DMSO; ≥9.66 mg/mL in EtOH,#N/A,,,HIF-PH inhibitor,https://www.apexbt.com/search.php?catalog=B7960B8019,Pimavanserin,706779-91-1,B03,L1021-20,427.55,DMSO,C25H34FN3O2,FC1=CC=C(C=C1)CN(C(NCC(C=C2)=CC=C2OCC(C)C)=O)C3CCN(C)CC3,≥21.38 mg/mL in DMSO; insoluble in H2O; ≥54.5 mg/mL in EtOH,Free Base,GPCR/G protein,5-HT Receptor,5-HT2A inverse agonist,https://www.apexbt.com/search.php?catalog=B8019B8021,GS-7340,379270-37-8,B04,L1021-20,476.47,DMSO,C21H29N6O5P,O=[[C@H@](N[[C@H](C(OC(C)C)=O)C)(CO[[C@H](C)CN1C2=NC=NC(N)=C2N=C1)OC3=CC=CC=C3,insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL in DMSO,Free Base,Microbiology & Virology,HIV,HIV reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B8021B8214,Dihydrotestosterone(DHT),521-18-6,B05,L1021-20,290.44,DMSO,C19H30O2,C[[C@H]12CCC(C[[C@H]1([H])CC[[C@H@]3([H])[[C@H]4([H])CC[[C@H](O)[[C@H@](CC[[C@H@]32[H])4C)=O,≥29 mg/mL in DMSO; insoluble in H2O; ≥13.6 mg/mL in EtOH,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=B8214B8227,Avibactam sodium,1192491-61-4,B06,L1021-20,287.23,DMSO,C7H10N3NaO6S,O=S(ON1[[C@H@]2(CC[[C@H]([[C@H](C1=O)C2)C(N)=O)[H])([O-])=O.[Na+],≥28.7 mg/mL in DMSO; insoluble in EtOH; ≥48.2 mg/mL in H2O,,Microbiology & Virology,Anti-infection,_-lactamase inhibitor,https://www.apexbt.com/search.php?catalog=B8227B8316,Harmine,442-51-3,B07,L1021-20,212.25,DMSO,C13H12N2O,CC1=NC=CC2=C1NC3=C2C=CC(OC)=C3,insoluble in H2O; ≥33 mg/mL in DMSO with ultrasonic; ≥6.35 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,"PPAR,MAO","Potent and selective inhibitor of DYRK1A, 5-HT antagonist and MAO inhibitor",https://www.apexbt.com/search.php?catalog=B8316B8352,Urethane,51-79-6,B08,L1021-20,89.09,DMSO,C3H7NO2,NC(OCC)=O,≥11.8 mg/mL in EtOH; ≥13.3 mg/mL in H2O; ≥15.9 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=B8352B8359,_-L-Rhamnose monohydrate,6155-35-7,B09,L1021-20,182.17,DMSO,C6H14O6,C[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)O1.O,≥14.15 mg/mL in H2O; ≥51.4 mg/mL in DMSO; ≥9.42 mg/mL in EtOH,,Others,Others,"Part of plant cell wall polysaccharides, rhamnogalacturonan I and rhamnogalacturonan",https://www.apexbt.com/search.php?catalog=B8359B8374,Indinavir sulfate,157810-81-6,B10,L1021-20,711.87,DMSO,C36H49N5O8S,CC(C)(C)NC(=O)C1CN(CCN1CC(O)CC(CC2=CC=CC=C2)C(=O)NC3C(O)CC4=C3C=CC=C4)CC5=CN=CC=C5.O[S](O)(=O)=O,insoluble in EtOH; ≥29.6 mg/mL in H2O; ≥35 mg/mL in DMSO,Sulfate,,,,https://www.apexbt.com/search.php?catalog=B8374B8387,Erdafitinib,1346242-81-6,B11,L1021-20,446.54,DMSO,C25H30N6O2,CN(N=C1)C=C1C2=NC3=CC(N(CCNC(C)C)C4=CC(OC)=CC(OC)=C4)=CC=C3N=C2,insoluble in H2O; ≥15 mg/mL in EtOH; ≥54.5 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=B8387B8389,Butamben,94-25-7,C01,L1021-20,193.24,DMSO,C11H15NO2,NC1=CC=C(C(OCCCC)=O)C=C1,insoluble in H2O; ≥46 mg/mL in EtOH; ≥66.5 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=B8389B8398,Remdesivir (GS-5734),1809249-37-3,C02,L1021-20,602.58,DMSO,C27H35N6O8P,NC1=NC=NN2C1=CC=C2[[C@H@]3(C#N)[[C@H](O)[[C@H](O)[[C@@H](COP(OC4=CC=CC=C4)(N[[C@@H](C)C(OCC(CC)CC)=O)=O)O3,insoluble in H2O; insoluble in EtOH; ≥51.4 mg/mL in DMSO,#N/A,,,Antiviral nucleoside analogue,https://www.apexbt.com/search.php?catalog=B8398B8453,Baloxavir marboxil,1985606-14-1,C03,L1021-20,571.55,DMSO,C27H23F2N3O7S,O=C1C=CN(N([[C@H]2(N(C3=O)CCOC2)[H])[[C@H]4C5=CC=C(C(F)=C5CSC6=CC=CC=C46)F)C3=C1OCOC(OC)=O,insoluble in EtOH; insoluble in H2O; ≥43.8 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=B8453B8486,Roquinimex,84088-42-6,C04,L1021-20,308.33,DMSO,C18H16N2O3,CN(C1=CC=CC=C1)C(=O)C2=C(O)C3=C(C=CC=C3)N(C)C2=O,≥30.8 mg/mL in DMSO,Free Base,Immunology & Inflammation,Immunology & Inflammation related,inhibits the secretion of TNF-_,https://www.apexbt.com/search.php?catalog=B8486B8600,Thiamine pyrophosphate,154-87-0,C05,L1021-20,460.767382,H2O,C12H19ClN4O7P2S,[Cl-].CC1=NC=C(C[N+]2=CSC(=C2C)CCO[P](O)(=O)O[P](O)(O)=O)C(=N1)N,insoluble in DMSO; insoluble in EtOH; ≥50.1 mg/mL in H2O,hydrochloride,Metabolism,Vitamin,"Thiamine pyrophosphate hydrochloride is a thiamine (vitamin B1) derivative which is produced by the enzyme thiamine diphosphokinase. It is a coenzyme of many enzymes, most of which occur in prokaryotes and is involved in the regulation of basic metabolism.",https://www.apexbt.com/search.php?catalog=B8600B8604,L-Arginine (hydrochloride),1119-34-2,C06,L1021-20,210.66,H2O,C12H19ClN4O7P2S,OC([C@@H](N)CCCNC(N)=N)=O.Cl,≥100mg/mL (474.70 mM) in H2O,,Immunology/Inflammation,NOS,Precursor of nitric oxide synthesis,https://www.apexbt.com/search.php?catalog=B8604B8606,R-(_)-Mandelic Acid,611-71-2,C07,L1021-20,152.15,DMSO,C8H8O3,OC([C@H](O)C1=CC=CC=C1)=O,30mg/mL(197.17 mM) in DMSO,,Others,Others,Used as a building block to synthesize pharmaceutical drugs such as penicillin and cephalosporin,https://www.apexbt.com/search.php?catalog=B8606B8623,Irinotecan hydrochloride,100286-90-6,C08,L1021-20,623.14,DMSO,C33H39ClN4O6,O=C(OC1=CC2=C(CC)C3=C(C(N4C3)=CC([C@](CC)(O)C(OC5)=O)=C5C4=O)N=C2C=C1)N(CC6)CCC6N7CCCCC7.Cl,insoluble in EtOH; insoluble in H2O; ≥45.5 mg/mL in DMSO,,DNA Damage/DNA Repair,Autophagy; Topoisomerase,DNA topoisomerase I inhibitor,https://www.apexbt.com/search.php?catalog=B8623B8631,Vitamin K1,84-80-0,C09,L1021-20,450.7,DMSO,C31H46O2,O=C1C(C)=C(C/C=C(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)\C)C(C2=C1C=CC=C2)=O,insoluble in H2O; insoluble in DMSO; ≥18.8 mg/mL in EtOH,,Metabolism system,Osteocalcin,"Essential vitamin for the synthesis of coagulation factors II, VII, IX, and X in the liver",https://www.apexbt.com/search.php?catalog=B8631B8632,L-Cycloserine,339-72-0,C10,L1021-20,102.09,DMSO,C3H6N2O2,O=C1NOC[C@@H]1N,insoluble in EtOH; ≥42.9 mg/mL in H2O; ≥8.78 mg/mL in DMSO,,Metabolism,Transferase,Potent inhibitor of serine palmitoyl transferase (SPT),https://www.apexbt.com/search.php?catalog=B8632B8660,Vitamin A,68-26-8,C11,L1021-20,286.45,DMSO,C20H30O,CC1=C(C(C)(C)CCC1)/C=C/C(C)=C/C=C/C(C)=C/CO,< 1mg/mL (insoluble or slightly soluble) in DMSO;< 0.1mg/mL (insoluble) in H2O,,Others,Others,Precursor of active retinoids,https://www.apexbt.com/search.php?catalog=B8660B8664,Isosorbide Dinitrate,87-33-2,D01,L1021-20,236.14,DMSO,C6H8N2O8,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,47mg/mL(199.03 mM) in DMSO,,Others,Others,Organic nitrate ester and nitric oxide (NO) donor,https://www.apexbt.com/search.php?catalog=B8664B8667,Cilastatin,82009-34-5,D02,L1021-20,358.45,DMSO,C16H26N2O5S,OC([C@H](N)CSCCCC/C=C(C(O)=O)\NC([C@@H]1CC1(C)C)=O)=O,insoluble in EtOH; insoluble in H2O; ≥19.63 mg/mL in DMSO,,Others,Others,Renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor,https://www.apexbt.com/search.php?catalog=B8667B8668,Bambuterol (hydrochloride),81732-46-9,D03,L1021-20,403.9,DMSO,C18H30ClN3O5,OC(CNC(C)(C)C)C1=CC(OC(N(C)C)=O)=CC(OC(N(C)C)=O)=C1.Cl,41mg/mL (101.51 mM; Need ultrasonic and warming) in DMSO,,GPCR/G protein,Adrenergic Receptor,"Prodrug for terbutaline, long-acting _-adrenoceptor agonist",https://www.apexbt.com/search.php?catalog=B8668B8669,Ceftazidime pentahydrate,78439-06-2,D04,L1021-20,636.65,DMSO,C22H32N6O12S2,O=C1N2[C@]([C@@H]1NC(/C(C3=CSC(N)=N3)=N\OC(C)(C(O)=O)C)=O)([H])SCC(C[N+]4=CC=CC=C4)=C2C([O-])=O.O.O.O.O.O,insoluble in EtOH; insoluble in H2O; ≥46 mg/mL in DMSO,,Others,Others,Broad-spectrum _-lactam antibiotic used for parenteral administration,https://www.apexbt.com/search.php?catalog=B8669B8671,Chlortalidone,77-36-1,D05,L1021-20,338.77,DMSO,C14H11ClN2O4S,O=C1NC(O)(C2=CC=C(Cl)C(S(=O)(N)=O)=C2)C3=C1C=CC=C3,insoluble in EtOH; insoluble in H2O; ≥49.7 mg/mL in DMSO,,Others,Others,Diuretic drug used to treat hypertension,https://www.apexbt.com/search.php?catalog=B8671B8675,Etidronate disodium,7414-83-7,D06,L1021-20,249.99,H2O,C2H6Na2O7P2,[Na+].[Na+].CC(O)([P](O)([O-])=O)[P](O)([O-])=O,insoluble in DMSO; insoluble in EtOH; ≥44.7 mg/mL in H2O,Sodium,Others,phosphatase,"Etidronate is a non-aminobisphosphonate, show protein tyrosine phosphatase (PTP) inhibitory activity, used for the treatment of Paget's disease and the prevention of heterotopic ossification.",https://www.apexbt.com/search.php?catalog=B8675B8679,Terconazole,67915-31-5,D07,L1021-20,532.46,DMSO,C26H31Cl2N5O3,ClC1=CC=C([C@@]2(CN3C=NC=N3)OC[C@H](COC4=CC=C(N5CCN(C(C)C)CC5)C=C4)O2)C(Cl)=C1,≥30mg/mL (56.34 mM) in DMSO,,Microbiology & Virology,Anti-infection,Orally bioavailable broad-spectrum triazole antifungal agent,https://www.apexbt.com/search.php?catalog=B8679B8681,Fenoldopam (mesylate),67227-57-0,D08,L1021-20,401.86,DMSO,C17H20ClNO6S,OC1=C(O)C(Cl)=C(CCNCC2C3=CC=C(O)C=C3)C2=C1.O=S(O)(C)=O,insoluble in EtOH; ≥10.8 mg/mL in H2O; ≥52.8 mg/mL in DMSO,,Neuroscience,Dopamine Receptor,Agonist of dopamine D1A (D1R) and D1B (D5R) receptors,https://www.apexbt.com/search.php?catalog=B8681B8682,Nitrofurantoin,67-20-9,D09,L1021-20,238.16,DMSO,C8H6N4O5,O=C(C1)NC(N1/N=C/C2=CC=C([N+]([O-])=O)O2)=O,≥40mg/mL (167.95 mM) in DMSO,,Microbiology & Virology,Anti-infection,"Nitrofuran antibiotic, substrate of bacterial nitrofuran reductase",https://www.apexbt.com/search.php?catalog=B8682B8683,Guanethidine (sulfate),645-43-2,D10,L1021-20,296.39,DMSO,C10H24N4O4S,NC(NCCN1CCCCCCC1)=N.OS(=O)(O)=O,≥24mg/mL (80.97 mM) in H2O,,Others,Others,Antihypertensive agent,https://www.apexbt.com/search.php?catalog=B8683B8684,Nilutamide,63612-50-0,D11,L1021-20,317.22,DMSO,C12H10F3N3O4,[O-][N+](C1=CC=C(N2C(NC(C)(C)C2=O)=O)C=C1C(F)(F)F)=O,63mg/mL(198.6 mM) in DMSO;63mg/mL(198.6 mM) in Ethanol;Insoluble in H2O,,Endocrinology and Hormones,Androgen Receptor,Antagonist of the androgen receptor,https://www.apexbt.com/search.php?catalog=B8684B8690,Acetohydroxamic Acid,546-88-3,E01,L1021-20,75.07,H2O,C2H5NO2,CC(NO)=O,≥200mg/mL (2664.18 mM) in H2O,,Microbiology & Virology,Anti-infection,"Irreversible inhibitor of urease, derivative of hydroxyurea",https://www.apexbt.com/search.php?catalog=B8690B8692,Penicillamine,52-67-5,E02,L1021-20,149.21,H2O,C5H11NO2S,SC(C)(C)[C@@H](N)C(O)=O,≥100mg/mL (670.20 mM) in H2O,,Others,Others,"Orally bioavailable copper chelator, antirheumatic",https://www.apexbt.com/search.php?catalog=B8692B8694,Atropine,51-55-8,E03,L1021-20,289.37,DMSO,C17H23NO3,O=C(C(CO)C1=CC=CC=C1)OC2C[C@@]3([H])N(C)[C@](C2)([H])CC3,insoluble in H2O; ≥21.95 mg/mL in DMSO; ≥23.8 mg/mL in EtOH,,Neuroscience,mAChR,"Non-selective, competitive antagonist of the muscarinic acetylcholine receptor",https://www.apexbt.com/search.php?catalog=B8694B8697,Crotamiton,483-63-6,E04,L1021-20,203.28,DMSO,C13H17NO,O=C(/C=C/C)N(CC)C1=C(C)C=CC=C1,insoluble in H2O; ≥56.6 mg/mL in DMSO; ≥64.7 mg/mL in EtOH,,Microbiology & Virology,Parasite,Scabicidal and antipruritic agent,https://www.apexbt.com/search.php?catalog=B8697B8699,Fluorometholone,426-13-1,E05,L1021-20,376.46,DMSO,C22H29FO4,O=C1C=C[C@@]2(C)C([C@@H](C)C[C@]([C@@](CC[C@]3(O)C(C)=O)([H])[C@]3(C)C[C@@H]4O)([H])[C@@]24F)=C1,insoluble in EtOH; insoluble in H2O; ≥20.35 mg/mL in DMSO,,GPCR/G protein,Glucocorticoid Receptor,Synthetic glucocorticoid with anti-inflammatory and anti-allergic properties,https://www.apexbt.com/search.php?catalog=B8699B8702,Flunisolide,3385-03-3,E06,L1021-20,434.5,DMSO,C24H31FO6,F[C@H]1C[C@@]([C@]([C@@](C)(C=C2)C1=C([H])C2=O)([H])[C@H]3O)([H])[C@@]4([H])[C@@](C3)(C)[C@]5(C(CO)=O)OC(C)(C)O[C@]5([H])C4,≥250mg/mL (575.37 mM) in DMSO,,,,Fluorinated corticosteroid receptor agonist,https://www.apexbt.com/search.php?catalog=B8702B8711,Rasagiline,136236-51-6,E07,L1021-20,171.24,DMSO,C12H13N,C#CCN[C@@H]1CCC2=C1C=CC=C2,insoluble in H2O; ≥47 mg/mL in DMSO; ≥49.1 mg/mL in EtOH,,Metabolism,MAO,Selective and irreversible propargylamine inhibitor of monoamine oxidase (MAO) B,https://www.apexbt.com/search.php?catalog=B8711B8714,Quinine,130-95-0,E08,L1021-20,324.42,DMSO,C20H24N2O2,O[C@H](C1=C(C=C2OC)C(C=C2)=NC=C1)[C@@]3([H])[N@@]4CC(C=C)[C@](CC4)([H])C3,insoluble in H2O; ≥49.4 mg/mL in DMSO; ≥50.5 mg/mL in EtOH,,Microbiology & Virology,Parasite; Potassium Channel,"Potassium channel blocker, orally active",https://www.apexbt.com/search.php?catalog=B8714B8718,Dolasetron,115956-12-2,E09,L1021-20,324.37,DMSO,C19H20N2O3,O=C(O[[C@H]1C[[C@H]([H])([[C@H]([[C@H@]([H])(C2)C1)C3)CC2C3=O)C4=CNC5=C4C=CC=C5,insoluble in H2O; ≥27.15 mg/mL in EtOH; ≥56.2 mg/mL in DMSO,,GPCR/G Protein,5-HT3,Potent antagonist of the serotonin (5-HT) receptor subtype 5-HT3,https://www.apexbt.com/search.php?catalog=B8718B8719,Tolazamide,1156-19-0,E10,L1021-20,311.4,DMSO,C14H21N3O3S,O=C(NS(C1=CC=C(C)C=C1)(=O)=O)NN2CCCCCC2,≥39mg/mL (125.24 mM) in DMSO,,Others,Others,Sulfonylurea receptor 1 (SUR1) inhibitor,https://www.apexbt.com/search.php?catalog=B8719B9001,"Dibutyryl-cAMP, sodium salt",16980-89-5,E11,L1021-20,491.37,DMSO,C18H23N5NaO8P,CCCC(NC1=NC=NC2=C1N=CN2[[C@H]3O[[C@H]4[[C@@H](OP(OC4)([O-])=O)[[C@H]3OC(CCC)=O)=O.[Na+],≥49.1 mg/mL in H2O; ≥23.7 mg/mL in DMSO; ≥3.21 mg/mL in EtOH with gentle warming and ultrasonic,,MAPK Signaling,cAMP,Cell-permeable cAMP analog that activates cAMP-dependent protein kinases,https://www.apexbt.com/search.php?catalog=B9001C3055,3-acetyl-11-keto-_-Boswellic Acid,67416-61-9,F01,L1021-20,512.7,DMSO,C32H48O5,O=C1C=C2[[C@H](CC[[C@H]3(C)[[C@H@]2([H])[[C@@H](C)[[C@H](C)CC3)(C)[[C@H]4(C)CC[[C@H@]5([H])[[C@H@](C)(C(O)=O)[[C@H](OC(C)=O)CC[[C@H]5(C)[[C@H]41[H],insoluble in H2O; ≥27.95 mg/mL in EtOH; ≥53 mg/mL in DMSO,#N/A,Metabolism,5-Lipoxygenase,5-lipoxygenase inhibitor,https://www.apexbt.com/search.php?catalog=C3055C3090,Polymyxin B (sulfate),1405-20-5,F02,L1021-20,1301.6,H2O,C56H98N16O13·H2SO4,O=C(C(NC(C(CCN)NC(CCCCC(C)CC)=O)=O)C(C)O)NC(CCN)C(NC(CCNC(C(NC(C(NC(C(CCN)N1)=O)CCN)=O)C(O)C)=O)C(NC(CCN)C(NC(CC2=CC=CC=C2)C(NC(CC(C)C)C1=O)=O)=O)=O)=O.O=S(O)(O)=O,≤2mg/ml in PBS(pH7.2),#N/A,Microbiology & Virology,Antibiotic,bactericidal activity against major multidrug-resistant Gram-negative bacteria.,https://www.apexbt.com/search.php?catalog=C3090C3106,Pargyline (hydrochloride),306-07-0,F03,L1021-20,195.7,DMSO,C11H13N·HCl,CN(CC#C)CC1=CC=CC=C1.Cl,≥33.55 mg/mL in EtOH; ≥51.6 mg/mL in H2O; ≥7.55 mg/mL in DMSO,,Metabolism,MAO,MAO inhibitor,https://www.apexbt.com/search.php?catalog=C3106C3108,Linoleic Acid,60-33-3,F04,L1021-20,280.45,DMSO,C18H32O2,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,insoluble in H2O; ≥29 mg/mL in EtOH; ≥31.6 mg/mL in DMSO,,Others,Others,"Essential fatty acid, precursor of arachidonic acid (AA) and various prostaglandins",https://www.apexbt.com/search.php?catalog=C3108C3119,Clenbuterol (hydrochloride),21898-19-1,F05,L1021-20,313.7,DMSO,C12H18Cl2N2O·HCl,ClC1=CC(C(O)CNC(C)(C)C)=CC(Cl)=C1N.Cl,insoluble in H2O; ≥13.15 mg/mL in DMSO; ≥16.3 mg/mL in EtOH,,GPCR/G protein,Adrenergic Receptor,sympathomimetic _2-adrenoceptor agonist used as a bronchodilator in the treatment of pulmonary diseases,https://www.apexbt.com/search.php?catalog=C3119C3233,Tauroursodeoxycholic Acid,14605-22-2,F06,L1021-20,499.7,DMSO,C26H45NO6S,C[C@H](CCC(NCCS(O)(=O)=O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C,≥50 mg/mL in DMSO; ≥4.8 mg/mL in H2O with ultrasonic; ≥55.7 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C3233C3238,Methicillin (sodium salt),132-92-3,F07,L1021-20,402.4,DMSO,C17H19N2O6S·Na,O=C(N[[C@@H]1C(N2[[C@H]1([H])SC(C)(C)[[C@@H]2C([O-])=O)=O)C3=C(OC)C=CC=C3OC.[Na+],≥14.4 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,semisynthetic penicillin antibiotic,https://www.apexbt.com/search.php?catalog=C3238C3253,_-Asarone,2883-98-9,F08,L1021-20,208.25,DMSO,C12H16O3,COC1=CC(=C(\C=C\C)C=C1OC)OC,≥36.9 mg/mL in DMSO; ≥36.8 mg/mL in EtOH; insoluble in H2O,free base,Others,Others, pharmacologically active compounds,https://www.apexbt.com/search.php?catalog=C3253C3278,Proxyphylline,603-00-9,F09,L1021-20,238.2,DMSO,C10H14N4O3,CN(C(N1C)=O)C2=C(N(CC(O)C)C=N2)C1=O,≥10.1 mg/mL in DMSO; ≥22.77 mg/mL in EtOH with ultrasonic; ≥26.5 mg/mL in H2O,,GPCR/G protein,Adenosine Receptor,A1 adenosine receptor antagonist,https://www.apexbt.com/search.php?catalog=C3278C3310,Sofalcone,64506-49-6,F10,L1021-20,450.52,DMSO,C27H30O6,CC(C)=CCOC1=CC=C(/C=C/C(=O)C2=C(OCC(O)=O)C=C(OCC=C(C)C)C=C2)C=C1,≥66.6 mg/mL in DMSO; ≥3.15 mg/mL in EtOH (Need ultrasonic and warming); insoluble in H2O,free base,"Infection

Inflammation/Immunology",Autophagy,anti-ulcer drugs and mucosal protectors,https://www.apexbt.com/search.php?catalog=C3310C3328,DL-_-Difluoromethylornithine (hydrochloride hydrate),96020-91-6,F11,L1021-20,236.6,H2O,C6H12F2N2O2·HCl [H2O],FC(F)C(C(O)=O)(N)CCCN.Cl.O,insoluble in DMSO; insoluble in EtOH; ≥11.55 mg/mL in H2O,,Metabolism,ornithine decarboxylase,"ornithine decarboxylase inhibitor, irreversible",https://www.apexbt.com/search.php?catalog=C3328C3334,(S)-Ketoprofen,22161-81-5,G01,L1021-20,254.3,DMSO,C16H14O3,O=C(C1=CC=CC([[C@H](C)C(O)=O)=C1)C2=CC=CC=C2,insoluble in H2O; ≥10.6 mg/mL in DMSO; ≥20.55 mg/mL in EtOH,,Neuroscience,COX,COX-1 and COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=C3334C3338,Vincamine,1617-90-9,G02,L1021-20,354.44,DMSO,C21H26N2O3,CCC12CCCN3CCC4=C(C13)[N](C5=CC=CC=C45)C(O)(C2)C(=O)OC,≥9.11 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,free base,Others,Others,peripheral vasodilator,https://www.apexbt.com/search.php?catalog=C3338C3347,Isoxsuprine (hydrochloride),579-56-6,G03,L1021-20,337.8,DMSO,C18H23NO3·HCl,OC1=CC=C(C(O)C(C)NC(C)COC2=CC=CC=C2)C=C1.Cl,insoluble in H2O; insoluble in EtOH; ≥16.3 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=C3347C3418,Oxiconazole (nitrate),64211-46-7,G04,L1021-20,492.1,DMSO,C18H13Cl4N3O·HNO3,ClC1=CC(Cl)=C(/C(CN2C=NC=C2)=N/OCC3=C(Cl)C=C(Cl)C=C3)C=C1.[O-][N+](O)=O,insoluble in H2O; ≥16.05 mg/mL in DMSO; ≥2.89 mg/mL in EtOH with ultrasonic,,Microbiology & Virology,Antibiotic,antifungal imidazole,https://www.apexbt.com/search.php?catalog=C3418C3436,D-(+)-Raffinose (hydrate),17629-30-0,G05,L1021-20,594.51,DMSO,C18H42O21,O[C@@H]1[C@@H](O)[C@@H](OC[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@]3(CO)O[C@H](CO)[C@@H](O)[C@@H]3O)O2)O[C@H](CO)[C@@H]1O.O.O.O.O.O,insoluble in EtOH; ≥20.55 mg/mL in H2O; ≥48 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C3436C3486,Thymidine,50-89-5,G06,L1021-20,242.2,DMSO,C10H14N2O5,CC1=CN([[C@@H]2O[[C@H](CO)[[C@@H](O)C2)C(NC1=O)=O,≥24.2 mg/mL in DMSO with gentle warming; ≥3.75 mg/mL in EtOH with ultrasonic; ≥53.6 mg/mL in H2O,,DNA,DNA Synthesis,,https://www.apexbt.com/search.php?catalog=C3486C3509,Chlorprothixene (hydrochloride),6469-93-8,G07,L1021-20,352.3,DMSO,C18H18ClNS·HCl,ClC1=CC2=C(C=C1)SC3=CC=CC=C3/C2=C/CCN(C)C.Cl,≥16.75 mg/mL in DMSO; ≥18.23 mg/mL in EtOH with ultrasonic; ≥53.9 mg/mL in H2O,,Neuroscience,Dopamine Receptor,,https://www.apexbt.com/search.php?catalog=C3509C3558,4-Methylbenzylidene camphor,36861-47-9,G08,L1021-20,254.4,DMSO,C18H22O,CC1=CC=C(/C=C2[[C@H]3CC[[C@H@](C)(C3(C)C)C/2=O)C=C1,insoluble in H2O; ≥10 mg/mL in DMSO; ≥111.2 mg/mL in EtOH,,Endocrinology and Hormones,Estrogen/progestogen Receptor,,https://www.apexbt.com/search.php?catalog=C3558C3560,SKF 525A (hydrochloride),62-68-0,G09,L1021-20,390.0,DMSO,C23H31NO2·HCl,O=C(OCCN(CC)CC)C(C1=CC=CC=C1)(CCC)C2=CC=CC=C2.Cl,≥20.2 mg/mL in DMSO; ≥45.2 mg/mL in H2O; ≥97.2 mg/mL in EtOH,,Metabolism,P450,cytochrome P (CYP)450 inhibitor,https://www.apexbt.com/search.php?catalog=C3560C3589,L-(_)-Fucose,2438-80-4,G10,L1021-20,164.16,DMSO,C6H12O5,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O,≥139.6 mg/mL in H2O; ≥3.1 mg/mL in EtOH with gentle warming and ultrasonic; ≥81.4 mg/mL in DMSO,,Immunology/Inflammation,Immunology & Inflamm,,https://www.apexbt.com/search.php?catalog=C3589C3644,Danazol,17230-88-5,G11,L1021-20,337.5,DMSO,C22H27NO2,O[[C@H@]1(C#C)CC[[C@H@]2([H])[[C@H]3([H])CCC4=CC5=C(C=NO5)C[[C@H]4(C)[[C@H@]3([H])CC[[C@H@]21C,insoluble in H2O; ≥11.05 mg/mL in DMSO; ≥14.84 mg/mL in EtOH with ultrasonic,,Endocrinology and Hormones,Androgen Receptor,weak androgenic effects,https://www.apexbt.com/search.php?catalog=C3644C3789,DL-_-Lipoic Acid,1077-28-7,H01,L1021-20,206.33,DMSO,C8H14O2S2,OC(=O)CCCCC1SSCC1,insoluble in H2O; ≥34.4 mg/mL in EtOH; ≥40.3 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C3789C3812,Cefonicid (sodium salt),61270-78-8,H02,L1021-20,586.5,DMSO,C18H16N6O8S3·2Na,O=C(N[[C@H]1[[C@H](SCC(CSC2=NN=NN2CS([O-])(=O)=O)=C3C([O-])=O)([H])N3C1=O)[[C@H](O)C4=CC=CC=C4.[Na+].[Na+],≥22.95 mg/mL in DMSO; insoluble in EtOH; ≥44.5 mg/mL in H2O,,Microbiology & Virology,Antibiotic,second-generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=C3812C3816,Pentoxifylline,6493-05-6,H03,L1021-20,278.31,H2O,C13H18N4O3,CC(CCCCN1C(N(C)C(N=CN2C)=C2C1=O)=O)=O,≥14 mg/mL in EtOH; ≥19.55 mg/mL in H2O; ≥26.35 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C3816C3837,Pimozide,2062-78-4,H04,L1021-20,461.6,DMSO,C28H29F2N3O,FC1=CC=C(C(CCCN2CCC(N3C(NC4=C3C=CC=C4)=O)CC2)C5=CC=C(F)C=C5)C=C1,insoluble in H2O; insoluble in EtOH; ≥17.95 mg/mL in DMSO,,Neuroscience,Dopamine Receptor,dopamine receptors inhibitor,https://www.apexbt.com/search.php?catalog=C3837C3862,Tropine,120-29-6,H05,L1021-20,141.21,DMSO,C8H15NO,CN1C2CCC1CC(O)C2,≥25.3 mg/mL in EtOH; ≥29.6 mg/mL in DMSO; ≥34.6 mg/mL in H2O,free base,Others,Others,"Tropine is a naturally occurring tropane alkaloid that serves as an intermediate in the synthesis of a variety of bioactive alkaloids, many of which have potent neurological actions.",https://www.apexbt.com/search.php?catalog=C3862C3929,Trehalose (hydrate),6138-23-4,H06,L1021-20,378.33,H2O,C12H22O11·2H2O,O.O.OCC1OC(OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,insoluble in EtOH; ≥46.7 mg/mL in DMSO; ≥610 mg/mL in H2O,dihydrate,Others,Others,Trehalose is a non-reducing sugar. It is thought to provide plants and animals with the ability to withstanding periods of dehydration.,https://www.apexbt.com/search.php?catalog=C3929C3945,Glycocholic Acid,475-31-0,H07,L1021-20,465.62,DMSO,C26H43NO6,C[C@H](CCC(NCC(O)=O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@@]21C,insoluble in H2O; ≥27.95 mg/mL in EtOH; ≥55.7 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C3945C3969,Stearic Acid methyl ester,112-61-8,H08,L1021-20,298.5,DMSO,C19H38O2,CCCCCCCCCCCCCCCCCC(OC)=O,insoluble in H2O; ≥18.5 mg/mL in EtOH; ≥3.025 mg/mL in DMSO with gentle warming and ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=C3969C3989,Chlorcyclizine (hydrochloride),14362-31-3,H09,L1021-20,337.3,DMSO,C18H21ClN2·HCl,CN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.Cl,≥11 mg/mL in DMSO with gentle warming; ≥14.7 mg/mL in EtOH; ≥9.44 mg/mL in H2O with ultrasonic,,Neuroscience,Histamine Receptor,,https://www.apexbt.com/search.php?catalog=C3989C3991,Cefadroxil (hydrate),66592-87-8,H10,L1021-20,381.4,DMSO,C16H17N3O5S·H2O,OC1=CC=C([[C@@H](N)C(N[[C@@H]2C(N3[[C@H]2([H])SCC(C)=C3C(O)=O)=O)=O)C=C1.O,insoluble in EtOH; insoluble in H2O; ≥5.8 mg/mL in DMSO with gentle warming,,Microbiology & Virology,Antibiotic,broad-spectrum antibiotic,https://www.apexbt.com/search.php?catalog=C3991C3999,5-hydroxy-L-Tryptophan,4350-09-8,H11,L1021-20,220.22,DMSO,C11H12N2O3,OC1=CC=C2C(C(C[C@H](N)C(O)=O)=CN2)=C1,insoluble in EtOH; ≥10.42 mg/mL in H2O; ≥51.9 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C3999C4009,CP21R7,125314-13-8,A01,L1021-21,317.3,DMSO,C19H15N3O2,NC1=CC=CC(C(C(N2)=O)=C(C3=CN(C)C4=C3C=CC=C4)C2=O)=C1,insoluble in EtOH; insoluble in H2O; ≥14.25 mg/mL in DMSO,,PI3K/Akt/mTOR Signaling,GSK-3,,https://www.apexbt.com/search.php?catalog=C4009C4035,Triclosan,3380-34-5,A02,L1021-21,289.5,DMSO,C12H7Cl3O2,ClC1=C(OC2=CC=C(Cl)C=C2O)C=CC(Cl)=C1,insoluble in H2O; ≥10.95 mg/mL in DMSO; ≥47.7 mg/mL in EtOH,,Microbiology & Virology,Antibiotic,broad-spectrum antibacterial agent,https://www.apexbt.com/search.php?catalog=C4035C4042,L-Selenomethionine,3211-76-5,A03,L1021-21,196.11,H2O,C5H11NO2Se,OC([C@@H](N)CC[Se]C)=O,insoluble in DMSO; insoluble in EtOH; ≥11.77 mg/mL in H2O,,Immunology/Inflammation,ROS,,https://www.apexbt.com/search.php?catalog=C4042C4051,(±)-Baclofen,1134-47-0,A04,L1021-21,213.7,H2O,C10H12ClNO2,ClC1=CC=C(C(CN)CC(O)=O)C=C1,insoluble in DMSO; insoluble in EtOH; ≥3.06 mg/mL in H2O with gentle warming,,Neuroscience,GABA Receptor,,https://www.apexbt.com/search.php?catalog=C4051C4077,Nortriptyline (hydrochloride),894-71-3,A05,L1021-21,299.8,DMSO,C19H21N·HCl,CNCC/C=C1C2=C(C=CC=C2)CCC3=C/1C=CC=C3.Cl,≥10.1 mg/mL in H2O; ≥10.34 mg/mL in EtOH; ≥15 mg/mL in DMSO,,Neuroscience,5-HT Receptor,norepinephrine and serotonin transporters blocker,https://www.apexbt.com/search.php?catalog=C4077C4087,Mebendazole,31431-39-7,A06,L1021-21,295.3,DMSO,C16H13N3O3,O=C(C1=CC=C(NC(NC(OC)=O)=N2)C2=C1)C3=CC=CC=C3,insoluble in H2O; insoluble in EtOH; ≥13 mg/mL in DMSO,,Cell Cycle/Checkpoint,Microtubule/Tubulin,broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis,https://www.apexbt.com/search.php?catalog=C4087C4102,Maltotriose,1109-28-0,A07,L1021-21,504.44,DMSO,C18H32O16,OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@]([C@H](O)CO)([H])[C@H](O)[C@@H](O)C=O)O[C@@H]2CO)([H])O1,≥1.74 mg/mL in EtOH; ≥20.8 mg/mL in DMSO; ≥46 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C4102C4117,Imipramine (hydrochloride),113-52-0,A08,L1021-21,316.9,H2O,C19H24N2·HCl,CN(C)CCCN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.Cl,≥12.5 mg/mL in DMSO; ≥22.3 mg/mL in H2O; ≥22.9 mg/mL in EtOH,,Neuroscience,5-HT Receptor,serotonin and norepinephrine transporters inhibitor,https://www.apexbt.com/search.php?catalog=C4117C4125,Ethacrynic Acid,58-54-8,A10,L1021-21,303.14,DMSO,C13H12Cl2O4,O=C(O)COC1=CC=C(C(C(CC)=C)=O)C(Cl)=C1Cl,insoluble in H2O; ≥15.15 mg/mL in DMSO; ≥44.4 mg/mL in EtOH,,Membrane Transporter/Ion Channel,NKCC,,https://www.apexbt.com/search.php?catalog=C4125C4131,Sulfaphenazole,526-08-9,A11,L1021-21,314.4,DMSO,C15H14N4O2S,NC1=CC=C(S(NC2=CC=NN2C3=CC=CC=C3)(=O)=O)C=C1,insoluble in H2O; ≥13.15 mg/mL in DMSO; ≥9.92 mg/mL in EtOH with ultrasonic,,Metabolism,P450,CYP2C9 inhibitor,https://www.apexbt.com/search.php?catalog=C4131C4137,Clorgyline (hydrochloride),17780-75-5,B01,L1021-21,308.6,DMSO,C13H15Cl2NO·HCl,ClC1=CC=C(OCCCN(C)CC#C)C(Cl)=C1.Cl,≥17.65 mg/mL in DMSO; ≥18.2 mg/mL in EtOH; ≥24.8 mg/mL in H2O,,Metabolism,MAO,,https://www.apexbt.com/search.php?catalog=C4137C4140,Edrophonium (chloride),116-38-1,B02,L1021-21,201.7,DMSO,C10H16NO·Cl,OC1=CC([N+](C)(C)CC)=CC=C1.[Cl-],≥10.24 mg/mL in EtOH; ≥22.6 mg/mL in H2O; ≥7.6 mg/mL in DMSO,,Neuroscience,AChE,acetylcholinesterase (AChE) inhibitor,https://www.apexbt.com/search.php?catalog=C4140C4153,Doxepin (hydrochloride),1229-29-4,B03,L1021-21,315.8,DMSO,C19H21NO·HCl,CN(C)CC/C=C1C2=C(C=CC=C2)COC3=C/1C=CC=C3.Cl,≥15.85 mg/mL in DMSO; ≥23.7 mg/mL in H2O; ≥26.5 mg/mL in EtOH,,Neuroscience,Histamine Receptor,"histamine, serotonin, adrenergic, and muscarinic receptors antagonist",https://www.apexbt.com/search.php?catalog=C4153C4157,Pyrogallol,87-66-1,B04,L1021-21,126.11,DMSO,C6H6O3,OC1=C(O)C(O)=CC=C1,≥27 mg/mL in EtOH; ≥28.15 mg/mL in H2O; ≥28.8 mg/mL in H2O; ≥29 mg/mL in DMSO; ≥49.1 mg/mL in EtOH,,Immunology/Inflammation,ROS,,https://www.apexbt.com/search.php?catalog=C4157C4159,Tyramine,51-67-2,B05,L1021-21,137.18,DMSO,C8H11NO,OC1=CC=C(CCN)C=C1,insoluble in EtOH; insoluble in H2O; ≥17.57 mg/mL in DMSO,,GPCR/G Protein,TAAR,,https://www.apexbt.com/search.php?catalog=C4159C4183,Cefazolin (sodium salt),27164-46-1,B06,L1021-21,476.5,DMSO,C14H13N8O4S3·Na,O=C(CN1N=NN=C1)N[[C@H](C2=O)[[C@H]3([H])N2C(C([O-])=O)=C(CSC4=NN=C(C)S4)CS3.[Na+],≥25.5 mg/mL in DMSO; insoluble in EtOH; ≥37 mg/mL in H2O,,Microbiology & Virology,Antibiotic,"broad-spectrum, first-generation cephalosporin antibiotic",https://www.apexbt.com/search.php?catalog=C4183C4185,Iopromide,73334-07-3,B07,L1021-21,791.11,DMSO,C18H24I3N3O8,O=C(N(CC(O)CO)C)C1=C(I)C(C(NCC(O)CO)=O)=C(I)C(NC(COC)=O)=C1I,≥79.1 mg/mL in DMSO; ≥34.85 mg/mL in EtOH; ≥40 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C4185C4188,Docosahexaenoic Acid,6217-54-5,B08,L1021-21,328.49,DMSO,C22H32O2,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,insoluble in H2O; ≥44.9 mg/mL in DMSO; ≥50.7 mg/mL in EtOH ,,Others,Others,,https://www.apexbt.com/search.php?catalog=C4188C4195,Menaquinone 4,863-61-6,B09,L1021-21,444.65,DMSO,C31H40O2,O=C1C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C)=C(C)C(C2=CC=CC=C21)=O,insoluble in H2O; ≥10.26 mg/mL in DMSO; ≥15.77 mg/mL in EtOH,,Metabolism,Vitamin,,https://www.apexbt.com/search.php?catalog=C4195C4201,Androsterone,53-41-8,B10,L1021-21,290.44,DMSO,C19H30O2,O=C1CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C,insoluble in H2O; ≥54.6 mg/mL in EtOH,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=C4201C4274,Quinestrol,152-43-2,B11,L1021-21,364.5,DMSO,C25H32O2,C[[C@H@]12[[C@H@]([H])(CC[[C@H@]2(O)C#C)[[C@H]([[C@H]3([H])CC1)([H])CCC4=C3C=CC(OC5CCCC5)=C4,insoluble in H2O; ≥12.15 mg/mL in DMSO; ≥16.57 mg/mL in EtOH,,Endocrinology and Hormones,Estrogen/progestogen Receptor,synthetic estrogen that is effective in hormone replacement therapy,https://www.apexbt.com/search.php?catalog=C4274C4313,Myristic Acid,544-63-8,C01,L1021-21,228.37,DMSO,C14H28O2,CCCCCCCCCCCCCC(O)=O,≤15mg/ml in ethanol;12mg/ml in DMSO;15mg/ml in dimethyl formamide,free base,Others,Others,A 14 carbon saturated fatty acid,https://www.apexbt.com/search.php?catalog=C4313C4341,Adenosine-5'-diphosphate,58-64-0,C02,L1021-21,427.2,DMSO,C10H15N5O10P2,O[[C@H]1[[C@H](N2C=NC3=C2N=CN=C3N)O[[C@H](COP(OP(O)(O)=O)(O)=O)[[C@H]1O,≥21.35 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥24.85 mg/mL in H2O,,Metabolism,Others,"central component of energy storage, metabolism, and signal transduction in vivo;agonist of purinergic receptors",https://www.apexbt.com/search.php?catalog=C4341C4360,Guaiacol,90-05-1,C03,L1021-21,124.14,H2O,C7H8O2,COC1=C(O)C=CC=C1,≥25.2 mg/mL in H2O; ≥35.4 mg/mL in EtOH; ≥40.4 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C4360C4417,Isoprinosine,36703-88-5,C04,L1021-21,1115.2,DMSO,C10H12N4O5·3C9H9NO3·3C5H13NO,OC[[C@@H]1[[C@@H](O)[[C@@H](O)[[C@H](N2C=NC3=C2NC=NC3=O)O1.OC(C4=CC=C(NC(C)=O)C=C4)=O.CC(O)CN(C)C.OC(C5=CC=C(NC(C)=O)C=C5)=O.CC(O)CN(C)C.OC(C6=CC=C(NC(C)=O)C=C6)=O.CC(O)CN(C)C,insoluble in EtOH; ≥58.7 mg/mL in H2O; ≥96 mg/mL in DMSO,#N/A,Immunology/Inflammation,Others,immunomodulatory effects,https://www.apexbt.com/search.php?catalog=C4417C4449,Scopoletin,92-61-5,C05,L1021-21,192.17,DMSO,C10H8O4,O=C1C=CC2=CC(OC)=C(C=C2O1)O,insoluble in H2O; ≥10.44 mg/mL in EtOH with ultrasonic; ≥54 mg/mL in DMSO,,Immunology/Inflammation,AChE,,https://www.apexbt.com/search.php?catalog=C4449C4493,Midodrine (hydrochloride),43218-56-0,C06,L1021-21,290.7,DMSO,C12H18N2O4·HCl,OC(CNC(CN)=O)C1=C(OC)C=CC(OC)=C1.Cl,insoluble in EtOH; ≥14.55 mg/mL in DMSO; ≥57.5 mg/mL in H2O,,GPCR/G protein,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=C4493C4497,6-Aminonicotinamide,329-89-5,C07,L1021-21,137.1,DMSO,C6H7N3O,Nc1ccc(cn1)C(=O)N,insoluble in H2O; insoluble in EtOH; ≥13.7 mg/mL in DMSO,#N/A,Metabolism,Dehydrogenase,6-phosphogluconate dehydrogenase inhibitor,https://www.apexbt.com/search.php?catalog=C4497C4559,Taurolidine,19388-87-5,C08,L1021-21,284.4,DMSO,C7H16N4O4S2,O=S1(CCN(CN2CNS(CC2)(=O)=O)CN1)=O,insoluble in EtOH; ≥2.64 mg/mL in H2O with gentle warming and ultrasonic; ≥52.8 mg/mL in DMSO,#N/A,Microbiology & Virology,Antibiotic,synthetic taurine analog with antimicrobial and anti-neoplastic actions,https://www.apexbt.com/search.php?catalog=C4559C4588,Cefotaxime (sodium salt),64485-93-4,C09,L1021-21,477.5,DMSO,C16H16N5O7S2·Na,[H][[C@H@]1([[C@@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O)N(C(C([O-])=O)=C(COC(C)=O)CS1)C2=O.[Na+],≥18.8 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=C4588C4607,Stearic Acid,57-11-4,C10,L1021-21,284.48,DMSO,C18H36O2,CCCCCCCCCCCCCCCCCC(O)=O,insoluble in H2O; ≥19.27 mg/mL in DMSO; ≥20.52 mg/mL in EtOH,,Others,NF-kB,,https://www.apexbt.com/search.php?catalog=C4607C4849,Cefoxitin (sodium salt),33564-30-6,C11,L1021-21,449.4,DMSO,C16H16N3O7S2·Na,O=C1[[C@H](NC(CC2=CC=CS2)=O)(OC)[[C@H]3([H])N1C(C([O-])=O)=C(COC(N)=O)CS3.[Na+],insoluble in EtOH; ≥12.9 mg/mL in DMSO; ≥54.8 mg/mL in H2O,,Microbiology & Virology,Antibiotic,second generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=C4849C4876,"1,2-Dioleoyl-3-trimethylammoniumpropane (chloride)",132172-61-3,D01,L1021-21,698.54,DMSO,C42H80ClNO4,[Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC,insoluble in H2O; ≥19.33 mg/mL in DMSO; ≥9.76 mg/mL in EtOH,Chloride,,,,https://www.apexbt.com/search.php?catalog=C4876C4902,Pentadecanoic Acid,1002-84-2,D02,L1021-21,242.4,EtOH,C15H30O2,OC(CCCCCCCCCCCCCC)=O,insoluble in H2O; insoluble in DMSO; ≥47.8 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C4902C4910,Spermine,71-44-3,D03,L1021-21,202.3,DMSO,C10H26N4,NCCCNCCCCNCCCN,≥37.6 mg/mL in DMSO; ≥43.5 mg/mL in EtOH; ≥47.5 mg/mL in H2O,,Neuroscience,NMDA,Mixed NMDA glutamate receptor agonist/antagonist at the polyamine site,https://www.apexbt.com/search.php?catalog=C4910C4977,Oleic Acid,112-80-1,D04,L1021-21,282.46,DMSO,C18H34O2,CCCCCCCC/C=C\CCCCCCCC(O)=O,insoluble in H2O; ≥58.2 mg/mL in DMSO; ≥62 mg/mL in ETOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C4977C4996,Clodronate (sodium salt hydrate),88416-50-6,D05,L1021-21,286.9,H2O,CH7Cl2NaO7P2,O.O.O.O.[Na+].[Na+].O[P]([O-])(=O)C(Cl)(Cl)[P](O)([O-])=O,insoluble in EtOH; insoluble in DMSO; ≥26.5 mg/mL in H2O,free base,,,,https://www.apexbt.com/search.php?catalog=C4996C5107,Palmitic Acid methyl ester,112-39-0,D06,L1021-21,270.45,DMSO,C17H34O2,CCCCCCCCCCCCCCCC(OC)=O,insoluble in H2O; ≥37 mg/mL in EtOH; ≥39.1 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C5107C5108,Amlexanox,68302-57-8,D07,L1021-21,298.29,DMSO,C16H14N2O4,CC(C1=CC=C2C(C(C3=C(O2)N=C(N)C(C(O)=O)=C3)=O)=C1)C,≥29.8 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Immunology/Inflammation,,,https://www.apexbt.com/search.php?catalog=C5108C5167,Fusidic Acid (sodium salt),751-94-0,D08,L1021-21,538.7,DMSO,C31H47O6·Na,O[[C@@H]1CC[[C@H@]2(C)[[C@H](CC[[C@H@]3(C)[[C@H@]2([H])[[C@H](O)C[[C@H]4([H])[[C@H]3(C)C[[C@H](OC(C)=O)/C4=C(C([O-])=O)/CC/C=C(C)/C)([H])[[C@@H]1C.[Na+],≥14.15 mg/mL in H2O; ≥31.7 mg/mL in EtOH; ≥52.4 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,steroidal antibiotic,https://www.apexbt.com/search.php?catalog=C5167C5183,Ibudilast,50847-11-5,D09,L1021-21,230.3,DMSO,C14H18N2O,CC(C)C1=NN(C=CC=C2)C2=C1C(C(C)C)=O,insoluble in H2O; ≥32 mg/mL in EtOH; ≥46.7 mg/mL in DMSO,,Metabolism,PDE,inhibitor of PDE4,https://www.apexbt.com/search.php?catalog=C5183C5222,Ingenol,30220-46-3,D10,L1021-21,348.43,DMSO,C20H28O5,CC1CC2C(C3C=C(CO)C(O)C4(O)C(O)C(=CC14C3=O)C)C2(C)C,insoluble in H2O; ≥32.75 mg/mL in EtOH; ≥60.6 mg/mL in DMSO,free base,,,,https://www.apexbt.com/search.php?catalog=C5222C5242,Citicoline (sodium salt),33818-15-4,D11,L1021-21,510.31,H2O,C14H25N4NaO11P2,O=P([O-])(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)N2C(N=C(C=C2)N)=O)OP(OCC[N+](C)(C)C)([O-])=O.[Na+],insoluble in DMSO; insoluble in EtOH; ≥38.1 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C5242C5264,(S)-Flurbiprofen,51543-39-6,E01,L1021-21,244.3,DMSO,C15H13FO2,FC1=CC([[C@@H](C(O)=O)C)=CC=C1C2=CC=CC=C2,insoluble in H2O; ≥10.9 mg/mL in DMSO; ≥69.1 mg/mL in EtOH,,Neuroscience,COX,inhibitors of COX-1 and COX-2,https://www.apexbt.com/search.php?catalog=C5264C5273,BHT,128-37-0,E02,L1021-21,220.35,DMSO,C15H24O,CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1,≥22 mg/mL in EtOH; insoluble in H2O; ≥81.6 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C5273C5286,"(R,S)-Atenolol",29122-68-7,E03,L1021-21,266.3,H2O,C14H22N2O3,NC(CC1=CC=C(OCC(O)CNC(C)C)C=C1)=O,≥12.5 mg/mL in DMSO; ≥43.8 mg/mL in EtOH; ≥9.1 mg/mL in H2O with gentle warming,,GPCR/G protein,Adrenergic Receptor,_1-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=C5286C5297,Morin,480-16-0,E04,L1021-21,302.24,DMSO,C15H10O7,OC1=CC(O)=C2C(C(O)=C(OC2=C1)C3=C(C=C(C=C3)O)O)=O,insoluble in H2O; ≥19.53 mg/mL in DMSO; ≥6.04 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C5297C5378,Cefixime,79350-37-1,E05,L1021-21,453.4,DMSO,C16H15N5O7S2,[H][[C@H@]1([[C@@H]2NC(/C(C3=CSC(N)=N3)=N\OCC(O)=O)=O)N(C(C(O)=O)=C(C=C)CS1)C2=O,insoluble in H2O; ≥46.2 mg/mL in DMSO; ≥6.88 mg/mL in EtOH,,Microbiology & Virology,Antibiotic,third generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=C5378C5419,tetrahydro-L-Biopterin (hydrochloride),69056-38-8,E06,L1021-21,314.17,DMSO,C9H17Cl2N5O3,C[C@@H]([C@@H]([C@@]([H])(CN(C(N(C(N)=N1)[H])=C2C1=O)[H])N2[H])O)O.Cl.Cl,≥30.35 mg/mL in DMSO; ≥4.91 mg/mL in EtOH with ultrasonic; ≥47.5 mg/mL in H2O,,Metabolism,Hydroxylase,,https://www.apexbt.com/search.php?catalog=C5419C5443,Palmitoleic Acid,373-49-9,E07,L1021-21,254.41,DMSO,C16H30O2,CCCCCC\C=C/CCCCCCCC(O)=O,insoluble in H2O; ≥40.6 mg/mL in DMSO; ≥48 mg/mL in EtOH,Free Base,,,,https://www.apexbt.com/search.php?catalog=C5443C5468,Undecanoic Acid,112-37-8,E08,L1021-21,186.29,DMSO,C11H22O2,OC(CCCCCCCCCC)=O,insoluble in H2O; ≥114.6 mg/mL in DMSO; ≥99.6 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C5468C5503,Kasugamycin (hydrochloride),19408-46-9,E09,L1021-21,415.8,H2O,C14H25N3O9·HCl,O[[C@H]1[[C@@H](O)[[C@H](O)[[C@H](O)[[C@@H](O[[C@H@]2([H])O[[C@H](C)[[C@@H](NC(C(O)=O)=N)C[[C@@H]2N)[[C@@H]1O.Cl,insoluble in EtOH; insoluble in DMSO; ≥41.6 mg/mL in H2O with gentle warming,,Microbiology & Virology,Antibiotic,aminoglycosidic antibiotic,https://www.apexbt.com/search.php?catalog=C5503C5518,_-Linolenic Acid,506-26-3,E10,L1021-21,278.4,EtOH,C18H30O2,CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O,≤100mg/ml in DMSO;100mg/ml in dimethyl formamide,#N/A,GPCR/G protein,Leukotriene Receptor,weak LTB4 receptor antagonist,https://www.apexbt.com/search.php?catalog=C5518C5539,Ciprofloxacin (hydrochloride),93107-08-5,E11,L1021-21,367.8,DMSO,C17H18FN3O3·HCl,FC1=CC2=C(C=C1N3CCNCC3)N(C4CC4)C=C(C(O)=O)C2=O.Cl,insoluble in EtOH; ≥33.87 mg/mL in H2O; ≥9.34 mg/mL in DMSO with ultrasonic,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=C5539C5580,Anisodamine,55869-99-3,F01,L1021-21,305.37,H2O,C17H23NO4,OCC(C(OC1CC(N2C)CC(O)C2C1)=O)C3=CC=CC=C3,≥13.32 mg/mL in EtOH; ≥13.65 mg/mL in H2O; ≥51.3 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,weak antagonist of _1-adrenoceptors,https://www.apexbt.com/search.php?catalog=C5580C5593,Cefsulodin (sodium salt),52152-93-9,F02,L1021-21,554.5,DMSO,C22H19N4O8S2·Na,O=C(N[[C@@H]1C(N2[[C@H]1([H])SCC(C[N+]3=CC=C(C(N)=O)C=C3)=C2C([O-])=O)=O)[[C@H](S([O-])(=O)=O)C4=CC=CC=C4.[Na+],≥22.75 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥49.3 mg/mL in H2O,,Microbiology & Virology,Antibiotic,_-lactam antibiotic,https://www.apexbt.com/search.php?catalog=C5593C5616,Phytol,150-86-7,F03,L1021-21,296.5,DMSO,C20H40O,CC(CCC[[C@@H](C)CCC[[C@@H](C)CCC/C(C)=C/CO)C,insoluble in H2O; ≥46.1 mg/mL in EtOH; ≥57.4 mg/mL in DMSO,,Others,RAR/RXR,activator of retinoid X receptors (RXRs),https://www.apexbt.com/search.php?catalog=C5616C5621,Spectinomycin (hydrochloride hydrate),22189-32-8,F04,L1021-21,495.4,DMSO,C14H24N2O7·2HCl [5H2O],[H][[C@H@]12[[C@H@](C(C[[C@@H](C)O2)=O)(O)O[[C@H]3([H])[[C@@H](NC)[[C@@H](O)[[C@@H](NC)[[C@H](O)[[C@H@]3([H])O1.Cl.Cl.O.O.O.O.O,≥49.5 mg/mL in H2O; ≥3.61 mg/mL in EtOH with gentle warming and ultrasonic; ≥92 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,aminocyclitol antibiotic,https://www.apexbt.com/search.php?catalog=C5621C5652,Folinic Acid (calcium salt),1492-18-8,F05,L1021-21,511.5,H2O,C20H21CaN7O7,[Ca++].NC1=NC(=C2N(C=O)C(CNC3=CC=C(C=C3)C(=O)NC(CCC([O-])=O)C([O-])=O)CNC2=N1)O,Insoluble in DMSO; insoluble in EtOH; ≥7.94 mg/mL in H2O with ultrasonic,calcium salt,Others,Others,Biofolic acid,https://www.apexbt.com/search.php?catalog=C5652C5675,Fendiline (hydrochloride),13636-18-5,F06,L1021-21,351.9,DMSO,C23H25N·HCl,CC(C1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,insoluble in H2O; ≥16.6 mg/mL in DMSO; ≥2.34 mg/mL in EtOH with ultrasonic,,GPCR/G protein,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=C5675C5679,N-acetyl-D-Glucosamine,7512-17-6,F07,L1021-21,221.21,DMSO,C8H15NO6,O=CC(C(C([C@@H](CO)O)O)O)NC(C)=O,insoluble in EtOH; insoluble in DMSO; ≥90.8 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C5679C5734,Trimipramine (maleate),521-78-8,F08,L1021-21,410.5,DMSO,C20H26N2·C4H4O4,CN(C)CC(C)CN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.OC(/C=C\C(O)=O)=O,insoluble in H2O; ≥13.02 mg/mL in EtOH; ≥18.5 mg/mL in DMSO,,Neuroscience,Histamine Receptor,potent antagonist of histamine H1 receptor,https://www.apexbt.com/search.php?catalog=C5734C5755,(S)-Naproxen,22204-53-1,F09,L1021-21,230.3,DMSO,C14H14O3,C[[C@H](C(O)=O)C1=CC=C2C=C(OC)C=CC2=C1,insoluble in H2O; ≥22.87 mg/mL in EtOH; ≥9.7 mg/mL in DMSO,,Neuroscience,COX,non-selective COX inhibitor,https://www.apexbt.com/search.php?catalog=C5755C5802,Carazolol,57775-29-8,F10,L1021-21,298.4,DMSO,C18H22N2O2,OC(CNC(C)C)COC1=C(C(C=CC=C2)=C2N3)C3=CC=C1,insoluble in H2O; ≥14.8 mg/mL in DMSO; ≥3.9 mg/mL in EtOH,#N/A,GPCR/G protein,Adrenergic Receptor,"high-affinity, lipophilic, non-selective ligand of the _-adrenergic receptors",https://www.apexbt.com/search.php?catalog=C5802C5847,Lutein,127-40-2,F11,L1021-21,568.87,DMSO,C40H56O2,O[C@@H]1CC(C)([C@H](C(C)=C1)/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C[C@H](CC2(C)C)O)C)C,insoluble in H2O; insoluble in EtOH; ≥5.28 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C5847C6100,Glycine,56-40-6,G01,L1021-21,75.07,H2O,C2H5NO2,NCC(O)=O,insoluble in EtOH; insoluble in DMSO; ≥54.6 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6100C6101,L-Proline,147-85-3,G02,L1021-21,115.13,H2O,C5H9NO2,OC([C@@H]1CCCN1)=O,insoluble in DMSO; ≥11.27 mg/mL in EtOH with ultrasonic; ≥35.5 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6101C6103,L-Valine,72-18-4,G03,L1021-21,117.15,H2O,C5H11NO2,OC([C@@H](N)C(C)C)=O,insoluble in DMSO; insoluble in EtOH; ≥24.05 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6103C6104,L-Leucine,61-90-5,G04,L1021-21,131.17,H2O,C6H13NO2,CC(C)C[C@H](N)C(O)=O,insoluble in EtOH; insoluble in DMSO; ≥17.43 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6104C6105,L-Tryptophan,73-22-3,G05,L1021-21,204.23,DMSO,C11H12N2O2,OC([C@@H](N)CC1=CNC2=C1C=CC=C2)=O,insoluble in EtOH; ≥6.46 mg/mL in H2O; ≥7 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6105C6108,L-Alanine,56-41-7,G06,L1021-21,89.09,H2O,C3H7NO2,OC([C@@H](N)C)=O,insoluble in EtOH; insoluble in DMSO; ≥18.55 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6108C6112,L-Hydroxyproline,51-35-4,G07,L1021-21,131.13,H2O,C5H9NO3,O[C@@H]1CN[C@H](C(O)=O)C1,insoluble in EtOH; insoluble in DMSO; ≥30.1 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6112C6113,L-Methionine,63-68-3,G08,L1021-21,149.21,H2O,C5H11NO2S,CSCC[C@H](N)C(O)=O,insoluble in EtOH; insoluble in DMSO; ≥8.02 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6113C6114,beta-Alanine,107-95-9,G09,L1021-21,89.09,H2O,C3H7NO2,NCCC(O)=O,insoluble in EtOH; insoluble in DMSO; ≥39.9 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6114C6115,Sodium benzoate,532-32-1,G10,L1021-21,144.1,H2O,C7H5NaO2,[O-]C(C1=CC=CC=C1)=O.[Na+],insoluble in DMSO; insoluble in EtOH; ≥40.9 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6115C6116,Benzophenone,119-61-9,G11,L1021-21,182.22,EtOH,C13H10O,O=C(C1=CC=CC=C1)C2=CC=CC=C2,insoluble in H2O; ≥14.6 mg/mL in EtOH; ≥47 mg/mL in DMSO,Free Base,,,,https://www.apexbt.com/search.php?catalog=C6116C6118,Benzyl alcohol,100-51-6,H01,L1021-21,108.14,DMSO,C7H8O,OCC1=CC=CC=C1,≥12.2 mg/mL in EtOH; ≥17.87 mg/mL in H2O; ≥44.6 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6118C6119,D-Alanine,338-69-2,H02,L1021-21,89.09,H2O,C3H7NO2,CC(N)C(O)=O,insoluble in DMSO; insoluble in EtOH; ≥16.75 mg/mL in H2O,free base,,,,https://www.apexbt.com/search.php?catalog=C6119C6122,L(+)-Ornithine hydrochloride,3184-13-2,H03,L1021-21,168.62,H2O,C5H13ClN2O2,Cl.NCCCC(N)C(O)=O,insoluble in EtOH; insoluble in DMSO; ≥98.4 mg/mL in H2O,free base,Metabolism,Endogenous Metabolite,L-Ornithine hydrochloride is a free amino acid that plays a central role in the urea cycle and is also important for the disposal of excess nitrogen.,https://www.apexbt.com/search.php?catalog=C6122C6124,Methylparaben,99-76-3,H04,L1021-21,152.15,DMSO,C8H8O3,OC1=CC=C(C(OC)=O)C=C1,insoluble in H2O; ≥103.6 mg/mL in DMSO; ≥104.6 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6124C6127,L-Threonine,72-19-5,H05,L1021-21,119.12,H2O,C4H9NO3,OC([C@@H](N)[C@H](O)C)=O,insoluble in DMSO; insoluble in EtOH; ≥39.67 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6127C6129,Hydroquinone,123-31-9,H06,L1021-21,110.11,DMSO,C6H6O2,OC1=CC=C(O)C=C1,22mg/mL(199.8 mM) in DMSO;22mg/mL(199.8 mM) in H2O;22mg/mL(199.8 mM) in Ethanol,,Immunology/Inflammation,ROS,,https://www.apexbt.com/search.php?catalog=C6129C6131,L-Pyroglutamic acid,98-79-3,H07,L1021-21,129.11,DMSO,C5H7NO3,OC(=O)[C@@H]1CCC(=O)N1,≥105.8 mg/mL in DMSO; ≥121.4 mg/mL in H2O; ≥8.09 mg/mL in EtOH,,Others,Others,L-pyroglutamic acid is a natural nutrient and amino acid derived from glutamic acid. It is a metabolite in the glutathione cycle that is converted to glutamate by 5-oxoprolinase.,https://www.apexbt.com/search.php?catalog=C6131C6132,D-Tartaric acid,147-71-7,H08,L1021-21,150.09,H2O,C4H6O6,OC(C(O)C(O)=O)C(O)=O,≥11.67 mg/mL in DMSO; ≥14.43 mg/mL in EtOH; ≥22.85 mg/mL in H2O,Free Base,Others,Others,"Tartaric acid is a white crystalline organic acid that occurs naturally in many plants, most notably in grapes. It has several applications for industrial and pharmaceutical use.",https://www.apexbt.com/search.php?catalog=C6132C6133,4-Aminophenol,123-30-8,H09,L1021-21,109.13,DMSO,C6H7NO,OC1=CC=C(N)C=C1,21mg/mL(192.43 mM) in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6133C6134,L-Lysine hydrochloride,657-27-2,H10,L1021-21,182.65,H2O,C6H15ClN2O2,OC([C@@H](N)CCCCN)=O.Cl,insoluble in EtOH; insoluble in DMSO; ≥37 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6134C6135,Isonicotinic acid,55-22-1,H11,L1021-21,123.11,DMSO,C6H5NO2,OC(C1=CC=NC=C1)=O,insoluble in EtOH; insoluble in H2O; ≥9.55 mg/mL in DMSO with ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6135C6136,Resorcinol,108-46-3,A01,L1021-22,110.11,DMSO,C6H6O2,OC1=CC(O)=CC=C1,22mg/mL(199.8 mM) in DMSO;22mg/mL(199.8 mM) in H2O;22mg/mL(199.8 mM) in Ethanol,,Microbiology & Virology,Anti-infection,,https://www.apexbt.com/search.php?catalog=C6136C6137,DL-Serine,302-84-1,A02,L1021-22,105.09,H2O,C3H7NO3,NC(CO)C(O)=O,insoluble in DMSO; insoluble in EtOH; ≥37.6 mg/mL in H2O,,Metabolism,PKM,,https://www.apexbt.com/search.php?catalog=C6137C6142,Sodium dodecyl sulfate,151-21-3,A03,L1021-22,288.38,H2O,C12H25NaO4S,O=S([O-])(OCCCCCCCCCCCC)=O.[Na+],insoluble in EtOH; ≥47.8 mg/mL in H2O; ≥6.26 mg/mL in DMSO with ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6142C6149,Thymol,89-83-8,A04,L1021-22,150.22,DMSO,C10H14O,CC1=CC=C(C(C)C)C(O)=C1,insoluble in H2O; ≥52.3 mg/mL in EtOH; ≥55.8 mg/mL in DMSO,,Immunology/Inflammation,,,https://www.apexbt.com/search.php?catalog=C6149C6160,2-Naphthol,135-19-3,A05,L1021-22,144.17,DMSO,C10H8O,OC1=CC=C(C=CC=C2)C2=C1,insoluble in H2O; ≥115 mg/mL in EtOH; ≥93.2 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6160C6171,Propylparaben,94-13-3,A06,L1021-22,180.2,DMSO,C10H12O3,OC1=CC=C(C(OCCC)=O)C=C1,insoluble in H2O; ≥34.3 mg/mL in DMSO; ≥39 mg/mL in EtOH,,Others,others,,https://www.apexbt.com/search.php?catalog=C6171C6177,L-Asparagine,70-47-3,A07,L1021-22,132.12,H2O,C4H8N2O3,NC(C[C@H](N)C(O)=O)=O,insoluble in EtOH; insoluble in DMSO; ≥25.6 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6177C6178,Butylparaben,94-26-8,A08,L1021-22,194.23,DMSO,C11H14O3,OC1=CC=C(C(OCCCC)=O)C=C1,insoluble in H2O; ≥116.2 mg/mL in DMSO; ≥47.2 mg/mL in EtOH,,Microbiology & Virology,Anti-infection,,https://www.apexbt.com/search.php?catalog=C6178C6180,Benzyl benzoate,120-51-4,A09,L1021-22,212.24,DMSO,C14H12O2,O=C(C1=CC=CC=C1)OCC2=CC=CC=C2,insoluble in H2O; ≥108.2 mg/mL in EtOH; ≥123.4 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6180C6183,Piperazine,110-85-0,A10,L1021-22,86.14,H2O,C4H10N2,C1NCCNC1,17mg/mL(197.35 mM) in H2O;17mg/mL(197.35 mM) in Ethanol;8mg/mLwarmed(92.87 mM) in DMSO,,Neuroscience,GABA Receptor,,https://www.apexbt.com/search.php?catalog=C6183C6187,4-Aminosalicylic acid,65-49-6,A11,L1021-22,153.14,DMSO,C7H7NO3,NC1=CC(O)=C(C(O)=O)C=C1,insoluble in H2O; ≥18.75 mg/mL in EtOH; ≥34.5 mg/mL in DMSO,,Microbiology & Virology,Anti-infection,,https://www.apexbt.com/search.php?catalog=C6187C6190,Methyl salicylate,119-36-8,B01,L1021-22,152.15,DMSO,C8H8O3,OC1=C(C(OC)=O)C=CC=C1,insoluble in H2O; ≥40.3 mg/mL in DMSO; ≥45 mg/mL in EtOH,,Membrane Transporter/Ion Channel,TRPV,,https://www.apexbt.com/search.php?catalog=C6190C6192,L-Menthol,2216-51-5,B02,L1021-22,156.27,DMSO,C10H20O,C[C@H]1C[C@@H](O)[C@H](C(C)C)CC1,≥2.05 mg/mL in H2O; ≥27.5 mg/mL in EtOH; ≥35.7 mg/mL in DMSO,,Endocrinology and Hormones,Opioid Receptor,,https://www.apexbt.com/search.php?catalog=C6192C6199,Salicylamide,65-45-2,B03,L1021-22,137.14,DMSO,C7H7NO2,O=C(N)C1=C(O)C=CC=C1,insoluble in H2O; ≥21.4 mg/mL in EtOH; ≥36.4 mg/mL in DMSO,,Immunology/Inflammation,Immunology & Inflamm,,https://www.apexbt.com/search.php?catalog=C6199C6203,Malic acid,6915-15-7,B04,L1021-22,134.09,DMSO,C4H6O5,OC(C(O)=O)CC(O)=O,≥21.05 mg/mL in H2O; ≥24 mg/mL in EtOH; ≥47 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6203C6206,delta-Gluconolactone,90-80-2,B05,L1021-22,178.14,DMSO,C6H10O6,O[C@@H]1[C@@H](O)C(O[C@H](CO)[C@H]1O)=O,insoluble in EtOH; ≥39.5 mg/mL in H2O; ≥48.6 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6206C6207,o-Toluic acid,118-90-1,B06,L1021-22,136.15,DMSO,C8H8O2,CC1=C(C(O)=O)C=CC=C1,insoluble in H2O; ≥31.6 mg/mL in DMSO; ≥38 mg/mL in EtOH,free base,Others,Others,,https://www.apexbt.com/search.php?catalog=C6207C6210,3-Hydroxy-2-methyl-4H-pyran-4-one,118-71-8,B07,L1021-22,126.11,DMSO,C6H6O3,CC(OC=C1)=C(O)C1=O,≥15.87 mg/mL in EtOH; ≥49.9 mg/mL in DMSO; ≥7.4 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6210C6215,Levulinic acid,123-76-2,B08,L1021-22,116.12,H2O,C5H8O3,OC(CCC(C)=O)=O,≥39.6 mg/mL in H2O; ≥61.2 mg/mL in DMSO; ≥74.4 mg/mL in EtOH,free base,Others,Others,,https://www.apexbt.com/search.php?catalog=C6215C6223,4-Nitrophenol,100-02-7,B09,L1021-22,139.11,DMSO,C6H5NO3,OC1=CC=C([N+]([O-])=O)C=C1,28mg/mL(201.27 mM) in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6223C6224,"1,4-Benzoquinone",106-51-4,B10,L1021-22,108.09,DMSO,C6H4O2,O=C(C=C1)C=CC1=O,21mg/mL(194.28 mM) in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6224C6225,Melamine,108-78-1,B11,L1021-22,126.12,DMSO,C3H6N6,NC1=NC(N)=NC(N)=N1,insoluble in EtOH; ≥2.59 mg/mL in H2O with ultrasonic; ≥27.7 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6225C6234,Dexpanthenol,81-13-0,C01,L1021-22,205.25,DMSO,C9H19NO4,CC(C)(CO)[C@@H](O)C(NCCCO)=O,≥101.6 mg/mL in DMSO; ≥111.2 mg/mL in EtOH; ≥97.4 mg/mL in H2O,,Metabolism,Vitamin,,https://www.apexbt.com/search.php?catalog=C6234C6244,Carvacrol,499-75-2,C02,L1021-22,150.22,DMSO,C10H14O,CC1=CC=C(C(C)C)C=C1O,insoluble in H2O; ≥28.1 mg/mL in EtOH; ≥28.8 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6244C6249,Sitagliptin,486460-32-6,C03,L1021-22,407.32,DMSO,C16H15F6N5O,N[C@@H](CC(N1CC2=NN=C(C(F)(F)F)N2CC1)=O)CC3=CC(F)=C(F)C=C3F,insoluble in H2O; ≥52.3 mg/mL in EtOH; ≥54.5 mg/mL in DMSO,,Proteases,DPP-4,,https://www.apexbt.com/search.php?catalog=C6249C6258,o-Cresol,95-48-7,C04,L1021-22,108.14,DMSO,C7H8O,CC1=C(O)C=CC=C1,,#N/A,Others,Others,,https://www.apexbt.com/search.php?catalog=C6258C6265,Propofol,2078-54-8,C05,L1021-22,178.27,DMSO,C12H18O,OC1=C(C(C)C)C=CC=C1C(C)C,≥27.2 mg/mL in DMSO; ≥45.4 mg/mL in EtOH; ≥48.9 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6265C6269,Acetamide,60-35-5,C06,L1021-22,59.07,DMSO,C2H5NO,CC(N)=O,≥38.6 mg/mL in DMSO; ≥51.4 mg/mL in EtOH; ≥52.6 mg/mL in H2O,free base,Others,Others,Acetamide is an organic compound that can be used as a plasticizer and an industrial solvent.,https://www.apexbt.com/search.php?catalog=C6269C6271,Pyrocatechol,120-80-9,C07,L1021-22,110.11,DMSO,C6H6O2,OC1=C(O)C=CC=C1,22mg/mL(199.8 mM) in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6271C6276,Ethyl gallate,831-61-8,C08,L1021-22,198.17,DMSO,C9H10O5,OC1=C(O)C=C(C(OCC)=O)C=C1O,≥16.9 mg/mL in H2O; ≥29.4 mg/mL in EtOH; ≥31.9 mg/mL in DMSO,,Immunology/Inflammation,NF-_B,,https://www.apexbt.com/search.php?catalog=C6276C6278,Glycylglycine,556-50-3,C09,L1021-22,132.12,H2O,C4H8N2O3,O=C(O)CNC(CN)=O,insoluble in EtOH; insoluble in DMSO; ≥52.7 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6278C6279,Geraniol,106-24-1,C10,L1021-22,154.25,DMSO,C10H18O,C/C(C)=C/CC/C(C)=C/CO,insoluble in H2O; ≥42.7 mg/mL in DMSO; ≥68 mg/mL in EtOH,free base,Others,Others,,https://www.apexbt.com/search.php?catalog=C6279C6281,Tryptamine,61-54-1,C11,L1021-22,160.22,DMSO,C10H12N2,NCCC1=CNC2=CC=CC=C12,insoluble in H2O; ≥28.1 mg/mL in EtOH; ≥31.4 mg/mL in DMSO,,GPCR/G Protein,TAAR,Tryptamine is a monoamine alkaloid and may play a role as a neuromodulator or neurotransmitter. It is an agonist of hTAAR1. It acts as a non-selective serotonin receptor agonist and serotonin-norepinephrine-dopamine releasing agent (SNDRA).,https://www.apexbt.com/search.php?catalog=C6281C6285,Bisphenol A,80-05-7,D01,L1021-22,228.29,DMSO,C15H16O2,OC1=CC=C(C(C)(C)C2=CC=C(O)C=C2)C=C1,insoluble in H2O; ≥14.33 mg/mL in DMSO; ≥21 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6285C6293,Furfural,98-01-1,D02,L1021-22,96.08,DMSO,C5H4O2,O=CC1=CC=CO1,,#N/A,Others,Others,,https://www.apexbt.com/search.php?catalog=C6293C6298,Terephthalic acid,100-21-0,D03,L1021-22,166.13,DMSO,C8H6O4,OC(C1=CC=C(C(O)=O)C=C1)=O,insoluble in EtOH; insoluble in H2O; ≥34.25 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6298C6305,Furazolidone,67-45-8,D04,L1021-22,225.16,DMSO,C8H7N3O5,O=[N+]([O-])C1=CC=C(/C=N/N2CCOC2=O)O1,insoluble in H2O; insoluble in EtOH; ≥10.6 mg/mL in DMSO,,Microbiology & Virology,Anti-infection,,https://www.apexbt.com/search.php?catalog=C6305C6308,Phthalic acid,88-99-3,D05,L1021-22,166.13,DMSO,C8H6O4,OC(C1=CC=CC=C1C(O)=O)=O,insoluble in H2O; ≥28 mg/mL in EtOH; ≥63.6 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6308C6313,m-Cresol,108-39-4,D06,L1021-22,108.14,DMSO,C7H8O,CC1=CC=CC(O)=C1,,#N/A,Others,Others,,https://www.apexbt.com/search.php?catalog=C6313C6315,Isosorbide 5-mononitrate,16051-77-7,D07,L1021-22,191.14,DMSO,C6H9NO6,O[C@H]1CO[C@@]2([H])[C@]1([H])OC[C@H]2O[N+]([O-])=O,≥47.1 mg/mL in EtOH; ≥48.2 mg/mL in H2O; ≥56.3 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6315C6320,p-Cresol,106-44-5,D08,L1021-22,108.14,H2O,C7H8O,OC1=CC=C(C)C=C1,,#N/A,Others,Others,,https://www.apexbt.com/search.php?catalog=C6320C6322,D-Glutamine,5959-95-5,D09,L1021-22,146.14,H2O,C5H10N2O3,NC(CC[C@@H](N)C(O)=O)=O,insoluble in EtOH; insoluble in DMSO; ≥18.27 mg/mL in H2O,,Neuroscience,GluR,,https://www.apexbt.com/search.php?catalog=C6322C6326,"(R)-(+)-1,2-Dithiolane-3-pentanoic acid",1200-22-2,D10,L1021-22,206.33,DMSO,C8H14O2S2,OC(CCCC[C@@H]1CCSS1)=O,insoluble in H2O; ≥46.3 mg/mL in DMSO; ≥52.6 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=C6326C6328,DL-_-Tocopherol,10191-41-0,D11,L1021-22,430.71,DMSO,C29H50O2,OC1=C(C)C(C)=C(O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CC2)C2=C1C,insoluble in H2O; ≥12.93 mg/mL in DMSO; ≥42.7 mg/mL in EtOH,,Metabolism,Vitamin,,https://www.apexbt.com/search.php?catalog=C6328C6358,Fluorescein,2321-07-5,E01,L1021-22,332.31,DMSO,C20H12O5,OC1=CC(OC(C2=C3C4=C(C=CC=C4)C(O)=O)=CC(C=C2)=O)=C3C=C1,insoluble in H2O; ≥45.3 mg/mL in EtOH; ≥49 mg/mL in DMSO,,Others,Fluorescent Dyes/Probes,Fluorescein is a synthetic fluorescent tracer,https://www.apexbt.com/search.php?catalog=C6358C6367,"Dapagliflozin ((2S)-1,2-propanediol, hydrate)",960404-48-2,E02,L1021-22,502.98,DMSO,C24H35ClO9,O[[C@H]1[[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[[C@H](CO)[[C@@H](O)[[C@@H]1O.C[[C@H](O)CO.O,insoluble in H2O; ≥27.4 mg/mL in EtOH; ≥69.7 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6367C6368,Delamanid,681492-22-8,E03,L1021-22,534.48,DMSO,C25H25F3N4O6,FC(F)(F)OC1=CC=C(OC2CCN(C3=CC=C(OC[[C@H@]4(C)CN5C(O4)=NC([N+]([O-])=O)=C5)C=C3)CC2)C=C1,insoluble in H2O; insoluble in EtOH; ≥24.9 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6368C6369,Tucidinostat,1616493-44-7,E04,L1021-22,390.41,DMSO,C22H19FN4O2,O=C(NCC1=CC=C(C(NC2=C(C=C(F)C=C2)N)=O)C=C1)/C=C/C3=CN=CC=C3,insoluble in H2O; insoluble in EtOH; ≥33.2 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6369C6371,Calcium dobesilate,20123-80-2,E05,L1021-22,418.41,DMSO,C12H10CaO10S2,OC1=CC=C(O)C(S([O-])(=O)=O)=C1.OC2=CC=C(O)C(S([O-])(=O)=O)=C2.[Ca+2],≥23.05 mg/mL in EtOH with gentle warming and ultrasonic; ≥45.5 mg/mL in DMSO; ≥50.3 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6371C6373,Dantrolene (sodium hemiheptahydrate),24868-20-0,E06,L1021-22,399.29,DMSO,C14H16N4NaO8.5,O=C1N([Na])C(CN1/N=C/C2=CC=C(O2)C3=CC=C([N+]([O-])=O)C=C3)=O,insoluble in EtOH; insoluble in H2O; ≥7.21 mg/mL in DMSO with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6373C6376,Adenosine 5'-monophosphate monohydrate,18422-05-4,E07,L1021-22,365.24,DMSO,C10H16N5O8P,NC1=NC=NC2=C1N=CN2[[C@@H]3O[[C@H](COP(O)(O)=O)[[C@@H](O)[[C@H]3O.O,insoluble in H2O; insoluble in EtOH; ≥6.28 mg/mL in DMSO with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6376C6377,Vidarabine monohydrate,24356-66-9,E08,L1021-22,285.26,DMSO,C10H15N5O5,NC1=NC=NC2=C1N=CN2[[C@@H]3O[[C@H](CO)[[C@@H](O)[[C@@H]3O.O,insoluble in H2O; insoluble in EtOH; ≥49.4 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6377C6378,Pikamilone,34562-97-5,E09,L1021-22,208.21,DMSO,C10H12N2O3,O=C(O)CCCNC(C1=CN=CC=C1)=O,insoluble in EtOH; insoluble in H2O; ≥19.6 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6378C6381,"UTP, Trisodium Salt",19817-92-6,E10,L1021-22,550.09,H2O,C9H12N2Na3O15P3,O=C1C=CN([[C@@H]2O[[C@H](COP(OP(OP([O-])(O)=O)([O-])=O)([O-])=O)[[C@@H](O)[[C@H]2O)C(N1)=O.[Na+].[Na+].[Na+],insoluble in EtOH; insoluble in DMSO; ≥101.2 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6381C6383,Sultamicillin Tosylate,83105-70-8,E11,L1021-22,766.86,DMSO,C32H38N4O12S3,CC1(C)[[C@H](C(OCOC([[C@@H]2N(C(C3)=O)[[C@H]3([H])SC2(C)C)=O)=O)N4C([[C@@H](NC([[C@H](N)C5=CC=CC=C5)=O)[[C@H@]4([H])S1(=O)=O)=O.OS(C6=CC=C(C)C=C6)(=O)=O,insoluble in H2O; ≥17.65 mg/mL in EtOH with ultrasonic; ≥65.8 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6383C6384,Sultamicillin,76497-13-7,F01,L1021-22,594.66,DMSO,C25H30N4O9S2,N[[C@@H](C(N[[C@H]1[[C@H](SC(C)(C)[[C@@H]2C(OCOC([[C@H]3C(C)(C)S([[C@H@](C4)([H])N3C4=O)(=O)=O)=O)=O)([H])N2C1=O)=O)C5=CC=CC=C5,insoluble in H2O; insoluble in EtOH; ≥30.65 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6384C6385,Loxoprofen Sodium,80382-23-6,F02,L1021-22,268.28,DMSO,C15H17NaO3,O=C(CCC1)C1CC2=CC=C(C(C)C([O-])=O)C=C2.[Na+],≥13.43 mg/mL in DMSO with ultrasonic; ≥39.4 mg/mL in EtOH; ≥43.9 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6385C6386,Clindamycin alcoholate,58207-19-5,F03,L1021-22,479.46,DMSO,C18H36Cl2N2O6S,C[[C@H](Cl)[[C@@H](NC([[C@H]1N(C)C[[C@H](CCC)C1)=O)[[C@H@]2([H])O[[C@H](SC)[[C@H](O)[[C@@H](O)[[C@H]2O.Cl.O,insoluble in EtOH; ≥38.15 mg/mL in H2O; ≥92.2 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6386C6387,Disopyramide,3737-09-5,F04,L1021-22,339.47,DMSO,C21H29N3O,CC(C)N(C(C)C)CCC(C1=NC=CC=C1)(C(N)=O)C2=CC=CC=C2,insoluble in H2O; ≥36.6 mg/mL in DMSO; ≥38 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6387C6388,Econazole,27220-47-9,F05,L1021-22,381.68,DMSO,C18H15Cl3N2O,ClC1=CC=C(COC(C2=C(Cl)C=C(Cl)C=C2)CN3C=CN=C3)C=C1,insoluble in H2O; ≥66.2 mg/mL in EtOH; ≥74 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6388C6389,Atropine sulfate,55-48-1,F06,L1021-22,676.82,DMSO,C34H48N2O10S,[H][[C@H@]1(N2C)C[[C@@H](OC(C(CO)C3=CC=CC=C3)=O)C[[C@H@]2([H])CC1.[H][[C@H@]4(N5C)C[[C@@H](OC(C(CO)C6=CC=CC=C6)=O)C[[C@H@]5([H])CC4.OS(O)(=O)=O,insoluble in EtOH; ≥58.7 mg/mL in DMSO with ultrasonic; ≥59.7 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6389C6390,Salbutamol,18559-94-9,F07,L1021-22,239.31,DMSO,C13H21NO3,OCC1=CC(C(O)CNC(C)(C)C)=CC=C1O,insoluble in H2O; ≥32 mg/mL in DMSO; ≥4.43 mg/mL in EtOH with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6390C6391,Betahistine mesylate,54856-23-4,F08,L1021-22,328.41,DMSO,C10H20N2O6S2,CNCCC1=CC=CC=N1.CS(O)(=O)=O.CS(O)(=O)=O,≥59.1 mg/mL in H2O; ≥60.8 mg/mL in DMSO; ≥62.5 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6391C6392,Dehydroepiandrosterone acetate,853-23-6,F09,L1021-22,330.46,DMSO,C21H30O3,C[[C@H]12C(C[[C@@H](OC(C)=O)CC2)=CC[[C@H]3([H])[[C@H]1([H])CC[[C@H@]4(C)[[C@H@]3([H])CCC4=O,insoluble in H2O; ≥11.24 mg/mL in EtOH with ultrasonic; ≥20.63 mg/mL in DMSO with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6392C6394,Balofloxacin Dihydrate,151060-21-8,F10,L1021-22,425.45,DMSO,C20H28FN3O6,OC(C1=CN(C2CC2)C3=C(OC)C(N4CCCC(NC)C4)=C(F)C=C3C1=O)=O,≥2mg/mL in DMSO; ≥2mg/mL in Ethanol; Insoluble in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6394C6398,Indigo carmine,860-22-0,F11,L1021-22,466.35,DMSO,C16H8N2Na2O8S2,O=C(C1=C(N/2)C=CC(S([O-])(=O)=O)=C1)C2=C3C(C(C=C(S([O-])(=O)=O)C=C4)=C4N\3)=O.[Na+].[Na+],insoluble in EtOH; ≥83.6 mg/mL in DMSO; ≥83.9 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6398C6399,Omeprazole Sodium,95510-70-6,G01,L1021-22,367.4,DMSO,C17H18N3NaO3S,COC1=CC(N=C(S(CC2=NC=C(C)C(OC)=C2C)=O)N3[Na])=C3C=C1,≥39.4 mg/mL in EtOH; ≥43.3 mg/mL in DMSO; ≥43.4 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6399C6400,Orphenadrine Hydrochloride,341-69-5,G02,L1021-22,305.84,DMSO,C18H24ClNO,CC1=CC=CC=C1C(OCCN(C)C)C2=CC=CC=C2.Cl,≥58.2 mg/mL in H2O; ≥58.6 mg/mL in DMSO; ≥60.6 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6400C6401,Chloropyramine hydrochloride,6170-42-9,G03,L1021-22,326.26,DMSO,C16H21Cl2N3,ClC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1.Cl,≥18.95 mg/mL in H2O; ≥20.1 mg/mL in DMSO; ≥20.4 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6401C6402,Isoproterenol sulfate dihydrate,299-95-6,G04,L1021-22,556.62,DMSO,C22H40N2O12S,OC1=CC(C(CNC(C)C)O)=CC=C1O.OC2=CC(C(CNC(C)C)O)=CC=C2O.OS(O)(=O)=O,insoluble in EtOH; ≥59.9 mg/mL in H2O; ≥74.7 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6402C6403,Icatibant Acetate,138614-30-9,G05,L1021-22,1364.57,H2O,C61H93N19O15S,N[[C@@H](C(N[[C@@H](CCCNC(N)=N)C(N1CCC[[C@H]1C(N2C[[C@H](O)C[[C@H]2C(NCC(N[[C@@H](CC3=CC=CS3)C(N[[C@H](C(N4C(CC(C=CC=C5)=C5C4)C(N6[[C@H](C(N[[C@@H](CCCNC(N)=N)C(O)=O)=O)C[[C@H@]7([H])[[C@H]6([H])CCCC7)=O)=O)CO)=O)=O)=O)=O)=O)=O)CCCNC(N)=N.CC(O)=O,≥11.43 mg/mL in DMSO; ≥50.8 mg/mL in EtOH; ≥51.4 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6403C6406,edetate calcium disodium,62-33-9,G06,L1021-22,374.27,H2O,C10H12CaN2Na2O8,O=C([O-])CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O.[Ca+2].[Na+].[Na+],insoluble in EtOH; insoluble in DMSO; ≥43.9 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6406C6407,Triiodothyronine,6893-02-3,G07,L1021-22,650.97,DMSO,C15H12I3NO4,IC1=CC(C[[C@H](N)C(O)=O)=CC(I)=C1OC2=CC=C(O)C(I)=C2,insoluble in H2O; insoluble in EtOH; ≥29.53 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6407C6418,Metronidazole Benzoate,13182-89-3,G08,L1021-22,275.26,DMSO,C13H13N3O4,O=C(OCCN1C(C)=NC=C1[N+]([O-])=O)C2=CC=CC=C2,insoluble in H2O; ≥34.4 mg/mL in EtOH; ≥43.3 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6418C6419,Scopolamine HBr trihydrate,6533-68-2,G09,L1021-22,438.31,DMSO,C17H28BrNO7,CN1[[C@H@]2([H])[[C@H](O3)([H])[[C@H]3([H])[[C@H]1([H])C[[C@H](OC([[C@H](CO)C4=CC=CC=C4)=O)C2.Br,≥34.8 mg/mL in EtOH; ≥57 mg/mL in H2O; ≥57.2 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6419C6421,Creatine monohydrate,6020-87-7,G10,L1021-22,149.15,H2O,C4H11N3O3,NC(N(CC(O)=O)C)=N.O,Soluble in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6421C6423,Terpinen-4-ol,562-74-3,G11,L1021-22,154.25,DMSO,C10H18O,CC1=CCC(O)(C(C)C)CC1,≥19.3 mg/mL in H2O; ≥24 mg/mL in DMSO; ≥25.1 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6423C6424,Octanoic acid,124-07-2,H01,L1021-22,144.21,DMSO,C8H16O2,CCCCCCCC(O)=O,≥21.7 mg/mL in EtOH; ≥25.2 mg/mL in H2O; ≥26.7 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6424C6427,Orcinol,504-15-4,H02,L1021-22,124.14,DMSO,C7H8O2,OC1=CC(O)=CC(C)=C1,≥24mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6427C6429,Valbenazine tosylate,1639208-54-0,H03,L1021-22,762.97,DMSO,C38H54N2O10S2,CC(C)C[[C@@H]1CN2[[C@H](C3=CC(OC)=C(OC)C=C3CC2)([H])C[[C@H]1OC([[C@@H](N)C(C)C)=O.CC4=CC=C(S(O)(=O)=O)C=C4.CC5=CC=C(S(O)(=O)=O)C=C5,insoluble in EtOH; insoluble in H2O; ≥64.1 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6429C6432,Octenidine (dihydrochloride),70775-75-6,H04,L1021-22,623.83,DMSO,C36H64Cl2N4,CCCCCCCC/N=C1C=CN(CCCCCCCCCCN2C=C/C(C=C2)=N\CCCCCCCC)C=C/1.Cl.Cl,≥41.9 mg/mL in EtOH; ≥8.29 mg/mL in H2O with ultrasonic; ≥9.06 mg/mL in DMSO with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6432C6434,Canagliflozin (hemihydrate),928672-86-0,H05,L1021-22,453.52,DMSO,C24H26FO5.5S,O[[C@H]1[[C@H](O)[[C@@H](CO)O[[C@@H](C2=CC=C(C)C(CC3=CC=C(C4=CC=C(F)C=C4)S3)=C2)[[C@@H]1O,insoluble in H2O; ≥40.2 mg/mL in EtOH; ≥83.4 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6434C6435,L-Arginine,74-79-3,H06,L1021-22,174.2,H2O,C6H14N4O2,NC(NCCC[[C@H](N)C(O)=O)=N,insoluble in EtOH; insoluble in DMSO; ≥11.45 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6435C6437,Camphor,76-22-2,H07,L1021-22,152.23,DMSO,C10H16O,CC(CCC1C2)(C1(C)C)C2=O,≥16 mg/mL in EtOH; ≥17 mg/mL in H2O; ≥19.2 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6437C6438,Cyclic somatostatin,38916-34-6,H08,L1021-22,1637.88,DMSO,C76H104N18O19S2,O=C([[C@H](CC1=CC=CC=C1)NC([[C@@H](NC([[C@H](CC(N)=O)NC([[C@H](CCCCN)N2)=O)=O)CC3=CC=CC=C3)=O)N[[C@H](C(N[[C@H](C(N[[C@H](C(N[[C@H](C(N[[C@H](C(N[[C@H](C(N[[C@@H](CSSC[[C@H](NC(CNC([[C@H](C)N)=O)=O)C2=O)C(O)=O)=O)CO)=O)[[C@H](O)C)=O)CC4=CC=CC=C4)=O)[[C@H](O)C)=O)CCCCN)=,insoluble in EtOH; ≥95.4 mg/mL in H2O; ≥97.4 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6438C6439,Calcitonin (salmon),47931-85-1,H09,L1021-22,3431.85,DMSO,C145H240N44O48S2,O=C([[C@H]([[C@@H](C)O)NC(CNC([[C@@H](NC(CNC([[C@@H](NC([[C@H](CC(N)=O)NC([[C@@H](NC([[C@H](CCCNC(N)=N)NC([[C@@H]1CCCN1C([[C@@H](NC([[C@H]([[C@H](O)C)NC([[C@H](CCC(N)=O)NC([[C@H](CC(C)C)NC([[C@@H](NC([[C@@H](NC([[C@@H](NC([[C@H](CCC(O)=O)NC([[C@@H](NC([[C@@H](NC([[C@@H](NC([,insoluble in EtOH; ≥123 mg/mL in H2O; ≥56.1 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6439C6440,Eptifibatide Acetate,148031-34-9,H10,L1021-22,892.01,DMSO,C37H53N11O11S2,OC(C[[C@H](NC(CNC([[C@@H](NC(CCSSC[[C@@H](C(N)=O)N1)=O)CCCCNC(N)=N)=O)=O)C(N[[C@@H](CC2=CNC3=C2C=CC=C3)C(N4CCC[[C@H]4C1=O)=O)=O)=O.CC(O)=O,insoluble in EtOH; ≥19.2 mg/mL in H2O with ultrasonic; ≥51 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6440C6442,Gonadorelin Acetate,71447-49-9,H11,L1021-22,1242.34,DMSO,C57H79N17O15,O=C([[C@H](CCC/N=C(N)/N)NC([[C@H](CC(C)C)NC(CNC([[C@H](CC(C=C1)=CC=C1O)NC([[C@H](CO)NC([[C@H](CC2=CNC3=CC=CC=C23)NC([[C@H](CC4=CN=CN4)NC([[C@H](CC5)NC5=O)=O)=O)=O)=O)=O)=O)=O)N6[[C@H](C(NCC(N)=O)=O)CCC6.OC(C)=O,insoluble in EtOH; ≥30.15 mg/mL in DMSO; ≥59.2 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6442C6443,GHRP-2,158861-67-7,A01,L1021-23,817.97,DMSO,C45H55N9O6,O=C(C(CC1=CNC2=CC=CC=C12)NC(C(C)NC(C(CC3=CC4=CC=CC=C4C=C3)N)=O)=O)NC(C(NC(C(NC(C(C)N)=O)=O)CCCCN)=O)CC5=CC=CC=C5,insoluble in EtOH; ≥12.45 mg/mL in H2O with ultrasonic; ≥74.1 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6443C6444,Nafarelin Acetate,76932-56-4,A02,L1021-23,1382.52,DMSO,C68H87N17O15,CC(O)=O.O=C([[C@H](CCC/N=C(N)/N)NC([[C@H](CC(C)C)NC([[C@@H](CC1=CC2=CC=CC=C2C=C1)NC([[C@H](CC(C=C3)=CC=C3O)NC([[C@H](CO)NC([[C@H@](CC4=CNC5=CC=CC=C45)([H])NC([[C@H](CC6=CN=CN6)NC([[C@H](CC7)NC7=O)=O)=O)=O)=O)=O)=O)=O)N8[[C@H](C(NCC(N)=O)=O)CCC8,insoluble in EtOH; ≥15.67 mg/mL in DMSO; ≥51.8 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6444C6446,Cinchonine(LA40221),118-10-5,A03,L1021-23,294.4,DMSO,C19H22N2O,O[[C@@H](C1=CC=NC2=CC=CC=C21)[[C@H]3(C[[C@@H]4CC[[C@H]3C[[C@H]4([H])C=C)[H],insoluble in H2O; ≥2.97 mg/mL in DMSO with ultrasonic; ≥3 mg/mL in EtOH with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6446C6447,Naringin Dihydrochalcone,18916-17-1,A04,L1021-23,582.55,DMSO,C27H34O14,O[[C@@H]1[[C@@H](O)[[C@H](C)O[[C@H@]([H])(O[[C@H]2[[C@H](OC3=CC(O)=C(C(CCC4=CC=C(O)C=C4)=O)C(O)=C3)O[[C@H](CO)[[C@@H](O)[[C@@H]2O)[[C@@H]1O,insoluble in H2O; ≥87.5 mg/mL in DMSO; ≥88 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6447C6448,Diammonium Glycyrrhizinate,79165-06-3,A05,L1021-23,856.99,DMSO,C42H68N2O16,O[[C@@H]1[[C@@H](O[[C@H]2([H])O[[C@H](C(O)=O)[[C@@H](O)[[C@H](O)[[C@H]2O)[[C@H](O[[C@@H]3C(C)(C)[[C@H@](CC[[C@H]([[C@H@](CC[[C@H]4(C)[[C@H]5([H])C[[C@H](C(O)=O)(C)CC4)(C)C5=C6)(C)[[C@H]7([H])C6=O)([H])[[C@H]7(C)CC3)([H])O[[C@H](C(O)=O)[[C@H]1O.N.N,insoluble in EtOH; ≥87 mg/mL in H2O; ≥98.8 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6448C6450,Promestriene,39219-28-8,A06,L1021-23,328.49,DMSO,C22H32O2,CCCOC1=CC(CC[[C@H]2([H])[[C@H]3([H])CC[[C@H@]4(C)[[C@H@]2([H])CC[[C@@H]4OC)=C3C=C1,insoluble in H2O; ≥12.36 mg/mL in DMSO with ultrasonic; ≥29.85 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6450C6452,Levamlodipine,103129-82-4,A07,L1021-23,408.88,DMSO,C20H25ClN2O5,CCOC(C1=C(COCCN)NC(C)=C(C(OC)=O)[[C@@H]1C2=CC=CC=C2Cl)=O,insoluble in H2O; ≥42.7 mg/mL in EtOH; ≥53.2 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6452C6453,Vitamin E Acetate,58-95-7,A08,L1021-23,472.74,DMSO,C31H52O3,CC(OC1=C(C(C)=C(O[[C@H](C)(CCC[[C@H](C)CCC[[C@@H](CCCC(C)C)C)CC2)C2=C1C)C)=O,≥40.6 mg/mL in DMSO; ≥53 mg/mL in EtOH; ≥54.2 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6453C6454,N-Ethylmaleimide (NEM),128-53-0,A09,L1021-23,125.13,DMSO,C6H7NO2,O=C(N1CC)C=CC1=O,≥16.8 mg/mL in DMSO; ≥18.6 mg/mL in EtOH; ≥19.2 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6454C6455,Mafenide hydrochloride,138-37-4,A10,L1021-23,222.69,DMSO,C7H11ClN2O2S,NCC1=CC=C(S(N)(=O)=O)C=C1.Cl,insoluble in EtOH; ≥30.2 mg/mL in H2O; ≥36.5 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6455C6457,Testosterone Enanthate,315-37-7,A11,L1021-23,400.59,DMSO,C26H40O3,O=C1CC[[C@H@]2(C)C(CC[[C@H]3([H])[[C@H]2([H])CC[[C@H@]4(C)[[C@H@]3([H])CC[[C@@H]4OC(CCCCCC)=O)=C1,insoluble in H2O; ≥24.55 mg/mL in DMSO; ≥65.1 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6457C6458,Iron sucrose,8047-67-4,B01,L1021-23,501.98,H2O,C12H22Fe2O14,O[[C@@H]1[[C@H@](O[[C@H]([[C@@H]([[C@H]2O)O)O[[C@H](CO)[[C@H]2O)(CO)O[[C@H](CO)[[C@H]1O.[Fe+3].[Fe+3].[O-2].[O-2].[O-2],insoluble in DMSO; insoluble in EtOH; ≥66.8 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6458C6460,Levothyroxine sodium,55-03-8,B02,L1021-23,798.85,DMSO,C15H10I4NNaO4,IC1=CC(C[[C@H](N)C([O-])=O)=CC(I)=C1OC2=CC(I)=C(O)C(I)=C2.[Na+],≥100mg/mL in DMSO;≥3mg/mL in Ethanol;Insoluble in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6460C6464,Flavone,525-82-6,B03,L1021-23,222.24,DMSO,C15H10O2,O=C1C=C(C2=CC=CC=C2)OC3=C1C=CC=C3,insoluble in H2O; ≥38.3 mg/mL in EtOH; ≥52.3 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6464C6465,(-)-Borneol,464-45-9,B04,L1021-23,154.25,DMSO,C10H18O,CC1(C)[[C@H]2(C)CC[[C@H@]1([H])C[[C@H]2O,insoluble in H2O; ≥61.6 mg/mL in EtOH; ≥68.4 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6465C6466,Metoclopramide HCl,7232-21-5,B05,L1021-23,336.26,DMSO,C14H23Cl2N3O2,COC1=CC(N)=C(Cl)C=C1C(NCCN(CC)CC)=O.Cl,≥50.1 mg/mL in DMSO; ≥57.2 mg/mL in EtOH; ≥59.7 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6466C6467,Fosfomycin Tromethamine,78964-85-9,B06,L1021-23,259.19,DMSO,C7H18NO7P,C[[C@@H]1O[[C@@H]1P(O)(O)=O.OCC(N)(CO)CO,insoluble in EtOH; ≥33.7 mg/mL in H2O; ≥40.2 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6467C6468,Bendroflumethiazide,73-48-3,B07,L1021-23,421.41,DMSO,C15H14F3N3O4S2,FC(F)(F)C(C(S(=O)(N)=O)=C1)=CC(NC2CC3=CC=CC=C3)=C1S(N2)(=O)=O,insoluble in H2O; ≥26.65 mg/mL in EtOH; ≥64.8 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6468C6469,Ademetionine disulfate tosylate,97540-22-2,B08,L1021-23,766.8,DMSO,C22H34N6O16S4,NC1=C(N=CN2[[C@@H]3O[[C@H](C[S+](C)CC[[C@H](N)C([O-])=O)[[C@@H](O)[[C@H]3O)C2=NC=N1.CC4=CC=C(S(O)(=O)=O)C=C4.OS(O)(=O)=O.OS(O)(=O)=O,insoluble in EtOH; ≥112.4 mg/mL in H2O; ≥121.4 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6469C6470,(+)-Camphor,464-49-3,B09,L1021-23,152.23,DMSO,C10H16O,C[[C@H@]12CC[[C@@H](C(C)2C)CC1=O,insoluble in H2O; ≥17.5 mg/mL in EtOH; ≥21.3 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6470C6471,8-Hydroxyquinoline,148-24-3,B10,L1021-23,145.16,DMSO,C9H7NO,OC1=CC=CC2=CC=CN=C12,≥50mg/mL in DMSO (Need ultrasonic),#N/A,,,,https://www.apexbt.com/search.php?catalog=C6471C6472,Eprodisate disodium,36589-58-9,B11,L1021-23,248.19,H2O,C3H6Na2O6S2,O=S(CCCS(=O)([O-])=O)([O-])=O.[Na+].[Na+],insoluble in DMSO; insoluble in EtOH; ≥45.4 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6472C6473,Sodium sulfadiazine,547-32-0,C01,L1021-23,272.26,DMSO,C10H9N4NaO2S,NC1=CC=C(S(N(C2=NC=CC=N2)[Na])(=O)=O)C=C1,insoluble in EtOH; ≥19.4 mg/mL in DMSO; ≥32.9 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6473C6475,Saxagliptin hydrate,945667-22-1,C02,L1021-23,333.43,DMSO,C18H27N3O3,O=C(N1[[C@H](C#N)C[[C@H@]2([H])[[C@H]1([H])C2)[[C@@H](N)[[C@H]34C[[C@@H](C[[C@H@]5(O)C4)C[[C@@H](C5)C3.O,≥11.87 mg/mL in H2O with ultrasonic; ≥25.85 mg/mL in EtOH; ≥41.4 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6475C6476,Sulfacetamide sodium salt hydrate,6209-17-2,C03,L1021-23,254.24,DMSO,C8H11N2NaO4S,NC1=CC=C(S(N([Na])C(C)=O)(=O)=O)C=C1.O,insoluble in EtOH; ≥33.5 mg/mL in H2O; ≥39 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6476C6478,Cefuroxime axetil,64544-07-6,C04,L1021-23,510.47,DMSO,C20H22N4O10S,O=C(OC(C)OC(C)=O)C(N1[[C@H@]([H])([[C@@H](C1=O)NC(/C(C2=CC=CO2)=N\OC)=O)SC3)=C3COC(N)=O,insoluble in H2O; ≥26.7 mg/mL in EtOH; ≥67.2 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6478C6479,L-Cysteine HCl,52-89-1,C05,L1021-23,157.62,DMSO,C3H8ClNO2S,SC[[C@H](N)C(O)=O.Cl,≥15.9 mg/mL in EtOH; ≥20.6 mg/mL in H2O; ≥38 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6479C6480,Manganese chloride,7773-01-5,C06,L1021-23,125.84,DMSO,Cl2Mn,[Mn+2].[Cl-].[Cl-],≥25 mg/mL in DMSO; ≥49.2 mg/mL in H2O; ≥6 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6480C6481,Acotiamide hydrochloride,773092-05-0,C07,L1021-23,541.06,DMSO,C21H37ClN4O8S,COC1=CC(O)=C(C(NC2=NC(C(NCCN(C(C)C)C(C)C)=O)=CS2)=O)C=C1OC.Cl.O.O.O,≥100mg/mL in DMSO;≥20mg/mL in Ethanol;≥5mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6481C6483,Levocetirizine Dihydrochloride,130018-87-0,C08,L1021-23,461.81,DMSO,C21H27Cl3N2O3,ClC1=CC=C([[C@@H](C2=CC=CC=C2)N3CCN(CCOCC(O)=O)CC3)C=C1.Cl.Cl,insoluble in EtOH; ≥26.05 mg/mL in DMSO; ≥26.3 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6483C6484,Squalene,111-02-4,C09,L1021-23,410.72,DMSO,C30H50,C/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C,insoluble in H2O; ≥19.15 mg/mL in DMSO; ≥29.9 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6484C6485,Cefetamet pivoxil hydrochloride,111696-23-2,C10,L1021-23,548.03,DMSO,C20H26ClN5O7S2,CC1=C(C(OCOC(C(C)(C)C)=O)=O)N2C([[C@H@]([H])(NC(/C(C3=CSC(N)=N3)=N\OC)=O)[[C@H@]2([H])SC1)=O.Cl,≥100mg/mL in DMSO;≥100mg/mL in Ethanol;Insoluble in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6485C6486,Propacetamol hydrochloride,66532-86-3,C11,L1021-23,300.78,DMSO,C14H21ClN2O3,O=C(CN(CC)CC)OC1=CC=C(NC(C)=O)C=C1.Cl,insoluble in EtOH; insoluble in DMSO; ≥51.7 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6486C6487,Sulfamethoxazole sodium,4563-84-2,D01,L1021-23,275.26,DMSO,C10H10N3NaO3S,NC1=CC=C(S(=O)(N(C2=NOC(C)=C2)[Na])=O)C=C1,insoluble in EtOH; ≥30.8 mg/mL in DMSO; ≥39.2 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6487C6488,Lynestrenol,52-76-6,D02,L1021-23,284.44,DMSO,C20H28O,O[[C@H@]1(C#C)CC[[C@H@]2([H])[[C@H]3([H])CCC4=CCCC[[C@H]4([H])[[C@H@]3([H])CC[[C@H@]21C,≥56mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6488C6489,Perospirone hydrochloride,129273-38-7,D03,L1021-23,463.04,DMSO,C23H31ClN4O2S,O=C1N(CCCCN2CCN(C3=NSC4=C3C=CC=C4)CC2)C([[C@H@]5([H])CCCC[[C@H]51[H])=O.Cl,insoluble in H2O; ≥24.25 mg/mL in EtOH; ≥51 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6489C6492,Indobufen,63610-08-2,D04,L1021-23,295.33,DMSO,C18H17NO3,O=C1N(C2=CC=C(C(C(O)=O)CC)C=C2)CC3=C1C=CC=C3,insoluble in H2O; ≥4.13 mg/mL in EtOH with ultrasonic; ≥43.6 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6492C6493,Mebeverine Hydrochloride,2753-45-9,D05,L1021-23,466.01,DMSO,C25H36ClNO5,O=C(OCCCCN(CC)C(CC1=CC=C(OC)C=C1)C)C2=CC=C(OC)C(OC)=C2.Cl,≥26.1 mg/mL in EtOH; ≥51.5 mg/mL in H2O; ≥58.6 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6493C6494,Melitracen hydrochloride,10563-70-9,D06,L1021-23,327.89,DMSO,C21H26ClN,CN(C)CC/C=C1C2=C(C=CC=C2)C(C)(C)C3=C\1C=CC=C3.Cl,≥65mg/mL in DMSO;≥65mg/mL in Ethanol;≥65mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6494C6495,Actarit,18699-02-0,D07,L1021-23,193.2,DMSO,C10H11NO3,O=C(O)CC1=CC=C(NC(C)=O)C=C1,insoluble in H2O; ≥18.9 mg/mL in EtOH; ≥35.8 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6495C6496,Bevantolol hydrochloride,42864-78-8,D08,L1021-23,381.89,DMSO,C20H28ClNO4,CC1=CC(OCC(O)CNCCC2=CC(OC)=C(OC)C=C2)=CC=C1.Cl,≥10.73 mg/mL in H2O with ultrasonic; ≥35.3 mg/mL in DMSO; ≥9.26 mg/mL in EtOH with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6496C6498,Rifamycin sodium salt,14897-39-3,D09,L1021-23,719.75,DMSO,C37H46NNaO12,[O-]C1=CC(N2)=C(O)C3=C1C4=C(O[[C@H@](O/C=C/[[C@H](OC)[[C@@H](C)[[C@@H](C(OC)=O)[[C@H](C)[[C@H](O)[[C@H](C)[[C@@H](O)[[C@@H](C)/C=C/C=C(C)\C2=O)(C)C4=O)C(C)=C3O.[Na+],insoluble in H2O; ≥128.5 mg/mL in DMSO; ≥41.2 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6498C6499,Ganciclovir sodium,107910-75-8,D10,L1021-23,277.21,H2O,C9H12N5NaO4,[O-]C1=NC(N)=NC2=C1N=CN2COC(CO)CO.[Na+],insoluble in DMSO; insoluble in EtOH; ≥49.6 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6499C6502,Geranyl acetate,105-87-3,D11,L1021-23,196.29,DMSO,C12H20O2,C/C(C)=C/CC/C(C)=C/COC(C)=O,≥12.75 mg/mL in H2O; ≥36.2 mg/mL in DMSO; ≥37.2 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6502C6503,Methotrexate disodium,7413-34-5,E01,L1021-23,498.4,H2O,C20H20N8Na2O5,CN(C1=CC=C(C(N[[C@@H](CCC([O-])=O)C([O-])=O)=O)C=C1)CC2=NC3=C(N)N=C(N)N=C3N=C2.[Na+].[Na+],insoluble in EtOH; insoluble in DMSO; ≥56.2 mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6503C6504,Pralidoxime Iodide,94-63-3,E02,L1021-23,264.06,DMSO,C7H9IN2O,O/N=C/C1=[N+](C)C=CC=C1.[I-],insoluble in EtOH; ≥13.45 mg/mL in H2O; ≥33.1 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6504C6507,Ropivacaine Mesilate,854056-07-8,E03,L1021-23,370.51,DMSO,C18H30N2O4S,O=C(NC1=C(C)C=CC=C1C)[[C@H]2N(CCCC2)CCC.CS(=O)(O)=O,≥250mg/mL in H2O,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6507C6508,Diaveridine,5355-16-8,E04,L1021-23,260.29,DMSO,C13H16N4O2,COC1=C(C=CC(CC2=CN=C(N)N=C2N)=C1)OC,insoluble in H2O; ≥1.87 mg/mL in EtOH with gentle warming and ultrasonic; ≥17.07 mg/mL in DMSO,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6508C6510,Ciprofloxacin hydrochloride hydrate,86393-32-0,E05,L1021-23,385.82,DMSO,C17H21ClFN3O4,FC1=CC2=C(N(C3CC3)C=C(C(O)=O)C2=O)C=C1N4CCNCC4.Cl.O,≥8mg/mL in DMSO;Insoluble in H2O;Insoluble in Ethanol,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6510C6511,D-Pantethine,16816-67-4,E06,L1021-23,554.72,DMSO,C22H42N4O8S2,O=C(NCCC(NCCSSCCNC(CCNC([[C@H](O)C(C)(CO)C)=O)=O)=O)[[C@H](O)C(CO)(C)C,≥4.13 mg/mL in H2O with ultrasonic; ≥81.8 mg/mL in DMSO; ≥82.6 mg/mL in EtOH,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6511C6513,Minoxidil sulphate,83701-22-8,E07,L1021-23,289.31,DMSO,C9H15N5O4S,NC1=NC(N2CCCCC2)=CC(N1OS(O)(=O)=O)=N,≥112 mg/mL in DMSO; ≥2.67 mg/mL in EtOH with gentle warming and ultrasonic; ≥4.94 mg/mL in H2O with ultrasonic,#N/A,,,,https://www.apexbt.com/search.php?catalog=C6513C6517,Maltitol,585-88-6,E08,L1021-23,344.31,DMSO,C12H24O11,O[C@H](CO)[C@H]([C@H](O)[C@H](CO)O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1,≥22.57mg/mL in DMSO with ultrasonic; insoluble in EtOH; ≥30.05 mg/mL in H2O,,Others,Others,"sugar alcohol, polyol",https://www.apexbt.com/search.php?catalog=C6517C6522,Sorbic acid,110-44-1,E09,L1021-23,112.13,DMSO,C6H8O2,C/C=C/C=C/C(O)=O,≥16 mg/mL in DMSO; ≥18.2 mg/mL in EtOH; insoluble in H2O,,Others,Others,natural compound that inhibit a wide range of bacteria,https://www.apexbt.com/search.php?catalog=C6522C6524,Laurocapram,59227-89-3,E10,L1021-23,281.48,DMSO,C18H35NO,O=C1N(CCCCCCCCCCCC)CCCCC1,≥26.5 mg/mL in DMSO; ≥44.2 mg/mL in EtOH; insoluble in H2O,,Others,Others,skin penetration enhancer,https://www.apexbt.com/search.php?catalog=C6524C6526,Diatrizoate sodium,737-31-5,E11,L1021-23,635.9,DMSO,C11H8I3N2NaO4,O=C(O[Na])C1=C(I)C(NC(C)=O)=C(I)C(NC(C)=O)=C1I,≥101.5 mg/mL in DMSO; ≥60.7 mg/mL in EtOH; ≥82.9 mg/mL in H2O,,Others,Others,X-Ray contrast agents,https://www.apexbt.com/search.php?catalog=C6526C6528,Clioquinol,130-26-7,F01,L1021-23,305.5,DMSO,C9H5ClINO,ClC1=C(C=CC=N2)C2=C(O)C(I)=C1,≥56.9 mg/mL in DMSO; ≥2.3 mg/mL in EtOH; insoluble in H2O,,Microbiology,Anti-infection,"antifungal, antitumour activity",https://www.apexbt.com/search.php?catalog=C6528C6536,4-(Aminomethyl)benzoic acid,56-91-7,F02,L1021-23,151.16,H2O,C8H9NO2,O=C(O)C1=CC=C(CN)C=C1,Insoluble in DMSO; insoluble in EtOH; ≥4.6 mg/mL in H2O with ultrasonic,,Others,Others,"anti-fibrinolytic, non-natural amino acid derivatives",https://www.apexbt.com/search.php?catalog=C6536C6540,Ethosuximide,77-67-8,F03,L1021-23,141.17,DMSO,C7H11NO2,O=C(C(C)(CC)C1)NC1=O,≥24.1 mg/mL in DMSO; ≥26.8 mg/mL in EtOH; ≥22.7 mg/mL in H2O,,Transmembrane Transporters,Calcium Channel,anti-epileptic drugs,https://www.apexbt.com/search.php?catalog=C6540C6542,Amitraz,33089-61-1,F04,L1021-23,293.41,DMSO,C19H23N3,CN(/C=N/C1=CC=C(C)C=C1C)/C=N/C2=CC=C(C)C=C2C,≥46.3 mg/mL in DMSO; ≥48.9 mg/mL in EtOH; insoluble in H2O,,Neuronal Signaling,Adrenergic Receptor,non-systemic acaricide and insecticide with alpha-adrenergic agonist activity,https://www.apexbt.com/search.php?catalog=C6542C6547,"(2S,3R,4S,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride",5505-63-5,F05,L1021-23,215.63,DMSO,C6H14ClNO5,O=C[C@@H](N)[C@H]([C@@H]([C@@H](CO)O)O)O.[H]Cl,≥16.05 mg/mL in DMSO; insoluble in EtOH; ≥31.2 mg/mL in H2O,,others,others,endogenous metabolite,https://www.apexbt.com/search.php?catalog=C6547C6550,Dexamethasone phosphate disodium,2392-39-4,F06,L1021-23,516.4,H2O,C22H28FNa2O8P,O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@]4(O)C(COP(O[Na])(O[Na])=O)=O)=C1,Insoluble in DMSO; insoluble in EtOH; ≥62.1 mg/mL in H2O,,Endocrinology & Hormones,Glucocorticoid Receptor,glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=C6550C6557,Caryophyllene oxide,1139-30-6,F07,L1021-23,220.35,DMSO,C15H24O,C=C1CC[C@@]2([H])O[C@]2(C)CC[C@@]3([H])C(C)(C)C[C@]13[H],≥31.4 mg/mL in DMSO; ≥36.1 mg/mL in EtOH; insoluble in H2O,,Others,Others,analgesic and anti-inflammatory,https://www.apexbt.com/search.php?catalog=C6557C6563,_-santonin,481-06-1,F08,L1021-23,246.3,DMSO,C15H18O3,O=C1[C@@H](C)[C@@](CC[C@@]2(C)C=CC(C(C)=C23)=O)([H])[C@]3([H])O1,≥24.8 mg/mL in DMSO; ≥8.38 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Microbiology,Anti-infection,anti-parasitic agent,https://www.apexbt.com/search.php?catalog=C6563C6567,9-Aminoacridine,90-45-9,F09,L1021-23,194.23,DMSO,C13H10N2,NC1=C(C=CC=C2)C2=NC3=CC=CC=C31,≥38.2 mg/mL in DMSO; ≥14.2 mg/mL in EtOH; insoluble in H2O,,Others,Others,antimicrobial,https://www.apexbt.com/search.php?catalog=C6567C6568,Ethidium bromide,1239-45-8,F10,L1021-23,394.31,DMSO,C21H20BrN3,CC[N+]1=C(C2=CC=CC=C2)C3=CC(N)=CC=C3C4=C1C=C(N)C=C4.[Br-],≥76.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Others,Others,nucleic acid staining,https://www.apexbt.com/search.php?catalog=C6568C6570,Dimenhydrinate,523-87-5,F11,L1021-23,469.96,DMSO,C24H28ClN5O3,O=C(N1C)N(C)C2=C(NC(Cl)=N2)C1=O.CN(C)CCOC(C3=CC=CC=C3)C4=CC=CC=C4,≥68.1 mg/mL in DMSO; ≥34.7 mg/mL in EtOH; insoluble in H2O,,Others,Others,"antiemetic, antihistamine",https://www.apexbt.com/search.php?catalog=C6570C6577,Dithranol,1143-38-0,G01,L1021-23,226.23,DMSO,C14H10O3,O=C1C2=C(C=CC=C2O)CC3=CC=CC(O)=C13,≥7.68 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Others,Others,Psoriasis medication,https://www.apexbt.com/search.php?catalog=C6577C6588,Purine,120-73-0,G02,L1021-23,120.11,DMSO,C5H4N4,C12=NC=NC=C1N=CN2,≥23.7 mg/mL in DMSO; ≥22.9 mg/mL in EtOH; ≥22 mg/mL in H2O,,purine,Others, heterocyclic aromatic organic compound,https://www.apexbt.com/search.php?catalog=C6588C6589,Tetracycline,60-54-8,G03,L1021-23,444.43,DMSO,C22H24N2O8,O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])[C@](C)(O)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4)N,≥74.9 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Microbiology,Anti-infection,broad-spectrum antibiotic,https://www.apexbt.com/search.php?catalog=C6589C6594,Propantheline bromide,50-34-0,G04,L1021-23,448.39,DMSO,C23H30BrNO3,CC([N+](C(C)C)(C)CCOC(C1C2=C(OC3=C1C=CC=C3)C=CC=C2)=O)C.[Br-],≥64.1 mg/mL in DMSO; ≥59.6 mg/mL in EtOH; ≥60.7 mg/mL in H2O,,Neuronal Signaling,AChR,antimuscarinic agent,https://www.apexbt.com/search.php?catalog=C6594C6596,Emeramide,351994-94-0,G05,L1021-23,284.4,DMSO,C12H16N2O2S2,O=C(C1=CC=CC(C(NCCS)=O)=C1)NCCS,≥42.8 mg/mL in DMSO; ≥10.28 mg/mL in EtOH with ultrasonic; insoluble in H2O,#N/A,#N/A,#N/A,antioxidant heavy metal chelator,https://www.apexbt.com/search.php?catalog=C6596C6603,3-Phenoxybenzoic acid,3739-38-6,G06,L1021-23,214.22,DMSO,C13H10O3,O=C(O)C1=CC=CC(OC2=CC=CC=C2)=C1,≥37.9 mg/mL in DMSO; ≥41.9 mg/mL in EtOH; insoluble in H2O,,Others,Others,endogenous metabolites,https://www.apexbt.com/search.php?catalog=C6603C6632,Cyclen,294-90-6,G07,L1021-23,172.27,H2O,C8H20N4,C1CNCCNCCNCCN1,Insoluble in DMSO; ≥32.4 mg/mL in EtOH; ≥15.55 mg/mL in H2O,,Others,Others,analogues of aza-crown ethers,https://www.apexbt.com/search.php?catalog=C6632C6634,Bendazol,621-72-7,G08,L1021-23,208.26,DMSO,C14H12N2,C1(CC2=CC=CC=C2)=NC3=CC=CC=C3N1,≥34.7 mg/mL in DMSO; ≥37 mg/mL in EtOH; insoluble in H2O,,Immunology & Inflammation,NOS,"antihypertensive drug, enhances NO synthase activity ",https://www.apexbt.com/search.php?catalog=C6634C6638,Idramantone,20098-14-0,G09,L1021-23,166.22,DMSO,C10H14O2,O=C1C(C2)CC3CC2(O)CC1C3,≥32.3 mg/mL in DMSO; ≥33.8 mg/mL in EtOH; ≥32.2 mg/mL in H2O,,Immunology & Inflammation,Immunology & Inflammation related,Idramantone is an immune agonist,https://www.apexbt.com/search.php?catalog=C6638C6646,Methylene Blue,61-73-4,G10,L1021-23,319.85,DMSO,C16H18ClN3S,CN(C)C1=CC=C2C(SC(C(C=C/3)=N2)=CC3=[N+](C)/C)=C1.[Cl-],≥60.8 mg/mL in DMSO; insoluble in EtOH; ≥14.87 mg/mL in H2O,,Others,Others,"monoamine oxidase A (MAO-A), guanylate cyclase (sGC) and NO synthase (NOS) inhibitor",https://www.apexbt.com/search.php?catalog=C6646C6659,Amifampridine,54-96-6,G11,L1021-23,109.13,DMSO,C5H7N3,NC1=C(N)C=CN=C1,≥19.1 mg/mL in DMSO; ≥19.4 mg/mL in EtOH; ≥10.05 mg/mL in H2O,,Others,Others,rare muscle disease drugs,https://www.apexbt.com/search.php?catalog=C6659C6660,Sophoricoside,152-95-4,H01,L1021-23,432.38,DMSO,C21H20O10,OC1=CC(O)=C(C(C(C2=CC=C(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C2)=CO4)=O)C4=C1,≥28.37 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Immunology & Inflammation,Immunology & Inflammation related,"an isoflavone with anti-inflammatory, anti-cancer and immunosuppressive properties",https://www.apexbt.com/search.php?catalog=C6660C6667,Benactyzine hydrochloride,57-37-4,H02,L1021-23,363.88,DMSO,C20H26ClNO3,O=C(OCCN(CC)CC)C(C1=CC=CC=C1)(O)C2=CC=CC=C2.[H]Cl,≥59.3 mg/mL in DMSO; ≥15.13 mg/mL in EtOH with ultrasonic; ≥17.8 mg/mL in H2O with ultrasonic,,Neuronal Signaling,AChR,muscarinic antagonist,https://www.apexbt.com/search.php?catalog=C6667C6668,Methylbenactyzine Bromide,3166-62-9,H03,L1021-23,422.36,DMSO,C21H28BrNO3,O=C(OCC[N+](CC)(CC)C)C(C1=CC=CC=C1)(O)C2=CC=CC=C2.[Br-],≥73.2 mg/mL in DMSO; ≥20.97 mg/mL in EtOH; ≥50.7 mg/mL in H2O,,Neuronal Signaling,AChR,muscarinic cholinergic receptor antagonist,https://www.apexbt.com/search.php?catalog=C6668C6669,Diiodohydroxyquinoline,83-73-8,H04,L1021-23,396.95,DMSO,C9H5I2NO,OC1=C2N=CC=CC2=C(I)C=C1I,≥16.97mg/mL in DMSO with ultrasonic; insoluble in EtOH; insoluble in H2O,,Microbiology,Anti-infection,antimicrobial,https://www.apexbt.com/search.php?catalog=C6669C6685,Succinylsulfathiazole,116-43-8,H05,L1021-23,355.39,DMSO,C13H13N3O5S2,O=C(O)CCC(NC1=CC=C(S(=O)(NC2=NC=CS2)=O)C=C1)=O,≥58.3 mg/mL in DMSO; ≥4.5 mg/mL in EtOH (Need ultrasonic and warming); insoluble in H2O,,Microbiology,Anti-infection,antibiotic,https://www.apexbt.com/search.php?catalog=C6685C6694,Methacholine chloride,62-51-1,H06,L1021-23,195.69,DMSO,C8H18ClNO2,CC(OC(C)=O)C[N+](C)(C)C.[Cl-],≥29.4 mg/mL in DMSO; ≥39.8 mg/mL in EtOH; ≥24.6 mg/mL in H2O,,Neuronal Signaling,AChR,non-selective muscarinic receptor agonist,https://www.apexbt.com/search.php?catalog=C6694C6701,Ceftiofur sodium,104010-37-9,H07,L1021-23,545.54,DMSO,C19H16N5NaO7S3,O=C(O[Na])C(N12)=C(CSC(C3=CC=CO3)=O)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O,≥78.9 mg/mL in DMSO; insoluble in EtOH; ≥36.85 mg/mL in H2O,,Microbiology,Anti-infection,broad spectrum cephalosporin,https://www.apexbt.com/search.php?catalog=C6701C6703,Dehydrocholic acid,81-23-2,H08,L1021-23,402.52,DMSO,C24H34O5,C[C@H](CCC(O)=O)[C@H]([C@]12C)CC[C@@]1([H])[C@]3([H])C(C[C@]4([H])CC(CC[C@]4(C)[C@@]3([H])CC2=O)=O)=O,≥72.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Others,Others,Semi-synthetic bile acid,https://www.apexbt.com/search.php?catalog=C6703C6705,Amlodipine maleate,88150-47-4,H09,L1021-23,524.95,DMSO,C24H29ClN2O9,O=C(C1=C(COCCN)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2Cl)OCC.OC(/C=C\C(O)=O)=O,≥74.9 mg/mL in DMSO; ≥14.04 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Transmembrane Transporters,Calcium Channel,dihydropyridine calcium channel blocker,https://www.apexbt.com/search.php?catalog=C6705C6709,Anethole trithione,532-11-6,H10,L1021-23,240.36,DMSO,C10H8OS3,S=C1SSC(C2=CC=C(OC)C=C2)=C1,≥42.7 mg/mL in DMSO; ≥1.73 mg/mL in EtOH (Need ultrasonic and warming); insoluble in H2O,,Others,Others,"thiocyclic choline, bile secretion stimulant",https://www.apexbt.com/search.php?catalog=C6709C6712,Hydroquinidine,1435-55-8,H11,L1021-23,326.43,DMSO,C20H26N2O2,O[C@@H](C1=CC=NC2=C1C=C(OC)C=C2)[C@]3([H])[N@](C[C@@H]4CC)CC[C@H]4C3,≥27.6 mg/mL in DMSO; ≥14.33 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Others,Others,antiarrhythmic agent,https://www.apexbt.com/search.php?catalog=C6712C6713,Pazufloxacin mesylate,163680-77-1,A01,L1021-24,414.4,DMSO,C17H19FN2O7S,O=C(C(C1=O)=CN2[C@@H](C)COC3=C(C4(N)CC4)C(F)=CC1=C23)O.CS(=O)(O)=O,≥81.6 mg/mL in DMSO; insoluble in EtOH; ≥71.3 mg/mL in H2O,,Microbiology,Anti-infection,antibacterial quinolone,https://www.apexbt.com/search.php?catalog=C6713C6716,Diethylcarbamazine citrate,1642-54-2,A02,L1021-24,391.42,DMSO,C16H29N3O8,O=C(N1CCN(C)CC1)N(CC)CC.O=C(CC(C(O)=O)(O)CC(O)=O)O,≥76.6 mg/mL in DMSO; ≥15.12 mg/mL in EtOH with ultrasonic; ≥68.5 mg/mL in H2O,,Microbiology,Anti-infection,inhibitors of arachidonic acid metabolism in microfilariae,https://www.apexbt.com/search.php?catalog=C6716C6718,Pyrantel tartrate,33401-94-4,A03,L1021-24,356.39,DMSO,C15H20N2O6S,CN1CCCN=C1/C=C/C2=CC=CS2.O=C(O)[C@H](O)[C@@H](O)C(O)=O,≥33.4 mg/mL in DMSO; insoluble in EtOH; ≥33.9 mg/mL in H2O,,Anti-infection,Parasite,nicotinic acetylcholine receptor (nAChR) agonist,https://www.apexbt.com/search.php?catalog=C6718C6722,Nikethamide,59-26-7,A04,L1021-24,178.23,DMSO,C10H14N2O,O=C(C1=CC=CN=C1)N(CC)CC,≥35.2 mg/mL in DMSO; ≥32.7 mg/mL in EtOH; ≥30.6 mg/mL in H2O,,Pyridine,Others,respiratory central activator,https://www.apexbt.com/search.php?catalog=C6722C6723,Theophylline-7-acetic acid,652-37-9,A05,L1021-24,238.2,DMSO,C9H10N4O4,O=C(O)CN1C=NC(N(C)C(N2C)=O)=C1C2=O,≥43.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,GPCR & G Protein,Adenosine Receptor,adenosine receptor antagonist,https://www.apexbt.com/search.php?catalog=C6723C6728,1H-pyrazole,288-13-1,A06,L1021-24,68.08,DMSO,C3H4N2,N1=CC=CN1,≥13.8 mg/mL in DMSO; ≥10.4 mg/mL in EtOH; ≥10.4 mg/mL in H2O,,others,others,endogenous metabolite,https://www.apexbt.com/search.php?catalog=C6728C6741,Dehydroacetic acid,520-45-6,A07,L1021-24,168.15,DMSO,C8H8O4,O=C1C(C(C)=O)C(C=C(C)O1)=O,≥31.5 mg/mL in DMSO; ≥10.47 mg/mL in EtOH; insoluble in H2O,,Microbiology,Anti-infection,fungicide and bactericide,https://www.apexbt.com/search.php?catalog=C6741C6744,Terpin hydrate,2451-01-6,A08,L1021-24,190.28,DMSO,C10H22O3,O[C@]1(C)CC[C@H](C(C)(C)O)CC1.O,≥35.7 mg/mL in DMSO; ≥38.1 mg/mL in EtOH; insoluble in H2O,,Others,Others,expectorant,https://www.apexbt.com/search.php?catalog=C6744C6750,DEET,134-62-3,A09,L1021-24,191.27,DMSO,C12H17NO,O=C(C1=CC=CC(C)=C1)N(CC)CC,≥30.6 mg/mL in DMSO; ≥33.8 mg/mL in EtOH; insoluble in H2O,,Microbiology,Anti-infection,insect repellent ingredient,https://www.apexbt.com/search.php?catalog=C6750C6752,Triacetonamine,826-36-8,A10,L1021-24,155.24,DMSO,C9H17NO,O=C1CC(C)(NC(C)(C1)C)C,≥30 mg/mL in DMSO; ≥28.7 mg/mL in EtOH; ≥28 mg/mL in H2O,,Others,Others,"intermediates for the synthesis of pharmaceutical products, pesticides and polymeric light stabilizers",https://www.apexbt.com/search.php?catalog=C6752C6756,Chloroxylenol,88-04-0,A11,L1021-24,156.61,DMSO,C8H9ClO,OC1=CC(C)=C(Cl)C(C)=C1,≥30.5 mg/mL in DMSO; ≥28.8 mg/mL in EtOH; insoluble in H2O,,Microbiology,Anti-infection,broad-spectrum antibacterial compound,https://www.apexbt.com/search.php?catalog=C6756C6757,Carbendazim,10605-21-7,B01,L1021-24,191.19,DMSO,C9H9N3O2,O=C(OC)NC1=NC2=CC=CC=C2N1,≥5.1mg/mL in DMSO with ultrasonic; insoluble in EtOH; insoluble in H2O,,Microbiology,Anti-infection,broad-spectrum antifungal drug,https://www.apexbt.com/search.php?catalog=C6757C6759,Batyl alcohol,544-62-7,B02,L1021-24,344.57,DMSO,C21H44O3,CCCCCCCCCCCCCCCCCCOCC(O)CO,≥3.95mg/mL in DMSO with ultrasonic; ≥136.5 mg/mL in EtOH; insoluble in H2O,,Immunology & Inflammation,Immunology & Inflammation related,endogenous metabolite,https://www.apexbt.com/search.php?catalog=C6759C6765,4-Aminoantipyrine,83-07-8,B03,L1021-24,203.24,DMSO,C11H13N3O,O=C1N(N(C(C)=C1N)C)C2=CC=CC=C2,≥36.2 mg/mL in DMSO; ≥27.7 mg/mL in EtOH; ≥35.8 mg/mL in H2O,,Others,Others,aminopyrine metabolite,https://www.apexbt.com/search.php?catalog=C6765C6766,Ethylvanillin,121-32-4,B04,L1021-24,166.17,DMSO,C9H10O3,O=CC1=CC=C(C(OCC)=C1)O,≥28.5 mg/mL in DMSO; ≥27.1 mg/mL in EtOH; insoluble in H2O,,Others,Others,edible spices and used in the production of chocolate,https://www.apexbt.com/search.php?catalog=C6766C6769,Bronopol,52-51-7,B05,L1021-24,199.99,DMSO,C3H6BrNO4,OCC(Br)(CO)[N+]([O-])=O,≥34.1 mg/mL in DMSO; ≥39.8 mg/mL in EtOH; ≥31.9 mg/mL in H2O,,Microbiology,Anti-infection,antimicrobial,https://www.apexbt.com/search.php?catalog=C6769C6772,Piperazine adipate,142-88-1,B06,L1021-24,232.28,H2O,C10H20N2O4,O=C(CCCCC(O)=O)O.N1CCNCC1,Insoluble in DMSO; insoluble in EtOH; ≥13.93 mg/mL in H2O with ultrasonic,,Others,Others,broad spectrum anthelmintic agent,https://www.apexbt.com/search.php?catalog=C6772C6773,Danthron,117-10-2,B07,L1021-24,240.21,DMSO,C14H8O4,O=C1C2=C(C(C3=C(O)C=CC=C13)=O)C(O)=CC=C2,≥9.08mg/mL in DMSO with ultrasonic; insoluble in EtOH; insoluble in H2O,,Others,Others,"AMPK activator, regulates glucose and lipid metabolism",https://www.apexbt.com/search.php?catalog=C6773C6776,DL-Panthenol,16485-10-2,B08,L1021-24,205.25,DMSO,C9H19NO4,O=C(C(C(C)(CO)C)O)NCCCO,≥34.7 mg/mL in DMSO; ≥35.4 mg/mL in EtOH; ≥33.2 mg/mL in H2O,,Others,Others,Vitaminogen for B5,https://www.apexbt.com/search.php?catalog=C6776C6781,Oxaceprol,33996-33-7,B09,L1021-24,173.17,DMSO,C7H11NO4,O=C([C@H]1N(C[C@@H](C1)O)C(C)=O)O,≥31.6 mg/mL in DMSO; ≥29.8 mg/mL in EtOH; ≥31.9 mg/mL in H2O,,Immunology & Inflammation,Immunology & Inflammation related,anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=C6781C6782,Osalmid,526-18-1,B10,L1021-24,229.23,DMSO,C13H11NO3,O=C(C1=CC=CC=C1O)NC2=CC=C(O)C=C2,≥42.9 mg/mL in DMSO; ≥42.8 mg/mL in EtOH; insoluble in H2O,,Anti-infection,ribonucleotide reductase,ribonucleotide reductase inhibitor,https://www.apexbt.com/search.php?catalog=C6782C6789,Citiolone,1195-16-0,B11,L1021-24,159.21,DMSO,C6H9NO2S,CC(NC1CCSC1=O)=O,≥28.9 mg/mL in DMSO; ≥31.5 mg/mL in EtOH; ≥30.4 mg/mL in H2O,,Others,Others,cysteine derivative,https://www.apexbt.com/search.php?catalog=C6789C6790,Methionine,348-67-4,C01,L1021-24,149.21,H2O,C5H11NO2S,N[C@@H](C(O)=O)CCSC,Insoluble in DMSO; insoluble in EtOH; ≥28.8 mg/mL in H2O,,Neuronal Signaling,GABA Receptor,GABA Receptor activitor,https://www.apexbt.com/search.php?catalog=C6790C6791,Acetylcholine iodide,2260-50-6,C02,L1021-24,273.11,DMSO,C7H16INO2,O=C(C)OCC[N+](C)(C)C.[I-],≥51.8 mg/mL in DMSO; insoluble in EtOH; ≥51.2 mg/mL in H2O,,Neuronal Signaling,AChR,neurotransmitter,https://www.apexbt.com/search.php?catalog=C6791C6831,4-Phenylbutyric acid,1821-12-1,C03,L1021-24,164.2,DMSO,C10H12O2,O=C(CCCC1=CC=CC=C1)O,≥31 mg/mL in DMSO; ≥29.5 mg/mL in EtOH; insoluble in H2O,,Phenyl, histone deacetylase (HDAC),endoplasmic reticulum stress (ER) and histone deacetylase (HDAC) inhibitor,https://www.apexbt.com/search.php?catalog=C6831C6841,Oxytetracycline hydrochloride,2058-46-0,C04,L1021-24,496.89,DMSO,C22H25ClN2O9,OC([C@@H](N(C)C)[C@]1([H])[C@@H](O)[C@](C2=C(O)[C@@]13O)([H])[C@](C)(O)C4=CC=CC(O)=C4C2=O)=C(C(N)=O)C3=O.Cl,≥93.6 mg/mL in DMSO; insoluble in EtOH; ≥76.3 mg/mL in H2O,,Microbiology,Anti-infection,antibiotic,https://www.apexbt.com/search.php?catalog=C6841C6858,Maleimide,541-59-3,C05,L1021-24,97.07,DMSO,C4H3NO2,O=C(C=C1)NC1=O,≥18.6 mg/mL in DMSO; ≥8.2 mg/mL in EtOH; ≥13.5 mg/mL in H2O,,others,dyes. ADC linker,antibody-drug coupling (ADC); preparation of fluorescent probes,https://www.apexbt.com/search.php?catalog=C6858C6864,Veratric acid,93-07-2,C06,L1021-24,182.17,DMSO,C9H10O4,O=C(C1=CC=C(C(OC)=C1)OC)O,≥34.1 mg/mL in DMSO; ≥15.55 mg/mL in EtOH; insoluble in H2O,,Phenyl,COX-2,"polyphenols with antioxidant, cardioprotective and anti-inflammatory activity;reduced up-regulated COX-2 expression and decreased PGE2 and IL-6 levels upon UVB radiation",https://www.apexbt.com/search.php?catalog=C6864C6866,Benzamidine HCl,1670-14-0,C07,L1021-24,156.61,DMSO,C7H9ClN2,N=C(N)C1=CC=CC=C1.Cl,≥30 mg/mL in DMSO; ≥23.5 mg/mL in EtOH; ≥22.8 mg/mL in H2O,,Proteases,Serine/threonin kina,Trypsin-like serine proteases inhibitor,https://www.apexbt.com/search.php?catalog=C6866C6883,Cloxiquine,130-16-5,C08,L1021-24,179.6,DMSO,C9H6ClNO,OC1=C2N=CC=CC2=C(C=C1)Cl,≥27.3 mg/mL in DMSO; ≥14.8 mg/mL in EtOH; insoluble in H2O,,Microbiology,Anti-infection,antimicrobial,https://www.apexbt.com/search.php?catalog=C6883C6885,Deoxycholic acid sodium salt,302-95-4,C09,L1021-24,414.55,DMSO,C24H39NaO4,C[C@@]12[C@]([C@@]([H])([C@@]3(C[C@@H]1O)[H])CC[C@]4([C@]3(C)CC[C@H](C4)O)[H])(CC[C@]2([H])[C@@H](CCC(O[Na])=O)C)[H],≥4.13mg/mL in DMSO (Need ultrasonic and warming); ≥15.4 mg/mL in EtOH (Need ultrasonic and warming); ≥32.04 mg/mL in H2O,,GPCR & G Protein,GPCR19,G protein-coupled bile acid receptor TGR5 activator,https://www.apexbt.com/search.php?catalog=C6885C6892,Acetylleucine,99-15-0,C10,L1021-24,173.21,DMSO,C8H15NO3,O=C(NC(CC(C)C)C(O)=O)C,≥28.5 mg/mL in DMSO; ≥33.2 mg/mL in EtOH; ≥7.57 mg/mL in H2O with ultrasonic,,Others,Others,medication for vertigo,https://www.apexbt.com/search.php?catalog=C6892C6905,2-Phenylacetamide,103-81-1,C11,L1021-24,135.16,DMSO,C8H9NO,O=C(CC1=CC=CC=C1)N,≥25.5 mg/mL in DMSO; ≥12.3 mg/mL in EtOH; ≥1.26 mg/mL in H2O with ultrasonic,,Endocrinology & Hormones,Estrogen/progestogen Receptor,endogenous metabolite,https://www.apexbt.com/search.php?catalog=C6905C6919,4-Biphenylacetic acid,5728-52-9,D01,L1021-24,212.24,DMSO,C14H12O2,O=C(CC1=CC=C(C=C1)C2=CC=CC=C2)O,≥33.9 mg/mL in DMSO; ≥11.67 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Immunology & Inflammation,Immunology & Inflammation related,"non-steroidal anti-inflammatory drugs, NSAIDs",https://www.apexbt.com/search.php?catalog=C6919C6931,ATP,56-65-5,D02,L1021-24,507.18,H2O,C10H16N5O13P3,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(OP(OP(O)(O)=O)(O)=O)=O)N2C=NC3=C2N=CN=C3N,Insoluble in DMSO; insoluble in EtOH; ≥38 mg/mL in H2O,,Immunology & Inflammation,Immunology & Inflammation related,endogenous signalling molecules; important substances for energy storage and metabolism,https://www.apexbt.com/search.php?catalog=C6931C6933,Carsalam,2037-95-8,D03,L1021-24,163.13,DMSO,C8H5NO3,O=C(OC1=CC=CC=C12)NC2=O,≥32.2 mg/mL in DMSO; ≥3.11 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Microbiology,Anti-infection,non-steroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=C6933C6934,Robenidine hydrochloride,25875-50-7,D04,L1021-24,370.66,DMSO,C15H14Cl3N5,N=C(N/N=C/C1=CC=C(Cl)C=C1)N/N=C/C2=CC=C(Cl)C=C2.Cl,≥73.6 mg/mL in DMSO; ≥3.11 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Microbiology,Anti-infection,anticoccidial; MRSA and VRE inhibitor,https://www.apexbt.com/search.php?catalog=C6934C6944,Carboxine,5234-68-4,D05,L1021-24,235.3,DMSO,C12H13NO2S,O=C(NC1=CC=CC=C1)C2=C(OCCS2)C,≥44.3 mg/mL in DMSO; ≥23 mg/mL in EtOH; insoluble in H2O,,Anti-infection,Others,Fungicides and seed protectants,https://www.apexbt.com/search.php?catalog=C6944C6948,Perflubron,423-55-2,D06,L1021-24,498.96,EtOH,C8BrF17,FC(F)(C(F)(C(F)(C(F)(C(F)(C(F)(C(F)(C(Br)(F)F)F)F)F)F)F)F)F,Insoluble in DMSO; ≥58.2 mg/mL in EtOH; insoluble in H2O,,Immunology & Inflammation,Immunology & Inflammation related,contrast media,https://www.apexbt.com/search.php?catalog=C6948C6949,Sulfabenzamide,127-71-9,D07,L1021-24,276.31,DMSO,C13H12N2O3S,O=C(C1=CC=CC=C1)NS(=O)(C2=CC=C(N)C=C2)=O,≥53.3 mg/mL in DMSO; ≥8.98 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Microbiology,Anti-infection,antimicrobial,https://www.apexbt.com/search.php?catalog=C6949C6952,Menadiol Diacetate,573-20-6,D08,L1021-24,258.27,DMSO,C15H14O4,CC1=CC(OC(C)=O)=C2C=CC=CC2=C1OC(C)=O,≥48.9 mg/mL in DMSO; ≥22.7 mg/mL in EtOH; insoluble in H2O,,Microbiology,Vitamin,"Vitamin K4, used in blood clotting",https://www.apexbt.com/search.php?catalog=C6952C6958,Menbutone,3562-99-0,D09,L1021-24,258.27,DMSO,C15H14O4,O=C(CCC(C1=C2C=CC=CC2=C(C=C1)OC)=O)O,≥47.8 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Others,Others,"Oxobutyric acid derivatives, Choleretic",https://www.apexbt.com/search.php?catalog=C6958C6962,Lawsone,83-72-7,D10,L1021-24,174.15,DMSO,C10H6O3,O=C1C(O)=CC(C2=C1C=CC=C2)=O,≥35.6 mg/mL in DMSO; ≥11.03 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Others,Others,"naphthoquinone dyes, with antibacterial and antioxidant activity",https://www.apexbt.com/search.php?catalog=C6962C6963,Thiamine nitrate,532-43-4,D11,L1021-24,327.36,H2O,C12H17N5O4S,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.[O-][N+]([O-])=O,≥3.12mg/mL in DMSO with ultrasonic; insoluble in EtOH; ≥12.32 mg/mL in H2O with ultrasonic,,Metabolism,Vitamin,Vitamins,https://www.apexbt.com/search.php?catalog=C6963C6964,Diatrizoic acid,117-96-4,E01,L1021-24,613.91,DMSO,C11H9I3N2O4,O=C(C1=C(C(NC(C)=O)=C(C(NC(C)=O)=C1I)I)I)O,≥87.3 mg/mL in DMSO; ≥3.85 mg/mL in EtOH (Need ultrasonic and warming); insoluble in H2O,,Others,Others,Iodinated contrast media; calcium disorders,https://www.apexbt.com/search.php?catalog=C6964C6968,10-Undecenoic acid,112-38-9,E02,L1021-24,184.28,DMSO,C11H20O2,C=CCCCCCCCCC(O)=O,≥36.8 mg/mL in DMSO; ≥36.5 mg/mL in EtOH; ≥31.8 mg/mL in H2O,,Others,Others,Pheromone (11Z)-hexadecenal synthesis starter,https://www.apexbt.com/search.php?catalog=C6968C6969,Acetophenone,98-86-2,E03,L1021-24,120.15,DMSO,C8H8O,CC(C1=CC=CC=C1)=O,≥22.8 mg/mL in DMSO; ≥21 mg/mL in EtOH; ≥19.8 mg/mL in H2O,,Phenyl,Others,an organic compound used in flavoring and in the synthesis of some medicines,https://www.apexbt.com/search.php?catalog=C6969C6974,Trimethobenzamide hydrochloride,554-92-7,E04,L1021-24,424.92,DMSO,C21H29ClN2O5,O=C(C1=CC(OC)=C(OC)C(OC)=C1)NCC2=CC=C(OCCN(C)C)C=C2.Cl,≥70 mg/mL in DMSO; ≥8.15 mg/mL in EtOH; ≥51 mg/mL in H2O,,Others,Others,oral antiemetics,https://www.apexbt.com/search.php?catalog=C6974C6976,Sparteine,492-08-0,E05,L1021-24,234.38,DMSO,C15H26N2,[H][C@]12CCCCN1C[C@H]3C[C@@H]2CN4CCCC[C@@]34[H],≥46.4 mg/mL in DMSO; ≥40.2 mg/mL in EtOH; insoluble in H2O,,Others,Others,nicotinic acetylcholine receptor (nACh receptor) inhibitor,https://www.apexbt.com/search.php?catalog=C6976C6983,Citicoline,987-78-0,E06,L1021-24,488.32,H2O,C14H26N4O11P2,C[N+](C)(C)CCOP(OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)[C@H](O)[C@@H]1O)(OP([O-])(O)=O)=O,Insoluble in DMSO; insoluble in EtOH; ≥20.7 mg/mL in H2O with ultrasonic,,Others,Others,"choline, natural compound ",https://www.apexbt.com/search.php?catalog=C6983C7006,Sulfaquinoxaline sodium,967-80-6,E07,L1021-24,322.32,DMSO,C14H11N4NaO2S,O=S(C1=CC=C(N)C=C1)([N-]C2=NC3=CC=CC=C3N=C2)=O.[Na+],≥60.2 mg/mL in DMSO; ≥12.14 mg/mL in EtOH with ultrasonic; ≥61.2 mg/mL in H2O,,Microbiology,Anti-infection,Veterinary antimicrobials,https://www.apexbt.com/search.php?catalog=C7006C7012,Febantel,58306-30-2,E08,L1021-24,446.48,DMSO,C20H22N4O6S,O=C(OC)N/C(NC(OC)=O)=N/C1=CC=C(C=C1NC(COC)=O)SC2=CC=CC=C2,≥69.1 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Microbiology,Anti-infection,parasitic insecticide,https://www.apexbt.com/search.php?catalog=C7012C7015,Enoxacin Sesquihydrate,84294-96-2,E09,L1021-24,347.34,DMSO,C15H20FN4O4.5,O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCNCC3)=N2)C1=O)O.[1.5H2O],≥7.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Microbiology,Anti-infection,broad-spectrum 6-fluoronaphthyridone antibacterial agent,https://www.apexbt.com/search.php?catalog=C7015C7022,Cetilistat,282526-98-1,E10,L1021-24,401.58,EtOH,C25H39NO3,CCCCCCCCCCCCCCCCOC(O1)=NC2=CC=C(C)C=C2C1=O,Insoluble in DMSO; ≥4.12 mg/mL in EtOH (Need ultrasonic and warming); insoluble in H2O,,Metabolism,Lipase,pancreatic lipase inhibitor,https://www.apexbt.com/search.php?catalog=C7022C7028,2'-Deoxyadenosine monohydrate,16373-93-6,E11,L1021-24,269.26,DMSO,C10H15N5O4,NC1=C(C2=NC=N1)N=CN2[C@@H]3O[C@H](CO)[C@@H](O)C3.O,≥50.1 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Cancer,Others,derivatives of nucleoside adenosine,https://www.apexbt.com/search.php?catalog=C7028C7040,Triflupromazine hydrochloride,1098-60-8,F01,L1021-24,388.88,DMSO,C18H20ClF3N2S,FC(F)(F)C1=CC=C(SC2=C3C=CC=C2)C(N3CCCN(C)C)=C1.Cl,≥74.5 mg/mL in DMSO; ≥27.55 mg/mL in EtOH; ≥58 mg/mL in H2O,,Neuronal Signaling,D1/D2 receptor,dopamine D1/D2 receptor antagonist,https://www.apexbt.com/search.php?catalog=C7040C7044,6-Methoxy-2-naphthoic acid,2471-70-7,F02,L1021-24,202.21,DMSO,C12H10O3,O=C(O)C1=CC=C2C=C(C=CC2=C1)OC,≥39.7 mg/mL in DMSO; ≥9.67 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Neuronal Signaling,NMDAR,NMDA receptor modulator,https://www.apexbt.com/search.php?catalog=C7044C7045,Apronal,528-92-7,F03,L1021-24,184.24,DMSO,C9H16N2O2,C=CCC(C(NC(N)=O)=O)C(C)C,≥32.3 mg/mL in DMSO; ≥6.28 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Others,Others,Hypnotic or sedative,https://www.apexbt.com/search.php?catalog=C7045C7047,Oxyclozanide,2277-92-1,F04,L1021-24,401.46,DMSO,C13H6Cl5NO3,O=C(C1=C(O)C(Cl)=CC(Cl)=C1Cl)NC2=CC(Cl)=CC(Cl)=C2O,≥68.5 mg/mL in DMSO; ≥20.53 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Microbiology,Anti-infection,veterinary dewormers,https://www.apexbt.com/search.php?catalog=C7047C7048,Phenazine methosulfate,299-11-6,F05,L1021-24,306.34,DMSO,C14H14N2O4S,C[N+]1=C(C=CC=C2)C2=NC3=C1C=CC=C3.O=S(OC)([O-])=O,≥52.4 mg/mL in DMSO; ≥18.43 mg/mL in EtOH with ultrasonic; ≥50 mg/mL in H2O,,Others,Others,free radical generating agent,https://www.apexbt.com/search.php?catalog=C7048C7049,Pempidine,79-55-0,F06,L1021-24,155.28,DMSO,C10H21N,CC1(CCCC(C)(N1C)C)C,≥29.7 mg/mL in DMSO; ≥27.6 mg/mL in EtOH; ≥25.2 mg/mL in H2O,,Neurological Disease,Others,ganglion blocking agent,https://www.apexbt.com/search.php?catalog=C7049C7054,Hydroquinine,522-66-7,F07,L1021-24,326.43,DMSO,C20H26N2O2,COC1=CC=C2N=CC=C([C@@H](O)[C@H]3[N@](C4)CC[C@H]([C@H]4CC)C3)C2=C1,≥52.5 mg/mL in DMSO; ≥27.25 mg/mL in EtOH; insoluble in H2O,,Others,Others,cinchona alkaloid,https://www.apexbt.com/search.php?catalog=C7054C7059,Olivetol,500-66-3,F08,L1021-24,180.24,DMSO,C11H16O2,OC1=CC(O)=CC(CCCCC)=C1,≥34.4 mg/mL in DMSO; ≥33.1 mg/mL in EtOH; insoluble in H2O,,GPCR & G Protein,Cannabinoid Receptor,competitive inhibitors of cannabinoid receptors CB1 and CB2,https://www.apexbt.com/search.php?catalog=C7059C7068,Clonixin,17737-65-4,F09,L1021-24,262.69,DMSO,C13H11ClN2O2,O=C(O)C1=CC=CN=C1NC2=CC=CC(Cl)=C2C,≥50 mg/mL in DMSO; ≥8 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Immunology & Inflammation,Immunology & Inflammation related,"non-steroidal anti-inflammatory drugs, NSAIDs",https://www.apexbt.com/search.php?catalog=C7068C7074,Hodostin,51-60-5,F10,L1021-24,334.39,DMSO,C13H22N2O6S,C[N+](C)(C1=CC=CC(OC(N(C)C)=O)=C1)C.O=S(OC)([O-])=O,≥46.6 mg/mL in DMSO; ≥28.1 mg/mL in EtOH; ≥52.1 mg/mL in H2O,,Neuronal Signaling,AChR,acetylcholinesterase (AChE) reversible inhibitor for the treatment of myasthenia gravis,https://www.apexbt.com/search.php?catalog=C7074C7080,Hydroxylammonium chloride,5470-11-1,F11,L1021-24,69.49,DMSO,ClH4NO,NO.Cl,≥10.6 mg/mL in DMSO; ≥11 mg/mL in EtOH; ≥11.6 mg/mL in H2O,,Others,Others,selective monoamine oxidase (MAO) inhibitor,https://www.apexbt.com/search.php?catalog=C7080C7081,Bromisoval,496-67-3,G01,L1021-24,223.07,DMSO,C6H11BrN2O2,CC(C(C(NC(N)=O)=O)Br)C,≥36.7 mg/mL in DMSO; ≥40.6 mg/mL in EtOH; insoluble in H2O,,Others,Others,sedative and hypnotic,https://www.apexbt.com/search.php?catalog=C7081C7082,Ensulizole,27503-81-7,G02,L1021-24,274.3,DMSO,C13H10N2O3S,O[S](=O)(=O)C1=CC2=C(C=C1)N=C([NH]2)C3=CC=CC=C3,≥48.1 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Immunology & Inflammation,ROS,sulphonated UV absorber,https://www.apexbt.com/search.php?catalog=C7082C7083,DL-Methionine,59-51-8,G03,L1021-24,149.21,H2O,C5H11NO2S,NC(C(O)=O)CCSC,Insoluble in DMSO; insoluble in EtOH; ≥8.7 mg/mL in H2O with ultrasonic,,Others,Others,sulphur-containing essential amino acids with oxidative stress defence,https://www.apexbt.com/search.php?catalog=C7083C7093,Choline bitartrate,87-67-2,G04,L1021-24,253.25,DMSO,C9H19NO7,OCC[N+](C)(C)C.O=C([C@@H]([C@H](C(O)=O)O)O)[O-],≥8.7 mg/mL in DMSO; ≥9.5 mg/mL in EtOH with ultrasonic; ≥46.9 mg/mL in H2O,,Others,Others,acetylcholine precursor,https://www.apexbt.com/search.php?catalog=C7093C7095,Diazolidinyl urea,78491-02-8,G05,L1021-24,278.22,DMSO,C8H14N4O7,O=C(N(CO)C(N(C1=O)CO)C(N1CO)=O)NCO,≥49.9 mg/mL in DMSO; insoluble in EtOH; ≥48.4 mg/mL in H2O,,Microbiology,Anti-infection,broad-spectrum preservatives,https://www.apexbt.com/search.php?catalog=C7095C7097,(1S)-(-)-_-Pinene,7785-26-4,G06,L1021-24,136.23,DMSO,C10H16,CC1([C@]2(CC=C([C@@]1(C2)[H])C)[H])C,≥20 mg/mL in DMSO; ≥20.7 mg/mL in EtOH; ≥19.8 mg/mL in H2O,,Others,Others,monoterpenoid,https://www.apexbt.com/search.php?catalog=C7097C7098,Isoeugenol,97-54-1,G07,L1021-24,164.2,DMSO,C10H12O2,OC1=CC=C(C=C1OC)/C=C/C,≥21.7 mg/mL in DMSO; ≥32 mg/mL in EtOH; insoluble in H2O,,Microbiology,Anti-infection,"a component of the essential oils of cinnamon, clove and nutmeg with antibacterial activity",https://www.apexbt.com/search.php?catalog=C7098C7099,Dichlorophen,97-23-4,G08,L1021-24,269.12,DMSO,C13H10Cl2O2,OC1=CC=C(C=C1CC2=CC(Cl)=CC=C2O)Cl,≥46.1 mg/mL in DMSO; ≥43.6 mg/mL in EtOH; insoluble in H2O,,Others,VDR,anti-cestode compound,https://www.apexbt.com/search.php?catalog=C7099C7101,L-Glutamic acid monosodium salt,142-47-2,G09,L1021-24,169.11,H2O,C5H8NNaO4,O=C(O[Na])CC[C@H](N)C(O)=O,Insoluble in DMSO; insoluble in EtOH; ≥27.9 mg/mL in H2O,,Others,Others,"Agonist of all subtypes of glutamate receptors (metabotropic erythropoietin,AMPA and NMDA)",https://www.apexbt.com/search.php?catalog=C7101C7104,Etofylline,519-37-9,G10,L1021-24,224.22,DMSO,C9H12N4O3,O=C(N(C1=C(C2=O)N(C=N1)CCO)C)N2C,≥44.9 mg/mL in DMSO; ≥6.93 mg/mL in EtOH with ultrasonic; ≥43.6 mg/mL in H2O,,Others,Others,"bronchodilators, anti-cholesterol drug",https://www.apexbt.com/search.php?catalog=C7104C7106,Herniarin,531-59-9,G11,L1021-24,176.17,DMSO,C10H8O3,O=C1C=CC2=CC=C(C=C2O1)OC,≥29.1 mg/mL in DMSO; ≥6.14 mg/mL in EtOH with ultrasonic; insoluble in H2O,,Others,Others,a natural coumarin-like compound with anti-tumour effects,https://www.apexbt.com/search.php?catalog=C7106C7112,Chlorhexidine diacetate,56-95-1,H01,L1021-24,625.55,DMSO,C26H38Cl2N10O4,N=C(NC(NCCCCCCNC(NC(NC1=CC=C(Cl)C=C1)=N)=N)=N)NC2=CC=C(Cl)C=C2.CC(O)=O.CC(O)=O,≥48.7 mg/mL in DMSO; ≥44.4 mg/mL in EtOH; ≥8.5 mg/mL in H2O with ultrasonic,,Microbiology,Anti-infection,disinfectants and topical anti-infectives,https://www.apexbt.com/search.php?catalog=C7112C7116,2-Aminoethanethiol,60-23-1,H02,L1021-24,77.15,DMSO,C2H7NS,NCCS,≥4.27mg/mL in DMSO with ultrasonic; ≥4.3 mg/mL in EtOH with ultrasonic; ≥14.6 mg/mL in H2O,,Others,Others,radioprotectants,https://www.apexbt.com/search.php?catalog=C7116C7117,D-Pantothenate sodium,867-81-2,H03,L1021-24,241.22,DMSO,C9H16NNaO5,OCC(C)(C)[C@@H](O)C(NCCC(O[Na])=O)=O,≥7.32mg/mL in DMSO with ultrasonic; ≥7.57 mg/mL in EtOH with ultrasonic; ≥41.6 mg/mL in H2O,,Metabolism,Vitamin,Vitamin B5 derivatives,https://www.apexbt.com/search.php?catalog=C7117C7118,2-Hydroxybenzyl alcohol,90-01-7,H04,L1021-24,124.14,DMSO,C7H8O2,OCC1=CC=CC=C1O,≥22.3 mg/mL in DMSO; ≥23.9 mg/mL in EtOH; ≥7.47 mg/mL in H2O with ultrasonic,,Others,Others,"intermediates for fragrances, pesticides and pharmaceuticals",https://www.apexbt.com/search.php?catalog=C7118C7119,D-Phenylalanine,673-06-3,H05,L1021-24,165.19,H2O,C9H11NO2,N[C@@H](C(O)=O)CC1=CC=CC=C1,Insoluble in DMSO; insoluble in EtOH; ≥5.3 mg/mL in H2O with ultrasonic,,Others,Others,inhibitors of endorphinase and enkephalinase,https://www.apexbt.com/search.php?catalog=C7119C7122,"2,4-Dichlorobenzyl alcohol",1777-82-8,H06,L1021-24,177.03,DMSO,C7H6Cl2O,OCC1=CC=C(C=C1Cl)Cl,≥34.4 mg/mL in DMSO; ≥32.3 mg/mL in EtOH; insoluble in H2O,,Microbiology,Anti-infection,preservative,https://www.apexbt.com/search.php?catalog=C7122C7123,Penicillin V potassium salt,132-98-9,H07,L1021-24,388.48,DMSO,C16H17KN2O5S,O=C([C@H](N1C2=O)C(C)(S[C@@]1([C@@H]2NC(COC3=CC=CC=C3)=O)[H])C)O[K],≥11.04mg/mL in DMSO with ultrasonic; insoluble in EtOH; ≥55.5 mg/mL in H2O,,Microbiology,Anti-infection,oral active antibiotic,https://www.apexbt.com/search.php?catalog=C7123C7124,Benzylpenicillin potassium,113-98-4,H08,L1021-24,372.48,DMSO,C16H17KN2O4S,O=C(O[K])[C@H](N1C2=O)C(C)(S[C@@]1([C@@H]2NC(CC3=CC=CC=C3)=O)[H])C,≥15.6mg/mL in DMSO with ultrasonic; insoluble in EtOH; ≥48.9 mg/mL in H2O,,Microbiology,Anti-infection,broad-spectrum penicillin antibiotics,https://www.apexbt.com/search.php?catalog=C7124C7129,D-Ribose,50-69-1,H09,L1021-24,150.13,DMSO,C5H10O5,O=C[C@H](O)[C@H](O)[C@H](O)CO,≥28.6 mg/mL in DMSO; ≥12.4 mg/mL in EtOH; ≥27.9 mg/mL in H2O,,Others,Others,"energy booster, ATP sugar component",https://www.apexbt.com/search.php?catalog=C7129C7137,(S)-(+)-Carvone,2244-16-8,H10,L1021-24,150.22,DMSO,C10H14O,C=C(C)[C@](CC=C1C)([H])CC1=O,≥23.4 mg/mL in DMSO; ≥22.7 mg/mL in EtOH; insoluble in H2O,,Others,Others,monoterpene,https://www.apexbt.com/search.php?catalog=C7137C7150,Uridine triacetate,4105-38-8,H11,L1021-24,370.31,DMSO,C15H18N2O9,O=C1NC(C=CN1[C@@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H]2OC(C)=O)=O,≥60.7 mg/mL in DMSO; ≥9.92 mg/mL in EtOH with ultrasonic; ≥9.37 mg/mL in H2O with ultrasonic,,Others,Others,orally active precursor drug to the natural nucleoside uridine,https://www.apexbt.com/search.php?catalog=C7150C7152,Gastrodenol,57644-54-9,A01,L1021-25,704.47,H2O,C12H10BiK3O14,O=C([O-])CC(C([O-])=O)(CC([O-])=O)O.O=C([O-])CC(C([O-])=O)(CC([O-])=O)O.[K+].[Bi+3].[K+].[K+],Insoluble in DMSO; insoluble in EtOH; ≥57.9 mg/mL in H2O,,Others,Others,drugs for upper intestinal ulcers and gastric ulcers,https://www.apexbt.com/search.php?catalog=C7152C7153,L-Xylose,609-06-3,A02,L1021-25,150.13,DMSO,C5H10O5,O=C[C@@H](O)[C@H](O)[C@@H](O)CO,≥27.5 mg/mL in DMSO; ≥3.73 mg/mL in EtOH with ultrasonic; ≥22.2 mg/mL in H2O,,Others,Others,the levulose structure of monosaccharide xylose,https://www.apexbt.com/search.php?catalog=C7153C7157,Amodiaquine hydrochloride,69-44-3,A03,L1021-25,428.78,DMSO,C20H24Cl3N3O,OC1=CC=C(C=C1CN(CC)CC)NC2=CC=NC3=CC(Cl)=CC=C23.Cl.Cl,≥55.5 mg/mL in DMSO; ≥16.8 mg/mL in EtOH with ultrasonic; ≥16.47 mg/mL in H2O with ultrasonic,,Immunology,HnMT,HnMT inhibitor; 4-Aminoquinoline antimalarials,https://www.apexbt.com/search.php?catalog=C7157C7161,DL-Arginine,7200-25-1,A04,L1021-25,174.2,H2O,C6H14N4O2,NC(C(O)=O)CCCNC(N)=N,Insoluble in DMSO; insoluble in EtOH; ≥26.2 mg/mL in H2O,,Others,Others,_-amino acid,https://www.apexbt.com/search.php?catalog=C7161C7165,(-)-Fenchone,7787-20-4,A05,L1021-25,152.23,DMSO,C10H16O,O=C1[C@@]2(C)C[C@@]([H])(C1(C)C)CC2,≥29.2 mg/mL in DMSO; ≥27.9 mg/mL in EtOH; ≥28.9 mg/mL in H2O,,Others,Others,"bicyclic monoterpenoids, components of absinthe and aniseed essential oils",https://www.apexbt.com/search.php?catalog=C7165C7178,Sodium ferulic,24276-84-4,A06,L1021-25,216.17,DMSO,C10H9NaO4,O=C(/C=C/C1=CC=C(C(OC)=C1)O)O[Na],≥34.7 mg/mL in DMSO; ≥3.32 mg/mL in EtOH with ultrasonic; ≥10.47 mg/mL in H2O with ultrasonic,,Others,Thrombin,fibroblast growth factor receptor (FGFR) inhibitor,https://www.apexbt.com/search.php?catalog=C7178C7191,Cholic acid sodium,361-09-1,A07,L1021-25,430.55,DMSO,C24H39NaO5,C[C@@H]([C@@]1([H])CC[C@]2([C@@]3([C@@H](C[C@@]4(C[C@@H](CC[C@@]4([C@]3(C[C@@H]([C@@]21C)O)[H])C)O)[H])O)[H])[H])CCC(O[Na])=O,≥56.1 mg/mL in DMSO; ≥2.45 mg/mL in EtOH with ultrasonic; ≥47 mg/mL in H2O,,Others,Others,bile salts of bile acids produced by the liver,https://www.apexbt.com/search.php?catalog=C7191C7192,Kojic acid,501-30-4,A08,L1021-25,142.11,DMSO,C6H6O4,O=C1C=C(OC=C1O)CO,≥25.7 mg/mL in DMSO; ≥7.57 mg/mL in EtOH with ultrasonic; ≥25.3 mg/mL in H2O,,Proteases,Tyrosinase,Aspergillus oryzae metabolite; also used in the production of food additives,https://www.apexbt.com/search.php?catalog=C7192C7193,Pralidoxime chloride,51-15-0,A09,L1021-25,172.61,DMSO,C7H9ClN2O,C[N+]1=CC=CC=C1/C=N/O.[Cl-],≥6.34mg/mL in DMSO with ultrasonic; ≥6.32 mg/mL in EtOH with ultrasonic; ≥29.1 mg/mL in H2O,,Neuronal Signaling,AChR,"Oximes, reactivators of acetylcholinesterase (AChE)",https://www.apexbt.com/search.php?catalog=C7193C7195,Propyphenazone (4-Isopropylantipyrine),479-92-5,A10,L1021-25,230.31,DMSO,C14H18N2O,O=C1N(N(C(C)=C1C(C)C)C)C2=CC=CC=C2,≥37.5 mg/mL in DMSO; ≥32.8 mg/mL in EtOH; insoluble in H2O,,immunology/Inflammation,COX,Cyclooxygenase-2 (COX-2) selective inhibitor,https://www.apexbt.com/search.php?catalog=C7195M1162,"1,2-propanediol",57-55-6,A11,L1021-25,76.09,DMSO,C3H8O2,CC(O)CO,≥11.5 mg/mL in DMSO; ≥10.8 mg/mL in EtOH; ≥11.1 mg/mL in H2O,free base,#N/A,#N/A,#N/A,https://www.apexbt.com/search.php?catalog=M1162M1180,xanthine,69-89-6,B01,L1021-25,152.11,DMSO,C5H4N4O2,O=C1NC(=O)C2=C(N1)N=C[NH]2,insoluble in H2O; insoluble in EtOH; ≥1.17 mg/mL in DMSO with gentle warming and ultrasonic,free base,,,,https://www.apexbt.com/search.php?catalog=M1180M1184,gentisate,490-79-9,B02,L1021-25,154.12,DMSO,C7H6O4,OC(=O)C1=C(O)C=CC(=C1)O,insoluble in H2O; ≥50.7 mg/mL in DMSO; ≥52.4 mg/mL in EtOH,free base,,,,https://www.apexbt.com/search.php?catalog=M1184M1191,hippurate,495-69-2,B03,L1021-25,179.17,DMSO,C9H9NO3,O=C(O)CNC(C1=CC=CC=C1)=O,insoluble in H2O; ≥26.25 mg/mL in EtOH with ultrasonic; ≥53.8 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=M1191M1199,galactose,59-23-4,B04,L1021-25,180.16,DMSO,C6H12O6,OCC1OC(O)C(O)C(O)C1O,insoluble in EtOH; ≥11.2 mg/mL in DMSO with ultrasonic; ≥18 mg/mL in H2O,free base,,,,https://www.apexbt.com/search.php?catalog=M1199M1200,glucuronate,6556-12-3,B05,L1021-25,194.14,DMSO,C6H10O7,O=C[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O)([H])C(O)=O,insoluble in EtOH; ≥53.7 mg/mL in H2O; ≥8.66 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=M1200M1201,lactose,63-42-3,B06,L1021-25,342.3,DMSO,C12H22O11,OCC(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(O)C=O,insoluble in EtOH; insoluble in DMSO; ≥49.4 mg/mL in H2O,free base,,,,https://www.apexbt.com/search.php?catalog=M1201M1202,sucrose,57-50-1,B07,L1021-25,342.3,DMSO,C12H22O11,OC[C@]1([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@](O[C@]2([C@](O)([H])[C@@](O)([H])[C@@](O2)([H])CO)CO)([H])O1,insoluble in EtOH; ≥17.9 mg/mL in DMSO with gentle warming and ultrasonic; ≥36.4 mg/mL in H2O,,Metabolism,Endogenous Metabolite,,https://www.apexbt.com/search.php?catalog=M1202M1214,mannose,3458-28-4,B08,L1021-25,180.16,DMSO,C6H12O6,OCC1OC(O)C(O)C(O)C1O,insoluble in EtOH; ≥45.5 mg/mL in DMSO; ≥62.6 mg/mL in H2O,Free Base,,,,https://www.apexbt.com/search.php?catalog=M1214M1226,cis-aconitate,585-84-2,B09,L1021-25,174.11,DMSO,C6H6O6,O=C(O)/C([H])=C(C(O)=O)/CC(O)=O,≥45.1 mg/mL in H2O; ≥49 mg/mL in EtOH; ≥55.2 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=M1226M1276,adipate,124-04-9,B10,L1021-25,146.14,DMSO,C6H10O4,OC(=O)CCCCC(O)=O,insoluble in H2O; ≥20.95 mg/mL in EtOH; ≥56 mg/mL in DMSO,Free Base,,,,https://www.apexbt.com/search.php?catalog=M1276M1278,fumarate,110-17-8,B11,L1021-25,116.07,DMSO,C4H4O4,OC(=O)\C=C\C(O)=O,insoluble in H2O; ≥21.67 mg/mL in EtOH with ultrasonic; ≥64.9 mg/mL in DMSO,free base,,,,https://www.apexbt.com/search.php?catalog=M1278M1279,maleate,110-16-7,C01,L1021-25,116.07,DMSO,C4H4O4,OC(=O)\C=C/C(O)=O,≥15.43 mg/mL in EtOH; ≥27.95 mg/mL in DMSO; ≥28.85 mg/mL in H2O,Free Base,,,,https://www.apexbt.com/search.php?catalog=M1279M1280,oxalate,144-62-7,C02,L1021-25,90.03,DMSO,C2H2O4,OC(=O)C(O)=O,≥21.2 mg/mL in H2O; ≥21.6 mg/mL in DMSO; ≥25.6 mg/mL in EtOH,free base,Others,NOS2,Inhibition of nitric oxide (NO) production induced by interferon-gamma (IFN-gamma) in mouse macrophages,https://www.apexbt.com/search.php?catalog=M1280M1301,azelate (nonanedioate),123-99-9,C03,L1021-25,188.22,DMSO,C9H16O4,O=C(O)CCCCCCCC(O)=O,insoluble in H2O; ≥21.25 mg/mL in EtOH with ultrasonic; ≥25.7 mg/mL in DMSO with ultrasonic,,Microbiology & Virology,Anti-infection,,https://www.apexbt.com/search.php?catalog=M1301M1303,caprate (10:0),334-48-5,C04,L1021-25,172.26,DMSO,C10H20O2,CCCCCCCCCC(O)=O,insoluble in H2O; ≥44 mg/mL in EtOH; ≥44.5 mg/mL in DMSO,free base,,,,https://www.apexbt.com/search.php?catalog=M1303M1324,pelargonate (9:0),112-05-0,C05,L1021-25,158.24,DMSO,C9H18O2,CCCCCCCCC(O)=O,≥42.1 mg/mL in H2O; ≥49 mg/mL in DMSO; ≥51.9 mg/mL in EtOH,free base,,,,https://www.apexbt.com/search.php?catalog=M1324M1325,sebacate (decanedioate),111-20-6,C06,L1021-25,202.25,DMSO,C10H18O4,OC(=O)CCCCCCCCC(O)=O,insoluble in H2O; ≥25.8 mg/mL in EtOH; ≥42.2 mg/mL in DMSO,free base,,,,https://www.apexbt.com/search.php?catalog=M1325M1354,glycolate (hydroxyacetate),79-14-1,C07,L1021-25,76.05,DMSO,C2H4O3,OCC(O)=O,≥28.8 mg/mL in EtOH with ultrasonic; ≥48.3 mg/mL in H2O; ≥53.5 mg/mL in DMSO,free base,,,,https://www.apexbt.com/search.php?catalog=M1354M1355,lactate,79-33-4,C08,L1021-25,90.08,DMSO,C3H6O3,CC(O)C(O)=O,≥44.5 mg/mL in DMSO; ≥64.6 mg/mL in EtOH; ≥9 mg/mL in H2O,free base,,,,https://www.apexbt.com/search.php?catalog=M1355M1361,pyruvate,127-17-3,C09,L1021-25,88.06,DMSO,C3H4O3,CC(=O)C(O)=O,≥43 mg/mL in EtOH; ≥55.2 mg/mL in DMSO; ≥8.8 mg/mL in H2O,Free Base,Metabolism,Endogenous Metabolite,"Pyruvic acid is an intermediate metabolite in the metabolism of carbohydrates, proteins, and fats.",https://www.apexbt.com/search.php?catalog=M1361M1375,histamine,51-45-6,C10,L1021-25,111.15,DMSO,C5H9N3,NCCC1=CN=CN1,≥11.1 mg/mL in H2O; ≥12.75 mg/mL in DMSO; ≥24.7 mg/mL in EtOH,,Neuroscience,Histamine Receptor,,https://www.apexbt.com/search.php?catalog=M1375M1376,thiamine,59-43-8,C11,L1021-25,300.81,H2O,C12H17ClN4OS,CC([N+](CC(C1=N)=CN=C(N1)C)=CS2)=C2CCO.[Cl-],insoluble in EtOH; ≥15.05 mg/mL in DMSO with gentle warming and ultrasonic; ≥60 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=M1376M1387,alpha-tocopherol,59-02-9,D01,L1021-25,430.71,DMSO,C29H50O2,CC(CCC[C@@](CCC[C@@](CCC[C@@]1(CCC2=C(C(O)=C(C(C)=C2O1)C)C)C)([H])C)([H])C)C,insoluble in H2O; ≥86 mg/mL in DMSO; ≥92.4 mg/mL in EtOH,,Neuroscience,"COX,VEGFR",,https://www.apexbt.com/search.php?catalog=M1387M1391,guanosine,118-00-3,D02,L1021-25,283.24,DMSO,C10H13N5O5,NC1=NC2=C(N=C[N]2C3OC(CO)C(O)C3O)C(=O)N1,insoluble in H2O; insoluble in EtOH; ≥49.1 mg/mL in DMSO,free base,,,,https://www.apexbt.com/search.php?catalog=M1391M1396,cytosine,71-30-7,D03,L1021-25,111.1,DMSO,C4H5N3O,NC1=NC(=O)NC=C1,insoluble in EtOH; insoluble in H2O; ≥11.64 mg/mL in DMSO with ultrasonic,free base,,,,https://www.apexbt.com/search.php?catalog=M1396M1407,UMP,58-97-9,D04,L1021-25,324.18,DMSO,C9H13N2O9P,OC1C(O)C(OC1CO[P](O)(O)=O)N2C=CC(=O)NC2=O,insoluble in EtOH; ≥25.95 mg/mL in H2O; ≥33.2 mg/mL in DMSO with ultrasonic,Free Base,,,,https://www.apexbt.com/search.php?catalog=M1407M1425,cortisone,53-06-5,D05,L1021-25,360.44,DMSO,C21H28O5,CC12CCC(=O)C=C1CCC3C4CCC(O)(C(=O)CO)C4(C)CC(=O)C23,insoluble in H2O; ≥59.5 mg/mL in DMSO; ≥6.3 mg/mL in EtOH with ultrasonic,Free Base,,,,https://www.apexbt.com/search.php?catalog=M1425M1482,D-(_)-Fructose,57-48-7,D06,L1021-25,180.16,DMSO,C6H12O6,OC[C@](O)([H])[C@](O)([H])[C@@](O)([H])C(CO)=O,insoluble in EtOH; ≥18.67 mg/mL in H2O; ≥19.87 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=M1482N1114,Puerarin,3681-99-0,D07,L1021-25,416.38,DMSO,C21H20O9,OC1C(OC(C(C(OC=C(C(C=C2)=CC=C2O)C3=O)=C3C=C4)=C4O)C(O)C1O)CO,≥10.26 mg/mL in EtOH with ultrasonic; ≥76.4 mg/mL in DMSO,#N/A,Natural Products,,,https://www.apexbt.com/search.php?catalog=N1114N1115,Neohesperidin,13241-33-3,D08,L1021-25,610.56,DMSO,C28H34O15,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)CO)O)O)O)O)O,insoluble in H2O; insoluble in EtOH; ≥42.1 mg/mL in DMSO,#N/A,Natural Products,ROS,"Neohesperidin, a flavanone glycoside found in citrus fruits, is an antioxidant agent.",https://www.apexbt.com/search.php?catalog=N1115N1272,Geniposidic acid,27741-01-1,D09,L1021-25,374.34,DMSO,C16H22O10,C1C=C(C2C1C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)O)CO,≥11.04 mg/mL in EtOH with ultrasonic; ≥14.2 mg/mL in DMSO; ≥26.3 mg/mL in H2O,Free Base,Natural Products,Immunology & Inflammation related,,https://www.apexbt.com/search.php?catalog=N1272N1289,Vindoline,2182-14-1,D10,L1021-25,456.53,DMSO,C25H32N2O6,O=C([[C@H@]1([[C@H]2([H])N(C([H])([H])[H])C3=C(C([H])=C([H])C(OC([H])([H])[H])=C3[H])[[C@H]24[[C@H@](C(C([H])([H])C([H])([H])[H])(C([H])=C([H])C5([H])[H])[[C@H@]1([H])OC(C([H])([H])[H])=O)([H])N5C([H])([H])C4([H])[H])O[H])OC([H])([H])[H],≥45.7 mg/mL in DMSO; insoluble in H2O; ≥10.08 mg/mL in EtOH with ultrasonic,,Natural Products,Microtubule Associated,,https://www.apexbt.com/search.php?catalog=N1289N1304,5-Methoxypsoralen,484-20-8,D11,L1021-25,216.19,DMSO,C12H8O4,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3,insoluble in H2O; insoluble in EtOH; ≥8.95 mg/mL in DMSO,Free Base,Natural Products,DNA/RNA Synthesis,,https://www.apexbt.com/search.php?catalog=N1304N1305,8-Methoxypsoralen,298-81-7,E01,L1021-25,216.19,DMSO,C12H8O4,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,insoluble in H2O; insoluble in EtOH; ≥6.5 mg/mL in DMSO ,Free Base,Natural Products,P450 (e.g. CYP17),CYP inhibitor,https://www.apexbt.com/search.php?catalog=N1305N1315,Parthenolide,20554-84-1,E02,L1021-25,248.32,DMSO,C15H20O3,C[[C@H@]12CC/C=C(C)/CC[[C@@H]3[[C@H](OC(C3=C)=O)[[C@@H]1O2,insoluble in H2O; ≥23.3 mg/mL in EtOH; ≥9.2 mg/mL in DMSO,,DNA Damage/DNA Repair,HDAC,,https://www.apexbt.com/search.php?catalog=N1315N1318,Vitexicarpin,479-91-4,E03,L1021-25,374.35,DMSO,C19H18O8,COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O,≥37.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,NF-_B,,https://www.apexbt.com/search.php?catalog=N1318N1327,Loganin,18524-94-2,E04,L1021-25,390.38,DMSO,C17H26O10,CC1C(CC2C1C(OC=C2C(=O)OC)OC3C(C(C(C(O3)CO)O)O)O)O,insoluble in EtOH; ≥25 mg/mL in H2O; ≥50 mg/mL in DMSO,,Natural Products,"BACE,AChR",Cox-1 inhibitor,https://www.apexbt.com/search.php?catalog=N1327N1332,Psoralen,66-97-7,E05,L1021-25,186.17,DMSO,C11H6O3,C1=CC(=O)OC2=CC3=C(C=CO3)C=C21,insoluble in H2O; ≥5.32 mg/mL in EtOH with gentle warming and ultrasonic; ≥55.1 mg/mL in DMSO,,Natural Products,TGF_1,,https://www.apexbt.com/search.php?catalog=N1332N1335,5-hydroxymethyl-2-furaldehyde,67-47-0,E06,L1021-25,126.11,DMSO,C6H6O3,C1=C(OC(=C1)C=O)CO,≥46.9 mg/mL in DMSO; ≥50 mg/mL in EtOH; ≥51.5 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1335N1338,Sanguinarine,2447-54-3,E07,L1021-25,332.33,DMSO,C20H14NO4,C[N+]1=CC2=C3OCOC3=CC=C2C(C=C4)=C1C(C4=C5)=CC6=C5OCO6,Limited solubility,,Natural Products,Antioxidant,,https://www.apexbt.com/search.php?catalog=N1338N1356,Asiatic acid,464-92-6,E08,L1021-25,488.7,DMSO,C30H48O5,CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)O,≥24.45 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,#N/A,Natural Products,p38 MAPK,Used in wound healing;anti-inflammatory,https://www.apexbt.com/search.php?catalog=N1356N1357,Asiaticoside,16830-15-2,E09,L1021-25,959.12,DMSO,C48H78O19,CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)O)O)O)O,≥44.6 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,ROS,,https://www.apexbt.com/search.php?catalog=N1357N1358,Isorhamnetin,480-19-3,E10,L1021-25,316.27,DMSO,C16H12O7,COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,insoluble in EtOH; insoluble in H2O; ≥31.8 mg/mL in DMSO,,Natural Products,PXR,,https://www.apexbt.com/search.php?catalog=N1358N1359,Magnolol,528-43-8,E11,L1021-25,266.32,DMSO,C18H18O2,C=CCC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)CC=C)O,insoluble in H2O; ≥11.8 mg/mL in DMSO; ≥65 mg/mL in EtOH,,Natural Products,NF-_B,,https://www.apexbt.com/search.php?catalog=N1359N1360,Geniposide,24512-63-8,F01,L1021-25,388.37,DMSO,C17H24O10,COC(=O)C1=COC(C2C1CC=C2CO)OC3C(C(C(C(O3)CO)O)O)O,≥10.06 mg/mL in EtOH with ultrasonic; ≥11.1 mg/mL in H2O; ≥18.8 mg/mL in DMSO,Free Base,Natural Products,Others,Iridoid glycoside with various bioactivities,https://www.apexbt.com/search.php?catalog=N1360N1368,Berberine,2086-83-1,F02,L1021-25,336.36,DMSO,C20H18NO4,[H]C(C([H])([H])C1=C2[H])([H])[N+](C([H])=C(C(OC([H])([H])[H])=C3OC([H])([H])[H])C(C([H])=C3[H])=C4[H])=C4C1=C([H])C5=C2OC([H])([H])O5,insoluble in H2O; insoluble in EtOH; ≥14.95 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1368N1369,Bergenin,477-90-7,F03,L1021-25,328.27,DMSO,C14H16O9,COC1=C(C=C2C(=C1O)C3C(C(C(C(O3)CO)O)O)OC2=O)O,insoluble in H2O; ≥14.55 mg/mL in DMSO; ≥2.55 mg/mL in EtOH with gentle warming and ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1369N1382,Catharanthine,2468-21-5,F04,L1021-25,336.42,DMSO,C21H24N2O2,O=C([[C@H@]1(C(N([H])C2=C([H])C([H])=C([H])C([H])=C32)=C3C([H])([H])C4([H])[H])[[C@H](C(C([H])([H])C([H])([H])[H])=C5[H])([H])N4C([H])([H])[[C@H@]5([H])C1([H])[H])OC([H])([H])[H],insoluble in H2O; insoluble in EtOH; ≥16.82 mg/mL in DMSO,Free Base,Natural Products,AChR,,https://www.apexbt.com/search.php?catalog=N1382N1390,Dehydroandrographolide,134418-28-3,F05,L1021-25,332.42,DMSO,C20H28O4,CC12CCC(C(C1CCC(=C)C2CC=C3C=COC3=O)(C)CO)O,≥33.2 mg/mL in DMSO; insoluble in H2O; ≥10.7 mg/mL in EtOH with ultrasonic,,Natural Products,Chloride Channel,,https://www.apexbt.com/search.php?catalog=N1390N1426,Irisflorentin,41743-73-1,F06,L1021-25,386.35,DMSO,C20H18O8,COC1=CC(=CC(=C1OC)OC)C2=COC3=CC4=C(C(=C3C2=O)OC)OCO4,≥38.6 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1426N1442,Theophylline,58-55-9,F07,L1021-25,180.16,DMSO,C7H8N4O2,CN1C2=C(C(=O)N(C1=O)C)NC=N2,insoluble in EtOH; insoluble in H2O; ≥22.53 mg/mL in DMSO,,Natural Products,Adenosine Receptor; Autophagy; Endogenous Metabolite; Phosphodiesterase (PDE),,https://www.apexbt.com/search.php?catalog=N1442N1461,Harpagoside,19210-12-9,F08,L1021-25,494.18,DMSO,C24H30O11,CC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)OC(=O)C=CC4=CC=CC=C4,≥49.4 mg/mL in EtOH; insoluble in H2O; ≥27.95 mg/mL in DMSO,,Natural Products,"GMNN - geminin, DNA replication inhibitor (human)",,https://www.apexbt.com/search.php?catalog=N1461N1470,Crotaline,315-22-0,F09,L1021-25,325.36,DMSO,C16H23NO6,O=C([[C@@H]([[C@H@](O)([[C@H@](O)1C)C)C)O[[C@H@]2(CCN3[[C@H@]2(C(COC1=O)=CC3)[H])[H],≥1.66 mg/mL in H2O with gentle warming and ultrasonic; ≥16.45 mg/mL in ETOH with gentle warming and ultrasonic; ≥67.2 mg/mL in DMSO ,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1470N1482,Cinnamaldehyde,14371-10-9,F10,L1021-25,132.16,DMSO,C9H8O,C1=CC=C(C=C1)C=CC=O,insoluble in H2O; ≥13.2 mg/mL in DMSO; ≥24.9 mg/mL in EtOH,#N/A,Natural Products,TRPV,Cinnamaldehyde is a flavonoid that is naturally synthesized by the shikimate pathway. Its supplementation can improve glucose and lipid homeostasis in diabetic animals a TRPA1 agonist.,https://www.apexbt.com/search.php?catalog=N1482N1486,Lathyrol,34420-19-4,F11,L1021-25,334.45,DMSO,C20H30O4,O=C(/C(C([H])([H])[H])=C([H])/[[C@H@]1([H])C(C([H])([H])[H])(C([H])([H])[H])[[C@H@]1([H])C([H])([H])C([H])([H])/C2=C([H])/[H])[[C@H@]3([[C@H]([[C@H]2([H])O[H])([H])[[C@H@]([[C@H](C([H])([H])[H])([H])C3([H])[H])([H])O[H])O[H],≥33.4 mg/mL in DMSO; insoluble in H2O; ≥2.42 mg/mL in EtOH with gentle warming and ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1486N1490,Brucine,357-57-3,G01,L1021-25,394.19,DMSO,C23H26N2O4,COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC,insoluble in H2O; ≥10.04 mg/mL in EtOH; ≥15.55 mg/mL in DMSO,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1490N1492,vitexin-2_-o-rhamnoside,64820-99-1,G02,L1021-25,578.16,DMSO,C27H30O14,CC1C(C(C(C(O1)OC2C(C(C(OC2C3=C(C=C(C4=C3OC(=CC4=O)C5=CC=C(C=C5)O)O)O)CO)O)O)O)O)O,insoluble in H2O; ≥10.44 mg/mL in EtOH with ultrasonic; ≥27.95 mg/mL in DMSO with ultrasonic,#N/A,Natural Products,Others,"Vitexin-2-O-rhamnoside is one of the main components of flavonoid of the leaves of Crataegus pinnatifida Bge. var major N. E. Br. It has many biological and pharmacological activities, such as antioxidation and treating heart disease.",https://www.apexbt.com/search.php?catalog=N1492N1496,Tyrosol,501-94-0,G03,L1021-25,138.07,DMSO,C8H10O2,C1=CC(=CC=C1CCO)O,≥10.24 mg/mL in H2O; ≥46.7 mg/mL in EtOH; ≥50.5 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1496N1500,Germacrone,6902-91-6,G04,L1021-25,218.17,DMSO,C15H22O,CC1=CCC(=C(C)C)C(=O)CC(=CCC1)C,≥21.8 mg/mL in DMSO; insoluble in H2O; ≥8.44 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1500N1503,Fructose,7660-25-5,G05,L1021-25,180.06,H2O,C6H12O6,C1C(C(C(C(O1)(CO)O)O)O)O,insoluble in DMSO; ≥13.02 mg/mL in EtOH; ≥18 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1503N1504,Homoharringtonine,26833-87-4,G06,L1021-25,545.62,DMSO,C29H39NO9,COC(=O)CC(O)(CCCC(C)(C)O)C(=O)OC1C2C3=CC4=C(OCO4)C=C3CCN5CCCC25C=C1OC,insoluble in H2O; ≥10.92 mg/mL in EtOH; ≥181.2 mg/mL in DMSO,,Natural Products,STAT,Cytotoxic alkaloid,https://www.apexbt.com/search.php?catalog=N1504N1578,Nuciferine,475-83-2,G07,L1021-25,295.38,DMSO,C19H21NO2,CN1CCC2=CC(=C(C3=C2C1CC4=CC=CC=C43)OC)OC,insoluble in H2O; ≥14.75 mg/mL in DMSO with gentle warming; ≥2.36 mg/mL in EtOH with gentle warming and ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1578N1582,Helicid,80154-34-3,G08,L1021-25,284.06,DMSO,C13H16O7,C1=CC(=CC=C1C=O)OC2C(C(C(C(O2)CO)O)O)O,≥28.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1582N1600,Evodiamine,518-17-2,G09,L1021-25,303.35,DMSO,C19H17N3O,O=C1N2[[C@H](C(N([H])C3=C([H])C([H])=C([H])C([H])=C43)=C4C([H])([H])C2([H])[H])([H])N(C([H])([H])[H])C5=C([H])C([H])=C([H])C([H])=C15,≥30.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,Natural Products,NF-_B,Indole alkaloid,https://www.apexbt.com/search.php?catalog=N1600N1605,Echinacoside,82854-37-3,G10,L1021-25,786.72,DMSO,C35H46O20,CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)COC4C(C(C(C(O4)CO)O)O)O)OCCC5=CC(=C(C=C5)O)O)O)O)O)O,≥78.7 mg/mL in DMSO; insoluble in EtOH; ≥60.1 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1605N1613,Ginsenoside Rg1,22427-39-0,G11,L1021-25,801.01,DMSO,C42H72O14,CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C,≥32 mg/mL in DMSO; insoluble in H2O; ≥26.9 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1613N1615,Ginsenoside Re,52286-59-6,H01,L1021-25,947.14,DMSO,C48H82O18,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O,≥43.1 mg/mL in DMSO; insoluble in H2O; ≥3.67 mg/mL in EtOH with ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1615N1620,Ginsenoside Rb1,41753-43-9,H02,L1021-25,1109.29,DMSO,C54H92O23,CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C,≥51.1 mg/mL in DMSO; ≥2.24 mg/mL in EtOH with gentle warming and ultrasonic; ≥48.1 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1620N1625,Formononetin,485-72-3,H03,L1021-25,268.27,DMSO,C16H12O4,COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O,insoluble in H2O; insoluble in EtOH; ≥53.7 mg/mL in DMSO,,Natural Products,Others,O-methylated isoflavone,https://www.apexbt.com/search.php?catalog=N1625N1630,Indigo,482-89-3,H04,L1021-25,262.27,DMSO,C16H10N2O2,O=C1/C(NC2=C1C=CC=C2)=C3C(C4=C(C=CC=C4)N\3)=O,insoluble in H2O; insoluble in EtOH; ≥11.18 mg/mL in DMSO with ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1630N1644,Hyodeoxycholic acid,83-49-8,H05,L1021-25,392.56,DMSO,C24H40O4,CC(CCC(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,insoluble in H2O; ≥23.25 mg/mL in DMSO; ≥52.8 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1644N1650,Ligustrazine Hydrochloride,76494-51-4,H06,L1021-25,172.66,DMSO,C8H12N2·HCl·2H2O,CC1=C(N=C(C(=N1)C)C)C.Cl,insoluble in H2O; ≥16.73 mg/mL in EtOH; ≥17.3 mg/mL in DMSO,,Natural Products,Immunology & Inflammation related,,https://www.apexbt.com/search.php?catalog=N1650N1651,Nicotinamide,98-92-0,H07,L1021-25,122.13,DMSO,C6H6N2O,C1=CC(=CN=C1)C(=O)N,≥13.75 mg/mL in EtOH; ≥29.75 mg/mL in H2O; ≥5.95 mg/mL in DMSO,Free Base,Natural Products,Sirtuin,PARP-1 inhibitor,https://www.apexbt.com/search.php?catalog=N1651N1663,Madecassoside,34540-22-2,H08,L1021-25,975.12,DMSO,C48H78O20,CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)O)O)O)O,≥47.6 mg/mL in DMSO; insoluble in EtOH; ≥5.45 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1663N1669,Deoxycholic acid,83-44-3,H09,L1021-25,392.57,DMSO,C24H40O4,CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C,insoluble in H2O; ≥13.2 mg/mL in DMSO; ≥23.2 mg/mL in EtOH,Free Base,Natural Products,Others,Bile Acid;proinflammatory agent,https://www.apexbt.com/search.php?catalog=N1669N1672,Honokiol,35354-74-6,H10,L1021-25,266.33,DMSO,C18H18O2,C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C,insoluble in H2O; ≥83 mg/mL in DMSO; ≥54.8 mg/mL in EtOH,,Immunology/Inflammation,I_B/IKK,,https://www.apexbt.com/search.php?catalog=N1672N1674,Piperine,94-62-2,H11,L1021-25,285.34,DMSO,C17H19NO3,C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3,insoluble in H2O; ≥12.25 mg/mL in DMSO; ≥6.15 mg/mL in EtOH,Free Base,Natural Products,P450 (e.g. CYP17),MAPK inhibitor,https://www.apexbt.com/search.php?catalog=N1674N1677,Sennoside B,128-57-4,A01,L1021-26,862.74,DMSO,C42H38O20,C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)OC7C(C(C(C(O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O,≥86.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,PDGFR,,https://www.apexbt.com/search.php?catalog=N1677N1678,Sennoside A,81-27-6,A02,L1021-26,862.74,DMSO,C42H38O20,C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)OC7C(C(C(C(O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O,≥39.9 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,MAO,,https://www.apexbt.com/search.php?catalog=N1678N1680,Cholic acid,81-25-4,A03,L1021-26,408.58,DMSO,C24H40O5,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,insoluble in H2O; ≥18.13 mg/mL in DMSO; ≥20.5 mg/mL in EtOH,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1680N1692,(+)-Catechin hydrate,225937-10-0,A04,L1021-26,308.28,DMSO,C15H14O7,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O.O,insoluble in H2O; ≥10.1 mg/mL in EtOH; ≥11.85 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1692N1699,Berberine hydrochloride,633-65-8,A05,L1021-26,371.81,DMSO,C20H18ClNO4,[H]C(C([H])([H])C1=C2[H])([H])[N+](C([H])=C(C(OC([H])([H])[H])=C3OC([H])([H])[H])C(C([H])=C3[H])=C4[H])=C4C1=C([H])C5=C2OC([H])([H])O5.[Cl-],insoluble in H2O; ≥18.6 mg/mL in DMSO with gentle warming; ≥2.17 mg/mL in EtOH with gentle warming and ultrasonic,,Natural Products,Anti-infection,,https://www.apexbt.com/search.php?catalog=N1699N1700,Betaine hydrochloride,590-46-5,A06,L1021-26,153.61,DMSO,C5H11NO2 HCl,C[N+](C)(C)CC(=O)O.[Cl-],insoluble in EtOH; ≥20.15 mg/mL in H2O; ≥4.5 mg/mL in DMSO,Hydrochloride,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1700N1704,Yohimbine Hydrochloride,65-19-0,A07,L1021-26,390.9,DMSO,C21H26N2O3·HCl,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl,insoluble in EtOH; insoluble in H2O; ≥8.9 mg/mL in DMSO,,Natural Products,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=N1704N1707,Coumarin,91-64-5,A08,L1021-26,146.14,DMSO,C9H6O2,C1=CC=C2C(=C1)C=CC(=O)O2,insoluble in H2O; ≥5.75 mg/mL in DMSO; ≥8.2 mg/mL in EtOH,Free Base,Natural Products,Immunology & Inflammation related,Precursor in chemical reaction,https://www.apexbt.com/search.php?catalog=N1707N1708,Stevioside,57817-89-7,A09,L1021-26,804.88,DMSO,C38H60O18,CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O,≥80.5 mg/mL in DMSO; insoluble in H2O; ≥4.42 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1708N1709,Betaine,107-43-7,A10,L1021-26,117.15,DMSO,C5H11NO2,C[N+](C)(C)CC(=O)[O-],≥27 mg/mL in H2O; ≥3.6 mg/mL in DMSO with gentle warming; ≥57.4 mg/mL in EtOH,Free Base,Natural Products,Others,PCR Reagent,https://www.apexbt.com/search.php?catalog=N1709N1710,Gastrodin,62499-27-8,A11,L1021-26,286.28,DMSO,C13H18O7,C1=CC(=CC=C1CO)OC2C(C(C(C(O2)CO)O)O)O,≥12.9 mg/mL in DMSO; ≥18.5 mg/mL in H2O; ≥18.67 mg/mL in EtOH with ultrasonic,,Natural Products,Immunology & Inflammation related,,https://www.apexbt.com/search.php?catalog=N1710N1711,Silymarin,22888-70-6,B01,L1021-26,482.44,DMSO,C25H22O10,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL in DMSO,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1711N1713,Dihydroartemisinin,71939-50-9,B02,L1021-26,284.35,DMSO,C15H24O5,[H][[C@H@]1(C([H])([H])C2([H])[H])[[C@H]3([[C@H@]([[C@H@]4([H])C([H])([H])[H])([H])C([H])([H])C([H])([H])[[C@H@]1([H])C([H])([H])[H])OO[[C@H@]2(C([H])([H])[H])O[[C@H@]3([H])O[[C@H@]4([H])O[H],insoluble in H2O; ≥14.05 mg/mL in DMSO; ≥4.53 mg/mL in EtOH with ultrasonic,,Microbiology & Virology,Antimalaria,,https://www.apexbt.com/search.php?catalog=N1713N1714,Arbutin,497-76-7,B03,L1021-26,272.25,DMSO,C12H16O7,C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,≥13.7 mg/mL in DMSO; ≥18.7 mg/mL in H2O; ≥8.3 mg/mL in EtOH with ultrasonic,Free Base,Natural Products,Tyrosinase,,https://www.apexbt.com/search.php?catalog=N1714N1719,Kaempferol,520-18-3,B04,L1021-26,286.24,DMSO,C15H10O6,C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,insoluble in H2O; insoluble in EtOH; ≥12.25 mg/mL in DMSO,,Apoptosis,Apoptosis Inducers,,https://www.apexbt.com/search.php?catalog=N1719N1722,Sinomenine,115-53-7,B05,L1021-26,329.39,DMSO,C19H23NO4,O=C1C([H])([H])[[C@H@]2(C(C(O[H])=C3OC([H])([H])[H])=C(C([H])=C3[H])C4([H])[H])[[C@H@](C([H])=C1OC([H])([H])[H])([H])[[C@H@]4([H])N(C([H])([H])[H])C([H])([H])C2([H])[H],≥14.2 mg/mL in DMSO; ≥18.53 mg/mL in H2O; ≥2.76 mg/mL in EtOH with gentle warming and ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1722N1723,Dioscin,19057-60-4,B06,L1021-26,869.05,DMSO,C45H72O16,CC1CCC2(OC1)OC3CC4C5CC=C6CC(CCC6(C)C5CCC4(C)C3C2C)OC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7OC9OC(C)C(O)C(O)C9O,≥35.55 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,Natural Products,Others,Natural saponin with anti-tumor activities,https://www.apexbt.com/search.php?catalog=N1723N1725,Xylitol,87-99-0,B07,L1021-26,152.15,DMSO,C5H12O5,C(C(C(C(CO)O)O)O)O,insoluble in EtOH; ≥18.87 mg/mL in H2O; ≥6.6 mg/mL in DMSO,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1725N1729,Sodium Aescinate,20977-05-3,B08,L1021-26,1131.26,DMSO,C55H86O24,O[[C@H]1[[C@H](O[[C@H]2[[C@H](O)[[C@@H](O)[[C@H](O)[[C@@H](CO)O2)[[C@@H](C(O)=O)O[[C@@H](OC3CCC(C(CC=C4[[C@H@]5(C)C[[C@@H](O)C6(CO)C4CC(C)(C)C(OC(/C(C)=C([H])/C)=O)[[C@@H]6OC(C)=O)C5(C)CC7)(C)C7[[C@H]3(CO)C)[[C@@H]1O[[C@@H]8[[C@H](O)[[C@@H](O)[[C@H](O)[[C@@H](CO)O8,≥115.3 mg/mL in DMSO; insoluble in EtOH; ≥11.48 mg/mL in H2O with ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1729N1735,Caffeic acid,331-39-5,B09,L1021-26,180.15,DMSO,C9H8O4,C1=CC(=C(C=C1C=CC(=O)O)O)O,insoluble in H2O; ≥13.18 mg/mL in EtOH; ≥8 mg/mL in DMSO,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1735N1738,Cytisine,485-35-8,B10,L1021-26,190.24,DMSO,C11H14N2O,O=C1N(C2=C([H])C([H])=C1[H])C([H])([H])[[C@H@]3([H])C([H])([H])[[C@H]2([H])C([H])([H])N([H])C3([H])[H],≥27.3 mg/mL in H2O; ≥27.5 mg/mL in EtOH; ≥7.3 mg/mL in DMSO,Free Base,Natural Products,AChR,,https://www.apexbt.com/search.php?catalog=N1738N1753,Scutellarin,27740-01-8,B11,L1021-26,462.37,DMSO,C21H18O12,C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O)O,≥46.2 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1753N1764,"6,7-Dihydroxycoumarin",305-01-1,C01,L1021-26,178.14,DMSO,C9H6O4,C1=CC(=O)OC2=CC(=C(C=C21)O)O,insoluble in H2O; insoluble in EtOH; ≥7.8 mg/mL in DMSO,,Natural Products,Lipoxygenase,,https://www.apexbt.com/search.php?catalog=N1764N1766,Esculin,531-75-9,C02,L1021-26,340.28,DMSO,C15H16O9·xH2O,OC1=C(C=C(C=C2)C(OC2=O)=C1)OC3C(O)C(O)C(O)C(CO)O3,insoluble in EtOH; insoluble in H2O; ≥36.9 mg/mL in DMSO,#N/A,Natural Products,,,https://www.apexbt.com/search.php?catalog=N1766N1768,Rosmarinic acid,20283-92-5,C03,L1021-26,360.33,DMSO,C18H16O8,C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,≥100.8 mg/mL in DMSO; ≥111.2 mg/mL in EtOH; ≥22.84 mg/mL in H2O with gentle warming,,Natural Products,I_B/IKK,Anti-inflammatory and antimicrobial reagent,https://www.apexbt.com/search.php?catalog=N1768N1769,Chlorogenic acid,327-97-9,C04,L1021-26,354.31,DMSO,C16H18O9,O=C(O)[[C@H]1(C[[C@H]([[C@@H]([[C@@H](C1)O)O)OC(/C=C/C2=CC=C(C(O)=C2)O)=O)O,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥18.77 mg/mL in EtOH,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1769N1778,Baicalin,21967-41-9,C05,L1021-26,446.37,DMSO,C21H18O11,C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O,≥21.8 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,GABA Receptor,,https://www.apexbt.com/search.php?catalog=N1778N1783,Polydatin,27208-80-6,C06,L1021-26,390.39,DMSO,C20H22O8,OC1=CC(/C=C/C2=CC=C(O)C=C2)=CC(OC3[[C@H](O)[[C@@H](O)[[C@H](O)[[C@@H](CO)O3)=C1,insoluble in EtOH; insoluble in H2O; ≥16.45 mg/mL in DMSO,Free Base,Natural Products,Phospholipase (e.g. PLA),,https://www.apexbt.com/search.php?catalog=N1783N1789,Salidroside,10338-51-9,C07,L1021-26,300.3,DMSO,C14H20O7,C1=CC(=CC=C1CCOC2C(C(C(C(O2)CO)O)O)O)O,≥30 mg/mL in DMSO; insoluble in H2O; ≥52.7 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1789N1790,Podophyllotoxin,518-28-5,C08,L1021-26,414.41,DMSO,C22H22O8,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,≥166.67 mg/mL in DMSO; insoluble in H2O; ≥11.58 mg/mL in EtOH,,DNA Damage/DNA Repair,Topoisomerase,,https://www.apexbt.com/search.php?catalog=N1790N1792,Glycyrrhizic acid,1405-86-3,C09,L1021-26,822.94,DMSO,C42H62O16,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,≥36.55 mg/mL in DMSO; insoluble in H2O; ≥82.4 mg/mL in EtOH with gentle warming,,Natural Products,"Dehydrogenase,MAO,High-mobility Group",,https://www.apexbt.com/search.php?catalog=N1792N1796,Coenzyme Q10,303-98-0,C10,L1021-26,863.34,DMSO,C59H90O4,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,≥21.18 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,Endogenous Metabolite; Reactive Oxygen Species,,https://www.apexbt.com/search.php?catalog=N1796N1798,Tetrandrine,518-34-3,C11,L1021-26,622.76,DMSO,C38H42N2O6,CN1CCC2=CC(OC)=C(OC)C(OC3=C(OC)C=C4C([[C@H]5N(C)CC4)=C3)=C2[[C@@H]1CC6=CC=C(OC)C(OC7=CC=C(C5)C=C7)=C6,insoluble in EtOH; insoluble in H2O; ≥14.75 mg/mL in DMSO,,Natural Products,Calcium Channel,,https://www.apexbt.com/search.php?catalog=N1798N1804,Sodium Danshensu,67920-52-9,D01,L1021-26,220.16,DMSO,C9H9NaO5,OC(C([O-])=O)CC1=CC(O)=C(O)C=C1.[Na+],insoluble in DMSO; insoluble in EtOH; ≥22.1 mg/mL in H2O with gentle warming,,Natural Products,P450 (e.g. CYP17),,https://www.apexbt.com/search.php?catalog=N1804N1806,Salvianolic acid B,121521-90-2,D02,L1021-26,718.59,DMSO,C36H30O16,C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C3C(C(OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O,≥71.9 mg/mL in EtOH; ≥13.38 mg/mL in H2O; ≥13.75 mg/mL in DMSO,#N/A,Natural Products,Sirtuin,,https://www.apexbt.com/search.php?catalog=N1806N1807,Daidzin,552-66-9,D03,L1021-26,416.37,DMSO,C21H20O9,OC1C(OC(OC2=CC(OC=C(C(C=C3)=CC=C3O)C4=O)=C4C=C2)C(O)C1O)CO,insoluble in H2O; insoluble in EtOH; ≥41.4 mg/mL in DMSO,#N/A,Natural Products,,"Anti-oxidant,anti-carcinogenic reagent",https://www.apexbt.com/search.php?catalog=N1807N1809,Hesperidin,520-26-3,D04,L1021-26,610.56,DMSO,C28H34O15,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,insoluble in H2O; insoluble in EtOH; ≥72.67 mg/mL in DMSO with ultrasonic,,Natural Products,Others,Flavonoids from citrus species,https://www.apexbt.com/search.php?catalog=N1809N1823,Ursolic acid,77-52-1,D05,L1021-26,456.68,DMSO,C30H48O3,CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)O,≥21.55 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1823N1825,Osthole,484-12-8,D06,L1021-26,244.29,DMSO,C15H16O3,CC(=CCC1=C(C=CC2=C1OC(=O)C=C2)OC)C,insoluble in H2O; ≥10.3 mg/mL in DMSO; ≥11.2 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1825N1826,Oleanolic acid,508-02-1,D07,L1021-26,456.71,DMSO,C30H48O3,CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)O)C,insoluble in H2O; insoluble in EtOH; ≥11.075 mg/mL in DMSO,,Natural Products,Anti-infection,,https://www.apexbt.com/search.php?catalog=N1826N1827,Artemisinine,63968-64-9,D08,L1021-26,282.33,DMSO,C15H22O5,O=C1O[[C@H]2([H])OC3(C([H])([H])[H])OO[[C@H]42[[C@H](C([H])([H])C3([H])[H])([H])[[C@H@](C([H])([H])[H])([H])C([H])([H])C([H])([H])[[C@H@]4([H])[[C@H@]1([H])C([H])([H])[H],insoluble in EtOH; insoluble in H2O; ≥13.7 mg/mL in DMSO,Free Base,Natural Products,Anti-infection,,https://www.apexbt.com/search.php?catalog=N1827N1828,Apigenin,520-36-5,D09,L1021-26,270.24,DMSO,C15H10O5,C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O,insoluble in EtOH; insoluble in H2O; ≥9.8 mg/mL in DMSO ,,Natural Products,P450 (e.g. CYP17),,https://www.apexbt.com/search.php?catalog=N1828N1830,Gallic acid,149-91-7,D10,L1021-26,170.12,DMSO,C7H6O5,C1=C(C=C(C(=C1O)O)O)C(=O)O,insoluble in H2O; ≥5.95 mg/mL in DMSO; ≥8 mg/mL in EtOH,,Natural Products,ROS,,https://www.apexbt.com/search.php?catalog=N1830N1831,Luteolin,491-70-3,D11,L1021-26,286.24,DMSO,C15H10O6,C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O,insoluble in H2O; ≥2.83 mg/mL in EtOH with ultrasonic; ≥27.5 mg/mL in DMSO,#N/A,Immunology/Inflammation,I_B/IKK,Antioxidant and free radical scavenger,https://www.apexbt.com/search.php?catalog=N1831N1833,Rutin,153-18-4,E01,L1021-26,610.51,DMSO,C27H30O16,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,≥29.65 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,maleate,Natural Products,Immunology & Inflammation related,,https://www.apexbt.com/search.php?catalog=N1833N1835,Oxymatrine,16837-52-8,E02,L1021-26,264.36,DMSO,C15H24N2O2,[O-][N+]12[[C@H]3([H])[[C@H@](C([H])([H])C([H])([H])C2([H])[H])([H])[[C@H](C([H])([H])C([H])([H])C([H])([H])C4=O)([H])N4C([H])([H])[[C@H]3([H])C([H])([H])C([H])([H])C1([H])[H],≥11.68 mg/mL in H2O; ≥8.3 mg/mL in EtOH; ≥9.55 mg/mL in DMSO,#N/A,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1835N1837,Amygdalin,29883-15-6,E03,L1021-26,457.42,DMSO,C20H27NO11,C1=CC=C(C=C1)C(C#N)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O,≥22.35 mg/mL in DMSO; insoluble in EtOH; ≥15.4 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1837N1838,Hyperoside,482-36-0,E04,L1021-26,464.38,DMSO,C21H20O12,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,≥46.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1838N1840,Quercitrin,522-12-3,E05,L1021-26,448.38,DMSO,C21H20O11,CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O,≥44.8 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,Immunology & Inflammation related,,https://www.apexbt.com/search.php?catalog=N1840N1841,Quercetin,117-39-5,E06,L1021-26,302.24,DMSO,C15H10O7,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,insoluble in H2O; ≥15.1 mg/mL in DMSO; ≥3.28 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,PI3K,Antitumor agent,https://www.apexbt.com/search.php?catalog=N1841N1842,Taxifolin,480-18-2,E07,L1021-26,304.25,DMSO,C15H12O7,C1=CC(=C(C=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥16.9 mg/mL in EtOH,,Natural Products,VEGFR,,https://www.apexbt.com/search.php?catalog=N1842N1845,Tanshinone I,568-73-0,E08,L1021-26,276.29,DMSO,C18H12O3,CC1=CC=CC2=C1C=CC3=C2C(=O)C(=O)C4=C3OC=C4C,≥27.6 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,Phospholipase (e.g. PLA),,https://www.apexbt.com/search.php?catalog=N1845N1846,Tanshinone IIA,568-72-9,E09,L1021-26,294.34,DMSO,C19H18O3,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL in DMSO,,Immunology/Inflammation,I_B/IKK,,https://www.apexbt.com/search.php?catalog=N1846N1847,Paeonol,552-41-0,E10,L1021-26,166.18,DMSO,C9H10O3,CC(=O)C1=C(C=C(C=C1)OC)O,insoluble in H2O; ≥15.47 mg/mL in EtOH; ≥5.75 mg/mL in DMSO,#N/A,Natural Products,MAO,MAO inhibitor;multi-functional phenolic compound,https://www.apexbt.com/search.php?catalog=N1847N1855,Andrographolide,5508-58-7,E11,L1021-26,350.44,DMSO,C20H30O5,CC12CCC(C(C1CCC(=C)C2CC=C3C(COC3=O)O)(C)CO)O,insoluble in EtOH; insoluble in H2O; ≥16 mg/mL in DMSO,,Immunology/Inflammation,I_B/IKK,,https://www.apexbt.com/search.php?catalog=N1855N1856,Hesperitin,520-33-2,F01,L1021-26,302.29,DMSO,C16H14O6,COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O,insoluble in H2O; ≥15.1 mg/mL in DMSO; ≥2.44 mg/mL in EtOH with gentle warming and ultrasonic,#N/A,Natural Products,"TGF-beta/Smad,Histamine Receptor",,https://www.apexbt.com/search.php?catalog=N1856N1858,Baicalein,491-67-8,F02,L1021-26,270.24,DMSO,C15H10O5,C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O)O)O,insoluble in H2O; ≥10.9 mg/mL in DMSO; ≥2.61 mg/mL in EtOH with ultrasonic,,Natural Products,P450 (e.g. CYP17),,https://www.apexbt.com/search.php?catalog=N1858N1862,Daidzein,486-66-8,F03,L1021-26,254.24,DMSO,C15H10O4,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O,insoluble in EtOH; insoluble in H2O; ≥11.6 mg/mL in DMSO,Free Base,Natural Products,Others,Anti-cancer reagent,https://www.apexbt.com/search.php?catalog=N1862N1867,Reserpine,50-55-5,F04,L1021-26,608.27,DMSO,C33H40N2O9,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,insoluble in H2O; insoluble in EtOH; ≥13 mg/mL in DMSO with gentle warming,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1867N1875,DL-Menthol,89-78-1,F05,L1021-26,156.15,DMSO,C10H20O,CC1CCC(C(C1)O)C(C)C,insoluble in H2O; ≥15.6 mg/mL in DMSO; ≥31.35 mg/mL in EtOH,#N/A,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1875N1876,Phloridzin,60-81-1,F06,L1021-26,436.41,DMSO,C21H24O10,C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2OC3C(C(C(C(O3)CO)O)O)O)O)O)O,≥25.75 mg/mL in DMSO; insoluble in H2O; ≥16.23 mg/mL in EtOH with ultrasonic,Free Base,Natural Products,SGLT,,https://www.apexbt.com/search.php?catalog=N1876N1877,Cinnamic acid,140-10-3,F07,L1021-26,148.17,DMSO,C9H8O2,C1=CC=C(C=C1)C=CC(=O)O,insoluble in H2O; ≥21.7 mg/mL in EtOH; ≥7.25 mg/mL in DMSO,Free Base,Natural Products,Others,Unsaturated carboxylic acid,https://www.apexbt.com/search.php?catalog=N1877N1878,Fumalic acid,1135-24-6,F08,L1021-26,194.18,DMSO,C10H10O4,COC1=C(C=CC(=C1)C=CC(=O)O)O,insoluble in H2O; ≥5.31 mg/mL in EtOH; ≥9.45 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1878N1880,D-(-)-Salicin,138-52-3,F09,L1021-26,286.28,DMSO,C13H18O7,C1=CC=C(C(=C1)CO)OC2C(C(C(C(O2)CO)O)O)O,insoluble in EtOH; ≥10.4 mg/mL in H2O; ≥14 mg/mL in DMSO,,Natural Products,COX,,https://www.apexbt.com/search.php?catalog=N1880N1885,Saikosaponin A,20736-09-8,F10,L1021-26,780.99,DMSO,C42H68O13,CC1OC(OC2CCC3(C)C(CCC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C2(C)CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C1O,≥39.05 mg/mL in EtOH; insoluble in H2O; ≥9.6 mg/mL in DMSO,,Natural Products,NF-_B,,https://www.apexbt.com/search.php?catalog=N1885N1900,Ginkgolide A,15291-75-5,F11,L1021-26,408.4,DMSO,C20H24O9,O[[C@H@]1([[C@H]2(O[[C@H]3OC4=O)[[C@H]5([[C@H]3([[C@H](C[[C@H]5OC2=O)C(C)(C)C)[[C@H]4O)C[[C@H]1OC6=O)[[C@H]6C,insoluble in H2O; ≥20.42 mg/mL in DMSO; ≥5.02 mg/mL in EtOH with ultrasonic,Free Base,Natural Products,GABA Receptor,,https://www.apexbt.com/search.php?catalog=N1900N1901,Z-Ligustilide,4431-01-0,G01,L1021-26,190.24,DMSO,C12H14O2,O=C1O/C(C2=C1C=CCC2)=C\CCC,insoluble in H2O; ≥16.45 mg/mL in DMSO; ≥42 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1901N1904,Rhynchophylline,76-66-4,G02,L1021-26,384.46,DMSO,C22H28N2O4,CCC1CN2CCC3(C2CC1C(=COC)C(=O)OC)C4=CC=CC=C4NC3=O,≥38.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,potassium voltage-gated channel subfamily H member 2 ,,https://www.apexbt.com/search.php?catalog=N1904N1908,Ginkgolide C,15291-76-6,G03,L1021-26,440.4,DMSO,C20H24O11,O=C1OC2([H])C(C(C(C3([H])OC4=O)(C4([H])C([H])([H])[H])O[H])1OC5([H])OC6=O)(C3([H])O[H])C5(C6([H])O[H])C(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])([H])C2([H])O[H],≥44 mg/mL in DMSO; insoluble in H2O; ≥12.17 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1908N1935,L-Carnitine inner salt,541-15-1,G04,L1021-26,161.2,DMSO,C7H15NO3,C[N+](C)(C)CC(CC(=O)[O-])O,insoluble in EtOH; ≥53.2 mg/mL in H2O; ≥7.6 mg/mL in DMSO,Free Base,Natural Products,Others,Quaternary amine found in mammalian tissue,https://www.apexbt.com/search.php?catalog=N1935N1940,Tanshinone IIA---sulfonic sodium,69659-80-9,G05,L1021-26,396.39,DMSO,C19H17NaO6S,O=S(C1=C(C(C2=O)=C(O1)C(C=CC3=C4CCCC3(C)C)=C4C2=O)C)([O-])=O.[Na+],≥39.6 mg/mL in DMSO; insoluble in EtOH; ≥2.09 mg/mL in H2O with ultrasonic,,Natural Products,CaMK,,https://www.apexbt.com/search.php?catalog=N1940N1941,Butane diacid,110-15-6,G06,L1021-26,118.09,DMSO,C4H6O4,C(CC(=O)O)C(=O)O,insoluble in EtOH; ≥10.2 mg/mL in H2O with ultrasonic; ≥11.8 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1941N1949,Panaxtriol,32791-84-7,G07,L1021-26,476.39,DMSO,C30H52O4,CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CC(C5C4(CCC(C5(C)C)O)C)O)C)O)C)C,≥23.8 mg/mL in DMSO with ultrasonic; insoluble in H2O; ≥25.1 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N1949N2032,Aristolochic Acid A,313-67-7,G08,L1021-26,341.27,DMSO,C17H11NO7,COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O,insoluble in EtOH; insoluble in H2O; ≥17.05 mg/mL in DMSO with gentle warming and ultrasonic,,Natural Products,,,https://www.apexbt.com/search.php?catalog=N2032N2075,Folic acid,59-30-3,G09,L1021-26,441.4,DMSO,C19H19N7O6,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,insoluble in EtOH; insoluble in H2O; ≥18 mg/mL in DMSO with gentle warming,Free Base,Natural Products,Vitamin,,https://www.apexbt.com/search.php?catalog=N2075N2076,Berberine Sulfate,633-66-9,G10,L1021-26,433.43,DMSO,C20H19NO8S,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.OS(=O)(=O)[O-],≥21.65 mg/mL in DMSO; ≥27.85 mg/mL in H2O; ≥3.36 mg/mL in EtOH with gentle warming,,Natural Products,Anti-infection,,https://www.apexbt.com/search.php?catalog=N2076N2085,L-Theanine,3081-61-6,G11,L1021-26,174.2,H2O,C7H14N2O3,CCNC(=O)CCC(C(=O)O)N,insoluble in EtOH; insoluble in DMSO; ≥9.74 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2085N2091,(+)- Corydaline,518-69-4,H01,L1021-26,369.44,DMSO,C22H27NO4,CC1C2C3=CC(=C(C=C3CCN2CC4=C1C=CC(=C4OC)OC)OC)OC,insoluble in H2O; insoluble in EtOH; ≥18.13 mg/mL in DMSO with ultrasonic,#N/A,Natural Products,Others,"Corydaline, an isoquinoline alkaloid, is one of the major active constituents in a new prokinetic botanical agent. 

Corydaline promotes gastric emptying and small intestinal transit and facilitates gastric accommodation.

Corydaline exhibits the anti-acetylcholinesterase, antiallergic, and antinociceptive activities.

Corydaline has potent inhibition of CYP2C19 and CYP2C9.",https://www.apexbt.com/search.php?catalog=N2091N2095,Trans-Anethole,4180-23-8,H02,L1021-26,148.2,DMSO,C10H12O,COC1=CC=C(C=C1)/C=C/C,≥29.1 mg/mL in DMSO; ≥27.6 mg/mL in EtOH; insoluble in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2095N2117,3-n-Butylphathlide,6066-49-5,H03,L1021-26,190.24,DMSO,C12H14O2,O=C1OC(CCCC)C2=CC=CC=C21,≥15.15 mg/mL in H2O; ≥19 mg/mL in DMSO; ≥77.1 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2117N2131,Wedelolactone,524-12-9,H04,L1021-26,314.25,DMSO,C16H10O7,COC1=CC(=C2C(=C1)OC(=O)C3=C2OC4=CC(=C(C=C43)O)O)O,insoluble in EtOH; insoluble in H2O; ≥44.4 mg/mL in DMSO,,Immunology/Inflammation,I_B/IKK,,https://www.apexbt.com/search.php?catalog=N2131N2134,Acetate gossypol,12542-36-8,H05,L1021-26,578.61,DMSO,C32H34O10,OC(C(C(C=O)=C1O)=C2C(C(C)C)=C1O)=[[C@H@](C(C)=C2)[[C@H@](C(C)=C3)=C(C(C3=C4C(C)C)=C(C=O)C(O)=C4O)O.OC(C)=O,insoluble in H2O; ≥12.54 mg/mL in EtOH; ≥46.5 mg/mL in DMSO,#N/A,Natural Products,,,https://www.apexbt.com/search.php?catalog=N2134N2135,Gossypol,303-45-7,H06,L1021-26,518.55,DMSO,C30H30O8,CC1=C(C(=C2C(=C1)C(=C(C(=C2C=O)O)O)C(C)C)O)C3=C(C=C4C(=C3O)C(=C(C(=C4C(C)C)O)O)C=O)C,≥25.95 mg/mL in DMSO; insoluble in H2O; ≥2.1 mg/mL in EtOH,#N/A,Apoptosis,Bcl-2 Family,PAF inhibitor;anti-fertility and anti-cancer,https://www.apexbt.com/search.php?catalog=N2135N2159,Eupatilin,22368-21-4,H07,L1021-26,344.32,DMSO,C18H16O7,COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O)OC)O)OC,≥34.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,#N/A,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2159N2182,Harmine hydrochloride,343-27-1,H08,L1021-26,248.71,DMSO,C13H13ClN2O,CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC.Cl,≥24.9 mg/mL in DMSO with gentle warming and ultrasonic; insoluble in EtOH; ≥2.53 mg/mL in H2O with gentle warming and ultrasonic,,Natural Products,DYRK,,https://www.apexbt.com/search.php?catalog=N2182N2189,Sinomenine Hydrochloride,6080-33-7,H09,L1021-26,365.85,DMSO,C19H24ClNO4,CN1CCC23CC(=O)C(=CC2C1CC4=C3C(=C(C=C4)OC)O)OC.Cl,insoluble in EtOH; ≥13.26 mg/mL in H2O; ≥14.7 mg/mL in DMSO,,Natural Products,"Immunology & Inflammation related,Autophagy",,https://www.apexbt.com/search.php?catalog=N2189N2203,Fargesin,31008-19-2,H10,L1021-26,370.4,DMSO,C21H22O6,COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)OC,≥37 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2203N2250,Vinorelbine,71486-22-1,H11,L1021-26,778.93,DMSO,C45H54N4O8,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,≥25.9 mg/mL in DMSO; insoluble in H2O; ≥11.2 mg/mL in EtOH,Free Base,Natural Products,Microtubule Associated,,https://www.apexbt.com/search.php?catalog=N2250N2256,vinblastine,865-21-4,A01,L1021-27,810.97,DMSO,C46H58N4O9,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,≥37.4 mg/mL in DMSO; insoluble in EtOH; ≥5.36 mg/mL in H2O with ultrasonic,Free Base,Natural Products,"Microtubule Associated,AChR",,https://www.apexbt.com/search.php?catalog=N2256N2258,Lannaconitine,32854-75-4,B01,L1021-27,584.64,DMSO,C32H44N2O8,CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5(C6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C,≥58.5 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥2.65 mg/mL in EtOH with gentle warming,,Natural Products,Sodium Channel,,https://www.apexbt.com/search.php?catalog=N2258N2275,Protopine,130-86-9,C01,L1021-27,353.37,DMSO,C20H19O5,CN1CCC2=CC3=C(C=C2C(=O)CC4=C(C1)C5=C(C=C4)OCO5)OCO3,insoluble in EtOH; insoluble in H2O; ≥17.65 mg/mL in DMSO with ultrasonic,,Natural Products,Calcium Channel,,https://www.apexbt.com/search.php?catalog=N2275N2282,Umbelliferone,93-35-6,D01,L1021-27,162.14,DMSO,C9H6O3,C1=CC(=CC2=C1C=CC(=O)O2)O,insoluble in H2O; insoluble in EtOH; ≥7.55 mg/mL in DMSO ,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2282N2301,Allantoin,97-59-6,E01,L1021-27,158.12,DMSO,C4H6O3N4,C1(C(=O)NC(=O)N1)NC(=O)N,insoluble in H2O; insoluble in EtOH; ≥11.56 mg/mL in DMSO with ultrasonic,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2301N2307,D-Pinitol,10284-63-6,F01,L1021-27,194.18,DMSO,C7H14O6,COC1C(C(C(C(C1O)O)O)O)O,insoluble in EtOH; ≥35.4 mg/mL in H2O; ≥59.9 mg/mL in DMSO,#N/A,Natural Products,Others,"D-pinitol is a naturally occurring compound derived from soy and has significant pharmacological activitites such as inhibition of the T-helpercell-1 response, antiviral, larvicidal, antiinflammatory, antihyperlipidemic, cardioprotective, inhibition of ovalbumin-induced airway inflammation and antioxidant.",https://www.apexbt.com/search.php?catalog=N2307N2309,Eriodictyol,552-58-9,G01,L1021-27,288.25,DMSO,C15H12O6,C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC(=C(C=C3)O)O,≥28.8 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2309N2324,Curculigoside,85643-19-2,H01,L1021-27,466.44,DMSO,C22H26O11,COC1=C(C(=CC=C1)OC)C(=O)OCC2=C(C=CC(=C2)O)OC3C(C(C(C(O3)CO)O)O)O,≥23.3 mg/mL in EtOH with ultrasonic; insoluble in H2O; ≥132.2 mg/mL in DMSO,,Natural Products,Immunology & Inflammation related,,https://www.apexbt.com/search.php?catalog=N2324N2334,Dehydrocostus Lactone,477-43-0,A02,L1021-27,230.3,DMSO,C15H18O2,C=C1CCC2C(C3C1CCC3=C)OC(=O)C2=C,insoluble in EtOH; insoluble in H2O; ≥7.85 mg/mL in DMSO ,,Natural Products,I_B/IKK,,https://www.apexbt.com/search.php?catalog=N2334N2337,Gramine,87-52-5,B02,L1021-27,174.24,DMSO,C11H14N2,CN(C)CC1=CNC2=CC=CC=C21,insoluble in H2O; ≥17.4 mg/mL in DMSO; ≥4.41 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2337N2355,Madecassic acid,18449-41-7,C02,L1021-27,504.7,DMSO,C30H48O6,CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)O,≥22.9 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2355N2371,Naringin,10236-47-2,D02,L1021-27,580.53,DMSO,C27H32O14,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O,≥24.55 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,#N/A,Natural Products,P450 (e.g. CYP17),,https://www.apexbt.com/search.php?catalog=N2371N2408,Genipin,6902-77-8,E02,L1021-27,226.23,DMSO,C11H14O5,COC(=O)C1=COC(C2C1CC=C2CO)O,≥101.6 mg/mL in EtOH; ≥5.97 mg/mL in H2O; ≥9.8 mg/mL in DMSO,Free Base,Natural Products,Others,used to treat symptoms of type 2 diabetes,https://www.apexbt.com/search.php?catalog=N2408N2418,Linalool,78-70-6,F02,L1021-27,154.25,DMSO,C10H18O,CC(=CCCC(C)(C=C)O)C,insoluble in H2O; ≥37.2 mg/mL in EtOH; ≥57.2 mg/mL in DMSO,,Natural Products,NMDAR,,https://www.apexbt.com/search.php?catalog=N2418N2456,Palmitic acid,57-10-3,G02,L1021-27,256.42,DMSO,C16H32O2,CCCCCCCCCCCCCCCC(=O)O,insoluble in H2O; ≥47.9 mg/mL in EtOH with ultrasonic; ≥8.95 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2456N2466,"3,4-Dihydroxybenzoic acid",99-50-3,H02,L1021-27,154.03,DMSO,C7H6O4,C1=CC(=C(C=C1C(=O)O)O)O,≥4.62 mg/mL in H2O with ultrasonic; ≥4.9 mg/mL in DMSO; ≥49.2 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2466N2471,Berbamine hydrochloride,6078-17-7,A03,L1021-27,681.65,DMSO,C37H42Cl2N2O6,COC1=CC2=C(C(OC3=CC([[C@H@](CC4=CC=C5C=C4)([H])N(C)CC6)=C6C=C3OC)=C1OC)[[C@H](CC7=CC=C(O)C(O5)=C7)([H])N(C)CC2.Cl.Cl,≥68 mg/mL in DMSO; ≥10.68 mg/mL in H2O; ≥4.57 mg/mL in EtOH,,Natural Products,Bcr-Abl,,https://www.apexbt.com/search.php?catalog=N2471N2473,Neosperidin dihydrochalcone,20702-77-6,B03,L1021-27,612.21,DMSO,C28H36O15,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C(C(=C3)O)C(=O)CCC4=CC(=C(C=C4)OC)O)O)CO)O)O)O)O)O,≥22.6 mg/mL in DMSO; insoluble in H2O; ≥44.7 mg/mL in EtOH,#N/A,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2473N2491,Aloin,1415-73-2,C03,L1021-27,418.13,DMSO,C21H22O9,C1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(C=C3C2C4C(C(C(C(O4)CO)O)O)O)CO)O,insoluble in H2O; ≥19.45 mg/mL in DMSO; ≥9.36 mg/mL in EtOH,#N/A,Natural Products,Tyrosinase,,https://www.apexbt.com/search.php?catalog=N2491N2505,Scopolamine butylbromide,149-64-4,D03,L1021-27,440.37,DMSO,C21H30NO4Br,O=C([[C@H](C1=CC=CC=C1)CO)O[[C@H]2C[[C@@H]3[[C@H@+](CCCC)(C)[[C@H](C2)[[C@H]4O[[C@@H]34.[Br-],insoluble in EtOH; ≥11.14 mg/mL in H2O; ≥12.5 mg/mL in DMSO,Free Base,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2505N2535,Diosimin,520-27-4,E03,L1021-27,608.17,DMSO,C28H32O15,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,≥21.6 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2535N2558,Sclareol,515-03-7,F03,L1021-27,308.29,DMSO,C20H36O2,CC1(CCCC2(C1CCC(C2CCC(C)(C=C)O)(C)O)C)C,insoluble in H2O; ≥43.4 mg/mL in DMSO; ≥59.4 mg/mL in EtOH,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2558N2570,Scopolamine hydrobromide,114-49-8,G03,L1021-27,384.26,DMSO,C17H22BrNO4,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br,insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL in DMSO,Hydrobromide,Natural Products,AChR,,https://www.apexbt.com/search.php?catalog=N2570N2577,Trigonelline Hydrochloride,6138-41-6,H03,L1021-27,173.6,DMSO,C7H8ClNO2,C[N+]1=CC=CC(=C1)C(=O)O.[Cl-],insoluble in EtOH; ≥34.45 mg/mL in H2O; ≥4.05 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2577N2591,10-Hydroxycamptothecin,64439-81-2,A04,L1021-27,364.35,DMSO,C20H16N2O5,O[[C@H@]1(CC)C2=C(COC1=O)C(N(CC3=C4N=C(C=C5)C(C=C5O)=C3)C4=C2)=O,≥36.4 mg/mL in DMSO with gentle warming and ultrasonic; insoluble in H2O; insoluble in EtOH,,Natural Products,Topoisomerase,,https://www.apexbt.com/search.php?catalog=N2591N2702,Chitosamine hydrochloride,66-84-2,B04,L1021-27,215.63,H2O,C6H13NO5·HCl,C(C(C(C(C(C=O)N)O)O)O)O.Cl,insoluble in DMSO; insoluble in EtOH; ≥43.2 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2702N2703,Nicotine,54-11-5,C04,L1021-27,162.23,DMSO,C10H14N2,CN1CCCC1C2=CN=CC=C2,≥15.4 mg/mL in EtOH; ≥22.65 mg/mL in H2O; ≥75 mg/mL in DMSO,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2703N2706,Synephrine,94-07-5,D04,L1021-27,167.21,DMSO,C9H13NO2,CNCC(C1=CC=C(C=C1)O)O,insoluble in H2O; insoluble in EtOH; ≥8.5 mg/mL in DMSO,,Natural Products,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=N2706N2730,Chondroitin sulfate,9007-28-7,E04,L1021-27,489.45,H2O,(C14H21NO14S)n,COC1OC(CO[S](O)(=O)=O)C(O)C(OC2OC(C(C)C(O)C2O)C(O)=O)C1NC(C)=O,insoluble in EtOH; insoluble in DMSO; ≥154.8 mg/mL in H2O,,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2730N2734,Glucosamine sulfate,29031-19-4,F04,L1021-27,277.25,DMSO,C6H13NO5·H2SO4,N[[C@H@]([[C@H](O)([H])[[C@H@](O)([H])[[C@H@](O)([H])CO)([H])C=O.OS(O)(=O)=O,,sulfate,Natural Products,,,https://www.apexbt.com/search.php?catalog=N2734N2758,Aucubin,479-98-1,G04,L1021-27,346.33,DMSO,C15H22O9,C1=COC(C2C1C(C=C2CO)O)OC3C(C(C(C(O3)CO)O)O)O,≥34.6 mg/mL in DMSO; insoluble in EtOH; ≥26.2 mg/mL in H2O,,Natural Products,,,https://www.apexbt.com/search.php?catalog=N2758N2771,Cepharanthine,481-49-2,H04,L1021-27,606.71,DMSO,C37H38N2O6,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,≥21.9 mg/mL in DMSO; insoluble in H2O; ≥24.6 mg/mL in EtOH,Free Base,Natural Products,TNF-_,antiperoxidant potency,https://www.apexbt.com/search.php?catalog=N2771N2788,Trigonelline,535-83-1,A05,L1021-27,137.05,H2O,C7H7NO2,C[N+]1=CC=CC(=C1)C(=O)[O-],insoluble in EtOH; ≥26 mg/mL in H2O; ≥8.5 mg/mL in DMSO with gentle warming and ultrasonic,#N/A,Natural Products,Others,,https://www.apexbt.com/search.php?catalog=N2788P10002,4-Aminobutyric acid,56-12-2,B05,L1021-27,103.12,H2O,C4H9NO2,C(CC(=O)O)CN,insoluble in EtOH; insoluble in DMSO; ≥10.3 mg/mL in H2O,,Others,APIs,,https://www.apexbt.com/search.php?catalog=P10002P10019,Prulifloxacin (Pruvel),123447-62-1,C05,L1021-27,461.46,DMSO,C21H20FN3O6S,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C,insoluble in EtOH; insoluble in H2O; ≥23.05 mg/mL in DMSO with gentle warming and ultrasonic,,Others,APIs,,https://www.apexbt.com/search.php?catalog=P10019